<SEC-DOCUMENT>0001516513-23-000036.txt : 20230526
<SEC-HEADER>0001516513-23-000036.hdr.sgml : 20230526
<ACCEPTANCE-DATETIME>20230526080634
ACCESSION NUMBER:		0001516513-23-000036
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		109
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230526
DATE AS OF CHANGE:		20230526

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Doximity, Inc.
		CENTRAL INDEX KEY:			0001516513
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		IRS NUMBER:				272485512
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40508
		FILM NUMBER:		23963122

	BUSINESS ADDRESS:	
		STREET 1:		500 THIRD STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
		BUSINESS PHONE:		(650) 549-4330

	MAIL ADDRESS:	
		STREET 1:		500 THIRD STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>docs-20230331.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:4d1277b4-10a9-4732-8720-53d63c4cfd14,g:0c268704-e9e1-4ac2-87ff-5caa0e49a51f,d:b1b51d92d3ac43179e2f8bdfac24a353--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:docs="http://www.doximity.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>docs-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18wLTEtMS0xLTE4MTc2OQ_14825969-ef68-4c44-951d-aa7072e9aa80">0001516513</ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18xLTEtMS0xLTE4MTc2OQ_54f865a6-c8b2-4419-8afe-eb31e28ca229">2023</ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18yLTEtMS0xLTE4MTc2OQ_fccd0138-8c6d-4472-a6a7-a4ae361d2c4f">FY</ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18zLTEtMS0xLTE4MTc2OQ_72e8846f-9b5c-4bb4-9fa6-a2a2aab17469">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzE3MDQyNDMwMjMzNTky_1995d277-8431-4487-a901-191b21f55f52">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzE3MDQyNDMwMjMyMTQz_3e9d7d07-1cf9-455d-9196-8ee9cf5d4f4c">http://fasb.org/us-gaap/2022#SellingAndMarketingExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="docs-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97abaadc2504001892e499621c9a22d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie515b3edc3ec46ef8e0798e729e1c42d_I20230519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i429c89ea5d0c416f85960bc2a4c84894_I20230519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73fa6205d93043c89ed98735725c4862_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2663b241eb57491e938b976279a54ef3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b796d52a1c24138acd0adc60a1d55b6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51bee6fa91384d2b859a47c7b4a2bdf1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i239eff19d97e41b9b0482aa745e705a8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac170db1b65461e92998fa288b22bb1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aec2a3cf466470d83a702d7d3b279e8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46d6f06521b34618831102060f160822_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic816ea61c72b4526baf4f08dda97575f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca3ba7268b644c385960bab4881daa4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a4a27e961b4732a69f4329e75908ce_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c7aad5f38d74f8ea3efd5af5a079c17_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3f4e1f1e9ef42a596eb67129ffa34b2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee132da446eb4ed08a23cdf121ea6b0c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ff263310c7e4813b992a8d0b1ad53cc_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0955332a233f4c018f259ff874af4f61_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i351c61ddd53e415fb0132c3f28ec7e27_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eb2e149b8ed4edea42e1794b79eead8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifccc74565273499782a3a98a62beb0f7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64036fdea8df4afda807a5cece385147_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e68429295e421e87c13df53148e23a_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713bedb0e69c494c8ed7f90198455f80_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d98fc03def4365a7f3fa504e96b220_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd694dc2e48a4412a000d9b02c10f96e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i419e8bf8b3aa40158f8de4af142458a2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i448d1c798e6544a99cf0cf2663a4894b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccdb5f0a810d4eebb2bafe0d42b2c742_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6eef4e680704bceaea439b7961166cd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i279a208c32804584b31bfd94d3dd86ac_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae932e69d134ab791bd1c42fff0771b_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iccbddb5d88f943d18b1e2bca79988299_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9c60a7a5216441aacc21b7da53bdeb8_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2e9777aeaf94d178823baaa223076df_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9cad1e062b649388bc8309807dd70ec_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia35ab93e92f745bf8d13e1856e15688d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a7a508b84f14a2c89f8f76f79912495_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMarketingSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66fbd0824ee44aa4999edf05fdba61a6_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionHiringSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id95916c6936340cdade0aa07aaf2b43c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i395392694ee54a58a68d60da43cd9346_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193acb95329a49ffa11b381f072505f0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13475fef7778429390ef0860c7b05a45_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf3ecb7779284d14862d24d80dc3241e_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bc3bbea93e64ae99dfb98af6a33b945_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0728b940a9f64fc9bf1ed1b456fbfb6a_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>docs:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i396b959629334256bafddb8623b58bbb_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8189eaf3c5a341eb905e447cbdc1e660_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad7a18fbd0c14f8ba371333c97190a67_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd6a54410372468a8511243ad114dbe9_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad31f043cf54368a2e28a707d138b65_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c10798df81841449d5dbfb26d76969d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6779a54192f451097a27ad596eba040_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie833f8b08d684b3bb2c16e4a4497f123_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i201f487ed07e45f08dc9cea2b1958064_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9331d77b340451ca2423fed1eb629d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia473d08e40b3424da33538edeca5a18a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e08c2c5bc6c4949a1de1927437917b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7961eb9eb71b4575b98a42d5964377ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06de78b66e74d5080cb4950adc00e7e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i946014a5671d4e999aa1c822257039c4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfbd7fea093845f382923f9f0125016c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e31cc3adeec45e18d64bd94c7d49110_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0010efa975ea4d45a2dbde4069444622_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2da9dd48330643cea24f08da15d08f08_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a55bf9be127468b8145b679c3cf838e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3fd684df0de4636aa6962e405af5eea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e3f89117d4a4f85908606a734310a23_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id941a7f003394c1fb37f82255dbe3a41_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie594ea2a3b124a90b0be930db8daf27e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6537334aae64a1692c21c4e30957279_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973077bac51d46c88beba9ea2d79c88b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffc1194235564259b4e5b6767a113b31_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c8099fd0c864406be81e7c53be8b1d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80bd4f5f67e2484cb7851cf004cdfad5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36192b7a614641d2838f423484ca11ba_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1239324fd29a4d1993d7b6b495489a13_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66936efbaed5446aa82b9ca004d420ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec0fbdefb9f344138749e5e674d592cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6c235234c42491f8e4131aaefe2d585_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98667fb3a0514e69a891a6c081d597f0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094e2dbabb8e4569979ac9d1ad7c84d9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0963b486b6ee4c8e9ddec603fe52aa57_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6e57af6f2b4495abe15bf65ff24f3e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b3c5e95b7974760b927c85be52fe69e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58e4533ec3b849e492c02f5e01cd9d6a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e67dedfef14071b24d1b252a8bbef3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1801570f9a834b549ef10690ad07160d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcf35ce1750d4d47b705f6c8963f102c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib56e571af58f495b8ff9277d066ea6b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied4d9be5d4554ad18ecaefd25a72b9a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id00a28ee4e38426aa959a32377ae4867_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ce81717c598448da1d06f768af2f4ba_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0b8ad77a8b54ef28439d747d79868d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifae67aa06b9f4fdd9689aa90c7f5dc18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id70c3b9155fa4014bd5667ee3349735b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98636d2454d045d09a3f9d68e1038e6d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9831b78d3b4c462b8337fda154bdd3ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if458aec6fca44eddbd86df4028e655b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b84df18f95a4433bdee213a281e943c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea633cae78847bd9a91472bbef8eaeb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bde8858ac6a4a3eb52f9c270d702920_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2286649f7330456ea7cbe19b6772994e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff5a0797ef9423a9741628a3da70909_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47804551dcb6422893826946bddd57c2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05928ff03824eacb3dec61c64f97f64_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib75f9bcdbb0d429ea39c456129fe42b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f27c894e80643b7bb1023a488f98851_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a9950d0144847e69bf21ab85c40dee1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af851fc24a442e8aee600463f49f4bb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d09321a4a9a437083a3c246e5205811_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05788cb1cd704a9aa7f2c4a233d58bfc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07b39367e3554a54949428ce5c073cd4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5d7ef86da204a758e391dfe903e1498_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266a23a458034fcab5ce09b2e8f653a3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2e893789f44ff5b5960e5ae1657eee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if00cf42cc410455b9902a0c72c79d686_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56cca9f8ee3e46cd915bfb9e19b9f84d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i935023b9804f4655be2ead76741d2746_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86a6490c23ed4240aa47bc61b8c3cc1d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4ea9461173a44349f0685c96d1dcce1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aa9ca7e9e934914903f4b7ed4c4ec8c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c19be996cea4d049a4bb47f817d6982_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibabb2f6f89e14ad0ac35698b41047d5f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d946978d3a54bbcb36b85d5855cebd0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d38645272f547daad9432aae576444c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c236f2898f14fbfa92c2686609c680c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e816f48c9cd41c8ba78b4ddd652f74f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb93a4838e9c497484028bc965359528_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7538ba3acbdc47ac862773381252a6f1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie236fc059a234762bbc16ada70ba77e4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92af9636372c49d2a9396d3c6194fe71_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieda7830848534f8f99c833d0078f6325_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d87a52b74e641e5a5e5d658f483a695_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3300bb0e530443a969df765b1b31393_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02c06a11eaaf4c74901e4c3250b6056e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2667c5bdf5084cac925ae49f37d0694b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f3d74c12b094566806aae4a3ee77109_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f39a5b24bf14e7e8210e52e2c38875c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i005f944628624d14994ceacb3670c691_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24c46d6de0854211be7d105d64fb8545_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6b38e693ec6459a8eb430afd06d1251_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9c77e864c11452c9c2ce068c5c61f23_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a659e594ee4fce9a6eb802ff0c4752_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5a6f37cf644c71865652f7c26ad37b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c5538d593e0408abf61ba5d1091154b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida82cc5649fa4f7d87b92b1e33c7bbf4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i491fd2bcc91649b49adbc5e628f544ad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i909ed7ebdc6e40c2b4891ea6cce48b16_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe2e05eecb8e45dab3610612e9815a2f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5378ae045e224699baa5bf281d6856b8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b07362e43874a6594d73dabd00c8bd4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5254616f1e114acbae4ffe43531c2c3e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f9cc7883e82437ebb578096cb2a8fd6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eba1ae8f23b43768d9773249e2d7a88_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fb568cd7f51427db6f63dfe746772cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i028db93b3eea4709b1441884e9e13e7c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b800cd958594616ba0a181f993bd05f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69297980cac1443bb352fff016d929b6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie68ef9f8618c452ea229d8ad30b5bf6a_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i792a31a0059348cda0386afa68fcd936_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab8cf2152e6a45f19fde2dadc29bceb1_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7176555421542a3996fd5fb7b63446f_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedea9d7e7d2f4459ae223d71da4c8b3e_D20230401-20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33d40acad4a14920a7156beb462b2eb5_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e291345f6a64a58aaf2f650b1ba9147_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078c5a28b0454db6b490e4fff852e96e_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f275888ff1e48c7a97763a827fcee54_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifffbf1b0e78f4ac596aeef622400a7dd_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7a96ee455094c298ce4724ad93c884e_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96330e2ec3d34bf5b8ce4bf07abe50a2_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd1e4f4b78c402ab313d73be32dece7_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd29a5137477430b8f27c6edb2086fbe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a6d175e49204bda81ef5fb379cd9fea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a6c090726294b758ee283e14aedd42c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea1fb9c634ba4816850d26fbc19237a3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5fc25c9a4e64fa18623717924e129f3_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8232534e9744410f8e611d99b9e84386_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>docs:vote</xbrli:measure></xbrli:unit><xbrli:context id="ib0806f84593344d893e74652c3b10250_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20facf15f91a4b51a59cf495eff488b0_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf068271d669438eafc6af652e833d08_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4aeaddbe31d41d99ae6142cc71b26ca_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ddd079c5de94e16b92910b68fa5ba6d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3443fdd6919e400180bc0aa7089b7a55_I20220512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10df40a9fbe74c14b3193c4c8faa6cfd_D20220512-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-12</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e8f6b95c6e94f2d8a158e8e14a0d188_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i073baaa025aa4391ae3be3ed0f9b6b8b_D20221028-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-28</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i185f2fc156dc487daa4da85b1135e893_D20221028-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-28</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dd14ac8c2ad476a91aae55b5e50e12b_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60ed2d73233c4b148efb0ab0281f05c5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99dac51b2929424c872d9593a38b3a9c_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic83bcd7a1cdd424a827ac1b242d45d64_D20211001-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">docs:ShareBasedPaymentArrangementSubsequentToTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79cbc3050a9f4e728de0f2541e8414d5_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39c41ee9b35d4ca198dae8381879c81d_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f71bd088ee4c3fa9152d5f8241176d_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib20f32b4eb624a099afa796abcc7e5e7_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c602ccebaef4e4fb1436ee5279c5deb_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ff09070ac64dc9a6c3517e07569162_D20211001-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a2d89272fb4cd08d7941569bcdac06_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b910594e0447b48176dee4458443bc_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dcfc10564a84d99afdf2868944eaf6f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i329535dcf29942da975d098642b9ca8c_D20100401-20100430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestLessThanThresholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-04-01</xbrli:startDate><xbrli:endDate>2010-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f5a97d0329f49aba3a9c73948197302_D20100401-20100430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestAtThresholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-04-01</xbrli:startDate><xbrli:endDate>2010-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9add1738f524485aa3f0e69e33348404_D20100401-20100430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-04-01</xbrli:startDate><xbrli:endDate>2010-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4731ee97e9044ac481efdbc35006ea21_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i237ab3fe7b4848009fc6504e611304a8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EmployeeStockPurchasePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i392549f122de4599a31a1bc930b60d7c_D20170401-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-04-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f2625bab237468f82960faeaa65ecd8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7716737ca7654b41b69b01245e63ae37_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b225b55e25041dca4b2711a6a9a0a19_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida806691cbf34206b1424fc5e64367de_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1179d128dab4059b72b6142b8bc8b8d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dfa57621a8d47a2a7dc41b2f9ba12c7_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i991245b0925a47909f34aedbdca61682_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87182a9d8de4d7fbe7b3181cb3305b0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26986aac2225480487211e3064de5fd8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic468072a804447168766f95eca229ba8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4652006ba32649869cae91401685e771_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974d976e0f864a8ea9541b7b73048e70_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa33e8ecd9a84ebfae3604c0b6afa814_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia38954e2b9174a84b2206f208d8b037c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ada4a0cc2124109ba680255244c2035_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie09eece225b24d259739810162abac64_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e2a2f066c684b6dbfa470b1af8ddf0e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if594047406484611a6549a4cd2fd4424_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i999bcffa27f543c7af8d4b487ac793aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3057033fffd40dbb4f5e5ee0064bd42_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i775865ed2f994ca4b21733ec560d2c8a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b047f5f9ca746b7b52daa842f8517c4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49f50d35db5d4553b776c905f48f0eb1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i455bb77bdffd4042986f586a60bc3c32_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63c582bee6244ae9bf6eba0489faaa89_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic806ae5f2fb3486d8a36fbf8855115c8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ef8644397db461d970fc87d9283f043_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id81f09cb89e346d9b6bab4046c526ee3_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74e15aef3d274c7b9ac433e9e2fe446b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb2ef783dd62482f9546438633e5ef6a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2705eaddbac94b21a48222ef233d1bae_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1643d43bb3664592a6b37cafbac8f20c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7528701bd71f4ef1b51847193823879c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa288c7de6084883bc844573b299fa09_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8811c0f4a5d34a13b7ee23df9071c2f2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28297a7cc3e04248b1ee658ba91be269_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d3afc740f4462684bea44adc594e9c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f982a6f25a441579e268bbeafa0e133_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic706608c6ad1415d94545d91154d4ff2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia75bd356b16a493fbe592c7374ec7564_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2251c5f98a1541d58cc80a3e18e94e7c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28e082f86864f4680a3d75aa82cec9b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a2e271385b4f50b853a1db39b70580_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ee62022dbc4678aa4e1eda92d558d6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68d0cfc8bce14eb0bbdb2d1d8791664f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76d02cec04034dcebafb0e2d3f74bd25_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d9e728004f0418fb411e0ffbf42921b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17ea570245b84a03b7cfc4320cff3431_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76934d327b4e4c10a7eaeee01e5c0d44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbca9608b0944cceac22ef5ca0e4cb5a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i906daea421694946be847efacad3faf2_D20211008-20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-08</xbrli:startDate><xbrli:endDate>2021-10-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b04179a332405c949f34abf3c2def8_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9d45f1ab6dd4164bda35547de20a2ec_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c5d3ad3fc5494998c4463ceb353d93_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">docs:OfficeSpaceLeaseInIrvingTexasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>docs:segment</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549 </span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.403%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:25pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YWQzZTQ5OTY4ZmNiNGU1NjhkMDBkNTY3NzdmNDMyNTMvdGFibGVyYW5nZTphZDNlNDk5NjhmY2I0ZTU2OGQwMGQ1Njc3N2Y0MzI1M18wLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjM3NzFjZTJiYTExNjRiNWQ5OGM2NzkwMjFiYTg1NmY2Xzk_b73cd804-8335-47da-9c77-9f319c58f1c9">10-K</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:0.1%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18wLTAtMS0xLTE4MTc2OQ_f68636e5-26e2-49c1-8cb6-d4ed76e177c4">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">For the fiscal year ended <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18xLTEtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjkxYjNmMzg0MDNjZDRmNGU5YjllMTk2MTUzZjVlYzY5XzMw_5c05c867-a98f-46af-85b4-b8569d272a92"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18xLTEtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjkxYjNmMzg0MDNjZDRmNGU5YjllMTk2MTUzZjVlYzY5XzMw_4faf9a47-a690-4044-b13f-ea994a4550fc">March&#160;31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">or</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18zLTAtMS0xLTE4MTc2OQ_15d63cb7-6565-4339-9852-32cde39dcb85">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">              </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc3_482a5b25-af2e-4590-8d15-e0ccd46f4b20">001-40508</ix:nonNumeric></span></div><div style="margin-bottom:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.070%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:25pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6Mjg1YTA1ZDhjMThhNDQwYWJlZDFlOGNiYTZhNzk0ZWEvdGFibGVyYW5nZToyODVhMDVkOGMxOGE0NDBhYmVkMWU4Y2JhNmE3OTRlYV8wLTAtMS0xLTE4MTc2OQ_c9e331b2-4098-4e3e-be54-3f9f0e4f6f97">Doximity, Inc.</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exact Name of Registrant as Specified in Its Charter) </span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:32.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8wLTAtMS0xLTE4MTc2OQ_b37e3da0-18e1-4e5e-a9ef-99118b7b9d97">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8wLTItMS0xLTE4MTc2OQ_fb6b7127-7ceb-4336-9640-c72599e0df57">27-2485512</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or Other Jurisdiction of Incorporation or Organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification Number)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzU_d1d73885-7be9-4583-8b32-800f326cc4be">500 3rd St.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzg_89a4b2ce-4754-4bd5-8c2c-665b8a5c5524">Suite 510</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzEx_43971792-df2c-4050-95f7-02b57f2f4b4d">San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzE1_9ec32fda-0b95-49f7-8bd7-fa2c840a45d8">CA</ix:nonNumeric> <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzE4_e61bd4b6-3233-4218-9ae1-90d19ae2b58a">94107</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl80LTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOmU4NjlhNGYzMzQ2NjQwOGVhNDI4Y2E0MWI3YTA3YTAwXzU_f03454fa-13aa-4149-80d5-d06963f4b9b7">(650)</ix:nonNumeric> <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl80LTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOmU4NjlhNGYzMzQ2NjQwOGVhNDI4Y2E0MWI3YTA3YTAwXzg_37ac0ed1-adbc-4b7c-9699-045c16bb9dd3">549-4330</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MjY2MThlMTIzMTIxNGZmNGJkMDk4ZmE3ZWY2NmZlOGIvdGFibGVyYW5nZToyNjYxOGUxMjMxMjE0ZmY0YmQwOThmYTdlZjY2ZmU4Yl8xLTAtMS0xLTE4MTc2OQ_4ff3f1fc-d8c5-4a5a-b917-f3e109f6d55f">Class A common stock, $0.001 par value per share</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MjY2MThlMTIzMTIxNGZmNGJkMDk4ZmE3ZWY2NmZlOGIvdGFibGVyYW5nZToyNjYxOGUxMjMxMjE0ZmY0YmQwOThmYTdlZjY2ZmU4Yl8xLTItMS0xLTE4MTc2OQ_d56ab647-8004-41f5-8bc7-702e02d943d2">DOCS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MjY2MThlMTIzMTIxNGZmNGJkMDk4ZmE3ZWY2NmZlOGIvdGFibGVyYW5nZToyNjYxOGUxMjMxMjE0ZmY0YmQwOThmYTdlZjY2ZmU4Yl8xLTQtMS0xLTE4MTc2OQ_d86b5923-441c-4029-9e1d-14a3158d2c61">The New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to section 12(g) of the Act: None </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. &#9746; <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8xNzA0MjQzMDIzNzA2Ng_b6dafcc6-42c0-4a85-a234-4aa6da334b5e">Yes</ix:nonNumeric> &#9744; No </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. &#9744; Yes &#9746; <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDcz_0d96d208-ad38-4874-8dc2-aacf62238c0b">No</ix:nonNumeric> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#9746; <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc1_9a744b32-719e-4167-ba47-709d76dc2a91">Yes</ix:nonNumeric> &#9744; No </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#9746; <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc4_02b91258-5f5f-4e0a-899c-b2f474e22a00">Yes</ix:nonNumeric> &#9744; No </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;and "emerging growth company" in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.995%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YjgxOWM1ZWU2YTVlNDhjZDlkOTc0YjlhMDU2Yjg0MDMvdGFibGVyYW5nZTpiODE5YzVlZTZhNWU0OGNkOWQ5NzRiOWEwNTZiODQwM18wLTAtMS0xLTIyMTUzNQ_29d5ae6b-a090-4515-b962-1f2f85e65b6e">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated filer </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YjgxOWM1ZWU2YTVlNDhjZDlkOTc0YjlhMDU2Yjg0MDMvdGFibGVyYW5nZTpiODE5YzVlZTZhNWU0OGNkOWQ5NzRiOWEwNTZiODQwM18xLTQtMS0xLTE4MTc2OQ_7847df68-ea86-4f69-a890-4c15d2fdc40d">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YjgxOWM1ZWU2YTVlNDhjZDlkOTc0YjlhMDU2Yjg0MDMvdGFibGVyYW5nZTpiODE5YzVlZTZhNWU0OGNkOWQ5NzRiOWEwNTZiODQwM18yLTQtMS0xLTE4MTc2OQ_0c8d5ee6-a5ea-4260-b786-809f6f511b25">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDgy_2d2df387-d30e-4b41-adc5-d65c58fb75da">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements &#9744;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). &#9744; Yes <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8xNzA0MjQzMDIzNzA2OA_65ce7f9d-2457-4e13-9201-436e5d6f4f66">&#9746;</ix:nonNumeric> No</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting stock held by non-affiliates of the registrant as of September&#160;30, 2022, based on the closing price of $30.22 for a share of Class A common stock on the New York Stock Exchange, was approximately $<ix:nonFraction unitRef="usd" contextRef="ie97abaadc2504001892e499621c9a22d_I20220930" decimals="-7" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8yNTUx_62bc883d-c380-4d00-a4d9-d9fb4cfc01c9">3.63</ix:nonFraction>&#160;billion. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The registrant had outstanding <ix:nonFraction unitRef="shares" contextRef="ie515b3edc3ec46ef8e0798e729e1c42d_I20230519" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDgw_6e1563e0-3e50-4dd2-877c-1489bb8e01a5">121,441,605</ix:nonFraction> shares of Class A common stock and <ix:nonFraction unitRef="shares" contextRef="i429c89ea5d0c416f85960bc2a4c84894_I20230519" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8yNjI1_47ea480a-606b-443a-a729-fe33dcdcf61a">73,224,944</ix:nonFraction> shares of Class B common stock as of May&#160;19, 2023. </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc0_c6ddda64-2c65-42d0-9560-3529bfa758a8" escape="true">Portions of the registrant&#8217;s Definitive Proxy Statement relating to the 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#8217;s fiscal year ended March&#160;31, 2023.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_13">Part I</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_16">Item 1. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_19">Item 1A. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_19">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_22">Item 1B.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_22">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_25">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_25">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_28">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_28">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_31">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_31">43</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_34">Part II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_34">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_37">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_37">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_37">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_40">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_40">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_40">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_43">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_43">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_43">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_79">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_79">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_79">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_82">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_82">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_82">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_157">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_157">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_157">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_160">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_160">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_160">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_163">Item 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_163">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_163">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_166">Item 9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_166">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_166">95</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_169">Part III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_169">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_172">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_172">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_172">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_175">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_175">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_175">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_178">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_178">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_178">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_181">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_181">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_181">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_184">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_184">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_184">96</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_187">Part IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_187">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_190">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_190">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_190">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_193">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_193">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_193">9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_193">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_196">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ib1b51d92d3ac43179e2f8bdfac24a353_196">99</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws, which are statements that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;shall,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;intends,&#8221; &#8220;target,&#8221; &#8220;projects,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; or &#8220;continue&#8221; or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements contained in this Annual Report on Form 10-K include, but are not limited to, statements about: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our revenue, expenses, and other operating results;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future financial performance;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations and management of future growth;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to acquire new members and successfully retain existing members;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to acquire new customers and successfully retain existing customers;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve or maintain our profitability;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future investments in our business, our anticipated capital expenditures, and our estimates regarding our capital requirements;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and success of our sales and marketing efforts, and our ability to promote our brand;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to effectively manage our growth, including our ability to identify, retain, and recruit personnel, and maintain our culture;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with laws and regulations; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully defend litigation brought against us; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain, protect, and enhance our intellectual property rights and any costs associated therewith;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain data privacy and data security;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to respond to rapid technological changes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the impact of uncertainty in the current economic environment and macroeconomic uncertainty, including the resurgence or resolution of the COVID-19 pandemic or other pandemics, epidemics or infectious diseases;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to compete effectively with existing competitors and new market entrants; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the growth rates of the markets in which we compete;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the increased expenses associated with being a public company; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sufficiency of our cash and cash equivalents and marketable securities to meet our liquidity needs;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with modified or new laws and regulations applying to our business;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully identify, acquire, and integrate companies and assets;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments and projections relating to our competitors and our industry, including competing solutions;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact from future regulatory, judicial, and legislative changes or developments that may affect our customers&#8217; or our business; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risks related to our Class A common stock and our dual class common stock structure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this Annual Report on Form 10-K. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Annual Report on Form 10-K primarily on our current expectations and projections about future events and trends that we believe may affect our business, results of operations, financial condition, and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Annual Report on Form 10-K. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements made in this Annual Report on Form 10-K relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Annual Report on Form 10-K to reflect events or circumstances after the date of this Annual Report on Form 10-K or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Annual Report on Form 10-K, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_16"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the leading digital platform for U.S. medical professionals, as measured by the number of U.S. physician members, with over two million medical professional members as of March&#160;31, 2023. Our members include more than 80% of physicians across all 50 states and every medical specialty, as well as over 50% of U.S. nurse practitioners and physician assistants, and over 90% of graduating U.S. medical students. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to help every physician be more productive and provide better care for their patients. We are physicians-first, putting technology to work for doctors instead of the other way around. That guiding principle has enabled Doximity to become an essential and trusted professional platform for physicians. Doximity&#8217;s physician cloud puts modern software tools in the hands of physicians and other medical professionals. We provide our members with capabilities specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, monitor their work schedules, and manage their careers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the core of our platform is the largest medical professional network in the nation, which creates proximity within our community of doctors and hundreds of thousands of other medical professionals. Our focus on clinician-centric product design and productivity has led to high levels of adoption and endorsement by health professionals. For example, we had over 380,000 unique active providers use our telehealth tools in the quarter ended March&#160;31, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model is designed to both respect and support physicians while driving value for our customers through our Marketing, Hiring, and Telehealth Solutions (as defined below). Our revenue-generating customers, primarily pharmaceutical manufacturers and health systems, have access to a suite of commercial solutions that benefit from broad physician usage.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;Marketing Solutions&#8221; enable our pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Our Marketing Solutions deliver high engagement and help those customers embrace the shift to digital marketing. We count the top pharmaceutical manufacturers, hospitals, and health systems as our customers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;Hiring Solutions&#8221; provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from our network of both active and passive potential medical professional candidates, who might otherwise be missed through traditional recruiting channels. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;Telehealth Solutions&#8221;, which are software tools that include voice and video Dialer, are designed to easily connect patients with care providers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ecosystem we have created in the medical community benefits from powerful network effects. Medical professional engagement with our platform increases as the breadth and utility of our tools expands, attracting even more members and driving broader and more effective communication and collaboration among healthcare professionals. This also drives greater value for our pharmaceutical and health system customers that seek to interact with specific groups of physicians. In turn, the insights that we gain from increased use of our platform enable us to invest in improving our tools and solutions to meet the changing needs of our members, customers, and the patients that they care for, ultimately creating a win-win-win for all constituents in our ecosystem.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our member interactions have enabled us to build a vast, interactive data set intelligently combining proprietary information and previously-siloed public information. When combined with our customized algorithms and our team of analysts, engineers, and clinical experts, we believe we have unique, unparalleled insight into the specific needs of U.S. medical professionals that would be highly challenging and time-consuming for any competitor to replicate.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Tools for Medical Professionals</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Doximity platform is free to join and use for U.S. medical professionals. Becoming a member of Doximity is as simple as navigating to our homepage or downloading our mobile app, and completing our simple identity and credential verification process. Our platform provides most medical professionals with a pre-populated Doximity professional profile reflecting publicly and commercially available third-party data which members can further supplement, update, and refine.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once verified, members gain access to our network, newsfeed, and&#8212;depending on their credentials&#8212;our productivity tools, including voice and video Dialer.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Professional Network</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Profile.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Members have a personalized and validated professional profile on the Doximity network that acts as a digital curriculum vitae. Profile information includes education and training, hospital affiliations, and practice contact information as well as certifications and licenses, specialization and clinical expertise, links to published research reports and press mentions, clinical trial participation, and any awards conferred. Our technology automatically searches for and updates profiles with new relevant information such as additional press mentions and awards. Members may also choose to share personal contact information (such as email or cell phone number) with other medical professionals on our platform.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Connectivity with colleagues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our network makes it easy for professionals to connect and stay in touch with the broader medical community. We regularly suggest new connections to members, such as co-residents, co-fellows, co-authors, colleagues from the same hospital or practice, and medical school classmates, enabling referrals, and sharing of medical knowledge and career opportunities.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Search. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members can use our powerful search technology to find other medical professionals by name, specialty, expertise, affiliation, or location. For example, a physician may have a patient with a chronic condition that requires specialist care at another health system or in another state. The physician can use our search tool to find the right expert for the specific chronic condition at the closest health system, and potentially leverage mutual connections for a warm introduction. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Careers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform provides numerous tools that empower physicians to manage their careers effectively from training through retirement. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">For practicing physicians.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Members can browse permanent and locum tenens opportunities, set up job alerts to stay abreast of career opportunities matching their interests, and directly connect with our Hiring Solutions customers. Members also have access to detailed job market data, such as our Salary Map, which provides an unparalleled county-level look at physician compensation trends across specialties and geographies.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">For students and residents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Members beginning their medical careers can discover and compare training programs across the country using Residency Navigator, a tool that provides a transparent look into U.S. medical residency programs, powered by peer nominations, ratings, and firsthand reviews, giving medical students the information they need to navigate their future in medicine and to help choose the right program for their career goals. We do not accept fees or payments from hospitals or medical residency programs to impact their ranking or visibility on Residency Navigator. Residency Navigator serves as a relationship funnel for new members at the beginning of their medical careers. Over 90% of graduating U.S. medical students join Doximity to use tools including Residency Navigator before earning their medical degree.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Newsfeed</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our newsfeed serves as the personalized, curated home screen for each member when they sign on to the Doximity platform. We leverage artificial intelligence, or AI, including machine learning, or ML, to create a personalized and curated newsfeed for each of our members. Our platform provides access, free of charge to all of our members, to content from a variety of internal and third-party sources, including content created in-house and content linked to third-party sites (some of which may require a separate subscription).</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Medical articles.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our platform uses both algorithms and clinical editors to select content from a variety of sources based on a member&#8217;s profile and reading interests. Information used to select articles includes each member&#8217;s specialties, qualifications, connections, and content preferences, along with what is popular across our network at that time. We are able to aggregate connections to relevant content from a variety of different sources, such as medical journals and specialist websites that a member might otherwise have to search for separately.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Medical videos.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Information about recent clinical trials or research results are distributed in an easy-to-consume video format, optimized for desktop or mobile viewing. Videos are designed to be brief, relevant and eye-catching to disseminate knowledge without wasting a physician&#8217;s time.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Continuing Medical Education, or CME, credit. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform automatically tracks the articles that our members read, logging eligible CME credit for them as they go.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Peer and colleague updates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Doximity members can stay abreast of and celebrate the professional updates and accomplishments of their peers and colleagues, from new jobs to awards, newly authored publications, and press mentions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Clinical discussions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Members can comment on and react to posts directly in their newsfeeds. For example, members might discuss the results of a new clinical study, or even ask questions to the author of that study. Ultimately, dialogue and interactive elements drive engagement within the ecosystem and facilitate peer-to-peer education.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Op-Med. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members can submit Op-Med articles for publication on Doximity. These articles are long-form content written by clinicians for clinicians, covering topics such as front-line experiences and practice-changing viewpoints. They provide the opportunity for our members to express their expertise and further elevate and engage the profession.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Sponsored content. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain articles, videos, and other types of content are identified as sponsored content and are designed to be highly relevant to our members. Sponsored content is created in concert with our customers, including pharmaceutical manufacturers and health systems, and may include information about medications, clinical trials, guidelines and resources, and trends in medical and patient care. Sponsored content is developed in collaboration with our customer success team to ensure they meet the high quality standards of our community.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Productivity</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of our platform are able to access our productivity tools, a suite of Health Insurance Portability and Accountability Act, or HIPAA, compliant communication and digital workflow tools that are designed with their needs in mind to make their daily workflows more efficient. We include the following critical digital tools in one easy-to-use app and website. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Digital Workflow: Fax and eSignature.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Doximity platform allows physicians to send and receive HIPAA-compliant faxes through our mobile app or website. Members can electronically create, sign, edit, date, add attachments, and customize the cover page for their faxed documents, eliminating the need to print, manually sign, and re-scan documents. This streamlines patient care coordination and digital record keeping. .</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Secure Messaging. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Doximity messaging functionality enables members to collaborate securely regarding patient consultations and coordinate care across multiple care team members, specialists, systems, or locations. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Dialer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our members can connect with their patients through our Dialer telehealth feature: Dialer Free is available for free to verified healthcare provider members, Dialer Pro is a paid version with some enhanced capabilities, and Dialer Enterprise is available for purchase by health systems and hospitals. Calls can be voice or video-based, and our service provides valuable features such as a preset Caller ID displaying the provider&#8217;s office number, the ability to easily add an interpreter or family member, or to hand off the call to another member of the care team with one click, all in a HIPAA-compliant manner.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Solutions for Healthcare Customers</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer Marketing, Hiring, and Telehealth Solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and certain other healthcare companies on a predominantly subscription basis. Our solutions benefit both our customers and our members, containing useful and relevant information for the member's particular area of practice and their patients&#8217; needs, while being respectful of their time.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing Solutions</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a digital marketing platform for pharmaceutical manufacturers and health systems to serve our members with tailored sponsored content that is highly relevant to their clinical practices, including information about medications, clinical trials, guidelines and resources, and trends in medical and patient care. Pharmaceutical manufacturers purchase programs on a brand-by-brand basis, and health systems execute programs on a service line-by-service line basis. Service lines in health systems refer to patient-centric clinical specialties, such as cardiology, oncology, neurology, and otolaryngology, among others. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers are able to specify a combination of audience attributes, such as specialty, credential, and location, and also choose modules. Modules are the core building blocks of the marketing plan and are additive to one another. We package them into sponsored programs to meet the needs of individual brands and service lines. Our sponsored modules can be categorized as Awareness, Interactivity, and Peer, as follows:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Awareness:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sponsored modules that generate awareness and build name recognition, such as text and video articles. The content of these modules may include updates on how certain drugs perform in clinical trials, the opening of new hospitals or departments within a health system, or other information that is relevant to our members.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Interactivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: sponsored modules that enable digital activities such as conference attendance, connecting with a sales representative, booking an appointment, or ordering product samples.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Peer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: sponsored modules that enable our members to connect and build professional relationships with thought-leaders, department chairs, and other experts within the Doximity network.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continuously seek to develop new modules in response to customer feedback and market trends and to address specific needs of our customers. For example, an Interactivity module may appear adjacent to articles about scientific congresses or professional meetings. We take a rigorous approach to launching new modules, including internal and customer pilots.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to make sponsored content useful, relevant, and informative for our members. We have a customer success team that ensures both that our customers receive tangible, measurable, and repeatable benefits from their marketing spend, and that our members have access to sponsored content that is relevant, informative, and meets the high quality standards of our community. The team works directly with our customers to deeply understand a customer&#8217;s goals, priorities, and messaging before helping with content and media formats. Our team can develop new content or fine-tune and reformat existing content for digital and feed-friendly marketing. We also provide ongoing support and reporting at the customer&#8217;s request.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have become a valued collaborator to our customers. We have a track record of expanding throughout the medication portfolios of pharmaceutical customers and into additional service lines throughout a health system while also upselling additional modules.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hiring Solutions</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our Hiring Solutions to both health systems and medical recruiting firms, which pay for subscriptions that provide them the ability to search and connect with medical professionals on Doximity. Our AI and ML-supported platform enables customers to run highly targeted hiring campaigns across a range of medical specialties and sub-specialties, uncovering passive but eligible candidates for proactive outreach for any locum tenens or permanent position. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our modules for Hiring Solutions consist of the following:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Job posts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Individual listings on our platform for open jobs, either posted directly by a health system or by a recruiting firm. Our members can search and browse these listings.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Direct message.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recruiters, physicians, and administrators can direct message members who might be a good fit for a given open position. These messages may or may not be for an opening that has been posted on our job posts.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both job posts and direct messages are sold as a subscription that entitles the customer to a certain number of job listings or messages on a self-serve basis throughout the subscription period. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a tech-enabled, higher-touch Hiring Solution called Curative Talent, combining Doximity&#8217;s data science and intelligence with the service of Curative&#8217;s customer-focused recruiters. Our account managers at Curative work with health systems to source both locum tenens and permanent staffing, leveraging our platform and providing a higher level of support on an ongoing basis than our self-service Hiring Solutions. Health systems contract staffing placements directly with Curative on an hourly-fee or a placement-fee basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Telehealth Solutions for Health Systems</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide Dialer Enterprise to health systems and hospitals seeking an accessible and powerful telehealth solution. The organic adoption of our direct-to-member offerings&#8212;Dialer Free and Dialer Pro&#8212; is an important factor driving our Enterprise offerings. Many users have already adopted Dialer into their regular workflow and this familiarity significantly streamlines implementation when health systems are deploying Dialer Enterprise while competitor solutions often require a full physician training.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialer Enterprise enables unlimited access to Dialer for all users across a health system&#8217;s organization, and unlocks the same premium feature set as Dialer Pro with an added service layer for the organization that includes a dedicated customer success manager, premium user support, and monthly utilization reporting. Health system customers also have the opportunity to brand the user and patient experience as well as leverage their own security and HIPAA contractual requirements to create consistent protocols for use. Our health system team can also integrate Dialer into our customer's electronic medical record system so that their users can access Dialer directly within their existing clinical workflows.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialer Enterprise is sold as a subscription, with pricing based on the size of the health system. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Scheduling Capabilities for Health Systems</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer a shift scheduling service to health systems through our acquisition of AMiON, which closed on April 1, 2022. AMiON helps health systems easily manage care coverage across their service lines, by enabling administrators and staff to view work schedules, communicate with colleagues, swap and adjust shifts, and sync work shifts to personal calendars.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strengths</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exhibits a number of key strengths which we believe position us to drive sustained growth. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are the trusted and secure physician-first platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Since our founding, Doximity has been built to be physician-first, with trust at the core of what we do. We verify the identities and credentials of our medical professionals through integration with third-party databases. In addition, our communications solutions are HIPAA compliant, providing medical professionals with a critical platform for protected communications.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We have the largest digital network of medical professionals.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our members have the broadest available range of professional connections and networking opportunities through our platform, and we believe we have become the primary physician-to-physician connectivity medium. The scale and strength of our network have made us a strategic collaborator of choice for pharmaceutical manufacturers and health systems. We enable these organizations to engage with a valuable and otherwise difficult-to-reach audience, covering an increasing number of specialized medical professionals and enabling targeted outreach.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We benefit from powerful network effects. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the medical professionals and customers that use our platform benefit immensely from access to our large and dynamic ecosystem, and we fuel the expansion of this network of medical professionals, pharmaceutical manufacturers, and health systems by adding new tools and solutions to our platform. As we expand our capabilities, Doximity becomes more attractive to new and existing members and customers, ultimately generating more data and insights that allow us to develop better tools and solutions, and build greater scale. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are deeply embedded in physician workflows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tools and third-party integrations are designed to solve workflow pain points for physicians. Our tools provide physicians with the ability to deliver best-in-class healthcare, spend more time with patients, and ultimately improve patient care. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We innately understand physician workflows are different from traditional technology workflows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Through having product leaders who are physicians, designers, and engineers familiar with healthcare services, and an extended team of medical professionals in our advisory committees, we are able to build solutions that enable physicians to better care for their patients and act as an extension of their practice. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are strategic to our customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a unique, digital channel to connect our customers with the most valuable professionals in healthcare. Marketing Solutions customers, such as pharmaceutical manufacturers and health systems, gain access to a solution with a proven return on investment. Hiring Solutions customers, including health systems and medical recruiting firms, gain access to a comprehensive nationwide network and database of specialty and sub-specialty professionals. We align our goals with our customers and help them make the necessary leap to digital. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategies</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Grow the Doximity Network.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While we will continue to grow our number of physician members, we are under-penetrated among other types of medical professionals such as nurse practitioners, and have an opportunity to expand our offering to physical therapists, dentists, psychologists, and many other professions. As more medical professionals join our platform, we become a more valuable connectivity tool for members, and a more valuable marketing and hiring channel for pharmaceutical manufacturers and health systems. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Continuously improve and innovate on our platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Improving our existing capabilities, and innovating to add new tools and solutions, will make our platform more valuable to members, helping to attract new members and customers, while increasing the engagement of existing ones. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Expand within existing customers of our solutions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our existing customers represent a significant opportunity to grow our platform. Many of our large pharmaceutical customers initially run marketing programs for a certain number of brands but have a track record of increasing their spend with us both by adding modules and expanding across more of their portfolio of brands once they have seen the quantifiable benefits of our Marketing Solutions. Health systems have a similar track record of expanding their usage of our platform across different service lines. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Attract new customers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an opportunity to engage additional pharmaceutical manufacturers and health systems and potential customers in other industries as we raise awareness of our offerings through our sales and marketing efforts and as we expand our offerings.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Further monetize our Telehealth Solutions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our telehealth tools are used and trusted by hundreds of thousands of our members, and the rapid adoption by health systems of our commercial Telehealth Solution, Dialer Enterprise, following its launch reflects that professional trust. Our Dialer Enterprise solution is still in its early stages</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and we have significant whitespace ahead of us. We continue to look for opportunities to sell solutions that build on our Telehealth offering.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Grow our patient-facing tools.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Patients can search for the right doctor or hospital for their needs through our collaboration with the Doctor Finder tool of U.S. News &amp; World Report, which publicly displays summary physician profiles and hospital rankings powered by an integration with our Doximity network. We also collaborate with U.S. News &amp; World Report to offer a direct-to-patient scheduling tool for health systems. We see opportunities to expand our offerings to patients in the future. Consumers on the platform would also create a significant value opportunity for our customers.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Consider strategic acquisitions to expand our platform capabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the past, we have selectively used mergers and acquisitions to accelerate our product roadmap to bring medical professionals and customers more complete solutions and increase demand for our products. For example, in fiscal 2021, we acquired Curative Talent, a medical recruiting agency, in order to augment our Hiring Solutions with a tech-enabled, higher-touch service, and on April 1, 2022, we acquired the AMiON shift scheduling service to further expand our physician cloud platform. We plan to continue evaluating similar opportunities and execute on them if we find the right fit for our members, customers, and our company.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Technology Platform</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology platform supports a vast network of member connections, with regularly updated profiles, secure communication and productivity tools, and vast amounts of searchable indexed data. Together, we believe these features of our physician cloud form a valuable competitive strength. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Platform Advantages</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Extensive and dynamic database of U.S. physician information:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the launch of our business, members have interacted with each other and our technology platform hundreds of millions of times. This has enabled us to build a vast, interactive data set intelligently combining proprietary information and previously siloed public information. Along with user-entered input, our proprietary algorithms constantly identify new information for our members from hundreds of third-party sources that are isolated and siloed in the healthcare space. The up-to-date and scaled nature of our database is critical to the value proposition for both our members and our pharmaceutical manufacturer and health system customers. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Statistical and machine learning methodologies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We utilize proprietary statistical and machine learning methodologies across our platform for a number of use cases to benefit our members. Some of the major components include:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Aggregating and coupling disjointed datasets from numerous medical sources into a live database of physician information to perform descriptive, diagnostic, and prescriptive analysis. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical news tailored to a member&#8217;s specific specialty, clinical areas of interest, and viewing history, ensuring that each member&#8217;s news feed is personalized to them and that the digital marketing content of our pharmaceutical and health system customers will be served to members that are more likely to find it relevant and interesting based on their profile and viewing history.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Automatically matching top candidates with openings offered by recruiters and administrators based on job history, interests, and geography.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Extensive, interactive database of U.S. medical residency and employment data:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We collect and maintain a vast repository of residency and employment data from our members, which includes member reviews on their experience at hospitals and residency programs, detailed statistics on user experiences regarding program setting and training environment, and a salary map across different specialties and geographies across the country. We make this data </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">available to all of our members in easily accessible portals which are automatically updated as our members provide additional data on the platform. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Proprietary productivity and telehealth tools:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our productivity and telehealth tools have been built to be physician-first with usability in mind at every step. Built on top of a modern software stack that ensures rapid scalability and enterprise-grade reliability, our tools allow doctors to communicate via messages, voice, and video&#8212;and their patients do not need to install an app to be connected. On top of this base service, we have designed a broad range of customized, physician-first telehealth features specific to our platform such as &#8216;call nudge&#8217; reminding a patient of a visit, &#8216;straight to voicemail&#8217; enabling physicians to choose not to disturb patients after-hours, and the flexibility to switch between voice and video at will, among others.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Design Principles:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our technology stack and product development teams are set up to enable rapid prototyping and development of new features via controlled rollouts. We focus on innovative, useful and unobtrusive features that are designed to optimize the healthcare professional&#8217;s workflow. And at all times, we follow the stringent security and privacy requirements of a physician&#8217;s data; our messaging tools are compliant with HIPAA and validated through external auditing procedures.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ a direct sales organization composed of highly trained team members. The sales organization is segmented primarily by customer type. For example, there is one enterprise-focused team concentrating on pharmaceutical manufacturers and another concentrating on health systems. Our direct sales organization also reaches customers through indirect channels, such as third-party marketing agencies utilized by our pharmaceutical and health system customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The direct sales organization is supported by marketing and customer success specialists. We generate customer leads, accelerate sales opportunities, and build brand awareness through our marketing programs, both digitally and offline. These programs target decision-makers to provide information about our company and solutions through digital advertising, field marketing events, integrated marketing programs (including direct email and online advertising), industry events, trade shows, and conferences. Our customer success team supports customer retention by working directly with customers to produce higher engagement with our solutions, which in turn expands their use of the platform in the future.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have built a scaled and highly differentiated platform, we face competition across different aspects of our business. We have experienced, and expect to continue to experience, intense competition from a number of companies, and we expect such competition to increase as our industry evolves. Specifically, we compete for medical professionals as platform members, and for pharmaceutical and health system companies as customers for our Marketing, Hiring, and Telehealth Solutions. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competing for members: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with large technology companies that have developed online networking and collaboration tools such as LinkedIn, Facebook, Google, and Twitter, in addition to smaller, emerging companies. However, we believe we are the only professional network solely dedicated to medical professionals, with a purpose-built platform specifically designed to address a broad range of unique needs of today&#8217;s healthcare professionals.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competing for customers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete across several categories to access spend in the healthcare category. We specifically compete for access to marketing, hiring, and telehealth budgets. We believe that our platform and the network of medical professionals on Doximity allow us to provide our customers with solutions that result in attractive returns on their marketing and hiring budgets. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We compete with online and offline outlets that provide marketing and advertising services that enable pharmaceutical manufacturers and health systems to educate medical professionals about their brands. These outlets include health-related websites and mobile apps.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Hiring:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We compete in the healthcare staffing industry with job boards, self-service recruiting tools, and medical recruiting firms in national, regional, and local markets. We compete with large healthcare staffing companies as well as smaller, more regionally focused companies. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Telehealth: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with providers of communication solutions, such as Zoom Video Communications and Microsoft Teams. In addition, we compete with dedicated telehealth services, such as Teladoc Health and Amwell, in addition to smaller, emerging companies that provide telehealth services on behalf of employers and insurance plans.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industries in which our products are offered are evolving rapidly and are becoming increasingly competitive. Larger and more established companies may focus on our market and could directly compete with us. Smaller companies, including application developers, could also launch new products and services that compete with us and that could gain market acceptance quickly. We also expect our existing competitors in the markets for Marketing, Hiring, and Telehealth Solutions to continue to focus on these areas. Many of our competitors and potential competitors have significantly greater financial, technological, and other resources than we do and greater name recognition and more established distribution networks and relationships with healthcare providers than us. As a result, many of these companies may respond more quickly to new or emerging technologies and standards and changes in customer requirements. These companies may be able to invest more resources in research and development, strategic acquisitions, sales and marketing, patent prosecution, litigation, and financing capital equipment acquisitions for their customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors may announce new products, services, or enhancements that better address changing industry standards or the needs of members and customers, such as mobile access. Any such increased competition could cause pricing pressure, loss of market share or decreased member engagement, any of which could adversely affect our business and operating results. Internet search engines could also change their methodologies in ways that adversely affect our ability to optimize our page rankings within their search results. If this occurs, our ability to successfully market our services to customers may be harmed and our business results may suffer.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our People, Culture, Values, and Human Capital Resources</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Doximity, we organize our teams into small, nimble groups that operate autonomously, are empowered to make decisions quickly, and aim to stay close to our members and customers. We prioritize diversity and inclusion, and regularly track our progress against quantifiable goals. We have always been a geographically distributed team. We supplement our workforce with contractors and consultants in the United States and internationally.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We champion the following core values: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Get Stuff Done:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are doers. We solve problems every day by treating obstacles like an adventure. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Straight Talk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We say what we think and every voice is heard and respected. Transparency makes us stronger.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Stretch Goals:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Innovation requires risk-taking. We challenge assumptions and shoot for the stars.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Bring the Real You: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bring our quirky, unique selves to work. Diverse personalities create a more interesting and creative environment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing, and integrating our existing and new employees. The principal purposes of our equity incentive plans are to attract, retain, and motivate selected employees, consultants, and directors through the granting of stock-based compensation awards and cash-based performance bonus awards. To our knowledge, none of our employees is represented by a labor union or covered by a collective bargaining agreement. We have not experienced any work stoppages, and we consider our relations with our employees to be good. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had a total of 977 full-time equivalent employees. More than a third of our full-time equivalent employees work in R&amp;D, including in product, engineering, and data. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Protection, Security, and Regulatory Compliance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The data we collect and process is an integral part of our tools and solutions, allowing us to ensure our members are verified, the experience we provide is engaging and personalized, and the content we present is the most relevant. In addition, our business is subject to extensive, complex, and rapidly changing federal and state laws and regulations governing data processing, healthcare regulation, financial services laws, regulations and rules, such as HIPAA, and related matters. Our respect for laws and regulations regarding the processing of personal data underlies our strategy to improve our member experience and build trust in our network and platform. While we believe we comply in all material respects with applicable laws and regulations, these regulations can vary significantly from jurisdiction to jurisdiction, and interpretation and enforcement of existing laws and regulations may change periodically. Federal and state legislatures also may enact various legislative proposals that could materially impact certain aspects of our business. For additional information, see &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212;We are subject to stringent and changing laws, regulations, self-regulatory schemes, contractual obligations, and standards related to privacy, data protection, and information security. The actual or perceived failure by us, our customers, partners, or vendors to comply with such obligations could harm our reputation, subject us to significant fines and liability, or otherwise adversely affect our business..&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Collection and Protection</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect and may use personal information to help run our business (including for analytical purposes) and to communicate and otherwise reach our network members. In some instances, we may use third-party service providers to assist us in these efforts.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We endeavor to treat our members&#8217; personal information with respect and maintain member trust. We provide our members with options designed to allow them to control their information, such as allowing our members to decide which profile contact information is viewable publicly and which is accessible to new connections. Members can also request deletion of their personal information or to opt out of selling or sharing their personal information under applicable privacy laws and procedures. Our privacy and security teams are devoted to processing and fulfilling member requests regarding access to and deletion of their personal information. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician information that is posted to profiles is protected with anti-scraping technologies such as a Web Application Firewall, Runtime Application Self-Protection, Bot Protection, Rate-Limiting, and our network employs DDoS mitigation technology to protect against attacks. All data is encrypted in transit and at rest using TLS 1.2, and personal health information is encrypted at rest using AES-256 encryption. Along with a dedicated in-house security team and contracted security researchers, we maintain a comprehensive bug bounty program for proactive vulnerability inspection of our entire offering.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. state and federal health information privacy and security laws</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous U.S. federal and state laws and regulations related to the privacy and security of personally identifiable information, including health information. In particular, HIPAA established privacy and security standards that limit the use and disclosure of protected health information, referred to as PHI, and require the implementation of administrative, physical, and technical safeguards to ensure the confidentiality, integrity, and availability of individually identifiable health information in electronic form. Our members as well as many of our Dialer Enterprise customers are regulated as covered entities under HIPAA. As a service provider who creates, receives, maintains, or transmits PHI on behalf of these covered entities for certain of our services, Doximity is a &#8220;business associate&#8221; as defined under HIPAA. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of HIPAA may result in civil and criminal penalties and a single breach incident can result in violations of multiple standards. In the event of a breach, we must also comply with HIPAA&#8217;s breach notification rule and our covered entity enterprise customers may require we provide assistance in the breach notification process and may seek indemnification and other contractual remedies. State attorneys general also have the right to prosecute HIPAA violations committed against residents of their states, and individuals have used HIPAA standards as the basis for the duty of care in state civil suits, such as those for negligence or recklessness in misusing personal information. In addition, HIPAA mandates that HHS conduct periodic compliance audits of HIPAA-covered entities and their business associates for compliance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, many states in which we operate and in which our members and customers as well as their patients reside also have laws that protect the privacy and security of sensitive and personal information, including health information, information regarding mental health and substance use treatment, and other information related to the provision of healthcare services. Some of these laws also prohibit unfair privacy and security practices and deceptive statements about privacy and security and place specific requirements on certain types of activities, such as data security and texting. These laws may be similar to or even more protective than HIPAA and other federal privacy laws. For example, the laws of the State of California, in which we operate, are more restrictive than HIPAA, including the provisions of the California Consumer Privacy Act, or CCPA, which went into effect January 1, 2020, and the California Privacy Act, or CPRA, which went into effect on January 1, 2023, and significantly modified the CCPA. While any information we process in our role as a business associate may be exempt from state privacy laws, other records and information we maintain on our members may be subject to these laws. Where state laws are more protective than HIPAA or require us to take action such as breach notification, we must comply with the state laws we are subject to, in addition to HIPAA. In certain cases, it may be necessary to modify our planned operations and procedures to comply with these more stringent state laws. Not only may some of these state laws impose fines and penalties upon violators, but also some, unlike HIPAA, may afford private rights of action to individuals who believe their personal information has been misused. In addition, state laws are changing rapidly, and there is discussion of a new federal privacy law or federal breach notification law, to which we may be subject. For additional information, see &#8220;Risk Factors&#8212;Risks Related to the Healthcare Industry.&#8221;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and State Telecommunications Laws</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of federal and state laws and regulations potentially applicable to communications by phone, text message, or facsimile, including the TCPA, and those laws and regulations are continuously evolving. Our services that allow members and other platform users to leverage such telephonic communications may be subject to these laws and regulations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Healthcare Laws and Regulations and Health Reform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are many laws that govern the activities of healthcare professionals, some of which may be applied to us because of our relationships with them. Some of these requirements may apply to us even if we do not have a physical presence in the state, based solely on our agreements with providers licensed in the state. Many states limit the scope of business relationships between business entities and medical professionals. For example, while many states&#8217; fee-splitting laws only prohibit a physician from sharing medical fees with a referral source, some states have interpreted certain management agreements between business entities and physicians as unlawful fee-splitting. These laws generally prohibit us from exercising control over the medical judgments or decisions of physicians and non-physician healthcare providers and from engaging in certain financial arrangements, such as splitting professional fees with healthcare providers. In addition, certain federal and state anti-kickback and false claims laws may apply to us indirectly through our arrangements with healthcare professionals and entities. Statutes and regulations relating to the practice of medicine, anti-kickback, fraud, fee-splitting, and similar issues vary widely from state to state. Because these laws are often vague, their application is frequently dependent on court rulings and attorney general opinions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there have been several legislative and regulatory changes and proposed reforms of the healthcare system to contain costs, improve quality, and expand access to care, as well as changes and proposed reforms relating to public health emergencies and pandemic responses. Failure to comply with any of these laws or regulations could lead to adverse judicial or administrative action against us and/or our provider customers, civil or criminal penalties, receipt of cease and desist orders from state regulators, loss of provider licenses, the need to make changes to the terms of engagement of our provider customers that interfere with our business, and other materially adverse consequences. For additional information, see &#8220;Risk Factors&#8212;Risks Related to the Healthcare Industry.&#8221; </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our intellectual property rights are valuable and important to our business. We rely on a combination of trademarks, copyrights, patents, trade secrets, license agreements, confidentiality procedures, non-disclosure agreements, employee disclosure and invention assignment agreements, as well as other legal and contractual rights, to establish and protect our proprietary rights. However, our contractual provisions may not always be effective at preventing unauthorized parties from obtaining our intellectual property and proprietary technologies. In addition, though we rely in part upon these legal and contractual protections, we believe that factors such as the skills and ingenuity of our employees and the functionality and frequent enhancements to our platform are larger contributors to our success in the market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we have five provisional patent applications in the United States. We continually review our development efforts to assess the existence and patentability of new intellectual property.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an ongoing trademark and service mark registration program pursuant to which we register our brand names, product names, and logos in the United States to the extent we determine appropriate and cost-effective. As of March&#160;31, 2023, we have a total of eleven registered or applied-for trademarks in the United States and four registered trademarks in non-U.S. jurisdictions. We also have registered domain names for websites that we use in our business, such as www.doximity.com and other variations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to pursue additional intellectual property protection to the extent we believe it would be beneficial and cost-effective. Despite our efforts to protect our intellectual property rights, they may not be respected in the future or may be invalidated, circumvented, or challenged. In addition, if we were to expand internationally, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as laws in the United States. We may be dependent on third-party content, technology, and intellectual property in connection with our business. We expect that infringement claims may increase as the number of products and competitors in our market increase. In addition, to the extent that we gain greater visibility and market exposure as a public company, we face a higher risk of being the subject of intellectual property infringement claims from third parties. Any third party intellectual property claims against us could significantly increase our expenses and could have a significant and negative impact on our business, results of operations, and financial condition.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have experienced some seasonality based on the timing of marketing programs, subscription launches on our platform and budgetary timing of purchases of additional modules.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and we subsequently changed the name to Doximity, Inc. in June 2010. Our principal executive offices are located at 500 3rd Street, Suite 510, San Francisco, California 94107, and our telephone number is (650) 549-4330. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file electronically with the SEC our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, our Proxy Statement, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In addition, copies of these reports and other information may be obtained, free of charge, on our website at www.investors.doximity.com as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We webcast our earnings calls and certain events we participate in or host with members of the investment community on our investor relations website. Additionally, we provide notifications of news or announcements regarding our financial performance, including SEC filings, investor events, press and earnings releases, and blogs as part of our investor relations website. We have used, and intend to continue to use, our investor relations website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Further corporate governance information, including our corporate governance guidelines, composition of our board and its committees, and Code of Conduct, are also available on our investor relations website under the heading &#8220;Governance Documents.&#8221; The contents of our websites are not intended to be incorporated by reference into this Annual Report on Form 10-K or in any other report or document we file with the SEC, and any references to our websites are intended to be inactive textual references only. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A description of the risks and uncertainties associated with our business is set forth below. You should carefully consider the risks and uncertainties described below, together with all of the other information contained in this Annual Report on Form 10-K, including our consolidated financial statements and the related notes thereto, and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; The risks and uncertainties described below may not be the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, results of operations, financial condition, and prospects could be harmed. In that event, the trading price of our Class A common stock could decline and you could lose a portion or all of your investment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors Summary</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The below is a summary of principal risks to our business and risks associated with ownership of our stock. It is only a summary. You should read the more detailed discussion of risks set forth below and elsewhere in this report for a more complete discussion of the risks listed below and other risks. Additional risks, beyond those summarized below, set forth in this section, or discussed elsewhere in this Annual Report on Form 10-K, may apply to our business, activities or operations as currently conducted or as we may conduct them in the future or in the markets in which we operate or may in the future operate. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to effectively manage our growth, we may be unable to execute our business plan, adequately address competitive challenges or maintain our corporate culture, and our business, financial condition, and results of operations could be harmed;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a limited operating history, which makes it difficult to evaluate our current business and future prospects and to predict our future operating results, and therefore increases the risk of investment;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to retain existing members or add new members, our revenue, operating results, financial condition, and business may be significantly harmed;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we do not continue to attract new customers, or if existing customers do not renew their subscriptions, renew on less favorable terms, or fail to purchase additional solutions, it could have a material adverse effect on our business, financial condition, and results of operations;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our revenue is relatively concentrated within a small number of key customers, and the loss of one or more of such key customers could slow the growth rate of our revenue or cause our revenue to decline;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect to face increasing competition in the market for our solutions;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to maintain and enhance our reputation and brand recognition, our business, financial conditions, and results of operations will be harmed;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Making business decisions that prioritize the interests of our members may adversely impact our financial results;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, develop, motivate, and retain our personnel, we may not be able to grow effectively;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to maintain, protect, or enforce our intellectual property rights could harm our business and results of operations; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The dual class structure of our common stock has the effect of concentrating voting control with our executive officers (including our Chief Executive Officer) and directors and their affiliates; this will limit or preclude your ability to influence corporate matters.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to adequately address these and other risks we face, our business, results of operations, financial condition and prospects may be harmed. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to effectively manage our growth, we may be unable to execute our business plan, adequately address competitive challenges or maintain our corporate culture, and our business, financial condition, and results of operations could be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since launching our platform in fiscal 2012, we have experienced rapid growth and we continue to rapidly and significantly expand our operations. While we have experienced significant revenue growth in prior periods, it is not indicative of our future revenue growth. We expect our revenue growth rate may decline. In fiscal 2023 and 2022, our revenue grew by 22% and&#160;66%, respectively, as compared to the prior years. In addition, our full-time equivalent employee headcount has grown from 887 as of March&#160;31, 2022 to 977 as of March&#160;31, 2023. This expansion increases the complexity of our business and places significant strain on our management, personnel, operations, systems, technical performance, financial resources, and internal financial control and reporting functions. We may not be able to manage growth effectively, which could damage our reputation, limit our growth, and negatively affect our operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth and expansion of our business creates significant challenges for our management, operational, and financial resources. In the event of continued growth of our operations or in the number of our third-party relationships, our information technology systems and our internal controls and procedures may not be adequate to support our operations. To effectively manage our growth, we must continue to improve our operational, financial, and management processes and systems and to effectively expand, train, and manage our employee base. As our organization continues to grow and we are required to implement more complex organizational management structures, we may find it increasingly difficult to maintain the benefits of our corporate culture, including our ability to quickly develop and launch new and innovative solutions. This could negatively affect our business performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to invest heavily in growing our business, which may cause our sales and marketing, research and development, and other expenses to increase and our margins to decline. Our net income and adjusted EBITDA margins may decrease as we grow our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our historical rate of growth may not be sustainable or indicative of our future rate of growth. We believe that our continued growth in revenue, as well as our ability to improve or maintain margins and profitability, will depend upon, among other factors, our ability to address the challenges, risks, and difficulties described elsewhere in this &#8220;Risk Factors&#8221; section and the extent to which our various offerings grow and contribute to our results of operations. We cannot provide assurance that we will be able to successfully manage any such challenges or risks to our future growth. In addition, our customer base may not continue to grow or may decline due to a variety of possible risks, including increased competition, changes in the regulatory landscape, and the maturation of our business. Any of these factors could cause our revenue growth to decline and may adversely affect our margins and profitability. Failure to grow our revenue or improve our margins could have a material adverse effect on our business, financial condition, and results of operations. You should not rely on our historical rate of revenue growth as an indication of our future performance.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited operating history, which makes it difficult to evaluate our current business and future prospects and to predict our future operating results, and therefore increases the risk of investment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doximity, Inc. was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and we subsequently changed the name to Doximity, Inc. in June 2010. We began commercial offerings in fiscal 2012, and by fiscal 2014 we began serving our pharmaceutical and health system customers on some of our early stage solutions. As a result of our limited operating history and rapid growth, our ability to forecast our future operating results, including revenue, cash flows, and profitability, is limited and subject to a number of uncertainties, including our ability to effectively plan for and model future growth. We have encountered and will encounter risks and challenges frequently experienced by growing companies with competitive offerings, such as the risks and uncertainties described in this Annual Report on Form 10-K. In addition, our business is affected by general economic and business conditions around the world, including the impact of the COVID-19 pandemic or any other similar pandemic or epidemic. If our assumptions regarding these risks and uncertainties are incorrect or change due to changes in our markets, or if we do not address these risks successfully, our operating and financial results may differ materially from our expectations and our business may suffer. These risks and challenges include our ability to:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and increase our number of registered members for our platform;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and increase our number of customers for our solutions;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase revenue from the solutions we provide; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully compete with other companies that are currently in, or may in the future enter, the online professional network space, telehealth, or productivity tools;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and improve the infrastructure underlying our network, including Amazon Web Services and our apps and websites, including with respect to data protection and cybersecurity; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and further develop a scalable, high-performance technology infrastructure that can efficiently and reliably handle increased member usage, as well as the deployment of new features and tools; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully update our network, including expanding our network and offerings, develop and update our apps, features, offerings, and services to benefit our members&#8217; experience;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">responsibly use the data that our members share with us to provide solutions that make our members more successful and productive and that are critical to the hiring and marketing needs of enterprises and professional organizations; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with existing and new laws and regulations applicable to our business and our industry;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">process, store, and use personal data in compliance with governmental regulation and other legal obligations related to privacy; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and enhance the value of our reputation and brand;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to earn and preserve our members&#8217; trust with respect to their professional reputation and information; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively manage our growth; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire, integrate, and retain talented people at all levels of our organization.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to retain existing members or add new members, our revenue, operating results, financial condition, and business may be significantly harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The size of our member base and our members&#8217; level of engagement are critical to our success. Our financial performance has been and will continue to be significantly determined by our success in adding, retaining, and engaging members. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If medical professionals do not perceive our platform to be useful, reliable, and trustworthy, we may not be able to attract or retain members or otherwise maintain or increase the frequency and duration of their engagement. A decrease in member retention, growth, or engagement could render us less attractive to our pharmaceutical manufacturer and health system customers, which may have a material and adverse impact on our revenue, business, financial condition, and results of operations. Any number of factors could potentially negatively affect member retention, growth, and engagement, including if:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we fail to introduce new and improved tools or if we introduce new tools for our members that are not favorably received;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there are changes in member sentiment about the quality or usefulness of our tools or concerns related to privacy and sharing, safety, security, or other factors;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we are unable to manage and prioritize information to ensure members are presented with content that is interesting, useful, and relevant to them;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there are adverse changes in our tools that are mandated by legislation, regulatory authorities, or litigation, including settlements or consent decrees;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">technical or other problems prevent us from delivering our tools in a rapid and reliable manner or otherwise affect the member experience; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we adopt policies or procedures related to areas such as sharing our member data that are perceived negatively by our members or the general public; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new offerings from our competitors are introduced to the market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to maintain and increase our member base and member engagement, our revenue, operating results, financial condition, business, and future growth potential may be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not continue to attract new customers, or if existing customers do not renew their subscriptions, renew on less favorable terms, or fail to purchase additional solutions, it could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to grow our business, we must continually attract new customers, sell additional solutions to existing customers and reduce the level of non-renewals in our business. Our ability to do so depends in large part on the success of our sales and marketing efforts. Most customers engage with us on particular marketing programs, either directly or through marketing agencies that act on their behalf. We do not typically enter into long-term contracts with our pharmaceutical manufacturer customers, who represent a significant portion of our revenue. When we do enter into long-term relationships with customers, they can generally terminate their relationship with us or move their marketing activity to a new agency with whom we do not currently do business. Even if we are successful in attracting new customers and their agencies, it may take several months or years for them to meaningfully increase the amount they spend with us. Further, larger pharmaceutical customers with multiple brands typically have brand-level marketing budgets and marketing decision makers, and we may not be able to leverage our success into expanded business with other brands within the customer&#8217;s portfolio. Moreover, customers may place internal limits on the allocation of their marketing budgets to digital marketing, to particular programs, to a particular marketing vendor, or for other reasons. We may not accurately predict future trends with respect to rates of customer renewals, upgrades, and expansions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers of our Marketing Solutions may not continue to do business with us if their marketing content does not reach their intended audiences. Therefore, we must continue to demonstrate to our customers that using our Marketing Solutions offering is the most effective and cost-efficient way to maximize their results. Similarly, we must demonstrate that our Hiring Solutions are important recruiting tools for enterprises, professional organizations, and individuals and that our Hiring Solutions provide them with access to the target audience. Our Hiring Solutions customers will discontinue their purchases of our solutions if we fail to effectively connect them with the talent they seek. Finally, for our Telehealth Solutions, we may not be able to retain existing customers or attract new customers if we fail to provide high quality solutions, if customers are unable to realize the value of our solutions, or if we are not able to measure and demonstrate the value that our solutions provide.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer base may decline or fluctuate due to a number of factors, including the prices of our solutions, the prices of products and services offered by our competitors, reduced hiring by our customers or reductions in their talent or marketing spending levels due to macroeconomic or other factors, and the efficacy and cost-effectiveness of our solutions. In particular, our overall performance depends, in part, on worldwide economic conditions. In recent months, we have observed increased economic uncertainty in the United States and abroad. As our customers react to global economic conditions, including the impact of inflation on wages and labor costs, raw material costs, reduced discretionary spending, and the potential for a global recession, we may see them reduce spending on our solutions and take additional precautionary measures to limit or delay expenditures and preserve capital and liquidity. In addition, if any of our customers with whom we conduct business are unable to access funds pursuant to instruments or lending arrangements with a financial institution that falls into receivership or experience similar liquidity issues, such parties&#8217; ability to pay their obligations to us or to enter into new commercial arrangements requiring additional payments to us could be adversely affected. Reductions in spending on our solutions, delays in purchasing decisions, lack of renewals, and an inability to attract new customers, as well as pressure for extended billing terms or pricing discounts, could limit our ability to grow our business and could negatively affect our operating results and financial condition. Internet search engines could also change their methodologies in ways that adversely affect our ability to optimize our page rankings within their search results. If this occurs, our ability to successfully market our services may be harmed. If we are unable to retain and increase sales of our solutions to existing customers and their agencies or attract new ones for any of the reasons above or for other reasons, our business, financial condition, and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenue is relatively concentrated within a small number of key customers, and the loss of one or more of such key customers could slow the growth rate of our revenue or cause our revenue to decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended March&#160;31, 2023 and 2022, no customer accounted for 10% or more of total revenue. For the fiscal year ended March&#160;31, 2021, one of our customers accounted for 10% or more of total revenue. In addition, some of our customers purchase our services indirectly through marketing agencies, some of whom represent a number of customers. The sudden loss of any of our largest customers or the renegotiation of any of our largest customer contracts, either directly or through marketing agencies, could have a significant impact on our revenue, the growth rate of our revenue, our reputation, and our ability to obtain new customers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we engage in active discussions and renegotiations with our customers, either directly or through marketing agencies, in respect of the solutions we provide and the terms of our customer agreements, including our fees. As our customers&#8217; businesses respond to market dynamics, financial pressures, and regulatory changes or delays impacting their businesses, and as our customers make strategic business decisions regarding how to market their offerings, our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customers seek to, and we expect will continue to seek to, amend the terms of their arrangements with us. In the ordinary course, we renegotiate the terms of our agreements with our customers in connection with renewals or extensions of these agreements. These discussions and future discussions could result in reductions to the fees and changes to the scope contemplated by our original customer contracts and consequently could negatively impact our revenue, business, and prospects. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we rely on a limited number of customers and agencies for a significant portion of our revenue, we depend on the creditworthiness of these entities. If the financial condition of these entities declines, our credit risk could increase. Should one or more of our significant customers or agencies declare bankruptcy, be declared insolvent, or otherwise be restricted by state or federal laws or regulation from continuing in some or all of their operations, this could adversely affect our ongoing revenue, the collectability of our accounts receivable, and affect our bad debt reserves and net income.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to face increasing competition in the market for our solutions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition across different aspects of our business, and we expect such competition to increase. Our industry and the markets we serve are evolving rapidly and becoming increasingly competitive. Larger and more established companies may focus on our markets and could directly compete with us. Smaller companies could also launch new products and services that compete with us and that could gain market acceptance quickly. We also expect our existing competitors in the markets for Marketing and Hiring Solutions to continue to focus on these areas. A number of these companies may have greater financial, technological, and other resources than we do and greater name recognition and more established distribution networks and relationships with healthcare providers than us, which may enable them to compete more effectively. Specifically, we compete for medical professionals as members against large technology companies that have developed online networking and collaboration tools like LinkedIn, Facebook, Google, and Twitter, in addition to smaller, emerging companies. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also compete to access marketing, hiring, and telehealth budgets of pharmaceutical and health system companies as customers for our Marketing, Hiring, and Telehealth Solutions. We compete for customers for our Marketing Solutions with online outlets such as health-related websites and mobile apps, like WebMD&#8217;s Medscape, as well as offline organizations that provide marketing and advertising services that enable pharmaceutical manufacturers and health systems to educate medical professionals. We compete for customers for our Hiring Solutions with large and regional staffing companies, job boards, self-service recruiting tools, and medical recruiting firms. We compete for customers for our Telehealth Solutions with other providers of telehealth offerings such as American Well and Teladoc Health, and other companies that offer telehealth capabilities such as Zoom Video Communications who may further focus on our market and could directly compete with us. We also compete for members, customers, and professional organizations in the market for online professional networks which continues to rapidly evolve. Our competitors may announce new products, services, or enhancements that better address changing industry standards or the needs of members and customers, such as mobile access. Any such increased competition could cause pricing pressure, loss of market share, or decreased member engagement, any of which could adversely affect our business and operating results. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to maintain and enhance our reputation and brand recognition, our business, financial conditions, and results of operations will be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that maintaining and enhancing our reputation and brand recognition is critical to our relationships with existing customers and members and our ability to attract new customers and members. The promotion of our brand may require us to make substantial investments and we anticipate that, as our market becomes increasingly competitive, these marketing initiatives may become increasingly difficult and expensive. Our marketing activities may not be successful or yield increased revenue, and to the extent that these activities yield increased revenue, the increased revenue may not offset the expenses we incur, and our results of operations could be harmed. In addition, any factor that diminishes our reputation or that of our management, including failing to meet the expectations of our customers and members, could make it substantially more difficult for us to attract new customers. Similarly, because our customers often act as references for us with prospective new customers, any existing customer that questions the quality of our work or that of our employees could impair our ability to secure additional new customers. If we do not successfully maintain and enhance our reputation and brand recognition with our members and customers, our business may not grow and we could lose these relationships, which would harm our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Making business decisions that prioritize the interests of our members may adversely impact our financial results. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;physicians first&#8221; philosophy may mean we make decisions based on the best interests of our members, which we believe is essential to our success in increasing our member growth rate and engagement, creating value for our members, and in serving the best interests of the Company and our stockholders. Therefore, in the past, we have forgone, and may in the future forgo, certain expansion or revenue opportunities that we do not believe are in the best interests of our members, even if </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our decision negatively impacts our operating results. In addition, our philosophy of putting our members first may cause disagreements, or negatively impact our relationships, with our existing or prospective customers. Our decisions may not result in the benefits that we expect, in which case our member engagement, business, and operating results could be harmed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our members&#8217; profiles are out-of-date, inaccurate, or lack the information that members and customers want to see, we may not be able to realize the full potential of our network, which could adversely impact the growth of our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our members do not update their information or provide accurate and complete information when they join our platform, the value of our platform may be negatively impacted because our value proposition as a professional network and as a source of accurate and comprehensive data will be weakened. For example, incomplete or outdated member information would diminish the ability of our Marketing Solutions customers to reach their target audiences and our ability to provide our customers with valuable insights. Similarly, customers of our Hiring Solutions may not find members that meet their qualifications or may misidentify a candidate as having such qualifications, which could result in mismatches that erode customer confidence in our solutions. Therefore, we must provide features and tools that demonstrate the value of our network to our members and motivate them to contribute additional, timely, and accurate information to their profile and our network. In addition, we must ensure that methods by which we identify relevant audiences for our customers results in accurate targeting. If we fail to successfully undertake these activities, our business and operating results could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The telehealth market is immature and volatile, and if it does not develop, or if it develops more slowly than we expect, if it encounters negative publicity, or if we are not successful in demonstrating and promoting the benefits of our solutions, the growth of our business will be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The telehealth market is relatively new and unproven, and it is uncertain whether it will achieve and sustain high levels of demand, consumer acceptance, and market adoption. The success of our Telehealth Solutions will depend to a substantial extent on the willingness of our members to use, and to increase the frequency and extent of their utilization of, our network, as well as on our ability to demonstrate the value of telehealth to employers, health plans, government agencies, and other purchasers of healthcare for beneficiaries. If any of these events do not occur or do not occur quickly, it could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our corporate culture has contributed to our success, and if we cannot maintain our corporate culture as we grow, we could lose the innovation, teamwork, passion, and focus on execution that we believe contribute to our success, and our business may be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a critical component to our success has been our corporate culture. We have invested substantial time and resources in building our team. As we continue to grow, we may find it difficult to maintain these important aspects of our corporate culture, especially given that the majority of our workforce works remotely. We have experienced, and may continue to experience, rapid growth and organizational change, including growth and organizational change resulting from our acquisition of and subsequent integration with other businesses, which will continue to place significant demands on our management and our operational and financial infrastructure. As we continue to grow, we must effectively integrate, develop, and motivate a large number of new employees, and we must maintain the beneficial aspects of our corporate culture. We will require significant capital expenditures and the allocation of valuable management resources to grow and change in this way, without undermining our corporate culture. Any failure to preserve our culture could negatively affect our future success, including our ability to retain and recruit personnel and to effectively focus on and pursue our corporate objectives.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to attract top talent, we have had to offer, and believe we will need to continue to offer, highly competitive compensation packages before we can validate the productivity of those employees. In addition, fluctuations in the price of our common stock may make it more difficult or costly to use equity compensation to motivate, incentivize, and retain our employees. We face significant competition for talent from other healthcare, technology, and high-growth companies, which include both large enterprises and privately-held companies. We may not be able to hire new employees quickly enough to meet our needs. If we fail to effectively manage our hiring needs and successfully integrate our new hires, our efficiency and ability to meet our forecasts and our employee morale, productivity, and retention could suffer, and our business, results of operations, and financial condition could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of one or more of any of the pharmaceutical brands that purchase our solutions could cause our revenue to decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell subscriptions for our marketing solutions across different brands within our pharmaceutical customers. The success of pharmaceutical brands and associated marketing spend can depend on patent life, competition, and other factors. For example, in the past we have lost marketing spend and associated revenue when a pharmaceutical brand marketed on our platform lost patent protection. The loss of the business of a significant brand could damage our relationship with that customer </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and its other brands, and our revenue, operating results, financial condition, business, and future growth potential may be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We calculate certain operational metrics using internal systems and tools and do not independently verify such metrics. Certain metrics are subject to inherent challenges in measurement, and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present certain operational metrics herein, including size of our network of medical professionals and other metrics. We calculate these metrics using internal systems and tools that are not independently verified by any third party. These metrics may differ from estimates or similar metrics published by third parties or other companies due to differences in sources, methodologies, or the assumptions on which we rely. Our internal systems and tools have a number of limitations, and our methodologies for tracking these metrics may change over time, which could result in unexpected changes to our metrics, including the metrics we publicly disclose on an ongoing basis. If the internal systems and tools we use to track these metrics undercount or overcount performance or contain algorithmic or other technical errors, the data we present may not be accurate. While these numbers are based on what we believe to be reasonable estimates of our metrics for the applicable period of measurement, there are inherent challenges in measuring the size of our network and other metrics. For example, we face challenges in accurately calculating the number of practicing doctors or other professionals in our network at a given time. In addition, limitations or errors with respect to how we measure data or with respect to the data that we measure may affect our understanding of certain details of our business, which would affect our long-term strategies. If our operating metrics or our estimates are not accurate representations of our business, or if investors do not perceive our operating metrics to be accurate, or if we discover material inaccuracies with respect to these figures, our reputation may be significantly harmed, and our operating and financial results could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market opportunity estimates and growth forecasts that we may issue from time to time are subject to significant uncertainty and are based on assumptions and estimates which may not prove to be accurate. Our estimates and forecasts relating to size and expected growth of our target market may prove to be inaccurate. Even if the markets in which we compete meet these size estimates and growth forecasts, our business may not grow at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and uncertainties.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our operating results and financial metrics may be difficult to predict as a result of seasonality.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced some seasonality in both revenue and net income based on the timing of marketing program subscription launches on our platform and budgetary timing of purchases of additional modules. We may be affected by seasonal trends in the future, particularly as our business matures. Additionally, this seasonality may be reflected to a much lesser extent, and sometimes may not be immediately apparent, in our revenue. To the extent we experience this seasonality, it may cause fluctuations in our operating results and financial metrics and make forecasting our future operating results and financial metrics more difficult.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results have in the past and may in the future continue to fluctuate on a quarterly and annual basis and if we fail to meet the expectations of analysts or investors, our stock price and the value of your investment could decline substantially.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results have in the past, and may in the future, continue to fluctuate significantly on a quarterly and annual basis and may fail to match our past performance, and if we fail to meet or exceed the expectations of securities analysts or investors, the trading price of our Class A common stock could decline. Moreover, our stock price may be based on expectations of our future performance that may be unrealistic or that may not be met. Some of the important factors that could cause our revenue and operating results to fluctuate from quarter to quarter include:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to increase sales of our solutions to new customers and expand sales of additional solutions to our existing customers; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which existing customers renew their agreements with us and the timing and terms of those renewals;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the termination or renegotiation by our significant customers of their agreements with us;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the entrance of new competitors in our market whether by established companies or new companies; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our pricing policies or those of our competitors; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of investing in our technology infrastructure, which may be greater than we anticipate; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain or increase our member base and member engagement; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions or outages in our website availability, actual or perceived breaches of privacy, and compromises of our member data; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general industry and macroeconomic conditions which would adversely impact sales.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates or judgments relating to our critical accounting policies prove to be incorrect, our results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP and our key metrics require management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and amounts reported in our key metrics. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Estimates&#8221;. The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity and the amount of revenue and expenses that are not readily apparent from other sources. Significant assumptions and estimates used in preparing our consolidated financial statements include those related to revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors, resulting in a decline in the trading price of our Class A common stock.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent and changing laws, regulations, self-regulatory schemes, contractual obligations, and standards related to privacy, data protection, and information security. The actual or perceived failure by us, our customers, partners, or vendors to comply with such obligations could harm our reputation, subject us to significant fines and liability, or otherwise adversely affect our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, and share (collectively, &#8220;Process&#8221;, or &#8220;Processing&#8221;) sensitive, confidential, and proprietary information (collectively, &#8220;Sensitive Information&#8221;) in connection with providing our services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous domestic and foreign laws, regulations, self-regulatory schemes, and standards regarding privacy, data protection, and information security and Processing (collectively, &#8220;Data Protection Laws&#8221;), the number and scope of which is changing, subject to differing applications and interpretations, and which may be inconsistent across jurisdictions or in conflict with each other. The regulatory framework for privacy, data protection, and information security issues worldwide is evolving and is likely to remain in flux for the foreseeable future. Various governmental and consumer agencies have also called for new regulations and changes in industry practices. Practices regarding privacy, data protection, and information security have recently come under increased public and regulatory scrutiny. The actual or perceived failure to address or comply with applicable Data Protection Laws by us or our customers, partners, or vendors could increase our compliance and operational costs, expose us to regulatory scrutiny, actions, fines, and penalties, result in reputational harm, lead to a loss of customers, reduce the use of our services, result in litigation and liability, have a material adverse effect on our business operations or financial results, or otherwise result in other material harm to our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a &#8220;Business Associate&#8221; as defined under the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, which we collectively refer to as HIPAA, and the U.S. Department of Health and Human Services Office of Civil Rights, or OCR, may impose significant penalties on a Business Associate for a failure to comply with an applicable requirement of HIPAA. Penalties may include civil monetary penalties, criminal monetary penalties and imprisonment. The U.S. Department of Justice, or the DOJ, is responsible for criminal prosecutions under HIPAA. State attorneys general also have the right to prosecute HIPAA violations committed against residents of their states. While HIPAA does not create a private right of action that would allow individuals to sue in civil court for HIPAA violations, its standards have been used as the basis for the duty of care in state civil suits, such as those for negligence or recklessness in misusing individuals&#8217; health information. Furthermore, in the event of a breach as defined by HIPAA, the Business Associate may have to comply with specific reporting requirements under HIPAA regulations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The security measures that we and our third-party vendors and subcontractors have in place in an effort to ensure compliance with privacy and data protection laws may not protect our facilities and systems from security breaches, acts of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vandalism or theft, computer viruses, misplaced or lost data, programming and human errors, or other similar events. Under the HITECH Act, as a Business Associate, we may also be liable for privacy and security breaches and failures of our subcontractors. Even though we provide for appropriate protections through our agreements with our subcontractors, we still have limited control over their actions and practices. A breach of privacy or security of individually identifiable health information by a subcontractor may result in an enforcement action, including criminal and civil liability, against us. We are not able to predict the extent of the impact such incidents may have on our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforcement actions against us could be costly and could interrupt regular operations, which may adversely affect our business. While we have not received any notices of violation of any Data Protection Law and believe we are in compliance with such laws, there can be no assurance that we will not receive such notices in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable Data Protection Laws may also include state medical privacy laws, including those related to mental health and substance use treatment, and the provision of healthcare services, as well as federal and state consumer protection laws. These laws may not be preempted by HIPAA, may be more protective than HIPAA, and may be subject to varying interpretations by the courts and government agencies, creating complex compliance issues for us and our customers and partners and potentially exposing us to additional expense, adverse publicity and liability, any of which could adversely affect our business. Federal and state consumer protection laws are increasingly being applied by the U.S. Federal Trade Commission, or FTC, and states&#8217; attorneys general to regulate the Processing of personal or personally identifiable information, through websites or otherwise, and to regulate the presentation of website content. The FTC in particular has approved consent decrees resolving complaints and their resulting investigations into the privacy and security practices of a number of online social media companies. These reviews can and have resulted in changes to our solutions and policies, and could result in additional changes in the future. If we are unable to comply with any such reviews or decrees that result in recommendations or binding changes, or if the recommended changes result in degradation of our solutions, our business could be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, U.S. states have begun to introduce more comprehensive Data Protection Laws. For example, the California Consumer Privacy Act, or CCPA, went into effect in January 2020 and established a new privacy framework for covered businesses such as ours that expands the scope of personal information and provides new privacy rights for California residents. These changes required us to modify our data processing practices and policies and incur compliance related costs and expenses. The CCPA also provides for civil penalties for violations, as well as a private right of action for data breaches, which may increase the likelihood and cost of data breach litigation. Additionally, the California Privacy Rights Act, or CPRA, went into effect on January 1, 2023 and significantly modified the CCPA by, among other things, creating a dedicated privacy regulatory agency, requiring businesses to implement data minimization and data integrity principles, and imposing additional requirements for contracts addressing the processing of personal information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Data Protection Laws, we are or may be subject to the terms of our internal and external policies, representations, publications, frameworks, self-regulatory standards, and industry certification commitments (collectively, &#8220;Privacy Policies&#8221;), and contractual obligations to third parties related to privacy, data protection, and information security (collectively, &#8220;Data Protection Obligations&#8221;), including the Payment Card Industry Data Security Standards (&#8220;PCI-DSS&#8221;), the rules imposed by credit card brands (e.g., VISA and Mastercard), and Security Organization Control 2 certification commitments. We strive to comply with applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations, but we may at times fail to do so or may be perceived to have failed to do so, in which case we may be subject to and suffer a material harm to our business. For example, in the event we fail to comply with the PCI-DSS, we could be in breach of our obligations under customer and other contracts. Moreover, despite our efforts, we may not be successful in achieving compliance if our personnel, customers, partners, or vendors do not comply with applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations. We may be subject to and suffer material harm to our business if our Privacy Policies are, in whole or part, found to be inaccurate, incomplete, deceptive, unfair, or misrepresentative of our actual practices. In addition, any such failure or perceived failure could result in public statements against us by consumer advocacy groups or others, which may cause us material reputational harm.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our customers may expect us to comply with more stringent privacy, data protection, and information security requirements than those imposed by applicable Data Protection Laws, and we may be obligated contractually to comply with additional or different standards relating to our handling or protection of data on or by our offerings. For example, our mobile application is distributed through third-party platforms such as those operated by Apple and Google. These third parties may impose technical and privacy, data protection, and information security requirements on companies that distribute applications through their platforms. These requirements are subject to change and may adversely impact our ability to Process personal information. Complying with these requirements may cause us to incur additional expense, and the failure to comply with these requirements may cause us to lose access to the app store and users, and our business would be harmed. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New or amended Data Protection Laws, and changes in the interpretation of existing Data Protection Laws and our Data Protection Obligations, could impair our, our customers&#8217;, our partners&#8217;, or our vendors&#8217; ability to Process personal information, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which could have a material adverse effect on our business, financial condition, and results of operations. The enactment of the CCPA has prompted similar legislative developments in other states, which could create the potential for a patchwork of overlapping but different state laws. The federal government is also considering comprehensive privacy legislation. If we begin to conduct business in Europe, complying with the General Data Protection Regulation, or GDPR, would entail significant costs and increase our liability risks. The GDPR imposes more stringent data protection requirements and would require us to undertake significant operational changes in order to comply, which could have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations imposing complex and burdensome obligations, and with substantial uncertainty in their interpretation and compliance, we have faced and may face challenges in addressing and complying with them, and fundamentally changing our business activities, Privacy Policies, and practices, and may expend significant resources in an effort to do so, any of which could result in material harm to business, financial condition, results of operations, or other harm.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our security measures are compromised now or in the future, or the security, confidentiality, integrity, or availability of our information technology, software, services, communications, or data is compromised, limited, or fails, this could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform involves the storage and transmission of Sensitive Information. As a result, unauthorized access or security breaches as a result of third-party action (e.g., cyber-attacks), employee error, product defect, malfeasance, or other factors could result in the loss of information, inappropriate use of or access to information, service interruption, service degradation, outages, service level credits, litigation, indemnity obligations, damage to our reputation, and other liability. Our  platform also utilizes artificial intelligence and machine learning technology to provide services, and this technology may be susceptible to cybersecurity threats. While we maintain and continue to improve our security measures, we may be unable to adequately anticipate security threats or to implement adequate preventative measures, in part, because the techniques used to obtain unauthorized access or sabotage systems change frequently and generally are not identified until they are launched against a target. Moreover, the detection, prevention, and remediation of known or unknown security vulnerabilities, including those arising from third-parties, is becoming increasingly expensive and may cause us to incur significant costs in the future. We process significant amounts of Sensitive Information, including protected health information, personal information, data concerning our members, and in some cases, limited amounts of data concerning the patients they treat in connection with our members&#8217; utilization of our network and related services. While we have implemented security measures to protect such data, techniques used to gain unauthorized access to data and systems, disable or degrade service, or sabotage systems are constantly evolving, and we may be unable to anticipate such techniques or implement adequate preventative measures to avoid unauthorized access or other adverse impacts to such data or our systems. We may use third-party service providers and subprocessors to help us deliver services and engage in Processing on our behalf, including, without limitation, the processing of payment card information. If we, our service providers, partners, or other relevant third parties have experienced or in the future experience any security incidents that result in any data loss, deletion or destruction, unauthorized access to, loss of, unauthorized acquisition or disclosure of, or inadvertent exposure of, Sensitive Information, or compromise related to the security, confidentiality, integrity, or availability of our (or their) information technology, software, services, communications, or data (collectively, a Security Breach), it may result in material harm to our business, including, without limitation, regulatory investigations or enforcement actions, litigation, indemnity obligations, negative publicity, and financial loss.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our service is vulnerable to threat actors, software bugs, malicious code (such as computer viruses and internet worms), personnel theft or misuse, break-ins, phishing attacks, denial-of-service attacks (including credential stuffing), ransomware attacks, natural disasters, terrorism, war, telecommunication and electrical failures, server malfunction, software or hardware failures, loss of data or other computer assets, adware, or other similar issues or other attacks or similar disruptions, any of which could lead to system interruptions, delays, or shutdowns, causing loss of critical data or the unauthorized access of data. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to expend significant resources, fundamentally change our business activities and practices, or modify our services, software, operations, or information technology in an effort to protect against Security Breaches and to mitigate, detect, and remediate actual and potential vulnerabilities. Applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations may require us to implement specific security measures or use industry-standard or reasonable measures to protect against Security Breaches. The recovery systems, security protocols, network protection mechanisms, and other security measures that we (and our third parties) have integrated into our platform, systems, networks, and physical facilities, which are designed to protect against, detect, and minimize Security Breaches, may not be adequate to prevent or detect service interruption, system failure, or data loss.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable Data Protection Laws, Privacy Policies, or Data Protection Obligations may require us to notify affected individuals, regulators, customers, credit reporting agencies, and others in the event of a Security Breach. Patients about whom we obtain health information, as well as the providers who share this information with us, may have statutory or contractual </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights that limit our ability to use and disclose the information. We may be required to expend significant capital and other resources to ensure ongoing compliance with applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations. Claims that we have violated individuals&#8217; privacy rights or breached our Data Protection Obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain insurance for our business, the coverage under our policies may not apply to the liabilities or damages as a result of the events referenced above or be adequate to compensate us for all losses that may occur. There can also be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages as a result of the events referenced above.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a substantial portion of our workforce is currently working remotely on a part- or full-time basis. This could increase our cyber security risk, create data accessibility concerns, and make us more susceptible to communication disruptions. Any of the foregoing could have a material adverse effect on us.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on evolving technologies, including network and mobile infrastructure, as well as our own capabilities, to maintain and scale our business and maintain competitiveness. Any significant interruptions or delays in service in our products, on our apps or websites or any undetected errors or design faults could adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on the use of information technologies and systems, developing technologies, and our reputation and ability to acquire, retain, and serve our customers are dependent upon the reliable performance of our apps and websites and the underlying network infrastructure. As our operations grow, we must continuously improve and upgrade our systems and infrastructure while maintaining or improving the reliability and integrity of our infrastructure. Our future success also depends on our ability to adapt our systems and infrastructure to meet rapidly evolving consumer trends and demands while continuing to improve the performance, features, and reliability of our solutions in response to competitive services and offerings. We expect the use of alternative platforms such as tablets and wearables will continue to grow and the emergence of niche competitors who may be able to optimize offerings, services, or strategies for such platforms will require new investment in technology. New developments in other areas, such as cloud computing, have made it easier for competition to enter our markets due to lower up-front technology costs. In addition, we may not be able to maintain our existing systems or replace or introduce new technologies and systems as quickly as we would like or in a cost-effective manner. There is also no guarantee that we will possess the financial resources or personnel, for the research, design, and development of new applications or services, or that we will be able to utilize these resources successfully and avoid technological or market obsolescence. Further, there can be no assurance that technological advances by one or more of our competitors or future competitors will not result in our present or future applications and services becoming uncompetitive or obsolete. If we were unable to enhance our offerings and network capabilities to keep pace with rapid technological and regulatory change, or if new technologies emerge that are able to deliver competitive offerings at lower prices, more efficiently, more conveniently, or more securely than our offerings, our business, financial condition, and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success will also depend on the interoperability of our offerings with a range of third-party technologies, systems, networks, operating systems, and standards, including iOS and Android; the availability of our mobile apps in app stores and in &#8220;super-app&#8221; environments; and the creation, maintenance, and development of relationships with key participants in related industries, some of which may also be our competitors. In addition, if accessibility of various apps is limited by executive order or other government actions, the full functionality of devices may not be available to our customers. Moreover, third-party platforms, services, and offerings are constantly evolving, and we may not be able to modify our platform to assure its compatibility with those of third parties. If we lose such interoperability, we experience difficulties or increased costs in integrating our offerings into alternative devices or systems, or manufacturers or operating systems elect not to include our offerings, make changes that degrade the functionality of our offerings, or give preferential treatment to competitive products, the growth of our business, results of operations, and financial condition could be materially adversely affected. This risk may be exacerbated by the frequency with which consumers change or upgrade their devices. In the event consumers choose devices that do not already include or support our platform or do not install our mobile apps when they change or upgrade their devices, our customer engagement may be harmed.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Artificial intelligence (AI) and machine learning (ML) serve a key role in many of our services. As with many technological innovations, AI and ML present risks and challenges that could affect its adoption, and therefore our business. AI and ML present emerging ethical issues and if we enable or offer solutions that draw controversy due to their perceived or actual impact on society, we may experience brand or reputational harm, competitive harm or legal liability. Potential government regulation in the space of AI and ML ethics also may increase the burden and cost of research and development in this area, subjecting us to brand or reputational harm, competitive harm or legal liability. Failure to address AI and ML ethics </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">issues by us or others in our industry could undermine public confidence in AI and ML and slow adoption of AI and ML in our products and services.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to enforcement actions or litigation as a result of our or our members&#8217; failure to comply with laws and regulations relating to communications, even though noncompliance was inadvertent or unintentional.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain systems and procedures designed to ensure that our communications and the communications made by members and others using our platform comply with applicable laws and regulations; however, some legal/regulatory frameworks provide for the imposition of fines or penalties for noncompliance even though the noncompliance was inadvertent or unintentional and even though there were systems and procedures designed to ensure compliance in place at the time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, members use our platform to engage in telephone, text message, and facsimile communications with patients and other doctors and healthcare professionals. There are a number of federal and state laws and regulations potentially applicable to such communications, including the federal Telephone Consumer Protection Act, or TCPA, and those laws and regulations are continuously evolving. A determination by a court or regulatory agency that any of these laws and regulations are applicable to or operate to prohibit or limit telephone, text message, and facsimile communications made by members or others using our platform could invalidate all or some portions of our customer contracts, could require us to change or terminate some portions of our business, could require us to refund portions of our service fees, and could have an adverse effect on our business. In addition, if a court or regulatory agency determines that communications made by members or others using our platform violate any of these laws or regulations and that we are responsible for the violation, we may be subject to substantial damages, substantial civil penalties, and adverse publicity that could have a material adverse effect on our business and financial condition. For violations of the TCPA, the law provides for a private right of action under which a plaintiff may recover statutory damages of $500 for each call, text message, or facsimile made in violation of the statute&#8217;s prohibitions. A court also may treble the amount of damages upon a finding of a &#8220;willful or knowing&#8221; violation of the statute. There is no statutory cap on maximum aggregate exposure. In addition, the Federal Communications Commission, or FCC, which implements and enforces the TCPA, a state attorney general or other federal and state regulators may seek civil penalties in an enforcement action for violations of the TCPA or other laws and regulations potentially applicable to telephone, text message, and facsimile communications made by members or others using our platform.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may incur liability as a result of information retrieved from or transmitted over the Internet or published using our platform and legislation regulating content on our platform may require us to change our solutions or business practices and may adversely affect our business and financial results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our platform allows for the exchange of news, information, and other content, we may face claims relating to the content that is published or made available on our platform. In particular, the nature of our business exposes us to claims related to defamation, dissemination of misinformation, discrimination, harassment, intellectual property rights, rights of publicity and privacy, personal injury torts, laws regulating hate speech or other types of content, and breach of contract, among others. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Communications Decency Act, or CDA, provides statutory protections to online service providers like us who distribute third-party content. However, in the United States, government authorities, elected officials, and political candidates have called for amendments to Section 230 of the CDA that would purport to limit or remove protections afforded to interactive computer service providers and our current protections from liability for third-party content in the United States could decrease or change. We could incur significant costs investigating and defending such claims and, if we are found liable, significant damages. We could also face fines, orders restricting or blocking our services in particular geographies, or other government-imposed remedies as a result of content hosted on our platform.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Content-related legislation or judicial review may require us to change our solutions or business practices, increase our compliance costs, or otherwise impact our operations or our ability to provide services in certain geographies. In addition, we could incur significant costs investigating and defending claims for violating such requirements and, if we are found liable, significant damages. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience fluctuations in our tax obligations and effective tax rate, which could materially and adversely affect our results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. federal and state income taxes. Tax laws, regulations, and administrative practices in various jurisdictions may be subject to significant change, with or without advance notice, due to economic, political, and other conditions, and significant judgment is required in evaluating and estimating our provision and accruals for these taxes. There are many transactions that occur during the ordinary course of business for which the ultimate tax determination is uncertain. Our effective tax rates could be affected by numerous factors, such as changes in tax, accounting, and other laws, regulations, administrative practices, principles, and interpretations, the mix and level of earnings in a given taxing jurisdiction, or our ownership or capital structures.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we accumulated $15.3 million of state and no federal net operating loss carryforwards, or NOLs, to reduce future taxable income, portions of which will begin to expire in 2035. Under Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, or the Code, if a corporation undergoes an &#8220;ownership change,&#8221; the corporation&#8217;s ability to use its pre-change NOLs and other tax attributes, including R&amp;D tax credits, to offset its post-change income or taxes may be limited. In general, an &#8220;ownership change&#8221; will occur if there is a cumulative change in our ownership by &#8220;5 percent stockholders&#8221; that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. Based on an assessment of our historical ownership changes through March&#160;31, 2023, we do not anticipate a current limitation on the tax attributes. Our ability to use NOLs and other tax attributes to reduce future taxable income and liabilities may be subject to limitations as a result of ownership changes that may occur in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current law, U.S. federal net operating losses incurred in taxable years beginning after December 31, 2017 may be carried forward indefinitely. Such U.S. federal net operating losses generally may not be carried back to prior taxable years, except that net operating losses generated in 2018, 2019, and 2020 may be carried back to each of the five tax years preceding the tax years of such losses. Additionally, for tax years beginning after December 31, 2020, the deductibility of U.S. federal net operating losses incurred in taxable years beginning after December 31, 2017, is limited to 80% of taxable income. Our net operating losses may also be impaired or restricted under state law. At the state level, there may be periods during which the use of net operating losses is suspended or otherwise limited, which could increase or permanently accelerate state taxes owed. For example, California imposed limits on the usability of California state net operating losses to offset taxable income in tax years beginning after 2019 and before 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, develop, motivate, and retain our personnel, we may not be able to grow effectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to maintain our competitive position is largely dependent on the services of our senior management and other key personnel. In addition, our future success depends on our continuing ability to attract, develop, motivate, and retain highly qualified and skilled employees. The market for such positions is competitive, especially in the San Francisco Bay Area. Qualified individuals are in high demand and we may incur significant costs to attract them. In addition, the loss of any of our senior management or other key employees, in particular our Chief Executive Officer, or our inability to recruit and develop mid-level managers could materially and adversely affect our ability to execute our business plan and we may be unable to find adequate replacements. Competition for qualified employees is intense in our industry, and the loss of even a few qualified employees, or an inability to attract, retain, and motivate additional highly skilled employees required for the planned expansion of our business could harm our operating results and impair our ability to grow. To attract and retain key personnel, we use various measures, including an equity incentive program for key executive officers and most employees. These measures may not be enough to attract and retain the personnel we require to operate our business effectively. All of our employees are at-will employees, meaning that they may terminate their employment relationship with us at any time, and their knowledge of our business and industry would be extremely difficult to replace. If we fail to retain talented senior management and other key personnel, or if we do not succeed in attracting well-qualified employees or retaining and motivating existing employees, our business, financial condition, and results of operations may be materially adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to litigation, which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been subject to litigation in the past, and may become subject to litigation in the future. Some of these claims may result in significant defense costs and potentially significant judgments against us, some of which we are not, or cannot be, insured against. We generally intend to defend ourselves vigorously; however, we cannot be certain of the ultimate outcomes of any claims that may arise in the future. Resolution of these types of matters against us may result in our having to pay significant fines, judgments, or settlements, which, if uninsured, or if the fines, judgments, and settlements exceed insured levels, could adversely impact our earnings and cash flows, thereby having a material adverse effect on our business, financial condition, results of operations, cash flow, and per share trading price of our Class A common stock. Certain litigation or the resolution of certain litigation may affect the availability or cost of some of our insurance coverage, which could adversely impact our results of operations and cash flows, expose us to increased risks that would be uninsured, and adversely impact our ability to attract directors and officers.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent volatility in capital markets and lower market prices for many securities may affect our ability to access new capital through sales of shares of our Class A common stock or the issuance of indebtedness, which may harm our liquidity, limit </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">our ability to grow our business, pursue acquisitions, or improve our operating infrastructure and restrict our ability to compete in our markets.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including the need to develop new features and tools or enhance our existing solutions, improve our operating infrastructure, or acquire complementary businesses and technologies. Accordingly, we have engaged and may continue to engage in equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our Class A common stock. Any debt financing we secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. Recent volatility in capital markets and lower market prices for many securities may, among other things, affect our ability to access new capital on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be harmed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may seek to grow our business through acquisitions of, or investments in, new or complementary businesses, technologies, tools, or solutions, or through strategic alliances, and the failure to manage these acquisitions, investments or alliances, or to integrate them with our existing business, could have a material adverse effect on us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, we completed an acquisition of Curative Talent and, on April 1, 2022 we completed the acquisition of the AMiON business, and we may in the future consider opportunities to acquire or make additional investments in new or complementary businesses, technologies, offerings, tools, or solutions, or enter into strategic alliances, that may enhance our capabilities and platform in general, complement our current offerings, or expand the breadth of our markets. Our ability to successfully grow through these types of strategic transactions depends upon our ability to identify, negotiate, acquire, and integrate suitable target businesses, technologies, tools, and solutions and to obtain any necessary financing, and is subject to numerous risks, including:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to identify acquisition, investment, or other strategic alliance opportunities that we deem suitable or available on favorable terms;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">problems integrating the acquired business, technologies, tools, or solutions, including issues maintaining uniform standards, procedures, controls, and policies; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">integrating personnel from the acquired company;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated costs associated with acquisitions, investments, or strategic alliances; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse impacts on our overall margins; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management&#8217;s attention from our existing business; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with entering new markets in which we may have limited or no experience; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential loss of key employees of acquired businesses; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased legal and accounting compliance costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a significant portion of the purchase price of companies we acquire may be allocated to acquired goodwill and other intangible assets. In the future, if our acquisitions do not yield expected returns, we may be required to take impairment charges to our results of operations based on our impairment assessment process, which could harm our results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience challenges with managing the integration and growth related to these acquisitions or other future acquisitions. The operation and integration of the acquired technologies and business operations may require substantial financial costs and management attention. If we fail to manage such integration processes in a timely and effective manner, our business and financial results may suffer. If we are unable to identify suitable acquisitions or strategic relationships, or if we are unable to integrate any acquired businesses, technologies, tools, and solutions effectively, our business, financial condition, and results of operations could be materially and adversely affected. Also, while we employ several different methodologies to assess potential business opportunities, the new businesses may not meet or exceed our expectations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships with third-parties that may not result in the development of commercially viable solutions or the generation of significant future revenue.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, or technology partnerships to develop proposed solutions and to pursue new markets. Proposing, negotiating, and implementing collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships may be a lengthy and complex process. Other companies, including those with substantially greater financial, marketing, sales, technology, or other business resources, may compete with us for these opportunities or arrangements. We may not identify, secure, or complete any such transactions or arrangements in a timely manner, on a cost-effective basis, on acceptable terms, or at all. We have limited institutional knowledge and experience with respect to these business development activities, and we may also not realize the anticipated benefits of any such transaction or arrangement. In particular, these collaborations may not result in the development of solutions that achieve commercial success or result in significant revenue and could be terminated prior to developing any solutions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we may not be in a position to exercise sole decision making authority regarding the transaction or arrangement, which could create the potential risk of creating impasses on decisions, and our collaborators may have economic or business interests or goals that are, or that may become, inconsistent with our business interests or goals. It is possible that conflicts may arise with our collaborators, such as conflicts concerning the achievement of performance milestones, or the interpretation of significant terms under any agreement, such as those related to financial obligations or the ownership or control of intellectual property developed during the collaboration. If any conflicts arise with our current or future collaborators, they may act in their self-interest, which may be adverse to our best interest, and they may breach their obligations to us. In addition, we have limited control over the amount and timing of resources that our current collaborators or any future collaborators devote to our collaborators&#8217; or our future solutions. Disputes between us and our collaborators may result in litigation or arbitration which would increase our expenses and divert the attention of our management. Further, these transactions and arrangements are contractual in nature and may be terminated or dissolved under the terms of the applicable agreements and, in such event, we may not continue to have rights to the products relating to such transaction or arrangement or may need to purchase such rights at a premium.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to successfully execute on our growth initiatives, business strategies, or operating plans.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continually executing on growth initiatives, strategies, and operating plans designed to enhance our business and extend our solutions. The anticipated benefits from these efforts are based on several assumptions that may prove to be inaccurate. Moreover, we may not be able to successfully complete these growth initiatives, strategies, and operating plans and realize all of the benefits, including growth targets and cost savings, that we expect to achieve or it may be more costly to do so than we anticipate. A variety of risks could cause us not to realize some or all of the expected benefits. These risks include, among others, delays in the anticipated timing of activities related to such growth initiatives, strategies, and operating plans, increased difficulty and cost in implementing these efforts, including difficulties in complying with new regulatory requirements and the incurrence of other unexpected costs associated with operating our business. Moreover, our continued implementation of these programs may disrupt our operations and performance. As a result, we cannot assure you that we will realize these benefits. If for any reason the benefits we realize are less than our estimates, or the implementation of these growth initiatives, strategies, and operating plans adversely affect our operations or cost more or take longer to effectuate than we expect, or if our assumptions prove inaccurate, our business, financial condition, and results of operations may be materially adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We employ third-party licensed software and software components for use in or with our solutions, and the inability to maintain these licenses or the presence of errors or security vulnerabilities in the software we license could limit the functionality of our solutions and result in increased costs or reduced service levels, which could adversely affect our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our network incorporates or utilizes certain third-party software and software components obtained under licenses from other companies. We anticipate that we will continue to rely on such third-party software and development tools from third parties in the future. Although we believe that there are commercially reasonable alternatives to the third-party software we currently license, this may not always be the case, or it may be difficult or costly to replace. Our use of additional or alternative third-party software would require us to enter into license agreements with third parties. In addition, if the third-party software we utilize has errors, security vulnerabilities, or otherwise malfunctions, the functionality of our solutions may be negatively impacted and our business may suffer. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on software-as-a-service, or SaaS, technologies from third parties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on SaaS technologies from third parties in order to operate critical functions of our business, including financial management services, relationship management services, marketing services, and data storage services. For example, we rely on Amazon Web Services for a substantial portion of our computing and storage capacity, and rely on Google for storage capacity and collaboration tools. We are also highly dependent on our technology integration with products offered by certain third parties. Amazon Web Services provides us with computing and storage capacity pursuant to an agreement that continues until terminated by either party. Similarly, Google provides us with storage capacity and certain collaboration tools, and also may non-renew its agreement by providing 15 days notice prior to the end of the then-current term. Some of our other vendor agreements may be unilaterally terminated by the counterparty for convenience. If these services become unavailable due to contract cancellations, extended outages or interruptions, because they are no longer available on commercially reasonable terms or prices, or for any other reason, our expenses could increase, our ability to manage our finances could be interrupted, our processes for managing our offerings and supporting our consumers and partners could be impaired, and our ability to access or save data stored to the cloud may be impaired until equivalent services, if available, are identified, obtained, and implemented, all of which could harm our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our growth depends in part on the success of our strategic relationships with third parties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to depend on relationships with various third parties, including access to platforms and content providers and distributors to grow our business, authors who provide content (including learning and development material), and channel partners. Identifying, negotiating, and maintaining relationships with third parties require significant time and resources, as does integrating third-party content and technology. Our agreements with technology and content providers and similar third parties are typically non-exclusive and do not prohibit them from working with our competitors or from offering competing services. In some cases, in particular with respect to content providers, these relationships are undocumented, or, if there are agreements in place, they may be easily terminable. Our competitors may be effective in providing incentives to these parties to favor their solutions or may prevent us from developing strategic relationships with these parties. These third parties may decide that working with us is not in their interest. In addition, these third parties may not perform as expected under our agreements with them, and we have had, and may in the future have, disagreements or disputes with these parties, which could negatively affect our brand and reputation. It is possible that these third parties may not be able to devote the resources we expect to the relationship or they may terminate their relationships with us. Further, as members increasingly access our services through mobile devices, we are becoming more dependent on the distribution of our mobile applications through third parties, and we may not be able to access their application program interfaces or be able to distribute our applications or provide ease of integration, and this may also impact our ability to monetize our mobile solutions. If we are unsuccessful in establishing or maintaining our relationships with third parties, our ability to compete in the marketplace or to grow our business could be impaired, and our operating results could suffer. Even if we are successful, these relationships may not result in improved operating results.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any restrictions on our use of, or ability to license, data, or our failure to license data and integrate third-party technologies, could have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend upon licenses from third parties for some of the technology and data used in our applications, and for some of the technology platforms upon which these applications are built and operate. We expect that we may need to obtain additional licenses from third parties in the future in connection with the development of our solutions and services. In addition, we obtain a portion of the data that we use from government entities, public records, and our partners for specific partner engagements. We believe that we have all rights necessary to use the data that is incorporated into our solutions and services. However, we cannot assure you that our licenses for information will allow us to use that information for all potential or contemplated applications and solutions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, data providers could withdraw their data from us or restrict our usage for any reason, including if there is a competitive reason to do so, if legislation is passed restricting the use of the data, or if judicial interpretations are issued restricting use of the data that we currently use in our solutions and services. In addition, data providers could fail to adhere to our quality control standards in the future, causing us to incur additional expense to appropriately utilize the data. If a substantial number of data providers were to withdraw or restrict their data, or if they fail to adhere to our quality control standards, and if we are unable to identify and contract with suitable alternative data suppliers and integrate these data sources into our service offerings, our ability to provide solutions and services to our partners would be materially adversely impacted, which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also integrate into our proprietary applications and use third-party software to maintain and enhance, among other things, content generation and delivery, and to support our technology infrastructure. Our use of third-party technologies exposes us to increased risks, including, but not limited to, risks associated with the integration of new technology into our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solutions, the diversion of our resources from development of our own proprietary technology, and our inability to generate revenue from licensed technology sufficient to offset associated acquisition and maintenance costs. These technologies may not be available to us in the future on commercially reasonable terms or at all and could be difficult to replace once integrated into our own proprietary applications. Most of these licenses can be renewed only by mutual consent and may be terminated if we breach the terms of the license and fail to cure the breach within a specified period of time. Our inability to obtain, maintain, or comply with any of these licenses could delay development until equivalent technology can be identified, licensed, and integrated, which would harm our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our third-party licenses are non-exclusive and our competitors may obtain the right to use any of the technology covered by these licenses to compete directly with us. If our data suppliers choose to discontinue support of the licensed technology in the future, we might not be able to modify or adapt our own solutions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting rules, assumptions, and/or judgments could materially and adversely affect us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting rules and interpretations for certain aspects of our operations are highly complex and involve significant assumptions and judgment. These complexities could lead to a delay in the preparation and dissemination of our financial statements. Furthermore, changes in accounting rules and interpretations or in our accounting assumptions and/or judgments could significantly impact our financial statements. In some cases, we could be required to apply a new or revised standard retroactively, resulting in restating prior period financial statements. Any of these circumstances could have a material adverse effect on our business, prospects, liquidity, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, and financial condition or result of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the United States and our tax provision could also be impacted by changes in accounting principles and changes in U.S. federal and state tax laws applicable to corporations. For example, legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act, or Tax Act, and the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, of 2020 significantly changed how the U.S. Department of Treasury imposes income taxes on U.S. corporations. For tax years beginning after December 31, 2021, the Tax Act eliminated the option to deduct research and development expenditures in the current period and requires taxpayers to capitalize and amortize U.S.-based research and development expenditures over five years.  This legislation has accelerated the utilization of our net operating losses and research and development tax credits in the U.S. federal and state jurisdictions. We made significant judgments and assumptions in the interpretation of these laws and in our calculations reflected in our financial statements. The U.S. Department of Treasury, the Internal Revenue Service, or the IRS, and other standard-setting bodies may issue additional guidance on how the provisions of the Tax Act and CARES Act will be applied or otherwise administered, and additional accounting guidance or interpretations may be issued in the future that is different from our current interpretation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as an example, on August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022, which includes changes to the U.S. corporate income tax system, including a 15% minimum tax based on &#8220;adjusted financial statement income&#8221; for certain large corporations which will not be effective until fiscal year 2024 and a 1% excise tax on share repurchases after December 31, 2022. We are currently assessing the potential impact of these legislative changes on our business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to limit our liabilities by contract or through insurance may be ineffective or insufficient to cover our future liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to limit, by contract, our liability for damages arising from our negligence, errors, mistakes, or security breaches. Contractual limitations on liability, however, may not be enforceable or may otherwise not provide sufficient protection to us from liability for damages and we are not always able to negotiate meaningful limitations. We maintain liability insurance coverage, including coverage for cybersecurity and errors and omissions. It is possible, however, that claims could exceed the amount of our applicable insurance coverage, if any, or that this coverage may not continue to be available on acceptable terms or in sufficient amounts. Even if these claims do not result in liability to us, investigating and defending against them could be expensive and time-consuming and could divert management&#8217;s attention away from our operations. In addition, negative publicity caused by these events may delay market acceptance of our solutions and services, any of which could materially and adversely affect our reputation and our business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be disrupted by a pandemic, epidemic, or outbreak of an infectious disease.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any pandemic, endemic or other infectious disease may adversely affect our business, results of operations, and financial condition by causing us to change the way we or our customers or members conduct business and engage with us.  As an example, the COVID-19 pandemic, including its variants, affected our business operations, including, among other impacts, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">causing the majority of our employees to work from home, impacting the way our customers engage with our business, and influencing the regulatory framework in which we operate. The full extent to which it will impact our business, results of operations, and financial condition is still unknown and will depend on future developments, which are highly uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts to our business as a result of its global economic impact, including any recession that has occurred or may occur in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the potential economic impact and the duration of any pandemic, epidemic, or outbreak of an infectious disease, including COVID-19, may be difficult to assess or predict, the widespread COVID-19 pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity. The impact of any pandemic, epidemic, or outbreak of an infectious disease, including COVID-19, on the needs, expectations, and spending levels of our customers could impact our ability to maintain or grow our business and, as a result, our operating and financial results could be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that a pandemic adversely affects our business, financial condition, and results of operations, it may also have the effect of heightening many of the other risks described in this &#8220;Risk Factors&#8221; section.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be disrupted by catastrophic events such as power disruptions, data security breaches, and terrorism.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Natural disasters or other catastrophic events may cause damage or disruption to our operations, commerce, and the global economy, and thus could harm our business. In the event of a major earthquake, hurricane, fire, cyber-attack, major political disruption, any U.S. federal government debt default due to a failure to increase the debt ceiling, war (including the ongoing conflict in Ukraine), terrorist attack, disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(including the COVID-19 pandemic or any other pandemic or epidemic), power loss, telecommunications failure, or other catastrophic events, we may be unable to continue our operations, in part or in whole, and may endure reputational harm, breaches of data security, and loss of critical data, all of which could harm our business, results of operations, and financial condition. Our insurance coverage may not compensate us for losses that may occur in the event of an earthquake or other significant natural disaster, such as fires, floods, severe weather, droughts, and travel-related health concerns including pandemics and epidemics. In addition, acts of terrorism, including malicious internet-based activity, could cause disruptions to the internet or the economy as a whole. Even with our disaster recovery arrangements, access to our platform could be interrupted. If our systems were to fail or be negatively impacted as a result of a natural disaster or other event, our ability to deliver our platform and solution to our customers and members would be impaired or we could lose critical data. If we are unable to develop adequate plans to ensure that our business functions continue to operate during and after a disaster, and successfully execute on those plans in the event of a disaster or emergency, our business, financial condition, and results of operations would be harmed.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented a disaster recovery program that allows us to move website traffic to a backup data center in the event of a catastrophe. This allows us the ability to move traffic in the event of a problem, and the ability to recover in a short period of time. However, to the extent our disaster recovery program does not effectively support the movement of traffic in a timely or complete manner in the event of a catastrophe, our business and results of operations may be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not carry business interruption insurance sufficient to compensate us for the potentially significant losses, including the potential harm to our business, financial condition, and results of operations that may result from interruptions in access to our platform as a result of system failures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we grow our business, the need for business continuity planning and disaster recovery plans will grow in significance. If we are unable to develop adequate plans to ensure that our business functions continue to operate during and after a disaster, and successfully execute on those plans in the event of a disaster or emergency, our business and reputation would be harmed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reputation and/or business could be negatively impacted by ESG matters and/or other reporting of such matters.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is an increasing focus from regulators, certain investors, and other stakeholders concerning matters relating to environmental social and governance factors (&#8220;ESG&#8221;), both in the United States and internationally. We communicate certain ESG-related initiatives and/or commitments regarding environmental matters, diversity, and other matters on our website and elsewhere. These initiatives or commitments could be difficult or costly to achieve. We could fail to achieve, or be perceived to fail to achieve, our ESG-related initiatives or commitments. In addition, we could be criticized for the timing, scope or nature of these activities, or for any revisions to them. To the extent that our disclosures about ESG matters increase, we could be criticized for the accuracy, adequacy, or completeness of such disclosures. Our actual or perceived failure to achieve our ESG-related initiatives or commitments could negatively impact our reputation, result in ESG-focused investors not purchasing and holding our stock, or otherwise materially harm our business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our risk management policies and procedures may not be fully effective in mitigating our risk exposure in all market environments or against all types of risk.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a rapidly changing industry. Accordingly, our risk management policies and procedures may not be fully effective to identify, monitor, and manage all the risks our business encounters. If our policies and procedures are not fully effective or we are not successful in identifying and mitigating all risks to which we are or may be exposed, we may suffer uninsured liability, harm to our reputation, or be subject to litigation or regulatory actions that could adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we have put into place various policies and practices intended to reduce exposure to credit risk. Events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. Our policies and practices may not be sufficient to withstand the impact of such events which could therefore could adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we are not a borrower or party to any instruments with a financial institution currently in receivership, if any of our lenders or counterparties to any such instruments were to be placed into receivership, we may be unable to access such funds. In addition, if any of our customers, suppliers or other parties with whom we conduct business are unable to access funds pursuant to such instruments or lending arrangements with such a financial institution, such parties&#8217; ability to pay their obligations to us or to enter into new commercial arrangements requiring additional payments to us could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may incur significant additional costs and expenses, including costs and expenses associated with obligations relating to being a public company, which will require significant resources and management attention and may divert focus from our business operations, and we may generate losses in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur significant expenses in developing our technology, marketing, and providing the tools and solutions we offer, and acquiring customers. Our costs may increase due to our continued new product development and general administrative expenses, such as legal and accounting expenses related to becoming and being a public company. As a public company, we will continue to incur significant legal, accounting, insurance, and other expenses, which we expect to further increase now that we are no longer an &#8220;emerging growth company.&#8221;  Compliance with these reporting requirements and other rules of the SEC and the rules of the New York Stock Exchange have and will continue to increase our legal and financial compliance costs and make some activities more time-consuming and costly. Furthermore, the need to establish the corporate infrastructure demanded of a public company may divert management&#8217;s attention from implementing our growth strategy, which could prevent us from successfully implementing our strategic initiatives and improving our business, operating results, financial condition, and prospects. If we fail to manage these additional costs or increase our revenue, we may incur losses in the future.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to implement and maintain effective internal controls over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a public company, we are required to maintain internal controls over financial reporting and to report any material weaknesses in such internal controls. We are required to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. In addition, now that we are no longer an &#8220;emerging growth company,&#8221; an independent registered public accounting firm must also issue a report on the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. Our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed, or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could harm our business, results of operations, and financial condition and could cause a decline in the market price of our Class A common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of designing and implementing internal controls over financial reporting is time consuming, costly, and complicated. If during the evaluation and testing process, we identify one or more material weaknesses in our internal control over financial reporting or determine that existing material weaknesses have not been remediated, our management will be unable to assert that our internal control over financial reporting is effective. Even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may conclude that there are material weaknesses with respect to our internal controls or the level at which our internal controls are documented, designed, implemented, or reviewed. If we are unable to assert that our internal control over financial reporting is effective, or when required in the future, if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the valuation of our common stock could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to halt the operations of entities that copy our intellectual property or that aggregate our data as well as data from other companies, including social networks, or copycat online services that may misappropriate our data. These activities could harm our brand and our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, third parties may try to access content or data from our networks through scraping, robots, or other means and use this content and data or combine this content and data with other content and data as part of their services. These activities could degrade our brand, negatively impact our website performance, and harm our business. We have employed contractual, technological, or legal measures in an attempt to halt unauthorized activities, but these measures may not be successful. In addition, if our members and customers do not comply with our terms of service, they also may be able to abuse our tools, solutions, and services and provide access to our solutions and content to unauthorized users. We may not be able to detect any or all of these types of activities in a timely manner and, even if we could, technological and legal measures may be insufficient to stop these actions. In some cases, particularly in the case of online services operating from outside of the United States, our available legal remedies may not be adequate to protect our business against such activities. Regardless of whether we can successfully enforce our rights against these parties, any measures that we may take could require us to expend significant financial or other resources.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may initiate legal proceedings alleging that we are infringing or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends on our ability to develop and commercialize our services and use our proprietary technology without infringing the intellectual property or proprietary rights of third parties. From time to time, we may be subject to legal proceedings and claims in the ordinary course of business with respect to intellectual property. We are not currently subject to any material claims from third parties asserting infringement of their intellectual property rights. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property disputes can be costly to defend and may cause our business, operating results, and financial condition to suffer. Whether merited or not, we have in the past and may in the future face allegations that we, our partners, our licensees, or parties indemnified by us have infringed or otherwise violated the patents, trademarks, copyrights, or other intellectual property rights of third parties. Such claims may be made by competitors seeking to obtain a competitive advantage or by other parties. Some third parties may be able to sustain the costs of complex litigation more effectively than we can because they have substantially greater resources. Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our Class A common stock. Moreover, any uncertainties resulting from the initiation and continuation of any legal proceedings could have a material adverse effect on our ability to raise the funds necessary to continue our operations. Assertions by third parties that we violate their intellectual property rights could therefore have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in recent years, individuals and groups have begun purchasing intellectual property assets for the purpose of making claims of infringement and attempting to extract settlements from companies like ours. We may also face allegations that our employees have misappropriated the intellectual property or proprietary rights of their former employers or other third parties. It may be necessary for us to initiate litigation to defend ourselves in order to determine the scope, enforceability, and validity of third-party intellectual property or proprietary rights, or to establish our respective rights. In some cases, rather than licensing third party content, we rely on the doctrine of fair use as we incorporate excerpts of third party content in a curated content feed for our users, and we may face allegations that such use of third party content does not qualify to be treated as a fair use. Regardless of whether claims that we are infringing patents or other intellectual property rights have merit, such claims can be time-consuming, divert management&#8217;s attention and financial resources, and can be costly to evaluate and defend. Results of any such litigation are difficult to predict and may require us to stop commercializing or using our solutions or technology, obtain licenses, modify our services and technology while we develop non-infringing substitutes or incur substantial damages, settlement costs or face a temporary or permanent injunction prohibiting us from marketing or providing the affected solutions and services. If we require a third-party license, it may not be available on reasonable terms or at all, and we may have to pay substantial royalties, upfront fees, or grant cross-licenses to intellectual property rights for our solutions and services. We may also have to redesign our solutions or services so they do not infringe third-party intellectual property rights, which may not be possible or may require substantial monetary expenditures and time, during which our technology and solutions may not be available for commercialization or use. Even if we have an agreement to indemnify us against such costs, the indemnifying party may be unable to uphold its contractual obligations. If we cannot or do not obtain a third-party license to the infringed technology, license the technology on reasonable terms, or obtain similar technology from another source, our revenue and earnings could be adversely impacted.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because patent applications can take years to issue and are often afforded confidentiality for some period of time there may currently be pending applications, unknown to us, that later result in issued patents that could cover one or more of our solutions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to maintain, protect, or enforce our intellectual property rights could harm our business and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pursue the registration of our domain names, trademarks, and service marks in the United States. We also strive to protect our intellectual property rights by relying on federal, state, and common law rights, as well as contractual restrictions. We typically enter into confidentiality and invention assignment agreements with our employees and contractors, and confidentiality agreements with parties with whom we conduct business in order to limit access to, and disclosure and use of, our proprietary information. However, we may not be successful in executing these agreements with every party who has access to our confidential information or contributes to the development of our technology or intellectual property rights. Those agreements that we do execute may be breached, and we may not have adequate remedies for any such breach. These contractual arrangements and the other steps we have taken to protect our intellectual property rights may not prevent the misappropriation or disclosure of our proprietary information nor deter independent development of similar technology or intellectual property by others. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective trade secret, patent, copyright, trademark, and domain name protection is expensive to obtain, develop, and maintain, both in terms of initial and ongoing registration or prosecution requirements and expenses and the costs of defending our rights. We have invested in and may, over time, increase our investment in protecting our intellectual property through patent filings that could be expensive and time-consuming. Our trademarks and other intellectual property rights may be challenged by others or invalidated through administrative process or litigation. We have not yet obtained any issued patents that provide protection for our technology or products, and we cannot guarantee that any of our pending patent applications will result in any issued patents. Moreover, any issued patents we obtain may not provide us with a competitive advantage and, as with any technology, competitors may be able to develop similar or superior technologies to our own, now or in the future. In addition, it has become increasingly difficult to obtain and assert patents relating to software or business methods, as many such patents have been invalidated for being too abstract to constitute patent-eligible subject matter. We do not know whether this will affect our ability to obtain patents on our innovations, or successfully assert any patents we may pursue in litigation or pre-litigation campaigns. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monitoring unauthorized use of the content on our apps and websites, and our other intellectual property and technology, is difficult and costly. Our efforts to protect our proprietary rights and intellectual property may not have been and may not be adequate to prevent their misappropriation or misuse. Third parties, including our competitors, could be infringing, misappropriating, or otherwise violating our intellectual property rights. We may not be successful in stopping unauthorized use of our content or other intellectual property or technology. Further, we may not have been and may not be able to detect unauthorized use of our technology or intellectual property, or to take appropriate steps to enforce our intellectual property rights. Any inability to meaningfully enforce our intellectual property rights could harm our ability to compete and reduce demand for our solutions and services. Our competitors may also independently develop similar technology. Effective patent, trademark, copyright, and trade secret protection may not be available to us in every jurisdiction in which our solutions or technology are hosted or available. Further, legal standards relating to the validity, enforceability, and scope of protection of intellectual property rights are uncertain. The laws in the United States and elsewhere change rapidly, and any future changes could adversely affect us and our intellectual property. Our failure to meaningfully protect our intellectual property rights could result in competitors offering solutions that incorporate our most technologically advanced features, which could reduce demand for our solutions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may find it necessary or appropriate to initiate claims or litigation to enforce our intellectual property rights, protect our trade secrets, or determine the validity and scope of intellectual property rights claimed by others. In any lawsuit we bring to enforce our intellectual property rights, a court may refuse to stop the other party from using the technology at issue on grounds that our intellectual property rights do not cover the use or technology in question. Further, in such proceedings, the defendant could counterclaim that our intellectual property is invalid or unenforceable and the court may agree, in which case we could lose valuable intellectual property rights. Litigation is inherently uncertain and any litigation of this nature, regardless of outcome or merit, could result in substantial costs and diversion of management and technical resources, any of which could adversely affect our business and results of operations. If we fail to maintain, protect, and enforce our intellectual property, our business and results of operations may be harmed. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States. Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. The legal systems of some countries, particularly developing countries, do not favor the enforcement of intellectual property protection. This could make it difficult for us to stop the infringement or misappropriation of our intellectual property rights. Proceedings to enforce our intellectual property in foreign jurisdictions could result in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substantial costs and divert our efforts and attention from other aspects of our business. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our technology and the enforcement of intellectual property.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our brand is critical to the success of our business, and we utilize trademark registration and other means to protect it. Our business would be harmed if we were unable to protect our brand against infringement and its value was to decrease as a result.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registered or unregistered trademarks or trade names that we own or license may be challenged, infringed, circumvented, declared generic, lapsed, or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential partners. In addition, third parties may in the future file for registration of trademarks similar or identical to our trademarks. If they succeed in registering or developing common law rights in such trademarks, and if we are not successful in challenging such third-party rights, we may not be able to use these trademarks to commercialize our technologies or solutions in certain relevant countries. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position could be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely heavily on trade secrets and confidentiality agreements to protect our unpatented know-how, technology, and other proprietary information, including our technology platform, and to maintain our competitive position. With respect to our technology platform, we consider trade secrets and know-how to be one of our primary sources of intellectual property. However, trade secrets and know-how can be difficult to protect. We seek to protect these trade secrets and other proprietary technology in part by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside contractors, consultants, advisors, and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. The confidentiality agreements are designed to protect our proprietary information and, in the case of agreements or clauses containing invention assignment, to grant us ownership of technologies that are developed through a relationship with employees or third parties. We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary information, including our technology and processes. Despite these efforts, no assurance can be given that the confidentiality agreements we enter into will be effective in controlling access to such proprietary information and trade secrets. The confidentiality agreements on which we rely to protect certain technologies may be breached, may not be adequate to protect our confidential information, trade secrets, and proprietary technologies and may not provide an adequate remedy in the event of unauthorized use or disclosure of our confidential information, trade secrets, or proprietary technology. Further, these agreements do not prevent our competitors or others from independently developing the same or similar technologies and processes, which may allow them to provide a service similar or superior to ours, which could harm our competitive position. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, it could harm our competitive position, business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our solutions utilize open source software, and any failure to comply with the terms of one or more of these open source licenses could adversely affect our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our solutions include software covered by open source licenses. The terms of various open source licenses have not been interpreted by U.S. courts, and there is a risk that such licenses could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to market our solutions. By the terms of certain open source licenses, we could be required to release the source code of our proprietary software, and to make our proprietary software available under open source licenses, if we combine our proprietary software with open source software in a certain manner. In the event that portions of our proprietary software are determined to be subject to an open source license, we could be required to publicly release the affected portions of our source code, re-engineer all or a portion of our solutions, or otherwise be limited in the licensing of our solutions, each of which could reduce or eliminate the value of our solutions and services. In addition to risks related to license requirements, usage of open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide non-infringement warranties or warranties related to the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance or suitability of the software. Many of the risks associated with usage of open source software cannot be eliminated and could adversely affect our business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations under license or technology agreements with third parties, we may be required to pay damages and we could lose license rights that are critical to our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We license certain intellectual property, including technologies and software from third parties, that is important to our business, and in the future we may enter into additional agreements that provide us with licenses to valuable intellectual property or technology. If we fail to comply with any of the obligations under our license agreements, we may be required to pay damages and the licensor may have the right to terminate the license. Termination by the licensor would cause us to lose valuable rights, and could prevent us from selling our solutions and services, or adversely impact our ability to commercialize future solutions and services. Our business would suffer if any current or future licenses terminate, if the licensors fail to abide by the terms of the license, if the licensors fail to enforce licensed patents against infringing third parties, if the licensed intellectual property are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms. In addition, our rights to certain technologies are licensed to us on a non-exclusive basis. The owners of these non-exclusively licensed technologies are therefore free to license them to third parties, including our competitors, on terms that may be superior to those offered to us, which could place us at a competitive disadvantage. Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor&#8217;s rights. In addition, the agreements under which we license intellectual property or technology from third parties are generally complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement. Any of the foregoing could harm our competitive position, business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot license rights to use technologies on reasonable terms, we may not be able to commercialize new solutions or services in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may identify additional third-party intellectual property we may need to license in order to engage in our business, including to develop or commercialize new solutions or services. However, such licenses may not be available on acceptable terms or at all. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources, and greater development or commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. Even if such licenses are available, we may be required to pay the licensor substantial royalties based on sales of our solutions and services. Such royalties are a component of the cost of our solutions or services and may affect the margins on our solutions and services. In addition, such licenses may be non-exclusive, which could give our competitors access to the same intellectual property licensed to us. If we are unable to enter into the necessary licenses on acceptable terms or at all, if any necessary licenses are subsequently terminated, if our licensors fail to abide by the terms of the licenses, if our licensors fail to prevent infringement by third parties, or if the licensed intellectual property rights are found to be invalid or unenforceable, our business, financial condition, results of operations, and prospects could be affected. If licenses to third-party intellectual property rights are, or become required for us, to engage in our business, the rights may be non-exclusive, which could give our competitors access to the same technology or intellectual property rights licensed to us. Moreover, we could encounter delays and other obstacles in our attempt to develop alternatives. Defense of any lawsuit or failure to obtain any of these licenses on favorable terms could prevent us from commercializing solutions and services, which could harm our competitive position, business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third-party platforms, such as the Apple App Store and Google Play App Store, to distribute our platform and offerings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our apps are accessed and operate through third-party platforms or marketplaces, including the Apple App Store and Google Play App Store, which also serve as significant online distribution platforms for our apps. As a result, the expansion and prospects of our business and our apps depend on our continued relationships with these providers and any other emerging platform providers that are widely adopted by consumers. We are subject to the standard terms and conditions that these providers have for application developers, which govern the content, promotion, distribution, and operation of apps on their platforms or marketplaces, and which the providers can change unilaterally on short or no notice. Our business would be harmed if the providers discontinue or limit our access to their platforms or marketplaces; the platforms or marketplaces decline in popularity; the platforms modify their algorithms, communication channels available to developers, respective terms of service or other policies, including fees; the providers adopt changes or updates to their technology that impede integration with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other software systems or otherwise require us to modify our technology or update our apps in order to ensure that consumers can continue to access and use our platform. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If alternative providers increase in popularity, we could be adversely impacted if we fail to create compatible versions of our apps in a timely manner, or if we fail to establish a relationship with such alternative providers. Likewise, if our current providers alter their operating platforms, we could be adversely impacted as our offerings may not be compatible with the altered platforms or may require significant and costly modifications in order to become compatible. If our providers do not perform their obligations in accordance with our platform agreements, we could be adversely impacted. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, some of these platforms or marketplaces have been unavailable for short periods of time. If this or a similar event were to occur on a short- or long-term basis, or if these platforms or marketplaces otherwise experience issues that impact the ability of consumers to download or access our apps and other information, it could have a material adverse effect on our brand and reputation, as well as our business, financial condition, and operating results.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Healthcare Industry</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The healthcare regulatory and political framework is uncertain and evolving.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare laws and regulations are rapidly evolving and may change significantly in the future, which could adversely affect our financial condition and results of operations. Certain regulatory changes that have occurred in response to the COVID-19 pandemic, have created opportunities for us. For example, many states have expanded Medicaid and commercial coverage for telehealth, in many cases at parity with brick and mortar services and with $0 co-pay. However, if states do not maintain this reimbursement parity after the pandemic, this could lower usage of our network. In addition, OCR has announced that they will not impose penalties for noncompliance with the regulatory requirements under the HIPAA Rules for covered healthcare providers in connection with good faith provision of telehealth during the COVID-19 nationwide public health emergency. However, if this enforcement discretion is rescinded and if other changes are rolled back after the pandemic, such changes could negatively impact usage on our network.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidation in the healthcare industry could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many healthcare industry participants are consolidating to create larger and more integrated healthcare delivery systems with greater market power. We expect regulatory and economic conditions to result in additional consolidation in the healthcare industry in the future. As consolidation accelerates, the economies of scale of our customers&#8217; organizations may grow. If a customer experiences sizable growth following consolidation, it may determine that it no longer needs to rely on us and may reduce its demand for our solutions and services. In addition, as healthcare providers and life sciences companies consolidate to create larger and more integrated healthcare delivery systems with greater market power, these providers may try to use their market power to negotiate fee reductions for our solutions and services. Finally, consolidation may also result in the acquisition or future development by our healthcare provider and life sciences customers of solutions and services that compete with our solutions and services. Any of these potential results of consolidation could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our customers fail to comply with federal and state healthcare laws, including those governing fee splitting, our business, and financial relationships, we or our customers may be subject to significant administrative, civil, and criminal penalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a participant in the healthcare industry, our operations and relationships, and those of our customers, are regulated by a number of federal, state, and local governmental entities. The impact of these regulations can adversely affect us even though we may not be directly regulated by certain specific healthcare laws and regulations. We must ensure that our solutions and services can be used by our customers in a manner that complies with those laws and regulations. Inability of our customers to do so could affect the marketability of our solutions and services or our compliance with our customer contracts, or even expose us to direct liability under the theory that we had assisted our customers in a violation of healthcare laws or regulations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, many states limit the scope of business relationships between business entities and medical professionals, particularly with respect to fee splitting. While many states&#8217; fee-splitting laws only prohibit a physician from sharing medical fees with a referral source, some states have interpreted certain management agreements between business entities and physicians as unlawful fee-splitting. Statutes and regulations relating to the practice of medicine, fee-splitting, and similar issues vary widely from state to state. Because these laws are often vague, their application is frequently dependent on court rulings and attorney general opinions. Some of these requirements may apply to us even if we do not have a physical presence in the state, based solely on our agreements with providers licensed in the state. However, regulatory authorities or other parties, including our providers, may assert that we are engaged in the corporate practice of medicine or that our contractual </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arrangements with our provider customers constitute unlawful fee splitting. These laws generally prohibit us from exercising control over the medical judgments or decisions of physicians and non-physician healthcare providers and from engaging in certain financial arrangements, such as splitting professional fees with healthcare providers. In this event, failure to comply could lead to adverse judicial or administrative action against us and/or our provider customers, civil or criminal penalties, receipt of cease and desist orders from state regulators, loss of provider licenses, the need to make changes to the terms of engagement of our provider customers that interfere with our business and other materially adverse consequences. Further, certain laws may apply to us indirectly through our relationships with healthcare professionals. For example, certain federal and state anti-kickback and false claims laws may apply to us indirectly through our arrangements with healthcare professionals and entities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations may change rapidly, and it is frequently unclear how they apply to our business. Any failure of our solutions or services to comply with these laws and regulations could result in substantial administrative, civil, or criminal liability and could, among other things, adversely affect demand for our services, force us to expend significant capital, research and development, and other resources to address the failure, invalidate all or portions of some of our contracts with our customers, require us to change or terminate some portions of our business, require us to refund portions of our revenue, cause us to be disqualified from serving customers doing business with government payors, and give our customers the right to terminate our contracts with them, any one of which could have an adverse effect on our business. Even an unsuccessful challenge by regulatory authorities of our activities could result in adverse publicity and could require a costly response from us. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our solutions address heavily regulated functions within the life sciences industry, and failure to comply with applicable laws and regulations could lessen the demand for our solutions or subject us to significant claims and losses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers use our solutions for business activities that are subject to a complex regime of laws and regulations, including requirements regarding processing of health data (as set forth in 45 CFR Part 164 of HIPAA), and other state, local, and federal laws and regulations. Our solutions are expected to be capable of use by our customers in compliance with such laws and regulations. Our efforts to provide solutions that comply with such laws and regulations are time-consuming and costly and include validation procedures that may delay the release of new versions of our solutions. As these laws and regulations change over time, we may find it difficult to adjust our solutions to comply with such changes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we increase the number of solutions we offer, the complexity of adjusting our solutions to comply with legal and regulatory changes will increase. If we are unable to effectively manage this increase or if we are not able to provide solutions that can be used in compliance with applicable laws and regulations, customers may be unwilling to use our solutions and any such non-compliance could result in the termination of our customer agreements or claims arising from such agreements with our customers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any failure of our customers to comply with laws and regulations applicable to the functions for which our solutions are used could result in fines, penalties, or claims for substantial damages against our customers that may harm our business or reputation. If such failure were allegedly caused by our solutions or services, our customers may make a claim for damages against us, regardless of our responsibility for the failure. We may be subject to lawsuits that, even if unsuccessful, could divert our resources and our management&#8217;s attention and adversely affect our business and customer relationships, and our insurance coverage may not be sufficient to cover such claims against us.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evolving government regulations may increase our costs or adversely affect our results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a regulatory climate that is uncertain, our operations may be subject to direct and indirect adoption, expansion, or reinterpretation of various laws and regulations. There could be laws and regulations applicable to our business that we have not identified or that, if changed, may be costly to us, and we cannot predict all the ways in which implementation of such laws and regulations may affect us. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we cannot predict the likelihood, nature, or extent of health reform initiatives that may arise from future legislation or administrative action, particularly following any changes in the Presidential administration. The introduction of new solutions may require us to comply with additional, yet undetermined, laws and regulations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we must modify our operations to comply with future laws, such modifications may undermine our existing and future offerings' attractiveness to customers, and our revenue may decline and our business, financial condition, and results of operations could be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Class A Common Stock </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price may be volatile or may decline regardless of our operating performance, resulting in substantial losses for investors of our Class A common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our Class A common stock may fluctuate significantly in response to numerous factors, many of which are beyond our control, including:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our financial conditions and results of operations; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the financial projections we may provide to the public, any changes in these projections, or our failure to meet these projections; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of securities analysts to initiate or maintain coverage of our company, changes in financial estimates or ratings by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant technical innovations, acquisitions, strategic partnerships, joint ventures, results of operations, or capital commitments; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in stock market valuations and operating performance of other healthcare and technology companies generally, or those in our industry in particular; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and volume fluctuations in the overall stock market, including as a result of trends in the economy as a whole; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our board of directors or management; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of large blocks of our Class A common stock, including sales by certain affiliates of Jeff Tangney, Emergence Capital Partners II, L.P., or Emergence Capital Partners, or our executive officers and directors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lawsuits threatened or filed against us; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated or actual changes in laws, regulations, or government policies applicable to our business; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our capital structure, such as future issuances of debt or equity securities; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">short sales, hedging, and other derivative transactions involving our capital stock; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions in the United States, including inflation and the interest rate environment and the impact of any U.S. federal government debt default due to a failure to increase the debt ceiling;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;flash crashes,&#8221; &#8220;freeze flashes,&#8221; or other glitches that disrupt trading on the securities exchange on which we are listed;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other global economic or political events or factors, including those resulting from war, pandemics, incidents of terrorism, or responses to these events; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other factors described in the sections of this Annual Report on Form 10-K titled &#8220;Risk Factors&#8221; and &#8220;Special Note Regarding Forward-Looking Statements.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock market has recently experienced extreme price and volume fluctuations. The market prices of securities of companies have experienced fluctuations that often have been unrelated or disproportionate to their results of operations. Market fluctuations could result in extreme volatility in the price of shares of our Class A common stock, which could cause a decline in the value of your investment. Price volatility may be greater if the public float and trading volume of shares of our Class A common stock is low. Furthermore, in the past, stockholders have sometimes instituted securities class action litigation against companies following periods of volatility in the market price of their securities. Any similar litigation against us could result in substantial costs, divert management&#8217;s attention and resources, and harm our business, financial condition, and results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The dual class structure of our common stock has the effect of concentrating voting control with our executive officers (including our Chief Executive Officer) and directors and their affiliates&#894; this will limit or preclude your ability to influence corporate matters.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class B common stock has ten votes per share, and our Class A common stock has one vote per share. Stockholders who hold shares of Class B common stock, including our executive officers and directors and their affiliates, together hold approximately 86% of the voting power of our outstanding capital stock as of March&#160;31, 2023. Because of the ten-to-one voting ratio between our Class B common stock and Class A common stock, the holders of our Class B common stock collectively will continue to control a substantial majority of the combined voting power of our common stock and therefore, assuming no material sales of such shares, will be able to control all matters submitted to our stockholders for approval until ten years from the date the Company filed its final prospectus with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, or the Securities Act, on June 25, 2021, including the election of directors, amendments of our organizational documents, and any merger, consolidation, sale of all or substantially all of our assets, or other major corporate transaction. This concentrated control will limit or preclude your ability to influence corporate matters for the foreseeable future. In addition, this may prevent or discourage unsolicited acquisition proposals or offers for our capital stock that you may feel are in your best interest as one of our stockholders. Future transfers by holders of Class B common stock will generally result in those shares converting to Class A common stock, subject to limited exceptions, such as certain transfers effected for estate planning purposes. The conversion of Class B common stock to Class A common stock will have the effect, over time, of increasing the relative voting power of those holders of Class B common stock who retain their shares in the long term. If, for example, our executive officers (including our Chief Executive Officer), employees, directors and their affiliates retain a significant portion of their holdings of Class B common stock for an extended period of time, they could, in the future, continue to control a majority of the combined voting power of our Class A common stock and Class B common stock.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales and issuances of our Class A common stock or rights to purchase Class A common stock, including pursuant to our equity incentive plans, could result in additional dilution of the percentage ownership of our stockholders and could cause the stock price of our Class A common stock to decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may sell Class A common stock, convertible securities, or other equity securities in one or more transactions at prices and in a manner we determine from time to time. We expect to issue securities to employees and directors pursuant to our equity incentive plans. If we sell common stock, convertible securities, or other equity securities in subsequent transactions, or common stock is issued pursuant to equity incentive plans, our investors may be materially diluted. New investors in such subsequent transactions could gain rights, preferences, and privileges senior to those of holders of our common stock, including our Class A common.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If a substantial number of shares become available for sale and are sold in a short period of time, the market price of our Class A common stock could decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our existing stockholders sell substantial amounts of our Class A common stock in the public market in a short period of time, the market price of our Class A common stock could decrease significantly. The perception in the public market that our existing stockholders might sell shares of Class A common stock could also depress our market price. Our executive officers and directors and certain of our stockholders are subject to the Rule 144 holding period requirements. After the holding periods have elapsed and, in the case of restricted stock, the shares have vested, additional shares will be eligible for sale in the public market. The market price of shares of our Class A common stock may drop significantly when the restrictions on resale by our existing stockholders lapse. A decline in the price of shares of our Class A common stock might impede our ability to raise capital through the issuance of additional shares of our Class A common stock or other equity securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain stockholders have rights, under our investors&#8217; rights agreement, to require us to register shares owned by them for public sale in the United States. We also have certain holders of outstanding options that, if fully exercised, would result in the issuance of shares of Class A common stock. All of the shares of Class A common stock issuable upon the exercise of stock options and the shares reserved for future issuance under our equity compensation plans have been registered for public resale under the Securities Act. As a result, subject to the satisfaction of applicable exercise periods, the shares issued upon exercise of outstanding stock options will be available for immediate resale in the United States in the open market. Sales of our Class A common stock as restrictions end or pursuant to registration rights may make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. These sales could also cause the trading price of our Class A common stock to fall and make it more difficult for you to sell shares of our Class A common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain of our employees, executive officers, and directors have entered into, and may further enter into, Rule 10b5-1 trading plans providing for sales of shares of our Class A common stock from time to time. Under a Rule 10b5-1 trading plan, a broker executes trades pursuant to parameters established by the employee, director, or officer when entering into the plan, without further direction from the employee, officer, or director. Our employees, executive officers, and directors also </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may buy or sell additional shares outside of a Rule 10b5-1 trading plan when they are not in possession of material, nonpublic information, subject to the Rule 144 requirements referred to above.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish or cease publishing research or reports about our business, or they publish negative reports about our business, our share price and trading volume could decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our Class A common stock depends in part on the research and reports that securities or industry analysts publish about us or our business, our market, and our competitors. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our shares or publish negative views on us or our shares, our share price would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware law and provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make a merger, tender offer, or proxy contest more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our Class A common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions in our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that may make the acquisition of our company more difficult, including the following: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amendments to certain provisions of our amended and restated certificate of incorporation or amendments to our amended and restated bylaws generally require the approval of at least 66 2/3% of the voting power of our outstanding capital stock; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dual class common stock structure, which provides certain affiliates of Jeff Tangney and Emergence Capital Partners, individually or together, with the ability to significantly influence the outcome of matters requiring stockholder approval, even if they own significantly less than a majority of the shares of our outstanding Class A common stock and Class B common stock; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our staggered board of directors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at any time when the holders of our Class B common stock no longer beneficially own, in the aggregate, at least the majority of the voting power of our outstanding capital stock, our stockholders will only be able to take action at a meeting of stockholders and will not be able to take action by written consent for any matter; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated certificate of incorporation does not provide for cumulative voting; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">vacancies on our board of directors are able to be filled only by our board of directors and not by stockholders, subject to the rights granted pursuant to the stockholders agreement; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a special meeting of our stockholders may only be called by the chairperson of our board of directors or our Chief Executive Officer, as applicable, or a majority of our board of directors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrict the forum for certain litigation against us to Delaware or the federal courts, as applicable; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated certificate of incorporation authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued without further action by our stockholders; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice procedures apply for stockholders (other than the parties to our stockholders agreement) to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, Section 203 of the Delaware General Corporation Law may discourage, delay or prevent a change in control of our company. Section 203 imposes certain restrictions on mergers, business combinations and other transactions between us and holders of 15% or more of our common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could discourage, delay or prevent a transaction involving a change in control of our company. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions they desire, any of which, under certain circumstances, could limit the opportunity for our stockholders to receive a premium for their shares of our Class A common stock, and could also affect the price that some investors are willing to pay for our Class A common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated bylaws designate specific state or federal courts located as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the Court of Chancery of the State of Delaware is the sole and exclusive forum for any state law claims for:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any derivative action or proceeding brought on our behalf;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws; or</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim that is governed by the internal affairs doctrine, or Delaware Forum Provision.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act or the Exchange Act. Further, our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States will be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or the Federal Forum Provision. In addition, our amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Delaware Forum Provision and the Federal Forum Provision in our amended and restated bylaws may impose additional litigation costs on stockholders in pursuing any such claims. Additionally, these forum selection clauses may limit our stockholders&#8217; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage the filing of lawsuits against us and our directors, officers and employees, even though an action, if successful, might benefit our stockholders. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are &#8220;facially valid&#8221; under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. If the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid. The Court of Chancery of the State of Delaware and the federal district courts of the United States may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends for the foreseeable future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently intend to retain any future earnings to finance the operation and expansion of our business and we do not expect to declare or pay any dividends in the foreseeable future. In addition, Delaware law may impose requirements that may restrict our ability to pay dividends to holders of our common stock. As a result, stockholders must rely on sales of their Class A common stock after price appreciation as the only way to realize any future gains on their investment.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to securities class action litigation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. If we face such litigation, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could have a material adverse effect on our business, financial condition or results of operations. </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_22"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_25"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters is located in San Francisco, California and consists of approximately 9,197 square feet of space under a lease that expires on December&#160;31, 2023. We also lease office space in Irving, Texas. We lease all of our facilities and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">do not own any real property. We believe that our facilities are sufficient to meet our needs for the immediate future, and that, should it be needed, suitable additional space will be available to accommodate expansion of our operations.</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_28"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For discussion around our legal proceedings, please refer to Note 14&#8212;Commitments and Contingencies included in Part II, Item 8 of this Annual Report on Form 10-K. </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_31"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_37"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class A common stock is listed on the New York Stock Exchange, or NYSE, under the symbol &#8220;DOCS&#8221; and began trading on June&#160;24, 2021. Prior to that date, there was no public trading market for our Class A common stock. There is no established public trading market for our Class B common stock. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Record</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May&#160;23, 2023, there were 437 stockholders of record of our Class A common stock and 70 stockholders of record for our Class B common stock. Because many of our shares of Class A common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividend on our capital stock. We currently intend to retain any future earnings and do not expect to pay any dividends in the foreseeable future. Any future determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions, and other factors that our board of directors may deem relevant. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters&#8221; included in Part III, Item 12 of this Annual Report on Form 10-K for more information regarding securities authorized for issuance.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Equity Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Proceeds</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;28, 2021, we closed our IPO of 22,505,750 shares of our Class A common stock sold by us, including 3,495,000 shares pursuant to the exercise of the underwriters&#8217; option to purchase additional shares of our Class A common stock, and 4,289,250 shares of Class A common stock sold by an existing stockholder, at an offering price of $26.00 per share, resulting in proceeds to us of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs. All of the shares issued and sold in our IPO were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No. 333-256584), which was declared effective by the SEC on June&#160;23, 2021. Morgan Stanley &amp; Co. LLC, Goldman Sachs &amp; Co. LLC, J.P. Morgan Securities LLC, Piper Sandler &amp; Co., William Blair &amp; Company, L.L.C., Canaccord Genuity LLC, Needham &amp; Company, LLC, Raymond James &amp; Associates, Inc., and SVB Leerink LLC acted as underwriters for the offering. We incurred offering expenses of approximately $5.5 million. No payments for such expenses were made to our directors or officers or their associates, holders of 10% or more of any class </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our equity securities, or to our affiliates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of the sale of the shares of our Class A common stock referenced in the preceding sentences, the IPO terminated. There has been no material change in the planned use of proceeds from our IPO from those disclosed in the Final Prospectus.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information with respect to the repurchases of our Class A common stock during the three months ended March 31, 2023:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:19.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total Number of Shares Repurchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total Number of Shares Purchased as Part of Publicly Announced Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">January 1 - 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February 1 - 28, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March 1 - 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">523,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">523,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">523,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">523,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.84pt">On October&#160;28, 2022, the Company&#8217;s board of directors authorized a program to repurchase up to $70.0 million of the Company&#8217;s Class A common stock. The repurchases could be executed from time to time for a period of 12 months through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. As of March&#160;31, 2023, $54.0 million remained available and authorized for repurchase.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This performance graph shall not be deemed &#8220;soliciting material&#8221; or to be &#8220;filed&#8221; with the SEC, for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below shows the cumulative total return to our stockholders between June&#160;24, 2021 (the date that our Class A common stock commenced trading on the NYSE) through March&#160;31, 2023 in comparison to the S&amp;P 500 Index and the S&amp;P 500 Information Technology Index. The graph assumes (i) that $100 was invested in each of our Class A common stock, the S&amp;P 500 Index, and the S&amp;P 500 Information Technology Index at their respective closing prices on June 24, 2021 and (ii) reinvestment of gross dividends. The stock price performance shown in the graph represents past performance and should not be considered an indication of future stock price performance. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><img src="docs-20230331_g1.jpg" alt="4458" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. [Reserved]</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and accompanying notes that are included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties, as described under the heading &#8220;Special Note Regarding Forward-Looking Statements&#8221; in this Annual Report on Form 10-K. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the section titled &#8220;Risk Factors&#8221; or in other parts of this Annual Report on Form 10-K. Our historical results are not necessarily indicative of the results that may be expected for any period in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A discussion regarding our financial condition and results of operations for the fiscal year ended March&#160;31, 2023 compared to the fiscal year ended March&#160;31, 2022 is presented below. A discussion regarding our financial condition and results of operations for the fiscal year ended March&#160;31, 2022 compared to the fiscal year ended March&#160;31, 2021 can be found in &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022 and filed with the SEC on May&#160;27, 2022.</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_46"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the leading digital platform for U.S. medical professionals, as measured by the number of U.S. physician members. Our members include more than&#160;80% of physicians across all 50 states and every medical specialty. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our mission is to help every physician be more productive and provide better care for their patients. We are physicians-first, putting technology to work for doctors instead of the other way around. That guiding principle has enabled Doximity to become an essential and trusted professional platform for physicians. Our cloud-based platform provides our members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, monitor their work schedules,  and manage their careers. Doximity membership is free for physicians. Our revenue-generating customers, primarily pharmaceutical manufacturers and healthcare systems, have access to a suite of commercial solutions that benefit from broad physician usage.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the core of our platform is the largest medical professional network in the nation, which creates proximity within our community of doctors and hundreds of thousands of other medical professionals. Verified members can search and connect with colleagues and specialists, which allows them to better coordinate patient care and streamline referrals. Our newsfeed addresses the ever increasing sub-specialization of medical expertise and volume of medical research by delivering news and information that is relevant to each physician's clinical practice. We also support physicians in their day-to-day practice of medicine with mobile-friendly and easy-to-use clinical workflow tools such as voice and video dialer, secure messaging, and digital faxing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model has delivered high revenue growth at scale with profitability. For the fiscal years ended March&#160;31, 2023, 2022 and 2021, we recognized revenue of $419.1 million, $343.5 million, and $206.9 million, respectively, representing year-over-year growth rates of 22% and 66%, respectively. Our net income was $112.8 million, $154.8 million, and $50.2 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. For the fiscal years ended March&#160;31, 2023, 2022 and 2021, we generated adjusted EBITDA of $184.0 million, $150.3 million, and $64.8 million, respectively. We have accomplished this while focusing on our core mission to help every physician be more productive and provide better care for their patients. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_52"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Business and Financial Metrics</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor a number of key business and financial metrics to assess the health and success of our business, including: </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customers with Trailing 12-Month Subscription Revenue Greater than $100,000.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The number of customers with trailing 12-month (&#8220;TTM&#8221;) subscription revenue greater than $100,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $100,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of customers with at least $100,000 of revenue has grown steadily in recent years as we have engaged new customers and expanded within existing ones. This cohort of customers accounted for approximately 87%&#160;of our revenue in fiscal 2023. </span></div><div style="margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of customers with at least $100,000 of revenue </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">294</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">254</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">188</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> The metric excludes the impact of the AMiON acquisition, which closed on April 1, 2022, including customers of, and subscription revenue generated from, the AMiON on-call scheduling and messaging application, and the impact of such acquisition was immaterial to the periods presented. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Net Revenue Retention Rate.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net revenue retention rate is calculated by taking the TTM subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.</span></div><div style="margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net revenue retention rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_________________________</span></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The metric excludes the impact of the AMiON acquisition, which closed on April 1, 2022, including customers of, and subscription revenue generated from, the AMiON on-call scheduling and messaging application, and the impact of such acquisition was immaterial to the periods presented.</span></div><div style="margin-top:1pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center"><span style="background-color:#ffff00;color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_58"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing Solutions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers purchase a subscription to Marketing Solutions, either directly or through marketing agencies, for the ability to share tailored content on the Doximity platform via a variety of modules for defined time periods. We generally bill customers a portion of the contract upon contract execution and then bill throughout the remainder of the contract based on various time-based milestones. Generally, we bill in advance of revenue recognition. When revenue is recognized in advance of billings, we record unbilled revenue. Unbilled revenue is recorded on the consolidated balance sheets within prepaid expenses and other current assets. Subscriptions to Marketing Solutions include the following contractual arrangements:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subscriptions for specific modules delivered on a monthly basis to a consistent number of targeted Doximity members during the subscription period. Pricing is based on the number and composition of the targeted Doximity members, and on the specific modules purchased.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integrated subscriptions for a fixed subscription fee that are not tied to a single module, allowing customers to utilize any combination of modules during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these subscription-based contractual arrangements, we recognize revenue over time as control of the service is transferred to the customer.</span></div><div style="margin-bottom:4pt;margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hiring Solutions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers access to our platform which enables them to post job openings or deliver a fixed number of monthly messages to our network of medical professionals. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period, and revenue is recognized ratably over the contractual term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our acquisition of Curative Talent, completed in fiscal 2021, we also generate revenue from temporary and permanent medical recruiting services which we charge on an hourly-fee, and retainer and placement-fee basis, respectively. Revenue for temporary placement services is recognized net of third-party contractor fees. For the fiscal years ended March&#160;31, 2023, 2022, and 2021, the revenue from temporary and permanent medical recruiting services was not significant to our total revenue.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue is primarily comprised of expenses related to cloud hosting, personnel-related expenses for our customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delivery and support of our platform. Our cost of revenue also includes the amortization of internal-use software development costs, editorial and other content-related expenses, and allocated overhead. Cost of revenue is driven by the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">growth of our member network and utilization of our telehealth tools. We intend to continue to invest additional resources in our cloud infrastructure and our customer support organizations to support the growth of our business and expect these expenses to increase on an absolute dollar basis.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit and Gross Margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit is total revenue less total cost of revenue. Gross margin is gross profit expressed as a percentage of total revenue. Gross profit and gross margin has been and will continue to be affected by a number of factors, including the timing of our acquisition of new customers and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">les of additional solutions to existing customer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the timing and extent of our investments in our operations, cloud hosting costs, growth in our customer success team, and the timing of amortization of internal-use software development costs and deferred contract costs. We expect our gross margin to remain relatively steady over the near term, although our quarterly gross margin is expected to fluctuate from period to period depending on the interplay of these and other factors. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist of research and development, sales and marketing, and general and administrative expenses. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related expenses associated with our engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred. We expect research and development expenses will increase on an absolute dollar basis as we continue to grow our platform and product offerings. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expense is primarily comprised of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personnel-related expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, sales incentive compensation, travel, and other event expenses. Sales and marketing expense also includes costs for third-party services and contractors, information technology and software-related costs, allocated overhead, amortization of intangible assets, and change in fair value of contingent earn-out consideration liability. We capitalize sales incentive compensation that is considered to be incremental and recoverable costs of obtaining a contract with a customer. These sales incentive compensation costs are amortized over the period of benefit. We expect sales and marketing expense to increase and to be our largest expense on an absolute basis. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense is primarily comprised of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personnel-related expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with our executive, finance, legal, human resources, information technology, and facilities employees. General and administrative expense includes fees for third-party legal and accounting services, insurance expense, information technology and software-related costs, and allocated overhead. We expect that general and administrative expense will increase on an absolute dollar basis as we incur compliance costs associated with being a publicly-traded company, including legal, audit, and consulting fees. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consists primarily of investment income earned on our cash equivalents and marketable securities.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for (Benefit from) Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes consists primarily of income taxes in U.S. federal, state, and local jurisdictions in which we conduct business. We continue to maintain a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which includes California research and development credits, California alternative minimum tax credits, and capital loss carryforwards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our consolidated results of operations data and such data as a percentage of revenue for the periods presented. </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:62.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">303,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">190,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">113,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">114,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,818&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,210&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.84pt">Costs and expenses include stock-based compensation expense as follows:</span></div><div style="margin-bottom:9pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,834&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(percentage of revenue)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Fiscal Years Ended March 31, 2023 and 2022</span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">419,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75,504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the fiscal year ended March&#160;31, 2023 increased $75.5 million as compared to the fiscal year ended 2022. The increase was primarily driven by a $70.4 million increase in subscription revenue. Of the increase in subscription revenue, $15.3 million was driven by the addition of new subscription customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$55.1 million was due to the expansion of existing customers. The expansion of existing customers was primarily driven by average revenue per existing Marketing Solutions customer increasing by 21% as a result of adding new and growing existing brands and service lines. Approximately 93% of our revenue for the fiscal year ended March&#160;31, 2023 was derived from subscription customers. The remaining increase in revenue was driven by an increase in medical recruiting services. </span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of revenue, gross profit and gross margin</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">365,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">303,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue for the fiscal year ended March&#160;31, 2023 increased $13.7 million as compared to the fiscal year ended 2022. The increase in cost of revenue was primarily driven by a $5.4 million increase in personnel-related costs as a result of headcount growth of 24%, and a $5.2 million increase in expense related to the U.S. News partnership, of which $2.8 million related to the U.S. News Warrant granted in October 2021. In addition, there was an increase of $1.9 million in stock-based compensation expense, primarily due to headcount growth and awards granted to existing employees.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin for the fiscal year ended March&#160;31, 2023 decreased primarily due to headcount growth and expenses related to our U.S. News partnership, offset by growth in revenues.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense for the fiscal year ended March&#160;31, 2023 increased $17.8 million as compared to the fiscal year ended 2022. The increase in research and development expense was primarily driven by a $9.6 million increase in personnel-related costs as a result of headcount growth of approximately 12%. The increase was also driven by a $5.5 million increase in stock-based compensation primarily attributable to headcount growth and awards granted to existing employees.  In addition, there was a $1.9 million increase in third-party software costs as a result of increased research and development activities and a $1.1 million increase in employee events and travel-related expenses as compared to the prior period.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> We define new subscription customers as revenue generating subscription customers in the current fiscal period who did not contribute any revenue for the same period in the prior fiscal year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and marketing</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expense for the fiscal year ended March&#160;31, 2023 increased $31.4 million as compared to the fiscal year ended 2022. The increase in sales and marketing expense was primarily driven by a $9.5 million increase in personnel-related costs due to headcount growth of 17%. The increase was also driven by an $8.8 million increase in stock-based compensation expense, primarily due to headcount growth and awards granted to existing employees and a $4.9 million increase in costs related to employee events, travel, trade shows, conferences, and other marketing activities. There was also an increase of $3.2 million due to amortization expense for the intangible assets acquired in the AMiON acquisition. The remaining increase is primarily related to a $2.0 million increase in commissions and incentive compensation costs driven by an increase in sales activity and a $1.4 million increase in consulting services.</span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">999&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense for the fiscal year ended March&#160;31, 2023 increased $1.0 million as compared to the fiscal year ended 2022. The increase in general and administrative expense was primarily driven by a $2.2 million increase in personnel-related costs due to headcount growth of 23%. These increases were offset by a $2.6 million decrease in stock-based compensation expense primarily due to lower expense from a market-based award which completed vesting in the first quarter of fiscal 2023 and lower expense from other performance-based awards. The remaining change was to support the growth of the business. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income, net</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the fiscal year ended March&#160;31, 2023 increased $7.6 million as compared to the fiscal year ended 2022, primarily driven by increases in interest income due to higher yields earned on our cash equivalents and marketable securities portfolio and a higher average portfolio balance in fiscal 2023 as compared to fiscal 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for (benefit from) income taxes</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended March&#160;31, 2023, we had income tax expense of $20.3 million compared to an income tax benefit of $40.8 million for the fiscal year ended 2022. This change was primarily driven by a decrease in stock option activities resulting in a decrease in tax deductions and research and development tax credits.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">___________________</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">NM: Percentage not meaningful.</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_64"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have financed operations primarily through proceeds received from sales of equity securities and payments received from our customers. As of March&#160;31, 2023, our principal sources of liquidity were cash and cash equivalents </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and marketable securities of $841.0 million. Our marketable securities consist of U.S. government and agency securities, corporate notes and bonds, commercial paper, certificates of deposit, asset-backed securities, and sovereign bonds. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we completed our IPO, in which we issued and sold 22,505,750 shares of our Class A common stock at $26.00 per share, including 3,495,000 shares issued upon the exercise of the underwriters&#8217; option to purchase additional shares. We received proceeds of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;12, 2022, the Company&#8217;s board of directors authorized a program to repurchase up to $70.0 million of the Company&#8217;s Class A common stock. As of September 30, 2022, the Company repurchased and retired 2,150,982 shares of Class A common stock for an aggregate purchase price of $70.0 million, thereby completing this share repurchase program. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;28, 2022, the Company&#8217;s board of directors authorized an additional program to repurchase up to $70.0 million of the Company&#8217;s Class A common stock. The repurchases may be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. As of March&#160;31, 2023, the Company repurchased and retired 523,647 shares of Class A common stock for an aggregate purchase price of $16.0 million, and $54.0 million remained available and authorized for repurchases.</span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents and marketable securities will be sufficient to support working capital and capital expenditure requirements for at least the next 12 months.</span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including our revenue growth rate, the timing and the amount of cash received from customers, the expansion of sales and marketing activities, timing of share repurchases, and the timing and extent of spending to support research and development efforts. Further, we may in the future enter into arrangements to acquire or invest in businesses and technologies. We may be required to seek additional equity or debt financing. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional capital when desired, our business, financial condition, and results of operations could be adversely affected. </span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not entered into any off-balance sheet arrangements and do not have any holdings in variable interest entities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details regarding our cash requirements from noncancelable operating lease obligations and other contractual commitments, see Note 14&#8212;Commitments and Contingencies and Note 15&#8212;Leases included in Part II, Item 8 of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(640,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">560,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash provided by operating activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities was $179.6 million for the fiscal year ended March&#160;31, 2023. This consisted of net income of $112.8 million, adjusted for non-cash items of $87.8 million and a net outflow from operating assets and liabilities of $21.0 million. Non-cash items primarily consisted of stock-based compensation expense of $47.8 million, deferred income taxes of $13.2 million, depreciation and amortization expense of $10.3 million, amortization of deferred contract costs of $8.8 million, and amortization of the premium on marketable securities of $3.1 million. The net outflow from operating assets and liabilities was driven by a $26.2 million increase in accounts receivable due to the growth of our business and the timing of collections, an $8.5 million increase in deferred contract costs due to increased sales activity, and a $3.4 million increase in prepaid expenses and other assets. These outflows were partially offset by an increase of $17.5 million in deferred revenue due to the timing of customer billings and program launches.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities was $126.6 million for the fiscal year ended March&#160;31, 2022. This consisted of net income of $154.8 million, adjusted for non-cash items of $12.1 million and a net outflow in operating assets and liabilities of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$40.3 million. Non-cash items primarily consisted of stock-based compensation expense of $31.4 million, amortization of deferred contract costs of $9.8 million, depreciation and amortization expense of $5.0 million, amortization of the premium on marketable securities of $4.3 million, offset by a negative non-cash adjustment for deferred tax benefit of $41.2 million. The net decrease in operating assets and liabilities was driven by a $31.0 million increase in accounts receivable due to the growth of our business and the timing of collections, a $9.6 million increase in deferred contract costs due to increased sales activity, and a $9.1 million increase in prepaid expenses and other assets. These decreases were partially offset by an increase of $8.7 million in accounts payable, accrued expenses and other liabilities, which was primarily a result of increased accrued payroll, bonus, and related expenses due to increased headcount and timing of payments and increased rebate liabilities due to higher sales combined with the timing of payments.</span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in investing activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities was $59.9 million for the fiscal year ended March&#160;31, 2023, which primarily consisted of $190.6 million of marketable securities purchases, $53.5 million paid for the acquisition of AMiON, $4.5 million for internal-use software development costs, and $1.7 million for purchases of property and equipment. These payments were partially offset by proceeds from the sale of marketable securities of $107.2 million and proceeds from the maturities of marketable securities of $83.1 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities was $640.6 million for the fiscal year ended March&#160;31, 2022, which primarily consisted of purchases of marketable securities of $1.3 billion, partially offset by proceeds from the sale of marketable securities of $633.8 million, proceeds from the maturities of marketable securities of $47.9 million, and capitalization of internal-use software development costs of $3.8 million.</span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash provided by (used in) financing activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities was $74.5 million for the fiscal year ended March&#160;31, 2023, which primarily consisted of common stock repurchases of $85.3 million and $3.8 million of taxes paid related to the net share settlement of equity awards. These payments were partially offset by $9.9 million of proceeds from the exercise of stock options and common stock warrants and $4.8 million of proceeds from the issuance of common stock related to the employee stock purchase plan.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities was $560.4 million for the fiscal year ended March&#160;31, 2022, which primarily consisted of $553.9 million of proceeds from the issuance of common stock upon our initial public offering after deducting underwriting fees and commissions, $12.6 million of net proceeds from the exercise of stock options, and $1.4 million of proceeds from the issuance of common stock in connection with the employee stock purchase plan. These proceeds were partially offset by $4.0 million in payments for deferred offering costs and $2.7 million in payments from the repurchase and retirement of common stock. </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_55"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use adjusted EBITDA and free cash flow to measure our performance, identify trends, formulate financial projections, and make strategic decisions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a key measure we use to assess our financial performance and is also used for internal planning and forecasting purposes. We believe adjusted EBITDA is helpful to investors, analysts, and other interested parties because it can assist in providing a more consistent and comparable overview of our operations across our historical financial periods.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA and adjusted EBITDA margin are non-GAAP measures and are presented for supplemental informational purposes only and should not be considered as alternatives or substitutes to the financial information presented in accordance with GAAP. These measures have certain limitations in that they do not include the impact of certain expenses that are reflected in our consolidated statements of operations that are necessary to run our business. Other companies, including other companies in our industry, may not use these measures or may calculate these measures differently than as presented in this Annual Report on Form 10-K, limiting their usefulness as comparative measures.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of net income to adjusted EBITDA, adjusted EBITDA margin, and net income margin (in thousands, except percentages): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted to exclude the following:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in fair value of contingent earn-out consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">183,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">419,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow is a key performance measure that our management uses to assess our overall performance. We consider free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by our business that can be used for strategic opportunities, including investing in our business, making strategic acquisitions, and strengthening our financial position. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe free cash flow is a useful indicator of business performance, free cash flow is presented for supplemental informational purposes only and should not be considered a substitute for financial information presented in accordance with GAAP. Free cash flow has limitations as an analytical tool, and it should not be considered in isolation or as a substitute for analysis of other GAAP financial measures, such as net cash provided by operating activities. Some of the limitations of free cash flow are that it may not properly reflect future contractual commitments that have not been realized in the current period. Our free cash flow may not be comparable to similarly titled measures of other companies because they may not calculate free cash flow in the same manner as we calculate the measure, limiting its usefulness as a comparative measure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of our free cash flow to the most comparable GAAP measure, net cash provided by operating activities, for each of the periods indicated (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">179,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,701)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Free cash flow</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">173,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other cash flow components:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(59,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(640,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(70,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(74,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">560,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_70"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements and the related notes thereto included elsewhere in this Annual Report on Form 10-K are prepared in accordance with GAAP. The preparation of our financial statements also requires us to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. We base our estimates and judgments on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results could differ significantly from the estimates made by management. To the extent that there are </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that of our significant accounting policies, which are described in Note 2&#8212;Summary of Significant Accounting Policies included in Part II, Item 8 of this Annual Report on Form 10-K, the following accounting policies involve a greater degree of judgment and complexity. Accordingly, we believe the below policies are the most critical to aid in fully understanding and evaluating our consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress. The total transaction price is allocated to the individual module subscriptions, which represent separate performance obligations, based on the relative standalone selling price. We commence revenue recognition when the first content for the specific module is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. For these integrated campaign subscriptions, we record revenue ratably over the subscription period commencing with the beginning of the subscription term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for stock-based compensation in accordance with the authoritative guidance on stock compensation. Under the fair value recognition provisions of this guidance, stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense, net of estimated forfeitures, in the consolidated statements of operations over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are estimated based upon our historical experience and we revise the estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Determining the grant-date fair value of stock options, warrants, and purchase rights under the employee stock purchase plan, or ESPP, requires judgment. We estimate the fair value of restricted stock units, or RSUs, at our stock price on the grant date. We use the Black-Scholes option-pricing model to determine the fair value of stock options, warrants, and the ESPP. The determination of the grant-date fair value using the Black-Scholes model is affected by the fair value of our common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, when there was no public market for our common stock, significant judgment was involved in determining the fair value of our common stock and the expected stock price volatility. Our board of directors considered numerous objective and subjective factors to determine the fair value of our common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of our preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. The expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. We have not granted stock options to employees subsequent to the IPO.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of businesses acquired in business combinations are included in our consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business being recorded at their estimated fair values on the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill. The purchase price allocation process requires management to make significant judgment </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">s</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and estimates, including the selection of valuation methodologies, estimates of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates. These factors are also considered in determining the useful life of the acquired intangible assets. These estimates are based in part on historical experience, market conditions and information obtained from management of the acquired companies and are inherently uncertain. We engage the assistance of valuation specialists in concluding on fair value measurements in connection with determining fair values of assets acquired and liabilities assumed in business combinations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out consideration payable in cash arising from business combinations is recorded at fair value as a liability on the acquisition date and remeasured at each reporting date. Changes in fair value are recorded in sales and marketing expenses in the consolidated statements of operations. Determining the fair value of the contingent earn-out consideration each period requires management to make assumptions and judgments. These estimates involve inherent uncertainties, and if different assumptions had been used, the fair value of contingent consideration could have been materially different from the amounts recorded. The significant inputs used in the fair value measurement of the contingent earn-out consideration liability are the discount rate and the timing and amounts of the future payments, which are based upon estimates of future achievement of the performance metrics.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction-related costs are expensed as incurred and are included in general and administrative expenses in the consolidated statements of operations.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_73"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2&#8212;Summary of Significant Accounting Policies included in Part II, Item 8 of this Annual Report on Form 10-K for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_79"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our operations are within the United States and we do not have any foreign currency exposure. We are exposed to market risks in the ordinary course of our business, including the effects of interest rate changes and inflation.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents and marketable securities primarily consist of cash on hand and highly liquid investments in money market funds, corporate notes and bonds, asset-backed securities, commercial paper, certificates of deposit, U.S. government and agency securities, and sovereign bonds. As of March&#160;31, 2023 and 2022, we had cash and cash equivalents of $158.0 million and $112.8 million and marketable securities of $683.0 million and $685.3 million, respectively. We do not enter into investments for trading or speculative purposes. Our investments are exposed to market risk due to fluctuations in interest rates, which may affect our interest income and the fair value of our investments. Fixed rate securities may have their market value adversely affected due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fall short of expectation due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that decline in market value due to changes in interest rates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A hypothetical 100 basis point increase in interest rates would have resulted in a decrease of $5.0 million and $10.6 million, respectively, in the market value of our cash equivalents and marketable securities as of March&#160;31, 2023 and March&#160;31, 2022. Fluctuations in the value of our investments caused by a change in interest rates are recorded in other comprehensive income and are realized in net income only if we sell the underlying securities. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of Inflation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that inflation has had a material effect on our business, results of operations, or financial condition. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs. Our inability or failure to do so could harm our business, financial condition, and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Statements and Supplementary Data</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:89.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page(s)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_85">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184Mi9mcmFnOmI0NGJjYTY4M2E1ZDQ1MDliN2I4MWQ1M2M3M2ZhMTlhL3RhYmxlOjgwOWMzYTQyM2FhMTQ0Y2I4M2U0MmZhNTJlODAxYTUxL3RhYmxlcmFuZ2U6ODA5YzNhNDIzYWExNDRjYjgzZTQyZmE1MmU4MDFhNTFfMS0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjozYTA0Mjg0ODA4NDE0ODQxODFlNzBjYWExYjc1M2VlOF83MQ_5889e625-e9fb-41a1-91f4-ebabf3da59e9">34</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_85">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_88">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_88">62</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_91">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_91">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_94">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_94">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_97">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_97">65</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_100">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_100">67</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_103">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_103">69</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Tabl</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">e of Contents</a></span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the Stockholders and the Board of Directors of Doximity, Inc.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Doximity, Inc. and subsidiaries (the "Company") as of March 31, 2023 and 2022, the related consolidated statements of operations, comprehensive income, redeemable convertible preferred stock and stockholders&#8217; equity, and cash flows, for each of the three years in the period ended March 31, 2023, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of March 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated May 26, 2023, expressed an unqualified opinion on the Company's internal control over financial reporting.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition &#8211; Subscriptions &#8211; Refer to Notes 2 and 3 to the Financial Statements </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span><span style="color:#000000;font-family:'Calibri Light',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into subscription revenue contracts to host customer-sponsored content on their platform and provide access to the Company&#8217;s professional database of healthcare professionals for referral or marketing purposes for defined subscription periods. These contracts are in the form of (i) module-specific subscriptions, for which revenue recognition commences when the first content for the specific module is launched on the platform for the initial monthly period, and recognized over time as each subsequent content period is delivered and (ii) integrated subscriptions, for which revenue is recognized ratably over the subscription period commencing with the beginning of the subscription term. Management identifies and evaluates the relevant contractual terms in its higher value subscription revenue contracts (&#8220;contract terms and conditions&#8221;) based on its accounting policy in order to determine the pattern of revenue recognition. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the significance of the proper identification and evaluation of contract terms and conditions to the pattern of revenue recognition, performing audit procedures to evaluate whether management properly identified and evaluated the relevant contract terms and conditions that impact the pattern of revenue recognition required a high degree of auditor judgment and an increased extent of effort.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Tabl</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">e of Contents</a></span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Company's identification and evaluation of the contract terms and conditions within higher value subscription revenue contracts and the resulting impact on the pattern of revenue recognition included the following, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We assessed management&#8217;s significant accounting policies related to revenue recognition for compliance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over subscription contract revenue, including those over the identification and evaluation of contract terms and conditions and the resulting impact on revenue recognition.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We selected a sample of higher value subscription revenue contracts and performed the following: </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Obtained and read the related contract documents and evaluated whether management had properly identified the contract terms and conditions. </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Assessed management&#8217;s evaluation of the impact of the contract terms and conditions on the pattern of revenue recognition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations &#8211; Refer to Note 8 to the Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the acquisition of AMiON on April 1, 2022 for total purchase consideration of $74.6 million, consisting of $53.5 million in cash and $21.1 million in fair value of contingent earn-out consideration. The Company accounted for the acquisition as a business combination. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill. This includes a customer relationships intangible asset of $27.2 million. The Company estimated the fair value of the customer relationships using the multiple period excess earnings method cost approach, which requires estimates of the direct cash flows expected to be generated from the existing customers acquired. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the fair value of the acquired customer relationships intangible asset as a critical audit matter because of the significant estimates used by management to value the asset. This required a high degree of auditor judgement and an increased extent of effort, including the involvement of our fair value specialists, when performing audit procedures to evaluate the reasonableness of managements forecast of existing customer revenue and forecasted expenses and the selection of the discount rate. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to management&#8217;s forecast of existing customer revenue, forecasted expenses, and the discount rate used in the valuation of the customer relationships intangible asset included the following, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over the valuation of the acquired intangible assets, including management&#8217;s controls related to the forecasted existing customer revenue, future expenses, and discount rate.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We assessed the reasonableness of management&#8217;s forecast of existing customer revenue and expenses by comparing the forecast to historical results, certain peer companies, and industry data.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate by:</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Testing the source information underlying the determination of the discount rate and testing the mathematical accuracy of the calculation.</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Developing a range of independent estimates and comparing those to the discount rate selected by management.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.128%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NS9mcmFnOjg2MzQzZDJlY2ExOTQwMmI4MWNmMzgzNTJlOGM4MjRkL3RhYmxlOmI5NmEwOGQyYzk1YjQyNGE4YTZmNjc5YWE0NTYxNmQ1L3RhYmxlcmFuZ2U6Yjk2YTA4ZDJjOTViNDI0YThhNmY2NzlhYTQ1NjE2ZDVfMC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjo4MmFkNjFjMWE1ZjY0ODFiODEzNTcyODVmMGQwMjRiN184_7799a6e0-842d-4b6c-85b5-314f0b88a6ad">Deloitte &amp; Touche LLP</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NS9mcmFnOjg2MzQzZDJlY2ExOTQwMmI4MWNmMzgzNTJlOGM4MjRkL3RhYmxlOmI5NmEwOGQyYzk1YjQyNGE4YTZmNjc5YWE0NTYxNmQ1L3RhYmxlcmFuZ2U6Yjk2YTA4ZDJjOTViNDI0YThhNmY2NzlhYTQ1NjE2ZDVfMS0wLTEtMS0xODE3Njk_bf177f68-4df4-4105-842f-bf27b3f61e47">San Francisco, California</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2015.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_987"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Tabl</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">e of Contents</a></span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the Stockholders and the Board of Directors of Doximity, Inc.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of Doximity Inc. and subsidiaries (the &#8220;Company&#8221;) as of March 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by COSO.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements of the Company as of and for the year ended March 31, 2023, of the Company and our report dated May 26, 2023 expressed an unqualified opinion on those financial statements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.125%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Deloitte &amp; Touche LLP</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Francisco, California</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNC0xLTEtMS0xODE3Njk_091bb7cd-ac2d-4788-bad9-66bcebcfc1f9">158,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNC0zLTEtMS0xODE3Njk_38a64866-ed39-4d32-8f48-f25f3a342a08">112,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNS0xLTEtMS0xODE3Njk_c1ba2836-a81d-4e58-9ac3-408b132025b7">682,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNS0zLTEtMS0xODE3Njk_65f48971-aa8c-4266-84eb-79f92a230490">685,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjo2ODg1ZmNlYjVkMWM0ZGI2YTBjODczYmZiMjBiNDgzM182Nw_9571158f-210d-4377-b52e-da630da49826">887</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjo2ODg1ZmNlYjVkMWM0ZGI2YTBjODczYmZiMjBiNDgzM183NA_65cddf5d-8f68-4a9b-8139-c78ffc2298fa">359</ix:nonFraction> as of March&#160;31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0xLTEtMS0xODE3Njk_2092b295-fccf-490a-a5dd-487832ce281b">107,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0zLTEtMS0xODE3Njk_6467d9e7-1c58-4fe4-84c8-7e3e43db5008">81,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNy0xLTEtMS0xODE3Njk_ffb94a4f-b786-4c4e-b24a-66fedb2a1cb5">22,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNy0zLTEtMS0xODE3Njk_d4a7b47a-c1ea-4fd9-a3a5-981f1855b5e3">19,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred contract costs, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CapitalizedContractCostNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOC0xLTEtMS0xODE3Njk_1e7c2c49-2095-422c-8131-77a3efb43eab">5,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CapitalizedContractCostNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOC0zLTEtMS0xODE3Njk_47a28143-28da-4804-b7db-527341ae444d">5,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOS0xLTEtMS0xODE3Njk_425b6d7b-3b0d-492f-8b34-796ff71dc177">975,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOS0zLTEtMS0xODE3Njk_6c37419f-0d81-4ede-baef-01e48aea484e">904,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTAtMS0xLTEtMTgxNzY5_2b66059e-2853-4528-8042-c77616219c7e">11,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTAtMy0xLTEtMTgxNzY5_81f12817-5aa0-4152-b2c1-b195089e3c9f">8,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTEtMS0xLTEtMTgxNzY5_dcc1e831-9da5-4b28-81f3-452aba2d381b">34,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTEtMy0xLTEtMTgxNzY5_fbf80563-8a5d-48a2-bc3c-ffcb71de7f2e">48,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTItMS0xLTEtMTgxNzY5_35f4d038-66c4-4e92-83cf-b3baadf104b2">13,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTItMy0xLTEtMTgxNzY5_94de1d21-f8c1-4b57-b798-6e9d5530ab8a">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTMtMS0xLTEtMTgxNzY5_6602bd95-b9d5-498f-8e90-d45cef31f978">31,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTMtMy0xLTEtMTgxNzY5_23ba2989-8e22-4467-9cb7-a523774e87ff">7,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTQtMS0xLTEtMTgxNzY5_442c044e-62fa-4360-83b0-31c0396834df">67,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTQtMy0xLTEtMTgxNzY5_f86aee44-5527-45b5-b4ce-1370e7b0d66c">18,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTUtMS0xLTEtMTgxNzY5_f5d47564-5d06-4677-8439-bf064999174f">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTUtMy0xLTEtMTgxNzY5_1ba95601-ddf8-4e12-81d9-4697f2fd88ca">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTYtMS0xLTEtMTgxNzY5_50ff7e53-81d2-499e-af92-36e335d72bfd">1,136,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTYtMy0xLTEtMTgxNzY5_d80b3499-936d-401c-a20b-3b0d76b5ddff">991,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTktMS0xLTEtMTgxNzY5_9b344f7e-f462-44e5-a820-2ecf08992ae5">1,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTktMy0xLTEtMTgxNzY5_7db26c5a-b24b-49c7-b7fb-a0185be6a95f">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjAtMS0xLTEtMTgxNzY5_be7c2b02-403b-47aa-ac18-b41ebadca37d">31,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjAtMy0xLTEtMTgxNzY5_e0ac82ac-e6e4-4dff-be83-f71b9c48fd1b">25,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjEtMS0xLTEtMTgxNzY5_37faa8b9-6bd3-4e29-b72e-8e3cbaf448c0">105,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjEtMy0xLTEtMTgxNzY5_d011d061-37b8-45f2-9b9c-de7527c977d3">84,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjItMS0xLTEtMTgxNzY5_44abe5be-e4c9-416a-a31e-7dc30fb0d130">1,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjItMy0xLTEtMTgxNzY5_b957994b-174f-4a86-992f-c8946a96f503">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjMtMS0xLTEtMTgxNzY5_9f961239-3190-4131-8fa1-641cacc62c18">139,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjMtMy0xLTEtMTgxNzY5_9b3fc70e-ae90-4000-a6f3-16f9ec368fbb">111,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjQtMS0xLTEtMTgxNzY5_1ebd124a-6734-464c-a2de-57e1b0d643b5">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjQtMy0xLTEtMTgxNzY5_6626dbd1-296c-4c65-bee9-3133bea92823">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjUtMS0xLTEtMTgxNzY5_d52abf40-f7e8-4a7b-bc12-2f1050445deb">13,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjUtMy0xLTEtMTgxNzY5_f7816941-a177-4b1c-bb8c-e550dd0f54b2">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contingent earn-out consideration liability, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMS0xLTEtMTgzNTI3_2c733f7a-eb6c-47a9-b614-bbd7ce22af47">15,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMy0xLTEtMTgzNTI3_c7727590-f31d-4795-956a-bb9023996e02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMS0xLTEtMTgxNzY5_c47e4a0b-129b-4562-b603-d5c05e694457">1,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMy0xLTEtMTgxNzY5_7e49cbd3-052e-42f1-9737-4712a7082a52">956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjctMS0xLTEtMTgxNzY5_1926be9b-cb8a-4f8d-8e6f-9f4482f96db7">170,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjctMy0xLTEtMTgxNzY5_53966fb4-3851-440f-a756-7c56e9553ac9">112,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commitments and contingencies (Note 14)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjgtMS0xLTEtMTgxNzY5_ea0ff6e4-8006-4078-b665-ac0e29fdddd3"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjgtMy0xLTEtMTgxNzY5_c86d50d4-150a-4f34-a63b-7d14cb0feb46"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfMjE_7662ac03-570d-4cc6-9352-50e1f9485b17"><ix:nonFraction unitRef="usdPerShare" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfMjE_88ae7282-24dc-47e4-a8ce-b2ca8eaea4a2">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MDQ1_2b482f6f-6a9a-4bf7-aec9-2c3586570428"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MDQ1_628a09d6-af0b-48ac-bb21-0f151bbebe47">100,000</ix:nonFraction></ix:nonFraction> shares authorized as of March&#160;31, 2023 and 2022, respectively; <ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_89f67ee7-b472-420f-8793-8b7239c94e71"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_8dd38866-198d-40d3-a1bf-f5eaaa3b83df"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_cf4f1870-8c9f-405b-ac27-8827e7ccdbef"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_e5552c09-6639-4d49-b511-ed49fff50e47">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMS0xLTEtMTgxNzY5_038614f8-9f55-498f-ae7a-b0531d52fa8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMy0xLTEtMTgxNzY5_60d0ee2e-0a05-494f-ab62-637baf0f22d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Class A and Class B common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMzg_88c4f8ed-0a27-4815-9f3f-13ecb96659b1"><ix:nonFraction unitRef="usdPerShare" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMzg_ec8d5391-fd89-4f74-8084-e0ab82fffeb4">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfNTI_77ae495d-8a5f-4776-a86c-c35a6dde4b1e"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfNTI_c5b4d041-a136-4295-b6c9-91502207780d">1,500,000</ix:nonFraction></ix:nonFraction> shares authorized as of March&#160;31, 2023 and 2022, respectively; <ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTEx_56e7ae30-ece5-4091-bd0d-d32eebf6e2a4"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTEx_97ec36ff-1758-4528-a0ca-4ba83b309371">193,941</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTE4_07207aac-b33a-4029-9e6d-69df94ba2b1e"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTE4_56235399-254d-492b-bf76-392564269282">192,398</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMS0xLTEtMTgxNzY5_a6f851c1-4988-42e9-812d-9af53c8f86db">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMy0xLTEtMTgxNzY5_d0b2f775-ad80-4634-a292-df3f157f6109">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzQtMS0xLTEtMTgxNzY5_b4b7fd7e-a5e6-45da-af05-f0e5276932f5">762,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzQtMy0xLTEtMTgxNzY5_c02effc7-0aaf-4cd2-87d1-bd7bc22f1d8d">702,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzUtMS0xLTEtMTgxNzY5_b5d1e7af-c57f-4126-9f0d-8b63dc4eb8f2">14,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzUtMy0xLTEtMTgxNzY5_2e65f0ec-de17-4871-8521-b7792f2a4ae3">15,294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzYtMS0xLTEtMTgxNzY5_b1f9f0c9-eba6-4c5e-8c80-6424fd41a4ac">217,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzYtMy0xLTEtMTgxNzY5_cf85269a-c91d-4855-98f6-1d94c28b5d46">191,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzctMS0xLTEtMTgxNzY5_a7ef52f7-8e13-4c3a-bc2e-6aa6bc958486">966,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzctMy0xLTEtMTgxNzY5_4bda6501-3c72-4753-8ab7-7ff2527f7d09">878,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzgtMS0xLTEtMTgxNzY5_2687e19b-74d9-42b9-abe4-600ed0d7fd8d">1,136,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzgtMy0xLTEtMTgxNzY5_99fd4ef6-b7b9-45d0-990d-659a9fdbe266">991,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_91"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMi0xLTEtMS0xODE3Njk_8fb1a422-0b5c-4ea7-8177-780db18a58a0">419,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMi0zLTEtMS0xODE3Njk_acdddf1c-1872-4055-a64a-9ac7a8fae6fa">343,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMi01LTEtMS0xODE3Njk_bac6ec42-f483-4f52-9798-7d8799eb87e0">206,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMy0xLTEtMS0xODE3Njk_b2c4c690-7436-41d2-a1a3-eb9d9763bea8">53,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMy0zLTEtMS0xODE3Njk_4abb291d-25af-4e84-b19b-206288ad058a">39,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMy01LTEtMS0xODE3Njk_e14c384b-8abc-495d-b079-3067eddd4d5b">31,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNC0xLTEtMS0xODE3Njk_1168b126-8869-47fc-80e0-5a439f06c60a">365,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNC0zLTEtMS0xODE3Njk_8175c619-b918-409c-a5da-860a637967af">303,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNC01LTEtMS0xODE3Njk_3d5d59fc-d903-46e4-92cb-30de9afd6f87">175,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNi0xLTEtMS0xODE3Njk_f60c1195-a89a-4dfc-ac4a-731c5b501654">80,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNi0zLTEtMS0xODE3Njk_fed572f4-b26a-405a-ad2f-b85ac848f7cd">62,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNi01LTEtMS0xODE3Njk_fe6b04a9-d868-4f23-814f-6f456b488bca">43,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNy0xLTEtMS0xODE3Njk_f766e87b-97d9-4a6a-b82b-2d0963e75b6d">123,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNy0zLTEtMS0xODE3Njk_1dcdffbb-6035-426b-a577-bf16a39c6c5d">92,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNy01LTEtMS0xODE3Njk_cb84a2ff-d2d1-4f21-9784-f921d66e3171">62,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOC0xLTEtMS0xODE3Njk_b94f1705-a6f9-40c9-afd1-72ff70e6041d">36,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOC0zLTEtMS0xODE3Njk_c81a1a56-0fac-41ee-8bb2-7f02ddfe5a7b">35,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOC01LTEtMS0xODE3Njk_034ae70e-979e-49e4-9cee-92b78fad0c50">16,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOS0xLTEtMS0xODE3Njk_f8bb73e4-af9f-48c1-a696-6a91442447e7">240,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOS0zLTEtMS0xODE3Njk_401aa987-1c6e-45d3-8bc6-8c5d23827301">190,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOS01LTEtMS0xODE3Njk_bb0e8df2-cbec-4ac2-aea8-9770acc5c193">122,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTAtMS0xLTEtMTgxNzY5_ca1e121b-744e-42f7-9756-40cb520bdede">125,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTAtMy0xLTEtMTgxNzY5_506ee365-c953-4a64-847f-fbb3b722e733">113,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTAtNS0xLTEtMTgxNzY5_0d4d188f-60d7-4684-b092-d9ad8eb08e98">53,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTEtMS0xLTEtMTgxNzY5_1698de17-98cd-4d1e-b6dc-51f4e1a65143">8,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTEtMy0xLTEtMTgxNzY5_5bb56e54-7ffc-41f5-9436-66da146a3502">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTEtNS0xLTEtMTgxNzY5_4331df10-b4a4-4885-a9f2-123cba66d79e">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTItMS0xLTEtMTgxNzY5_c85d9945-cdc1-4def-9d0e-abf846ea61db">133,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTItMy0xLTEtMTgxNzY5_9f11d196-508c-4f5a-9ce0-373969412ddb">114,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTItNS0xLTEtMTgxNzY5_87121884-b1c0-4e0a-96fa-c13a88c41b1a">57,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTMtMS0xLTEtMTgxNzY5_1b455efb-e8f0-40c3-961d-5e59c54cb9eb">20,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTMtMy0xLTEtMTgxNzY5_1597f2be-0098-4034-a01f-bfb56cc01dd9">40,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTMtNS0xLTEtMTgxNzY5_7edff81e-f1d6-4fb5-9d2d-ff17ffc0d0b9">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTQtMS0xLTEtMTgxNzY5_f981371d-7e36-4cd1-b327-dbf188ff0eb1">112,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTQtMy0xLTEtMTgxNzY5_6f3af263-9887-409e-9e86-2904b87c1efc">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTQtNS0xLTEtMTgxNzY5_a45ecdba-edcf-456f-b7b0-ad79532066d5">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMS0xLTEtMTgxNzY5_6194d07a-0346-4624-968e-cc08a611f6f7"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMS0xLTEtMTgxNzY5_b2b62bf4-625f-47af-ac4a-99651309eadc">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMy0xLTEtMTgxNzY5_1275d853-6671-4468-946f-cb2f687908cc"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMy0xLTEtMTgxNzY5_ea04b119-b564-4b86-8f89-4b3d091e5198">21,526</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtNS0xLTEtMTgxNzY5_b99eab24-b151-4550-89e0-d1555123b3c9"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtNS0xLTEtMTgxNzY5_e226fd08-6306-41ce-b739-a91e35ae6fa0">28,654</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMS0xLTEtMTgxNzY5_60a5de1a-eb3a-43d2-a1b5-5add4b3e0448"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMS0xLTEtMTgxNzY5_ddf66632-cf4a-429e-af67-ea06668a78f5">112,818</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMy0xLTEtMTgxNzY5_158da3b9-4b47-468c-960f-d2d6909a3154"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMy0xLTEtMTgxNzY5_63a71c4f-627a-40ac-8018-e05496f0ea7d">133,257</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtNS0xLTEtMTgxNzY5_25d9a3c4-5a3e-4029-b06c-fc8d00d96761"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtNS0xLTEtMTgxNzY5_952ea8b4-1d6a-4be9-891d-4e232ffba5a3">21,556</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTgtMS0xLTEtMTgxNzY5_d07512d5-fe25-4eec-9849-b8c40d212341">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTgtMy0xLTEtMTgxNzY5_171411b5-5e85-4f0b-bf7c-9d8c26b649cd">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTgtNS0xLTEtMTgxNzY5_6f48f1a8-bd5b-431a-a443-20c87ab92223">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTktMS0xLTEtMTgxNzY5_a4ddbae1-eb7d-40a8-96f0-b33bbe3be5f2">0.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTktMy0xLTEtMTgxNzY5_13d3a21d-2dc5-4c46-a847-8fa568f008a9">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTktNS0xLTEtMTgxNzY5_075ef360-2ca4-442d-abf5-fafb42a1656f">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjEtMS0xLTEtMTgxNzY5_747a15aa-4ef8-4c64-b4ac-9bf8aaef584c">193,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjEtMy0xLTEtMTgxNzY5_ec1ecfee-7872-4988-b2a0-49116f752030">163,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjEtNS0xLTEtMTgxNzY5_f0bc3d6a-b09d-42c0-b8c0-647b97f733de">74,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjItMS0xLTEtMTgxNzY5_9d84a15b-63d0-412a-9c16-f8670abb265c">213,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjItMy0xLTEtMTgxNzY5_c83ac2d6-45a6-437d-a110-78f404adda72">191,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjItNS0xLTEtMTgxNzY5_903007cd-ccad-40eb-bd3d-e63c5ea0842c">95,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfMi0xLTEtMS0xODE3Njk_cc1d69e2-fc65-4de7-b8dc-89502c02fba1">112,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfMi0zLTEtMS0xODE3Njk_7402711e-c116-47ce-ab7a-4568d3661860">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfMi01LTEtMS0xODE3Njk_d92b1787-81b1-49bd-a17b-8111f713b8d0">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in unrealized gain (loss) on available-for-sale-securities, net of tax benefit (provision) of $(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjpmOGRmMmQ0ODRmOGU0MGQ1YTQwZjkyMDVlMjBiMGU5Nl83_ec0cecdf-6a87-43bc-b561-586796212b92">425</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjpmOGRmMmQ0ODRmOGU0MGQ1YTQwZjkyMDVlMjBiMGU5Nl8xMQ_efd9d56b-787c-4780-bf40-ab7a0d43e975">5,199</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjpmOGRmMmQ0ODRmOGU0MGQ1YTQwZjkyMDVlMjBiMGU5Nl8xOQ_2a937127-68e7-4369-90ce-4dd4e51a514d">0</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0xLTEtMS0xODE3Njk_110942dc-9eea-43e0-a336-0060fc497406">1,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0zLTEtMS0xODE3Njk_b8241599-5488-41da-817f-aea43a941958">15,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC01LTEtMS0xODE3Njk_3122fb58-95da-4ab0-bfc3-1af2e80c2256">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNi0xLTEtMS0xODE3Njk_c1f63267-644b-4a1c-92d8-6fb1c5426202">114,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNi0zLTEtMS0xODE3Njk_31cea890-3bce-4cda-95ed-a274f4486f38">139,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNi01LTEtMS0xODE3Njk_764ce5e8-8089-4784-a790-b481cdfe35f2">50,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.891%"><tr><td style="width:1.0%"></td><td style="width:26.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Redeemable Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Retained Earnings (Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders' Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2020 </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xLTEtMS0xODE3Njk_d2986681-63f0-4985-9841-c515e51c297b">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0zLTEtMS0xODE3Njk_2cb9f8c4-25f8-474e-94cf-fcf07277651c">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i51bee6fa91384d2b859a47c7b4a2bdf1_I20200331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi02LTEtMS0xODE3Njk_9b96cf61-bf31-4172-bfd8-cfa6af5bff72">68,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i51bee6fa91384d2b859a47c7b4a2bdf1_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi04LTEtMS0xODE3Njk_db839a1d-f9fd-4c6e-9a6b-9181a2ef272b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i239eff19d97e41b9b0482aa745e705a8_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xMC0xLTEtMTgxNzY5_e76f8522-fe85-43a1-8983-2ff200a1afe4">14,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8ac170db1b65461e92998fa288b22bb1_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xMi0xLTEtMTgxNzY5_f020f78a-beca-4289-9844-2eecd750a579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2aec2a3cf466470d83a702d7d3b279e8_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xNC0xLTEtMTgxNzY5_0f7b0253-265c-4625-b7e2-8e4f5d3e0f5e">13,886</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xNi0xLTEtMTgxNzY5_d6cd867a-5680-4adc-9df4-0ff7fffcbd73">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMy0xMC0xLTEtMTgxNzY5_252d74a9-a945-4f4f-9efa-ea66f94cdc23">7,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMy0xNi0xLTEtMTgxNzY5_891998cc-7d5e-4e46-8c6c-5b0c22a17676">7,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC02LTEtMS0xODE3Njk_7b37ad01-ae1c-4a6b-88df-2295e803b3af">13,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC04LTEtMS0xODE3Njk_9f44c4d4-7dda-47dd-bd20-ea51b378663a">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC0xMC0xLTEtMTgxNzY5_264e00ed-7868-40b5-b6da-fc254b74fd36">8,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC0xNi0xLTEtMTgxNzY5_7ff99185-d9a3-4461-bd77-dfc2bc1da80d">8,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in exchange for services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS02LTEtMS0xODMxNTc_bd463ccb-fee6-48b4-a236-24aef6b70c87">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xMC0xLTEtMTgzMTU3_570dffc8-15d3-4e7e-9978-6a7c3ac11a29">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xNi0xLTEtMTgzMTU3_22b1fe58-cbcc-4c3c-8cb4-fc2d47710724">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi02LTEtMS0xODMxNjY_e622e645-9683-43e7-acaf-f889538f73a5">258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xMC0xLTEtMTgzMTY2_f1f92c72-c9ca-4328-b4d7-6a3fc68a2815">2,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xNi0xLTEtMTgzMTY2_906d0a8d-a0be-47d7-bf0b-8903214f2798">2,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrant expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xMC0xLTEtMTgxNzY5_cd2583e8-38cd-4329-b8b4-8f4ad5da11c6">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xNi0xLTEtMTgxNzY5_6c48d6f9-851d-4a03-a45f-658f9df7544a">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46d6f06521b34618831102060f160822_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xMi0xLTEtMTgxNzY5_41cf89d7-335a-4670-9a57-15252715001b">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xNi0xLTEtMTgxNzY5_5e6a2710-991a-451e-8436-483f98e30e91">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with an acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy02LTEtMS0xODE3Njk_c477b7fe-3b7a-43b8-baa3-5aa61565038e">690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy04LTEtMS0xODE3Njk_5a6a85cf-707c-4d66-9047-983b5da0c9ed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy0xMC0xLTEtMTgxNzY5_f5d53cbf-194d-49a9-ad78-b24109df589f">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy0xNi0xLTEtMTgxNzY5_59e68907-bd8d-4f0a-aadd-13f494f64834">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic816ea61c72b4526baf4f08dda97575f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOC0xNC0xLTEtMTgxNzY5_273fb652-fd69-4d7a-be88-bec3afc30e0c">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOC0xNi0xLTEtMTgxNzY5_9cc02920-742a-4070-a223-23b596ee114f">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xLTEtMS0xODE3Njk_0a36fabe-8d39-4d31-a219-cb7c55d777e1">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0zLTEtMS0xODE3Njk_d7d0da30-8c80-48c4-b969-a98584817fb2">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie2a4a27e961b4732a69f4329e75908ce_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS02LTEtMS0xODE3Njk_57056945-ab4c-475f-acd5-f25183e6b9ef">82,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie2a4a27e961b4732a69f4329e75908ce_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS04LTEtMS0xODE3Njk_746f186f-7bc7-4e60-b505-cf3d53300148">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0c7aad5f38d74f8ea3efd5af5a079c17_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xMC0xLTEtMTgxNzY5_0c6097b4-fad2-40ea-9877-0c07154cd04e">30,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id3f4e1f1e9ef42a596eb67129ffa34b2_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xMi0xLTEtMTgxNzY5_73afcf2b-91cd-4349-b424-b21538107827">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iee132da446eb4ed08a23cdf121ea6b0c_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xNC0xLTEtMTgxNzY5_117e3759-46a1-48d9-b49d-143d11cb2bd6">36,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xNi0xLTEtMTgxNzY5_87f3da4f-ef2f-43f5-83ee-0a5ddc3efe84">66,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTAtMTAtMS0xLTE4MTc2OQ_26b646c1-444e-4b19-9aac-704649fccec5">29,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTAtMTYtMS0xLTE4MTc2OQ_53beda1c-f441-4b63-9507-4bdfdec613b3">29,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtNi0xLTEtMTgxNzY5_4dbe35ae-28b0-4e83-970c-60382197229f">10,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtOC0xLTEtMTgxNzY5_7301ad51-cef6-4849-9735-ab167bb5e4fa">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtMTAtMS0xLTE4MTc2OQ_2a6d9929-26bc-45e1-804c-a260faf625c0">12,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtMTYtMS0xLTE4MTc2OQ_79d64c17-de48-41e2-a06e-d9b9c0c3543d">12,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTQtNi0xLTEtMTgzMTgx_90f00eeb-55c0-4d49-9e6a-96d24944ed91">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tax withholding on shares under stock-based compensation awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTAtMS0xLTE4MzE5Mg_b018637f-2c4f-40a5-9923-b60e82407a81">817</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTYtMS0xLTE4MzE5Mg_33ccbb72-f8d0-4ff7-984e-2f3194485e04">817</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTMtNi0xLTEtMTgxNzY5_9155f88d-f2a6-42c2-a38b-872365dd1f22">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTMtMTAtMS0xLTE4MTc2OQ_c6b2c5bb-2dbb-4b70-b949-b4b03d258bef">2,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTMtMTYtMS0xLTE4MTc2OQ_dd1c9a51-217b-43a3-8263-f66f3579d26a">2,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrant expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTQtMTAtMS0xLTE4MTc2OQ_5876b501-4ef4-44d3-b178-0dc36c3167e4">2,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTQtMTYtMS0xLTE4MTc2OQ_f71e4dc3-f8fc-4910-84e0-a97fb7ebc532">2,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ff263310c7e4813b992a8d0b1ad53cc_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTItMS0xLTE4MTc2OQ_7c66d0d9-5c7e-454b-92e2-60f06d277260">15,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTYtMS0xLTE4MTc2OQ_9932ecde-96f1-4fc1-9dc2-37900e4110fc">15,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Conversion of redeemable convertible preferred stock upon initial public offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMS0xLTEtMTgzMjAy_7767442b-4028-4912-8603-ae2a97a9b2fc">76,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMy0xLTEtMTgzMjAy_ea6fdf45-79b9-491d-af76-de62bd7ac81f">81,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktNi0xLTEtMTgzMjAy_4f48cb4d-5da8-4f8e-b334-c73241bad49c">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktOC0xLTEtMTgzMjAy_8c2550fc-a7c8-40de-ac4c-19d8b0e06ed3">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMTAtMS0xLTE4MzIwMg_6087eb58-604a-4152-88c6-95f906c6c7e2">81,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMTYtMS0xLTE4MzIwMg_d5e890fc-8f6a-4685-9131-5467f2cc81dc">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock upon initial public offering, net of offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtNi0xLTEtMTgxNzY5_06289ea1-7915-4e01-b31d-c0e482c48fc7">22,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtOC0xLTEtMTgxNzY5_71595bc3-5701-48df-9177-80e4abb7b3f0">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtMTAtMS0xLTE4MTc2OQ_b5f164b2-8ec7-44bf-b8b8-629369547b0c">548,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtMTYtMS0xLTE4MTc2OQ_44370dda-82ad-4eca-8f26-83d63eb72957">548,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with the employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMjEtNi0xLTEtMTgzMjE2_a127d4f3-eb60-4610-b5b9-3be0672a48f1">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMjEtMTAtMS0xLTE4MzIxNg_10cfbeb2-902a-4ff6-a4e4-5629ce4f87dc">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMjEtMTYtMS0xLTE4MzIxNg_36a85e3a-ee06-4385-898d-98c8ecec254b">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0955332a233f4c018f259ff874af4f61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTctMTQtMS0xLTE4MTc2OQ_c26de2ff-cabd-41bd-ba3f-7edb91e79e8b">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTctMTYtMS0xLTE4MTc2OQ_61fb2b1a-bb6d-4cf1-b0ce-893f5070aa25">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMS0xLTEtMTgxNzY5_32bb07f2-d7ae-4475-88a6-62331506f18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMy0xLTEtMTgxNzY5_1f2ebe6a-9698-47f3-82cf-20c22abeaf71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtNi0xLTEtMTgxNzY5_64db7d82-48a5-456b-bec2-f8c8dc9d4b91">192,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtOC0xLTEtMTgxNzY5_afdb01f5-b250-46e2-9210-8a13f0826240">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4eb2e149b8ed4edea42e1794b79eead8_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTAtMS0xLTE4MTc2OQ_fe05266b-91b7-45a8-8f50-609cc3c0ac89">702,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifccc74565273499782a3a98a62beb0f7_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTItMS0xLTE4MTc2OQ_0475c1aa-f8ed-4ca7-9035-7663b12fb547">15,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i64036fdea8df4afda807a5cece385147_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTQtMS0xLTE4MTc2OQ_a21d728b-8b7d-4f0a-b2ac-2189e9454e19">191,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTYtMS0xLTE4MTc2OQ_03dc5441-d002-4649-bd3d-10d38ed348cd">878,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.376%"><tr><td style="width:1.0%"></td><td style="width:24.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.478%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Redeemable Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Retained Earnings (Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders' Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2022 </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xLTEtMS0xODE3Njk_32bb07f2-d7ae-4475-88a6-62331506f18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0zLTEtMS0xODE3Njk_1f2ebe6a-9698-47f3-82cf-20c22abeaf71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi02LTEtMS0xODE3Njk_64db7d82-48a5-456b-bec2-f8c8dc9d4b91">192,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi04LTEtMS0xODE3Njk_afdb01f5-b250-46e2-9210-8a13f0826240">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4eb2e149b8ed4edea42e1794b79eead8_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xMC0xLTEtMTgxNzY5_fe05266b-91b7-45a8-8f50-609cc3c0ac89">702,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifccc74565273499782a3a98a62beb0f7_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xMi0xLTEtMTgxNzY5_0475c1aa-f8ed-4ca7-9035-7663b12fb547">15,294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i64036fdea8df4afda807a5cece385147_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xNC0xLTEtMTgxNzY5_a21d728b-8b7d-4f0a-b2ac-2189e9454e19">191,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xNi0xLTEtMTgxNzY5_03dc5441-d002-4649-bd3d-10d38ed348cd">878,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMy0xMC0xLTEtMTgxNzY5_14ca2f80-c34c-44d5-bfda-9aaac717f581">43,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMy0xNi0xLTEtMTgxNzY5_18a62d93-40e5-4633-8b01-0f6d27b5bc8f">43,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options and common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331" decimals="-3" name="docs:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC02LTEtMS0xODE3Njk_63716984-1c0c-4c3f-a272-cc0d84afa432">3,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331" decimals="-3" name="docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC04LTEtMS0xODE3Njk_7b0871a6-bd82-4e63-9292-832ccae78761">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331" decimals="-3" name="docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC0xMC0xLTEtMTgxNzY5_428b17ac-4799-4642-be87-a452f378a19e">9,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC0xNi0xLTEtMTgxNzY5_ffc6876d-4baa-4703-8c9b-2f6f8db606a1">9,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNS02LTEtMS0xODE3Njk_73df6528-a94f-463b-a2b5-1cd3d67ebdd3">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tax withholding on shares under stock-based compensation awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNi0xMC0xLTEtMTgxNzY5_49a19a96-9867-4eb1-b8fd-44041d2bcb97">3,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNi0xNi0xLTEtMTgxNzY5_874c6468-a552-4522-81ee-ac2af487ba22">3,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy02LTEtMS0xODE3Njk_5841436a-baaa-4d14-8e23-2701604bb84d">2,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy04LTEtMS0xODE3Njk_6d338a07-6e59-4a1f-a2d1-e0daf7099e42">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i49e68429295e421e87c13df53148e23a_D20220401-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy0xNC0xLTEtMTgxNzY5_4f099301-0409-41db-8391-17f11f9a1838">86,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy0xNi0xLTEtMTgxNzY5_e2c19f1a-1748-4e1c-8797-2291d542912f">86,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrant expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfOC0xMC0xLTEtMTgxNzY5_327cfff2-a8f1-49ba-adce-571abab9d591">5,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfOC0xNi0xLTEtMTgxNzY5_3c8e1747-b6bc-46dc-afab-681f42198ace">5,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with the employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTItNi0xLTEtMTgxNzY5_579143f9-1e10-47ec-b5ea-6648db68cf0a">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTItMTAtMS0xLTE4MTc2OQ_9da16923-3d00-4c3a-b115-96d1d7ed49ba">4,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTItMTYtMS0xLTE4MTc2OQ_fa41a259-5c1d-41d3-a33c-258ae8c058d7">4,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i713bedb0e69c494c8ed7f90198455f80_D20220401-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTEtMTItMS0xLTE5NjY3Nw_733a804f-5650-4882-b67f-42589c1948d0">1,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTEtMTYtMS0xLTE5NjY3Nw_93d5a5f2-35af-4077-b2e0-0221e09d4a2d">1,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i49e68429295e421e87c13df53148e23a_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTMtMTQtMS0xLTE4MTc2OQ_24d3c47f-da5e-45bf-a1cb-3a9898f63163">112,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTMtMTYtMS0xLTE4MTc2OQ_c94e43b5-eec7-4295-97bc-e4658c8d2bec">112,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMS0xLTEtMTgxNzY5_8d4f9b9f-40fb-4562-870a-89c76c5db416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMy0xLTEtMTgxNzY5_f759e864-72f9-404c-9e2e-2462fa1ada7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i84d98fc03def4365a7f3fa504e96b220_I20230331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtNi0xLTEtMTgxNzY5_4cd6421f-8aed-461f-9bf4-5cbcecdb9034">193,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i84d98fc03def4365a7f3fa504e96b220_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtOC0xLTEtMTgxNzY5_74b36622-a13a-4018-8675-0aea5fff6411">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd694dc2e48a4412a000d9b02c10f96e_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTAtMS0xLTE4MTc2OQ_8e7b6b5b-87ee-414e-844f-5074035dffb4">762,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i419e8bf8b3aa40158f8de4af142458a2_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTItMS0xLTE4MTc2OQ_7116885c-7058-4f96-a54d-6f5784501cb7">14,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i448d1c798e6544a99cf0cf2663a4894b_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTQtMS0xLTE4MTc2OQ_5a49f1d9-7df5-4ac2-aee0-e8305264db54">217,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTYtMS0xLTE4MTc2OQ_ea50d7eb-7db8-4a3f-b240-bb0387fd35af">966,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMtMS0xLTEtMTgxNzY5_82b39ca5-2b32-4225-9013-3e4d980c2d2f">112,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMtMy0xLTEtMTgxNzY5_df10be92-729d-4f8d-91a7-7fe01f1ff852">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMtNS0xLTEtMTgxNzY5_358f945b-2538-4510-86b5-3b36d291e131">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjustments to reconcile net income to net cash provided by operating activities: </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzUtMS0xLTEtMTgxNzY5_79bf1ae3-77b2-4bea-8a6a-0da1a6e1550e">10,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzUtMy0xLTEtMTgxNzY5_2a52b0fb-cf3c-4cec-9854-362edf52b8e0">5,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzUtNS0xLTEtMTgxNzY5_3a1a73e6-fa4a-4449-9a78-938db3c7d358">3,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzYtMS0xLTEtMTgxNzY5_ab6bf352-5c24-484b-ac9c-391021e6e5b7">13,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzYtMy0xLTEtMTgxNzY5_f24ad12b-f388-415f-9cdd-a9a6ae7b03fd">41,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzYtNS0xLTEtMTgxNzY5_213cb383-9e57-4ecf-954a-6b605aa950c3">4,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation, net of amounts capitalized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzctMS0xLTEtMTgxNzY5_02e880f4-f67e-4479-8591-b16f1e6bdfb5">47,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzctMy0xLTEtMTgxNzY5_868c649e-1696-45a9-945e-77ae1b7f4ad3">31,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzctNS0xLTEtMTgxNzY5_c4fdd910-1bd8-4ce8-a0bd-7629fdff9b6d">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzgtMS0xLTEtMTgxNzY5_e4406d3d-df1e-49cf-a596-def3d5a23e46">2,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzgtMy0xLTEtMTgxNzY5_eea8c926-0cb3-4e9f-9685-551a5cf92bcf">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzgtNS0xLTEtMTgxNzY5_60f4e22d-e1bf-41f1-992f-6af007a6693f">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of premium on marketable securities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEwLTEtMS0xLTE4MTc2OQ_45db474e-36cd-4d92-b62a-6745b42509e0">3,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEwLTMtMS0xLTE4MTc2OQ_f3414f01-4dae-4855-b6ec-1b6846dd106f">4,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEwLTUtMS0xLTE4MTc2OQ_3e88bb26-d7e8-4ae1-abac-f9e5570c42c2">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss on sale of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzExLTEtMS0xLTE4MTc2OQ_5a786e3e-0639-4889-a5d1-fe281b0b9839">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzExLTMtMS0xLTE4MTc2OQ_b2c7545e-7879-4cd8-8ba0-8d60eb017dee">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzExLTUtMS0xLTE4MTc2OQ_1c981509-4c3e-4ef1-b809-4d382c12c537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEyLTEtMS0xLTE4MTc2OQ_e7c4b39b-2040-4f0b-a30e-f3275ec11b50">8,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEyLTMtMS0xLTE4MTc2OQ_b880e45a-9d59-4b35-995f-c9be73fac57b">9,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEyLTUtMS0xLTE4MTc2OQ_7d0398db-1964-415d-8b22-5f6dd18f4b24">6,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gain on sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEzLTEtMS0xLTE4MTc2OQ_0f0f2517-24e8-47b5-9351-ff2ba84d979c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEzLTMtMS0xLTE4MTc2OQ_09e3c50f-805a-463b-b7fb-e11d801b1296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEzLTUtMS0xLTE4MTc2OQ_e2a140e1-b2a6-419b-b5d9-afbffa31ec45">4,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE0LTEtMS0xLTE4MTc2OQ_963ed918-4451-40fb-8320-c44bd28cbe5e">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE0LTMtMS0xLTE4MTc2OQ_7cdcd060-52d1-4bed-901d-5f067138a2fe">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE0LTUtMS0xLTE4MTc2OQ_f4c09089-2c8b-457e-840d-47b19ec52908">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities, net of effect of acquisition:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE2LTEtMS0xLTE4MTc2OQ_f276dce2-2620-488e-b266-9b94769433bb">26,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE2LTMtMS0xLTE4MTc2OQ_6ebb5d55-7033-4227-85d6-259b2949f3e4">31,017</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE2LTUtMS0xLTE4MTc2OQ_ff3e5225-c575-4a7e-bec1-3b0bbc5836c0">20,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE3LTEtMS0xLTE4MTc2OQ_e99e2da4-7cdf-4ecc-95c1-f74672ee3440">3,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE3LTMtMS0xLTE4MTc2OQ_70b93f96-326e-4555-8006-7ba19bc8fa11">9,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE3LTUtMS0xLTE4MTc2OQ_9258a470-f21e-4a29-b6cb-250bc16ebe83">1,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE4LTEtMS0xLTE4MTc2OQ_519a86d0-1386-4028-ad5a-03819588029c">8,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE4LTMtMS0xLTE4MTc2OQ_01256442-e70d-44c5-bc41-956654ba4dea">9,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="docs:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE4LTUtMS0xLTE4MTc2OQ_b2b2af21-6239-4e28-ac45-0dc3b534b2c4">9,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE5LTEtMS0xLTE4MTc2OQ_ca2f3969-c523-4d76-bfdf-d0ba15d2f68c">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE5LTMtMS0xLTE4MTc2OQ_0830f3be-1e7c-4f05-9c2a-12b899501317">8,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE5LTUtMS0xLTE4MTc2OQ_9af216e6-b9ed-4ed1-962c-c78757380f69">7,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIwLTEtMS0xLTE4MTc2OQ_d6874c0f-3a9c-4436-bedd-0b9389817622">17,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIwLTMtMS0xLTE4MTc2OQ_c621e4cd-19c1-48f9-a052-8a884df3a653">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIwLTUtMS0xLTE4MTc2OQ_b93ffac9-7395-4d58-98ec-1e2d1d25b95e">38,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIxLTEtMS0xLTE4MTc2OQ_a1e0e62d-96a8-47aa-855b-ca527f214b34">213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIxLTMtMS0xLTE4MTc2OQ_489d6894-5975-4819-924e-82520924f896">1,107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIxLTUtMS0xLTE4MTc2OQ_f06b2144-d4be-4dc5-bd1e-bdfbd4e432c5">2,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIzLTEtMS0xLTE4MTc2OQ_5bc3be43-f6aa-40dc-83bc-090419a17d7b">179,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIzLTMtMS0xLTE4MTc2OQ_65edb959-0977-474b-8967-e2a5bcd547a0">126,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIzLTUtMS0xLTE4MTc2OQ_1463437a-6576-4069-8db3-4b449d4534bb">82,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for acquisition, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTEtMS0xLTE4MzU0OA_e4412851-5907-4db7-bfed-a64ce55d0650">53,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTMtMS0xLTE4MzU0OA_06d0dcf5-ae1d-4495-bbd9-d4fd7c4a36f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTUtMS0xLTE4MzU0OA_bcb18908-f803-425d-963d-a39b113887ae">31,682</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTEtMS0xLTE4MTc2OQ_514f7aeb-77c0-4245-83c4-732e0d4b524c">1,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTMtMS0xLTE4MTc2OQ_d48bc891-3046-4d37-ac4d-dc28d91ac137">1,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTUtMS0xLTE4MTc2OQ_45d3e4ca-f264-44ff-9f5f-cf2b9e0c070c">245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI2LTEtMS0xLTE4MTc2OQ_50b9e809-f9f3-496b-a182-48b920dc4f1d">4,483</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI2LTMtMS0xLTE4MTc2OQ_9db769cc-d53c-4316-a3ac-27e65c914d0a">3,785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI2LTUtMS0xLTE4MTc2OQ_a4c8995f-5f13-45db-af6e-6e0ebea1ec1e">4,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI3LTEtMS0xLTE4MTc2OQ_abf2e77b-e3ad-4d2c-bf9e-3a4ed9796761">190,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI3LTMtMS0xLTE4MTc2OQ_b60aad48-1b2e-4746-aec7-810c3b8c1b85">1,317,193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI3LTUtMS0xLTE4MTc2OQ_1a11c9bd-cd2d-4cf0-a1bc-7af417022597">78,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI4LTEtMS0xLTE4MTc2OQ_cee55311-1f89-4c09-ad48-75d3e585164b">83,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI4LTMtMS0xLTE4MTc2OQ_2c04ea6a-663e-447d-96a4-01da59e4e72b">47,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI4LTUtMS0xLTE4MTc2OQ_0d982c1d-2b58-4eb2-9229-d70a4a0a9ec7">40,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI5LTEtMS0xLTE4MTc2OQ_4a0e5577-1f21-410f-9a3f-e07ede3c7f20">107,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI5LTMtMS0xLTE4MTc2OQ_590889b0-7e58-4b93-9164-314f9abd265a">633,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI5LTUtMS0xLTE4MTc2OQ_52d20c74-2bd9-4a0d-a717-39b56f646298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMxLTEtMS0xLTE4MTc2OQ_6b7e9ce1-21cb-4bdb-8e20-9eed6c9103e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMxLTMtMS0xLTE4MTc2OQ_ae93b11b-18a6-4b86-844c-f5dc7beb5ac8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMxLTUtMS0xLTE4MTc2OQ_4c022a44-cebe-4f5e-aba1-46afb3f7138d">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMyLTEtMS0xLTE4MTc2OQ_4b76542e-f5b8-415b-bc60-1d535dd70e52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMyLTMtMS0xLTE4MTc2OQ_0f753e4a-728a-406f-afb6-22be18d9ad25">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMyLTUtMS0xLTE4MTc2OQ_67464bf1-81ad-4a80-9db4-87e50f9a058d">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMzLTEtMS0xLTE4MTc2OQ_16915ef5-1a33-4e60-805b-01d003a96d6b">59,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMzLTMtMS0xLTE4MTc2OQ_38302aab-788e-4e2b-b015-3bd097a65e5c">640,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMzLTUtMS0xLTE4MTc2OQ_b501ca1d-d408-4925-9865-23df74d9773c">70,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM1LTEtMS0xLTE4MTc2OQ_f126f4f8-8d28-4c09-bf9b-150b39c213b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM1LTMtMS0xLTE4MTc2OQ_918de7a7-68d1-45aa-adb7-19030fb6d20e">553,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM1LTUtMS0xLTE4MTc2OQ_444eea67-a1fd-478d-a852-fac2e424bc3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock upon exercise of stock options and common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM2LTEtMS0xLTE4MTc2OQ_f19a4e7e-a1fb-408f-9dd9-bfd575dbb2e1">9,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM2LTMtMS0xLTE4MTc2OQ_a10f21e4-b0ca-44fb-88e7-b68c6633449a">12,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM2LTUtMS0xLTE4MTc2OQ_e1f28da8-0206-436a-827a-ff0b567e7bb1">8,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock in connection with the employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM3LTEtMS0xLTE4MTc2OQ_fcbcc300-890f-4034-8591-9698fa6a4e8e">4,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM3LTMtMS0xLTE4MTc2OQ_ada29e54-0984-46e5-b2a9-81f92fac9e35">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM3LTUtMS0xLTE4MTc2OQ_68cbd6e7-5f9e-4969-aefb-bbd95ae7bc24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM4LTEtMS0xLTE4MTc2OQ_f5a14a51-eea0-4960-8e12-f2eef5fc9669">3,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM4LTMtMS0xLTE4MTc2OQ_a243967e-6708-4095-a2f0-11ceb0b872af">817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM4LTUtMS0xLTE4MTc2OQ_9556e2b0-5cae-4130-90b7-d71c08080ba7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM5LTEtMS0xLTE4MTc2OQ_d7c113fb-598b-450a-87b2-96ea75cfff90">85,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM5LTMtMS0xLTE4MTc2OQ_94a05bd6-6111-4f86-99e0-431c0ae9850d">2,698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM5LTUtMS0xLTE4MTc2OQ_3cff5482-02f9-4d68-9fd1-2c814af6ae55">2,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Payments of deferred offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQwLTEtMS0xLTE4MTc2OQ_703ef5b4-35f3-4736-a789-ba864ff7cd2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQwLTMtMS0xLTE4MTc2OQ_2d540c92-f0c0-4a6b-97c0-2030d687fa16">3,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQwLTUtMS0xLTE4MTc2OQ_32aae6de-20c9-4ee4-8ea9-635ae350e585">1,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQyLTEtMS0xLTE4MTc2OQ_f3504caf-18ae-405e-acc5-3af50f12921d">74,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQyLTMtMS0xLTE4MTc2OQ_292f4d7b-06e2-4f93-bd4a-30fd8afed2d7">560,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQyLTUtMS0xLTE4MTc2OQ_3399e234-b0e0-4e9b-b562-50a4bf0f4ff6">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQzLTEtMS0xLTE4MTc2OQ_d59ad872-6d85-4288-96cc-cfa7b2194f5b">45,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQzLTMtMS0xLTE4MTc2OQ_76377477-a1d6-4594-8e9b-568f23e7e5ac">46,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQzLTUtMS0xLTE4MTc2OQ_6f576216-1be9-4c86-bfe7-0c5d7eb1fe89">17,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ0LTEtMS0xLTE4MTc2OQ_b32d04de-859e-4f60-ad4e-cbadb36047d8">112,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ0LTMtMS0xLTE4MTc2OQ_e96475da-292f-4610-8298-9b80aa051ced">66,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ0LTUtMS0xLTE4MTc2OQ_123f5e48-d269-4a41-aaa0-8bc3c8dbedb1">48,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash and cash equivalents, end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ1LTEtMS0xLTE4MTc2OQ_9bd9f1c2-c973-453b-893a-662f9fdffdd4">158,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ1LTMtMS0xLTE4MTc2OQ_f24de2aa-0211-4716-9a0d-c6723a768684">112,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ1LTUtMS0xLTE4MTc2OQ_5be30c7a-807b-447d-bccc-308104ebfb27">66,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Supplemental disclosures of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzEtMS0xLTEtMTgxNzY5_6a64b86b-1719-4fc6-b392-d99e1cab4906">5,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzEtMy0xLTEtMTgxNzY5_7d723e83-e564-455d-b178-26afbdfcb5a2">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzEtNS0xLTEtMTgxNzY5_09e5bee6-30e9-46e7-b02e-9b621b5363c2">5,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-cash financing and investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Conversion of redeemable convertible preferred stock to common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzMtMS0xLTEtMTgxNzY5_8e65ba79-0671-4b05-851f-6d5cdc144083">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzMtMy0xLTEtMTgxNzY5_decc3f4d-293b-45fb-9d73-2e6136504ca5">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzMtNS0xLTEtMTgxNzY5_7521e0b9-a047-4cdb-ab46-9138e57a87e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unpaid deferred offering costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:StockIssuancesCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzQtMS0xLTEtMTgxNzY5_ab996cec-2686-4605-bd32-fb0f5b6bee77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:StockIssuancesCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzQtMy0xLTEtMTgxNzY5_3b43c8a3-0e07-423c-8782-b36d3ac6e34c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="docs:StockIssuancesCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzQtNS0xLTEtMTgxNzY5_1b0e125e-a05e-4f49-b24f-fbe6f2ea9ed1">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock issued in acquisition</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:StockIssuedAcquisitions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzUtMS0xLTEtMTgxNzY5_6687468d-913c-40ac-9e7f-fa514d558dc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:StockIssuedAcquisitions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzUtMy0xLTEtMTgxNzY5_acd44801-ba37-4d08-8c46-07fa273b4d82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="docs:StockIssuedAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzUtNS0xLTEtMTgxNzY5_7fe17522-f615-467f-9415-5c035e515c03">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Capitalized stock-based compensation for internal-use software development costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzYtMS0xLTEtMTgxNzY5_4405cf5a-6294-4286-93d1-a2aefcbf4327">865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzYtMy0xLTEtMTgxNzY5_c07f0ddb-7b50-4f37-8141-e0f71a32c86a">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzYtNS0xLTEtMTgxNzY5_b3d7796b-585b-4368-bc41-8988114ec85d">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts held in escrow related to sale of business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:EscrowDepositsRelatedToSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzctMS0xLTEtMTgxNzY5_9a71c06a-eb1a-4032-b8a6-66d55cd27536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:EscrowDepositsRelatedToSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzctMy0xLTEtMTgxNzY5_4dbe2f4e-7dad-4363-b551-e09bd66c1dd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="docs:EscrowDepositsRelatedToSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzctNS0xLTEtMTgxNzY5_746042e1-7b75-4cd9-9db2-a3c397e9f3b6">470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of contingent earn-out consideration included in purchase consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMS0xLTEtMjAwMjIx_59d08c23-378c-465f-842a-a6599f35ce82">21,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMy0xLTEtMjAwMjIx_c1df7ca2-856e-4506-9823-f31991db000b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktNS0xLTEtMjAwMjIx_0fdda81d-9451-4030-b009-8e52a61c3683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets obtained in exchange for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMS0xLTEtMTgxNzY5_18b87bef-0d12-42a1-b523-505ca4679463">14,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMy0xLTEtMTgxNzY5_4be4146e-2bac-4a71-ad4a-51740fc42c1c">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktNS0xLTEtMTgxNzY5_da474e81-3e7d-4445-bee5-3ea9f441ca64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase included in accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzExLTEtMS0xLTIxMzUwNA_bf33cc64-fa2b-4793-8f69-6d74146f1c3f">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzExLTMtMS0xLTIxMzUwNA_342b00d2-872f-4d38-bfc1-57671f910a28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzExLTUtMS0xLTIxMzUwNA_f1bbc3da-2419-4aa6-873c-9b341a7beae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_106"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzI3MzA_b00bdede-498c-4d77-b9a0-457b8138e6b8" continuedAt="i104efee42c5f44dcac7001ddef3403e2" escape="true">Description of Business</ix:nonNumeric></span></div><ix:continuation id="i104efee42c5f44dcac7001ddef3403e2" continuedAt="i0f84bc49472c4bcf89ce6f0b219ee882"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doximity,&#160;Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, monitor their work schedules, and manage their careers. The Company&#8217;s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company&#8217;s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company completed its initial public offering (&#8220;IPO&#8221;), in which the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="iccdb5f0a810d4eebb2bafe0d42b2c742_D20210601-20210630" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzExMjM_27dda943-0632-4333-8adb-5f82ba97377d">22,505,750</ix:nonFraction> shares of its Class A common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="ib6eef4e680704bceaea439b7961166cd_I20210630" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzExNjQ_1ea9c095-272d-413a-89b7-6f35f7dd8ddd">26.00</ix:nonFraction> per share, including <ix:nonFraction unitRef="shares" contextRef="i279a208c32804584b31bfd94d3dd86ac_D20210601-20210630" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzExODg_549508fb-67c0-43c1-98de-dd0f2e2972f4">3,495,000</ix:nonFraction> shares issued upon the exercise of the underwriters&#8217; option to purchase additional shares. The Company received proceeds of $<ix:nonFraction unitRef="usd" contextRef="iccdb5f0a810d4eebb2bafe0d42b2c742_D20210601-20210630" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzEzMTU_a798e9d7-8f40-4fb3-bab6-a718783cb0a7">548.5</ix:nonFraction> million after deducting underwriting discounts and commissions as well as deferred offering costs. In connection with the IPO, all <ix:nonFraction unitRef="shares" contextRef="iaae932e69d134ab791bd1c42fff0771b_D20210601-20210630" decimals="INF" name="us-gaap:ConversionOfStockSharesConverted1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzE0NDE_bfa02f78-b0d6-4797-a5c2-1dcaa34666fb">76,286,618</ix:nonFraction> shares of the Company&#8217;s outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of Class B common stock on a <ix:nonFraction unitRef="number" contextRef="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630" decimals="INF" name="docs:ConversionOfStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzE2MDg_4466d40d-6c5d-4dea-b150-ac631b35e765">one</ix:nonFraction>-to-one basis. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred offering costs, which consist of direct incremental legal, consulting, banking, and accounting fees relating to the Company&#8217;s planned initial public offering, were capitalized. Upon the consummation of the IPO, $<ix:nonFraction unitRef="usd" contextRef="iccbddb5d88f943d18b1e2bca79988299_I20210630" decimals="-5" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzE4NDk_4fba6dff-9850-42b9-b3fb-f534fb5a19a5">5.5</ix:nonFraction> million of deferred offering costs were offset against proceeds. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Split</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0f84bc49472c4bcf89ce6f0b219ee882">On June&#160;8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation effecting a <ix:nonFraction unitRef="number" contextRef="id9c60a7a5216441aacc21b7da53bdeb8_D20210608-20210608" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzIwODA_7b068928-7040-4ca0-96cf-57eb5f7637cd">2</ix:nonFraction>-for-1 forward split of the Company&#8217;s issued and outstanding stock, including outstanding stock-based instruments and redeemable convertible preferred stock. The par value of the common and redeemable convertible preferred stock was not adjusted as a result of the stock split. As such, the Company has reclassified amounts from additional paid-in capital to common stock. All issued and outstanding shares of common stock, stock-based instruments, redeemable convertible preferred stock, and per-share amounts included in the accompanying consolidated financial statements have been adjusted to reflect this stock split for all periods presented.</ix:continuation> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_109"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYx_76dd35a9-91fa-41de-833a-c71f9f90bba1" continuedAt="i85c3be6687334237ac9dd32c9f868d31" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i85c3be6687334237ac9dd32c9f868d31" continuedAt="ieac112e657594f5d94a17cb2c34dd117"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYz_d6d5b4a6-5b6d-472f-845d-8b9c9f4504eb" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUz_86c40266-1107-4661-8994-3da4343a36a8" escape="true">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation.</ix:nonNumeric> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY1_a5774b1d-7e1c-4ce3-b5fb-9534276c1294" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUw_160b6d87-5884-4c90-a0be-e317f4768872" continuedAt="iae430e9a277843ee870007ec503ecc00" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ieac112e657594f5d94a17cb2c34dd117" continuedAt="i643c2ed3cb8443c3963874cb2aa85827"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iae430e9a277843ee870007ec503ecc00">estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment.</ix:continuation></span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU0_b81186ef-2195-4d3b-b597-e8fd05280565" continuedAt="if3d665c43fec4de3bec54aafdb4917f0" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if3d665c43fec4de3bec54aafdb4917f0">Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales.</ix:continuation> <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYy_5d1fc432-1c1e-4418-bdf9-ac6b97ea1a49" continuedAt="i8503346d73354bf0b915e6f0fb63b832" escape="true">The Company&#8217;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:</ix:nonNumeric></span></div><ix:continuation id="i8503346d73354bf0b915e6f0fb63b832"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2e9777aeaf94d178823baaa223076df_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTphMmNmNWExN2E3ZDI0YWY1ODY4NmM0ZTIzYWUzODQ5Yy90YWJsZXJhbmdlOmEyY2Y1YTE3YTdkMjRhZjU4Njg2YzRlMjNhZTM4NDljXzMtNS0xLTEtMTgxNzY5_dfd08fd8-576d-4b49-ba5a-59b5bca14294">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9cad1e062b649388bc8309807dd70ec_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTphMmNmNWExN2E3ZDI0YWY1ODY4NmM0ZTIzYWUzODQ5Yy90YWJsZXJhbmdlOmEyY2Y1YTE3YTdkMjRhZjU4Njg2YzRlMjNhZTM4NDljXzMtNy0xLTEtMTgxNzY5_007c19a6-f01e-4133-a29b-7618f59f80f3">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia35ab93e92f745bf8d13e1856e15688d_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTphMmNmNWExN2E3ZDI0YWY1ODY4NmM0ZTIzYWUzODQ5Yy90YWJsZXJhbmdlOmEyY2Y1YTE3YTdkMjRhZjU4Njg2YzRlMjNhZTM4NDljXzMtOS0xLTEtMTgxNzY5_6cb70dfa-ee90-4ebb-bb4c-3180af020e4a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-bottom:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* Less than 10%</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of assessing the concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company&#8217;s services directly or indirectly through marketing agencies.</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ2_f0d21dac-0981-49c3-80e4-c50d589145f0" continuedAt="ia70266d191984b33acbbff2f90010d49" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is primarily derived from the sale of subscriptions for the following solutions:</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Marketing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#8217;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Hiring Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Providing customers access to the Company&#8217;s professional tools where recruiters can access the Company&#8217;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, through the following five steps:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the contract with a customer</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the terms and conditions of its contracts and the Company&#8217;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#8217;s rights regarding the services to be transferred and the payment terms for the services, it has determined that the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#8217;s ability and intent to pay, which is based on a variety of factors, including the customer&#8217;s payment history or, in the case of a new customer, the customer&#8217;s credit and financial information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual terms for Marketing Solutions contracts are generally <ix:nonNumeric contextRef="i6a7a508b84f14a2c89f8f76f79912495_D20220401-20230331" name="docs:ContractWithCustomerTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzUyMjM_d08ddba2-3c14-47af-8e20-b1971ebe25d1">12</ix:nonNumeric> months or less. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions contracts are cancellable with a customary notice period. The Company does not  refund prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i643c2ed3cb8443c3963874cb2aa85827" continuedAt="i8ecc8d6b271440d19674b443bb4ff664"><ix:continuation id="ia70266d191984b33acbbff2f90010d49" continuedAt="i823e2943adde474d9d7c6af64b629248"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment was not made. The contractual term for Hiring Solutions contracts is generally <ix:nonNumeric contextRef="i66fbd0824ee44aa4999edf05fdba61a6_D20220401-20230331" name="docs:ContractWithCustomerTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQzOTgwNDY2MjExNzg_de183213-679e-4050-a881-22e63efa8bfa">12</ix:nonNumeric> months. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the customers&#8217; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#8217;s Awareness modules may include a sponsored article, short animated videos or other short-form content that is presented to the targeted member.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period, subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Determine the transaction price </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#8217;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Allocate the transaction price to performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price (&#8220;SSP&#8221;). The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of SSP is based on historical sales of standalone services. The Company estimates the SSP for arrangements where standalone sales do not provide sufficient </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i8ecc8d6b271440d19674b443bb4ff664" continuedAt="iabf0a04d31c3466794ca08014abe488d"><ix:continuation id="i823e2943adde474d9d7c6af64b629248" continuedAt="i731db1ef94b3429c8bd315ca7baca202"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evidence of the SSP. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Recognize revenue when or as the Company satisfies a performance obligation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#8217;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#8217;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract, while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#8217;s contracts do not contain significant financing components. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#8217;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes sales compensation that is considered to be incremental and recoverable costs of obtaining a contract with a customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales compensation earned for the renewal of Marketing Solutions contracts is commensurate with compensation earned for a new or expansion Marketing Solutions contract, whereas compensation for the renewal of Hiring Solutions subscription contracts is earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="iabf0a04d31c3466794ca08014abe488d" continuedAt="ie1cb943f1ed04172aa23fdd3b8665c9e"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i731db1ef94b3429c8bd315ca7baca202">Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from <ix:nonNumeric contextRef="id95916c6936340cdade0aa07aaf2b43c_I20230331" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzE1NDc4_1f42e863-5c9c-4de3-abbc-62bc15ee51b9">7</ix:nonNumeric> months to <ix:nonNumeric contextRef="i395392694ee54a58a68d60da43cd9346_I20230331" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzE1NDg0_fd296dd2-1110-4a08-b9e8-cdc4536c2fdb">13</ix:nonNumeric> months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of <ix:nonNumeric contextRef="i193acb95329a49ffa11b381f072505f0_I20230331" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzE1NjQ0_84b96427-a133-4e0c-85cb-e7253c083032">4</ix:nonNumeric> years, which is determined by the nature of the Company&#8217;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. The portion of deferred compensation expected to be recognized within one year of the balance sheet date is recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Amortization of deferred contract costs are included in cost of revenue and sales and marketing expense in the consolidated statements of operations. Sales compensation that is not considered incremental costs are expensed in the same period as they are earned.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY2_03fa56cd-23b7-434c-bf91-adc5e9ca4446" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="docs:CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU1_30140036-8ccf-4351-b1cc-6cdb2cf133af" continuedAt="ia9af851bfc92449aac917cf153ffbe59" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Marketable Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2023 and 2022 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#8217; equity on the consolidated balance sheets. The Company&#8217;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net, and any remaining unrealized losses are recorded to other comprehensive income (loss). If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ie1cb943f1ed04172aa23fdd3b8665c9e" continuedAt="ibd40a87beca8479589581d0543f38dab"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia9af851bfc92449aac917cf153ffbe59">The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYw_8db3595a-f8e2-496a-95da-b5d030687487" continuedAt="ic0dd3f64fdbc4ccf97d21d26d55cfe60" escape="true">Accounts Receivable and Allowance for Doubtful Accounts</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic0dd3f64fdbc4ccf97d21d26d55cfe60">Accounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#8217;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations, payment history and the customer&#8217;s current financial condition.</ix:continuation> The Company had no material bad debt write offs for the years ending March&#160;31, 2023, 2022, and 2021.</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY3_a2b28875-930b-4cd6-96dd-091b92fbb30c" continuedAt="i794b9fca28d24a009de1d8913ca058f5" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU3_57202aa8-ca0a-4515-828e-a47dfc685e30" continuedAt="i5988905e519d422291335204239ec2cf" escape="true">The estimated useful life of each asset category is as follows:</ix:nonNumeric></span></div><div><ix:continuation id="i5988905e519d422291335204239ec2cf" continuedAt="i3d2cd8c14e5c409aa97b9a6774688a31"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i13475fef7778429390ef0860c7b05a45_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzAtMS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZWI2M2ZkZjcyODE1NDI3NWEzNjM2NjliZDE5ZTk5YmVfNA_e0785d1d-f78c-4735-b67f-c15629006aa1">3</ix:nonNumeric>-<ix:nonNumeric contextRef="ibf3ecb7779284d14862d24d80dc3241e_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzAtMS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZWI2M2ZkZjcyODE1NDI3NWEzNjM2NjliZDE5ZTk5YmVfNw_b4c6e9b0-8dfb-4d7a-b9ba-778e6b5da190">5</ix:nonNumeric> years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bc3bbea93e64ae99dfb98af6a33b945_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzEtMS0xLTEtMTgxNzY5_28af3399-73d0-453f-a2a4-8f159fbd78a8">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0728b940a9f64fc9bf1ed1b456fbfb6a_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzItMS0xLTEtMTgxNzY5_186f40c6-cb6f-4938-90ac-e3d1dc58bf5a">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i794b9fca28d24a009de1d8913ca058f5">When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. Maintenance and repairs are expensed as incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:InternalUseSoftwarePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY0_150ba5b9-4407-486d-8c60-da13ff97aacf" continuedAt="i374c4a69e1924bce8c17a554e79d76e4" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal-Use Software Development Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i374c4a69e1924bce8c17a554e79d76e4">Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUy_bcb648b9-844f-41a8-8a7c-63e37a077f69" continuedAt="ib1140aa809c94714af29bc206e174592" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib1140aa809c94714af29bc206e174592">When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, including the selection of valuation methodologies, estimates of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates. Acquisition costs, such as legal and consulting fees, are expensed as incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY4_24e971dd-68ef-44d6-815e-c67e7238e2a7" continuedAt="if9cbaa85a6004a8a9598d35ca6b43c69" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has <ix:nonFraction unitRef="reporting_unit" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="0" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzIzODQ0_4e7c26f6-f61e-4398-8661-5411a36f1b8c">one</ix:nonFraction> reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ibd40a87beca8479589581d0543f38dab" continuedAt="i5a07610e0637452ba12e9aa8d50fac59"><ix:continuation id="if9cbaa85a6004a8a9598d35ca6b43c69" continuedAt="if1369c20137f4edb9804d793459ce281"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in cost of revenue and sales and marketing expense. </span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if1369c20137f4edb9804d793459ce281">Management evaluates the recoverability of the Company&#8217;s long-lived assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDcw_bb3d69dc-b302-4b7a-8331-41dd7ac9bbdb" continuedAt="i9b8a0ef3a5e24ae18361d8000ebe5ddb" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#8217;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU and PSU is based on the fair value of the Company&#8217;s Class A common stock, which is traded on the NYSE, on the date of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP (&#8220;ESPP rights&#8221;), and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#8217;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the Company granted stock options and warrants which were valued using the Black-Scholes pricing model, and after the IPO, the Company has granted warrants and ESPP rights which were valued using the Black-Scholes pricing model. The assumptions used in the Black-Scholes models are determined as follows: </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the awards. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Prior to the IPO, when there was no public market for the Company&#8217;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. After the IPO, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. Prior to the IPO, the Company estimated the expected term for awards granted to employees using the simplified method as the Company&#8217;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For awards granted to non-employees, the Company used the contractual term as the expected term. For ESPP rights, the expected term is equivalent to the offering period. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i5a07610e0637452ba12e9aa8d50fac59" continuedAt="i1e53368b51cb4acbbac417dd7e9cc38d"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="i9b8a0ef3a5e24ae18361d8000ebe5ddb" continuedAt="i2099e91edbae4b3982582674ea146065"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. </span></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i2099e91edbae4b3982582674ea146065" continuedAt="i484e6b72f2dd4df99de2dbb53286ce6c">Fair Value Per Share of the Company&#8217;s Common Stock</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i484e6b72f2dd4df99de2dbb53286ce6c">&#8212;Because the Company&#8217;s common stock was not publicly traded until the completion of the IPO, the Company&#8217;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#8217;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#8217;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. After the IPO, the Company used the closing stock price of the Company&#8217;s Class A common stock, which is traded on the NYSE.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY5_2a275a73-e28c-4e95-86c2-5a2cef0a21e6" continuedAt="i95871241f88f4ea78b3a7562c1dd613f" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is or contains a lease at inception. All of the Company&#8217;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. As none of the Company&#8217;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i95871241f88f4ea78b3a7562c1dd613f">The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDcy_60371118-ce80-4eb4-abaf-4d4cf37ebf89" continuedAt="i586d0bce47054246b95eb544940ecd7f" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the two-class method to compute basic and diluted net income per share attributable to common stockholders when shares meet the definition of participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the automatic conversion of the Company&#8217;s outstanding redeemable convertible preferred stock to Class B common stock in connection with the IPO, the Company had redeemable convertible preferred stock. The redeemable convertible preferred stock was considered to be a participating security because the holders were each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#8217;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate. Redeemable convertible preferred stock was therefore included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, and common stock warrants. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i1e53368b51cb4acbbac417dd7e9cc38d" continuedAt="i649810a9482746768c763df0e29ab825"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i586d0bce47054246b95eb544940ecd7f">The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.</ix:continuation></span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ4_ca08d927-4859-4b42-9772-ca08d440ee0c" continuedAt="i3880010f5f9c4d06aae78c4660d524fe" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3880010f5f9c4d06aae78c4660d524fe">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#8217;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ3_e0a83139-1de7-4037-bf04-bc1ef03f3c5c" continuedAt="i61b735feaeb644ed92ccabacfe839dab" escape="true">Legal Contingencies</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i61b735feaeb644ed92ccabacfe839dab">The Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUx_664d0c17-0575-4fa9-9bfc-81277d5d1c4c" continuedAt="i36a6c33d354a45a99b45e1673edb9785" escape="true">Cost of Revenue </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="i36a6c33d354a45a99b45e1673edb9785" continuedAt="i4d124e8e580d467fa623daaa35a132e3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of expenses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to cloud hosting, personnel-related expenses for the Company&#8217;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4d124e8e580d467fa623daaa35a132e3">delivery and support of the Company&#8217;s platform. Cost of revenue also includes the amortization of internal-use software development costs, editorial and other content-related expenses, and allocated overhead.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDcx_e4d4dfdd-9906-4854-bc99-a7e99b3acae0" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the Company&#8217;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ5_cecfad04-0358-43e3-bf30-a12ba0ebbd72" continuedAt="id203ffcad6b646e3a32523f8153c5828" escape="true">Advertising Expenses </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id203ffcad6b646e3a32523f8153c5828">Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations.</ix:continuation> Advertising expense was $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzM3NzIx_4a1e8d47-ce87-4fb6-9b34-d39308029ce7">2.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzM3NzI1_d72f34b2-8222-45d6-b9f0-a217790b9d76">2.8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzM3NzMz_d4512b05-aa3d-4b4b-a7d8-5e2118488077">2.6</ix:nonFraction> million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively.</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU5_2a629518-89d9-42ab-a88e-fe8f2212462a" continuedAt="i813471295d8d417db391ee114bd50781" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. Most amendments within this guidance </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i649810a9482746768c763df0e29ab825" continuedAt="i2d32701a39c34a0b80c52dc0d7c56dc6"><ix:continuation id="i813471295d8d417db391ee114bd50781" continuedAt="i0808ea5f99824ae69e084fcc8f8f9a75">are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance on April 1, 2022, and the adoption of this guidance did not have a material impact on the consolidated financial statements. </ix:continuation></ix:continuation></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="i2d32701a39c34a0b80c52dc0d7c56dc6" continuedAt="i461523021afd40c182646a50ebd81715"><ix:continuation id="i0808ea5f99824ae69e084fcc8f8f9a75" continuedAt="i18715974cf784f32b4e8526e2f3caa2d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers,</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i461523021afd40c182646a50ebd81715"><ix:continuation id="i18715974cf784f32b4e8526e2f3caa2d"> as if it had originated the contracts. Previously, the Company recognized contract assets and contract liabilities at the acquisition date based on fair value estimates, which had resulted in a reduction to unearned revenue on the balance sheet, and therefore, a reduction to revenues that would have otherwise been recorded as an independent entity. The Company adopted this guidance on April 1, 2022, using the prospective approach. The adoption is applicable to business combinations occurring on or after April 1, 2022, including the Company&#8217;s acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians completed on April 1, 2022 (the &#8220;AMiON&#8221; Acquisition). See Note 8&#8212;Business Combinations for additional discussion regarding the AMiON acquisition.</ix:continuation></ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_112"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzc1NA_51c534fb-00d1-44f1-8242-09211fa2233c" continuedAt="id29965ff91604ee2899b18e0269a5248" escape="true">Revenue Recognition </ix:nonNumeric></span></div><ix:continuation id="id29965ff91604ee2899b18e0269a5248" continuedAt="i901f8e7d2743438f899ab3ff02326496"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Disaggregation </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzc1NQ_1b80c3ad-1251-45ee-895f-acb7246f2a36" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subscription</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i396b959629334256bafddb8623b58bbb_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzItMS0xLTEtMTgxNzY5_b7c0828d-a0f6-463c-abe0-c59962490eb4">389,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8189eaf3c5a341eb905e447cbdc1e660_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzItMy0xLTEtMTgxNzY5_cc6b5c25-750f-41b3-b081-5573b247cb59">319,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iad7a18fbd0c14f8ba371333c97190a67_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzItNS0xLTEtMTgxNzY5_3d2c72ab-9a31-4985-9304-feb9c4a9b264">192,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd6a54410372468a8511243ad114dbe9_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzMtMS0xLTEtMTgxNzY5_feb28cf3-3c37-4479-831d-c84133290a80">29,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2ad31f043cf54368a2e28a707d138b65_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzMtMy0xLTEtMTgxNzY5_a1396396-43c1-4c8e-b343-b2a7a8ed798d">24,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1c10798df81841449d5dbfb26d76969d_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzMtNS0xLTEtMTgxNzY5_9691c3cb-f459-44a0-bb94-fed9c6e9131c">14,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzQtMS0xLTEtMTgxNzY5_f19b9734-a397-4851-8cf3-cab2c9ac12a3">419,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzQtMy0xLTEtMTgxNzY5_6bf1bad5-e3d7-4c2a-bc56-e3d9e139833f">343,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzQtNS0xLTEtMTgxNzY5_621d9a48-4a74-49f1-898d-78fcca1ad49f">206,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzc1Mw_4d216acb-427b-4f9c-8e2e-d7e7182bdb4e" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company&#8217;s deferred revenue balances were as follows (in thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzItMS0xLTEtMTgxNzY5_3a4bf063-e8a2-4b28-b025-c041ea021ee2">84,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzItMy0xLTEtMTgxNzY5_86027be8-a0d0-43dc-bc3a-18dfd6ebb41d">83,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions, net, during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:ContractWithCustomerLiabilityAdditionsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzMtMS0xLTEtMTgxNzY5_b0f2dc73-ef12-4647-9b31-d65110f8f0c0">439,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:ContractWithCustomerLiabilityAdditionsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzMtMy0xLTEtMTgxNzY5_2c6e4a3a-2a1c-4ac5-bbff-f6cb8608d79e">345,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from the beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzQtMS0xLTEtMTgxNzY5_51f80ff6-12ae-4065-a339-1556a84925ce">83,231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzQtMy0xLTEtMTgxNzY5_8114df23-38e6-4324-a774-f6ba335d0335">82,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from contracts invoiced during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzUtMS0xLTEtMTgxNzY5_6449b0bd-629a-46fc-bf49-473ace740729">335,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzUtMy0xLTEtMTgxNzY5_119f8b6f-0b38-4e6d-a4cc-459c784a338f">261,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzYtMS0xLTEtMTgxNzY5_cb34bd68-cbc6-4c70-9fa6-149fc0a9149a">105,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzYtMy0xLTEtMTgxNzY5_5e7c7450-b85e-4469-86c2-463800759849">84,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the additions, net, during the period was $<ix:nonFraction unitRef="usd" contextRef="id6779a54192f451097a27ad596eba040_D20220401-20230331" decimals="-5" name="docs:ContractWithCustomerLiabilityAdditionsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzU0OTc1NTgxNDk0Mg_bdbc5e62-20ad-4b9d-a74d-8c7011caec6d">2.9</ix:nonFraction> million of additions due to the AMiON acquisition which closed on April&#160;1, 2022. See Note 8 &#8212; Business Combinations for additional information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unbilled revenue balances were $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzI1Nw_34ac65ba-81bc-4c30-93da-0d2396fb9430">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-5" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzI2MQ_bbc8ac1d-46eb-4d2c-b81a-fd296939488b">1.4</ix:nonFraction> million as of March&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i901f8e7d2743438f899ab3ff02326496">The Company capitalized $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="docs:CapitalizedContractCostAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzM1Ng_233ae87f-a94c-4fdd-994e-cffac1e656cb">8.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="docs:CapitalizedContractCostAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzM2MA_e3693386-2295-4a45-af96-727008a3902b">9.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="docs:CapitalizedContractCostAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzM2OA_ffcadd51-25d0-4977-a546-884e18d38e17">9.4</ix:nonFraction> million of contract acquisition costs for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. Amortization of deferred contract costs was $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzUwMg_287f923b-752f-4b9b-b445-fb80fbd27f99">8.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzUwNg_e1a79273-98b8-4bb3-bcad-b8aa4bed4950">9.8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzUxNA_c1957978-597b-40df-b5f3-f43054aeb4fe">6.9</ix:nonFraction> million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. Deferred contract costs are periodically analyzed for impairment. There were <ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzY1MQ_26054433-8382-4740-8308-f48bfc5e3882"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzY1MQ_54ea6070-4335-4cc1-ad7a-7d14fcd5d475"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzY1MQ_8c30f994-c1d7-47b0-863b-252ea0efaa9c">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses relating to deferred contract costs during the fiscal years ended March&#160;31, 2023, 2022, and 2021.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzEzNjM_fd5d68e5-88c0-47b7-828e-d22492c2a2de" continuedAt="ic1b26f3045f347d49879fe393e8abd1e" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="ic1b26f3045f347d49879fe393e8abd1e" continuedAt="ib29c8ce41a304c33a212d47fc847f1bc"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzEzNjY_bd72ca16-de7c-42d7-abe2-a42d16afeca8" continuedAt="if246886a50204b1a816bc0472f7b41e4" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie833f8b08d684b3bb2c16e4a4497f123_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzUtMS0xLTEtMTgxNzY5_6c871946-c4a7-4971-b286-18fe2dc54410">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie833f8b08d684b3bb2c16e4a4497f123_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzUtOS0xLTEtMTgxNzY5_84b8acb4-4e29-4cde-b560-a9d2fa0d15e6">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i201f487ed07e45f08dc9cea2b1958064_I20230331" decimals="-3" name="docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzctMS0xLTEtMTgxNzY5_1f48c1ec-93fe-40a3-b5cc-0a8cdff3a428">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i201f487ed07e45f08dc9cea2b1958064_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzctOS0xLTEtMTgxNzY5_7a6f4888-e1bc-42b0-a20b-7152f0e6319b">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktMS0xLTEtMTgxNzY5_de98e034-748b-43a6-9f8f-4f743a3202e4">7,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktMy0xLTEtMTgxNzY5_31e23da6-1275-463e-9a8a-6e5599b654e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktNS0xLTEtMTgxNzY5_cf42e447-30e3-476f-b346-a614f317ae19">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktOS0xLTEtMTgxNzY5_5b6220bb-5b6d-430b-b43c-166dc288ada7">7,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTEtMS0xLTE4MTc2OQ_2b9ad826-f785-472b-bc13-7a7e040a2941">27,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTMtMS0xLTE4MTc2OQ_964babe7-a0ad-45f1-a6f3-04b1d267aac9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTUtMS0xLTE4MTc2OQ_9aea716d-d434-44d7-92ff-14e671e7f7c1">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTktMS0xLTE4MTc2OQ_8df7fbf7-aa06-481a-ad78-6b8e60cad2bf">27,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTEtMS0xLTE4MTc2OQ_cc88affa-b367-4cf5-be48-7bb6aa760bf1">78,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTMtMS0xLTE4MTc2OQ_7bc12f8a-6bc9-42ab-80da-d64c4c3da5e3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTUtMS0xLTE4MTc2OQ_7483de85-04d0-4fc8-815c-6a0be8ae0aac">126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTktMS0xLTE4MTc2OQ_2f3e3514-28bb-4526-bebc-5273b606740d">78,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTEtMS0xLTE4MTc2OQ_51f0ca85-cf2f-4f3a-b254-e7488523c96b">119,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTMtMS0xLTE4MTc2OQ_0e58b3eb-e896-4849-8ea9-c008bdd34381">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTUtMS0xLTE4MTc2OQ_86077c45-5590-4bbe-a6f1-630c1a55f764">778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTktMS0xLTE4MTc2OQ_eab9f4f4-4fab-40ee-9304-94506c73aa4f">118,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTEtMS0xLTE4MTc2OQ_9c6e02af-eb0e-4180-a4f6-059657b32b3e">7,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTMtMS0xLTE4MTc2OQ_e6e70e0c-f866-4d87-9c0b-7a7bbb09c216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTUtMS0xLTE4MTc2OQ_cf2164f1-e950-4318-aa2d-8200e30bd5f9">360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTktMS0xLTE4MTc2OQ_863d5111-d170-4412-897d-854ef940bae2">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946014a5671d4e999aa1c822257039c4_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTEtMS0xLTE4MTc2OQ_1e07de40-0d94-430f-9af9-f9e72dec1564">461,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946014a5671d4e999aa1c822257039c4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTMtMS0xLTE4MTc2OQ_7711e2c0-72e4-4e86-aa16-9c8c5892ae0b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i946014a5671d4e999aa1c822257039c4_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTUtMS0xLTE4MTc2OQ_af1c15a9-0f76-4335-bafb-cc3db9c77f2f">17,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946014a5671d4e999aa1c822257039c4_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTktMS0xLTE4MTc2OQ_09ac4199-b135-4955-bc7d-8c01c960adcf">444,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfbd7fea093845f382923f9f0125016c_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTEtMS0xLTE4MTc2OQ_66feef11-56d4-4a7c-991e-3afcff0c3291">701,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfbd7fea093845f382923f9f0125016c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTMtMS0xLTE4MTc2OQ_c5211c87-0fa6-456f-94c9-e59cea480995">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfbd7fea093845f382923f9f0125016c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTUtMS0xLTE4MTc2OQ_f4226dd1-5a9b-480a-8d2e-c90d43349732">18,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfbd7fea093845f382923f9f0125016c_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTktMS0xLTE4MTc2OQ_f3c6c264-9210-4b36-8938-715ee8315b8c">682,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTEtMS0xLTE4MTc2OQ_fae0ceed-2e0f-41ca-a2ad-c463815f9fcd">828,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTMtMS0xLTE4MTc2OQ_a73e74c1-a066-40f2-80e4-0b03af8ae10e">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTUtMS0xLTE4MTc2OQ_2f6b7f89-553a-4e37-9199-c7adea01d9bb">18,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTktMS0xLTE4MTc2OQ_101649c7-4e59-4dea-b95b-fb170d381f30">809,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzEzNjQ_318ade29-98b3-4fd7-8c92-f261e8eb33c1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the contractual maturities of the Company&#8217;s available-for-sale debt securities were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzEtMS0xLTEtMTgxNzY5_228e8971-8421-470a-9705-07e46b11478e">360,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due in one year to two years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzItMS0xLTEtMTgxNzY5_ebc88183-a963-4e41-9da7-accd5c2085c1">315,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzMtMS0xLTEtMjI1OTgw_29739e9d-98e3-43a9-87f8-0e9b4b83f087">7,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzMtMS0xLTEtMTgxNzY5_f6c8863f-bf97-4e5b-b24e-d5755769cd00">682,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities because certain borrowers have the right to call or prepay certain obligations.</span></div></ix:nonNumeric><ix:continuation id="if246886a50204b1a816bc0472f7b41e4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtMS0xLTEtMTgxNzY5_81ea811b-c770-41b8-a4df-ce115b2dc23d">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtMy0xLTEtMTgxNzY5_8ab3b642-20a5-4234-8330-9bb23ed168c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtNS0xLTEtMTgxNzY5_1d5431f9-5545-4367-99be-f543e485cd3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtOS0xLTEtMTgxNzY5_96cc9ff6-95a4-4b8c-9801-7140ea935d7b">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtMS0xLTEtMTgxNzY5_10d95439-7c42-4777-b424-91b928ab9fed">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtMy0xLTEtMTgxNzY5_9cd16e71-0170-49ab-aab6-4a97f10753c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtNS0xLTEtMTgxNzY5_2d56ba7b-4485-4fda-a9ee-b44f12888886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtOS0xLTEtMTgxNzY5_a2024f7f-86e9-41f9-a95b-0c030c7d08db">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctMS0xLTEtMTgxNzY5_987816b7-2c85-425d-90fb-c6a8989b9f99">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctMy0xLTEtMTgxNzY5_f841dc66-6d7a-4dcd-a3d8-9be00d8fc491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctNS0xLTEtMTgxNzY5_ace10521-ccd7-43e4-aca2-f2fe97d56392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctOS0xLTEtMTgxNzY5_a7a960c8-a567-49a3-9fd0-268329982e2b">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktMS0xLTEtMTgxNzY5_776c0074-a3bf-4b71-8e22-889a91da76d8">7,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktMy0xLTEtMTgxNzY5_1c31e6f7-cfe5-43b7-bd31-85e44f78ed12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktNS0xLTEtMTgxNzY5_a727ab56-6ce1-4242-ab48-0641436932ec">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktOS0xLTEtMTgxNzY5_2d93c7c5-fbc7-45a9-9043-fd379909eaf8">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTEtMS0xLTE4MTc2OQ_be8276f5-173f-49bd-8ec1-3334c7cb028f">9,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTMtMS0xLTE4MTc2OQ_5addab6d-53dc-4068-aea4-5c1ef02ddf32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTUtMS0xLTE4MTc2OQ_3a6418f1-b06e-44b4-9bd1-88e3c52e5759">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTktMS0xLTE4MTc2OQ_b0a5ad98-fbda-4e37-b04e-64a6778e3d82">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTEtMS0xLTE4MTc2OQ_50d76136-8017-4967-9944-f0d6a83ae460">129,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTMtMS0xLTE4MTc2OQ_0cf495a0-e1f4-4cfd-9c19-67bb578c19e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTUtMS0xLTE4MTc2OQ_fd93a516-8a71-40c0-a855-997ebd81a498">1,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTktMS0xLTE4MTc2OQ_01b3031e-bc82-4a3c-943b-d9fe0ade3034">128,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTEtMS0xLTE4MTc2OQ_917b8e43-b27c-430e-bd7a-501d86e5ad2c">8,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTMtMS0xLTE4MTc2OQ_09a495b8-337a-486e-959d-3808ec335869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTUtMS0xLTE4MTc2OQ_3f279640-7367-4465-a687-4a1523b4cf85">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTktMS0xLTE4MTc2OQ_5708e305-6d0b-4347-a087-e3df7263d754">8,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTEtMS0xLTE4MTc2OQ_ff3f80ff-2362-4426-b821-ee52628acd85">549,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTMtMS0xLTE4MTc2OQ_c21d1712-d4cc-4d61-b417-ae60f8d01bab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTUtMS0xLTE4MTc2OQ_c740ce21-380e-44cb-961d-1758a3b2f5a6">18,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTktMS0xLTE4MTc2OQ_928fd192-fdc2-4bc9-a7ab-d5e55262fd4c">531,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic6537334aae64a1692c21c4e30957279_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTEtMS0xLTE4MTc2OQ_039b69f7-d3eb-4250-b60f-c377e94a3d4a">705,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic6537334aae64a1692c21c4e30957279_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTMtMS0xLTE4MTc2OQ_4eea023a-c538-497c-89b5-6f3445f09133">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ic6537334aae64a1692c21c4e30957279_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTUtMS0xLTE4MTc2OQ_975f5c7e-753a-42fc-89c4-a37138a7f5d8">20,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic6537334aae64a1692c21c4e30957279_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTktMS0xLTE4MTc2OQ_ae854317-69da-4625-977c-d0638ff8846f">685,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTEtMS0xLTE4MTc2OQ_eeb89aca-05fe-44df-8a0d-572298e89097">728,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTMtMS0xLTE4MTc2OQ_cf0b08e3-3648-401c-a76b-9363d8b6141e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTUtMS0xLTE4MTc2OQ_93b66b5a-44bf-4be0-a7c4-2b8f556f16b7">20,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTktMS0xLTE4MTc2OQ_b9d52ad5-c0fc-4512-84fd-4d390fad80ac">708,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and 2022, the Company has recognized accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzQyNQ_abf905a1-e980-458a-b1dd-483e66e5c8af">2.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzQzMg_292b6fb6-bf7a-4082-9143-f1eeabd5856e">2.1</ix:nonFraction> million, respectively, which is included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzE3MDQyNDMwMjMzNTky_1995d277-8431-4487-a901-191b21f55f52">prepaid expenses and other current assets</span> in the consolidated balance sheets. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib29c8ce41a304c33a212d47fc847f1bc">The unrealized losses associated with the Company&#8217;s debt securities were $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzYyMw_7e56bc25-fbb6-4629-b1d9-6863e9c6e4a3">18.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzU0OTc1NTgxNTU4MQ_2f9b9126-4bbb-423d-b043-8e925dccac90">20.5</ix:nonFraction> million as of March&#160;31, 2023 and 2022, respectively. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did <ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="docs:DebtSecuritiesAvailableForSaleImpairmentsLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzgzNg_47a95a4a-63c3-43d8-89a8-348308335b7c">no</ix:nonFraction>t recognize any impairment on these securities as of March&#160;31, 2023 and 2022. The Company did <ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="0" name="docs:DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzkxMQ_867ebd16-7d48-4df2-a369-b08c684aefcd"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="0" name="docs:DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzkxMQ_bd710ccf-1d3b-421a-ac18-c02161ca2732">no</ix:nonFraction></ix:nonFraction>t recognize any credit losses related to the Company&#8217;s debt securities during the fiscal years ended March&#160;31, 2023 and 2022. The fair value related to the debt securities with unrealized loss for which no credit losses were recognized was $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzExMzE_e46d6e2a-3362-4bbb-9539-ee457b8def94">653.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-5" name="docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzU0OTc1NTgxNTYzMg_f0ccb01f-bb55-4106-a087-b2036c354ce3">684.7</ix:nonFraction> million as of March&#160;31, 2023 and 2022, respectively.</ix:continuation></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_118"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzI4OA_45644628-d297-4420-9686-99fea06bbf55" continuedAt="i1dfe494ad2224a74898fcab3e160852f" escape="true">Fair Value Measurements </ix:nonNumeric></span></div><ix:continuation id="i1dfe494ad2224a74898fcab3e160852f" continuedAt="i6909b2ef9eda494d94a840009cc4c288"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzI4OQ_5456d553-11c5-4aa3-9853-554ea25186de" escape="true"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzI4OQ_974a8f25-7531-453f-8541-ae2e9958b6ef" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy for the Company&#8217;s assets and liabilities measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973077bac51d46c88beba9ea2d79c88b_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtMS0xLTEtMTgxNzY5_07798b4b-7b8d-46bf-a41d-19a5f8834b1a">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iffc1194235564259b4e5b6767a113b31_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtMy0xLTEtMTgxNzY5_72869743-3c0f-4d05-8581-f17a528cdc43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5c8099fd0c864406be81e7c53be8b1d0_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtNS0xLTEtMTgxNzY5_f36169e7-f497-4beb-b2c6-8076c3e80985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i80bd4f5f67e2484cb7851cf004cdfad5_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtNy0xLTEtMTgxNzY5_63e23e0a-e5ce-49cd-9e18-1ac58195753b">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i36192b7a614641d2838f423484ca11ba_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctMS0xLTEtMTgxNzY5_7059b162-15ea-45fa-aeda-c1d1cf5b3b79">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1239324fd29a4d1993d7b6b495489a13_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctMy0xLTEtMTgxNzY5_95109d9e-63e9-4e86-aa1c-16ec32f6890e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i66936efbaed5446aa82b9ca004d420ad_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctNS0xLTEtMTgxNzY5_381a68d5-a38e-4d99-9bbc-f60d116e940f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec0fbdefb9f344138749e5e674d592cf_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctNy0xLTEtMTgxNzY5_5571d39f-6b7a-48d3-b775-27ac39c66202">126,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie6c235234c42491f8e4131aaefe2d585_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktMS0xLTEtMTgxNzY5_e7451eb2-d4eb-412c-b2be-dbc8588d5eb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i98667fb3a0514e69a891a6c081d597f0_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktMy0xLTEtMTgxNzY5_ab559f83-8f4f-4fa3-a641-9ee7716578c4">7,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i094e2dbabb8e4569979ac9d1ad7c84d9_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktNS0xLTEtMTgxNzY5_4c587f4c-c5b4-4fa7-a6f6-ede46c7a7d8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0963b486b6ee4c8e9ddec603fe52aa57_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktNy0xLTEtMTgxNzY5_db94ab70-0d00-4ee2-8ba4-23d16c0fa333">7,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife6e57af6f2b4495abe15bf65ff24f3e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTEtMS0xLTE4MTc2OQ_df48cbf8-3b46-49cb-bf1d-57eef320cde5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5b3c5e95b7974760b927c85be52fe69e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTMtMS0xLTE4MTc2OQ_9249106c-759c-4828-9a57-d0bfc8666169">27,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58e4533ec3b849e492c02f5e01cd9d6a_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTUtMS0xLTE4MTc2OQ_28d1a948-4bc3-42ae-849e-5bc8304fc5c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i09e67dedfef14071b24d1b252a8bbef3_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTctMS0xLTE4MTc2OQ_8c8bc0e2-1750-485d-9b02-df72819f92bd">27,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1801570f9a834b549ef10690ad07160d_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTEtMS0xLTE4MTc2OQ_2fabd0a3-8cd1-4765-9af4-facf06a4ef34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifcf35ce1750d4d47b705f6c8963f102c_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTMtMS0xLTE4MTc2OQ_f6fd39c3-3e72-4845-9c77-8802a15646ac">78,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib56e571af58f495b8ff9277d066ea6b9_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTUtMS0xLTE4MTc2OQ_57cfac91-e72c-4641-bc58-6dc8ff195370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ied4d9be5d4554ad18ecaefd25a72b9a7_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTctMS0xLTE4MTc2OQ_6e898113-d3a2-47ee-b451-0bb3a772a18d">78,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id00a28ee4e38426aa959a32377ae4867_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTEtMS0xLTE4MTc2OQ_0a1f0ce1-97b6-4cb1-a82c-f80d69f33c7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2ce81717c598448da1d06f768af2f4ba_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTMtMS0xLTE4MTc2OQ_0d212d82-8a0c-4fce-901c-e275ac01361b">118,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if0b8ad77a8b54ef28439d747d79868d3_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTUtMS0xLTE4MTc2OQ_d12a815b-dadc-456e-8574-cbdb3ed83499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifae67aa06b9f4fdd9689aa90c7f5dc18_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTctMS0xLTE4MTc2OQ_d5771531-1487-4399-bde8-923fb3610fad">118,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id70c3b9155fa4014bd5667ee3349735b_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTEtMS0xLTE4MTc2OQ_3b416796-3535-4495-9c87-294da1861c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i98636d2454d045d09a3f9d68e1038e6d_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTMtMS0xLTE4MTc2OQ_e9a2cde3-2740-43cc-9a43-1ec094da1f55">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9831b78d3b4c462b8337fda154bdd3ed_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTUtMS0xLTE4MTc2OQ_938db677-c75c-4fe5-9479-1c9a7c5e4415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if458aec6fca44eddbd86df4028e655b9_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTctMS0xLTE4MTc2OQ_b3adbdd2-e9b0-4a00-a9a8-b6141c6147ff">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b84df18f95a4433bdee213a281e943c_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTEtMS0xLTE4MTc2OQ_c4b19f1c-bced-4203-9120-444d2e58ea8e">439,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6ea633cae78847bd9a91472bbef8eaeb_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTMtMS0xLTE4MTc2OQ_0de5e289-9832-4039-afdc-441c7e20c206">4,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7bde8858ac6a4a3eb52f9c270d702920_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTUtMS0xLTE4MTc2OQ_51db7f6e-2691-42fa-908e-8eea8395da03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2286649f7330456ea7cbe19b6772994e_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTctMS0xLTE4MTc2OQ_0a0f3ce7-7178-48fe-8700-5a780eec7daa">444,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3ff5a0797ef9423a9741628a3da70909_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTEtMS0xLTE4MTc2OQ_db67fdd7-4d6c-4c0f-8cab-7c8546deb288">439,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i47804551dcb6422893826946bddd57c2_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTMtMS0xLTE4MTc2OQ_0002f8a1-2192-4123-bfef-8c661ca51251">243,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic05928ff03824eacb3dec61c64f97f64_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTUtMS0xLTE4MTc2OQ_d6089724-c558-4d29-b816-c1252e73d357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib75f9bcdbb0d429ea39c456129fe42b7_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTctMS0xLTE4MTc2OQ_ffde4c8a-bab2-4f45-86c3-b78956ff1f4e">682,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8f27c894e80643b7bb1023a488f98851_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTEtMS0xLTE4MTc2OQ_5a7feee9-8476-418d-9b0d-35a2de48d1e7">566,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3a9950d0144847e69bf21ab85c40dee1_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTMtMS0xLTE4MTc2OQ_6215e164-7f00-46a0-b714-f7a1af90ab20">243,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8af851fc24a442e8aee600463f49f4bb_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTUtMS0xLTE4MTc2OQ_c636270e-1ba2-44b8-bd34-488043b50e43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0d09321a4a9a437083a3c246e5205811_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTctMS0xLTE4MTc2OQ_905e89df-1d0e-4bd7-bb5d-2905455b3b30">809,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contingent earn-out consideration liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8f27c894e80643b7bb1023a488f98851_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTEtMS0xLTE5Njk4Mg_8e469b39-a85d-4779-91de-1d29cee297da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3a9950d0144847e69bf21ab85c40dee1_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTMtMS0xLTE5Njk4Mg_a9fbdc74-e25a-4c15-a257-25601e1159bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8af851fc24a442e8aee600463f49f4bb_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTUtMS0xLTE5Njk4Mg_e9da28de-70d1-4911-af37-1f6d7c75b8c4">21,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0d09321a4a9a437083a3c246e5205811_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTctMS0xLTE5Njk4Mg_69fa5363-5364-4a9e-816e-58338d272c80">21,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total contingent earn-out consideration liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8f27c894e80643b7bb1023a488f98851_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTEtMS0xLTE5Njk5Nw_c1d1e4c2-4890-48b3-9e23-8f745c69d4af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3a9950d0144847e69bf21ab85c40dee1_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTMtMS0xLTE5Njk5Nw_a64604a7-0400-4deb-a97e-b7c06ce7e8b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8af851fc24a442e8aee600463f49f4bb_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTUtMS0xLTE5Njk5Nw_0b8f9442-0d79-40d6-8a89-d0223e17cedd">21,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0d09321a4a9a437083a3c246e5205811_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTctMS0xLTE5Njk5Nw_83fa6398-d874-4cf9-9b79-b035769360dc">21,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i05788cb1cd704a9aa7f2c4a233d58bfc_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtMS0xLTEtMTgxNzY5_99848eaa-507b-4f54-ace6-08aaed94e7c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i07b39367e3554a54949428ce5c073cd4_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtMy0xLTEtMTgxNzY5_77c70e15-80c2-41eb-9af2-3e7ff1f0b46d">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib5d7ef86da204a758e391dfe903e1498_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtNS0xLTEtMTgxNzY5_d6515d2e-9146-4cc4-b1d1-f616d0229de1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i266a23a458034fcab5ce09b2e8f653a3_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtNy0xLTEtMTgxNzY5_cbe5f570-4b94-4e38-aeaf-c3b61bc61156">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6d2e893789f44ff5b5960e5ae1657eee_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtMS0xLTEtMTgxNzY5_7013a966-ec64-4123-9f7e-cd023eb60fde">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if00cf42cc410455b9902a0c72c79d686_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtMy0xLTEtMTgxNzY5_0e371c78-cd6d-4b03-94aa-9d5e19702654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i56cca9f8ee3e46cd915bfb9e19b9f84d_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtNS0xLTEtMTgxNzY5_88424a2e-601d-42dd-aab3-c3d4aeb1be18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i935023b9804f4655be2ead76741d2746_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtNy0xLTEtMTgxNzY5_77bbd1aa-15f9-470e-9725-426a6a35cf1c">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i86a6490c23ed4240aa47bc61b8c3cc1d_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctMS0xLTEtMTgxNzY5_378b26af-c6b8-43df-9ae7-0c2042ebbb19">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic4ea9461173a44349f0685c96d1dcce1_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctMy0xLTEtMTgxNzY5_728e9521-fd3f-4d47-a8d8-144a5d7cd7c6">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7aa9ca7e9e934914903f4b7ed4c4ec8c_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctNS0xLTEtMTgxNzY5_1d7e359b-a499-48a7-b8d2-b0593d04dcb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1c19be996cea4d049a4bb47f817d6982_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctNy0xLTEtMTgxNzY5_39d838d2-e07f-4878-9871-e4090092c46e">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibabb2f6f89e14ad0ac35698b41047d5f_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktMS0xLTEtMTgxNzY5_889ea33d-53a7-487e-a457-28308a91d173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8d946978d3a54bbcb36b85d5855cebd0_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktMy0xLTEtMTgxNzY5_93a48e7d-4d66-4de3-bea4-09ebbbb29c40">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5d38645272f547daad9432aae576444c_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktNS0xLTEtMTgxNzY5_cfe42484-8d98-4fa7-8c1e-700abdd503d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4c236f2898f14fbfa92c2686609c680c_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktNy0xLTEtMTgxNzY5_45c09285-a8c9-4688-a6f8-b3c8736d7a76">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0e816f48c9cd41c8ba78b4ddd652f74f_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTEtMS0xLTE4MTc2OQ_ab6927a1-be3e-4712-af41-2063f9702a96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idb93a4838e9c497484028bc965359528_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTMtMS0xLTE4MTc2OQ_547afea8-c551-40a6-b96b-44a1249ea765">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7538ba3acbdc47ac862773381252a6f1_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTUtMS0xLTE4MTc2OQ_5b9b39d5-7950-46db-a838-19483010dc05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie236fc059a234762bbc16ada70ba77e4_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTctMS0xLTE4MTc2OQ_5dbe12f8-fc2f-40b1-9b65-a6d5ca7553fa">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i92af9636372c49d2a9396d3c6194fe71_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTEtMS0xLTE4MTc2OQ_9590ac9b-2b52-4253-95bd-11de8a0468a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieda7830848534f8f99c833d0078f6325_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTMtMS0xLTE4MTc2OQ_521f44a8-bab8-4787-8cf6-db83a241f470">128,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3d87a52b74e641e5a5e5d658f483a695_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTUtMS0xLTE4MTc2OQ_682a419f-5f62-4e4b-b1e8-ec54ab02f648">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia3300bb0e530443a969df765b1b31393_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTctMS0xLTE4MTc2OQ_efa9bf79-62e8-4c73-8208-42ff9269f496">128,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i02c06a11eaaf4c74901e4c3250b6056e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTEtMS0xLTE4MTc2OQ_6d529e4e-2ecd-438e-bb1b-0cf088789502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2667c5bdf5084cac925ae49f37d0694b_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTMtMS0xLTE4MTc2OQ_1ddcb8a5-061b-4836-94d9-723abf684707">8,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f3d74c12b094566806aae4a3ee77109_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTUtMS0xLTE4MTc2OQ_4a5013c2-e162-4893-ab9b-e988dbb22349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f39a5b24bf14e7e8210e52e2c38875c_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTctMS0xLTE4MTc2OQ_7da0c029-e0a5-4552-aae4-a88913620123">8,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i005f944628624d14994ceacb3670c691_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTEtMS0xLTE4MTc2OQ_dcb06d1c-44f7-44e4-bc94-def37109c547">530,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i24c46d6de0854211be7d105d64fb8545_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTMtMS0xLTE4MTc2OQ_ccee33a2-b950-4fec-baa3-a1cfc75d1aa2">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic6b38e693ec6459a8eb430afd06d1251_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTUtMS0xLTE4MTc2OQ_6ef67497-6ff0-42de-ab0c-8e649d4b85ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic9c77e864c11452c9c2ce068c5c61f23_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTctMS0xLTE4MTc2OQ_e2401974-0da2-4b98-91dc-12d68e33c87b">531,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i28a659e594ee4fce9a6eb802ff0c4752_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTEtMS0xLTE4MTc2OQ_c97fa619-9249-4ee4-8d76-abf81a4673c4">530,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6d5a6f37cf644c71865652f7c26ad37b_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTMtMS0xLTE4MTc2OQ_4973935e-56c1-4214-9d08-22ae770827d3">155,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8c5538d593e0408abf61ba5d1091154b_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTUtMS0xLTE4MTc2OQ_bb6f1532-602d-4c79-8b69-5a832fd8693e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ida82cc5649fa4f7d87b92b1e33c7bbf4_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTctMS0xLTE4MTc2OQ_c48259bd-f095-41b7-a41c-112d4eb3d34b">685,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i491fd2bcc91649b49adbc5e628f544ad_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTEtMS0xLTE4MTc2OQ_37d213e7-1cb9-497e-b5d6-ba8957d106db">550,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i909ed7ebdc6e40c2b4891ea6cce48b16_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTMtMS0xLTE4MTc2OQ_320518f5-07cc-44b3-a8d1-28d6a4e7850b">157,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe2e05eecb8e45dab3610612e9815a2f_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTUtMS0xLTE4MTc2OQ_a15d4ef9-a45b-45f9-ab70-1cd1e02fafa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5378ae045e224699baa5bf281d6856b8_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTctMS0xLTE4MTc2OQ_30be2a34-948a-4561-9469-14a40f6283c8">708,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended March&#160;31, 2023 and 2022, the Company had no transfers between levels of the fair value hierarchy.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i6909b2ef9eda494d94a840009cc4c288"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Earn-out Consideration Liability</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzE3MDQyNDMwMjMyMTQy_bc979538-af5a-4e9e-9822-350a739e513b" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the contingent earn-out consideration liability (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.525%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning fair value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzEtMy0xLTEtMTg0MTkx_1cfce055-b9f8-47e2-9f94-7a3e2975922f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions in the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzItMy0xLTEtMTg0MTkx_ac2dcb6c-b2cf-4710-8228-d787d26349ba">21,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzMtMy0xLTEtMTg0MTkx_024b4d85-fec8-45b4-be28-1f2862cdeb63">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending fair value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzUtMy0xLTEtMTg0MTkx_3118e2b1-bb22-4828-bd99-172556306e09">21,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent earn-out consideration liability relates to the AMiON acquisition, which closed on April 1, 2022. The fair value of the liability is remeasured at each reporting date until the related contingency is resolved, with any changes to the fair value recognized as <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzE3MDQyNDMwMjMyMTQz_3e9d7d07-1cf9-455d-9196-8ee9cf5d4f4c">sales and marketing expense</span> in the consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of the contingent earn-out consideration liability, the Company used the discounted cash flow method. The significant inputs used in the fair value measurement of the contingent earn-out consideration liability are the discount rate and the timing and amounts of the future payments, which are based upon estimates of future achievement of the performance metrics. As these inputs are not based on observable market data, they represent a Level 3 measurement within the fair value hierarchy. Changes in the significant inputs used would significantly impact the fair value of the contingent earn-out consideration liability.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8&#8212;Business Combinations for additional discussion regarding the AMiON acquisition.</span></div></ix:continuation><div id="ib1b51d92d3ac43179e2f8bdfac24a353_121"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzg3OA_ade653aa-91dd-4477-a61e-b78cf03c00a9" continuedAt="i78b8e06f0b974838b4180d719ca84077" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="i78b8e06f0b974838b4180d719ca84077"><ix:continuation id="i3d2cd8c14e5c409aa97b9a6774688a31"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b07362e43874a6594d73dabd00c8bd4_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzItMS0xLTEtMTgxNzY5_61e67341-635e-40c9-a900-cd5ed3ccc1af">2,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5254616f1e114acbae4ffe43531c2c3e_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzItMy0xLTEtMTgxNzY5_2e083b3d-50c1-4596-ba8e-5176aab519d1">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f9cc7883e82437ebb578096cb2a8fd6_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzMtMS0xLTEtMTgxNzY5_a13bcd7b-6139-4fd6-855a-e177b6fd09be">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0eba1ae8f23b43768d9773249e2d7a88_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzMtMy0xLTEtMTgxNzY5_c862c1fa-491c-4e51-abfa-5da4618a5e25">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb568cd7f51427db6f63dfe746772cf_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzQtMS0xLTEtMTgxNzY5_c9efcc09-cdcc-4e8d-a496-bfa261aabd64">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i028db93b3eea4709b1441884e9e13e7c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzQtMy0xLTEtMTgxNzY5_9ea6a8b2-4607-442e-bd00-188deef8094d">796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4b800cd958594616ba0a181f993bd05f_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzUtMS0xLTEtMTgxNzY5_9e4869b5-020f-463b-bd00-17fe702ece8b">20,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i69297980cac1443bb352fff016d929b6_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzUtMy0xLTEtMTgxNzY5_362840ce-008f-45e4-849b-7b441272b520">15,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzYtMS0xLTEtMTgxNzY5_fcc45e85-28b7-489c-aea7-2370dc1d80ef">24,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzYtMy0xLTEtMTgxNzY5_971020c9-23ad-4e34-8a43-237b21d34630">16,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzctMS0xLTEtMTgxNzY5_e9229497-a862-4bdd-9626-9ff86af01e4a">13,575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzctMy0xLTEtMTgxNzY5_a497d905-9f87-4960-9d14-4b3ee00f7f63">8,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzgtMS0xLTEtMTgxNzY5_ab9b03ea-af9c-4d23-943e-6f8217dde42e">11,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzgtMy0xLTEtMTgxNzY5_b61ee80c-334b-439b-8406-63b0a5386d0d">8,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense on property and equipment for the fiscal years ended March&#160;31, 2023, 2022, and 2021 was $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzIyMA_8e479955-3f6c-439a-9415-03d7e4104385">5.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzIyNA_7e12c00d-8a32-42c0-815c-1185a4186ac2">4.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzIzMQ_64b39fd0-7f08-4097-b246-2715e40455b4">2.6</ix:nonFraction> million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzM0Nw_13b77d66-d39a-486f-8da7-e3f5fddd6d9e">4.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzM1MQ_acfa76e2-236d-4906-9c42-efae0ba1bb4c">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzM1OA_2d21aba8-2724-4232-a945-3a15878d0ef5">2.2</ix:nonFraction> million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2023, 2022, and 2021, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzYyMw_486cd01d-3976-46e0-9aaa-f188568ec7b8">5.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzYyNw_e89dd8fb-fadb-48e0-9186-3b2d539849ee">4.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzYzNQ_a1f3dcd1-5ce1-445d-b216-c2b00cbd4f0f">4.6</ix:nonFraction> million, respectively, of internal-use software development costs, which are included in property and equipment, net on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="0" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzc4NA_683af5ed-e2f1-48b2-8611-1d76361862c5"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="0" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzc4NA_bc241482-f789-4c93-855d-dd89c15c2b67"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="0" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzc4NA_df6f2634-6e5f-4b7a-838f-2073b042a82a">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment was recognized on property and equipment during the years ended March&#160;31, 2023, 2022, and 2021.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90ZXh0cmVnaW9uOjZkMTgyNWNjMDM2NzQxZDk4N2YyZDNiZjBjNzliNGYyXzE1Mg_9c3c2245-c55c-4b4a-9318-1fcc22277b91" continuedAt="i9f4db76630b34f61a6a907f51cce5752" escape="true">Accrued Expenses and Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="i9f4db76630b34f61a6a907f51cce5752"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90ZXh0cmVnaW9uOjZkMTgyNWNjMDM2NzQxZDk4N2YyZDNiZjBjNzliNGYyXzE1Mw_ffe70cad-20b6-40c3-a764-1a4cb06af93c" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzItMS0xLTEtMTgxNzY5_4e763433-0af4-41a2-a935-67a9fe8c826e">5,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzItMy0xLTEtMTgxNzY5_e794419d-9a89-4e6c-9cde-25beef751643">6,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued payroll, bonus, and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzMtMS0xLTEtMTgxNzY5_2b11ffda-2c9b-4d26-b18c-82f137f26352">8,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzMtMy0xLTEtMTgxNzY5_873f1e5e-576e-41b0-8020-7e1c846a5cd3">8,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employee contributions under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:AccruedEmployeeStockPurchasePlanCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzQtMS0xLTEtMTgxNzY5_40cb720e-cb4a-4378-a344-b2123b14b03b">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="docs:AccruedEmployeeStockPurchasePlanCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzQtMy0xLTEtMTgxNzY5_c40ede64-869b-4932-ba97-fb529c4ccf5a">621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Rebate liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:RebateLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzUtMS0xLTEtMTgxNzY5_fb9b25a2-af1a-4e14-a99c-7d646e753335">3,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="docs:RebateLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzUtMy0xLTEtMTgxNzY5_575e3713-a8b3-4dda-b5cf-e34950c28cc4">4,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzYtMS0xLTEtMTgxNzY5_8560a462-77ea-4ef4-b52b-8da6a9c924d4">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzYtMy0xLTEtMTgxNzY5_9bad3815-8ecf-4852-bb76-ef17d296cd27">785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of contingent earn-out consideration liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMS0xLTEtMTk3MDI0_e32a95b6-8f1f-46d7-8a17-51220bea026f">5,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMy0xLTEtMTk3MDI0_ca9d63a5-cde5-40c1-9c7e-5e22d40fe672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMS0xLTEtMTgxNzY5_3406e0f6-0651-4c88-95ec-d7cd1ecf3b71">5,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMy0xLTEtMTgxNzY5_e0e8d898-a0d9-43b6-8c70-9e731bed955f">4,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzgtMS0xLTEtMTgxNzY5_2f5f460d-f953-43d3-99ff-42a10718d497">31,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzgtMy0xLTEtMTgxNzY5_6e244c55-3490-44db-bca7-4313ff4fbde0">25,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_127"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzI2Mzk_d3e16d5c-f138-4a3f-b8ed-b73098528260" continuedAt="i3232dc1f7cfd427cb4c062289948a164" escape="true">Business Combinations</ix:nonNumeric></span></div><ix:continuation id="i3232dc1f7cfd427cb4c062289948a164" continuedAt="i624f03e456274bcf8e6403527e62df69"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Curative Talent Acquisition </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company completed the acquisition of THMED, LLC (subsequently renamed Curative Talent, LLC, &#8220;Curative&#8221;), which was accounted for as a business combination. Curative provides temporary and permanent healthcare staffing services to hospitals, medical groups, and other healthcare facilities across the United States. The acquisition-date fair value of the consideration transferred was $<ix:nonFraction unitRef="usd" contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzQ5OQ_6434946c-5e8d-4339-8a84-f6700b0289d9">34.7</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzUxNw_e1c34ba2-12ad-4a4e-9ffb-2b095a4c6060">33.6</ix:nonFraction> million in cash and <ix:nonFraction unitRef="shares" contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzUzMg_a549fb50-d6e4-43dc-aa47-b7053e5bbce5">689,656</ix:nonFraction> shares of common stock valued at $<ix:nonFraction unitRef="usd" contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU2OA_86963a5f-bdef-424c-97db-5fd8ac233a48">1.1</ix:nonFraction> million. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzI2NDA_52fe1a10-1e8f-437a-a326-287fca4cd580" continuedAt="i7f69925917e24586983ca76a6e3e240d" escape="true">The purchase consideration allocation was as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify"><ix:continuation id="i7f69925917e24586983ca76a6e3e240d" continuedAt="i7f79be5d29c040c1a5f3ca6abfebbf91"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzEtMS0xLTEtMTgxNzY5_01c23fe3-ab34-4267-b625-d1f5bb0c40cd">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzItMS0xLTEtMTgxNzY5_329f5853-7e80-47fa-a9e0-e1f140ea7eaa">4,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="docs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzMtMS0xLTEtMTgxNzY5_05f6928a-0c88-4fb3-babe-4f82aabbe6c3">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzQtMS0xLTEtMTgxNzY5_8c173f96-a461-4006-8322-809f1fdc2989">10,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzUtMS0xLTEtMTgxNzY5_f3af1af7-aaa7-4813-b328-be9e69edc803">17,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzgtMS0xLTEtMTgxNzY5_29c193df-3c53-4600-9846-507d96857473">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzktMS0xLTEtMTgxNzY5_3df7a004-8e0e-4502-bfe7-9c1b667bb96b">15,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzEwLTEtMS0xLTE4MTc2OQ_9cfbc1bf-8307-4511-8e5c-ab47019c4e94">18,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzExLTEtMS0xLTE4MTc2OQ_59fde3ea-97d2-4ee5-b144-387751fb4bfc">34,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the future benefits as a result of the acquisition that will enhance the Company&#8217;s product available to both new and existing customers and increase the Company&#8217;s competitive position. Goodwill is deductible for income tax purposes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition-related costs were $<ix:nonFraction unitRef="usd" contextRef="ie68ef9f8618c452ea229d8ad30b5bf6a_D20190401-20200331" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzExNzI_1bce92d3-2181-4d98-be57-ab4aa426999a">1.2</ix:nonFraction> million and were recorded as general and administrative expense in the Company&#8217;s consolidated statements of operations during the fiscal year ended March&#160;31, 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired are comprised of customer relationships with an estimated useful life of <ix:nonNumeric contextRef="i792a31a0059348cda0386afa68fcd936_D20200401-20200401" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE0MTk_d1c6419d-e560-4742-b688-d040ab0d80a0">10</ix:nonNumeric> years. The fair value assigned to the customer relationship was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the Company&#8217;s consolidated financial statements from the acquisition date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company sold a portion of Curative Talent&#8217;s business for total consideration of $<ix:nonFraction unitRef="usd" contextRef="iab8cf2152e6a45f19fde2dadc29bceb1_I20201031" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE5MjA_993e5a9d-f51f-4cd6-845c-d8610505f038">4.7</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ia7176555421542a3996fd5fb7b63446f_D20201001-20201031" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE5MzM_14349588-f9a3-4d26-8877-b4b1437d3a91">4.2</ix:nonFraction> million has been received in cash and the remaining $<ix:nonFraction unitRef="usd" contextRef="iab8cf2152e6a45f19fde2dadc29bceb1_I20201031" decimals="-5" name="docs:DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE5ODA_877815eb-1595-489c-8cb8-40f6ac395df5">0.5</ix:nonFraction> million was held in escrow, subject to standard representations </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i624f03e456274bcf8e6403527e62df69"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and warranties. The net assets of this business were not material. The Company recognized a gain on sale for the total consideration during the fiscal year ended March&#160;31, 2021 as a result of this sale. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AMiON Acquisition </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2022, the Company completed the acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians (&#8220;the AMiON acquisition&#8221;) to further expand our physician cloud platform. The acquisition-date fair value of the consideration was $<ix:nonFraction unitRef="usd" contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDM4Nw_35d167fe-ff94-42bb-bab7-d4362e2c513f">74.6</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQwNQ_6ffae8b7-17e2-4581-b490-81364e32911b">53.5</ix:nonFraction> million in cash and $<ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQyNA_b186d683-96e3-4221-a112-1cb80fac7493">21.1</ix:nonFraction> million in fair value of contingent earn-out consideration.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the definitive agreement for the AMiON acquisition, the Company will pay contingent earn-out consideration of up to $<ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ0Mg_0c0736e2-c3f1-4999-bc39-a6a3c808ec16">24.0</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ2MA_253676ef-605d-402b-87d9-bc373042a29d">4.0</ix:nonFraction> million is a minimum guarantee and the remaining $<ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-5" name="docs:BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ3OQ_eb931412-545d-4503-aba0-6926346bb502">20.0</ix:nonFraction> million is subject to the achievement of certain operational performance metrics over the next <ix:nonNumeric contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401" name="docs:BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDUxMA_ac1f2dee-c5d4-4887-8455-eda26d858887">four years</ix:nonNumeric>. The contingent earn-out consideration is payable in cash in annual installments over the next <ix:nonNumeric contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401" name="docs:BusinessCombinationContingentConsiderationLiabilityPayablePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ5NQ_dccab3da-b08a-42dc-b89b-ba7d7c3677cd">four years</ix:nonNumeric>, with approximately $<ix:nonFraction unitRef="usd" contextRef="iedea9d7e7d2f4459ae223d71da4c8b3e_D20230401-20230630" decimals="-5" name="docs:PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDg1MA_12a2e71a-77d5-4965-ab03-e42ad9138928">6.0</ix:nonFraction>&#160;million settled in the first quarter of fiscal 2024. The contingent earn-out consideration is classified as a liability, the short-term portion of which is included in accrued expenses and other current liabilities and the long-term portion is in contingent earn-out consideration liability, non-current in the consolidated balance sheets. See Note 5&#8212;Fair Value Measurements for additional information regarding the valuation of the contingent earn-out consideration liability. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in May 2022, <ix:nonFraction unitRef="shares" contextRef="i33d40acad4a14920a7156beb462b2eb5_D20220501-20220531" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDUyMg_aab91aa1-8899-47fb-bc59-ceb1c6e6ac4d">93,458</ix:nonFraction> RSUs with a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i33d40acad4a14920a7156beb462b2eb5_D20220501-20220531" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDUzMw_59915b70-59d6-46c5-bba6-decd398e9fe2">32.99</ix:nonFraction> per share were granted to the eligible employees joining the Company in connection with the AMiON acquisition. The shares will vest on a quarterly basis over <ix:nonNumeric contextRef="i7e291345f6a64a58aaf2f650b1ba9147_D20220501-20220531" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU0Nw_3081d624-2f5c-4b12-87ae-3aa66a6830e8">four years</ix:nonNumeric> based on continued service. The aggregate grant date fair value of these RSUs is accounted for as post-acquisition stock-based compensation expense and is recognized on a straight-line basis over the requisite service period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AMiON acquisition was accounted for as a business combination. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. <ix:continuation id="i7f79be5d29c040c1a5f3ca6abfebbf91" continuedAt="ibdbfd496af5142e19caf273526591996">The purchase consideration allocation was as follows (in thousands):</ix:continuation></span></div><div style="margin-bottom:9pt;text-align:justify"><ix:continuation id="ibdbfd496af5142e19caf273526591996"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzItMS0xLTEtMTg0NDAw_af0e5381-9bb8-4b2b-b2ad-8289bde0f726">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i078c5a28b0454db6b490e4fff852e96e_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzQtMS0xLTEtMTg0NDAw_fb3d8538-8bd3-47df-b1a3-efa2f00d56fb">27,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0f275888ff1e48c7a97763a827fcee54_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzUtMS0xLTEtMTg0NDAw_d24381a7-2530-4322-a3d5-472584f41ff3">820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifffbf1b0e78f4ac596aeef622400a7dd_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzYtMS0xLTEtMTg0NDAw_cdc620d8-5cb1-4722-99a6-ceb0e8971b4f">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzctMS0xLTEtMTg0NDAw_bdcb9c31-38d8-4666-8864-f5cc0c1c18c9">29,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzEwLTEtMS0xLTE4NDQwMA_7bf056dd-178f-412f-aa37-d5a29d014023">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzExLTEtMS0xLTE4NDQwMA_e9fdea84-d7ad-46a6-817f-a4abd479ffc7">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzEzLTEtMS0xLTE4NDQwMA_4fc6139f-58a2-43d9-9430-c2e7fed23c1e">25,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzE0LTEtMS0xLTE4NDQwMA_40719c1f-ad07-4408-b7e6-bd345f3c64a7">49,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzE1LTEtMS0xLTE4NDQwMA_7fac0ac0-a3d0-404b-ab4b-271f25482646">74,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill generated from the AMiON acquisition represents the future benefits from the development of future customer relationships and the assembled workforce. Goodwill from this business combination is deductible for income tax purposes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired are comprised of customer relationships, trademarks, and developed technology with estimated useful lives of <ix:nonNumeric contextRef="ic7a96ee455094c298ce4724ad93c884e_D20220401-20220401" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU1OQ_1b971f2d-20e6-494a-9ffe-420bd9870263">9</ix:nonNumeric> years, <ix:nonNumeric contextRef="i96330e2ec3d34bf5b8ce4bf07abe50a2_D20220401-20220401" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU2OQ_9274d753-2a7b-40f9-a532-d9958ca9fa19">3</ix:nonNumeric> years, and <ix:nonNumeric contextRef="i9dd1e4f4b78c402ab313d73be32dece7_D20220401-20220401" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU4MQ_23329aa0-9bfa-47a9-b529-e1696f711453">18</ix:nonNumeric> months, respectively. The fair value assigned to the customer relationships was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the consolidated financial statements from the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition-related costs were not material and were recorded as general and administrative expense in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate operating results and pro forma results of operations for AMiON have not been presented as the effect of this acquisition was not material to the Company&#8217;s financial results.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_870"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE3MDQyNDMwMjMxNzYy_4838ad3a-be71-41c8-91b9-7b5925d2e748" continuedAt="i388f79b9900e4e74beb38934c20d7774" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i388f79b9900e4e74beb38934c20d7774"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzQxMg_2367d31b-80d4-4c86-bb9e-c223e085855e" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd29a5137477430b8f27c6edb2086fbe_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzItMS0xLTEtMTg0MjI5_043c64ef-9ae1-4f65-80dc-87b1a4ccc4ef">37,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0a6d175e49204bda81ef5fb379cd9fea_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzItMy0xLTEtMTg0MjI5_89c2624a-abb2-45d9-998c-efb265bd9f1f">9,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8a6c090726294b758ee283e14aedd42c_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzMtMS0xLTEtMTg0MjI5_1700d091-55df-4e93-aceb-dc53ae2db359">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iea1fb9c634ba4816850d26fbc19237a3_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzMtMy0xLTEtMTg0MjI5_e42acc92-c3f2-42ef-acee-f1ea586b813d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzQtMS0xLTEtMTg0MjI5_1fecddce-1179-4a85-a4f2-2a6c7aa24502">38,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzQtMy0xLTEtMTg0MjI5_01d62023-8d20-40bb-8242-e9fe8061b8b1">9,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzUtMS0xLTEtMTg0MjI5_ff87a2b0-dd7c-4d1c-ab96-7a1119f26229">6,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzUtMy0xLTEtMTg0MjI5_505194dc-64d1-4618-9826-cc8e25098b5e">1,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzYtMS0xLTEtMTg0MjI5_c7d4c970-f8d6-491e-9ccf-dae32a67d930">31,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzYtMy0xLTEtMTg0MjI5_6d0f47c0-dd25-4941-a611-70d56dca0264">7,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzEzOA_97604919-97c9-4ed4-9cf4-2e81fe37eb9d">4.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE0Mg_74f57751-ce4d-4eec-8275-e94181f8ec1c">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE0OQ_b3994181-ec19-433f-a4b1-506c26c44e24">1.1</ix:nonFraction> million for the fiscal years ended March&#160;31, 2023, 2022, and 2021 respectively.</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzQxMw_2fdd9da1-f8e6-425d-b233-bbafa6e6859d" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, future amortization expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzEtMS0xLTEtMTg0MjI5_71ae1440-05df-41a3-9bac-98fcfb552dfc">4,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzItMS0xLTEtMTg0MjI5_cb98e790-c509-4cb4-9f9f-57202d181552">4,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzMtMS0xLTEtMTg0MjI5_7a07dfdb-f20c-47c7-9d87-8a3f94b8a943">4,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzQtMS0xLTEtMTg0MjI5_99dfe820-2e13-436d-be89-6195004f87f9">4,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzUtMS0xLTEtMTg0MjI5_886f25fa-36b3-4f44-a1d6-14b8b1647aa7">4,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzYtMS0xLTEtMTg0MjI5_513ba979-fb40-40d1-93af-bd9efce01f7c">11,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzctMS0xLTEtMTg0MjI5_9c93cf58-3429-466f-af9e-bb587f87bea5">31,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE3MDQyNDMwMjMxNzYx_df43a753-1833-44aa-b75e-a6831d89b86e" escape="true"><div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill were as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTo5ZjMxZjA5YmNlYzE0MmY2OWE2ZjBmZDhlMTY4ODM4NC90YWJsZXJhbmdlOjlmMzFmMDliY2VjMTQyZjY5YTZmMGZkOGUxNjg4Mzg0XzEtMS0xLTEtMTg0NjUy_5d2bceef-abf7-4d7c-aaf5-bbac00300655">18,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTo5ZjMxZjA5YmNlYzE0MmY2OWE2ZjBmZDhlMTY4ODM4NC90YWJsZXJhbmdlOjlmMzFmMDliY2VjMTQyZjY5YTZmMGZkOGUxNjg4Mzg0XzItMS0xLTEtMTg0NjUy_253c373d-9daf-4136-963f-3b05c1ceef48">49,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTo5ZjMxZjA5YmNlYzE0MmY2OWE2ZjBmZDhlMTY4ODM4NC90YWJsZXJhbmdlOjlmMzFmMDliY2VjMTQyZjY5YTZmMGZkOGUxNjg4Mzg0XzMtMS0xLTEtMTg0NjUy_8750e275-676e-45eb-8563-3a94cb4a2a51">67,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the Company&#8217;s goodwill balance of $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNTAwOA_c7e1bb7a-d98f-4c48-9833-281c5df072be">18.9</ix:nonFraction> million during the fiscal year ended March&#160;31, 2022. <ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNDY0OQ_77becd1a-da90-49ec-9372-6c5547cdd5aa"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNDY0OQ_c169e340-0140-4dd0-9845-abaa1a3c94eb"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNDY0OQ_f02cdb63-0840-46a9-ae61-931863027a73">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment charges on goodwill were recorded during the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div></ix:continuation><div id="ib1b51d92d3ac43179e2f8bdfac24a353_130"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="docs:TemporaryEquityTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU4NzQ_5bc858e4-5df5-429f-bf11-59b3df9110b8" continuedAt="i042f2c58b4e740cfb969857d1aa6a418" escape="true">Redeemable Convertible Preferred Stock</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i042f2c58b4e740cfb969857d1aa6a418">Upon completion of the IPO in June 2021, all shares of the Company&#8217;s redeemable convertible preferred stock outstanding, totaling <ix:nonFraction unitRef="shares" contextRef="ia5fc25c9a4e64fa18623717924e129f3_D20210601-20210630" decimals="INF" name="us-gaap:ConversionOfStockSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzMwMw_ff237fea-d1a7-4a3c-90fc-dbc2a35f36fe">76,286,618</ix:nonFraction>, were automatically converted into an equivalent number of shares of Class B common stock on a <ix:nonFraction unitRef="number" contextRef="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630" decimals="INF" name="docs:ConversionOfStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzQwMQ_863f7749-5551-4c57-815a-cbdc535a07f6">one</ix:nonFraction>-to-one basis. The carrying value of redeemable convertible preferred stock of $<ix:nonFraction unitRef="usd" contextRef="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630" decimals="-5" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzQ4MQ_194ecf77-7fee-42b1-82f1-8a61fa4c8115">81.5</ix:nonFraction> million was reclassified into stockholders&#8217; equity. As of March&#160;31, 2023 and 2022, there were <ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_67df02df-d2f4-4e2b-a53a-94a0fbaf0350"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_85273c17-ab18-492a-a07b-ecc50b108da5"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="0" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_a3cf076c-a95a-4277-89ba-4e9e30dc3286"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_ef380972-2cdb-4b8f-99e0-c5bfc63fd2f9">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of redeemable convertible preferred stock issued or outstanding.</ix:continuation></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_133"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc2_4f0c14c4-b6a2-4c4b-9951-f7ebf5a9b581" continuedAt="i544994c414d54647958855ddfc3d89a9" escape="true">Equity</ix:nonNumeric></span></div><ix:continuation id="i544994c414d54647958855ddfc3d89a9" continuedAt="i2b5aa8b1ea4c4f178172797618a1678e"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, the Company&#8217;s amended and restated certificate of incorporation became effective, which authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="iccbddb5d88f943d18b1e2bca79988299_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE3Ng_adbae9f8-6357-4355-9a28-40f8ca7b7470">100,000,000</ix:nonFraction> shares of undesignated preferred stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="iccbddb5d88f943d18b1e2bca79988299_I20210630" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzIzOA_8c5f371f-ac60-4b14-9d9a-79847db9cfef">0.001</ix:nonFraction> per share with rights </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i2b5aa8b1ea4c4f178172797618a1678e" continuedAt="ib9fb5d2af4a9452cae1b26911a1d2a76"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and preferences, including voting rights, designated from time to time by the board of directors. As of March&#160;31, 2023 and 2022, there were <ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_3365ebaa-6b3e-4571-a079-7e4968f895e7"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_a5b412dc-f71d-4d9a-bd09-7b6a8e3c21f5"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_ce8321b8-16b0-41c8-a9d5-1c3417e12eb9"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_f3b5b505-665e-4584-8a0f-5f6d1de9b52c">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of preferred stock issued and outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock and Creation of Dual-Class Structure </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation which authorized <ix:nonFraction unitRef="shares" contextRef="i8232534e9744410f8e611d99b9e84386_I20210608" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzg5OA_858a1cd1-d2c0-4f25-9623-8da883567420">1,000,000,000</ix:nonFraction> shares of Class A common stock with par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8232534e9744410f8e611d99b9e84386_I20210608" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzk1MA_04a180bf-a498-454b-8acb-914f45af39fe">0.001</ix:nonFraction> and <ix:nonFraction unitRef="vote" contextRef="i8232534e9744410f8e611d99b9e84386_I20210608" decimals="INF" name="docs:CommonStockVotingRightsNumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzk1Nw_7c525f08-a629-402b-a993-cb78a8bd7b8f">one</ix:nonFraction> vote per share, and <ix:nonFraction unitRef="shares" contextRef="ib0806f84593344d893e74652c3b10250_I20210608" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzk4MA_13de073c-14cf-41f8-9b70-9f73fbd720ff">500,000,000</ix:nonFraction> shares of Class B common stock with par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib0806f84593344d893e74652c3b10250_I20210608" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwMzI_04beab98-a748-4f3c-9e20-be39d7008fd6">0.001</ix:nonFraction> and <ix:nonFraction unitRef="vote" contextRef="ib0806f84593344d893e74652c3b10250_I20210608" decimals="INF" name="docs:CommonStockVotingRightsNumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwMzk_22aded0c-95fd-41bf-9fa0-5c16fe8a616a">ten</ix:nonFraction> votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company&#8217;s <ix:nonFraction unitRef="shares" contextRef="i20facf15f91a4b51a59cf495eff488b0_D20210608-20210608" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzExOTA_61e7b3db-8d80-421a-bcd7-a6731f9f5c03">85,523,836</ix:nonFraction> shares of then-existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into <ix:nonFraction unitRef="number" contextRef="ibf068271d669438eafc6af652e833d08_D20210608-20210608" decimals="0" name="docs:ConversionOfStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzOTA_c116aeee-5df9-4a32-964e-1f517c4c78c6">one</ix:nonFraction> share of Class A common stock. As of March&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="id4aeaddbe31d41d99ae6142cc71b26ca_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE0NDU_64d3baf0-aadd-4402-80be-41a6ea924ac7">120,682,472</ix:nonFraction> shares of Class A common stock, and <ix:nonFraction unitRef="shares" contextRef="i9ddd079c5de94e16b92910b68fa5ba6d_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE0ODQ_c42e4171-3459-42c0-a239-7f0f67e18f09">73,258,344</ix:nonFraction> shares of Class B common stock outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;12, 2022, the Company&#8217;s board of directors authorized a program to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i3443fdd6919e400180bc0aa7089b7a55_I20220512" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODg3NQ_fe983f00-1604-40b4-93a1-efd881ee1e21">70</ix:nonFraction> million of the Company&#8217;s Class A common stock. As of September 30, 2022, the Company repurchased and retired <ix:nonFraction unitRef="shares" contextRef="i10df40a9fbe74c14b3193c4c8faa6cfd_D20220512-20220930" decimals="0" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODg5MA_86580530-8e6c-4212-be5e-b9f0b354a54b">2,150,982</ix:nonFraction> shares of Class A common stock for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i10df40a9fbe74c14b3193c4c8faa6cfd_D20220512-20220930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODkwNg_efc56988-009a-49ba-bcf1-ad4d1c3ae38b">70</ix:nonFraction> million, thereby completing this share repurchase program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;28, 2022, the Company&#8217;s board of directors authorized an additional program to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i5e8f6b95c6e94f2d8a158e8e14a0d188_I20221028" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODk0Mg_b6c8b2fd-070c-47d0-bfa8-56af5a03901c">70</ix:nonFraction> million of the Company&#8217;s Class A common stock. The repurchases may be executed from time to time over the next <ix:nonNumeric contextRef="i073baaa025aa4391ae3be3ed0f9b6b8b_D20221028-20221028" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODk1Nw_d2eae321-bc90-4c67-87af-fbe56c1b80f3">12</ix:nonNumeric> months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. As of March&#160;31, 2023, the Company repurchased and retired <ix:nonFraction unitRef="shares" contextRef="i185f2fc156dc487daa4da85b1135e893_D20221028-20230331" decimals="0" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg0MDY3OA_bb96cec0-2b7b-4bed-a6a5-985a2128f5fc">523,647</ix:nonFraction> shares of Class A common stock for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i185f2fc156dc487daa4da85b1135e893_D20221028-20230331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg0MDY4NA_7bd4fd8b-ee7e-4fc4-b114-adfaa4f93a0a">16.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU3MDg_46df02ad-d96d-4262-bd66-456ff68b1bba">54.0</ix:nonFraction> million remained available and authorized for repurchases under this program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Warrants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company issued a warrant to purchase <ix:nonFraction unitRef="shares" contextRef="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE2MDk_3ce70d82-1e91-456b-b103-7c10eb9d25e3">250,000</ix:nonFraction> shares of common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE2NTk_51f470c5-1e13-49ad-8fe3-58f666d1cfea">0.72</ix:nonFraction> per share in connection with a contract signed between the Company and U.S. News &amp; World Report, L.P., or U.S. News. The warrant expires <ix:nonNumeric contextRef="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE4NzU_7eb0384e-4d22-4fce-9d6c-454fb5e98d89">10</ix:nonNumeric> years from the date of grant. As of March&#160;31, 2023, the warrant was fully vested. During the fiscal year ended March&#160;31, 2023, the warrant for <ix:nonFraction unitRef="shares" contextRef="i8dd14ac8c2ad476a91aae55b5e50e12b_D20220401-20230331" decimals="0" name="docs:ClassOfWarrantOrRightExercisesInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY4Nzc_157832ce-b4a0-4591-9d29-3ced4e53dbcb">125,000</ix:nonFraction> shares were exercised with an intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i8dd14ac8c2ad476a91aae55b5e50e12b_D20220401-20230331" decimals="-5" name="docs:ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY4OTU_8377129b-f993-4283-a1de-7e06eec39f09">4.0</ix:nonFraction> million. The remaining warrant for <ix:nonFraction unitRef="shares" contextRef="i60ed2d73233c4b148efb0ab0281f05c5_I20230331" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5Mjk_01020cd0-34c0-49e5-8cd6-ed1a0bdce86a">125,000</ix:nonFraction> shares was outstanding as of March&#160;31, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company issued a warrant to U.S. News (the &#8220;U.S. News Warrant&#8221;) to purchase <ix:nonFraction unitRef="shares" contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NDI_9b5a2c6c-022d-4e92-94d7-0c5bda462b6d">516,000</ix:nonFraction> shares of Class A common stock with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NTE_fbf948ea-fe35-4474-96ef-608552572b1c">12.56</ix:nonFraction> per share in connection with the execution of a commercial agreement with the U.S. News (the &#8220;Commercial Agreement&#8221;). The U.S. News Warrant expires <ix:nonNumeric contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NjI_5719ef90-7478-4f42-9a55-846f6102ef3c">10</ix:nonNumeric> years from the date of grant. The first tranche of the U.S. News Warrant vested on May 1, 2022 and the remainder will vest on a monthly basis over approximately <ix:nonNumeric contextRef="ic83bcd7a1cdd424a827ac1b242d45d64_D20211001-20211031" name="docs:WarrantsAndRightsOutstandingVestingPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NzQ_ec02d173-eb53-400b-ab83-8b45cad36d89">6</ix:nonNumeric> years. The grant-date fair value of the U.S. News Warrant was $<ix:nonFraction unitRef="usd" contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5OTE_ad797445-a07e-49c6-8f9a-05ead718264a">34.7</ix:nonFraction> million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $<ix:nonFraction unitRef="number" contextRef="i79cbc3050a9f4e728de0f2541e8414d5_I20211031" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMDU_2e061854-b906-4d31-9444-ed7687ca6aed">76.50</ix:nonFraction>, volatility of <ix:nonFraction unitRef="number" contextRef="i39c41ee9b35d4ca198dae8381879c81d_I20211031" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMTM_49d46bfb-99e3-4bec-9f4e-39cfe690670b">46.9</ix:nonFraction>%, risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="ic5f71bd088ee4c3fa9152d5f8241176d_I20211031" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMjE_c9b7fd02-a273-4e9c-b25d-0eef8e335506">1.61</ix:nonFraction>%, contractual term of <ix:nonNumeric contextRef="ib20f32b4eb624a099afa796abcc7e5e7_I20211031" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMzI_bb51a151-7913-4db7-acce-9c8a88b2cc5a">10</ix:nonNumeric> years, and an expected dividend of <ix:nonFraction unitRef="number" contextRef="i7c602ccebaef4e4fb1436ee5279c5deb_I20211031" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMzc_d4b10cb9-8bdf-4c72-97df-e2cc2c02b64e">0</ix:nonFraction>%. The fair value of the warrant is recognized as expense in cost of revenue in the consolidated statements of operations on a straight-line basis over its vesting term of <ix:nonNumeric contextRef="i31ff09070ac64dc9a6c3517e07569162_D20211001-20211031" name="docs:WarrantsAndRightsOutstandingVestingPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwNTY_604767fb-a760-4161-ae01-0c1596d23514">6.48</ix:nonNumeric> years. During the fiscal years ended March&#160;31, 2023 and 2022, $<ix:nonFraction unitRef="usd" contextRef="id7a2d89272fb4cd08d7941569bcdac06_D20220401-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcxMzE_1dac9974-f60e-4bfc-afb2-99658a4b4fb4">5.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if0b910594e0447b48176dee4458443bc_D20210401-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU3NTY_1f389041-5d55-45d1-b5bb-de386421f201">2.6</ix:nonFraction> million were recognized as stock-based compensation expense relating to the U.S. News Warrant, respectively. As of March&#160;31, 2023, unamortized compensation expense, net of estimated forfeitures, related to the unvested warrants was $<ix:nonFraction unitRef="usd" contextRef="i0dcfc10564a84d99afdf2868944eaf6f_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcxNDg_a3d31839-a448-4753-ba1d-a7727e4a78d7">26.8</ix:nonFraction> million, which is expected to be recognized over the remaining vesting period of <ix:nonNumeric contextRef="id7a2d89272fb4cd08d7941569bcdac06_D20220401-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcxNTU_a055de36-a38f-43a6-91ce-1c7ebbb24fde">5.0</ix:nonNumeric> years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2010 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2010, the Company&#8217;s board of directors and stockholders approved the adoption of the 2010 Equity Incentive Plan (the &#8220;2010 Plan&#8221;). The 2010 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. Options may </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ib9fb5d2af4a9452cae1b26911a1d2a76" continuedAt="i44e1468841394105b6c3489bfa3dc8a5"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be granted at a price per share not less than <ix:nonFraction unitRef="number" contextRef="i329535dcf29942da975d098642b9ca8c_D20100401-20100430" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1MzI_e8502f10-4719-4920-8a3d-b66c073347f3">100</ix:nonFraction>% of the fair market value at date of grant. If the incentive stock option is granted to a <ix:nonFraction unitRef="number" contextRef="i8f5a97d0329f49aba3a9c73948197302_D20100401-20100430" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1Mzg_ca1d3ded-b9c0-45b8-bc17-9072116541cc">10</ix:nonFraction>% stockholder, then the purchase or exercise price per share shall not be less than <ix:nonFraction unitRef="number" contextRef="i8f5a97d0329f49aba3a9c73948197302_D20100401-20100430" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1NDU_34161ebd-630e-4898-bd26-061845d65db8">110</ix:nonFraction>% of the fair market value per share of common stock on the grant date. Options granted under the 2010 Plan continue to vest until the last day of employment and generally vest over <ix:nonNumeric contextRef="i9add1738f524485aa3f0e69e33348404_D20100401-20100430" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1NTg_a132a8f0-1af6-4abf-94ca-1ea5cff67df0">four years</ix:nonNumeric> and expire <ix:nonNumeric contextRef="i9add1738f524485aa3f0e69e33348404_D20100401-20100430" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1Njk_b892236e-44d9-4b5a-b739-474e2885becd">10</ix:nonNumeric> years from the date of grant. Stock awards may also be granted for services performed by external consultants and vest according to an award-specific schedule as approved by the board of directors. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Stock Option and Incentive Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s board of directors approved the adoption of the 2021 Stock Option and Incentive Plan (the &#8220;2021 Plan&#8221;), which became effective upon the Company&#8217;s initial public offering and supersedes the 2010 Plan. The 2010 Plan continues to govern the terms of outstanding awards that were granted under the 2010 Plan. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. A total of <ix:nonFraction unitRef="shares" contextRef="i4731ee97e9044ac481efdbc35006ea21_I20210630" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1ODI_31e6be1a-2064-47bb-9383-75de06d3610d">22,500,000</ix:nonFraction> shares of Class A common stock was initially reserved for the 2021 Plan. The number of shares reserved and available for issuance for the 2021 Plan will automatically increase each April 1, beginning on April 1, 2022, by the lesser of <ix:nonFraction unitRef="number" contextRef="i4731ee97e9044ac481efdbc35006ea21_I20210630" decimals="2" name="docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1ODc_15fd666a-6fd5-4c50-996d-515a8975afef">5</ix:nonFraction>% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee. Any shares of Class B common stock that would have otherwise been returned to the Company&#8217;s 2010 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan after being automatically converted from shares of Class B common stock to Class A common stock. The 2010 Plan and the 2021 Plan are collectively referred to as the &#8220;Plans&#8221; in the notes to the consolidated financial statements, unless otherwise noted.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s board of directors approved the adoption of the ESPP, which became effective upon the Company&#8217;s initial public offering. A total of <ix:nonFraction unitRef="shares" contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1OTk_1d8b8116-9d14-462d-9985-41e36d0d1954">4,500,000</ix:nonFraction> shares of Class A common stock was initially reserved for the ESPP. The number of shares reserved and available for issuance for the ESPP will automatically increase each April 1, beginning on April 1, 2022 and continuing through April 1, 2031, by the lesser of <ix:nonFraction unitRef="shares" contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331" decimals="0" name="docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk2MTE_a7c9d4f4-0a1d-4138-b965-186138359441">6,750,000</ix:nonFraction> shares of Class A common stock, <ix:nonFraction unitRef="number" contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331" decimals="2" name="docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk2MTY_fe208d8d-1750-40f6-9f8c-260817c95b37">1</ix:nonFraction>% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. During fiscal 2018, the Company granted <ix:nonFraction unitRef="shares" contextRef="i392549f122de4599a31a1bc930b60d7c_D20170401-20180331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzcwOTQ_7e7b1d19-ba6e-40fd-9524-61936e0cc62a">4,682,582</ix:nonFraction> options outside of the Plans, of which <ix:nonFraction unitRef="shares" contextRef="i5f2625bab237468f82960faeaa65ecd8_I20230331" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzcxODA_e76f506b-26f1-456f-8dea-105e288889b6">2,027,917</ix:nonFraction> options were exercised and <ix:nonFraction unitRef="shares" contextRef="i5f2625bab237468f82960faeaa65ecd8_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTQ4OTk_781671c4-e888-4b5b-9010-f10eb92c972e">2,654,665</ix:nonFraction> were outstanding as of March&#160;31, 2023.</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc4_e4369ad0-a4d9-491c-89e0-4a61766d9d6d" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has shares of common stock reserved for issuance as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzItMS0xLTEtMTgxNzY5_13b34918-ab9f-46a2-aa37-379e89a52adf">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2010 Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7716737ca7654b41b69b01245e63ae37_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzQtMS0xLTEtMTgxNzY5_38ff5511-8ab7-4035-abbc-5276b497aa1c">19,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 Plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Awards outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b225b55e25041dca4b2711a6a9a0a19_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzctMS0xLTEtMTgxNzY5_1f50f6c2-cddf-4fa4-b125-0dfd758081ff">2,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b225b55e25041dca4b2711a6a9a0a19_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzktMS0xLTEtMTgxNzY5_00a34fb5-50dc-4e0e-94f1-83582e007109">31,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzEwLTEtMS0xLTE4MTc2OQ_f3fa6447-2895-4471-af1d-3b17de7d6e86">6,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding outside the Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f2625bab237468f82960faeaa65ecd8_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzExLTEtMS0xLTE4MTc2OQ_f2a51d7a-74cf-4d7c-b5a4-7da0b98c1a58">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzEyLTEtMS0xLTE4MTc2OQ_2b40f47e-8115-4300-ad2a-88f68e3bdefd">62,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i44e1468841394105b6c3489bfa3dc8a5" continuedAt="i9b4bde8c3d2e400093d0556ec6efec6f"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted generally vest over <ix:nonNumeric contextRef="ida806691cbf34206b1424fc5e64367de_D20220401-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU0MzI_0e70a8a3-b81a-482e-a423-6fa3b2eb7811">four years</ix:nonNumeric> with service-based, performance-based, and/or market-based conditions and expire <ix:nonNumeric contextRef="ida806691cbf34206b1424fc5e64367de_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU0NDU_af1e6252-34d9-45a8-9e9e-7858a8a9c2a7">ten years</ix:nonNumeric> from the date of grant. </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTcz_5999c7a4-4c5a-486c-a41f-a7c0933117d6" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activities within the Plans as well as outside of the Plans were as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtMS0xLTEtMTgxNzY5_f53ae775-9378-463d-bf8e-0a1ddf949263">26,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtMy0xLTEtMTgxNzY5_e5961a26-fa1a-4da6-a336-65fdf554ff25">4.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtNS0xLTEtMTgxNzY5_d2cd35c7-3992-43d7-ade7-10d99d74ee48">7.63</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtNy0xLTEtMTgxNzY5_94a1de4d-a91c-46ae-aa9a-291b443446e3">1,293,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzMtMS0xLTEtMTgxNzY5_94380f2d-3e0f-4073-9aa3-ca2079905dc9">3,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzMtMy0xLTEtMTgxNzY5_37d4df40-2104-4eb5-a95a-13adf31d76cc">2.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options forfeited or expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzQtMS0xLTEtMTgxNzY5_5924b631-62c8-4503-b21f-3487084f7d3a">859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzQtMy0xLTEtMTgxNzY5_532d730a-10bb-47e6-87fe-4781c6ca267e">4.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtMS0xLTEtMTgxNzY5_c8b270e9-1202-4489-b071-c863c7f4c540">22,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtMy0xLTEtMTgxNzY5_13a3edc7-c275-4e29-a201-dfcac0176f3e">4.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtNS0xLTEtMTgxNzY5_3a99546b-5fc8-4032-9e58-762635eb157c">6.56</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtNy0xLTEtMTgxNzY5_bf1d37f0-c64f-4f7a-a684-4bc348cdc129">627,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and exercisable as of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtMS0xLTEtMTgxNzY5_87b46269-c03b-4775-9735-ab172b832fff">11,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtMy0xLTEtMTgxNzY5_9f854387-2457-49e2-9e0c-60f55a5f2c28">2.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtNS0xLTEtMTgxNzY5_c604a645-cd98-4af8-bfb0-2fb1cf32aa54">5.62</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtNy0xLTEtMTgxNzY5_15d4aa33-bdd2-4538-9fe5-06f22a63d4db">354,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and expected to vest as of March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctMS0xLTEtMTgxNzY5_454288f5-5965-44eb-850b-363375e01832">21,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctMy0xLTEtMTgxNzY5_f5f1c62b-6745-4d1a-971c-517f6d35f596">4.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctNS0xLTEtMTgxNzY5_45ebdf2b-217b-4387-8d25-6fc2872ef086">6.51</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctNy0xLTEtMTgxNzY5_ddea5d5d-3147-406c-8538-e7586cb0c9f7">603,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the fiscal years ended March&#160;31, 2023, 2022, and 2021 was $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc2Nzk_fc47c08b-2a43-47c5-9469-3ed5f60d6df9">118.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc2ODM_4f7dd8e2-16f9-491e-b99d-e47c3edcfafe">521.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc2OTE_90e5d171-ea10-4cac-bc52-5cd9359291fa">52.6</ix:nonFraction> million respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of options granted for the fiscal years ended March&#160;31, 2022 and 2021 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc4MjA_43868b52-dc5c-48b6-bb1b-f0a4342d0da7">10.73</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc4Mjg_24180c8b-6a34-42c6-abde-c50da6e34aaf">3.18</ix:nonFraction> respectively. The Company has not granted any stock options since the first quarter of fiscal 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested stock options was $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzIxOTkwMjMyOTA4NzY_1330e990-4064-40f7-91dd-52affd2ea1b7">37.0</ix:nonFraction> million, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzIxOTkwMjMyOTA5NTA_f991c394-1474-4c7e-bed0-6b2f0c3051b5">2.92</ix:nonNumeric> years. </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc1_17d8a4b6-6300-462e-9713-3cfd44d36248" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if1179d128dab4059b72b6142b8bc8b8d_D20210401-20220331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItMy0xLTEtMTgxNzY5L3RleHRyZWdpb246ZjcyN2JlNTUzMWE1NDQxMmIzNDVmYTE5NjA4NmM4NDZfNA_ac3cf56c-413e-4859-80b4-cd385ccaa00d">18.41</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i1dfa57621a8d47a2a7dc41b2f9ba12c7_D20210401-20220331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItMy0xLTEtMTgxNzY5L3RleHRyZWdpb246ZjcyN2JlNTUzMWE1NDQxMmIzNDVmYTE5NjA4NmM4NDZfOQ_379db484-5050-4748-be09-48d66746ff0b">21.41</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i991245b0925a47909f34aedbdca61682_D20200401-20210331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MzBiZjI4MGVmYjJiNDIwYzhmODMxMWRmODgwZThkN2NfNA_3b9ce8e6-151f-49f6-bd0f-9efad59be3e9">2.06</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="id87182a9d8de4d7fbe7b3181cb3305b0_D20200401-20210331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MzBiZjI4MGVmYjJiNDIwYzhmODMxMWRmODgwZThkN2NfOQ_5aea01bd-4123-461b-8f50-1650f521fb7d">10.51</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246MTMwM2E4MTQ4MWNhNDYyZThlZmY0YTgyNzNiMTY0MzhfNA_1eeb047e-5aba-4839-81fd-8f00b34a2bdd">46.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246MTMwM2E4MTQ4MWNhNDYyZThlZmY0YTgyNzNiMTY0MzhfOQ_177459c2-a2c2-4485-9f42-e77c4fff5310">47.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246OGU1MmI1YWU1ZjE0NDJiNThmMjU4ZjljZjU0MGZjYjZfNA_345ab64c-5a9f-4892-ac18-13ebdddf0b6c">38.1</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246OGU1MmI1YWU1ZjE0NDJiNThmMjU4ZjljZjU0MGZjYjZfOQ_29654c3c-be0a-4469-beb1-67e99774e4c5">58.3</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246YWNhMzcxYzk5YjRiNGMzN2FiM2ZkMGUwOWZjNDc2Y2RfNA_73f71a2e-5bbf-4ee3-b808-92af9d0c8b0e">0.77</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246YWNhMzcxYzk5YjRiNGMzN2FiM2ZkMGUwOWZjNDc2Y2RfOQ_a1bb5fcc-0c75-4016-8f4e-27e730055296">1.02</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MjkwOWMwYTgxYjQyNGI3M2E1M2M2NDI2OGQ5ZTIwYmNfNA_47c9f039-c615-4788-aed3-ac118c4313c2">0.26</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MjkwOWMwYTgxYjQyNGI3M2E1M2M2NDI2OGQ5ZTIwYmNfOQ_b1cc0b90-b52f-4a01-8e25-1d58a717e2f7">1.02</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if1179d128dab4059b72b6142b8bc8b8d_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246NmI5NGJjODQ3MDhmNDBkMWI5YWQ2NTBmZTcxMmU0ZTZfNA_a087c582-3250-4b31-b662-9a144619d55b">5.00</ix:nonNumeric> - <ix:nonNumeric contextRef="i1dfa57621a8d47a2a7dc41b2f9ba12c7_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246NmI5NGJjODQ3MDhmNDBkMWI5YWQ2NTBmZTcxMmU0ZTZfOQ_3777d643-dd61-46ea-8a16-ceaaff67e9e5">6.09</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i991245b0925a47909f34aedbdca61682_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZmYwOWQ5MTRkNTdmNDMyYzgwOWVhMjI2NWJjNWNkZTZfNA_d9f05050-715d-46e8-8d24-2be64936b0c7">5.00</ix:nonNumeric> - <ix:nonNumeric contextRef="id87182a9d8de4d7fbe7b3181cb3305b0_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZmYwOWQ5MTRkNTdmNDMyYzgwOWVhMjI2NWJjNWNkZTZfOQ_aaac64f4-5b18-4591-bc62-0d7476e9f118">8.00</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzYtMy0xLTEtMTgxNzY5_4435949c-5990-4955-8607-b5ab400b3546">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzYtNS0xLTEtMTgxNzY5_81d9c01d-2943-4147-b110-72e14d070f65">&#8212;</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based and/or Market-Based Options </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the board of directors of the Company granted <ix:nonFraction unitRef="shares" contextRef="i4652006ba32649869cae91401685e771_D20180301-20180331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzgyOTE_50c8f264-e049-4408-b72b-4774f9f95959">1,792,000</ix:nonFraction> options to the Chief Executive Officer with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4652006ba32649869cae91401685e771_D20180301-20180331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzgzNTk_62130acd-36a3-4d36-80c7-6d530b55ad44">0.97</ix:nonFraction> per share under the 2010 Plan (the &#8220;2018 CEO Grant&#8221;) with a liquidity-event performance-based vesting condition based on the occurrence of a qualifying liquidity event, including an IPO, as well as stock price target after the consummation of the IPO. In September 2020, the 2018 CEO Grant was modified to extend the stock price target achievement cutoff date. The fair value of the 2018 CEO Grant was determined using a Monte Carlo simulation approach on the modification date. The achievement of the qualifying event was not considered to be probable prior to the Company&#8217;s IPO. Upon the Company's IPO, the liquidity-event performance-based condition was met. During the fiscal years ended March&#160;31, 2023 and 2022, $<ix:nonFraction unitRef="usd" contextRef="i974d976e0f864a8ea9541b7b73048e70_D20220401-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzkwNTc_9da5dd05-cb68-463f-bfc4-fab262d361de">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifa33e8ecd9a84ebfae3604c0b6afa814_D20210401-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjMzMA_2637e545-5690-425f-87b6-e5da3cc7a301">1.7</ix:nonFraction> million was recognized as stock-based compensation expense relating to the 2018 CEO Grant. As of March&#160;31, 2023, this option was fully vested.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had <ix:nonFraction unitRef="shares" contextRef="ia38954e2b9174a84b2206f208d8b037c_I20220331" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjE1OQ_6db040a7-1571-4790-9184-163ff343b3f8">480,000</ix:nonFraction> unvested options with performance-based and service-based vesting conditions. The performance conditions are satisfied upon meeting certain financial performance targets. During the fiscal year ended March&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjE4Ng_3bf57d88-7cb3-4521-bc4d-692dd4947c15">200,000</ix:nonFraction> options vested and <ix:nonFraction unitRef="shares" contextRef="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjE5Ng_d0b4711d-be58-4f29-b14c-6d6916326592">280,000</ix:nonFraction> options were forfeited. There were <ix:nonFraction unitRef="shares" contextRef="i9ada4a0cc2124109ba680255244c2035_I20230331" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjIwNQ_2c6f5fc0-ae2d-4608-b0a5-eeb51c3c258b">no</ix:nonFraction> unvested options remaining as of March&#160;31, 2023. The stock-based compensation expense related to these performance options was $<ix:nonFraction unitRef="usd" contextRef="ie09eece225b24d259739810162abac64_D20210401-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg4MzE2NQ_bc7e97a2-1b50-4c0b-abc8-847bbbf53a1d">1.7</ix:nonFraction> million for the fiscal year ended March&#160;31, 2022 and was <ix:nonFraction unitRef="usd" contextRef="i1e2a2f066c684b6dbfa470b1af8ddf0e_D20200401-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjIxOA_094533ba-753d-4110-93c3-50789e61109c"><ix:nonFraction unitRef="usd" contextRef="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjIxOA_5c04ed98-1d5d-4b4a-8020-db7c762319c2">immaterial</ix:nonFraction></ix:nonFraction> for the fiscal years ended March&#160;31, 2023 and 2021. There is <ix:nonFraction unitRef="usd" contextRef="i9ada4a0cc2124109ba680255244c2035_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjczMQ_4a5ca088-a603-482c-bce6-9d3e58fcecf7">no</ix:nonFraction> remaining unrecognized compensation expense as of March&#160;31, 2023. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i9b4bde8c3d2e400093d0556ec6efec6f" continuedAt="iae5d9884d1234feb9115dda7ba00c253"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units (&#8220;RSUs&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RSUs granted by the Company generally vest over <ix:nonNumeric contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgzODQxOA_a461eade-0e84-4764-bd06-453a44c54e49">four years</ix:nonNumeric> based on continued service.</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc3_861458d4-988d-41fe-9f30-3771eca90e11" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i999bcffa27f543c7af8d4b487ac793aa_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzEtMS0xLTEtMTgxNzY5_b07a5948-cb2b-4cc2-959c-bd2c305c7c84">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i999bcffa27f543c7af8d4b487ac793aa_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzEtMy0xLTEtMTgxNzY5_21b9a513-5151-433a-9ca9-718b584c4d99">68.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzItMS0xLTEtMTgxNzY5_afa10ce1-13cb-4043-9a19-da47d39ef0a5">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzItMy0xLTEtMTgxNzY5_11dde486-eb10-44c1-bc6a-8ad18b91f0e5">34.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzMtMS0xLTEtMTgxNzY5_32e19c68-3271-44bd-96b3-d385513b5290">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzMtMy0xLTEtMTgxNzY5_32a3a51f-0a9d-468f-8634-b8ad3e915284">51.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzQtMS0xLTEtMTgxNzY5_66c0b326-a903-44c4-a9af-17d92ef38f64">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzQtMy0xLTEtMTgxNzY5_b88fc543-92bf-4cb9-8890-15e3d9919463">44.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id3057033fffd40dbb4f5e5ee0064bd42_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzUtMS0xLTEtMTgxNzY5_8f27767a-b5a5-4134-8e75-5be6f6832f6c">1,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3057033fffd40dbb4f5e5ee0064bd42_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzUtMy0xLTEtMTgxNzY5_600e5ed8-8881-4545-8eb4-f877d746a609">40.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs vested during the fiscal years ended March&#160;31, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTI1_3a567e48-6907-4684-bc4a-f5a568054625">11.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i775865ed2f994ca4b21733ec560d2c8a_D20210401-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgzODQ1NQ_96de06b2-865b-40bf-8f8d-a687bed8b9d5">2.5</ix:nonFraction> million, respectively. No RSUs were granted before fiscal 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested RSUs was $<ix:nonFraction unitRef="usd" contextRef="id3057033fffd40dbb4f5e5ee0064bd42_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzExMDUy_bce5605a-6e66-43d4-ad22-cf55157f99ef">59.3</ix:nonFraction> million, and is expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzExMTM3_d39a7a9e-2666-464b-a765-e5682d9573f9">3.04</ix:nonNumeric> years. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units (&#8220;PSUs&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs have service-based and performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE3MDQyNDMwMjk5NzMz_3c450589-ff8f-4450-be64-88b589963721" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes PSU activity (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3b047f5f9ca746b7b52daa842f8517c4_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzEtMS0xLTEtMjAxMzEx_9de790a3-5e5f-4a9a-9025-02adef01f2f9">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b047f5f9ca746b7b52daa842f8517c4_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzEtMy0xLTEtMjAxMzEx_1d082e8d-84ae-4d10-a16f-7f4e29c41d26">80.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzItMS0xLTEtMjAxMzEx_f5332daa-d1ef-4764-b971-b4c3237060ae">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzItMy0xLTEtMjAxMzEx_3b1d666d-e682-4288-bdf8-f8ff7e43c0c4">34.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzMtMS0xLTEtMjAxMzEx_87a0ce47-cd2b-4bc1-8587-a0bed28eef8f">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzMtMy0xLTEtMjAxMzEx_45833060-84b4-4dcd-a56d-f1a8df7c0ead">80.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzQtMS0xLTEtMjAxMzEx_3560ea94-611e-4e9e-8170-c41dddb4d67d">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzQtMy0xLTEtMjAxMzEx_ede0ccc5-f9cb-41cd-8d08-f35a49a73b34">38.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i49f50d35db5d4553b776c905f48f0eb1_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzUtMS0xLTEtMjAxMzEx_4f8755a2-5c3b-40fc-9142-45888312424e">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i49f50d35db5d4553b776c905f48f0eb1_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzUtMy0xLTEtMjAxMzEx_32e9f850-d4af-49cc-96d5-1b6125a62546">34.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of PSUs vested during the fiscal year ended March&#160;31, 2023 $<ix:nonFraction unitRef="usd" contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg4MjgzMQ_06c5a8cc-52f6-45c2-8cea-79a9bed4786b">0.4</ix:nonFraction> million. <ix:nonFraction unitRef="shares" contextRef="i455bb77bdffd4042986f586a60bc3c32_D20210401-20220331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2OTcwNjM_7e4b280b-e0b4-4f09-9688-799843938ac8">No</ix:nonFraction> PSUs vested during the fiscal year ended March&#160;31, 2022 and no PSUs were granted before fiscal 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested PSUs that are probable of vesting was $<ix:nonFraction unitRef="usd" contextRef="i49f50d35db5d4553b776c905f48f0eb1_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg1MDQ2MA_20f528ed-2a0f-4a7b-a2f7-3fbdedaad424">3.0</ix:nonFraction> million, and is expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjI2Mw_12e03629-7e5a-42ca-be13-cd426ae5501e">0.76</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="iae5d9884d1234feb9115dda7ba00c253"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc0_138c219c-1667-433f-bd20-e7b3549d5283" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in&#160;thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i63c582bee6244ae9bf6eba0489faaa89_D20220401-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzItMS0xLTEtMTgxNzY5_e1d4e8de-9cf4-45b8-a1fe-396664b4040a">9,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic806ae5f2fb3486d8a36fbf8855115c8_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzItMy0xLTEtMTgxNzY5_596bbfa8-154a-412d-b94d-1f852466ec7f">4,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ef8644397db461d970fc87d9283f043_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzItNS0xLTEtMTgxNzY5_a52f94ae-de96-4fc4-b594-09567fbed704">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id81f09cb89e346d9b6bab4046c526ee3_D20220401-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzMtMS0xLTEtMTgxNzY5_deb3979c-9d1a-4534-8b0d-57ffb0b6a44b">12,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74e15aef3d274c7b9ac433e9e2fe446b_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzMtMy0xLTEtMTgxNzY5_85da68cd-14f4-4a8f-baf8-1975cd2bbd73">7,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb2ef783dd62482f9546438633e5ef6a_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzMtNS0xLTEtMTgxNzY5_20be871d-7dba-4c2a-9576-a0053870e419">1,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2705eaddbac94b21a48222ef233d1bae_D20220401-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzQtMS0xLTEtMTgxNzY5_4ce6d607-44d1-4e5f-a856-330d99bbafd8">16,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1643d43bb3664592a6b37cafbac8f20c_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzQtMy0xLTEtMTgxNzY5_e2cd6d3d-117c-4bee-8568-feff13eb1901">8,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7528701bd71f4ef1b51847193823879c_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzQtNS0xLTEtMTgxNzY5_b44d08e8-20b8-43c6-b7dc-01d2a6e3fc10">1,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaa288c7de6084883bc844573b299fa09_D20220401-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzUtMS0xLTEtMTgxNzY5_27e32fcc-e771-4569-b50b-3d6201099614">8,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8811c0f4a5d34a13b7ee23df9071c2f2_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzUtMy0xLTEtMTgxNzY5_72b77369-6009-41ec-a285-b7cc8a7d8f0c">11,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i28297a7cc3e04248b1ee658ba91be269_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzUtNS0xLTEtMTgxNzY5_415ea19f-94dd-4f3a-844d-7d73a2ca3429">2,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzYtMS0xLTEtMTgxNzY5_aa1bd0cc-8d16-43bd-b9c8-6bf5b9b4bbac">47,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzYtMy0xLTEtMTgxNzY5_aafac36e-50e8-4cc4-83d4-aba0dcb6b8b4">31,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzYtNS0xLTEtMTgxNzY5_62550e4f-e4d9-49cc-b545-80bbb7ddfefa">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ib1b51d92d3ac43179e2f8bdfac24a353_136"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90ZXh0cmVnaW9uOmE4OTM4ZjZjYTk2NDQyZThiN2E0YTNlMTNlODQ1OGI0XzQ1Ng_686cf917-6118-4554-bae0-a355909add2e" continuedAt="id0d72e8689f640f98e67080b3c2da684" escape="true">Net Income Per Share Attributable to Common Stockholders</ix:nonNumeric></span></div><ix:continuation id="id0d72e8689f640f98e67080b3c2da684"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90ZXh0cmVnaW9uOmE4OTM4ZjZjYTk2NDQyZThiN2E0YTNlMTNlODQ1OGI0XzQ1Nw_591fc06e-8e1b-4eb7-b57b-8260f7ecb941" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Numerator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzMtMS0xLTEtMTgxNzY5_82d4203e-836e-45c9-9305-e2f5b963c074">112,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzMtMy0xLTEtMTgxNzY5_e8257fc7-6896-498b-a361-bde552b720e5">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzMtNS0xLTEtMTgxNzY5_913eb524-b7ff-460a-b2b4-c9efad19d9c4">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMS0xLTEtMTgxNzY5_80e51203-0bae-452b-89fb-36124c5940f6"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMS0xLTEtMTgxNzY5_92a4ada9-7cb5-40ba-b5dd-9520d432ee62">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMy0xLTEtMTgxNzY5_8a438024-363b-4928-b810-14912007f968"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMy0xLTEtMTgxNzY5_b7dd40ca-bf45-4d8e-86af-e595f9dfbb73">21,526</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtNS0xLTEtMTgxNzY5_0a02b962-2378-4e08-9d1a-e2c8baa42234"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtNS0xLTEtMTgxNzY5_ab7a355a-fe63-47be-946d-a133955abfd8">28,654</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMS0xLTEtMTgxNzY5_b3ce84f8-883c-4f0d-af0c-5a261d041f4f"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMS0xLTEtMTgxNzY5_ffec26d0-e52e-4f47-a539-3968971940d6">112,818</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMy0xLTEtMTgxNzY5_5ac55c1d-1c16-4b6a-8ff0-b812f7c0d5e5"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMy0xLTEtMTgxNzY5_b0570a3b-a8c4-47da-b012-bee678695b83">133,257</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtNS0xLTEtMTgxNzY5_4d6fa71f-be8f-4792-8fb8-bddbe93ee26f"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtNS0xLTEtMTgxNzY5_b60fbf32-bc47-496d-825c-c2b74327d6ca">21,556</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Denominator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzctMS0xLTEtMTgxNzY5_ec73a09a-00c3-40e4-88af-97dc3fdcfe0b">193,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzctMy0xLTEtMTgxNzY5_ee558472-13f4-44a9-82b4-e7440e946905">163,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzctNS0xLTEtMTgxNzY5_92e4e3af-30ea-45be-b087-1aba1feb5906">74,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ida806691cbf34206b1424fc5e64367de_D20220401-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzgtMS0xLTEtMTgxNzY5_2159ad76-53e3-4d6a-896c-5ea82781c2b2">20,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzgtMy0xLTEtMTgxNzY5_15b22ee2-1191-41f9-934b-4f1a409b21de">27,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzgtNS0xLTEtMTgxNzY5_7740a41e-adc6-495e-95a2-15bbf0ea17ba">20,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEwLTEtMS0xLTE4MTc2OQ_1a3d4cbf-ee00-4dc8-80ce-bcebbb93c515">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEwLTMtMS0xLTE4MTc2OQ_d9badefc-7106-412b-acb9-88a4e6f56e00">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEwLTUtMS0xLTE4MTc2OQ_13135670-2ebe-4e8d-b5d9-8e04d1b4664e">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i01d3afc740f4462684bea44adc594e9c_D20220401-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzExLTEtMS0xLTE4MTc2OQ_28330cad-a0dd-4e9c-8798-375717e03acc">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9f982a6f25a441579e268bbeafa0e133_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzExLTMtMS0xLTE4MTc2OQ_e850a945-5285-494e-b6e1-258fd763882f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic706608c6ad1415d94545d91154d4ff2_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzExLTUtMS0xLTE4MTc2OQ_f137846a-0325-4472-bcbc-181603dfe484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEyLTEtMS0xLTE4MTc2OQ_840d83b8-ef91-4610-93f8-fc4a2a495aef">213,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEyLTMtMS0xLTE4MTc2OQ_f43effd4-b473-4996-99fa-47961d84f626">191,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEyLTUtMS0xLTE4MTc2OQ_2b227f7b-a2ad-4c7a-908d-ed783a396d16">95,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEzLTEtMS0xLTE4MTc2OQ_61620a1d-d637-492d-87a0-a7141b359125">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEzLTMtMS0xLTE4MTc2OQ_90438e02-d316-4d04-8b29-4420425fc2ec">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEzLTUtMS0xLTE4MTc2OQ_54c53143-1db9-415a-8a90-67c50ae993ea">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzE0LTEtMS0xLTE4MTc2OQ_5e1d9d77-577f-41d5-9ae5-a21dcc83d84e">0.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzE0LTMtMS0xLTE4MTc2OQ_6718982c-500b-4a15-87de-f8040bb88d56">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzE0LTUtMS0xLTE4MTc2OQ_4dab04d0-d528-429d-a54e-78cdec709fc5">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90ZXh0cmVnaW9uOmE4OTM4ZjZjYTk2NDQyZThiN2E0YTNlMTNlODQ1OGI0XzQ1OA_e3c0be24-711f-4351-befb-14cf16da9749" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia75bd356b16a493fbe592c7374ec7564_D20220401-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzItMS0xLTEtMTgxNzY5_dedbecab-5e0b-44d3-b529-40147ba48a9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2251c5f98a1541d58cc80a3e18e94e7c_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzItMy0xLTEtMTgxNzY5_2bd3cf5c-7ba7-4da9-9211-163f8d496798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie28e082f86864f4680a3d75aa82cec9b_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzItNS0xLTEtMTgxNzY5_e4522ae6-76cd-4e9e-87f4-5b7e22e98f9a">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i03a2e271385b4f50b853a1db39b70580_D20220401-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzUtMS0xLTEtMTgxNzY5_15ff4573-9fe5-49f1-8dd3-5ef1d2b4b765">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i20ee62022dbc4678aa4e1eda92d558d6_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzUtMy0xLTEtMTgxNzY5_4fb7b400-bdc3-4fe0-8827-6df54c77074d">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i68d0cfc8bce14eb0bbdb2d1d8791664f_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzUtNS0xLTEtMTgxNzY5_a18204a1-fa30-48b3-ba76-0adc264f23f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i76d02cec04034dcebafb0e2d3f74bd25_D20220401-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzYtMS0xLTEtMTgxNzY5_10a04a05-aefb-4c7f-835a-04349afa2d8a">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7d9e728004f0418fb411e0ffbf42921b_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzYtMy0xLTEtMTgxNzY5_42ddd7dd-fed2-4474-a7e5-b924b9fc750b">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i17ea570245b84a03b7cfc4320cff3431_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzYtNS0xLTEtMTgxNzY5_4c8c7445-2bc1-4594-9ea6-280db5dc4ddb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzctMS0xLTEtMTgxNzY5_a7c32fe2-3f47-4c2a-b780-8277e474aea8">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzctMy0xLTEtMTgxNzY5_24941fd2-61a9-4cf3-a9c0-09e64173b0bb">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzctNS0xLTEtMTgxNzY5_1e2b00dc-38e9-4279-baa0-b69ed979d905">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_139"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:-5.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODk_58941de5-5589-4fe5-9670-4a053f806829" continuedAt="if1e113ac46e64f08ad33bcd503de0f14" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="if1e113ac46e64f08ad33bcd503de0f14" continuedAt="i411dbe4128c249148232262afc85e861"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s income before income taxes was generated in the United States for the fiscal year ended March 31, 2023, 2022, and 2021. </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODg_17f00e17-2f39-4489-b7fa-a8c0d4ece478" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for (benefit from) income taxes consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzMtMS0xLTEtMTgxNzY5_9120ec20-9dba-47d5-bcaf-9d06b450e2a8">3,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzMtMy0xLTEtMTgxNzY5_d530afc3-a337-4e70-b537-1a2bcac14286">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzMtNS0xLTEtMTgxNzY5_ead033e1-f96d-4a6d-a5a6-80f4c0215674">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzQtMS0xLTEtMTgxNzY5_8598d93d-d6c2-4c0f-b107-feaf3b27a940">3,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzQtMy0xLTEtMTgxNzY5_9039c910-ab86-40ed-a912-dd566206cd21">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzQtNS0xLTEtMTgxNzY5_0f2352c0-3e63-469b-92d2-4776744b600a">1,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzUtMS0xLTEtMTgxNzY5_275a5ad7-5753-433c-ba34-2e61bc67c509">7,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzUtMy0xLTEtMTgxNzY5_fda8cd17-cbcc-45b6-91a7-e12f0558a013">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzUtNS0xLTEtMTgxNzY5_03832ef5-53fc-467f-873b-0750f28ecb11">2,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzctMS0xLTEtMTgxNzY5_fc3b273d-4a6b-466a-8203-6eb11088b14b">11,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzctMy0xLTEtMTgxNzY5_8688549f-62be-4a1a-b00e-855cf6197ad6">34,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzctNS0xLTEtMTgxNzY5_b2a80c8d-93ae-4965-af4a-458d94fde261">4,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzgtMS0xLTEtMTgxNzY5_d272ea6e-1e8f-4498-bf9b-38a52e017271">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzgtMy0xLTEtMTgxNzY5_e7577c78-a219-4236-9eb1-bb3c0c7593d2">6,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzgtNS0xLTEtMTgxNzY5_4b6b9599-47df-42b0-925e-ceb44f8c5e27">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzktMS0xLTEtMTgxNzY5_d3a832f5-b86a-4c27-b22a-5dc308797aed">13,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzktMy0xLTEtMTgxNzY5_f78d216a-d33f-47e5-b0bb-3341069d0d8f">41,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzktNS0xLTEtMTgxNzY5_32ae4164-5e3f-435b-b920-87d2b660022e">4,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzEwLTEtMS0xLTE4MTc2OQ_c3b001a2-f23b-4909-a78e-087735c3f13c">20,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzEwLTMtMS0xLTE4MTc2OQ_6991e4ce-c94e-4cf6-9f1b-704c7a30449f">40,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzEwLTUtMS0xLTE4MTc2OQ_f38571e5-669c-47e7-a13e-87dae54cb029">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODU_4c7b043b-b1ec-441c-b774-139f27aad220" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s provision for (benefit from) income taxes (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes at statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzItMS0xLTEtMTgxNzY5_e679044d-d051-4480-93f4-c0aef99aa921">27,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzItMy0xLTEtMTgxNzY5_49c24781-3719-420b-8dd2-d05a4f1bfdb5">23,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzItNS0xLTEtMTgxNzY5_7b9f2e1a-6ec5-4a71-a446-d5ad962c5f2a">12,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzMtMS0xLTEtMTgxNzY5_01c4014b-a04a-4751-80eb-f580ba710896">6,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzMtMy0xLTEtMTgxNzY5_ba12b397-bd81-489f-af7b-527fcfd05b72">5,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzMtNS0xLTEtMTgxNzY5_9c79f5b8-7d2d-4c2a-9549-ddbc5fc81e22">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzQtMS0xLTEtMTgxNzY5_6cf21d76-192e-441c-92b8-f51c887d003e">5,076</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzQtMy0xLTEtMTgxNzY5_736386ba-f999-4630-9e10-441858333fee">8,332</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzQtNS0xLTEtMTgxNzY5_da1f6f62-ab9d-4f80-b437-4dc2c28970b6">1,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzUtMS0xLTEtMTgxNzY5_6ebd1b0a-8696-489c-88b7-3ed8c8ba3b02">14,841</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzUtMy0xLTEtMTgxNzY5_49ca38a2-8739-4efe-ab09-b45074b4b6ab">71,780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzUtNS0xLTEtMTgxNzY5_a4dd26d5-2cdb-4bfd-bcdf-56550ff3ea32">5,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzYtMS0xLTEtMTgxNzY5_926fd6cb-d86f-427b-8986-a3c3a4436dbd">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzYtMy0xLTEtMTgxNzY5_02f951db-1273-44aa-92de-5e499ea4b407">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzYtNS0xLTEtMTgxNzY5_0a2259e3-1277-4604-aeb2-ee6c2d15bb0d">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzctMS0xLTEtMTgxNzY5_aedf0099-e16e-4b59-80d7-bb4adf9990b9">4,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzctMy0xLTEtMTgxNzY5_b06d4b51-348f-462b-82b3-727b1e79f33b">7,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzctNS0xLTEtMTgxNzY5_80c39c5d-5eac-44c1-a5d7-0bf8689220bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzgtMS0xLTEtMTgxNzY5_bdf832ca-acec-4aa6-b188-d962f3ccd81c">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzgtMy0xLTEtMTgxNzY5_e2f25e1f-8675-47f0-b1a6-64d44dda88e3">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzgtNS0xLTEtMTgxNzY5_eda2c2d8-0f87-46af-b581-00da1c8949c6">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzktMS0xLTEtMTgxNzY5_89d68d36-b22a-4625-bd51-ec7f90d3fcfe">20,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzktMy0xLTEtMTgxNzY5_2a957e8c-9e01-4187-bac5-972711977db0">40,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzktNS0xLTEtMTgxNzY5_b9306eeb-11bd-4ac8-a42c-702e381ee13f">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i411dbe4128c249148232262afc85e861" continuedAt="ifd0aed1cc03c492daca6b91b325dc5c5"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODY_bbfd55a8-9d6c-46ea-8b8e-099584e0c001" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities were as follows (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accruals and deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzMtMS0xLTEtMTgxNzY5_4240c572-ea9a-403c-96a6-31d3591f6f02">2,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzMtMy0xLTEtMTgxNzY5_4e562d23-3b87-4827-9036-edfd198e086a">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzQtMS0xLTEtMTgxNzY5_96cf8d95-7911-4195-a4a9-a653968e3b10">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzQtMy0xLTEtMTgxNzY5_79267418-8890-43d2-b20e-205f031fa2ed">32,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research &amp; development credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzUtMS0xLTEtMTgxNzY5_31f3e478-b9b2-4bb9-98f9-7a86ae837352">7,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzUtMy0xLTEtMTgxNzY5_e003d54b-d19e-47ee-8e3f-98164fe0624b">12,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzYtMS0xLTEtMTgxNzY5_0ae1a505-ec46-420b-8f82-2a39140757b7">3,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="docs:DeferredTaxAssetsLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzYtMy0xLTEtMTgxNzY5_195b51d2-b6eb-484d-bdef-bd046efc2ad5">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzctMS0xLTEtMTgxNzY5_024f6998-a52b-4c34-8cf5-589c1405166b">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzctMy0xLTEtMTgxNzY5_4a1ec83c-e671-442a-9332-dd46e68f90d7">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzgtMS0xLTEtMTgxNzY5_8d116200-c79c-4a0c-b3c0-f2ad91ea2c42">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzgtMy0xLTEtMTgxNzY5_f0a09e42-9c16-404d-90d7-7c44117f2d38">3,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzktMS0xLTEtMTgxNzY5_f95c0915-b3a7-4364-916c-6ffde504c965">4,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzktMy0xLTEtMTgxNzY5_90479674-a19c-4281-8e19-135ded7e8295">5,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Capitalized research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="docs:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTEtMS0xLTIxNTg0Ng_ef23ae0c-9fc3-48a7-9c57-a4464355e73c">19,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="docs:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTMtMS0xLTIxNTg0Ng_2ae27e30-7b5f-4be3-8519-08ab529d6dbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTEtMS0xLTE4MTc2OQ_af2640e4-016b-421a-a345-9c0acd5969ed">47,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTMtMS0xLTE4MTc2OQ_3ea65120-8d50-4def-a8fd-ed9aeed97923">55,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzExLTEtMS0xLTE4MTc2OQ_502aa125-c759-4735-b4d1-9e5068d2b9d7">5,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzExLTMtMS0xLTE4MTc2OQ_afc32f80-0fe9-4dc3-973e-ea5baa6342ee">4,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEyLTEtMS0xLTE4MTc2OQ_4822554b-339e-4988-bf98-b4134362db3c">41,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEyLTMtMS0xLTE4MTc2OQ_7f147a32-e729-40c0-a052-062038439e11">51,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE0LTEtMS0xLTE4MTc2OQ_51073d74-9a17-4c94-8213-bb11d985c301">2,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE0LTMtMS0xLTE4MTc2OQ_acfffaa7-ae9e-4f89-a2bc-b416ccf7d0cc">1,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE1LTEtMS0xLTE4MTc2OQ_c65054b8-814b-48b5-a432-c181bc47bbfd">3,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE1LTMtMS0xLTE4MTc2OQ_20d66787-9ca9-4e00-ad25-82d8378f46d4">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE2LTEtMS0xLTE4MTc2OQ_4e5b41ff-36d5-4958-a4a1-f934b293bdc1">692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE2LTMtMS0xLTE4MTc2OQ_70863aff-f092-44cb-bddf-6ebf49590607">398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE3LTEtMS0xLTE4MTc2OQ_7dbc8256-cce7-4db1-8125-8224a2bc9915">6,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE3LTMtMS0xLTE4MTc2OQ_013fa4cb-6543-4fb5-9d62-46ab347565c3">2,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE4LTEtMS0xLTE4MTc2OQ_ac689b6d-78a2-42c9-89d2-b75cdd036427">34,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE4LTMtMS0xLTE4MTc2OQ_6b5cb945-7a29-4ccf-aa05-215a6b529f0c">48,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which include California research and development credits, California alternative minimum tax credits, and capital loss carryforwards. The Company concluded, based upon the preponderance of positive evidence (i.e., a strong earnings history exclusive of the loss that created the future deductible amount, a history of taxable income in recent periods, the taxable loss is a result of excess tax benefit on stock exercises as a result of a non-recurring event (IPO), and the current forecast of income before taxes for the United States going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets could be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance was $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzE3MDc_0000c060-5a83-4d7b-85d2-a6871fa8ca1b">5.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzE3MTQ_d793e062-6b08-4f10-8885-a7bac8bb43f3">4.7</ix:nonFraction> million as of March&#160;31, 2023 and 2022, respectively, relating to the California research and development tax credits, California alternative minimum tax credits, and capital loss carryforwards. The valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzE4ODE_627d56f0-9cb0-4cc3-9886-cdc6ca3a85aa">0.5</ix:nonFraction> million during the fiscal year ended March&#160;31, 2023 primarily due to capital loss carryforwards. The valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzU0OTc1NTgyODkzNw_6ffca0bd-f754-4777-bc22-42f514fac1d9">1.8</ix:nonFraction> million during the fiscal year ended March&#160;31, 2022 primarily due to the increase in California research and development credits generated during the year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had net operating loss, or NOL, carryforwards for state tax purposes of $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzIyMTA_13cebefa-322f-41dc-82ac-0919a1f17f72">15.3</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="0" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzIyMTc_55e9a969-679a-4656-b427-0470177a6be2">no</ix:nonFraction> NOL carryforwards for federal tax purposes. Portions of the NOL carryforwards will expire at various dates beginning in the tax year ending March&#160;31, 2035. As of March&#160;31, 2023, the Company had research and development tax credit carryforwards for federal and state tax purposes of $<ix:nonFraction unitRef="usd" contextRef="i76934d327b4e4c10a7eaeee01e5c0d44_I20230331" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzI1MzM_ef243bb4-d7b6-45b3-b4e0-e1f618b7c187">7.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idbca9608b0944cceac22ef5ca0e4cb5a_I20230331" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzI1NDA_cc52520a-3bec-4170-9b54-71a35f63e8c3">9.0</ix:nonFraction> million, respectively. The federal research and development tax credit carryforwards will expire beginning in the year ending March&#160;31, 2042. The California state research and development tax credit carryforwards do not expire. The other state research and development tax credit carryforwards will expire at various dates beginning in the year ending March&#160;31, 2032. Based on an assessment of the Company&#8217;s historical ownership changes through March&#160;31, 2023, the Company does not anticipate a current limitation on the tax attributes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and 2022, the Company had unrecognized tax benefits, or UTBs, of $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzMwNDM_14b11123-a3d2-47b8-8fce-d2930c16a9fb">7.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzMwNTA_f4f7a260-951b-473d-a09f-4a0b6f364f02">6.2</ix:nonFraction> million, respectively. If realized, $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzMwODE_b91ebb49-ec54-45d4-92b8-a7349ff9f49a">5.9</ix:nonFraction> million would impact the effective tax rate while the remainder would reduce deferred tax assets subject to a full valuation allowance. The Company does not expect any material changes to its UTBs within the next 12 months.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ifd0aed1cc03c492daca6b91b325dc5c5"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2OTA_89124b72-1df7-411a-9fbf-b69477d058d4" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzItMS0xLTEtMTgxNzY5_c23bbfaa-db34-4d77-a1e5-e7e018139da6">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzItMy0xLTEtMTgxNzY5_472c59cd-a554-43c7-9f1f-5cfefc1f919a">3,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzItNS0xLTEtMTgxNzY5_2ac82521-f1c9-4077-b6b7-edb87f373225">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzMtMS0xLTEtMTgxNzY5_4ca5a788-2662-407e-983f-29457d38cbc2">2,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzMtMy0xLTEtMTgxNzY5_9c45f7f3-bb91-44d6-b388-5a30e940b05d">2,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzMtNS0xLTEtMTgxNzY5_59fdfb90-09a2-48b0-b462-81948ad6d331">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzQtMS0xLTEtMTgxNzY5_0ab2738b-2494-4bee-a1bb-4ce97ee59e7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzQtMy0xLTEtMTgxNzY5_e228b9b7-b3ec-40f7-8c39-c09bf77bcfc6">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzQtNS0xLTEtMTgxNzY5_6d0a6084-6b13-48b8-848e-49044ea78cce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzUtMS0xLTEtMTgxNzY5_68367bcf-f32a-45e5-9370-175a4b8cfbaf">472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzUtMy0xLTEtMTgxNzY5_e55879c8-f7d6-4567-a3f8-667d5ca0a3e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzUtNS0xLTEtMTgxNzY5_0dde245f-98a2-4432-9a14-b37b11c26e29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions related to a lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzYtMS0xLTEtMTgxNzY5_394f4040-c774-4152-ab7d-4a08bc80e608">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzYtMy0xLTEtMTgxNzY5_8bc2afd9-d1ce-4c40-87a1-a30e2e355e19">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzYtNS0xLTEtMTgxNzY5_3d832438-678a-4409-abb8-71443d07e0c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzctMS0xLTEtMTgxNzY5_c1a96cc9-b92b-4ac9-b446-e7f77c6f704e">7,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzctMy0xLTEtMTgxNzY5_39a40b1d-6b57-476e-8926-0df1b74e85fa">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzctNS0xLTEtMTgxNzY5_d75613c9-2c19-4418-b65e-7fb0741a452e">3,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties were not material during the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state jurisdictions. With limited exceptions, all tax years for which the Company has filed a tax return remain subject to examination.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_142"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM4NDg_f193ed4e-fdf3-4314-873c-6190e303f322" continuedAt="i0bcd2cb32f7e41f5886b0ec66724bdaf" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i0bcd2cb32f7e41f5886b0ec66724bdaf"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum Guarantees</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News for <ix:nonNumeric contextRef="i906daea421694946be847efacad3faf2_D20211008-20211008" name="docs:PartnershipAgreementExtensionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzY5MA_01b9a164-7ae6-45f7-b5f3-310a57c130c6">six years</ix:nonNumeric>. This agreement can be terminated after <ix:nonNumeric contextRef="i906daea421694946be847efacad3faf2_D20211008-20211008" name="docs:PartnershipsAgreementPeriodBeforeTerminationIsPermitted" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzczMw_9d5645d4-7467-472b-8ca6-80b1678fd4c8">three years</ix:nonNumeric> by either party. Under this amended agreement, the Company pays the U.S. News a portion of the revenue generated with the end customers, subject to annual minimum guarantees. As of March 31, 2023, the remaining annual minimum guarantees ranged from $<ix:nonFraction unitRef="usd" contextRef="ic9b04179a332405c949f34abf3c2def8_D20220401-20230331" decimals="-5" name="docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzE2NDkyNjc0NTg4Njk_e0d4dfc1-d37d-4df8-92d6-2f7051bc8f69">3.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ic9d45f1ab6dd4164bda35547de20a2ec_D20220401-20230331" decimals="-5" name="docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNjAyMQ_705519ff-a19c-4d2a-8136-4ae68a496cf5">6.2</ix:nonFraction> million, and the total minimum guarantee for the remaining noncancelable periods was $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzE2NDkyNjc0NTg4ODc_e68bebd5-ad8b-4b9f-89db-47a8712f691a">6.6</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ic9b04179a332405c949f34abf3c2def8_D20220401-20230331" decimals="-5" name="docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzE2NDkyNjc0NTg4NjM_12fbdb24-7a1b-485f-9b2b-0b8bfa1ef9ba">3.0</ix:nonFraction> million is expected to be paid within <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNjA5Ng_1982f9be-268a-4498-ac23-e0b20be3256b">1</ix:nonNumeric> year. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Commitments </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a web hosting arrangement for <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="docs:HostingArrangementPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNDA4Mw_26c683f4-fb2c-4821-8ed1-715514390575">3</ix:nonNumeric> years ending December&#160;31, 2024, with an annual commitment of $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="docs:HostingArrangementAnnualCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNDEyMw_b2f41dbf-fb9c-4fc0-afd7-4621c9f082da">5.2</ix:nonFraction> million. As of March&#160;31, 2023, the total remaining commitment was $<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNDE2NQ_5d451e35-3cbd-4930-8b2f-7cf328c8c770">5.2</ix:nonFraction> million. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company&#8217;s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company&#8217;s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no material claims under these indemnification provisions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material effect on its results of operations, financial position, or cash flows. <ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="INF" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM3Njk_8ab4038a-3609-4f87-8e69-fff15ce31c62"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="INF" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM3Njk_998965a2-6bc4-4b5a-bfcf-f157b46f7458"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="INF" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM3Njk_b68f5250-49a8-4613-9935-b9addb69e292">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> loss contingencies were recorded for the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_145"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzUwMQ_15cfbfe2-a032-4916-b7ea-ee816ea9e116" continuedAt="iaff66a9dcd08441aa2e2d5998908b851" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="iaff66a9dcd08441aa2e2d5998908b851"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has non-cancelable operating leases for the rental of office space with various expiration dates through 2030. During the fiscal year ended March 31, 2023, the office space lease in Irving, Texas with an approximately <ix:nonNumeric contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzU0OTc1NTgxNDg3OA_619b58af-a61b-4769-a073-b4c7b8247af9">8</ix:nonNumeric>-year term commenced and a related right-of-use asset and lease liability of $<ix:nonFraction unitRef="usd" contextRef="i40c5d3ad3fc5494998c4463ceb353d93_I20230331" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzU0OTc1NTgxNTI2OA_749c006c-df7e-4533-a771-4b90e01d9d64"><ix:nonFraction unitRef="usd" contextRef="i40c5d3ad3fc5494998c4463ceb353d93_I20230331" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzU0OTc1NTgxNTI2OA_e4a338a1-6ced-43c7-a45d-761b639c89b2">14.8</ix:nonFraction></ix:nonFraction> million was recognized. </span></div><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzQ5OA_59770b2d-1919-4943-92f9-c734338259e3" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzItMS0xLTEtMTgxNzY5_458b19e2-9bf1-4f75-9a81-32187019a5f7">2,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzItMy0xLTEtMTgxNzY5_1ef23b2b-c593-48aa-b2c7-2e1c6d451782">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzItNS0xLTEtMTgxNzY5_4b7d3204-bc6e-41bb-9eee-2ca728066c33">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzMtMS0xLTEtMTgxNzY5_60d77c73-627b-452b-81cf-7be8f75822d1">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzMtMy0xLTEtMTgxNzY5_8bb59f07-db9d-4311-88d0-56846574f193">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzMtNS0xLTEtMTgxNzY5_f5b150a1-1abd-4e49-a669-ce3addc60c87">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzQtMS0xLTEtMTgxNzY5_f2d42105-9763-442c-b69d-8c630ee0e9c2">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzQtMy0xLTEtMTgxNzY5_86fec0fc-a1b0-49f1-a6f4-3137c49b99bf">1,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzQtNS0xLTEtMTgxNzY5_e039f5da-f80e-4fb0-9dd2-d84b2fbb0906">2,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTplZTgzNjBjMjkyNjY0NDk2OGQ5MTk4OWRkZjJlNGYzNy90YWJsZXJhbmdlOmVlODM2MGMyOTI2NjQ0OTY4ZDkxOTg5ZGRmMmU0ZjM3XzItMS0xLTEtMTgxNzY5_0e655d9f-4107-47c7-84ba-1e68c3393467">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTplZTgzNjBjMjkyNjY0NDk2OGQ5MTk4OWRkZjJlNGYzNy90YWJsZXJhbmdlOmVlODM2MGMyOTI2NjQ0OTY4ZDkxOTg5ZGRmMmU0ZjM3XzItMy0xLTEtMTgxNzY5_f40c0987-fe44-4b1a-96d2-e46fff89ad8c">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTplZTgzNjBjMjkyNjY0NDk2OGQ5MTk4OWRkZjJlNGYzNy90YWJsZXJhbmdlOmVlODM2MGMyOTI2NjQ0OTY4ZDkxOTg5ZGRmMmU0ZjM3XzItNS0xLTEtMTgxNzY5_6b4383d5-dcd9-4b0e-86d1-ca76fc1efd30">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzItMS0xLTEtMTgxNzY5_6746c32b-bb2f-4962-9d76-21298e9fd523">7.06</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzItMy0xLTEtMTgxNzY5_e75aa950-0f2e-46fc-89a4-d88ae6efd460">1.64</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzItNS0xLTEtMTgxNzY5_b344e25f-8a0c-448a-a5cb-aaf16edee654">1.37</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzMtMS0xLTEtMTgxNzY5_9d920ee1-848b-4927-a31e-b7e973cd6186">4.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i2663b241eb57491e938b976279a54ef3_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzMtMy0xLTEtMTgxNzY5_0fab0fd0-83de-4997-959c-16cc85f7cb89">3.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzMtNS0xLTEtMTgxNzY5_eca04cf9-2236-48b1-89d7-feccb74ac4df">3.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzUwMA_fce82d3b-8e23-4022-b7de-e2e0be9018bb" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzEtMS0xLTEtMTgxNzY5_73742150-8172-428a-9676-0d3c431bb24e">2,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzItMS0xLTEtMTgxNzY5_e33b3ce1-713a-4991-a068-7b613afa9715">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzMtMS0xLTEtMTgxNzY5_adb61d6a-2c22-4a2e-9233-5d801fb3aa8e">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzQtMS0xLTEtMTk3MjQx_313d750f-33c0-4f33-a18c-ad1c5f7357a7">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzUtMS0xLTEtMTk3MjQx_3b272ddb-c46c-42bc-9079-ea296de5cfe3">2,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzYtMS0xLTEtMTk3MjQx_60dcb94f-f5bf-4528-a4ef-3d2ff168a4d2">6,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzQtMS0xLTEtMTgxNzY5_3805b16d-28fc-4c3d-b265-861ca2989bc8">18,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzUtMS0xLTEtMTgxNzY5_31b61f1c-9d35-40dd-b514-655f19dc00d8">2,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73fa6205d93043c89ed98735725c4862_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzYtMS0xLTEtMTgxNzY5_56506d3f-683c-4aa2-bd91-998856ded0d3">15,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ib1b51d92d3ac43179e2f8bdfac24a353_549755814858"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90ZXh0cmVnaW9uOmIzNGM0NDM4ODgyNzRlNmE5ZTQyOTJkYTY4YjY0ZDVjXzE3MDQyNDMwMjMwODUz_5d8e0fb4-c39b-4ebb-84c8-06917f03b3da" continuedAt="i4e110cccd93c43c5b7b28607f526ffc9" escape="true">Other Income, net</ix:nonNumeric></span></div><ix:continuation id="i4e110cccd93c43c5b7b28607f526ffc9"><ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90ZXh0cmVnaW9uOmIzNGM0NDM4ODgyNzRlNmE5ZTQyOTJkYTY4YjY0ZDVjXzI0MTg5MjU1ODExNDI5_f5589fe9-867d-427d-a192-ff0cfd2cea60" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzItMS0xLTEtMjIyNDM5_6131ae5f-d93c-462a-aeee-9b981eae2aa0">9,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzItMy0xLTEtMjIyNDM5_a42eba63-16e3-4dd7-8b34-1c6e3317cd22">2,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzItNS0xLTEtMjIyNjA5_1ba0e892-d4ad-4ae7-ae3c-144f80e8596c">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Realized loss on sale of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzMtMS0xLTEtMjIyNDM5_18f5a886-5544-49d5-8927-7f1a0cfdb4cb">1,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzMtMy0xLTEtMjIyNDM5_cb1d325e-eec6-406c-b02d-02e44ca9b525">1,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzMtNS0xLTEtMjIyNjA5_8699844b-2ec2-47a5-afaf-e81ef2d96653">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Realized gain on sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMS0xLTEtMjI2MjYw_7a0dafa9-4014-43f0-8c26-da04f7f0a567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMy0xLTEtMjI2MjYw_ea49fe20-0780-4871-ab70-67688340592a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtNS0xLTEtMjI2MjYw_6c3252cb-91c0-478a-bd34-511480aaa5b5">4,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMS0xLTEtMjIyNDM5_78bb92a3-a6de-4f60-a4ff-3d459e93fc8b">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMy0xLTEtMjIyNDM5_6d21e4d6-3c17-473e-9ab8-506726a95b85">448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtNS0xLTEtMjIyNjA5_89a6f4ca-2b22-404d-8a83-a0f6111b38df">533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzUtMS0xLTEtMjIyNDM5_fab23384-ac8e-425f-9279-f4dc654d29f0">8,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzUtMy0xLTEtMjIyNDM5_412b753c-8ee3-469c-aace-af4af88332f8">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzUtNS0xLTEtMjIyNjA5_21509117-dff0-4661-b418-c6b9bc4d4215">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;<ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzYxNA_1574103d-84eb-4a69-b0d9-9d9d10e7c0a7" continuedAt="ic3859942108e45738ca2157063bd6c1e" escape="true">Employee Benefit Plan</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3859942108e45738ca2157063bd6c1e">The Company sponsors a 401(k)&#160;savings plan. All U.S. employees are eligible to participate in the 401(k)&#160;plan after meeting certain eligibility requirements. Participants may elect to have a portion of their salary deferred and contributed to the 401(k)&#160;plan up to the limit allowed by applicable income tax regulations. The Company matched a portion of employee contributions to the 401(k) plan totaling $<ix:nonFraction unitRef="usd" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzQzNw_80801b12-926a-411a-801e-1dc44e5c3977">2.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzQ0MQ_ede52ec9-6f25-48ca-b377-6191d3ebfd73">2.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzQ0OQ_592653a2-573d-478e-9e95-4193ca7a9586">1.3</ix:nonFraction> million for the fiscal years ended March&#160;31, 2023, 2022 and 2021, respectively. Both employee contributions and the Company&#8217;s matching contributions are fully vested upon contribution.</ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_151"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNTEvZnJhZzo4NTJmNDIwMGFlZGI0OTE1YjdjNzAyMjdiYzA0YWJkNS90ZXh0cmVnaW9uOjg1MmY0MjAwYWVkYjQ5MTViN2M3MDIyN2JjMDRhYmQ1XzEwMTc_b341100b-0952-42f8-a9ad-9718959fa3dd" continuedAt="ie204d5b400a84114ba901b4a234edac5" escape="true">Segment and Geographic Information</ix:nonNumeric></span></div><ix:continuation id="ie204d5b400a84114ba901b4a234edac5"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company&#8217;s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company&#8217;s performance. As such, the Company has determined that it has <ix:nonFraction unitRef="segment" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNTEvZnJhZzo4NTJmNDIwMGFlZGI0OTE1YjdjNzAyMjdiYzA0YWJkNS90ZXh0cmVnaW9uOjg1MmY0MjAwYWVkYjQ5MTViN2M3MDIyN2JjMDRhYmQ1XzYyOQ_44b93239-f235-4476-8d3e-a2731d338a29"><ix:nonFraction unitRef="segment" contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNTEvZnJhZzo4NTJmNDIwMGFlZGI0OTE1YjdjNzAyMjdiYzA0YWJkNS90ZXh0cmVnaW9uOjg1MmY0MjAwYWVkYjQ5MTViN2M3MDIyN2JjMDRhYmQ1XzYyOQ_96e43419-8c74-4ef2-ab9c-1735d71657a9">one</ix:nonFraction></ix:nonFraction> operating and reportable segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s long-lived assets were based in the United States as of March&#160;31, 2023 and 2022. No country outside of the United States accounted for more than 10% of total revenue for the fiscal years ended March&#160;31, 2023, 2022, and 2021. Substantially all of the Company&#8217;s revenue was derived in the United States for the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">Table of Cont</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">e</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">nts</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_160"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Annual Report on Form 10-K. In designing and evaluating our disclosure controls and procedures, our management recognizes that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance that the objectives of the disclosure controls and procedures are met. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act). Our management conducted an assessment of the effectiveness of the Company&#8217;s internal control over financial reporting as of March&#160;31, 2023 based on the criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the assessment, management has concluded that our internal control over financial reporting was effective as of March&#160;31, 2023. The effectiveness of our internal control over financial reporting as of March&#160;31, 2023 has been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report, which is included in Item 8 of this Annual Report on Form 10-K. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_163"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will hold its Annual Meeting of Stockholders for fiscal year 2023 on July 26, 2023 at 9 a.m. Pacific Time. The Annual Meeting of Stockholders will be held virtually via a live audio-only webcast accessible at http://www.virtualshareholdermeeting.com/DOCS2023 for all stockholders of record at the close of business on June 1, 2023, the record date. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_166"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_169"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">able of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_172"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2023 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Conduct, which applies to all employees, including our principal executive officers, our principal financial officer, and all other executive officers. The Code of Conduct is available on our investor relations website at investors.doximity.com/governance. We plan to post any future amendments or waivers of our Code of Conduct on our website. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_175"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Executive Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2023 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2023.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_178"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2023 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2023.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_181"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2023 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2023.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_184"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Principal Accountant Fees and Services</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2023 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2023.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_187"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">able of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_190"></div><div style="-sec-extract:summary;margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15. Exhibits and Financial Statement Schedules</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.293%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:42.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit32-sx1a1.htm">Amended and Restated Certificate of Incorporation of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001516513/000162828021012207/exhibit34-sx1a1.htm">Amended and Restated Bylaws of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021011269/exhibit41s-1.htm">Form of Class A common stock certificate of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 28, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021011269/exhibit42-sx1.htm">Amended and Restated Investors&#8217; Rights Agreement, dated April 10, 2014, by and among the Registrant and certain of its stockholders.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 28, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000151651322000037/exhibit43-descriptionofsec.htm">Description of Securities.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021011269/exhibit43-sx1.htm">Warrant to Purchase Shares of Common Stock issued to U.S. News &amp; World Report, L.P., dated March 10, 2017.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 28, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000151651321000009/ex-422021usnewswarrantagre.htm">Warrant to Purchase Shares of Class A Common Stock issued to U.S. News &amp; World Report, L.P., dated June 14, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 12, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000151651321000028/usnwarrantextension.htm">Amendment to Warrant to Purchase Shares of Class A Common Stock issued to U.S. News &amp; World Report, L.P., dated September 2, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 10, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001516513/000151651321000028/usnewswarrantagreementamen.htm">Second Amendment to Warrant to Purchase Shares of Class A Common Stock issued to U.S. News &amp; World Report, L.P., dated October 8, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 10, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit101-sx1a1.htm">Form of Indemnification Agreement between the Registrant and each of its directors and executive officers.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit102-sx1a1.htm">2010 Equity Incentive Plan, as amended, and forms of agreements thereunder.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000151651322000037/exhibit103-2021stockoption.htm">2021 Stock Option and Incentive Plan, and forms of agreements thereunder.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit104-sx1a1.htm">2021 Employee Stock Purchase Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit105-sx1a1.htm">Senior Executive Cash Incentive Bonus Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit106-sx1a1.htm">Non-Employee Director Compensation Policy.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex-107xcraigoverpeckofferl.htm">Craig Overpeck Offer Letter</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit191-insidertradingp.htm">Insider Trading Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit211-listofsubsidiar.htm">Subsidiaries of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit231-consentfy23.htm">Consent of Deloitte &amp; Touche LLP, independent registered public accounting firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_199">Power of Attorney (incorporated by reference to the Signature page of this Annual Report on Form 10-K).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit31133123.htm">Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">able of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.293%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:42.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit31233123.htm">Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit32133123.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furnished herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit32233123.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furnished herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* The certifications attached as Exhibit 32.1 and 32.2 that accompany this Annual Report on Form 10-K are deemed furnished and not filed with the SEC and are not to be incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"># Indicates management contract or compensatory plan, contract or agreement.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_193"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Form 10-K Summary</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_196"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">able of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.984%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May&#160;26, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Jeffrey Tangney</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey Tangney</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May&#160;26, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Anna Bryson</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anna Bryson</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="ib1b51d92d3ac43179e2f8bdfac24a353_199"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib1b51d92d3ac43179e2f8bdfac24a353_7">able of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Anna Bryson and Jennifer Chaloemtiarana, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite or necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.213%"><tr><td style="width:1.0%"></td><td style="width:29.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.579%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Signature</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Jeffrey Tangney</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Director</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey Tangney</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Anna Bryson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anna Bryson</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Regina Benjamin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regina Benjamin</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Tim Cabral</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tim Cabral</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Phoebe Yang</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phoebe Yang</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Kevin Spain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kevin Spain</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Kira Wampler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 26, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kira Wampler</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>2
<FILENAME>ex-107xcraigoverpeckofferl.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i325138ba81084eeeb5e3f417a5f42dcf_33"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 10.7</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">April 27, 2023</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Craig Overpeck </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Craig,</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are excited to offer you a spot on our growing team at Doximity. Here are the details you likely care about most&#58;</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SVP, Commercial Operations</font></div><div style="margin-top:3pt;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start Date &#160;&#160;&#160;&#160;May 16, 2023</font></div><div style="margin-top:3pt;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual Salary &#160;&#160;&#160;&#160;$300,000</font></div><div style="margin-top:3pt;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity Grants&#160;&#160;&#160;&#160;$4M 4yr RSU, vests qtrly, no cliff</font></div><div style="margin-top:3pt;padding-left:72pt;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4M 4yr PSU, vests annually based on % to (stretch) goal</font></div><div style="margin-top:3pt;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Health insurance, 401k, Discretionary Time Off &#38; more*</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity grants in this offer letter will be granted upon your conversion from consultant to employee and will replace all previously issued grants. For the avoidance of doubt, the Services Agreement between you and Doximity dated as of November 18, 2022, and the equity grants associated therewith (except for the first vest tranche of May 15, 2023), will be terminated and of no further force or effect (except for those terms that survive as set forth in the Services Agreement) on your start date.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some less exciting, but equally important components of this offer&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">This offer is contingent upon clearance of background and&#47;or reference checks.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect you can legally work in the United States and will need documentation proving so within 3 business days of hire.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If you have not already done so, please disclose agreements relating to prior employment that may affect your role or eligibility to be employed within Doximity.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As a condition of employment, you are required to sign and comply with an At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement (also known as PIIA), attached. If you have questions, please reach out to us.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To accept our offer, please sign and date this letter, along with the PIIA. The two documents set forth the terms of your employment and supersede any prior representations made during the interview process.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We look forward to working with you!</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sincerely</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.403%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DOXIMITY</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey Tangney</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeff Tangney</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CEO</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Craig Overpeck</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig Overpeck</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SVP, Commercial Ops</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Enclosures</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">&#8226;</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%;padding-left:14.5pt">At-Will Employment</font><font style="color:#1c1c1d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">, </font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">Confidential Information</font><font style="color:#1c1c1d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">, </font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">Invention Assignment, and Arbitration Agreement</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>3
<FILENAME>exhibit191-insidertradingp.htm
<DESCRIPTION>EX-19.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i081062509d5943aa94a12965ed23a73c_1"></div><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Exhibit 19.1</font></div><div style="padding-left:72.05pt;padding-right:72.05pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DOXIMITY, INC.</font></div><div style="padding-left:0.03pt;padding-right:0.03pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INSIDER TRADING POLICY</font></div><div style="padding-left:72.05pt;padding-right:72.05pt;text-align:center"><font><br></font></div><div style="margin-top:2pt;padding-left:6.4pt;padding-right:5.75pt;text-align:justify;text-indent:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">This memorandum sets forth the policy of Doximity, Inc. and its subsidiaries (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;) regarding trading in the Company&#8217;s securities as described below and the disclosure of information concerning the Company. This Insider Trading Policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Insider Trading Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;) is designed to prevent insider trading or the appearance of impropriety, to satisfy the Company&#8217;s obligation to reasonably supervise the activities of Company personnel, and to help Company personnel avoid the severe consequences associated with violations of insider trading laws. It is your obligation to understand and comply with this Insider Trading Policy.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. OVERVIEW</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:19.45pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.89pt">To Whom Does this Insider Trading Policy Apply&#63;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.15pt;padding-right:6.5pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">This Insider Trading Policy is applicable to the Company&#8217;s directors, officers, employees and consultants and applies to any and all transactions by such persons and their Affiliated Persons (as defined below) in the Company&#8217;s securities, including its common stock, options to purchase common stock, any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants, exchange-traded options or other derivative securities), and any derivative securities that provide the economic equivalent of ownership of any of the Company&#8217;s securities or an opportunity, direct or indirect, to profit from any change in the value of the Company&#8217;s securities.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6.15pt;padding-right:13.85pt;text-align:justify;text-indent:36.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">In addition, all directors, designated officers, employees and consultants must comply with the Trading Procedures set forth in Part II of this Insider Trading Policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Trading Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;) (collectively, and solely for the purposes of this Insider Trading Policy, these persons are referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Insiders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;) provided that, except as otherwise indicated, the pre-clearance procedures set forth in Part II, Section B herein only apply to Access Persons (as defined below). Generally, the Trading Procedures establish trading windows outside of which the persons covered by the Trading Procedures will be restricted from trading in the Company&#8217;s securities.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:12.95pt;text-align:justify;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">This Insider Trading Policy, including, if applicable, the Trading Procedures contained herein, also applies to the following persons (collectively, these persons and entities are referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%">Affiliated Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">&#8221;)&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41.45pt;padding-right:6.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%;padding-left:14.5pt">your spouse or domestic partner, children, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws who reside in the same household as you&#59;</font></div><div style="margin-top:0.1pt;padding-left:41.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%;padding-left:14.5pt">your children or your spouse&#8217;s children who do not reside in the same household as you but are financially dependent on you&#59;</font></div><div style="margin-top:0.1pt;padding-left:41.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%;padding-left:14.5pt">any of your other family members who do not reside in your household but whose transactions are directed by you&#59;</font></div><div style="margin-top:0.1pt;padding-left:41.45pt;padding-right:6.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%;padding-left:14.5pt">any other individual over whose account you have control and to whose financial support you materially contribute. (Materially contributing to financial support would include, for example, paying an individual&#8217;s rent but not just a phone bill)&#59;</font></div><div style="padding-left:41.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%;padding-left:14.55pt">all trusts, family partnerships and other types of entities formed for your benefit or for the benefit of a member of your family and over which you have the ability to influence or direct investment decisions concerning securities&#59;</font></div><div style="padding-left:41.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.55pt">all persons who execute trades on your behalf&#59; and</font></div><div style="padding-left:41.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.55pt">all investment funds, trusts, retirement plans, partnerships, corporations and other types of entities over which you have the ability to influence or direct investment decisions concerning securities&#59; provided, however, that the Trading Procedures do not apply to any such entity that engages in the investment of securities in the ordinary course of its business (e.g., an investment fund or partnership) if such entity has established its own insider trading controls and procedures in compliance with applicable securities laws and it (or an affiliated entity) has represented to the Company that such Insider&#8217;s affiliated entities&#58; (a) engage in the investment of securities in the ordinary course of their respective businesses&#59; (b) have established insider trading controls and procedures in compliance with applicable securities laws&#59; and (c) are aware such securities laws prohibit any person or entity who has material, nonpublic information concerning the Company from purchasing or selling securities of the Company or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell securities.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.3pt;padding-right:15.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">You are responsible for ensuring compliance with this Insider Trading Policy, including the Trading Procedures contained herein, by all of your Affiliated Persons.</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:18.5pt;text-align:justify;text-indent:36.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">In the event that you leave the Company for any reason, this Insider Trading Policy, including, if applicable, the Trading Procedures contained herein, will continue to apply to you and your Affiliated Persons until the later of&#58; (1) the second trading day following the public release of earnings for the fiscal quarter in which you leave the Company or (2) the second trading day after any material nonpublic information known to you has become public or is no longer material.</font></div><div style="padding-right:18.5pt;text-align:justify"><font><br></font></div><div style="padding-left:19.45pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.89pt">What is Prohibited by this Insider Trading Policy&#63;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.65pt;padding-right:6.45pt;text-align:justify;text-indent:35.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">It is generally illegal for you to trade in the securities of the Company, whether for your account or for the account of another, while in the possession of material, nonpublic information about the Company. It is also generally illegal for you to disclose material, nonpublic information about the Company to others who may trade on the basis of that information. These illegal activities are commonly referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:111%">insider trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">.&#8221;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prohibition on Trading in Company Securities</font></div><div><font><br></font></div><div style="padding-left:6.65pt;padding-right:6.4pt;text-align:justify;text-indent:35.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">When you know or are in possession of material, nonpublic information about the Company, whether positive or negative, you are prohibited from the following activities&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:41.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%;padding-left:14.5pt">trading (whether for your account of for the account of another) in the Company&#8217;s securities, which includes common stock, options to purchase common stock, any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants, exchange-traded options or other derivative securities), and any derivative securities that provide the economic equivalent of ownership of any of the Company&#8217;s securities or an opportunity, direct or indirect, to profit from any change in the value of the Company&#8217;s securities, except for trades made in compliance with the affirmative defense of Rule 10b5-1 under the Exchange Act, such as when trades are made pursuant to a pre-approved written plan that was adopted, or trading instructions that were given, before you knew or had possession of such material, nonpublic information and certain other conditions are satisfied&#59;</font></div><div style="padding-left:41.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%;padding-left:14.55pt">giving trading advice of any kind about the Company&#59; and</font></div><div style="margin-top:0.7pt;padding-left:41.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">disclosing such material, nonpublic information about the Company, whether positive or negative, to anyone else (commonly known as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:104%">tipping</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8221;).</font></div><div style="margin-top:6.85pt;padding-left:6.2pt;padding-right:6.85pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">This Insider Trading Policy does not apply to&#58; (1) an exercise of an employee stock option when payment of the exercise price is made in cash or (2) the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures or (3) sales of shares of stock in connection with the vesting of restricted stock or upon settlement of restricted stock units solely to satisfy applicable tax withholding requirements.</font></div><div><font><br></font></div><div style="padding-left:6.15pt;padding-right:6.55pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">The policy does apply, however, to&#58; the use of outstanding Company securities to pay part or all of the exercise price of an option, any sale of stock as part of a broker-assisted cashless exercise of an option or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6.3pt;padding-right:6.4pt;text-align:justify;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">These prohibitions continue whenever and for as long as you know or are in possession of material, nonpublic information. Remember, anyone scrutinizing your transactions will be doing so after the fact, with the benefit of hindsight. As a practical matter, before engaging in any transaction, you should carefully consider how enforcement authorities and others might view the transaction in hindsight.</font></div><div style="margin-top:11.3pt;padding-left:6.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prohibition on Tipping</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6.3pt;padding-right:6.4pt;text-align:justify;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Providing material nonpublic information about the Company to another person who may trade or advise others to trade on the basis of that information is known as &#8220;tipping&#8221; and is illegal. You are prohibited from providing material nonpublic information about the Company to a friend, relative, or anyone else who might buy or sell a security or other financial instrument on the basis of that information, whether or not you intend to or actually do realize a profit (or any other benefit) from such tipping. Additionally, you are prohibited from recommending to any person that such person engage in or refrain from engaging in any transaction involving the Company&#8217;s securities, or otherwise give trading advice concerning the Company&#8217;s securities, if you are in possession of material nonpublic information about the Company.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:19.45pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.89pt">What is Material, Nonpublic Information&#63;</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:11.6pt;padding-left:6.15pt;padding-right:8.1pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">This Insider Trading Policy prohibits you from trading in the Company&#8217;s securities if you are in possession of information about the Company that is both &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:111%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:111%">nonpublic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">.&#8221; If you have a question whether certain information you are aware of is material or has been made public, you are encouraged to consult with the Compliance Officer. The Compliance Officer shall be the Company&#8217;s then-serving General Counsel.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Material&#8221; Information</font></div><div style="margin-top:11.6pt;padding-left:6.15pt;padding-right:8.1pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">Information about the Company is &#8220;material&#8221; if it could reasonably be expected to affect the investment or voting decisions of a stockholder or investor, or if the disclosure of the information could reasonably be expected to significantly alter the total mix of information in the marketplace about the Company. In simple terms, material information is any type of information that could reasonably be expected to affect the market price of the Company&#8217;s securities. Both positive and negative information may be material. While it is not possible to identify all information that would be deemed &#8220;material,&#8221; the following items are types of information that should be considered carefully to determine whether they are material&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:95.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%;padding-left:14.55pt">projections of future earnings or losses, or other earnings guidance&#59;</font></div><div style="margin-top:0.7pt;padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">earnings or revenue that are inconsistent with the consensus expectations of the investment community&#59;</font></div><div style="margin-top:0.25pt;padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">potential restatements of the Company&#8217;s financial statements, changes in auditors or auditor notification that the Company may no longer rely on an auditor&#8217;s audit report&#59;</font></div><div style="margin-top:0.35pt;padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">pending or proposed corporate mergers, acquisitions, tender offers, joint ventures or dispositions of significant assets&#59;</font></div><div style="margin-top:0.05pt;padding-left:95.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%;padding-left:14.55pt">changes in management or the Board of Directors&#59;</font></div><div style="margin-top:0.55pt;padding-left:95.45pt;padding-right:6.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">significant actual or threatened litigation or governmental investigations or major developments in such matters&#59;</font></div><div style="margin-top:0.05pt;padding-left:95.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%;padding-left:14.55pt">a cybersecurity or data privacy incident&#59;</font></div><div style="margin-top:0.65pt;padding-left:95.45pt;padding-right:6.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">significant developments regarding products, customers, suppliers, orders, contracts or financing sources (e.g., the acquisition or loss of a contract)&#59;</font></div><div style="margin-top:0.3pt;padding-left:95.45pt;padding-right:6.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">changes in dividend policy, declarations of stock splits, or public or private sales of additional securities&#59;</font></div><div style="margin-top:0.25pt;padding-left:95.45pt;padding-right:6.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%;padding-left:14.5pt">potential defaults under the Company&#8217;s credit agreements or indentures, or the existence of material liquidity deficiencies&#59; and</font></div><div style="margin-top:0.05pt;padding-left:95.45pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.55pt">bankruptcies or receiverships.</font></div><div style="margin-top:5.2pt;padding-left:6.25pt;padding-right:7.45pt;text-align:justify;text-indent:36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">By including the list above, the Company does not mean to imply that each of these items above is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;text-decoration:underline">per se</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> material. The information and events on this list still require determinations as to their materiality (although some determinations will be reached more easily than others). For example, some new products or contracts may clearly be material to an issuer&#59; yet that does not mean that all product developments or contracts will be material. This demonstrates, in our view, why no &#8220;bright-line&#8221; standard or list of items can adequately address the range of situations that may arise. Furthermore, the Company cannot create an exclusive list of events and information that have a higher probability of being considered material.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6.6pt;padding-right:15.2pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;) has stated that there is no fixed quantitative threshold amount for determining materiality, and that even very small quantitative changes can be qualitatively material if they would result in a movement in the price of the Company&#8217;s securities.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Nonpublic&#8221; Information</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6.6pt;padding-right:8.5pt;text-align:justify;text-indent:34.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Material information is &#8220;nonpublic&#8221; if it has not been disseminated in a manner making it available to investors generally. To show that information is public, it is necessary to point to some fact that establishes that the information has become publicly available, such as the filing of a report with the SEC, the distribution of a press release through a widely disseminated news or wire service, or by other means that are reasonably designed to provide broad public access. Before a person who possesses material, nonpublic information can trade, there also must be adequate time for the market as a whole to absorb the information that has been disclosed. For the purposes of this Insider Trading Policy, information will be considered public upon the opening of trading on the third full trading day following the Company&#8217;s public release of the information. For that purpose, a full day of trading means a session of regular trading hours on the New York Stock Exchange or the Nasdaq Stock Market between 9&#58;30 a.m. and 4&#58;00 p.m. Eastern Time (or such earlier closing time as has been set by exchange rules) has occurred.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:6.85pt;text-align:justify;text-indent:36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">For example, if the Company announces material nonpublic information of which you are aware </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:111%">before </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">trading begins on a Tuesday, the first time you can buy or sell Company securities is the opening of the market on Thursday, if each intervening day was a day that the stock exchanges were open for trading. However, if the </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:6.25pt;padding-right:6.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">Company announces this material information </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:111%">after </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">trading begins on that Tuesday, the first time that you can buy or sell Company securities is the opening of the market on Friday, if each intervening day was a day that the stock exchanges were open for trading.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:19.45pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.33pt">What are the Penalties for Insider Trading and Noncompliance with this Insider Trading Policy&#63;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6.4pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Both the SEC and the national securities exchanges, through the Financial Industry Regulatory Authority (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">FINRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;), investigate and are very effective at detecting insider trading. The SEC, together with the U.S. Attorneys, pursue insider trading violations vigorously. For instance, cases have been successfully prosecuted against trading by employees in foreign accounts, trading by family members and friends, and trading involving only a small number of shares.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:41.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The penalties for violating insider trading or tipping rules can be severe and include&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:95.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%;padding-left:14.55pt">disgorgement of the profit gained or loss avoided by the trading&#59;</font></div><div style="margin-top:0.45pt;padding-left:95.45pt;padding-right:6.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;padding-left:14.5pt">payment of the loss suffered by the persons who, contemporaneously with the purchase or sale of securities that are subject of such violation, have purchased or sold, as applicable, securities of the same class&#59;</font></div><div style="padding-left:95.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%;padding-left:14.55pt">payment of criminal penalties of up to $5,000,000&#59;</font></div><div style="margin-top:0.55pt;padding-left:95.45pt;padding-right:6.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%;padding-left:14.5pt">payment of civil penalties of up to three times the profit made or loss avoided&#59; and</font></div><div style="padding-left:95.45pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%;padding-left:14.55pt">imprisonment for up to 20 years.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:6.4pt;text-align:justify;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The Company and&#47;or the supervisors of the person engaged in insider trading may also be required to pay civil penalties or fines of $2 million or more, up to three times the profit made or loss avoided, as well as criminal penalties of up to $25,000,000, and could under certain circumstances be subject to private lawsuits.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6.25pt;padding-right:6.5pt;text-align:justify;text-indent:35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Violation of this Insider Trading Policy or any federal or state insider trading laws may subject the person violating such policy or laws to disciplinary action by the Company up to and including termination. The Company reserves the right to determine, in its own discretion and on the basis of the information available to it, whether this Insider Trading Policy has been violated. The Company may determine that specific conduct violates this Insider Trading Policy, whether or not the conduct also violates the law. It is not necessary for the Company to await the filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:19.8pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.89pt">How Do You Report a Violation of this Insider Trading Policy&#63;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:5.75pt;text-align:justify;text-indent:36.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">If you have a question about this Insider Trading Policy, including whether certain information you are aware of is material or has been made public, you are encouraged to consult with the Compliance Officer. In addition, if you violate this Insider Trading Policy or any federal or state laws governing insider trading, or know of any such violation by any director, officer or employee of the Company, you should report the violation immediately to the Compliance Officer.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II. TRADING PROCEDURES</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:19.45pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.89pt">Special Trading Restrictions Applicable to Insiders</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.65pt;padding-right:6.45pt;text-align:justify;text-indent:35.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">In addition to the restrictions on trading in Company securities set forth above, Insiders and their Affiliated Persons are subject to the following special trading restrictions&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:54.9pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">No Trading Except During Trading Windows.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.15pt;padding-right:7.2pt;text-align:justify;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The announcement of the Company&#8217;s quarterly financial results almost always has the potential to have a material effect on the market for the Company&#8217;s securities. Although an Insider may not know the financial results prior to public announcement, if an Insider engages in a trade before the financial results are disclosed to the public, such trades may give an appearance of impropriety that could subject the Insider and the Company to a charge of insider trading. Therefore, subject to limited exceptions described herein, Insiders may trade in Company securities only during four quarterly trading windows and then only after obtaining pre-clearance from the Compliance Officer in accordance with the procedures set forth below. Unless otherwise advised, the four trading windows consist of the periods that begin after market open on the third full trading day following the Company&#8217;s issuance of a press release (or other method of broad public dissemination) announcing its quarterly or annual earnings and end at the close of business on the last trading day of the second month of the then-current quarter, so long as the trading window is always at least five trading days in length. Insiders may be allowed to trade outside of a trading window </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:6.15pt;padding-right:7.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">only (a) pursuant to a pre-approved Rule 10b5-1 Plan as described below or (b) in accordance with the procedure for waivers as described below.</font></div><div style="padding-right:7.2pt;text-align:justify"><font><br></font></div><div style="padding-left:6.15pt;padding-right:7.2pt;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">By way of example only, if the Company&#8217;s issuance of a press release announcing its quarterly earnings occurred on Tuesday, February 8, the trading window would open on Friday, February 11 (the third full trading day) and close on Monday, February 28 (the last trading day of the second month of the quarter). See the graphic as an example, wherein the green shaded area would be the open window.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:127.55pt;padding-right:127.55pt;text-align:center"><img alt="image_3a.jpg" src="image_3a.jpg" style="height:137px;margin-bottom:5pt;vertical-align:text-bottom;width:233px"></div><div><font><br></font></div><div style="padding-left:53.45pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Special Closed Trading Periods.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:6.15pt;padding-right:7.2pt;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The Compliance Officer may designate, from time to time, a &#8220;Special Closed Window&#8221; during what would be a permitted trading window. During a Special Closed Window, designated Insiders (which could be all Insiders or a subset of them) may not trade in the Company&#8217;s securities. The Compliance Officer may also impose a Special Closed Window on Insiders or a subset of them to prohibit trading in the securities of other companies, including specified peers or competitors of the Company. The imposition of a Special Closed Window will not be announced to the Company generally, should not be communicated to any other person, and may itself be considered under this Insider Trading Policy to be material nonpublic information about the Company.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:54.5pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Prohibited Transactions.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">No Short Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. No Insider may at any time sell any securities of the Company that are not owned by such Insider at the time of the sale (a &#8220;short sale&#8221;).</font></div><div style="padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:14.5pt">No Purchases or Sales of Derivative Securities or Hedging Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. No Insider may buy or sell puts, calls, other derivative securities of the Company or any derivative securities that provide the economic equivalent of ownership of any of the Company&#8217;s securities or an opportunity, direct or indirect, to profit from any change in the value of the Company&#8217;s securities or engage in any other hedging transaction with respect to the Company&#8217;s securities, at any time.</font></div><div style="margin-top:0.2pt;padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">No Company Securities Subject to Margin Calls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. No Insider may use the Company&#8217;s securities as collateral in a margin account.</font></div><div style="padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:14.5pt">No Pledges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. No Insider may pledge Company securities as collateral for a loan (or modify an existing pledge).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:54.4pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Gifts.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.6pt;padding-right:6.45pt;text-align:justify;text-indent:35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">No Insider may give or make any other transfer of Company securities without consideration (e.g., a gift) during a period when the Insider is not permitted to trade unless the donee agrees not to sell the shares until such time as the Insider can sell.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:19.9pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.89pt">Pre-Clearance Procedures</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.6pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:111%">All directors and officers designated as officers subject to Section 16 of the Securities Exchange Act of 1934, as amended, as designated by the board of directors of the Company (the &#8220;Section 16 Officers&#8221;) and certain designated employees, consultants, contractors and other service providers of the Company and its subsidiaries as set forth in Exhibit A, who in the ordinary course of the performance of their duties have access to material, nonpublic information regarding the Company are &#8220;Access Persons.&#8221; You will be notified if you are an Access Person.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">Access Persons may only trade in Company securities if the trade has been approved by the Compliance Officer in accordance with the procedures set forth below. The Compliance Officer will review and either approve or prohibit all proposed trades by Insiders in accordance with the procedures set forth below. The Compliance </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:6.25pt;padding-right:6.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">Officer may consult with the Company&#8217;s other officers and&#47;or outside legal counsel and will receive approval for his&#47;her&#47;their own trades from the Chief Financial Officer.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:55.4pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Procedures. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Access Person may trade in Company securities until&#58;</font></div><div style="padding-left:59.45pt;text-align:justify"><font><br></font></div><div style="padding-left:95.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Access Person has notified the Compliance Officer of the amount and nature of the proposed trade(s) using a preclearance form developed by the Compliance Officer (the &#8220;Preclearance Form&#8221;). In order to provide adequate time for the preparation of any required reports under Section 16 of the Exchange Act, a Preclearance Form should, if practicable, be received by the Compliance Officer no more than five (5) but no less than one (1) business days prior to the intended trade date&#59;</font></div><div style="padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Access Person has certified to the Compliance Officer in writing prior to the proposed trade(s) that the Access Person is not in possession of material, nonpublic information concerning the Company&#59;</font></div><div style="padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">If the Access Person is also a director or a Section 16 Officer, the Access Person has informed the Compliance Officer, using the Preclearance Form, whether, to the Access Person&#8217;s best knowledge, the Access Person has (or is deemed to have) engaged in any opposite way transactions within the previous six months that were not exempt from Section 16(b) of the Exchange Act&#59;</font></div><div style="padding-left:95.45pt;padding-right:6.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">If the transaction involves a sale by an &#8220;affiliate&#8221; of the Company or of &#8220;restricted securities&#8221; (as such terms are defined under Rule 144 under the Securities Act of 1933, as amended (&#8220;Rule 144&#8221;)), the Access Person has informed the Compliance Officer, using the Preclearance Form, whether the transaction meets all of the applicable conditions of Rule 144&#59; and</font></div><div style="padding-left:95.45pt;padding-right:6.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Compliance Officer or his, her or their designee has approved the trade(s) and has certified such approval in writing. Such certification may be made via digitally-signed electronic mail or other secure electronic means.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6.15pt;padding-right:6.45pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Compliance Officer does not assume the responsibility for the consequences of prohibited insider trading. Compliance with insider trading remains an individual responsibility.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:55.4pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Additional Information</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6.25pt;padding-right:6.4pt;text-align:justify;text-indent:35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">Access Persons shall provide to the Compliance Officer any documentation reasonably requested by him or her in furtherance of the foregoing procedures. Any failure to provide such requested information will be grounds for denial of approval by the Compliance Officer.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:55.4pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">No Obligation to Approve Trades</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:6.45pt;text-align:justify;text-indent:36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">The existence of the foregoing approval procedures does not in any way obligate the Compliance Officer to approve any trade requested by an Insider. The Compliance Officer may reject any trading request at his, her or their sole discretion.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6.2pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">From time to time, an event may occur that is material to the Company and is known by only a few directors or executives. Insiders may not trade in Company securities if they are notified by the Compliance Officer that a proposed trade has not been cleared because of the existence of a material, nonpublic development. Even if that particular Insider is not aware of the material, nonpublic development involving the Company, if any Insider engages in a trade before a material, nonpublic development is disclosed to the public or resolved, the Insider and the Company might be exposed to a charge of insider trading that could be costly and difficult to refute even if the Insider was unaware of the development. So long as the event remains material and nonpublic, the Compliance Officer may determine not to approve any transactions in the Company&#8217;s securities. The Compliance Officer will subsequently notify the Insider once the material, nonpublic development is disclosed to the public or resolved. If an Insider requests clearance to trade in the Company&#8217;s securities during the pendency of such an event, the Compliance Officer may reject the trading request without disclosing the reason.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:54.2pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Completion of Trades.</font></div><div style="margin-top:11.6pt;padding-left:6.25pt;padding-right:10.55pt;text-align:justify;text-indent:35.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">After receiving written clearance to engage in a trade signed by the Compliance Officer, an Insider must complete the proposed trade within five (5) business days or make a new trading request. Even if an Insider has received clearance, the Insider may not engage in a trade if (i) such clearance has been rescinded by the Compliance Officer, (ii) the Insider has otherwise received notice that the trading window has closed or (iii) the Insider has or acquires material nonpublic information.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:54.55pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Post-Trade Reporting.</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:11.6pt;padding-left:6.25pt;padding-right:6.4pt;text-align:justify;text-indent:35.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">Any transactions in the Company&#8217;s securities by a director or a Section 16 Officer (including any gifts and any transactions effected pursuant to a Rule 10b5-1 Plan) must be reported to the Compliance Officer on the same day in which such a transaction occurs. Each report a Designated Person makes to the Compliance Officer should include the date of the transaction, quantity of shares, price and broker-dealer through which the transaction was effected. This reporting requirement may be satisfied by sending (or having such Designated Person&#8217;s broker send) duplicate confirmations of trades to the Compliance Officer if such information is received by the Compliance Officer on or before the required date. Compliance with this provision is imperative given the requirement of Section 16 of the Exchange Act that these persons generally must report changes in ownership of Company securities within two (2) business days. The sanctions for noncompliance with this reporting deadline include mandatory disclosure in the Company&#8217;s proxy statement for the next annual meeting of stockholders, as well as possible civil or criminal sanctions for chronic or egregious violators.</font></div><div style="margin-top:11.45pt;padding-left:21pt;text-indent:-14.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.89pt">Exemptions</font></div><div style="margin-top:11.65pt;padding-left:55.4pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Pre-Approved Rule 10b5-1 Plan.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.15pt;padding-right:6.4pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">Transactions effected pursuant to a Rule 10b5-1 Plan (as defined below) will not be subject to the Company&#8217;s trading windows or pre-clearance procedures, and Insiders are not required to complete a Preclearance Form for such transactions. Rule 10b5-1 of the Exchange Act provides an affirmative defense from insider trading liability under the federal securities laws for trading plans, arrangements or instructions that meet certain requirements. A trading plan, arrangement or instruction that meets the requirements of Rule 10b5-1 (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%">Rule 10b5-1 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">&#8221;) enables Insiders to establish arrangements to trade in Company securities outside of the Company&#8217;s trading windows, even when in possession of material, nonpublic information.</font></div><div style="margin-top:11.6pt;padding-left:5.45pt;padding-right:6.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">The Company has adopted a separate Rule 10b5-1 Trading Plan Policy that sets forth the requirements for putting in place a Rule 10b5-1 Plan with respect to Company securities</font><font style="color:#444746;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:54.25pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.55pt">Employee Benefit Plans.</font></div><div style="padding-left:6.3pt;padding-right:6.4pt;text-align:justify;text-indent:36.8pt"><font><br></font></div><div style="padding-left:6.3pt;padding-right:6.4pt;text-align:justify;text-indent:36.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Exercise of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">. The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to the exercise of an option to purchase securities of the Company when payment of the exercise price is made in cash. However, the exercise of an option to purchase securities of the Company is subject to the current reporting requirements of Section 16 of the Exchange Act and, therefore, Insiders must comply with the post-trade reporting requirement described in Section C above for any such transaction. In addition, the securities acquired upon the exercise of an option to purchase Company securities are subject to all of the requirements of this Insider Trading Policy, including the Trading Procedures contained herein. Moreover, the Trading Procedures apply to the use of outstanding Company securities to pay part or all of the exercise price of an option, any net option exercise, any exercise of a stock appreciation right, share withholding, any sale of stock as part of a broker assisted cashless exercise of an option, or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6.3pt;padding-right:6.4pt;text-align:justify;text-indent:36.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Tax Withholding on Restricted Stock&#47;Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">. The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to the (i) withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures or (ii) sale of shares of stock in connection with the vesting of restricted stock or upon settlement of restricted stock units solely to satisfy applicable tax withholding requirements.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6.3pt;padding-right:6.4pt;text-align:justify;text-indent:35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:111%">Employee Stock Purchase Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">. The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to (i) periodic wage withholding contributions by the Company or employees of the Company which are used to purchase the Company&#8217;s securities pursuant to the employees&#8217; advance instructions under the Company&#8217;s 2021 Employee Stock Purchase Plan or (ii) elections or withdrawals with respect to participation in the Company&#8217;s Employee Stock Purchase Plan or to purchases of securities under such plan. Any sale of securities acquired under such plan is subject to the prohibitions and restrictions of the Trading Procedures.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:20.45pt;text-indent:-14.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:4.98pt">Waivers</font></div><div style="margin-top:11.6pt;padding-left:6.2pt;padding-right:6.4pt;text-align:justify;text-indent:35.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">A waiver of any provision of this Insider Trading Policy, or the Trading Procedures contained herein, in a specific instance may be authorized in writing by the Audit Committee of the Board of Directors, and any such waiver shall be reported to the Company&#8217;s Board of Directors.</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART III. ACKNOWLEDGEMENT</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.25pt;padding-right:6.4pt;text-align:justify;text-indent:35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">This Insider Trading Policy will be delivered to all current Insiders and to all directors, officers, employees and consultants at the start of their employment or relationship with the Company, and acknowledged by the recipient in the manner proscribed by the Company. Such acknowledgment will constitute consent for the Company to impose sanctions for violation of the Insider Trading Policy, including the Trading Procedures, and to issue any necessary stop-transfer orders to the Company&#8217;s transfer agent to ensure compliance.</font></div><div style="margin-top:11.5pt;padding-left:6.25pt;padding-right:6.45pt;text-align:justify;text-indent:35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">An individual will be deemed to have acknowledged and agreed to comply with the Insider Trading Policy, as amended from time to time, when copies of such items have been made available to the recipients.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">* * *</font></div><div><font><br></font></div><div style="padding-left:6.65pt;text-indent:34.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">Questions regarding this Insider Trading Policy are encouraged and may be directed to the Compliance Officer.</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i081062509d5943aa94a12965ed23a73c_16"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.3pt;padding-left:189.42pt;padding-right:189.42pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:213%;text-decoration:underline">EXHIBIT A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:213%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:213%;text-decoration:underline">ACCESS PERSONS</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:9pt;padding-left:19.5pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3.05pt">DIRECTORS</font></div><div style="margin-top:9pt;padding-left:42.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All serving members of the board of directors of the Company at any time</font></div><div style="margin-top:9pt;padding-left:19.5pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3.05pt">OFFICERS (including officers who are also directors) </font></div><div style="margin-top:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Title</font></div><div style="margin-top:3pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All Section 16 Officers as identified from time to time</font></div><div style="margin-top:9pt;padding-left:17.45pt;text-indent:-12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3.05pt">OTHER ACCESS PERSONS</font></div><div style="margin-top:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As designated by the Compliance Officer from time to time</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>exhibit211-listofsubsidiar.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i972a08c3d46e45d7aefe6d4f284e67b4_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 21.1</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUBSIDIARIES OF DOXIMITY</font></div><div style="margin-bottom:26pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.583%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Name of Subsidiary</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Jurisdiction of Incorporation or Organization</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Curative Talent, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware, U.S.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Amion, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware, U.S.</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>exhibit231-consentfy23.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4c7ed10f6ff44f6a8b579b57f833f7f4_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 23.1</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in Registration Statement Nos. 333-257332, 333-257333, 333-258776, and 333- 265300 on Form S-8 of our reports dated May&#160;26, 2023, relating to the financial statements of Doximity, Inc. and the effectiveness of Doximity, Inc.&#8217;s internal control over financial reporting, appearing in this Annual Report on Form 10-K for the year ended March&#160;31, 2023.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Deloitte &#38; Touche LLP</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">San Francisco, California</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;26, 2023</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exhibit31133123.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic41327ffa8814eaaad2ec2944906fd7d_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey Tangney, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Doximity, Inc.&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 26, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey Tangney</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exhibit31233123.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9679f67cd44641a3abd0bf3c91cb6b3f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Anna Bryson, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Doximity, Inc.&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 26, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anna Bryson</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit32133123.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i444be7a8ddd34a03bf4b022e362c257c_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey Tangney, Chief Executive Officer of Doximity, Inc. (the &#8220;Company&#8221;), do hereby certify, to the best of my knowledge and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of the Company for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 26, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey Tangney</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exhibit32233123.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4120352a6b704f3ebd83f3852cce72f5_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Anna Bryson, Chief Financial Officer of Doximity, Inc. (the &#8220;Company&#8221;), do hereby certify, to the best of my knowledge and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of the Company for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 26, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anna Bryson</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>docs-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4d1277b4-10a9-4732-8720-53d63c4cfd14,g:0c268704-e9e1-4ac2-87ff-5caa0e49a51f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:docs="http://www.doximity.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.doximity.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.doximity.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.doximity.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusiness" roleURI="http://www.doximity.com/role/DescriptionofBusiness">
        <link:definition>0000010 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummarySignificantAccountingPolicies" roleURI="http://www.doximity.com/role/SummarySignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Summary Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.doximity.com/role/RevenueRecognition">
        <link:definition>0000012 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.doximity.com/role/Investments">
        <link:definition>0000013 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.doximity.com/role/FairValueMeasurements">
        <link:definition>0000014 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://www.doximity.com/role/PropertyandEquipmentNet">
        <link:definition>0000015 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilities" roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities">
        <link:definition>0000016 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.doximity.com/role/BusinessCombinations">
        <link:definition>0000017 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.doximity.com/role/IntangibleAssets">
        <link:definition>0000018 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStock" roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStock">
        <link:definition>0000019 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.doximity.com/role/Equity">
        <link:definition>0000020 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholders" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders">
        <link:definition>0000021 - Disclosure - Net Income Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.doximity.com/role/IncomeTaxes">
        <link:definition>0000022 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://www.doximity.com/role/CommitmentandContingencies">
        <link:definition>0000023 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.doximity.com/role/Leases">
        <link:definition>0000024 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenet" roleURI="http://www.doximity.com/role/OtherIncomenet">
        <link:definition>0000025 - Disclosure - Other Income, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlan" roleURI="http://www.doximity.com/role/EmployeeBenefitPlan">
        <link:definition>0000026 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.doximity.com/role/SegmentandGeographicInformation">
        <link:definition>0000027 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummarySignificantAccountingPoliciesPolicies" roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies">
        <link:definition>0000028 - Disclosure - Summary Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummarySignificantAccountingPoliciesTables" roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables">
        <link:definition>0000029 - Disclosure - Summary Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.doximity.com/role/RevenueRecognitionTables">
        <link:definition>0000030 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.doximity.com/role/InvestmentsTables">
        <link:definition>0000031 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.doximity.com/role/FairValueMeasurementsTables">
        <link:definition>0000032 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTables">
        <link:definition>0000033 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesTables" roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables">
        <link:definition>0000034 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.doximity.com/role/BusinessCombinationsTables">
        <link:definition>0000035 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.doximity.com/role/IntangibleAssetsTables">
        <link:definition>0000036 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.doximity.com/role/EquityTables">
        <link:definition>0000037 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholdersTables" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables">
        <link:definition>0000038 - Disclosure - Net Income Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.doximity.com/role/IncomeTaxesTables">
        <link:definition>0000039 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.doximity.com/role/LeasesTables">
        <link:definition>0000040 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenetTables" roleURI="http://www.doximity.com/role/OtherIncomenetTables">
        <link:definition>0000041 - Disclosure - Other Income, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessDetails" roleURI="http://www.doximity.com/role/DescriptionofBusinessDetails">
        <link:definition>0000042 - Disclosure - Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000043 - Disclosure - Summary of Significant Accounting Policies- Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" roleURI="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails">
        <link:definition>0000044 - Disclosure - Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
        <link:definition>0000045 - Disclosure - Summary of Significant Accounting Policies- Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationofRevenueDetails" roleURI="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails">
        <link:definition>0000046 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDeferredRevenueContractBalanceDetails" roleURI="http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails">
        <link:definition>0000047 - Disclosure - Revenue Recognition - Deferred Revenue Contract Balance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>0000048 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails">
        <link:definition>0000049 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1">
        <link:definition>0000049 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" roleURI="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails">
        <link:definition>0000050 - Disclosure - Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.doximity.com/role/InvestmentsNarrativeDetails">
        <link:definition>0000051 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" roleURI="http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails">
        <link:definition>0000052 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails" roleURI="http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails">
        <link:definition>0000053 - Disclosure - Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails">
        <link:definition>0000054 - Disclosure - Property and Equipment, Net - Total Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetNarrativeDetails" roleURI="http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails">
        <link:definition>0000055 - Disclosure - Property and Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>0000056 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeDetails" roleURI="http://www.doximity.com/role/BusinessCombinationsNarrativeDetails">
        <link:definition>0000057 - Disclosure - Business Combinations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchaseConsiderationAllocationDetails" roleURI="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails">
        <link:definition>0000058 - Disclosure - Business Combinations - Purchase Consideration Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchaseConsiderationAllocationDetails_1" roleURI="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1">
        <link:definition>0000058 - Disclosure - Business Combinations - Purchase Consideration Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsIntangibleAssetsNetDetails" roleURI="http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails">
        <link:definition>0000059 - Disclosure - Intangible Assets - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.doximity.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>0000060 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsFutureAmortizationExpenseDetails" roleURI="http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails">
        <link:definition>0000061 - Disclosure - Intangible Assets - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsChangesinCarryingAmountofGoodwillDetails" roleURI="http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails">
        <link:definition>0000062 - Disclosure - Intangible Assets - Changes in Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockDetails" roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails">
        <link:definition>0000063 - Disclosure - Redeemable Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityNarrativeDetails" roleURI="http://www.doximity.com/role/EquityNarrativeDetails">
        <link:definition>0000064 - Disclosure - Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityCommonStockReservedforIssuanceDetails" roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails">
        <link:definition>0000065 - Disclosure - Equity - Common Stock Reserved for Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockOptionActivityDetails" roleURI="http://www.doximity.com/role/EquityStockOptionActivityDetails">
        <link:definition>0000066 - Disclosure - Equity - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockOptionsValuationAssumptionsDetails" roleURI="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails">
        <link:definition>0000067 - Disclosure - Equity - Stock Options Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityRestrictedStockUnitActivityDetails" roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails">
        <link:definition>0000068 - Disclosure - Equity - Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityPerformanceBasedRestrictedStockUnitsActivityDetails" roleURI="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails">
        <link:definition>0000069 - Disclosure - Equity - Performance-Based Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockBasedCompensationExpenseDetails" roleURI="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails">
        <link:definition>0000070 - Disclosure - Equity - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails">
        <link:definition>0000071 - Disclosure - Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails">
        <link:definition>0000072 - Disclosure - Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails">
        <link:definition>0000073 - Disclosure - Income Taxes - Schedule of Income Tax Expense Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>0000074 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000075 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.doximity.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000076 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails" roleURI="http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails">
        <link:definition>0000077 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://www.doximity.com/role/CommitmentandContingenciesDetails">
        <link:definition>0000078 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.doximity.com/role/LeasesNarrativeDetails">
        <link:definition>0000079 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofLeaseExpenseDetails" roleURI="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails">
        <link:definition>0000080 - Disclosure - Leases - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>0000082 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>0000083 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>0000083 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenetDetails" roleURI="http://www.doximity.com/role/OtherIncomenetDetails">
        <link:definition>0000084 - Disclosure - Other Income, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanDetails" roleURI="http://www.doximity.com/role/EmployeeBenefitPlanDetails">
        <link:definition>0000085 - Disclosure - Employee Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationDetails" roleURI="http://www.doximity.com/role/SegmentandGeographicInformationDetails">
        <link:definition>0000086 - Disclosure - Segment and Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" abstract="false" name="PartnershipsAgreementPeriodBeforeTerminationIsPermitted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" abstract="false" name="DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_IndividualsWithVotingInterestLessThanThresholdMember" abstract="true" name="IndividualsWithVotingInterestLessThanThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" abstract="false" name="CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" abstract="true" name="SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" abstract="false" name="DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_WarrantsAndRightsOutstandingVestingPeriod" abstract="false" name="WarrantsAndRightsOutstandingVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_StockIssuancesCostsIncurredButNotYetPaid" abstract="false" name="StockIssuancesCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_PerformanceBasedRestrictedStockUnitsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" abstract="false" name="BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_HostingArrangementPeriod" abstract="false" name="HostingArrangementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_HostingArrangementAnnualCommitment" abstract="false" name="HostingArrangementAnnualCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="docs_THMEDLLCMember" abstract="true" name="THMEDLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ContractWithCustomerLiabilityAdditionsNet" abstract="false" name="ContractWithCustomerLiabilityAdditionsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" abstract="false" name="DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" abstract="false" name="ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" abstract="false" name="PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_USNewsWarrantMember" abstract="true" name="USNewsWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_PartnershipAgreementExtensionPeriod" abstract="false" name="PartnershipAgreementExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" abstract="true" name="DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" abstract="false" name="PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_ContractWithUSNewsWorldReportLPMember" abstract="true" name="ContractWithUSNewsWorldReportLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" abstract="false" name="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" abstract="false" name="DebtSecuritiesAvailableForSaleWithNoCreditAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_EscrowDepositsRelatedToSaleOfBusiness" abstract="false" name="EscrowDepositsRelatedToSaleOfBusiness" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" abstract="false" name="PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_SubscriptionMarketingSolutionsMember" abstract="true" name="SubscriptionMarketingSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_CommonStockVotingRightsNumberOfVotes" abstract="false" name="CommonStockVotingRightsNumberOfVotes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember" abstract="true" name="ShareBasedPaymentArrangementSubsequentToTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" abstract="false" name="APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_AMiONMember" abstract="true" name="AMiONMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPayablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" abstract="false" name="ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_FurnitureAndEquipmentMember" abstract="true" name="FurnitureAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" abstract="false" name="CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ConversionOfStockConversionRatio" abstract="false" name="ConversionOfStockConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="docs_ContractWithCustomerTerm" abstract="false" name="ContractWithCustomerTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_EmployeeStockPurchasePlan2021Member" abstract="true" name="EmployeeStockPurchasePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_RebateLiabilitiesCurrent" abstract="false" name="RebateLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_StockOptionAndIncentivePlan2021Member" abstract="true" name="StockOptionAndIncentivePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_TemporaryEquityTextBlock" abstract="false" name="TemporaryEquityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_EquityIncentivePlan2010Member" abstract="true" name="EquityIncentivePlan2010Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_IndividualsWithVotingInterestAtThresholdMember" abstract="true" name="IndividualsWithVotingInterestAtThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="docs_OfficeSpaceLeaseInIrvingTexasMember" abstract="true" name="OfficeSpaceLeaseInIrvingTexasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_CustomerAMember" abstract="true" name="CustomerAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_OtherShareBasedAwardsMember" abstract="true" name="OtherShareBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="docs_IncreaseDecreaseInCapitalizedContractCost" abstract="false" name="IncreaseDecreaseInCapitalizedContractCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" abstract="false" name="AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" abstract="false" name="RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_SubscriptionMember" abstract="true" name="SubscriptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_AccruedEmployeeStockPurchasePlanCurrent" abstract="false" name="AccruedEmployeeStockPurchasePlanCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" abstract="true" name="ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="docs_CapitalizedContractCostAdditions" abstract="false" name="CapitalizedContractCostAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_StockIssuedAcquisitions" abstract="false" name="StockIssuedAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" abstract="false" name="DebtSecuritiesAvailableForSaleImpairmentsLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" abstract="true" name="InitialPublicOfferingIncludingOverAllotmentOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_PortionOfCurativeTalentLLCMember" abstract="true" name="PortionOfCurativeTalentLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" abstract="false" name="PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_SubscriptionHiringSolutionsMember" abstract="true" name="SubscriptionHiringSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ClassOfWarrantOrRightExercisesInPeriod" abstract="false" name="ClassOfWarrantOrRightExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" abstract="false" name="ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>docs-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4d1277b4-10a9-4732-8720-53d63c4cfd14,g:0c268704-e9e1-4ac2-87ff-5caa0e49a51f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_15e9ff1c-9bb8-493d-bfc3-03afce6791af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c89a8fc2-585b-4a33-bd02-50614032f859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_15e9ff1c-9bb8-493d-bfc3-03afce6791af" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c89a8fc2-585b-4a33-bd02-50614032f859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7e8c169f-4ae2-43c5-a250-9ad6cecf14e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_15e9ff1c-9bb8-493d-bfc3-03afce6791af" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7e8c169f-4ae2-43c5-a250-9ad6cecf14e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e4930152-f5c8-4a47-9677-ca8869244e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_15e9ff1c-9bb8-493d-bfc3-03afce6791af" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e4930152-f5c8-4a47-9677-ca8869244e3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2e239a85-5991-4100-a72f-170828c7ed43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_15e9ff1c-9bb8-493d-bfc3-03afce6791af" xlink:to="loc_us-gaap_AccountsPayableCurrent_2e239a85-5991-4100-a72f-170828c7ed43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d5a11da-76bf-417b-a7bd-70965cda7db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d9d989bc-f661-425c-82c2-305c3518f09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d5a11da-76bf-417b-a7bd-70965cda7db2" xlink:to="loc_us-gaap_Liabilities_d9d989bc-f661-425c-82c2-305c3518f09d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c4373394-cf50-419d-a2eb-f07cfb2ce70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d5a11da-76bf-417b-a7bd-70965cda7db2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c4373394-cf50-419d-a2eb-f07cfb2ce70f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0fc70ad4-88b5-44cc-a726-1e848d1499f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d5a11da-76bf-417b-a7bd-70965cda7db2" xlink:to="loc_us-gaap_StockholdersEquity_0fc70ad4-88b5-44cc-a726-1e848d1499f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88e1af9d-a029-4ff4-a63f-cb828ddcccb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ed212abf-13ba-4fb5-9ad3-52308ae69d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88e1af9d-a029-4ff4-a63f-cb828ddcccb9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ed212abf-13ba-4fb5-9ad3-52308ae69d57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ceaf4a73-5a74-465b-a845-d50ea9529efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88e1af9d-a029-4ff4-a63f-cb828ddcccb9" xlink:to="loc_us-gaap_CommonStockValue_ceaf4a73-5a74-465b-a845-d50ea9529efa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a31c37bf-0aac-450c-8849-bcd8b6d745f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88e1af9d-a029-4ff4-a63f-cb828ddcccb9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a31c37bf-0aac-450c-8849-bcd8b6d745f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_9cb889d4-9c02-4c5f-99d5-f7eec9144839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88e1af9d-a029-4ff4-a63f-cb828ddcccb9" xlink:to="loc_us-gaap_AdditionalPaidInCapital_9cb889d4-9c02-4c5f-99d5-f7eec9144839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_62771a0d-7cb7-4eb6-899d-33e449750c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88e1af9d-a029-4ff4-a63f-cb828ddcccb9" xlink:to="loc_us-gaap_PreferredStockValue_62771a0d-7cb7-4eb6-899d-33e449750c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4e66091a-529a-43c9-a6d1-558679e1bce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:to="loc_us-gaap_Goodwill_4e66091a-529a-43c9-a6d1-558679e1bce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_865eab0f-e63a-4d63-91dd-eff3826a80ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_865eab0f-e63a-4d63-91dd-eff3826a80ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_65f8a040-f74c-41b2-8c70-16b8a219b592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:to="loc_us-gaap_AssetsCurrent_65f8a040-f74c-41b2-8c70-16b8a219b592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_63c50905-d2a2-458a-9349-23002687aa84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_63c50905-d2a2-458a-9349-23002687aa84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6435ecc1-46d6-4e8d-806a-e3348f5c0d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6435ecc1-46d6-4e8d-806a-e3348f5c0d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2d272d3f-a06a-4094-bfc7-9cc1dbe7e86f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2d272d3f-a06a-4094-bfc7-9cc1dbe7e86f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6fe7bb94-d824-4e3a-a60f-390126948cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4baec2b-2841-47e8-80ed-ace909f6f3aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6fe7bb94-d824-4e3a-a60f-390126948cc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fe1ede4d-597d-4903-a9fa-dc9f7d2026e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_5035089f-421f-4a15-b999-2a59ad5a7cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe1ede4d-597d-4903-a9fa-dc9f7d2026e2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_5035089f-421f-4a15-b999-2a59ad5a7cdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_be2634c6-f2fd-4ed8-af1c-59fc7e714692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe1ede4d-597d-4903-a9fa-dc9f7d2026e2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_be2634c6-f2fd-4ed8-af1c-59fc7e714692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_14ca907c-ab97-4052-a001-abdb55a3aeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe1ede4d-597d-4903-a9fa-dc9f7d2026e2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_14ca907c-ab97-4052-a001-abdb55a3aeb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bf3ed98b-d975-49b7-b913-e50a423681cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe1ede4d-597d-4903-a9fa-dc9f7d2026e2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bf3ed98b-d975-49b7-b913-e50a423681cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent_3fa9e121-017c-4a8f-87ae-e97e8d08ac77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe1ede4d-597d-4903-a9fa-dc9f7d2026e2" xlink:to="loc_us-gaap_CapitalizedContractCostNetCurrent_3fa9e121-017c-4a8f-87ae-e97e8d08ac77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4e4d4af3-6408-48ae-a487-d4f69bbe1356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_44ec2cd2-3a05-4cee-b5ed-63945304fb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e4d4af3-6408-48ae-a487-d4f69bbe1356" xlink:to="loc_us-gaap_LiabilitiesCurrent_44ec2cd2-3a05-4cee-b5ed-63945304fb6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_31ca1bd1-4192-4001-a3cb-47ae964f4634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e4d4af3-6408-48ae-a487-d4f69bbe1356" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_31ca1bd1-4192-4001-a3cb-47ae964f4634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_75083aa2-11f3-410a-8ef5-aafe4ff8a88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e4d4af3-6408-48ae-a487-d4f69bbe1356" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_75083aa2-11f3-410a-8ef5-aafe4ff8a88f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_58754e00-d05f-41bc-b283-36cd5fd963ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e4d4af3-6408-48ae-a487-d4f69bbe1356" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_58754e00-d05f-41bc-b283-36cd5fd963ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f0713dcb-2b68-4614-9df3-9382fb48bcbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e4d4af3-6408-48ae-a487-d4f69bbe1356" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f0713dcb-2b68-4614-9df3-9382fb48bcbe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de1450a9-a61c-45d9-928e-a704a9170048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_21320202-f502-4ca3-9a9c-e3b765619613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de1450a9-a61c-45d9-928e-a704a9170048" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_21320202-f502-4ca3-9a9c-e3b765619613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_065becd9-a09f-4521-b869-6c11bf0ddcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de1450a9-a61c-45d9-928e-a704a9170048" xlink:to="loc_us-gaap_OperatingIncomeLoss_065becd9-a09f-4521-b869-6c11bf0ddcf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7925374b-8ce4-4a54-8f7b-50ade4ce8bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ed5a6524-85b7-4d3d-89c9-0a0c51ac7c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7925374b-8ce4-4a54-8f7b-50ade4ce8bbf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ed5a6524-85b7-4d3d-89c9-0a0c51ac7c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a39aeee-b9ee-4b37-855a-cccad43f598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7925374b-8ce4-4a54-8f7b-50ade4ce8bbf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a39aeee-b9ee-4b37-855a-cccad43f598d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bbc69977-4afd-4fbf-97f0-33c6a4d608e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2aedfeb5-4b22-49c8-9cc1-6d3d3869ccd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bbc69977-4afd-4fbf-97f0-33c6a4d608e0" xlink:to="loc_us-gaap_GrossProfit_2aedfeb5-4b22-49c8-9cc1-6d3d3869ccd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f818420f-824f-4994-b6e7-e43ce2263a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bbc69977-4afd-4fbf-97f0-33c6a4d608e0" xlink:to="loc_us-gaap_OperatingExpenses_f818420f-824f-4994-b6e7-e43ce2263a37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8ccfcede-95ed-42e1-896c-14ef0c2d26c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dea26376-afb9-449f-9699-5e2a78a3ea87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8ccfcede-95ed-42e1-896c-14ef0c2d26c3" xlink:to="loc_us-gaap_NetIncomeLoss_dea26376-afb9-449f-9699-5e2a78a3ea87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_64f866c5-a70f-4f6b-8861-62610a72bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8ccfcede-95ed-42e1-896c-14ef0c2d26c3" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_64f866c5-a70f-4f6b-8861-62610a72bd53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ec5175ff-18d2-4b4f-96ac-1c753f755851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8cdac150-a0ef-42b3-86c2-36dda6f634e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ec5175ff-18d2-4b4f-96ac-1c753f755851" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8cdac150-a0ef-42b3-86c2-36dda6f634e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_a3ff9806-056a-4473-94fd-04d84656fca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ec5175ff-18d2-4b4f-96ac-1c753f755851" xlink:to="loc_us-gaap_CostOfRevenue_a3ff9806-056a-4473-94fd-04d84656fca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_85e1e3da-89f8-47e9-82e3-a48f2c3bab76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_92c942f0-f039-4d61-8b74-9773dbfd82d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_85e1e3da-89f8-47e9-82e3-a48f2c3bab76" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_92c942f0-f039-4d61-8b74-9773dbfd82d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_7c8b3958-d688-4ae0-9719-b0b8fcd6e8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_85e1e3da-89f8-47e9-82e3-a48f2c3bab76" xlink:to="loc_us-gaap_SellingAndMarketingExpense_7c8b3958-d688-4ae0-9719-b0b8fcd6e8f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f2682eb5-2fea-4e67-ba2f-052ba3f26f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_85e1e3da-89f8-47e9-82e3-a48f2c3bab76" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f2682eb5-2fea-4e67-ba2f-052ba3f26f9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_0a786b97-1620-4977-90d3-46c163141f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_278db659-9593-4e8e-9361-08d924c5894b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_0a786b97-1620-4977-90d3-46c163141f09" xlink:to="loc_us-gaap_NetIncomeLoss_278db659-9593-4e8e-9361-08d924c5894b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_e3a2b160-6fa1-46fd-bd61-5d89c6719872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_0a786b97-1620-4977-90d3-46c163141f09" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_e3a2b160-6fa1-46fd-bd61-5d89c6719872" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bc6f6ab-3491-4325-84c7-4a21a6714dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_03420d32-2fbd-46d7-ad80-e2e0953ddf85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bc6f6ab-3491-4325-84c7-4a21a6714dc3" xlink:to="loc_us-gaap_NetIncomeLoss_03420d32-2fbd-46d7-ad80-e2e0953ddf85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_60b031d1-1156-4e31-852d-5f95cc85173c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bc6f6ab-3491-4325-84c7-4a21a6714dc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_60b031d1-1156-4e31-852d-5f95cc85173c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5cfb86e8-7cfb-4b3c-9094-749ef6e48308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_NetIncomeLoss_5cfb86e8-7cfb-4b3c-9094-749ef6e48308" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_57a65132-dea4-432b-a362-b1d375ab0b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_57a65132-dea4-432b-a362-b1d375ab0b15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_668db66c-0cae-4ff0-a8bd-a6bcdf9541ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_668db66c-0cae-4ff0-a8bd-a6bcdf9541ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IncreaseDecreaseInCapitalizedContractCost_b4633a60-5bae-44bb-83f2-4d68007f3917" xlink:href="docs-20230331.xsd#docs_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_docs_IncreaseDecreaseInCapitalizedContractCost_b4633a60-5bae-44bb-83f2-4d68007f3917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_44772440-e9f0-4a43-a9d8-28df600c5a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_44772440-e9f0-4a43-a9d8-28df600c5a48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c7a2be06-4634-4068-b7c3-90c55557da0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c7a2be06-4634-4068-b7c3-90c55557da0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4f870971-e33d-4fef-9e6b-4d42c6d0d6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_ShareBasedCompensation_4f870971-e33d-4fef-9e6b-4d42c6d0d6a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_de156efd-3c60-4e16-a00e-2b744944c304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_de156efd-3c60-4e16-a00e-2b744944c304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_31e31e55-3e46-4920-86a3-b3d75b3ea103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_31e31e55-3e46-4920-86a3-b3d75b3ea103" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_01cc653c-2f5a-4fc3-b396-a58034fbad9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_01cc653c-2f5a-4fc3-b396-a58034fbad9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_747f2d1c-c73c-4617-ad82-a854eec27b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_747f2d1c-c73c-4617-ad82-a854eec27b15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_6ceb648c-7bf0-4672-a877-1b193ab10002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_6ceb648c-7bf0-4672-a877-1b193ab10002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_60a0e31a-8991-4900-8dc3-0e16457522ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_60a0e31a-8991-4900-8dc3-0e16457522ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_ac614194-8d4c-4d5b-823b-9914c95f240e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_ac614194-8d4c-4d5b-823b-9914c95f240e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b59c09e0-4f3a-40c7-a05e-06a4cd75dbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b59c09e0-4f3a-40c7-a05e-06a4cd75dbe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_86f4d6a6-3381-4597-bf2a-cb9b5eabbfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_640bb620-bb7b-4f2a-9bdd-e9f25baf517b" xlink:to="loc_us-gaap_GainLossOnInvestments_86f4d6a6-3381-4597-bf2a-cb9b5eabbfa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd5d54e7-204d-46dd-8f38-54624ff103c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_c614f8b8-2a90-4202-82c8-41179f86dd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd5d54e7-204d-46dd-8f38-54624ff103c5" xlink:to="loc_us-gaap_ProceedsFromStockPlans_c614f8b8-2a90-4202-82c8-41179f86dd24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9be9412a-c245-4888-b10e-95ed368ce86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd5d54e7-204d-46dd-8f38-54624ff103c5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9be9412a-c245-4888-b10e-95ed368ce86e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1e65dd65-b472-4bc3-9d5f-7449ab51e88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd5d54e7-204d-46dd-8f38-54624ff103c5" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1e65dd65-b472-4bc3-9d5f-7449ab51e88b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_efbb06cd-4be5-4c8f-8b1a-fc03283edf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd5d54e7-204d-46dd-8f38-54624ff103c5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_efbb06cd-4be5-4c8f-8b1a-fc03283edf1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a175b55e-4d77-42cd-a784-4df1b2d4fdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd5d54e7-204d-46dd-8f38-54624ff103c5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a175b55e-4d77-42cd-a784-4df1b2d4fdcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b347ffe4-fab5-43de-8310-7f90b859982a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd5d54e7-204d-46dd-8f38-54624ff103c5" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b347ffe4-fab5-43de-8310-7f90b859982a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64fef53a-3b4d-475b-a6de-8c54c0a42a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d11b7b0a-aca0-4a8f-902d-d81354d6c5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64fef53a-3b4d-475b-a6de-8c54c0a42a1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d11b7b0a-aca0-4a8f-902d-d81354d6c5f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79cd9fde-57b2-4abe-88af-8b7aa5deaeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64fef53a-3b4d-475b-a6de-8c54c0a42a1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79cd9fde-57b2-4abe-88af-8b7aa5deaeb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34bd5ffa-be92-4733-ae68-e9cfa02ab9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64fef53a-3b4d-475b-a6de-8c54c0a42a1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34bd5ffa-be92-4733-ae68-e9cfa02ab9e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_b65fc3b7-bde4-4820-8201-63c5f9fcad15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_b65fc3b7-bde4-4820-8201-63c5f9fcad15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_6ab54bef-e7d9-46a8-bd45-33bed026e77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_6ab54bef-e7d9-46a8-bd45-33bed026e77b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_96a8c4d4-f527-4f39-a457-ec2b9c1ebc01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_96a8c4d4-f527-4f39-a457-ec2b9c1ebc01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f296bb1-3545-4e33-a48e-90496fa2732e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f296bb1-3545-4e33-a48e-90496fa2732e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_a2db0172-7134-4188-b4a4-235744c58c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_a2db0172-7134-4188-b4a4-235744c58c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_e239718d-991e-4d84-bd81-181fb613f9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_e239718d-991e-4d84-bd81-181fb613f9d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_efc1359d-5b95-4cc7-a5e9-9d35f5524d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_efc1359d-5b95-4cc7-a5e9-9d35f5524d6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bd989247-a2b6-44cc-8e8b-7f9080492734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31872f55-7198-4e9b-ada2-423c2c51163f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bd989247-a2b6-44cc-8e8b-7f9080492734" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_44069627-5140-4ab1-8716-55e23a34e9cf" xlink:href="docs-20230331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_4a6a7bb7-e5c6-4ee0-9d36-08ad82ac1af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_44069627-5140-4ab1-8716-55e23a34e9cf" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_4a6a7bb7-e5c6-4ee0-9d36-08ad82ac1af8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_985f6d3e-679f-4364-acf8-dd0dae98f8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_44069627-5140-4ab1-8716-55e23a34e9cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_985f6d3e-679f-4364-acf8-dd0dae98f8b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_26b16f27-0aa8-4702-af1e-f5770b26ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_44069627-5140-4ab1-8716-55e23a34e9cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_26b16f27-0aa8-4702-af1e-f5770b26ab65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_9113385f-55b6-4bef-8a36-c4cf8a8e80f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0b29d0d0-4cd0-437a-badd-f87374e5482f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_9113385f-55b6-4bef-8a36-c4cf8a8e80f9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0b29d0d0-4cd0-437a-badd-f87374e5482f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c54dd7a4-b211-43c7-a9bc-3c5e204fbc7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_9113385f-55b6-4bef-8a36-c4cf8a8e80f9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c54dd7a4-b211-43c7-a9bc-3c5e204fbc7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_107edd12-5273-432d-966b-b3971f9e3cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_9113385f-55b6-4bef-8a36-c4cf8a8e80f9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_107edd12-5273-432d-966b-b3971f9e3cae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d8288d0a-f978-42db-abfc-ff06b086992a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_55cb4eb7-b9c8-46c4-b9d0-8b80f17521e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d8288d0a-f978-42db-abfc-ff06b086992a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_55cb4eb7-b9c8-46c4-b9d0-8b80f17521e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_25866c17-2ff6-4909-8685-37c6bf27a12d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d8288d0a-f978-42db-abfc-ff06b086992a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_25866c17-2ff6-4909-8685-37c6bf27a12d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_10a68adc-61ca-4b78-9466-ee1c6b994f01" xlink:href="docs-20230331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8d4dcc55-d9f1-4437-a550-2d7f647a414d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_10a68adc-61ca-4b78-9466-ee1c6b994f01" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8d4dcc55-d9f1-4437-a550-2d7f647a414d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_25ddbc03-ddbc-44e7-8993-7c0d131f1bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_10a68adc-61ca-4b78-9466-ee1c6b994f01" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_25ddbc03-ddbc-44e7-8993-7c0d131f1bb9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f0266823-bfb9-4455-bc49-a8ea47faca94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0e478f40-440f-49b7-9a28-7f9d1bd7553a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f0266823-bfb9-4455-bc49-a8ea47faca94" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0e478f40-440f-49b7-9a28-7f9d1bd7553a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ffbae411-5b41-4a5d-8d5f-f9de7ea385af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f0266823-bfb9-4455-bc49-a8ea47faca94" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ffbae411-5b41-4a5d-8d5f-f9de7ea385af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo_b1887ebf-86fc-4ecc-8f5c-90cf04723410" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f0266823-bfb9-4455-bc49-a8ea47faca94" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo_b1887ebf-86fc-4ecc-8f5c-90cf04723410" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b19485a9-b02b-49c2-b1bd-c6a7030c0fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dfc66b1b-1b50-48ce-9960-b35474b708bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b19485a9-b02b-49c2-b1bd-c6a7030c0fe6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dfc66b1b-1b50-48ce-9960-b35474b708bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_20bd1866-c899-4289-a693-0c97aa1ebb98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f0221ff8-4b23-489a-a952-3fca97cf5dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_20bd1866-c899-4289-a693-0c97aa1ebb98" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f0221ff8-4b23-489a-a952-3fca97cf5dec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_286dec49-83be-467e-83b7-9b35aab69c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_20bd1866-c899-4289-a693-0c97aa1ebb98" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_286dec49-83be-467e-83b7-9b35aab69c18" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_9f61d7e4-480b-415c-9bb1-3e36105bdab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_9f61d7e4-480b-415c-9bb1-3e36105bdab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d8ad1320-daf6-4b34-899e-3d8e34101c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d8ad1320-daf6-4b34-899e-3d8e34101c27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RebateLiabilitiesCurrent_8da6ec54-d185-40fc-8f10-86d94c1285f1" xlink:href="docs-20230331.xsd#docs_RebateLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:to="loc_docs_RebateLiabilitiesCurrent_8da6ec54-d185-40fc-8f10-86d94c1285f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_81b886e6-44e5-40bd-bed6-4dfe9c70458f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:to="loc_us-gaap_TaxesPayableCurrent_81b886e6-44e5-40bd-bed6-4dfe9c70458f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_82577a90-791b-4af4-b547-55df02c9b860" xlink:href="docs-20230331.xsd#docs_AccruedEmployeeStockPurchasePlanCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:to="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_82577a90-791b-4af4-b547-55df02c9b860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f3c49a37-3d0a-4818-befd-5cdfec68d62e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f3c49a37-3d0a-4818-befd-5cdfec68d62e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_a5433fc5-d45f-4b14-8eea-db7d6a3333a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e633a6d0-79fa-4d3b-b1bd-756e9127c44f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_a5433fc5-d45f-4b14-8eea-db7d6a3333a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsPurchaseConsiderationAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_726a70c8-13c2-4aaa-b423-bae6ad273cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e0015670-2879-45b0-998f-a839148977ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_726a70c8-13c2-4aaa-b423-bae6ad273cf4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e0015670-2879-45b0-998f-a839148977ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_5dc83fe3-af26-4bb5-9f7b-810ec7c63a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_726a70c8-13c2-4aaa-b423-bae6ad273cf4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_5dc83fe3-af26-4bb5-9f7b-810ec7c63a62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2ca74a78-92bd-4afe-99a5-22076f825049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_726a70c8-13c2-4aaa-b423-bae6ad273cf4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2ca74a78-92bd-4afe-99a5-22076f825049" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_70270880-7cc9-4141-b5db-de1152d3b71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_99c96217-f336-46be-8479-5a93ea4822be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_70270880-7cc9-4141-b5db-de1152d3b71b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_99c96217-f336-46be-8479-5a93ea4822be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e38473de-ea11-46a3-b578-f67caf05dfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_70270880-7cc9-4141-b5db-de1152d3b71b" xlink:to="loc_us-gaap_Goodwill_e38473de-ea11-46a3-b578-f67caf05dfe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5a6fa2b8-1a16-4989-8cd3-39f8b89da747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_be775c3a-f5e7-40e7-b9dc-5082a062c0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5a6fa2b8-1a16-4989-8cd3-39f8b89da747" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_be775c3a-f5e7-40e7-b9dc-5082a062c0a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_002909af-4909-4938-a243-134df12a190f" xlink:href="docs-20230331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5a6fa2b8-1a16-4989-8cd3-39f8b89da747" xlink:to="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_002909af-4909-4938-a243-134df12a190f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0425f7bf-46ef-4d74-8e4f-4093875f5915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5a6fa2b8-1a16-4989-8cd3-39f8b89da747" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0425f7bf-46ef-4d74-8e4f-4093875f5915" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f6812447-698a-4865-b067-0e9bab553641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5a6fa2b8-1a16-4989-8cd3-39f8b89da747" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f6812447-698a-4865-b067-0e9bab553641" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsPurchaseConsiderationAllocationDetails_1"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_76024515-2f3d-445e-a04c-aee10ef13211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b39e83e5-1016-4004-8de7-3a29f0d18d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_76024515-2f3d-445e-a04c-aee10ef13211" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b39e83e5-1016-4004-8de7-3a29f0d18d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee778f9f-42e5-48c3-b6b0-b4bad41a549d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_76024515-2f3d-445e-a04c-aee10ef13211" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee778f9f-42e5-48c3-b6b0-b4bad41a549d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82abefa5-67e4-4964-8505-80aad2c3d9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c23065d6-5288-4982-adcc-25f92cddf042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82abefa5-67e4-4964-8505-80aad2c3d9cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c23065d6-5288-4982-adcc-25f92cddf042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0f2a8fc6-227e-4a00-9618-57664d7ff65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_82abefa5-67e4-4964-8505-80aad2c3d9cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0f2a8fc6-227e-4a00-9618-57664d7ff65b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d69920da-9656-4828-ace4-fc6a29586a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_bf80b3ac-1ff2-4bf3-8d5c-0559c4dc3805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d69920da-9656-4828-ace4-fc6a29586a9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_bf80b3ac-1ff2-4bf3-8d5c-0559c4dc3805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2482df14-26c6-47ba-a2bc-cb4be3195d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d69920da-9656-4828-ace4-fc6a29586a9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2482df14-26c6-47ba-a2bc-cb4be3195d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c6678f98-f664-4c8b-a560-67f25d8baf70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d69920da-9656-4828-ace4-fc6a29586a9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c6678f98-f664-4c8b-a560-67f25d8baf70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a65a58ab-e14c-4e07-8ec4-a459edf91053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d69920da-9656-4828-ace4-fc6a29586a9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a65a58ab-e14c-4e07-8ec4-a459edf91053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_af0223b1-4340-477e-974a-0fe41873a947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d69920da-9656-4828-ace4-fc6a29586a9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_af0223b1-4340-477e-974a-0fe41873a947" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8ba70736-748d-49a7-a057-b8121a1bc2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d69920da-9656-4828-ace4-fc6a29586a9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8ba70736-748d-49a7-a057-b8121a1bc2be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityCommonStockReservedforIssuanceDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_31b2a31a-5eb7-4c01-9abe-5716495f1134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3f09a6e-cb5b-4f39-b6ff-77141ce49e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_31b2a31a-5eb7-4c01-9abe-5716495f1134" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3f09a6e-cb5b-4f39-b6ff-77141ce49e67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_37025daf-86e5-497a-8f03-830f4bc25e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_31b2a31a-5eb7-4c01-9abe-5716495f1134" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_37025daf-86e5-497a-8f03-830f4bc25e8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8cea6e91-f274-413f-882d-42fce9332fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_31b2a31a-5eb7-4c01-9abe-5716495f1134" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8cea6e91-f274-413f-882d-42fce9332fef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e758d55a-e847-469b-b3ed-832690605ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_31b2a31a-5eb7-4c01-9abe-5716495f1134" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e758d55a-e847-469b-b3ed-832690605ce1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2a677d48-cd53-4e70-84d6-d62d82349a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_9c0470d3-a2c4-4a45-a07e-017bbb46bc70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2a677d48-cd53-4e70-84d6-d62d82349a6c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_9c0470d3-a2c4-4a45-a07e-017bbb46bc70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_74300d80-89f9-4c39-8764-8a3573d6e96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2a677d48-cd53-4e70-84d6-d62d82349a6c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_74300d80-89f9-4c39-8764-8a3573d6e96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b89afdf1-6634-40bc-9277-25604f7b6575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2a677d48-cd53-4e70-84d6-d62d82349a6c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b89afdf1-6634-40bc-9277-25604f7b6575" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_06107bce-d254-4cc6-b8cf-b605e84bfe02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3f217f73-a562-4138-9b0a-078fc92466a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_06107bce-d254-4cc6-b8cf-b605e84bfe02" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3f217f73-a562-4138-9b0a-078fc92466a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9aef5dd4-25d2-4823-9769-bad1ae554f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_06107bce-d254-4cc6-b8cf-b605e84bfe02" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9aef5dd4-25d2-4823-9769-bad1ae554f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_b5f5ade2-b55b-4810-8cc0-326230c0fa31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6edd4004-eeca-40cb-8ed8-732f34f619d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_b5f5ade2-b55b-4810-8cc0-326230c0fa31" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6edd4004-eeca-40cb-8ed8-732f34f619d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ea307fa6-e7e1-4455-b0de-949e7c4a5736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_b5f5ade2-b55b-4810-8cc0-326230c0fa31" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ea307fa6-e7e1-4455-b0de-949e7c4a5736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_79535e7e-5c18-45a8-abbd-956636494d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_06b4500c-a9c2-4d52-9558-ad160251d3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79535e7e-5c18-45a8-abbd-956636494d6f" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_06b4500c-a9c2-4d52-9558-ad160251d3e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_4177c239-9c72-44df-b027-d7c06ba537f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79535e7e-5c18-45a8-abbd-956636494d6f" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_4177c239-9c72-44df-b027-d7c06ba537f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_d0c74ec7-bdc7-45fe-ae0d-49f496fcedc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_d0c74ec7-bdc7-45fe-ae0d-49f496fcedc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_cea9a3c3-313c-48ab-b16c-aadd8de94cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_cea9a3c3-313c-48ab-b16c-aadd8de94cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ec8ce999-1921-4337-a517-770e5a875029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ec8ce999-1921-4337-a517-770e5a875029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f2a6f99c-8dc6-43f4-8722-be79c1ffec02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f2a6f99c-8dc6-43f4-8722-be79c1ffec02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_8b390029-343b-4f41-a6da-c0dced2decb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_8b390029-343b-4f41-a6da-c0dced2decb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_2dcd1510-826e-460a-9b9d-aa0a09f560c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_2dcd1510-826e-460a-9b9d-aa0a09f560c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_36f55fcd-d738-443b-b843-ef8130e4d12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ef56ceeb-2fc0-4cdd-b777-b211dddd0088" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_36f55fcd-d738-443b-b843-ef8130e4d12c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_db3285e6-fa8f-4704-916c-4905b906433f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_58ff6302-f7bf-4699-9978-8b79f4110b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_db3285e6-fa8f-4704-916c-4905b906433f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_58ff6302-f7bf-4699-9978-8b79f4110b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0ce74d47-836c-4966-bcc8-734e95ea7b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_db3285e6-fa8f-4704-916c-4905b906433f" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_0ce74d47-836c-4966-bcc8-734e95ea7b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fd29542b-8f9b-4286-9fa5-a9a76a64d905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_bfb59870-68ec-4d05-afe7-8a6bbfc214f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fd29542b-8f9b-4286-9fa5-a9a76a64d905" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_bfb59870-68ec-4d05-afe7-8a6bbfc214f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_3453095b-8dbe-414e-b283-0ba36f12aaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fd29542b-8f9b-4286-9fa5-a9a76a64d905" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_3453095b-8dbe-414e-b283-0ba36f12aaab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2d34cb2e-6552-4cd8-9b1d-83ac2a715178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fd29542b-8f9b-4286-9fa5-a9a76a64d905" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2d34cb2e-6552-4cd8-9b1d-83ac2a715178" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsLeasingArrangements_c8a8f3d6-082e-4400-a27b-0877e4af1f5d" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_docs_DeferredTaxAssetsLeasingArrangements_c8a8f3d6-082e-4400-a27b-0877e4af1f5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7d0ab896-8680-4e2c-9679-87406aacc8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7d0ab896-8680-4e2c-9679-87406aacc8eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_ecedeedf-baf3-479d-ab2b-dc8695ad41b1" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_ecedeedf-baf3-479d-ab2b-dc8695ad41b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment_41062cf6-fb9a-45c4-85e6-5033d44219b9" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment_41062cf6-fb9a-45c4-85e6-5033d44219b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_50581813-508e-4961-8445-9b6a164f6515" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_50581813-508e-4961-8445-9b6a164f6515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_e646be0c-6f93-459c-98a8-0b16241fd026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_e646be0c-6f93-459c-98a8-0b16241fd026" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_f0452488-55e1-4fc3-9a63-e1306a177510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_f0452488-55e1-4fc3-9a63-e1306a177510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_963a787b-f1c4-457c-948b-2d635c5919a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5100918d-20f8-428c-9762-0634758d208d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_963a787b-f1c4-457c-948b-2d635c5919a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_db25dcac-96a6-4202-8e02-1deb493fe169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dea60992-b79a-4ccc-96c1-b240446a0da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_db25dcac-96a6-4202-8e02-1deb493fe169" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dea60992-b79a-4ccc-96c1-b240446a0da8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2d8e8fb1-00bf-44bf-b055-9c4fff56cca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_db25dcac-96a6-4202-8e02-1deb493fe169" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_2d8e8fb1-00bf-44bf-b055-9c4fff56cca6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_455e06ec-c8fc-491f-ac71-805b46f22221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_cb697fba-df0c-43f8-a52c-983825781462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_455e06ec-c8fc-491f-ac71-805b46f22221" xlink:to="loc_us-gaap_VariableLeaseCost_cb697fba-df0c-43f8-a52c-983825781462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_5edc6fbf-b633-4523-8800-19935584f4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_455e06ec-c8fc-491f-ac71-805b46f22221" xlink:to="loc_us-gaap_OperatingLeaseCost_5edc6fbf-b633-4523-8800-19935584f4cd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a05aaa2b-ac43-4a6c-8297-eaca7d941d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_711750a2-6806-4e99-a773-9f5eab78ffc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a05aaa2b-ac43-4a6c-8297-eaca7d941d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_711750a2-6806-4e99-a773-9f5eab78ffc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9d9aa569-fecf-4eea-a37c-73f5a419d598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a05aaa2b-ac43-4a6c-8297-eaca7d941d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9d9aa569-fecf-4eea-a37c-73f5a419d598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e3f37333-0b7f-41f4-b830-22d5696f873d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a05aaa2b-ac43-4a6c-8297-eaca7d941d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e3f37333-0b7f-41f4-b830-22d5696f873d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_294621c9-c025-48dd-bf38-39cbc60d758d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a05aaa2b-ac43-4a6c-8297-eaca7d941d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_294621c9-c025-48dd-bf38-39cbc60d758d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_89635350-4a84-4fff-9e5b-b7f523bb2bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a05aaa2b-ac43-4a6c-8297-eaca7d941d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_89635350-4a84-4fff-9e5b-b7f523bb2bae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_06d4aa2c-8809-4481-9fa5-30e10b3e7f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a05aaa2b-ac43-4a6c-8297-eaca7d941d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_06d4aa2c-8809-4481-9fa5-30e10b3e7f7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0bad381a-0b0f-4de0-9017-ea1dbc8075f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a13c8317-b074-44f8-9c49-5c18c1efa34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0bad381a-0b0f-4de0-9017-ea1dbc8075f0" xlink:to="loc_us-gaap_OperatingLeaseLiability_a13c8317-b074-44f8-9c49-5c18c1efa34a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fba4bff7-bda3-4f49-ab76-0aadb13bbd60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0bad381a-0b0f-4de0-9017-ea1dbc8075f0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fba4bff7-bda3-4f49-ab76-0aadb13bbd60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/OtherIncomenetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#OtherIncomenetDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/OtherIncomenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b1641d95-eec6-4663-a8c8-f1c0a7582ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_7e033efa-22eb-4373-97ff-4558be0cdc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_b1641d95-eec6-4663-a8c8-f1c0a7582ff0" xlink:to="loc_us-gaap_GainLossOnInvestments_7e033efa-22eb-4373-97ff-4558be0cdc69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5312d85c-0f39-4a5b-bc21-1ece2c598522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_b1641d95-eec6-4663-a8c8-f1c0a7582ff0" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5312d85c-0f39-4a5b-bc21-1ece2c598522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_a036be0a-4e51-4f31-af26-03278649162a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_b1641d95-eec6-4663-a8c8-f1c0a7582ff0" xlink:to="loc_us-gaap_OtherNonoperatingExpense_a036be0a-4e51-4f31-af26-03278649162a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_45c38506-ff07-4201-b1d4-1d3a1ea827d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_b1641d95-eec6-4663-a8c8-f1c0a7582ff0" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_45c38506-ff07-4201-b1d4-1d3a1ea827d4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>docs-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4d1277b4-10a9-4732-8720-53d63c4cfd14,g:0c268704-e9e1-4ac2-87ff-5caa0e49a51f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.doximity.com/role/CoverPage" xlink:type="simple" xlink:href="docs-20230331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/CoverPage" xlink:type="extended" id="i3e47bc16ef70445c9ee1975d1c459150_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ab9f2db5-56ef-4bb9-a67f-cf112358210d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentType_ab9f2db5-56ef-4bb9-a67f-cf112358210d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_5d2d0fdb-af3c-4a45-bb44-5397b3446d24" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentAnnualReport_5d2d0fdb-af3c-4a45-bb44-5397b3446d24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_29d3a7d7-6b54-4a33-88d3-caea2bbd6a47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentPeriodEndDate_29d3a7d7-6b54-4a33-88d3-caea2bbd6a47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_68596625-0354-4601-8458-00da93333e1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_CurrentFiscalYearEndDate_68596625-0354-4601-8458-00da93333e1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f0b4653d-5ff4-4671-8bb7-8ae8c48d8745" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentTransitionReport_f0b4653d-5ff4-4671-8bb7-8ae8c48d8745" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_aeb6dcd6-b2a5-4e85-adee-cf7942da728e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityFileNumber_aeb6dcd6-b2a5-4e85-adee-cf7942da728e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b1666d7d-a53d-4791-98ac-f81a8daddd21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityRegistrantName_b1666d7d-a53d-4791-98ac-f81a8daddd21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e33f2122-d138-44e4-8f2d-e9baba44690b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e33f2122-d138-44e4-8f2d-e9baba44690b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ceaee6af-40cc-447f-a45d-8d36bac76057" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityTaxIdentificationNumber_ceaee6af-40cc-447f-a45d-8d36bac76057" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e334736d-010b-4caa-96b3-054afeab6113" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressAddressLine1_e334736d-010b-4caa-96b3-054afeab6113" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_7d6358ac-af08-44b1-a1ea-fe467a132629" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressAddressLine2_7d6358ac-af08-44b1-a1ea-fe467a132629" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_058e08fd-dc93-4d18-8790-b5adae1d1dc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressCityOrTown_058e08fd-dc93-4d18-8790-b5adae1d1dc7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_723d1fc6-f556-4b9f-99dd-a37db943c057" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressStateOrProvince_723d1fc6-f556-4b9f-99dd-a37db943c057" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f8068ae7-8210-4179-b177-cab696f63239" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressPostalZipCode_f8068ae7-8210-4179-b177-cab696f63239" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_62422100-6faf-400a-8192-b59015ccf9ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_CityAreaCode_62422100-6faf-400a-8192-b59015ccf9ef" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0354b478-180d-4031-94f4-0a2a3cdd8848" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_LocalPhoneNumber_0354b478-180d-4031-94f4-0a2a3cdd8848" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0ef34e26-623b-4828-bf92-064b70e702a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_Security12bTitle_0ef34e26-623b-4828-bf92-064b70e702a1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d4c1536d-dc95-40c8-89b5-30e07f69b3d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_TradingSymbol_d4c1536d-dc95-40c8-89b5-30e07f69b3d9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e449a792-31a4-492c-aec3-efc565f0ede0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_SecurityExchangeName_e449a792-31a4-492c-aec3-efc565f0ede0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_3f5f962b-6343-4de9-8c40-332165999e88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_3f5f962b-6343-4de9-8c40-332165999e88" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_267092ac-e958-4950-843c-4bac5d77d901" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityVoluntaryFilers_267092ac-e958-4950-843c-4bac5d77d901" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_077eeaf6-4d23-4dbf-95b1-aac784e5a661" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityCurrentReportingStatus_077eeaf6-4d23-4dbf-95b1-aac784e5a661" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5b0c572d-13fb-4222-9f97-7bf64ccced48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityInteractiveDataCurrent_5b0c572d-13fb-4222-9f97-7bf64ccced48" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c22e6249-f266-430a-acac-5a7a8ccf2fb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityFilerCategory_c22e6249-f266-430a-acac-5a7a8ccf2fb0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c2aa75e1-b2ae-418c-a611-f94fb7104748" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntitySmallBusiness_c2aa75e1-b2ae-418c-a611-f94fb7104748" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7baeb2d6-c011-43b6-8977-be7844f84804" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityEmergingGrowthCompany_7baeb2d6-c011-43b6-8977-be7844f84804" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b50e7cc7-0671-49c4-8233-0307d7cedc26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b50e7cc7-0671-49c4-8233-0307d7cedc26" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_04794b22-379c-49bd-86ca-5d08bffe5053" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityShellCompany_04794b22-379c-49bd-86ca-5d08bffe5053" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_7aefa8a8-c083-4d88-a827-53f5c8de674e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityPublicFloat_7aefa8a8-c083-4d88-a827-53f5c8de674e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1cd18517-7f28-441f-bae0-efdd5c3ce4cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1cd18517-7f28-441f-bae0-efdd5c3ce4cd" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d58410d9-fa3e-4230-8df7-481875f96dd5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d58410d9-fa3e-4230-8df7-481875f96dd5" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5ce04db9-7a2c-42b1-a8fa-125f86cf13aa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityCentralIndexKey_5ce04db9-7a2c-42b1-a8fa-125f86cf13aa" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_1d7c32a3-a011-4673-98d2-71d431381f60" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentFiscalYearFocus_1d7c32a3-a011-4673-98d2-71d431381f60" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12bd9ed5-2165-4ac0-8f9e-5143cfc92e07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12bd9ed5-2165-4ac0-8f9e-5143cfc92e07" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e7da6fbf-3ba3-4a4e-a193-a7d33f09dea7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_AmendmentFlag_e7da6fbf-3ba3-4a4e-a193-a7d33f09dea7" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_fa6981ac-ff94-49bd-b8eb-b83dde660169" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentInformationTable_fa6981ac-ff94-49bd-b8eb-b83dde660169" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d7d782c8-9fe8-4715-a08c-7d91502a6265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_fa6981ac-ff94-49bd-b8eb-b83dde660169" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d7d782c8-9fe8-4715-a08c-7d91502a6265" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7d782c8-9fe8-4715-a08c-7d91502a6265_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d7d782c8-9fe8-4715-a08c-7d91502a6265" xlink:to="loc_us-gaap_ClassOfStockDomain_d7d782c8-9fe8-4715-a08c-7d91502a6265_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d7d782c8-9fe8-4715-a08c-7d91502a6265" xlink:to="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_c6057939-45d3-4de6-afd7-5d9b0b213d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:to="loc_us-gaap_CommonClassAMember_c6057939-45d3-4de6-afd7-5d9b0b213d62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_12ddd459-c3be-4d14-be78-41f7fb366b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:to="loc_us-gaap_CommonClassBMember_12ddd459-c3be-4d14-be78-41f7fb366b9f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i5a989228af314980935f650606fdabfb_CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e78cfeeb-9c1d-497d-8e30-51f85501fffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e78cfeeb-9c1d-497d-8e30-51f85501fffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d5ed002b-5535-498a-be69-deaca497d66b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d5ed002b-5535-498a-be69-deaca497d66b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5850164b-632e-4e34-a358-9b6ac297ff34" xlink:href="docs-20230331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5850164b-632e-4e34-a358-9b6ac297ff34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3357e39d-7250-4bec-bad5-714ac8da656b" xlink:href="docs-20230331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3357e39d-7250-4bec-bad5-714ac8da656b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_f9af1aba-8c47-4042-b041-960d0a41a09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1156ade8-c09b-4d0f-a3c0-e75a7aed7ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_3a9e43ba-a0af-4fde-8d73-210984f9608f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_SharesOutstanding_3a9e43ba-a0af-4fde-8d73-210984f9608f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3ee8af6c-63e2-4bab-8b50-6eb1031b6082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockholdersEquity_3ee8af6c-63e2-4bab-8b50-6eb1031b6082" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b981d54b-197e-4cda-be25-6ad1ddcdc436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b981d54b-197e-4cda-be25-6ad1ddcdc436" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_0e5a1ea5-e498-4263-9732-9b3644956ed0" xlink:href="docs-20230331.xsd#docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_0e5a1ea5-e498-4263-9732-9b3644956ed0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_8c857f51-1cd7-46ab-ba9d-d4585fa9e787" xlink:href="docs-20230331.xsd#docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_8c857f51-1cd7-46ab-ba9d-d4585fa9e787" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e7e7cefe-9c3b-489c-bec7-91905d955aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e7e7cefe-9c3b-489c-bec7-91905d955aaa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30281934-9580-485a-9a27-04533b53d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30281934-9580-485a-9a27-04533b53d58b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b261b7ff-98c6-469a-ac7b-95de4cc19d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b261b7ff-98c6-469a-ac7b-95de4cc19d4a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2276b646-3983-4cba-a26f-ad4eb49e3715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2276b646-3983-4cba-a26f-ad4eb49e3715" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_7b9a1f90-d898-437c-ac0e-febb34af14dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_7b9a1f90-d898-437c-ac0e-febb34af14dc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23cfb832-77d2-45e5-9cd3-1348d087faa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23cfb832-77d2-45e5-9cd3-1348d087faa3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ed517bf2-217f-4085-ae82-ad4a8705640d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ed517bf2-217f-4085-ae82-ad4a8705640d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e2e90726-173e-45ae-8801-e91729bcb15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e2e90726-173e-45ae-8801-e91729bcb15e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_6954e355-acc9-4fcf-bada-538fcfa7e4ca" xlink:href="docs-20230331.xsd#docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_6954e355-acc9-4fcf-bada-538fcfa7e4ca" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9be6bcb3-7afd-470d-817e-996668e3737a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9be6bcb3-7afd-470d-817e-996668e3737a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a14b55bb-f985-405a-9020-cdab2f755cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a14b55bb-f985-405a-9020-cdab2f755cee" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_58454fea-077d-44a1-b5d6-508315f47ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_58454fea-077d-44a1-b5d6-508315f47ecb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0960bbd6-e5f2-476e-a44f-7273038755f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0960bbd6-e5f2-476e-a44f-7273038755f6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_591945d8-9c80-447d-b834-1e38fe7c4606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_591945d8-9c80-447d-b834-1e38fe7c4606" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e74e1975-f21d-4cd7-ba81-d32fc6f1e1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e74e1975-f21d-4cd7-ba81-d32fc6f1e1e7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1455cebb-7d66-4238-97b7-06f2c2e05087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1455cebb-7d66-4238-97b7-06f2c2e05087" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bedb0c90-c46a-4ce4-b61b-3845a5c41ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bedb0c90-c46a-4ce4-b61b-3845a5c41ce9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_487b4b63-a780-4783-9875-dd25a56c3507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_487b4b63-a780-4783-9875-dd25a56c3507" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_411cae91-34e0-4cd7-b52c-58bc6de93ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_NetIncomeLoss_411cae91-34e0-4cd7-b52c-58bc6de93ff4" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_cb68b03d-3cbc-4db1-b0ac-542acbef9984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_61e418ab-6251-4dac-9bcb-8cb2508dcc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9d5b6c69-2eb3-4ebe-abbe-0b7c3124972f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:to="loc_us-gaap_StatementTable_9d5b6c69-2eb3-4ebe-abbe-0b7c3124972f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_633c734d-6cd7-40c4-beda-c7e41e737b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9d5b6c69-2eb3-4ebe-abbe-0b7c3124972f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_633c734d-6cd7-40c4-beda-c7e41e737b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_633c734d-6cd7-40c4-beda-c7e41e737b30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_633c734d-6cd7-40c4-beda-c7e41e737b30" xlink:to="loc_us-gaap_EquityComponentDomain_633c734d-6cd7-40c4-beda-c7e41e737b30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_633c734d-6cd7-40c4-beda-c7e41e737b30" xlink:to="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9ee84c1d-1735-4b50-b4e8-00a5b86de95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_CommonStockMember_9ee84c1d-1735-4b50-b4e8-00a5b86de95c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7115c339-644a-4e88-beec-9d7ae4275ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7115c339-644a-4e88-beec-9d7ae4275ea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c5217cd-2f0b-45a3-9d40-c915a29eef9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c5217cd-2f0b-45a3-9d40-c915a29eef9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5b4b4b69-15b2-4910-b9cd-42d682c4481f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_RetainedEarningsMember_5b4b4b69-15b2-4910-b9cd-42d682c4481f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/DescriptionofBusinessDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#DescriptionofBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/DescriptionofBusinessDetails" xlink:type="extended" id="i8a9aec47577440c4a440aeafd938e5eb_DescriptionofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_16a689ef-5940-4f8f-9586-5798f0440c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_16a689ef-5940-4f8f-9586-5798f0440c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_61de8e39-1110-4d66-926d-66af36c9dd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_61de8e39-1110-4d66-926d-66af36c9dd2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_94cb9ebe-19d4-449a-8dab-58f0d038a66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_94cb9ebe-19d4-449a-8dab-58f0d038a66d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_564a7ff8-927a-43d6-aaa4-a0c9f383a003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_564a7ff8-927a-43d6-aaa4-a0c9f383a003" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_5e485d14-0940-445e-bbc1-f2d94cc810ce" xlink:href="docs-20230331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_docs_ConversionOfStockConversionRatio_5e485d14-0940-445e-bbc1-f2d94cc810ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_e8be8429-3bf9-425f-8338-15fd8ae63a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_DeferredOfferingCosts_e8be8429-3bf9-425f-8338-15fd8ae63a23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_43b38984-152f-4697-92a8-84fe510e85de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_43b38984-152f-4697-92a8-84fe510e85de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1559f673-6492-4b42-baff-b55d90a5429a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1559f673-6492-4b42-baff-b55d90a5429a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_07c811e4-08aa-43b8-ab1a-29aa52b9b790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1559f673-6492-4b42-baff-b55d90a5429a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_07c811e4-08aa-43b8-ab1a-29aa52b9b790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_07c811e4-08aa-43b8-ab1a-29aa52b9b790_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_07c811e4-08aa-43b8-ab1a-29aa52b9b790" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_07c811e4-08aa-43b8-ab1a-29aa52b9b790_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_07c811e4-08aa-43b8-ab1a-29aa52b9b790" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_b1368bf8-f3b1-4414-be68-fdaa75688eae" xlink:href="docs-20230331.xsd#docs_InitialPublicOfferingIncludingOverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:to="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_b1368bf8-f3b1-4414-be68-fdaa75688eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_7d245644-fd64-45a6-9048-55cc67fac7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:to="loc_us-gaap_OverAllotmentOptionMember_7d245644-fd64-45a6-9048-55cc67fac7de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_54429956-5183-4265-a27d-abcc6872ba75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_54429956-5183-4265-a27d-abcc6872ba75" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ib60017d540bc4fd9a572072f9f410909_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerTerm_9a97b9d6-b18d-4609-8172-59255b6e5bdf" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_docs_ContractWithCustomerTerm_9a97b9d6-b18d-4609-8172-59255b6e5bdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fc67c9c0-8e90-4fd6-9486-8af70509404e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fc67c9c0-8e90-4fd6-9486-8af70509404e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_8511a627-2fe1-425d-9aea-6d2b39bbf052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_us-gaap_NumberOfReportingUnits_8511a627-2fe1-425d-9aea-6d2b39bbf052" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_a65fddce-fa34-4848-b2a1-020307b1c3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_us-gaap_AdvertisingExpense_a65fddce-fa34-4848-b2a1-020307b1c3fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a722002f-8afc-4586-a89d-f0bd9daa728d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:to="loc_srt_ProductOrServiceAxis_a722002f-8afc-4586-a89d-f0bd9daa728d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a722002f-8afc-4586-a89d-f0bd9daa728d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a722002f-8afc-4586-a89d-f0bd9daa728d" xlink:to="loc_srt_ProductsAndServicesDomain_a722002f-8afc-4586-a89d-f0bd9daa728d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a722002f-8afc-4586-a89d-f0bd9daa728d" xlink:to="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionHiringSolutionsMember_0b3dee26-d917-4fe9-835f-dbf458edd2af" xlink:href="docs-20230331.xsd#docs_SubscriptionHiringSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:to="loc_docs_SubscriptionHiringSolutionsMember_0b3dee26-d917-4fe9-835f-dbf458edd2af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMarketingSolutionsMember_bbf28dc2-0fca-489d-9e7a-9346ac582090" xlink:href="docs-20230331.xsd#docs_SubscriptionMarketingSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:to="loc_docs_SubscriptionMarketingSolutionsMember_bbf28dc2-0fca-489d-9e7a-9346ac582090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_770e465e-f57c-4c38-80c3-d5a2ab55f497" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:to="loc_srt_RangeAxis_770e465e-f57c-4c38-80c3-d5a2ab55f497" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_770e465e-f57c-4c38-80c3-d5a2ab55f497_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_770e465e-f57c-4c38-80c3-d5a2ab55f497" xlink:to="loc_srt_RangeMember_770e465e-f57c-4c38-80c3-d5a2ab55f497_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_770e465e-f57c-4c38-80c3-d5a2ab55f497" xlink:to="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d4856a42-0fbc-4dff-a6f8-51f98e81dd4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:to="loc_srt_MinimumMember_d4856a42-0fbc-4dff-a6f8-51f98e81dd4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_88989671-bbe7-4b25-af37-b8d972472b23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:to="loc_srt_MaximumMember_88989671-bbe7-4b25-af37-b8d972472b23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_70c0214e-baf4-45ef-b6a8-70b4950fb7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_70c0214e-baf4-45ef-b6a8-70b4950fb7cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_70c0214e-baf4-45ef-b6a8-70b4950fb7cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_70c0214e-baf4-45ef-b6a8-70b4950fb7cb" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_70c0214e-baf4-45ef-b6a8-70b4950fb7cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_70c0214e-baf4-45ef-b6a8-70b4950fb7cb" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_f9c896e0-a7a1-44ef-a909-0dd09941b4f0" xlink:href="docs-20230331.xsd#docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:to="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_f9c896e0-a7a1-44ef-a909-0dd09941b4f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_953bab37-52d4-440e-bc70-e8c2a34490cf" xlink:href="docs-20230331.xsd#docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:to="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_953bab37-52d4-440e-bc70-e8c2a34490cf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="extended" id="ib04ee50537e845e0a40a896a6b2f7fd0_SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_4ca382bd-6617-4a8d-bafc-491ca6c1ec70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_09fbfa24-6cd3-41bd-8215-ce477426890d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4ca382bd-6617-4a8d-bafc-491ca6c1ec70" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_09fbfa24-6cd3-41bd-8215-ce477426890d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4ca382bd-6617-4a8d-bafc-491ca6c1ec70" xlink:to="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_feaa7bf4-141a-4624-b79a-139200df201d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:to="loc_srt_MajorCustomersAxis_feaa7bf4-141a-4624-b79a-139200df201d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_feaa7bf4-141a-4624-b79a-139200df201d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_feaa7bf4-141a-4624-b79a-139200df201d" xlink:to="loc_srt_NameOfMajorCustomerDomain_feaa7bf4-141a-4624-b79a-139200df201d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d2ce8fcb-15c9-44c2-8389-3b711f29bcdd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_feaa7bf4-141a-4624-b79a-139200df201d" xlink:to="loc_srt_NameOfMajorCustomerDomain_d2ce8fcb-15c9-44c2-8389-3b711f29bcdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CustomerAMember_1fe4ebcd-4250-4e45-b79a-544fec11ccac" xlink:href="docs-20230331.xsd#docs_CustomerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d2ce8fcb-15c9-44c2-8389-3b711f29bcdd" xlink:to="loc_docs_CustomerAMember_1fe4ebcd-4250-4e45-b79a-544fec11ccac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e58d1475-1093-4859-a292-05d7016133cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e58d1475-1093-4859-a292-05d7016133cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e58d1475-1093-4859-a292-05d7016133cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e58d1475-1093-4859-a292-05d7016133cb" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e58d1475-1093-4859-a292-05d7016133cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e58d1475-1093-4859-a292-05d7016133cb" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_05c7e258-9f74-4336-9ef5-44b006ca9c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_05c7e258-9f74-4336-9ef5-44b006ca9c44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_2f79cfaa-1c8c-4e13-8b7d-877903336173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:to="loc_us-gaap_AccountsReceivableMember_2f79cfaa-1c8c-4e13-8b7d-877903336173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e650014f-10b0-4c60-b3c8-3595ad96f656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e650014f-10b0-4c60-b3c8-3595ad96f656" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e650014f-10b0-4c60-b3c8-3595ad96f656_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e650014f-10b0-4c60-b3c8-3595ad96f656" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e650014f-10b0-4c60-b3c8-3595ad96f656_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_92fe7392-1ba7-49cb-856b-e2b753b89f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e650014f-10b0-4c60-b3c8-3595ad96f656" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_92fe7392-1ba7-49cb-856b-e2b753b89f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_a53ed4b0-52c1-4a90-b018-bec72234efc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_92fe7392-1ba7-49cb-856b-e2b753b89f6d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_a53ed4b0-52c1-4a90-b018-bec72234efc9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended" id="ieb94a26c68824bb8b220c63d7e7d99a9_SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eff7953b-09ad-48c1-ad42-049af533809f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_971e7fa9-a4b6-44b8-817e-c3165961822a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eff7953b-09ad-48c1-ad42-049af533809f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_971e7fa9-a4b6-44b8-817e-c3165961822a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eff7953b-09ad-48c1-ad42-049af533809f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a6733aa-221d-4caf-8d62-84c431699ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a6733aa-221d-4caf-8d62-84c431699ec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1a6733aa-221d-4caf-8d62-84c431699ec1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a6733aa-221d-4caf-8d62-84c431699ec1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1a6733aa-221d-4caf-8d62-84c431699ec1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a6733aa-221d-4caf-8d62-84c431699ec1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_ff1dd5e1-766e-49ab-b3c1-531144a0d3f8" xlink:href="docs-20230331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:to="loc_docs_FurnitureAndEquipmentMember_ff1dd5e1-766e-49ab-b3c1-531144a0d3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_b7c06a9d-69a0-44d6-b5f9-fabfc70bf14a" xlink:href="docs-20230331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_b7c06a9d-69a0-44d6-b5f9-fabfc70bf14a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_599bf4a1-2c09-4ba0-b96d-5d74c8b463ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_599bf4a1-2c09-4ba0-b96d-5d74c8b463ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9c252af1-c465-49df-81dc-8f041c5dce74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:to="loc_srt_RangeAxis_9c252af1-c465-49df-81dc-8f041c5dce74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c252af1-c465-49df-81dc-8f041c5dce74_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9c252af1-c465-49df-81dc-8f041c5dce74" xlink:to="loc_srt_RangeMember_9c252af1-c465-49df-81dc-8f041c5dce74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9c252af1-c465-49df-81dc-8f041c5dce74" xlink:to="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c53b58bd-3a06-4e0b-a4a9-b306c4e2e36c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:to="loc_srt_MinimumMember_c53b58bd-3a06-4e0b-a4a9-b306c4e2e36c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a201abfd-500f-440a-9504-cef83a25a4a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:to="loc_srt_MaximumMember_a201abfd-500f-440a-9504-cef83a25a4a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended" id="i9ed1e265cb6e441ebf19de750d7c2a21_RevenueRecognitionDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_59c26ba2-0129-447c-b1b2-e6886f378b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2adedb0-6e7b-4161-9432-9285d7334c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_59c26ba2-0129-447c-b1b2-e6886f378b7d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2adedb0-6e7b-4161-9432-9285d7334c9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_80a24cf5-3716-4b5b-ae87-9d054951c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_59c26ba2-0129-447c-b1b2-e6886f378b7d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_80a24cf5-3716-4b5b-ae87-9d054951c726" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80a24cf5-3716-4b5b-ae87-9d054951c726" xlink:to="loc_srt_ProductOrServiceAxis_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e" xlink:to="loc_srt_ProductsAndServicesDomain_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e" xlink:to="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMember_8b35a796-4cca-4cf8-b53d-eaa297315c53" xlink:href="docs-20230331.xsd#docs_SubscriptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:to="loc_docs_SubscriptionMember_8b35a796-4cca-4cf8-b53d-eaa297315c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_fd2f2d5e-3f30-4486-af68-976bc210bec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:to="loc_us-gaap_ServiceOtherMember_fd2f2d5e-3f30-4486-af68-976bc210bec1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended" id="i6052fb82d0f640ab841bef93ff299b6b_RevenueRecognitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityAdditionsNet_cb6f7d7f-c305-4077-954b-03bf62613690" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerLiabilityAdditionsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_docs_ContractWithCustomerLiabilityAdditionsNet_cb6f7d7f-c305-4077-954b-03bf62613690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_f4e6e3e2-e465-4bea-93d4-921d813e255c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_f4e6e3e2-e465-4bea-93d4-921d813e255c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CapitalizedContractCostAdditions_feb47b58-67a9-429b-9d93-96a77d99618a" xlink:href="docs-20230331.xsd#docs_CapitalizedContractCostAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_docs_CapitalizedContractCostAdditions_feb47b58-67a9-429b-9d93-96a77d99618a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_2e0f8ed2-4aa9-4cf7-8b67-62d28ab02c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_2e0f8ed2-4aa9-4cf7-8b67-62d28ab02c39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss_6d40a05c-36e3-4e73-80b1-58f1b451fb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_us-gaap_CapitalizedContractCostImpairmentLoss_6d40a05c-36e3-4e73-80b1-58f1b451fb73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b09160f9-1a7d-4d40-8ca4-199e6242511a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b09160f9-1a7d-4d40-8ca4-199e6242511a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b09160f9-1a7d-4d40-8ca4-199e6242511a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b2e447e-e6a0-4325-89e6-47e5824c97d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b2e447e-e6a0-4325-89e6-47e5824c97d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_376ec73f-d1be-4c29-9a38-c464c2fe5e16" xlink:href="docs-20230331.xsd#docs_AMiONMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b2e447e-e6a0-4325-89e6-47e5824c97d9" xlink:to="loc_docs_AMiONMember_376ec73f-d1be-4c29-9a38-c464c2fe5e16" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="extended" id="i0c3caf1b498c47978bc737a643f72195_InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_6183bdab-8d32-461a-b9cc-5aa11fe2607e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_6183bdab-8d32-461a-b9cc-5aa11fe2607e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1d38050f-244b-40c9-a6aa-76b7586f2114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1d38050f-244b-40c9-a6aa-76b7586f2114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c59a31a7-7faf-4abf-b91f-c3f7ed11ed77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c59a31a7-7faf-4abf-b91f-c3f7ed11ed77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_16ec0d6f-77a5-4e52-8fa5-43d0abef831c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_16ec0d6f-77a5-4e52-8fa5-43d0abef831c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a69845bc-b32b-4d43-82d2-6f82a50cb534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a69845bc-b32b-4d43-82d2-6f82a50cb534" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_27049967-4872-497b-87c1-a1e22c41182a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_27049967-4872-497b-87c1-a1e22c41182a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_e84e6071-1211-4f20-ab0a-c893f6f82d55" xlink:href="docs-20230331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_e84e6071-1211-4f20-ab0a-c893f6f82d55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_6b9fe5a0-f63d-4b63-b875-2c92927d07f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_6b9fe5a0-f63d-4b63-b875-2c92927d07f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6df7311c-b68d-4bed-b161-d066c9e1c4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6df7311c-b68d-4bed-b161-d066c9e1c4cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6df7311c-b68d-4bed-b161-d066c9e1c4cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6df7311c-b68d-4bed-b161-d066c9e1c4cd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6df7311c-b68d-4bed-b161-d066c9e1c4cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6df7311c-b68d-4bed-b161-d066c9e1c4cd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_2c4c51dd-cd7f-4f03-adcf-f256afa3eb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_2c4c51dd-cd7f-4f03-adcf-f256afa3eb0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_17852ade-7799-42f9-bdc9-2788d046143b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:to="loc_us-gaap_DebtSecuritiesMember_17852ade-7799-42f9-bdc9-2788d046143b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_18d1e4fa-5f18-4343-b4bd-c20c9feed098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:to="loc_us-gaap_FinancialInstrumentAxis_18d1e4fa-5f18-4343-b4bd-c20c9feed098" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18d1e4fa-5f18-4343-b4bd-c20c9feed098_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_18d1e4fa-5f18-4343-b4bd-c20c9feed098" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18d1e4fa-5f18-4343-b4bd-c20c9feed098_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_18d1e4fa-5f18-4343-b4bd-c20c9feed098" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_90efdd9f-2908-4e27-8a14-662ca9b94334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CommercialPaperMember_90efdd9f-2908-4e27-8a14-662ca9b94334" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5f0f40bc-614b-4660-9b78-2786d97ff8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5f0f40bc-614b-4660-9b78-2786d97ff8a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_4c2aec78-668f-4f4b-9f5f-1d03ea7c507b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_4c2aec78-668f-4f4b-9f5f-1d03ea7c507b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_eaed6e5c-d757-4a3f-b8ed-b5681a34a76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CertificatesOfDepositMember_eaed6e5c-d757-4a3f-b8ed-b5681a34a76e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_3417a9ff-c0de-4fbb-b06a-7d1702cb6725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_3417a9ff-c0de-4fbb-b06a-7d1702cb6725" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_01158dc4-214a-4e17-82ea-dd16f5755028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_01158dc4-214a-4e17-82ea-dd16f5755028" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_5ffa37c3-2785-465f-90a1-a472ea0b2fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_5ffa37c3-2785-465f-90a1-a472ea0b2fb9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_d30ed886-cb7b-468e-8222-61ed2d5c6d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_d30ed886-cb7b-468e-8222-61ed2d5c6d06" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i3c4fb7055a284e498cc61599861a2cd9_FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_73ded63e-5833-4f21-9f18-3d2a6ff34215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_73ded63e-5833-4f21-9f18-3d2a6ff34215" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_182d4caf-51e5-41c0-b49f-2a29f37a6b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73ded63e-5833-4f21-9f18-3d2a6ff34215" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_182d4caf-51e5-41c0-b49f-2a29f37a6b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9b422103-3972-44c4-9921-877d4bee9d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9b422103-3972-44c4-9921-877d4bee9d22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_71bc56c7-29f4-4fbe-bbda-f75d26b9c9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_71bc56c7-29f4-4fbe-bbda-f75d26b9c9cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_789b5a6f-3c5f-413e-a36c-24b3d015e16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_789b5a6f-3c5f-413e-a36c-24b3d015e16a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_789b5a6f-3c5f-413e-a36c-24b3d015e16a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_789b5a6f-3c5f-413e-a36c-24b3d015e16a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_789b5a6f-3c5f-413e-a36c-24b3d015e16a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_789b5a6f-3c5f-413e-a36c-24b3d015e16a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6ee684b5-9197-4020-b948-cb9d4972b80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6ee684b5-9197-4020-b948-cb9d4972b80e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5db8e60b-d5ac-46a3-b358-7a7fcb60ed91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5db8e60b-d5ac-46a3-b358-7a7fcb60ed91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4bd513a0-dcce-4efc-974b-7b3a4f0fd5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4bd513a0-dcce-4efc-974b-7b3a4f0fd5ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e58144bc-ee9b-47e6-bc85-2a4508301d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e58144bc-ee9b-47e6-bc85-2a4508301d00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e58144bc-ee9b-47e6-bc85-2a4508301d00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e58144bc-ee9b-47e6-bc85-2a4508301d00" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e58144bc-ee9b-47e6-bc85-2a4508301d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b5e267d-2eec-497a-9895-d9ef8c480ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e58144bc-ee9b-47e6-bc85-2a4508301d00" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b5e267d-2eec-497a-9895-d9ef8c480ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_76c5b10c-082d-43b7-a0ae-ff8028611e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b5e267d-2eec-497a-9895-d9ef8c480ab2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_76c5b10c-082d-43b7-a0ae-ff8028611e46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2fe16654-320c-4f48-9591-dc1ef3a1b45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2fe16654-320c-4f48-9591-dc1ef3a1b45a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2fe16654-320c-4f48-9591-dc1ef3a1b45a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2fe16654-320c-4f48-9591-dc1ef3a1b45a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2fe16654-320c-4f48-9591-dc1ef3a1b45a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2fe16654-320c-4f48-9591-dc1ef3a1b45a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_311c3753-b792-45a6-b238-d668bd0e9ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_CommercialPaperMember_311c3753-b792-45a6-b238-d668bd0e9ef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c84dcfae-1943-4956-80b3-b49a588e7786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c84dcfae-1943-4956-80b3-b49a588e7786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_bfdff927-3555-4a19-ba02-8a97cd8d388f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_bfdff927-3555-4a19-ba02-8a97cd8d388f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1fad8cc9-0caa-47c5-9c1c-4c620cd65209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1fad8cc9-0caa-47c5-9c1c-4c620cd65209" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_2dca4c27-c7d2-4450-b309-b864f6b01a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_2dca4c27-c7d2-4450-b309-b864f6b01a9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_dd3cc08a-e3e9-413c-954a-b2b218651a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_dd3cc08a-e3e9-413c-954a-b2b218651a56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_09c0d3d6-f354-4318-8115-c0f86b4f6847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_09c0d3d6-f354-4318-8115-c0f86b4f6847" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_6e1a0daa-c6c2-424a-9f74-a684aadf912d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_6e1a0daa-c6c2-424a-9f74-a684aadf912d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_04e86f07-a2ca-4334-bea4-23b105b1fe51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:to="loc_us-gaap_DebtSecuritiesMember_04e86f07-a2ca-4334-bea4-23b105b1fe51" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="extended" id="i1ade74234412436a9ca46bfe36a465bd_PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_377eaf63-8f66-4386-b52d-4bcf62556e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_377eaf63-8f66-4386-b52d-4bcf62556e3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5643a6f-aa8d-4d8c-8262-d1771a69dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5643a6f-aa8d-4d8c-8262-d1771a69dc55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_41f866a8-17d9-4208-9ad2-ee40a83d8dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_41f866a8-17d9-4208-9ad2-ee40a83d8dd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_12d29f15-27cb-40d8-917a-874166a7e01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_12d29f15-27cb-40d8-917a-874166a7e01d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88e3fcd4-72b4-470b-88cb-bdb66af57452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_12d29f15-27cb-40d8-917a-874166a7e01d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88e3fcd4-72b4-470b-88cb-bdb66af57452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_88e3fcd4-72b4-470b-88cb-bdb66af57452_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88e3fcd4-72b4-470b-88cb-bdb66af57452" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_88e3fcd4-72b4-470b-88cb-bdb66af57452_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88e3fcd4-72b4-470b-88cb-bdb66af57452" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_91e53cfd-0b0a-4816-b63d-aa8a91aa74fd" xlink:href="docs-20230331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_docs_FurnitureAndEquipmentMember_91e53cfd-0b0a-4816-b63d-aa8a91aa74fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_33860e70-6074-4907-9515-3c44508f8d1a" xlink:href="docs-20230331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_33860e70-6074-4907-9515-3c44508f8d1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ed974154-3f52-40ba-bb9b-35d5789918b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ed974154-3f52-40ba-bb9b-35d5789918b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e57e8b06-cfd6-4c74-a49d-27f9bd6ed82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e57e8b06-cfd6-4c74-a49d-27f9bd6ed82a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended" id="ib8122dde660842cf88b2389305718592_BusinessCombinationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2937db6b-6a58-4b1b-8928-cc22657e505d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2937db6b-6a58-4b1b-8928-cc22657e505d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c5cad28b-123c-4b56-873c-0d8c06177f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c5cad28b-123c-4b56-873c-0d8c06177f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_19ba1fcb-91b0-49da-b67f-a4f1748381c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_19ba1fcb-91b0-49da-b67f-a4f1748381c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4765c1e5-7da9-4cd2-b06e-2963428d957c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4765c1e5-7da9-4cd2-b06e-2963428d957c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_72a99f66-c9b1-4214-94ac-90a161644799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_72a99f66-c9b1-4214-94ac-90a161644799" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a58c158d-aa8e-4be3-a707-b8a41f5ef612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a58c158d-aa8e-4be3-a707-b8a41f5ef612" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9190c124-356e-4856-95db-6636507a968b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9190c124-356e-4856-95db-6636507a968b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_413e8c02-7a3d-43a3-8206-e5dd77c92818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_413e8c02-7a3d-43a3-8206-e5dd77c92818" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_289b6a72-c3d1-42b9-a9ee-c01c3618c503" xlink:href="docs-20230331.xsd#docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_289b6a72-c3d1-42b9-a9ee-c01c3618c503" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93995d12-a507-4708-8a09-8395e13f678a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93995d12-a507-4708-8a09-8395e13f678a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d193ce41-e0e8-4de2-bec9-3345b276be76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d193ce41-e0e8-4de2-bec9-3345b276be76" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_00ff3758-a69a-4e7f-93c1-9ab9342d5983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_00ff3758-a69a-4e7f-93c1-9ab9342d5983" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance_3cdb5960-4aa8-487b-9224-009927bca957" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance_3cdb5960-4aa8-487b-9224-009927bca957" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod_ca971b07-8036-405e-bf9d-c9256305ab05" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod_ca971b07-8036-405e-bf9d-c9256305ab05" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_b363e8ae-fbc9-4952-81f7-36cc306b8b2f" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_b363e8ae-fbc9-4952-81f7-36cc306b8b2f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities_f6b0f0dc-1aeb-4c44-bd9f-d5f82be3842e" xlink:href="docs-20230331.xsd#docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities_f6b0f0dc-1aeb-4c44-bd9f-d5f82be3842e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e17852a7-494b-436f-9aeb-d1a44df20551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e17852a7-494b-436f-9aeb-d1a44df20551" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aaa55c36-a424-43a5-b2ca-fbafebf01bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aaa55c36-a424-43a5-b2ca-fbafebf01bbe" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51cdfa29-9ed7-4f2c-a9fb-30cf3dd38ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51cdfa29-9ed7-4f2c-a9fb-30cf3dd38ed7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4553e62c-efa1-4980-9fda-80efe6c240eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4553e62c-efa1-4980-9fda-80efe6c240eb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a325310-2fbd-4177-977b-56817d722520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a325310-2fbd-4177-977b-56817d722520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a325310-2fbd-4177-977b-56817d722520_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a325310-2fbd-4177-977b-56817d722520" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a325310-2fbd-4177-977b-56817d722520_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a325310-2fbd-4177-977b-56817d722520" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_8cb68ff3-2559-4e01-9c92-636ad3c6d687" xlink:href="docs-20230331.xsd#docs_THMEDLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:to="loc_docs_THMEDLLCMember_8cb68ff3-2559-4e01-9c92-636ad3c6d687" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_282147b6-95f7-4170-b628-caf46ea1cdb9" xlink:href="docs-20230331.xsd#docs_AMiONMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:to="loc_docs_AMiONMember_282147b6-95f7-4170-b628-caf46ea1cdb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c72048a9-723b-4d9c-984b-c49e11c42c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c72048a9-723b-4d9c-984b-c49e11c42c58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c72048a9-723b-4d9c-984b-c49e11c42c58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c72048a9-723b-4d9c-984b-c49e11c42c58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c72048a9-723b-4d9c-984b-c49e11c42c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c72048a9-723b-4d9c-984b-c49e11c42c58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_13402aab-150f-41d3-b8e2-5ec02238ba14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_13402aab-150f-41d3-b8e2-5ec02238ba14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_9a3971ac-1b29-4938-a9a9-aef6c7c48271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:to="loc_us-gaap_TrademarksMember_9a3971ac-1b29-4938-a9a9-aef6c7c48271" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c2c96295-5e8b-441a-bfa0-408a120a5732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c2c96295-5e8b-441a-bfa0-408a120a5732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1c6bfa1b-1f99-46f0-83d3-9bc274529572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1c6bfa1b-1f99-46f0-83d3-9bc274529572" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1c6bfa1b-1f99-46f0-83d3-9bc274529572_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1c6bfa1b-1f99-46f0-83d3-9bc274529572" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1c6bfa1b-1f99-46f0-83d3-9bc274529572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1f282dd5-4e49-4891-b2ac-feeef06b568a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1c6bfa1b-1f99-46f0-83d3-9bc274529572" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1f282dd5-4e49-4891-b2ac-feeef06b568a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0d974cde-decc-4591-ae2b-2c019a1ef5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1f282dd5-4e49-4891-b2ac-feeef06b568a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0d974cde-decc-4591-ae2b-2c019a1ef5d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_848aab53-d589-4ebb-b48c-0877fa15f3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_848aab53-d589-4ebb-b48c-0877fa15f3ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_848aab53-d589-4ebb-b48c-0877fa15f3ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_848aab53-d589-4ebb-b48c-0877fa15f3ad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_848aab53-d589-4ebb-b48c-0877fa15f3ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4ce524bf-1ea7-4933-a282-306aa43cb135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_848aab53-d589-4ebb-b48c-0877fa15f3ad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4ce524bf-1ea7-4933-a282-306aa43cb135" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PortionOfCurativeTalentLLCMember_30bae1a0-3966-4a51-a4d9-f77b0600bd37" xlink:href="docs-20230331.xsd#docs_PortionOfCurativeTalentLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4ce524bf-1ea7-4933-a282-306aa43cb135" xlink:to="loc_docs_PortionOfCurativeTalentLLCMember_30bae1a0-3966-4a51-a4d9-f77b0600bd37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_01db1b02-8732-424e-abb4-dda14f907d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_AwardTypeAxis_01db1b02-8732-424e-abb4-dda14f907d81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01db1b02-8732-424e-abb4-dda14f907d81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_01db1b02-8732-424e-abb4-dda14f907d81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01db1b02-8732-424e-abb4-dda14f907d81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_763d297f-0a0e-47cd-8800-68489b882c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_01db1b02-8732-424e-abb4-dda14f907d81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_763d297f-0a0e-47cd-8800-68489b882c1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_72cc90c1-932c-47c1-80dd-db7e5603b704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_763d297f-0a0e-47cd-8800-68489b882c1d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_72cc90c1-932c-47c1-80dd-db7e5603b704" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7fd33003-4f02-46f9-8876-74b888349e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7fd33003-4f02-46f9-8876-74b888349e63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7fd33003-4f02-46f9-8876-74b888349e63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7fd33003-4f02-46f9-8876-74b888349e63" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7fd33003-4f02-46f9-8876-74b888349e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3d1f9920-b0cc-4a45-b306-a9cc4205c6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7fd33003-4f02-46f9-8876-74b888349e63" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3d1f9920-b0cc-4a45-b306-a9cc4205c6e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_547dcf4b-c583-4d0d-a06d-83a016e91b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3d1f9920-b0cc-4a45-b306-a9cc4205c6e9" xlink:to="loc_us-gaap_SubsequentEventMember_547dcf4b-c583-4d0d-a06d-83a016e91b09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b054b795-28ae-4a08-b9b7-aceb8266388e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_srt_StatementScenarioAxis_b054b795-28ae-4a08-b9b7-aceb8266388e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b054b795-28ae-4a08-b9b7-aceb8266388e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_b054b795-28ae-4a08-b9b7-aceb8266388e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b054b795-28ae-4a08-b9b7-aceb8266388e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_57f84cde-16bb-40ad-832e-c7583b200aef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_b054b795-28ae-4a08-b9b7-aceb8266388e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_57f84cde-16bb-40ad-832e-c7583b200aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e861da32-f9cc-4dee-868a-b94fa6250bc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_57f84cde-16bb-40ad-832e-c7583b200aef" xlink:to="loc_srt_ScenarioForecastMember_e861da32-f9cc-4dee-868a-b94fa6250bc0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsPurchaseConsiderationAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails" xlink:type="extended" id="i8456c3dd7a564cfdade72d73a8b6070b_BusinessCombinationsPurchaseConsiderationAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c1e0a071-714e-4a5b-9f43-83e1b6f435ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c1e0a071-714e-4a5b-9f43-83e1b6f435ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6a67ae70-23c7-4076-bc83-03cd7043295b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6a67ae70-23c7-4076-bc83-03cd7043295b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_542682f7-980e-4a35-bcd9-d673f328a908" xlink:href="docs-20230331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_542682f7-980e-4a35-bcd9-d673f328a908" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2c03af74-dfd6-442e-9166-867fc40ec942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2c03af74-dfd6-442e-9166-867fc40ec942" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e5b5ddfb-85ad-4d3e-99c0-56a26d3682ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e5b5ddfb-85ad-4d3e-99c0-56a26d3682ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2232227e-eb60-4789-984c-9f724dbea1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2232227e-eb60-4789-984c-9f724dbea1f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c3f46141-c230-42af-9485-e142262bc55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c3f46141-c230-42af-9485-e142262bc55a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e595612f-ef9e-4d98-8f52-a684868bd528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e595612f-ef9e-4d98-8f52-a684868bd528" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a391a52d-0782-4555-b735-c174bd07ebb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a391a52d-0782-4555-b735-c174bd07ebb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8c7cfbaa-b328-4796-912b-8267ea5be45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_Goodwill_8c7cfbaa-b328-4796-912b-8267ea5be45f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_acf28531-c4ca-4565-9200-49e3c888041d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_acf28531-c4ca-4565-9200-49e3c888041d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_609f81ba-fe25-4de0-90b0-4737f61e74c7" xlink:href="docs-20230331.xsd#docs_THMEDLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:to="loc_docs_THMEDLLCMember_609f81ba-fe25-4de0-90b0-4737f61e74c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_cd195953-3266-49da-8385-62af5c4ff5ee" xlink:href="docs-20230331.xsd#docs_AMiONMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:to="loc_docs_AMiONMember_cd195953-3266-49da-8385-62af5c4ff5ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ef7566d-acad-4476-89d0-f7bed6b820b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ef7566d-acad-4476-89d0-f7bed6b820b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ef7566d-acad-4476-89d0-f7bed6b820b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ef7566d-acad-4476-89d0-f7bed6b820b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ef7566d-acad-4476-89d0-f7bed6b820b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ef7566d-acad-4476-89d0-f7bed6b820b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b6e0dfbb-8362-4687-9b12-65fda2e0e3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b6e0dfbb-8362-4687-9b12-65fda2e0e3d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55e6ec44-aa5a-4d4b-9a38-497f52506c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55e6ec44-aa5a-4d4b-9a38-497f52506c04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_948b26e9-da98-41c3-a680-b3c2ce7c5360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:to="loc_us-gaap_TrademarksMember_948b26e9-da98-41c3-a680-b3c2ce7c5360" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsIntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails" xlink:type="extended" id="i13e7a2a99cec4251a8fe8eeffea899b4_IntangibleAssetsIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b862042b-fda2-45de-98cb-b1535048688a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b862042b-fda2-45de-98cb-b1535048688a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10ff3435-c832-4505-9a0f-59a30397586c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10ff3435-c832-4505-9a0f-59a30397586c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df79c53b-4b77-46b5-bfea-f1e4bb9cdb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df79c53b-4b77-46b5-bfea-f1e4bb9cdb01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_441a95ff-7ecd-4972-9fbb-e5764739da72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_441a95ff-7ecd-4972-9fbb-e5764739da72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e4bb9c9a-2d3c-41a6-a969-207744675b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_441a95ff-7ecd-4972-9fbb-e5764739da72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e4bb9c9a-2d3c-41a6-a969-207744675b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e4bb9c9a-2d3c-41a6-a969-207744675b34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e4bb9c9a-2d3c-41a6-a969-207744675b34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e4bb9c9a-2d3c-41a6-a969-207744675b34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e4bb9c9a-2d3c-41a6-a969-207744675b34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_185b4783-928c-4621-a8a4-58a58e3c21c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_185b4783-928c-4621-a8a4-58a58e3c21c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_88d6e696-9a57-4dda-a135-6ba1f572bfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_88d6e696-9a57-4dda-a135-6ba1f572bfe9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#RedeemableConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails" xlink:type="extended" id="i57e3880db9274107abb38b38433e44d3_RedeemableConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_1d8ad57c-d09d-4c05-87b6-0fcc2a069b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_1d8ad57c-d09d-4c05-87b6-0fcc2a069b20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_147ccbc5-5adb-4492-828d-8eefefe4c20d" xlink:href="docs-20230331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_docs_ConversionOfStockConversionRatio_147ccbc5-5adb-4492-828d-8eefefe4c20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_b2f14927-9548-4d4a-8ff6-bf9e3e80f60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_b2f14927-9548-4d4a-8ff6-bf9e3e80f60b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_6a01ece7-9999-45ff-9d4d-47400ead05e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_6a01ece7-9999-45ff-9d4d-47400ead05e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_da6b3325-3546-4d22-911a-1db1a402f511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_da6b3325-3546-4d22-911a-1db1a402f511" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_cc29c464-0e63-48d2-8dad-e00fbb6ac393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_cc29c464-0e63-48d2-8dad-e00fbb6ac393" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_cc29c464-0e63-48d2-8dad-e00fbb6ac393" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e" xlink:to="loc_us-gaap_ClassOfStockDomain_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_669fc2d2-11fd-4827-abf1-d60c2b3cf3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e" xlink:to="loc_us-gaap_ClassOfStockDomain_669fc2d2-11fd-4827-abf1-d60c2b3cf3f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_bfc3da27-9269-4353-9c53-078f121ada5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_669fc2d2-11fd-4827-abf1-d60c2b3cf3f2" xlink:to="loc_us-gaap_CommonClassBMember_bfc3da27-9269-4353-9c53-078f121ada5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityNarrativeDetails" xlink:type="extended" id="id1b4d3f63d77413e82a1a0aeef7c6b41_EquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6ddfb3b6-9e3b-49c4-b6f0-f07320967078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6ddfb3b6-9e3b-49c4-b6f0-f07320967078" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a072aa81-d446-46b3-8a8f-d060631a4a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a072aa81-d446-46b3-8a8f-d060631a4a88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d805933d-6731-4c56-8dca-fa72a0265d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d805933d-6731-4c56-8dca-fa72a0265d59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_71e65682-fad2-45e6-a51e-f3ce2e7930a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_71e65682-fad2-45e6-a51e-f3ce2e7930a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_889abe43-0456-4fe9-8194-c44434ae586f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_889abe43-0456-4fe9-8194-c44434ae586f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2dc079a3-f339-4108-9b82-1689ec4bdb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2dc079a3-f339-4108-9b82-1689ec4bdb50" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes_fd226595-faf2-49e1-99f6-8772701edb7e" xlink:href="docs-20230331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_CommonStockVotingRightsNumberOfVotes_fd226595-faf2-49e1-99f6-8772701edb7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_546d53a7-9263-497c-a92e-b3432d685f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_546d53a7-9263-497c-a92e-b3432d685f5d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_bb740761-1fb8-4058-b729-802f4776bda1" xlink:href="docs-20230331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ConversionOfStockConversionRatio_bb740761-1fb8-4058-b729-802f4776bda1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_35bada68-e83d-4a10-b802-0aebda122e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_35bada68-e83d-4a10-b802-0aebda122e6c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_463571e2-971e-40b2-8eaa-7ccb038c3534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_463571e2-971e-40b2-8eaa-7ccb038c3534" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_77aa86fc-b0c3-4640-970d-366e7213da71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_77aa86fc-b0c3-4640-970d-366e7213da71" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_aade58e9-0f9c-4e9f-b572-0604c3303130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_aade58e9-0f9c-4e9f-b572-0604c3303130" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_69c8323c-b6e9-4c6b-b090-1f8b50599c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_69c8323c-b6e9-4c6b-b090-1f8b50599c46" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_92360adf-d923-44b6-b1d0-2910a4a28644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_92360adf-d923-44b6-b1d0-2910a4a28644" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b13f25b5-1c62-4939-bbcd-a05a1c49fd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b13f25b5-1c62-4939-bbcd-a05a1c49fd76" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_649f2b46-20ee-48ca-be05-b987ead2d280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_649f2b46-20ee-48ca-be05-b987ead2d280" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a7c6c585-c4c0-4854-b451-9466b1acfb45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a7c6c585-c4c0-4854-b451-9466b1acfb45" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ClassOfWarrantOrRightExercisesInPeriod_f2320e7b-34dd-442c-93cb-a1ecf1198cc0" xlink:href="docs-20230331.xsd#docs_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ClassOfWarrantOrRightExercisesInPeriod_f2320e7b-34dd-442c-93cb-a1ecf1198cc0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue_6efe52c4-dd07-4168-ad13-e2efb663a2b9" xlink:href="docs-20230331.xsd#docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue_6efe52c4-dd07-4168-ad13-e2efb663a2b9" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d6df749c-984e-4c2e-8d77-46539cb8c5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d6df749c-984e-4c2e-8d77-46539cb8c5c8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6eb8614d-d439-4dd5-81a4-a9757daa1ec2" xlink:href="docs-20230331.xsd#docs_WarrantsAndRightsOutstandingVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6eb8614d-d439-4dd5-81a4-a9757daa1ec2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_121de308-6a16-4d53-88e5-a223cf6239b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_121de308-6a16-4d53-88e5-a223cf6239b2" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_76357a6e-7631-4b13-b240-43d7060eb638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_76357a6e-7631-4b13-b240-43d7060eb638" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f5bb5cd9-cea2-4db4-a4da-f738ee92067b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f5bb5cd9-cea2-4db4-a4da-f738ee92067b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_786901d0-e42e-44ab-a9da-700526aee21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_786901d0-e42e-44ab-a9da-700526aee21a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8644998c-b8c4-4943-9640-194461288ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8644998c-b8c4-4943-9640-194461288ace" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_0ed252a9-da1f-42ce-a3cd-ba027e26eb48" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_0ed252a9-da1f-42ce-a3cd-ba027e26eb48" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_2b71d9a9-23f1-43bc-a532-5b6d06bbb8e4" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_2b71d9a9-23f1-43bc-a532-5b6d06bbb8e4" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d60f3efc-145a-4625-bdd9-8e70713307d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d60f3efc-145a-4625-bdd9-8e70713307d6" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5627846e-b237-4477-9375-5740d1b20366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5627846e-b237-4477-9375-5740d1b20366" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d9604a06-0c3f-4210-81a7-e6b2c540edc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d9604a06-0c3f-4210-81a7-e6b2c540edc5" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_2160dc8a-d415-46f5-a797-6e5abc8656b7" xlink:href="docs-20230331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_2160dc8a-d415-46f5-a797-6e5abc8656b7" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_25b4a97f-7d51-4772-8bf5-b11ea56215a2" xlink:href="docs-20230331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_25b4a97f-7d51-4772-8bf5-b11ea56215a2" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_86d199db-7de8-466a-8560-ef098c4589de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_86d199db-7de8-466a-8560-ef098c4589de" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_3b17693b-f810-4831-957c-a5aa7aca2062" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_3b17693b-f810-4831-957c-a5aa7aca2062" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98d92b9e-d05b-4c7b-a4ac-92cfb2da68d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98d92b9e-d05b-4c7b-a4ac-92cfb2da68d6" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9f12c979-13f8-4622-9a7d-ddf20d8a8d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9f12c979-13f8-4622-9a7d-ddf20d8a8d70" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cd0fc9d8-9bcf-4509-873a-0b43fffbd15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cd0fc9d8-9bcf-4509-873a-0b43fffbd15e" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10d521a-1711-4869-9439-84418116c2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10d521a-1711-4869-9439-84418116c2cc" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aa446f38-f4fa-47a9-9431-891d667dc11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aa446f38-f4fa-47a9-9431-891d667dc11e" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_152e6171-06fc-46a6-9bf3-d7f3413740b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_152e6171-06fc-46a6-9bf3-d7f3413740b2" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_daf50b06-1848-4997-8c98-78f0a01d8d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_daf50b06-1848-4997-8c98-78f0a01d8d13" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_1e84c03b-07dd-4034-a5b1-429f4977938b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_1e84c03b-07dd-4034-a5b1-429f4977938b" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3460660e-59ce-4136-a4c6-0e715a940339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3460660e-59ce-4136-a4c6-0e715a940339" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_67da31d1-8166-4aa1-96c3-657f0e8a1c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_67da31d1-8166-4aa1-96c3-657f0e8a1c28" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_48e4cfcd-0812-4a8a-8105-f8679777cb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_48e4cfcd-0812-4a8a-8105-f8679777cb23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_48e4cfcd-0812-4a8a-8105-f8679777cb23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48e4cfcd-0812-4a8a-8105-f8679777cb23" xlink:to="loc_us-gaap_ClassOfStockDomain_48e4cfcd-0812-4a8a-8105-f8679777cb23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9fbbe649-275d-480e-a7f4-6ddc8c3c0548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48e4cfcd-0812-4a8a-8105-f8679777cb23" xlink:to="loc_us-gaap_ClassOfStockDomain_9fbbe649-275d-480e-a7f4-6ddc8c3c0548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9fbbe649-275d-480e-a7f4-6ddc8c3c0548" xlink:to="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_2f5a3dbc-a62c-4af3-8087-a8a7a18fbaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:to="loc_us-gaap_CommonClassAMember_2f5a3dbc-a62c-4af3-8087-a8a7a18fbaa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_21876727-c693-4b3c-81e4-a7bb721acf25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:to="loc_us-gaap_CommonClassBMember_21876727-c693-4b3c-81e4-a7bb721acf25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_89696d67-eda8-4e83-a70f-42e3bd088e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_89696d67-eda8-4e83-a70f-42e3bd088e07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_89696d67-eda8-4e83-a70f-42e3bd088e07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_89696d67-eda8-4e83-a70f-42e3bd088e07" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_89696d67-eda8-4e83-a70f-42e3bd088e07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_89696d67-eda8-4e83-a70f-42e3bd088e07" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithUSNewsWorldReportLPMember_8dce26fc-8eff-42f0-a7b9-6b6f33ce61ef" xlink:href="docs-20230331.xsd#docs_ContractWithUSNewsWorldReportLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:to="loc_docs_ContractWithUSNewsWorldReportLPMember_8dce26fc-8eff-42f0-a7b9-6b6f33ce61ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_USNewsWarrantMember_7c446686-4578-4185-b17b-1e6b35ade2fa" xlink:href="docs-20230331.xsd#docs_USNewsWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:to="loc_docs_USNewsWarrantMember_7c446686-4578-4185-b17b-1e6b35ade2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f2eb6cc5-690c-4542-be92-cc56de9b2411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_PlanNameAxis_f2eb6cc5-690c-4542-be92-cc56de9b2411" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f2eb6cc5-690c-4542-be92-cc56de9b2411_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f2eb6cc5-690c-4542-be92-cc56de9b2411" xlink:to="loc_us-gaap_PlanNameDomain_f2eb6cc5-690c-4542-be92-cc56de9b2411_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f2eb6cc5-690c-4542-be92-cc56de9b2411" xlink:to="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_38d69f68-e97f-4cae-bced-06c2b9016c8e" xlink:href="docs-20230331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_EquityIncentivePlan2010Member_38d69f68-e97f-4cae-bced-06c2b9016c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_f45bca0c-d2ea-40d7-97f3-2f6d77ad76ab" xlink:href="docs-20230331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_f45bca0c-d2ea-40d7-97f3-2f6d77ad76ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_141ec2e7-e9ee-4725-8f39-c4c9d4d86831" xlink:href="docs-20230331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_141ec2e7-e9ee-4725-8f39-c4c9d4d86831" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_1b4a9c6e-4d88-4a6a-aa01-d34c29704400" xlink:href="docs-20230331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_1b4a9c6e-4d88-4a6a-aa01-d34c29704400" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ec00bad-ae54-464b-8ff5-9294bb3d6341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_AwardTypeAxis_1ec00bad-ae54-464b-8ff5-9294bb3d6341" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ec00bad-ae54-464b-8ff5-9294bb3d6341_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1ec00bad-ae54-464b-8ff5-9294bb3d6341" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ec00bad-ae54-464b-8ff5-9294bb3d6341_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1ec00bad-ae54-464b-8ff5-9294bb3d6341" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_123a8e65-2bd4-45fd-9081-fd04793c4522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_123a8e65-2bd4-45fd-9081-fd04793c4522" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e5f71b19-3689-4f65-b88b-556c3774ef7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e5f71b19-3689-4f65-b88b-556c3774ef7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_aeebcbe5-426b-465a-9d1f-036a0e76fab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_us-gaap_PerformanceSharesMember_aeebcbe5-426b-465a-9d1f-036a0e76fab4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_5d1f9fee-a607-452b-a5b8-c9a21b11b6e7" xlink:href="docs-20230331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_5d1f9fee-a607-452b-a5b8-c9a21b11b6e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_12d8a862-65c3-494c-8031-b3fdcaa04ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_12d8a862-65c3-494c-8031-b3fdcaa04ef6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_12d8a862-65c3-494c-8031-b3fdcaa04ef6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_12d8a862-65c3-494c-8031-b3fdcaa04ef6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_12d8a862-65c3-494c-8031-b3fdcaa04ef6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_12d8a862-65c3-494c-8031-b3fdcaa04ef6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_6005c739-26a7-4890-b8f2-8e184e29b472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_6005c739-26a7-4890-b8f2-8e184e29b472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_3d955e92-6b0c-4abe-a81b-d14be80ed50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_3d955e92-6b0c-4abe-a81b-d14be80ed50b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_d29cd31e-a815-44e1-b49b-4cc2a76d1cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_d29cd31e-a815-44e1-b49b-4cc2a76d1cc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1276503e-f567-4990-ae8c-8e571788cb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1276503e-f567-4990-ae8c-8e571788cb99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_3c2c78f4-7f4a-4a65-bc41-e57a35f79d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_3c2c78f4-7f4a-4a65-bc41-e57a35f79d77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_9e6ace9d-7413-4cd6-9edf-3d7579496364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_VestingAxis_9e6ace9d-7413-4cd6-9edf-3d7579496364" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_9e6ace9d-7413-4cd6-9edf-3d7579496364_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_9e6ace9d-7413-4cd6-9edf-3d7579496364" xlink:to="loc_us-gaap_VestingDomain_9e6ace9d-7413-4cd6-9edf-3d7579496364_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_dae5172d-6011-4c7c-ab7c-b8e6b7d73acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_9e6ace9d-7413-4cd6-9edf-3d7579496364" xlink:to="loc_us-gaap_VestingDomain_dae5172d-6011-4c7c-ab7c-b8e6b7d73acb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember_6f565470-a311-4546-ba55-9701cdf1ef2d" xlink:href="docs-20230331.xsd#docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_dae5172d-6011-4c7c-ab7c-b8e6b7d73acb" xlink:to="loc_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember_6f565470-a311-4546-ba55-9701cdf1ef2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_5eb5d436-5d3f-4c77-8b5d-551d9748202c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_GranteeStatusAxis_5eb5d436-5d3f-4c77-8b5d-551d9748202c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_5eb5d436-5d3f-4c77-8b5d-551d9748202c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_5eb5d436-5d3f-4c77-8b5d-551d9748202c" xlink:to="loc_us-gaap_GranteeStatusDomain_5eb5d436-5d3f-4c77-8b5d-551d9748202c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_5eb5d436-5d3f-4c77-8b5d-551d9748202c" xlink:to="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_c6d9c990-9ebb-48e1-bec4-b2889c6da184" xlink:href="docs-20230331.xsd#docs_IndividualsWithVotingInterestLessThanThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:to="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_c6d9c990-9ebb-48e1-bec4-b2889c6da184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestAtThresholdMember_6b40e255-0f8e-4178-9a87-8de0460a36a5" xlink:href="docs-20230331.xsd#docs_IndividualsWithVotingInterestAtThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:to="loc_docs_IndividualsWithVotingInterestAtThresholdMember_6b40e255-0f8e-4178-9a87-8de0460a36a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_20d414b1-a77c-4f0b-978c-2a11e8de58dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_srt_TitleOfIndividualAxis_20d414b1-a77c-4f0b-978c-2a11e8de58dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_20d414b1-a77c-4f0b-978c-2a11e8de58dd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_20d414b1-a77c-4f0b-978c-2a11e8de58dd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_20d414b1-a77c-4f0b-978c-2a11e8de58dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b85de43b-126e-4562-86f6-00b4128d3bc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_20d414b1-a77c-4f0b-978c-2a11e8de58dd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b85de43b-126e-4562-86f6-00b4128d3bc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_b720ac2d-93cf-43dd-965c-f4a6d70596c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b85de43b-126e-4562-86f6-00b4128d3bc0" xlink:to="loc_srt_ChiefExecutiveOfficerMember_b720ac2d-93cf-43dd-965c-f4a6d70596c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityCommonStockReservedforIssuanceDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="extended" id="ib2accf2830984369b0cd9c524c156064_EquityCommonStockReservedforIssuanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7b6024d9-827e-4b20-9067-c05aef28d4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7b6024d9-827e-4b20-9067-c05aef28d4c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_257c4c4d-e837-4d85-b0c5-60cd279b977e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_257c4c4d-e837-4d85-b0c5-60cd279b977e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bf4ff25c-d6e7-4ed5-bc2c-b079d053d8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bf4ff25c-d6e7-4ed5-bc2c-b079d053d8ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_76df89f6-a79c-4cea-b4ce-36c33952d339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_76df89f6-a79c-4cea-b4ce-36c33952d339" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f002fdba-06ae-4657-a49f-c528c925b0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f002fdba-06ae-4657-a49f-c528c925b0d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57bfc797-44f7-4273-bf39-73601705930b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57bfc797-44f7-4273-bf39-73601705930b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b69e33ef-bd69-4dba-8b66-fd0b48893d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57bfc797-44f7-4273-bf39-73601705930b" xlink:to="loc_us-gaap_PlanNameAxis_b69e33ef-bd69-4dba-8b66-fd0b48893d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b69e33ef-bd69-4dba-8b66-fd0b48893d40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b69e33ef-bd69-4dba-8b66-fd0b48893d40" xlink:to="loc_us-gaap_PlanNameDomain_b69e33ef-bd69-4dba-8b66-fd0b48893d40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b69e33ef-bd69-4dba-8b66-fd0b48893d40" xlink:to="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_a1cd03c6-fad7-4c4c-9680-506167917bf0" xlink:href="docs-20230331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_EquityIncentivePlan2010Member_a1cd03c6-fad7-4c4c-9680-506167917bf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_a6232ee5-a0d5-47e1-a15c-f818035b93c3" xlink:href="docs-20230331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_a6232ee5-a0d5-47e1-a15c-f818035b93c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_2ddc4839-960d-4005-ba90-a81e5401bc02" xlink:href="docs-20230331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_2ddc4839-960d-4005-ba90-a81e5401bc02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_fc43810e-b9c5-47a8-af51-29c0a2e57f86" xlink:href="docs-20230331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_fc43810e-b9c5-47a8-af51-29c0a2e57f86" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityStockOptionsValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="extended" id="iee59003721f444578273b0fccb195bf3_EquityStockOptionsValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_3746dcc2-3fd1-4253-b076-171952ec7b44" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_3746dcc2-3fd1-4253-b076-171952ec7b44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0f935ef0-d0fc-4115-88ef-6661484a0b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0f935ef0-d0fc-4115-88ef-6661484a0b52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_addfd607-a17f-4529-9119-a6086f283aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_addfd607-a17f-4529-9119-a6086f283aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6490d556-7217-40fb-910f-0c2890b19b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6490d556-7217-40fb-910f-0c2890b19b66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_33219604-1c90-4f1c-b38e-8cb684abff92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_33219604-1c90-4f1c-b38e-8cb684abff92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b3d9b0cf-cd61-462b-914c-3687023802e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b3d9b0cf-cd61-462b-914c-3687023802e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6eb11ced-e082-4659-9215-e0391a7e8dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6eb11ced-e082-4659-9215-e0391a7e8dbc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bad13742-cd80-4866-b8e6-395413e376c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:to="loc_srt_RangeAxis_bad13742-cd80-4866-b8e6-395413e376c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bad13742-cd80-4866-b8e6-395413e376c4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bad13742-cd80-4866-b8e6-395413e376c4" xlink:to="loc_srt_RangeMember_bad13742-cd80-4866-b8e6-395413e376c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bad13742-cd80-4866-b8e6-395413e376c4" xlink:to="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db523b74-dca9-4ffc-92df-91f521d2b550" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:to="loc_srt_MinimumMember_db523b74-dca9-4ffc-92df-91f521d2b550" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d34c3320-e1a4-4783-a0df-ed8976125649" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:to="loc_srt_MaximumMember_d34c3320-e1a4-4783-a0df-ed8976125649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_445e1f84-1d42-40f9-881f-726c568b32f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:to="loc_us-gaap_AwardTypeAxis_445e1f84-1d42-40f9-881f-726c568b32f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_445e1f84-1d42-40f9-881f-726c568b32f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_445e1f84-1d42-40f9-881f-726c568b32f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_445e1f84-1d42-40f9-881f-726c568b32f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73491d40-3305-411e-933d-71f5eaa0827a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_445e1f84-1d42-40f9-881f-726c568b32f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73491d40-3305-411e-933d-71f5eaa0827a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_53b7b656-e456-4ce8-956f-623e1c42e943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73491d40-3305-411e-933d-71f5eaa0827a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_53b7b656-e456-4ce8-956f-623e1c42e943" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityRestrictedStockUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="extended" id="i166411f98a7941a6aa1d3861a3714574_EquityRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f173cd2c-88b4-4e4d-bfe1-216dac156599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f173cd2c-88b4-4e4d-bfe1-216dac156599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84f80dc5-ac19-4425-8493-9e495a0e3c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84f80dc5-ac19-4425-8493-9e495a0e3c23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4789785e-984f-44d0-87d6-033db1f3c9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4789785e-984f-44d0-87d6-033db1f3c9be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d0e439a-b0c3-4fb8-9ad5-c62a5c0be306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d0e439a-b0c3-4fb8-9ad5-c62a5c0be306" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8f46e7df-2411-4a47-bcad-0783ebd454a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_99e35cdb-318a-45d0-8c50-10cd48399aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_99e35cdb-318a-45d0-8c50-10cd48399aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2b3e1b9f-6bab-45a2-8346-ee8095418d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2b3e1b9f-6bab-45a2-8346-ee8095418d28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_18261aaf-e95f-4278-a32e-87bab768972c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_18261aaf-e95f-4278-a32e-87bab768972c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_df82f942-ec4e-4929-9cb3-bddb7ba82155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_df82f942-ec4e-4929-9cb3-bddb7ba82155" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_76984394-0429-4758-a6ca-c1892ecc1f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7dd62798-4156-44c9-af2b-b2305eae1cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7dd62798-4156-44c9-af2b-b2305eae1cd8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4f3a2703-a342-402d-94e6-b46502324d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7dd62798-4156-44c9-af2b-b2305eae1cd8" xlink:to="loc_us-gaap_AwardTypeAxis_4f3a2703-a342-402d-94e6-b46502324d10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f3a2703-a342-402d-94e6-b46502324d10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4f3a2703-a342-402d-94e6-b46502324d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f3a2703-a342-402d-94e6-b46502324d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4b85994-bbf8-455a-ac69-1ea429464f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4f3a2703-a342-402d-94e6-b46502324d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4b85994-bbf8-455a-ac69-1ea429464f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4e19fdb2-4177-4a35-bd6e-3d0762c398e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4b85994-bbf8-455a-ac69-1ea429464f3f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4e19fdb2-4177-4a35-bd6e-3d0762c398e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityPerformanceBasedRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails" xlink:type="extended" id="i165b10e58f8943c4b4f14790ed8f418d_EquityPerformanceBasedRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e97f89b4-966b-484f-94dc-1d60092269f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e97f89b4-966b-484f-94dc-1d60092269f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_023b1e71-e766-48d0-be2c-1957cc5eaab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_023b1e71-e766-48d0-be2c-1957cc5eaab8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d806761a-7a63-4254-b3b9-f20c6eab4363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d806761a-7a63-4254-b3b9-f20c6eab4363" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d1e098a5-fe10-475c-b626-ad9ba7421ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d1e098a5-fe10-475c-b626-ad9ba7421ca7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d34739c9-2ef2-49c7-854c-b976e379412c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c219f9ef-9685-406f-a031-89ffcb7d1b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c219f9ef-9685-406f-a031-89ffcb7d1b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1764e2ef-473e-4438-9e58-7b11833154d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1764e2ef-473e-4438-9e58-7b11833154d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a4e59bf2-f4fa-4992-a59e-9910a904d067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a4e59bf2-f4fa-4992-a59e-9910a904d067" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_97632df7-7079-4fa6-aa06-b27b04751508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_97632df7-7079-4fa6-aa06-b27b04751508" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b72e4811-425f-4b6d-af62-208a7d27a9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38ee5138-1c74-4f46-b14c-7663322500a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38ee5138-1c74-4f46-b14c-7663322500a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2fe249cd-6ea3-46df-baf5-5093b0add7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38ee5138-1c74-4f46-b14c-7663322500a4" xlink:to="loc_us-gaap_AwardTypeAxis_2fe249cd-6ea3-46df-baf5-5093b0add7c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe249cd-6ea3-46df-baf5-5093b0add7c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2fe249cd-6ea3-46df-baf5-5093b0add7c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe249cd-6ea3-46df-baf5-5093b0add7c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec5407f0-5b1e-4bd4-8341-c8444101a9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2fe249cd-6ea3-46df-baf5-5093b0add7c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec5407f0-5b1e-4bd4-8341-c8444101a9f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_a6cc277c-71c0-43b8-85db-6dbac6a2b54d" xlink:href="docs-20230331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec5407f0-5b1e-4bd4-8341-c8444101a9f7" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_a6cc277c-71c0-43b8-85db-6dbac6a2b54d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="extended" id="i8f81f0c4aecf4dc9ababe349306c26a8_EquityStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b6a9d501-d963-442e-9537-9583af5af9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_276d8041-6389-4ba7-8c0b-22b1c40109b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b6a9d501-d963-442e-9537-9583af5af9f6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_276d8041-6389-4ba7-8c0b-22b1c40109b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_800cb3db-7ab7-461e-ba32-ea4343127e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b6a9d501-d963-442e-9537-9583af5af9f6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_800cb3db-7ab7-461e-ba32-ea4343127e6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_404492a7-3582-453c-8b35-8c627a2304fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_800cb3db-7ab7-461e-ba32-ea4343127e6b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_404492a7-3582-453c-8b35-8c627a2304fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_404492a7-3582-453c-8b35-8c627a2304fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_404492a7-3582-453c-8b35-8c627a2304fa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_404492a7-3582-453c-8b35-8c627a2304fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_404492a7-3582-453c-8b35-8c627a2304fa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c46457c1-e747-487c-b9dd-94174cf19939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_CostOfSalesMember_c46457c1-e747-487c-b9dd-94174cf19939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc66f465-f8b8-4fda-93f7-de3dc66fae67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc66f465-f8b8-4fda-93f7-de3dc66fae67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_8b5130bd-b4d4-4a09-90a5-822060a61460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_8b5130bd-b4d4-4a09-90a5-822060a61460" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fe6ded76-bd2f-4f83-9a0d-f97bfae73fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fe6ded76-bd2f-4f83-9a0d-f97bfae73fec" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended" id="id33ee4d6f5724ae8aae330c5daf8cd20_NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_53606dba-9120-4d71-a490-732774de6c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_NetIncomeLoss_53606dba-9120-4d71-a490-732774de6c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dac0c586-0167-491a-a3ba-d13a47dc6058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dac0c586-0167-491a-a3ba-d13a47dc6058" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_e68b5709-a1a5-4e3e-aa72-345daf945dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_e68b5709-a1a5-4e3e-aa72-345daf945dc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9fb2530d-589a-4ce6-b6ea-f3ead4e0364e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9fb2530d-589a-4ce6-b6ea-f3ead4e0364e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_9b4ba245-234e-48b9-b7a8-3d29777fa32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_9b4ba245-234e-48b9-b7a8-3d29777fa32d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_87c9c292-8077-4050-aedd-3eab2ed49ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_87c9c292-8077-4050-aedd-3eab2ed49ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1d656355-37fd-45f4-bc09-4c68f7a3e9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1d656355-37fd-45f4-bc09-4c68f7a3e9ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_adb21063-9b63-40b8-ac45-55107f49e508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_adb21063-9b63-40b8-ac45-55107f49e508" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2d1d2fe-a54d-4fab-92cc-28f0cfc77380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2d1d2fe-a54d-4fab-92cc-28f0cfc77380" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:href="docs-20230331.xsd#docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:to="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a1e680b0-b362-4ed1-bb45-37a9e8b56ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:to="loc_us-gaap_EarningsPerShareBasic_a1e680b0-b362-4ed1-bb45-37a9e8b56ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7d395e74-19b4-40e9-b614-87f329a35790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7d395e74-19b4-40e9-b614-87f329a35790" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4225ed31-2076-4712-a4f0-e18bd70a9ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4225ed31-2076-4712-a4f0-e18bd70a9ccb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b5c36be9-9344-4205-a132-56d282be6f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4225ed31-2076-4712-a4f0-e18bd70a9ccb" xlink:to="loc_us-gaap_AwardTypeAxis_b5c36be9-9344-4205-a132-56d282be6f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5c36be9-9344-4205-a132-56d282be6f50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b5c36be9-9344-4205-a132-56d282be6f50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5c36be9-9344-4205-a132-56d282be6f50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b5c36be9-9344-4205-a132-56d282be6f50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_04af12a9-3b1f-4add-987a-cf5f99eaf9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:to="loc_us-gaap_EmployeeStockOptionMember_04af12a9-3b1f-4add-987a-cf5f99eaf9c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_693726ec-7b06-44fe-b51e-72f13c99a1f8" xlink:href="docs-20230331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:to="loc_docs_OtherShareBasedAwardsMember_693726ec-7b06-44fe-b51e-72f13c99a1f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="extended" id="idc9e79ae77bd4ed5a0e5bb7ca9b85ae2_NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad648e4f-a9ca-43dc-9ed2-e5794e9087dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e61455e1-4ee8-4fe9-9bb9-a4dc37abb84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad648e4f-a9ca-43dc-9ed2-e5794e9087dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e61455e1-4ee8-4fe9-9bb9-a4dc37abb84c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6df5a84d-a548-4cd0-a763-e2d46f3a632f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad648e4f-a9ca-43dc-9ed2-e5794e9087dc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6df5a84d-a548-4cd0-a763-e2d46f3a632f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b41f10bd-e0c1-4447-8b07-166668869b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6df5a84d-a548-4cd0-a763-e2d46f3a632f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b41f10bd-e0c1-4447-8b07-166668869b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b41f10bd-e0c1-4447-8b07-166668869b44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b41f10bd-e0c1-4447-8b07-166668869b44" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b41f10bd-e0c1-4447-8b07-166668869b44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b41f10bd-e0c1-4447-8b07-166668869b44" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_c58adfb3-0c58-4ff2-8581-441f94f4884e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_c58adfb3-0c58-4ff2-8581-441f94f4884e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_d8e25671-9409-447e-963f-283e2df8df90" xlink:href="docs-20230331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:to="loc_docs_OtherShareBasedAwardsMember_d8e25671-9409-447e-963f-283e2df8df90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_50641ce5-c601-4af3-ba3a-cb2e91c64c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:to="loc_us-gaap_WarrantMember_50641ce5-c601-4af3-ba3a-cb2e91c64c3d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i3f37cf99a9b94844b3cb1f12fe109acd_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_12169096-dd2b-4de7-ab3c-189b426e9fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_12169096-dd2b-4de7-ab3c-189b426e9fd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_66f612dc-66f4-45c3-8bdf-8ce3e35387d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_66f612dc-66f4-45c3-8bdf-8ce3e35387d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_cdff8d8f-5124-4b76-b9b2-fba6f5f9010e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_cdff8d8f-5124-4b76-b9b2-fba6f5f9010e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_e7a4201b-0893-4719-8d34-5d8042a7d0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_e7a4201b-0893-4719-8d34-5d8042a7d0be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_a7c8b34d-0a73-4c41-b2c3-9a9714950af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_a7c8b34d-0a73-4c41-b2c3-9a9714950af2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_03013f91-ec8f-45bf-b5ba-9cdeb42d9f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_03013f91-ec8f-45bf-b5ba-9cdeb42d9f45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8a9173a1-0f80-4d1e-a539-5d3eaf16ee08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8a9173a1-0f80-4d1e-a539-5d3eaf16ee08" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_7b0fe50b-edbb-44ad-bd0a-6befd32406d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_7b0fe50b-edbb-44ad-bd0a-6befd32406d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_65660ad5-fe1b-4bec-be34-fdf1abf28722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_7b0fe50b-edbb-44ad-bd0a-6befd32406d2" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_65660ad5-fe1b-4bec-be34-fdf1abf28722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_65660ad5-fe1b-4bec-be34-fdf1abf28722_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_65660ad5-fe1b-4bec-be34-fdf1abf28722" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_65660ad5-fe1b-4bec-be34-fdf1abf28722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_65660ad5-fe1b-4bec-be34-fdf1abf28722" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_a88c524e-5bd2-4512-a404-70abeb109799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:to="loc_us-gaap_DomesticCountryMember_a88c524e-5bd2-4512-a404-70abeb109799" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f5e860e7-7dc2-42bf-ba91-71848375de72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f5e860e7-7dc2-42bf-ba91-71848375de72" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#CommitmentandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="extended" id="ibdea847a4bb746edb1b798635d4e240d_CommitmentandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementExtensionPeriod_82684f1a-b50e-4cb1-a8d0-477fa641dac6" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementExtensionPeriod_82684f1a-b50e-4cb1-a8d0-477fa641dac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_8ddf2c48-ba9a-4c3d-947d-37fcd71648e3" xlink:href="docs-20230331.xsd#docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_8ddf2c48-ba9a-4c3d-947d-37fcd71648e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_c2c15ed2-dc91-4e93-be83-d9ce9c60127a" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_c2c15ed2-dc91-4e93-be83-d9ce9c60127a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_fbe7caf0-e982-40fb-8dbf-9fb0166b2454" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_fbe7caf0-e982-40fb-8dbf-9fb0166b2454" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod_853b25a2-35f5-485b-bf4d-2a1e2d8dca32" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod_853b25a2-35f5-485b-bf4d-2a1e2d8dca32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementPeriod_899c2c49-c596-4bce-8c18-a39a53b53ac7" xlink:href="docs-20230331.xsd#docs_HostingArrangementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_HostingArrangementPeriod_899c2c49-c596-4bce-8c18-a39a53b53ac7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementAnnualCommitment_63d67730-eddf-4888-84f1-3dfa60df57b8" xlink:href="docs-20230331.xsd#docs_HostingArrangementAnnualCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_HostingArrangementAnnualCommitment_63d67730-eddf-4888-84f1-3dfa60df57b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_8f706233-f1fa-4fd8-b2ce-24f5478b34e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_us-gaap_OtherCommitment_8f706233-f1fa-4fd8-b2ce-24f5478b34e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_8971146f-ce7b-4aeb-be75-504450c6b649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_8971146f-ce7b-4aeb-be75-504450c6b649" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_b8f19a34-bad4-46df-a83a-28cabbfa8d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_us-gaap_OtherCommitmentsTable_b8f19a34-bad4-46df-a83a-28cabbfa8d99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6cd30960-128d-4df7-acb3-4efaa4c5d035" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_b8f19a34-bad4-46df-a83a-28cabbfa8d99" xlink:to="loc_srt_RangeAxis_6cd30960-128d-4df7-acb3-4efaa4c5d035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6cd30960-128d-4df7-acb3-4efaa4c5d035_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6cd30960-128d-4df7-acb3-4efaa4c5d035" xlink:to="loc_srt_RangeMember_6cd30960-128d-4df7-acb3-4efaa4c5d035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6cd30960-128d-4df7-acb3-4efaa4c5d035" xlink:to="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_78b9e120-bdf1-46d8-ad39-3c51d11f5ecd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:to="loc_srt_MinimumMember_78b9e120-bdf1-46d8-ad39-3c51d11f5ecd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a0e24b5-b069-4ec4-964a-31d084ac3d75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:to="loc_srt_MaximumMember_8a0e24b5-b069-4ec4-964a-31d084ac3d75" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/LeasesNarrativeDetails" xlink:type="extended" id="iceebe1aa35d94b87808daeff0d72bff0_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_262b204c-ac92-4de6-ad2f-b1ee99de6401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_262b204c-ac92-4de6-ad2f-b1ee99de6401" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9633799a-d2be-4788-9ba2-cabc7d2a5f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9633799a-d2be-4788-9ba2-cabc7d2a5f52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_73c3bbe1-0fdb-472e-b893-c6a6d3387823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:to="loc_us-gaap_OperatingLeaseLiability_73c3bbe1-0fdb-472e-b893-c6a6d3387823" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_33b73605-7e0a-4266-bf39-11d08f7367df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_33b73605-7e0a-4266-bf39-11d08f7367df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_fd877024-9a34-48c8-91db-8a28cfdecd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_33b73605-7e0a-4266-bf39-11d08f7367df" xlink:to="loc_us-gaap_LeaseContractualTermAxis_fd877024-9a34-48c8-91db-8a28cfdecd1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_fd877024-9a34-48c8-91db-8a28cfdecd1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_fd877024-9a34-48c8-91db-8a28cfdecd1d" xlink:to="loc_us-gaap_LeaseContractualTermDomain_fd877024-9a34-48c8-91db-8a28cfdecd1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_43df4072-3bf7-4231-8add-eebbe2ee2dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_fd877024-9a34-48c8-91db-8a28cfdecd1d" xlink:to="loc_us-gaap_LeaseContractualTermDomain_43df4072-3bf7-4231-8add-eebbe2ee2dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OfficeSpaceLeaseInIrvingTexasMember_f070d7bc-78cf-4e74-b006-59254d950810" xlink:href="docs-20230331.xsd#docs_OfficeSpaceLeaseInIrvingTexasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_43df4072-3bf7-4231-8add-eebbe2ee2dff" xlink:to="loc_docs_OfficeSpaceLeaseInIrvingTexasMember_f070d7bc-78cf-4e74-b006-59254d950810" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>docs-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4d1277b4-10a9-4732-8720-53d63c4cfd14,g:0c268704-e9e1-4ac2-87ff-5caa0e49a51f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_6f57a5a4-6f08-4864-bbc7-bac6e3b7fab4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_638457d3-fe80-427a-bcb7-6d50a3d16ee8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2160a98e-249f-4ee6-bbf8-88f764833cf2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8e0df169-0bed-4267-bd14-e813a2ac6e42_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_USNewsWarrantMember_edf24270-3de1-4e9a-b473-3d1906cb318c_terseLabel_en-US" xlink:label="lab_docs_USNewsWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. News Warrant</link:label>
    <link:label id="lab_docs_USNewsWarrantMember_label_en-US" xlink:label="lab_docs_USNewsWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. News Warrant [Member]</link:label>
    <link:label id="lab_docs_USNewsWarrantMember_documentation_en-US" xlink:label="lab_docs_USNewsWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. News Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_USNewsWarrantMember" xlink:href="docs-20230331.xsd#docs_USNewsWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_USNewsWarrantMember" xlink:to="lab_docs_USNewsWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_f8cd9f3e-108b-4dde-88ac-ec1764860359_terseLabel_en-US" xlink:label="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrant expense</link:label>
    <link:label id="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_label_en-US" xlink:label="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition</link:label>
    <link:label id="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_documentation_en-US" xlink:label="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:href="docs-20230331.xsd#docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:to="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_bd9d21f5-c40a-4291-9421-0fbd94401ed1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockIssuancesCostsIncurredButNotYetPaid_d55610f9-68a3-4aab-9462-93634a2ea6f3_terseLabel_en-US" xlink:label="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid deferred offering costs</link:label>
    <link:label id="lab_docs_StockIssuancesCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuances Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_docs_StockIssuancesCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuances Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:href="docs-20230331.xsd#docs_StockIssuancesCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:to="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c7394569-b2f3-48fe-ac95-d75468105399_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityTextBlock_ab21cefc-2d4a-4d63-8277-fd63dd56bc82_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_docs_TemporaryEquityTextBlock_label_en-US" xlink:label="lab_docs_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Text Block]</link:label>
    <link:label id="lab_docs_TemporaryEquityTextBlock_documentation_en-US" xlink:label="lab_docs_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityTextBlock" xlink:href="docs-20230331.xsd#docs_TemporaryEquityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityTextBlock" xlink:to="lab_docs_TemporaryEquityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9fb7ea77-355c-45f3-b66d-4bf706b0a107_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred provision (benefit):</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_d1c19c3b-ca46-423c-aaee-e00ced6d4c69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain (loss) on available-for-sale-securities, net of tax benefit (provision) of $(425), $5,199, and $0, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_871718ff-15bb-42c9-8781-185e996b22c8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fbff3f55-4dd5-455b-912a-910e0bd07784_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_196f72c4-d771-47ed-869f-448dde573dbb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_0310c1eb-989e-41de-b1c6-8853a9f03d0c_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized loss on sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_1e3da401-3a31-49f0-82f0-a253eb83a452_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_8fea5417-ead5-449b-ac7c-c19b98b49d82_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_3f0c6886-10b0-45f2-9e2e-738eaffb346a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8c0d67fd-8c42-4904-89c5-d8465c593ffd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_5e0a2917-5cf6-4fe0-a48b-36c78bf0bd45_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_18e4b357-a9bf-4c1e-9e19-c59c87f02358_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_e3967216-2d6b-4d88-bfad-a07ddd44e7e6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_92c4f01c-eaba-4a65-90a8-a67214953ff3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_d6ee7c67-ee05-4d9c-bf7c-6ad780045e01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6592bc58-d9cf-4577-9a3c-e9d241c35b45_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_6c3cd719-ce97-4aca-8784-bb22cc82c068_negatedTerseLabel_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from contracts invoiced during the period</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_label_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_documentation_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:to="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6e605da2-7b7d-477c-98a8-4972fbb36864_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9cdfc336-f7d3-4ac6-b26d-2e35614440bd_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_06e350a6-2323-4af0-801e-a22cc5d9769b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8eae464a-7c16-4f8d-a87a-bf6fa8e1c945_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f839e535-e91b-4a39-9504-b4acc86e24af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_88c57816-1243-485d-93ae-04a1644b3853_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c85c03d8-15b7-498f-962a-1aa8f904d732_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_32c00357-742e-4939-a119-e86edc81bd41_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions related to a lapse of statute</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithCustomerLiabilityAdditionsNet_aeb685f4-2aa5-470a-9786-002eaf60db3d_terseLabel_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions, net, during the period</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityAdditionsNet_label_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Additions, Net</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityAdditionsNet_documentation_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Additions, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerLiabilityAdditionsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:to="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_de646860-42c3-441b-a1e4-b0a1adaa9c1f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_93c09912-4b44-4434-8452-3b5d21660840_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with an acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_9554ded7-eddb-4ada-8428-6a62dac3abbc_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_a530535f-5037-4ae1-9b36-ffd62d0f546c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d92b9f61-5a1f-4964-aa88-4845652c36a2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_ae47911c-fa3c-4f0a-b172-05895a1f2d7f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_a43390d9-da20-4407-9aae-28b6dfb13e97_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_d77dbfa1-078a-4c38-8e09-f71eb03bd986_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_fbad1560-b22d-4ec0-b23d-4d6b3157a953_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_bc9cd397-d369-429a-a700-92bd73b3c321_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2509124e-5fdc-443f-8b4a-18b5b103cfb4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_bbaae8ca-8428-401d-a3e4-3ced8d835a7f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_c2914b74-7769-4f59-b557-bd5a554d0bd4_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_87b8b849-a683-4e17-95f6-2d10046117ad_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_af762588-b8bf-45e1-8cb8-c957d0cb459b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_35a600c3-0447-4ea7-9750-7efc034aaa4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_0dbd574f-d534-4a41-b693-5cb6c47d32a2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_41d7fcad-dfb8-42eb-ab63-e6051a50acdd_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_a6ff8768-e2fa-4f52-8039-cdaaf7ed54e8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_c05b8dde-f592-4528-8ee8-f85afaf3f00d_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_3ec34fa5-98f2-4651-a745-0c833dfac9fa_terseLabel_en-US" xlink:label="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_label_en-US" xlink:label="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other</link:label>
    <link:label id="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_documentation_en-US" xlink:label="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:href="docs-20230331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:to="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_5de9aada-b4fb-4ffe-bad4-172274904e92_terseLabel_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt securities which no credit losses were recognized</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_label_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, With No Credit Allowance</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_documentation_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, With No Credit Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:to="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d19380aa-e5e9-41a1-8aa1-1e1175a80e39_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_bc269164-7e2b-4dd7-bc62-354533410867_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_EquityIncentivePlan2010Member_9d9a595f-315d-4044-a128-0137a9b66afd_terseLabel_en-US" xlink:label="lab_docs_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan</link:label>
    <link:label id="lab_docs_EquityIncentivePlan2010Member_97cad103-f9b6-4bd8-a49d-ae9ef1d7463f_verboseLabel_en-US" xlink:label="lab_docs_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan</link:label>
    <link:label id="lab_docs_EquityIncentivePlan2010Member_label_en-US" xlink:label="lab_docs_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2010 [Member]</link:label>
    <link:label id="lab_docs_EquityIncentivePlan2010Member_documentation_en-US" xlink:label="lab_docs_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2010</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member" xlink:href="docs-20230331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_EquityIncentivePlan2010Member" xlink:to="lab_docs_EquityIncentivePlan2010Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9b5a6b26-a034-4c16-8379-984732879022_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_15c0dd12-ab76-47cd-8458-af88669f74e0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_dac4025a-8d64-4a02-bd60-ac97aaaa4bfd_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_27d93017-ce68-40b9-b7af-61f043b791de_terseLabel_en-US" xlink:label="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalent and Marketable Securities</link:label>
    <link:label id="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_label_en-US" xlink:label="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalent And Marketable Securities [Policy Text Block]</link:label>
    <link:label id="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_documentation_en-US" xlink:label="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalent And Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:href="docs-20230331.xsd#docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:to="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8a8ad1b4-f579-4564-9f14-aa3a0f54ccf0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6919b13a-5223-4688-a4af-2bf9bf6d8bfe_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_a1647646-1dc6-4489-8234-fca4b1c5179d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_5a0627ce-0559-4571-b964-7d426490c936_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_cad7adab-17e9-485b-be1c-271f55e4cdcb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e1bd294d-64d4-4de1-9f06-a9a48c5f4d70_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_75f93ff0-cfdd-4e3c-a5e2-f2657e129af5_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_07c8ae37-63f2-4036-858f-113d16dce79a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_a13894f5-b55c-4e57-8a6d-961810158abe_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_62cf60e0-3315-4a6b-9838-c2d143359f11_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_081bfd4c-f886-48c1-aac4-cd4978c47e4f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense excluding option</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d04cbcf1-a535-4977-bbee-8b421a9d6642_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_06cb9e24-eeae-48e9-9705-ede6447c838c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, state</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_471d4741-99a1-44f4-a499-28f73b0b3af2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_8e7915dc-d486-410f-bede-e62b83abf289_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3c2daff5-ee90-444c-943f-2563be290b73_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term, outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SubscriptionMarketingSolutionsMember_72874a47-9af7-4e96-ae52-a6713640dd0f_terseLabel_en-US" xlink:label="lab_docs_SubscriptionMarketingSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Marketing Solutions</link:label>
    <link:label id="lab_docs_SubscriptionMarketingSolutionsMember_label_en-US" xlink:label="lab_docs_SubscriptionMarketingSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Marketing Solutions [Member]</link:label>
    <link:label id="lab_docs_SubscriptionMarketingSolutionsMember_documentation_en-US" xlink:label="lab_docs_SubscriptionMarketingSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Marketing Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMarketingSolutionsMember" xlink:href="docs-20230331.xsd#docs_SubscriptionMarketingSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SubscriptionMarketingSolutionsMember" xlink:to="lab_docs_SubscriptionMarketingSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4bde58e8-81f2-4c97-a88a-3bccb0b64e53_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_8fd70977-37b2-44db-9bd2-0a559cc27e9e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_227cf910-6203-4188-aca8-81162e9d94ff_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_76e87cea-5b1a-468a-8504-6ed23ed955c8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6719fb37-bf43-46c3-9f75-0db77399e82d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_39776803-9fc8-405a-9f2e-bbe81a9022b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_8425784c-8616-49ed-9449-7f586ead882b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_40201875-7540-49b8-9af1-9641ed696d74_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2a47dbcf-945c-4626-a10b-3c5d96113de5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_HostingArrangementAnnualCommitment_5bfd298e-b6f0-4eab-a16e-7cc11b33bb61_terseLabel_en-US" xlink:label="lab_docs_HostingArrangementAnnualCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting arrangement annual commitment</link:label>
    <link:label id="lab_docs_HostingArrangementAnnualCommitment_label_en-US" xlink:label="lab_docs_HostingArrangementAnnualCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Annual Commitment</link:label>
    <link:label id="lab_docs_HostingArrangementAnnualCommitment_documentation_en-US" xlink:label="lab_docs_HostingArrangementAnnualCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Annual Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementAnnualCommitment" xlink:href="docs-20230331.xsd#docs_HostingArrangementAnnualCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_HostingArrangementAnnualCommitment" xlink:to="lab_docs_HostingArrangementAnnualCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3cc9738c-6026-4c9b-b345-d3c67bab197b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_0e2c4717-13e2-40d9-a166-10dfd1f71bf4_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_922266de-f634-4329-a4ea-1aa6acb7828d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_59e7590d-095e-47cd-a4e6-bcee09678c12_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_03eaf4d3-fcdd-4b69-bbfe-e0db5bd67d7e_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b33c2f53-fcee-4825-8020-938fc4febb20_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c10d081-6a8a-439f-9f66-2c715269b12d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acae5b66-50b9-43d4-82c8-f11f36f17b41_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_346b9024-68ac-4eb1-9ae6-4fd02b93aa19_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_72f703ac-ad47-4649-a6ab-896925ba73c3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon initial public offering, net of offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_a4a0d28a-0c33-4626-bc6f-144096852cab_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2b9bdac8-db5e-42f9-89c5-2b48857431ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_978e6606-bdc3-4d97-9147-fa6f5c147096_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1ec929dc-34e0-4ab4-a5e8-791bb3cdae13_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_9ef328a4-d8db-4d19-9bb9-18d514110987_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_e42b62c0-4210-406e-8c74-ecdbd4850d96_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock, shares converted (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_5e2d014d-4aa6-44a8-bc82-d2504ca45435_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6931869a-b599-45f7-9b49-360e3d1c405a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current provision:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_337edf92-8809-402b-9251-0c12142b48e2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5dcf7ff7-4758-45c4-a0a6-21a8dda03d5d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PortionOfCurativeTalentLLCMember_75d4664a-a2f1-4704-ac40-0d9bc6f74cb0_terseLabel_en-US" xlink:label="lab_docs_PortionOfCurativeTalentLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Curative Talent, LLC</link:label>
    <link:label id="lab_docs_PortionOfCurativeTalentLLCMember_label_en-US" xlink:label="lab_docs_PortionOfCurativeTalentLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Curative Talent, LLC [Member]</link:label>
    <link:label id="lab_docs_PortionOfCurativeTalentLLCMember_documentation_en-US" xlink:label="lab_docs_PortionOfCurativeTalentLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Curative Talent, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PortionOfCurativeTalentLLCMember" xlink:href="docs-20230331.xsd#docs_PortionOfCurativeTalentLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PortionOfCurativeTalentLLCMember" xlink:to="lab_docs_PortionOfCurativeTalentLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_44109972-25b8-4a77-a274-aa6c03369754_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_e1d3dcbc-0ab8-4096-b144-29b351697a63_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c03917b0-7652-45a4-88b1-9e3bdd975e20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_0e4d945c-056d-43d0-9d76-3bb8fb1c789e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_41744c2f-5fc0-40d3-a433-0ee2acf1c22c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited and expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_feac11b4-4d08-4afc-8225-6a7c0572de3d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_635550e6-a20d-4295-966c-359b001286e3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_c2fcfa47-754f-4eb2-b367-fbf7116078c9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out consideration liability, minimum guarantee</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_13344b4e-fdf9-45dc-b2a2-a4c6a7314013_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dd8da0e0-99dd-43d6-b604-0fd68ef35c55_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities_e9dc148d-16c2-49ab-afef-b05802ee8395_terseLabel_en-US" xlink:label="lab_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability settled</link:label>
    <link:label id="lab_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities_label_en-US" xlink:label="lab_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Contingent Consideration Liability, Operating And Financing Activities</link:label>
    <link:label id="lab_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities_documentation_en-US" xlink:label="lab_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Contingent Consideration Liability, Operating And Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" xlink:href="docs-20230331.xsd#docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" xlink:to="lab_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_f738c004-143f-4cdc-aa97-cfb070427e76_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockIssuedAcquisitions_f260badc-74d7-456b-b52b-9204211a8bb7_terseLabel_en-US" xlink:label="lab_docs_StockIssuedAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in acquisition</link:label>
    <link:label id="lab_docs_StockIssuedAcquisitions_label_en-US" xlink:label="lab_docs_StockIssuedAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued, Acquisitions</link:label>
    <link:label id="lab_docs_StockIssuedAcquisitions_documentation_en-US" xlink:label="lab_docs_StockIssuedAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedAcquisitions" xlink:href="docs-20230331.xsd#docs_StockIssuedAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockIssuedAcquisitions" xlink:to="lab_docs_StockIssuedAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0f4540c7-9354-45ea-84bf-6e8ec34e63e3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3f496492-c722-4f7f-bd6a-ec58e1a2b805_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_789ebb16-15e9-45b9-9630-37047c47af74_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_719e2d94-aa32-4241-a7c2-15f1d63c9972_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_f6f39d1e-e6f8-476c-a8cd-ca4647061c0b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1452aceb-8f4e-4223-bb95-8121fee61024_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_374045f7-7410-45aa-bd9b-a915b0ca2a9c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_aab5aa71-297e-4392-a374-399b13cda582_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8b7ffe7a-1367-4360-9df8-10dce69e33f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_8b9799f5-5323-40c2-b87f-ddfb3c9eabc3_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_87fc2feb-65fa-40ff-85d2-f882d550bbb2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_386fd9e1-b18d-45e8-b0e9-fc5ccfe45b96_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain (loss) on available-for-sale-securities, tax benefit (provision)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities, Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9788faad-3e81-4116-8cd3-978a791feca3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Deferred Revenue Balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_9e9ac4a1-3e66-4337-8fc4-bb1104dae714_negatedTerseLabel_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="docs-20230331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_031d28f7-f717-4750-84b3-8ecc21a036fb_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_4adcb897-ca98-4465-b7ce-a4be6adec6ef_terseLabel_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign bonds</link:label>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:to="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_1386e816-0ebc-4b2b-a90f-2ec13b3de6d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7914eb92-9f80-4034-bf17-fcfeac9f868c_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b4ac1b50-2361-49e1-9dc3-491625048cc5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense_9ebeafd5-0e70-43ab-be63-829d99ccc61f_terseLabel_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities credit losses</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense_label_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Expense</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense_documentation_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" xlink:to="lab_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_7cf4094b-5866-4379-b43a-e359d01b9943_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Class A and Class B common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_33e3cc5d-c909-49c0-9144-a123d6fa1d2a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue_2e35c283-1621-40a2-975d-d9b2e1c17cd0_terseLabel_en-US" xlink:label="lab_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised in period , intrinsic value</link:label>
    <link:label id="lab_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue_label_en-US" xlink:label="lab_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercises in Period, Intrinsic Value</link:label>
    <link:label id="lab_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue_documentation_en-US" xlink:label="lab_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" xlink:href="docs-20230331.xsd#docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" xlink:to="lab_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b127a9c2-4379-4c7c-993b-c0fc9196e49c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_d3af14aa-daf7-4a3c-b78c-988c344f0c80_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_1e34176d-61ac-4013-8c36-ad76d18613c0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c0cd6377-37f6-4f59-9ef7-78c51175fb7b_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember_3bff9cd3-d1d2-43a8-a04e-eb59efed3a3c_terseLabel_en-US" xlink:label="lab_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Subsequent to Tranche One</link:label>
    <link:label id="lab_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember_label_en-US" xlink:label="lab_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Subsequent to Tranche One [Member]</link:label>
    <link:label id="lab_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember_documentation_en-US" xlink:label="lab_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Subsequent to Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember" xlink:href="docs-20230331.xsd#docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember" xlink:to="lab_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cf2d7bb6-1957-4202-b448-61fc323995d5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18831ff1-27d0-41c8-a002-2950dadfeef8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_35d5e89c-e583-499a-8720-c08b335de6ab_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_77357997-c803-4c60-abcc-e443f263b763_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7ca1d9cd-7876-4392-82d2-4a068ac9a55a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll, bonus, and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_adee5bcd-bd1d-4bfa-a6d8-29316d9847fc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_09d6464c-df7e-48b0-b072-b6ca2710cbd8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_788426d8-f342-4c37-99f0-37c87fc2494f_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_8f1a053d-6267-4aa2-904f-d98d691db753_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_695aa058-53cf-4884-8400-578abc79cd70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_a4be5656-efd9-4363-bc78-076a8c7d46b6_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8d0166b8-132a-4bb6-b40c-34c6f1c107c1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d03b1a32-27ad-403f-84b5-7a2e5e8a6db0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_233f05f8-1dfd-4c68-b6ca-a6c9fddcb407_terseLabel_en-US" xlink:label="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts</link:label>
    <link:label id="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_label_en-US" xlink:label="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts [Member]</link:label>
    <link:label id="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_documentation_en-US" xlink:label="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:href="docs-20230331.xsd#docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:to="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9d9f41ff-6897-4fba-99a4-ec4eef2e7864_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_2546e617-c43a-4575-9726-78b5f65a4dc7_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_2c30d5f8-7a16-4f11-b2a4-53ab067b4d9d_terseLabel_en-US" xlink:label="lab_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options and common stock warrants</link:label>
    <link:label id="lab_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_label_en-US" xlink:label="lab_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options and Warrants Exercised</link:label>
    <link:label id="lab_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_documentation_en-US" xlink:label="lab_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options and Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:href="docs-20230331.xsd#docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:to="lab_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_faaa824c-6700-4dad-97fc-778934bc2c85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_e87dda3b-4bf4-406f-b5e3-425ed0d87bec_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Reserved for Issuance</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_e985b741-d38f-4c0a-83fe-13f1a04e5c74_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of assumed exercise of common stock warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_425b3118-99ff-4266-9738-afa0523a64a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued commissions</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_5ab24bbd-19a4-43f9-949e-426a685c87d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings attributable to participating securities, diluted</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3b635bfa-e97f-46ba-9918-acb403048473_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a0491b18-5c7d-4c34-848a-f05f7e09cde1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_016a2c20-7605-420e-91b8-cea75b4b1f20_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b4f20b5a-e09c-421b-8e12-3bd601c8152c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fb38d31-d825-495f-8713-768b6a6ec5b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_712b3765-997f-40ad-ab72-943c382148ed_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0ae4ee5c-a3db-427e-a279-8ca4b196db71_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_bd38339a-9cb9-4e3b-8ffc-2909215e381a_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e6e89dc0-534b-4c8a-938d-6ed11b5abf62_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense, weighted average period of recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_792348b1-3f94-466c-8835-807ca0c2880c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term, vested and exercisable at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_09d1199c-ab61-4c72-855e-54f5fc38d3f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_932810e4-5ba1-44f4-a054-f00ca03d7020_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock in connection with the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_6c8361f3-a850-46f0-887e-2404e0ac2669_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_3e73fc7c-72ac-4494-9c32-3e4350409876_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_901cc01a-11be-40cd-9155-1441e9cd98d7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7bee400e-11a6-4bbe-a13e-c5a9b7e22292_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon initial public offering, net of offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_b45888a2-1102-4808-a8c6-bfbf1d0b8275_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5db0a9e1-cbf0-4edc-bdcf-2b29c414ffef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_c0e67e93-1729-4fcf-98b7-0beab64e1d8b_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CustomerAMember_3fd93ef7-4561-46a8-9edf-985099eabafb_terseLabel_en-US" xlink:label="lab_docs_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A</link:label>
    <link:label id="lab_docs_CustomerAMember_label_en-US" xlink:label="lab_docs_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A [Member]</link:label>
    <link:label id="lab_docs_CustomerAMember_documentation_en-US" xlink:label="lab_docs_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CustomerAMember" xlink:href="docs-20230331.xsd#docs_CustomerAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CustomerAMember" xlink:to="lab_docs_CustomerAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_68d9fee6-c284-4d3d-8625-b1f535405781_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_58c0d967-f78b-4234-8028-8b7ac6d45a82_terseLabel_en-US" xlink:label="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering Including Over Allotment Option</link:label>
    <link:label id="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_label_en-US" xlink:label="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering Including Over Allotment Option [Member]</link:label>
    <link:label id="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_documentation_en-US" xlink:label="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering Including Over Allotment Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:href="docs-20230331.xsd#docs_InitialPublicOfferingIncludingOverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:to="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_80b922ae-2f4c-4d97-9c1d-b64ad9763315_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_7aa0aee2-e262-4ddf-9ed9-5c999575471c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_266511f5-a946-4c18-ad0f-7c83ec2ec43d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_25755af6-4050-41bc-8583-759178766d0c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95ea9493-8069-46dc-b95b-38b29bc4d014_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_95f0c321-f483-475a-917e-eef818ef4bcf_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_3707df98-33c9-4b94-9532-24a41fd27757_terseLabel_en-US" xlink:label="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other related expense</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_label_en-US" xlink:label="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Acquisition and Other Related Expense</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_documentation_en-US" xlink:label="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Acquisition and Other Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:to="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_9b5d3ced-2e27-4908-8d1b-e9f2cf31a4e0_terseLabel_en-US" xlink:label="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding outside the Plans</link:label>
    <link:label id="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_1510a1b4-45fb-465b-8bf0-e1acd8eb3e7e_verboseLabel_en-US" xlink:label="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding outside the plans</link:label>
    <link:label id="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_label_en-US" xlink:label="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021 [Member]</link:label>
    <link:label id="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_documentation_en-US" xlink:label="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:href="docs-20230331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:to="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_9a7a4cd0-a7c1-4f8b-aa46-59b71907cbb7_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3b46dd8d-5216-4799-a8ed-1ff8d7e05bb0_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1f3b3859-6b81-4498-8db6-fc5cdf536b6d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2234ca66-fc8d-4719-bbf4-0fc0bd98b51f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AMiONMember_acb7d079-af72-4446-a422-07ccd89cd190_terseLabel_en-US" xlink:label="lab_docs_AMiONMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMiON</link:label>
    <link:label id="lab_docs_AMiONMember_label_en-US" xlink:label="lab_docs_AMiONMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMiON [Member]</link:label>
    <link:label id="lab_docs_AMiONMember_documentation_en-US" xlink:label="lab_docs_AMiONMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMiON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember" xlink:href="docs-20230331.xsd#docs_AMiONMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AMiONMember" xlink:to="lab_docs_AMiONMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_cf77d7c9-a209-4641-9baa-fc49664f0d71_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_24cb678d-55d6-4043-8493-48dd7ef1a562_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_69a6560c-4f8d-4712-a5c6-d646f9f96f02_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2dab08f6-802e-4e8c-97bd-029581308a18_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockOptionAndIncentivePlan2021Member_545c08ea-f913-4891-b265-445839cbbc44_terseLabel_en-US" xlink:label="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Plan</link:label>
    <link:label id="lab_docs_StockOptionAndIncentivePlan2021Member_becd9552-b854-4b4b-9a2e-c11325c78eaf_verboseLabel_en-US" xlink:label="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Plan</link:label>
    <link:label id="lab_docs_StockOptionAndIncentivePlan2021Member_label_en-US" xlink:label="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Incentive Plan 2021 [Member]</link:label>
    <link:label id="lab_docs_StockOptionAndIncentivePlan2021Member_documentation_en-US" xlink:label="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Incentive Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member" xlink:href="docs-20230331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockOptionAndIncentivePlan2021Member" xlink:to="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7a1dbc4e-946a-4457-9802-9ed2e019a293_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_f99226ec-7fb1-4ed1-8736-a6bcfe3d2ea7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings attributable to participating securities, basic</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_1b3eb089-3ad3-4725-a1ce-22b8219114f0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_9199820a-5cee-43ec-afe4-7aebcddcf0cb_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c991a885-9b26-40ba-9688-38705470542a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_5eda7c7f-6195-4f2f-996f-e8a3869e6aeb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_2c70474b-ae50-4dc4-b677-61cc67f7a8d7_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_de3026aa-650c-4d84-92ba-450d157aab11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_aca50973-8297-47ec-9d85-6eb3d522fb49_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_337473ee-7806-48ed-8e8c-3dff02004a5a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_0825dd04-b11a-4466-bd82-ee6bc08920e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_8d034987-52e4-4652-bf41-2b480d3a700e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_af1647b4-298a-49ba-b6b5-fd2d14bf47c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_92f67b30-854f-4ab7-adc8-b59ceeb67b71_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c6dde72e-bfdb-4112-943f-6a540da6e297_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_67910121-fda1-4dff-bc3e-c884a041c57c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_ba265b0d-3cf7-48a9-a1b6-3016cca9c2cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5dad55f8-27a6-4938-bede-2de89b39a3cb_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e7c4445f-1231-4a68-90b5-85d9aef85bad_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7e6c3f4b-f671-4a01-8bba-4a32ead4b35b_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_47917370-3bbe-43cf-b753-a78a7e1e5025_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_15972297-afcc-4dc0-8be3-d8d1ebb696f6_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c621ac2e-45cd-49a4-89cb-d3d2c061dcd6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_THMEDLLCMember_972acb4c-38ea-4d0f-a6f2-e2909b72aefe_terseLabel_en-US" xlink:label="lab_docs_THMEDLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THMED, LLC</link:label>
    <link:label id="lab_docs_THMEDLLCMember_label_en-US" xlink:label="lab_docs_THMEDLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THMED, LLC [Member]</link:label>
    <link:label id="lab_docs_THMEDLLCMember_documentation_en-US" xlink:label="lab_docs_THMEDLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THMED, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember" xlink:href="docs-20230331.xsd#docs_THMEDLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_THMEDLLCMember" xlink:to="lab_docs_THMEDLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_663bdabd-33d9-41dd-af59-2b8ddcdac9b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d5075472-9919-4e2f-b41d-636e645e5efe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithUSNewsWorldReportLPMember_9a1603a9-2c75-41c5-984b-63f4e090f888_terseLabel_en-US" xlink:label="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With U.S. News &amp; World Report, L.P.</link:label>
    <link:label id="lab_docs_ContractWithUSNewsWorldReportLPMember_label_en-US" xlink:label="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With U.S. News &amp; World Report, L.P. [Member]</link:label>
    <link:label id="lab_docs_ContractWithUSNewsWorldReportLPMember_documentation_en-US" xlink:label="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With U.S. News &amp; World Report, L.P.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithUSNewsWorldReportLPMember" xlink:href="docs-20230331.xsd#docs_ContractWithUSNewsWorldReportLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithUSNewsWorldReportLPMember" xlink:to="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_abc4b3af-2948-466e-9b06-78834f0a8a02_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_aac580e0-300d-48df-ab61-cc81d4b92157_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b2e15519-12b3-4653-a154-a7387875cbdb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price called by warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_796b8418-245a-4917-8136-4a405cb3104c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceOtherMember_32d6db25-0a7a-4deb-86cc-f673e530dc7e_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other</link:label>
    <link:label id="lab_us-gaap_ServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceOtherMember" xlink:to="lab_us-gaap_ServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5d6245d7-a136-447f-a38e-199bbe51d28c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_eb4996fa-7f9c-45c6-89a2-69e7d8f903cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d59286d7-8741-4118-9955-b298a613f310_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of vested equity instruments</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_dafc9fb3-1849-4d3d-bd67-e5ba04fbbe92_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_9d667f3f-50bd-424d-a73d-893924c02d5d_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_b03876ab-3948-422f-919e-90a4f15a71da_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_IndividualsWithVotingInterestAtThresholdMember_2f37ef56-b677-4a77-9022-6ae424bc99fb_terseLabel_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest At Threshold</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestAtThresholdMember_label_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest At Threshold [Member]</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestAtThresholdMember_documentation_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest At Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:href="docs-20230331.xsd#docs_IndividualsWithVotingInterestAtThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:to="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_d9adc4d1-5142-428e-9d34-8ae784381ee0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_32ad7e0a-f7fa-49a6-a819-33e6555360de_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_535079fd-95fb-4cd5-abbd-8db79f9bbcd7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_30cf720a-5216-426c-b30d-8bbbd3f8f491_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9cfbe2cb-5bd8-4bde-84b2-5c2e5092d967_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_dacb1c7a-2bf3-4cf3-a5fe-f3f6235c5098_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_cc129222-28ba-42f8-957b-e79ad3582412_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e607201e-f583-4f20-9320-33d444e982f7_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_ffaf73cf-88e1-49c0-919c-f0eb8cd58cae_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred contract costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_914fce07-2042-428b-97d6-093e72eba47b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued and sold in initial public offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4d3c92a2-7b90-4eb9-9f07-d175bb0ae464_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ac8b97e3-6f46-41c5-a1f7-5043768abe91_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_92874761-10e2-4657-8c73-165b48d15cec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_14fa5ca6-b15d-41c4-97e9-5b900b9fd1dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of acquisition:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_21d88c1b-b60f-4514-9dcd-cb6f6a792790_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_56089988-4ad2-4ace-ac55-32f236e992b3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_16e82abd-8210-43c9-a8c9-a48e563ef81f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_a61fc443-01f6-4c0f-8da6-b193eb64b233_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_6818ef3e-9421-4a31-9842-cc6073697d1e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a84872d1-7019-4166-8558-127cfae1c3df_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d049df3b-b809-4d59-83e0-7910f42e21c3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense, option</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_df790306-34e0-4796-9400-290ff2dee50c_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_957dc5f5-8268-4260-b35d-6d5067bd8c90_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_069028e9-dec9-44aa-91cd-4dc8328ab317_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f60f634-8ddb-43de-8e1d-212eb887d9a8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_b28f2f4a-a766-4f8d-9755-e7ae8f118aab_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_850c3ed0-4b21-4a0e-96bb-ad973ce9e482_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0096fd2b-48ae-4661-9bb9-a7a2c7e33851_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_f7c46e89-aace-404a-98d3-4f06d19ace3d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_eae15772-165c-4687-a183-50b906a4add5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_df6a6824-8548-4388-93a1-b6ff78f58315_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_794ef978-ba6e-4fbf-9ef2-a8a5974ec82a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_5d0e7a7c-9b2f-4cc8-a3bd-964a1f8c4843_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_2c2ffddc-5592-4265-8e91-d20a0de7a9ce_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a75a246d-a0b3-40e2-8bef-1b3d075baea9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_b40fd6e2-0999-4488-9196-2528330fae18_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, cash equivalents and marketable securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9d0888bb-53ef-4814-8f5a-3a44eef43774_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4ab6f8e6-dedb-4de1-80bb-2f111689f8ef_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with an acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_2e3e8cf7-0693-4e1f-bf6b-8c71a806e2d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-Based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_984080b3-998b-457b-8ffd-81b46002c6f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Not Included with Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_65f4f50e-da16-4a1e-a7d9-2b68a41c2b81_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_50494d24-bdfa-46f8-acc3-15ea844201cc_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_208c04fa-6c6d-4c80-a8cb-50969ed30b09_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_37c30711-b25d-4c57-83b1-56678dfa7756_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_9bde1506-829c-4f0c-abbb-288046f3f199_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards, research</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_03c73ed1-3808-473a-a088-16c3df2d7003_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue</link:label>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledReceivablesCurrent" xlink:to="lab_us-gaap_UnbilledReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_35ad2862-d11d-4bdc-b637-c1b0f48af5f9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_c06a26c8-cd31-43c4-9ff8-7d4132453518_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_07dfde47-aeed-48b0-9f97-cf1a5e84948e_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CapitalizedContractCostAdditions_7072de0b-37f7-4422-bae8-8f241e23acc5_terseLabel_en-US" xlink:label="lab_docs_CapitalizedContractCostAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized contract acquisition costs</link:label>
    <link:label id="lab_docs_CapitalizedContractCostAdditions_label_en-US" xlink:label="lab_docs_CapitalizedContractCostAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Additions</link:label>
    <link:label id="lab_docs_CapitalizedContractCostAdditions_documentation_en-US" xlink:label="lab_docs_CapitalizedContractCostAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CapitalizedContractCostAdditions" xlink:href="docs-20230331.xsd#docs_CapitalizedContractCostAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CapitalizedContractCostAdditions" xlink:to="lab_docs_CapitalizedContractCostAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7ba58be1-6188-4344-b52d-8e87bfbdbc73_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a3beb147-e380-4c55-803c-947ed33d42ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_0e7c6abf-6ae1-4d7d-b343-1f8d3f097f48_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $887 and $359 as of March&#160;31, 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_961b0cd6-9f6c-4177-9172-bf184e538691_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_478b47b1-94f7-4cfd-b591-5cebf94bd102_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_a9030869-3209-49aa-a065-f7ac136963b5_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_5f620335-6ae6-42af-85b0-741ee7093494_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_a87c7f43-2d6c-4ea4-8b14-402ba555578c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7a21c1fa-b1a1-49ed-84b2-4a66630ca3af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, vested and exercisable at period end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_f762ae22-b8c7-4750-ba4b-cf4010933e14_terseLabel_en-US" xlink:label="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and deferred revenue</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_label_en-US" xlink:label="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_documentation_en-US" xlink:label="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:to="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_8f9a0a6f-a04b-4d55-add0-782b69f74056_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f117f15c-97bb-415f-b19e-cf65519538f3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ClassOfWarrantOrRightExercisesInPeriod_c7caefeb-6879-40f5-bda8-fb03f04ac2a6_terseLabel_en-US" xlink:label="lab_docs_ClassOfWarrantOrRightExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised in period (in shares)</link:label>
    <link:label id="lab_docs_ClassOfWarrantOrRightExercisesInPeriod_label_en-US" xlink:label="lab_docs_ClassOfWarrantOrRightExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercises in Period</link:label>
    <link:label id="lab_docs_ClassOfWarrantOrRightExercisesInPeriod_documentation_en-US" xlink:label="lab_docs_ClassOfWarrantOrRightExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ClassOfWarrantOrRightExercisesInPeriod" xlink:href="docs-20230331.xsd#docs_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ClassOfWarrantOrRightExercisesInPeriod" xlink:to="lab_docs_ClassOfWarrantOrRightExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_975df8f4-f0a6-4a85-b7cc-a268008df80c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_02e9cdba-4563-4dbd-8992-aaef56c3143b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_ca1818b0-8a30-4293-9640-6f3eeca6885b_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding, term</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0064dceb-670b-44ec-aae1-129b7d274547_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ComputerEquipmentAndSoftwareMember_3f9ff9d3-c595-4e5a-96f8-5aaebcf76ece_terseLabel_en-US" xlink:label="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computers and software</link:label>
    <link:label id="lab_docs_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_docs_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember" xlink:href="docs-20230331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ComputerEquipmentAndSoftwareMember" xlink:to="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_0d0b6b67-bbab-4471-a2a0-f1fd60b304a2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research &amp; development credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bba8e538-d0ce-4cbf-b67f-d6489c282cbc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db959a50-ff7a-4bfa-b5cd-f61d25729f9d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e87d2a01-a47a-4eca-84f5-106eec2156ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of contingent earn-out consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_e68cca62-e348-466e-a896-75dccc20e7b4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6737601-d1e7-4777-9fa9-2060bae201dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_51b0281c-2543-448e-a567-0800f0b36935_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, revenue guarantee during noncancelable period</link:label>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_label_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period</link:label>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:to="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_628abfb0-a3fe-42c9-b2cc-a683eef5960f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_adf9e49a-d700-4499-a610-fdfb7e21ea5a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses related to debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_dda57e9f-69b9-47cc-a87e-cc8c736b6d8f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_80862e0e-752a-4aa3-adc0-7e67ac739791_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_101138f4-7509-4d57-8336-39b28fdbce7d_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_b2efc784-4f78-41c8-bc5b-1683b5c43e71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, vested and expected to vest at period end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_88cb5d36-9c9b-4ab2-af2e-d12be8a35bc4_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_67e6e3b3-2e76-46b3-b020-dd081cb8c307_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_89241f70-66a3-4fdf-b7b1-180a90c77b58_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized deferred offering costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_798d2f80-8304-4b7c-aaba-f62e21fb4bfa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6cf2ba14-a41c-4eb3-91eb-326720969395_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_120eba15-a7e6-40d7-8506-22e7e11827ae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, federal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2ed271df-0a91-4d5a-aee1-a0cf7e9c017a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e54901b8-7c5f-4b6f-aeac-f92e15133b2c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b303d9c6-df06-4987-9f87-e17822fdfb7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_96bacb97-f52d-468c-8670-3c9b4425a3ed_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_7d21258b-023a-4af1-a66d-e2ca7550247b_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_41eae185-5aff-4d1d-81b9-7fc9ce6a8551_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ceca4703-3099-4c27-83fd-d4e5b8f05d83_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_eb6b9d6f-28d1-4a8d-836b-a17977f51029_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_b518e642-cc8c-4b8f-907a-6430c9a7d35d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_6cfd8f76-edac-480f-b34d-a320bc20ed8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_4643acde-3f0e-416b-947a-2f2df3f75ae2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contingent earn-out consideration liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d7a11f9f-0191-4470-8714-f9311d1ed682_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e04335cf-0bcf-4191-8ac7-92c64441d861_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ab55a274-4a02-4ded-97fb-b38f5d4dd77f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_11d18985-f3ec-4f81-bde5-24e2eb7b46da_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9430ccfc-72a3-41f5-a639-0175941f0906_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_eb589588-6bc6-4afc-809f-caf4e73683c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_b689c40f-6a68-4522-9a61-a386d153a10b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_f1c13e8c-9d15-415e-b40a-0dd612081e03_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3b2d2962-da8b-4aab-a5d9-136d57402e48_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b8f154a3-6bd6-420b-8795-f8018e17a920_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ConversionOfStockConversionRatio_8d70aa18-ef35-4b5c-a5e0-ea8730164f7d_terseLabel_en-US" xlink:label="lab_docs_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock conversion ratio</link:label>
    <link:label id="lab_docs_ConversionOfStockConversionRatio_label_en-US" xlink:label="lab_docs_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Stock, Conversion Ratio</link:label>
    <link:label id="lab_docs_ConversionOfStockConversionRatio_documentation_en-US" xlink:label="lab_docs_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio" xlink:href="docs-20230331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ConversionOfStockConversionRatio" xlink:to="lab_docs_ConversionOfStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_35bb4be3-c75b-4efd-80bc-bad873255c32_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_27bffd5a-51d2-42af-bc3c-96f8347477e6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7ecb23fa-d5cc-4832-b282-5d55a4704112_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_eb0a7a94-98e6-4c56-a3a8-aaf6fd23b498_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_050b8030-140c-4516-959f-1f2a0ab0a80e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_ee75a240-9878-437a-9527-1029bf18d7b3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AccruedEmployeeStockPurchasePlanCurrent_1e6f97ce-6421-4196-ae11-5de5a3356aee_terseLabel_en-US" xlink:label="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions under employee stock purchase plan</link:label>
    <link:label id="lab_docs_AccruedEmployeeStockPurchasePlanCurrent_label_en-US" xlink:label="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Stock Purchase Plan, Current</link:label>
    <link:label id="lab_docs_AccruedEmployeeStockPurchasePlanCurrent_documentation_en-US" xlink:label="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Stock Purchase Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:href="docs-20230331.xsd#docs_AccruedEmployeeStockPurchasePlanCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:to="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_050a0e0f-3d0f-487a-8bf4-2b83a868ea9e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_cf279ead-ab9e-4538-8ae1-b7cb703746c5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b80fa500-5a51-4fb5-9b01-5d2c993f7114_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4a4a0ef9-a246-4676-8d60-e2355e5e67df_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5afaba46-735d-409d-a16e-6dc652a5b9d1_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_97eb275d-7bb8-4b22-858a-dd77020a5156_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_157a9b63-0641-4e46-bd7b-83c162a1fed7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_f71da38a-2f9b-4412-bb14-15124a1e6be2_terseLabel_en-US" xlink:label="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnerships agreement, period before termination is permitted</link:label>
    <link:label id="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_label_en-US" xlink:label="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnerships Agreement Period Before Termination Is Permitted</link:label>
    <link:label id="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_documentation_en-US" xlink:label="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnerships Agreement Period Before Termination Is Permitted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:href="docs-20230331.xsd#docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:to="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_65261bcc-24b5-4000-91eb-521c3a66f555_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_05538d72-8bc4-46c8-9414-2db3521c7987_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, annual revenue guarantee to partnering company</link:label>
    <link:label id="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_label_en-US" xlink:label="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Annual Revenue Guarantee To Partnering Company</link:label>
    <link:label id="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Annual Revenue Guarantee To Partnering Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:to="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_5b166011-4231-4c5b-a52c-706f83ed7a3e_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-Use Software Development Costs</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AuditInformationAbstract_label_en-US" xlink:label="lab_docs_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_docs_AuditInformationAbstract_documentation_en-US" xlink:label="lab_docs_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AuditInformationAbstract" xlink:href="docs-20230331.xsd#docs_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AuditInformationAbstract" xlink:to="lab_docs_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_29d1ac85-aa6d-48ff-8f46-ac0512b9b8b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_2fd804c3-d7e0-43fc-ba33-578c82d63338_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_0830cc7d-3242-429d-a7bf-25e673a0e45e_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_c79abac0-28d2-42d5-ae6d-b30210fcad40_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out consideration included in purchase consideration</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_594162c4-597f-4a1f-8f12-d3ede0d7e004_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March&#160;31, 2023 and 2022, respectively; 193,941 and 192,398 shares issued and outstanding as of March&#160;31, 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_129aef15-3745-4c24-83aa-44a59b239e81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c6ef0fea-3d87-43c6-aaca-2215f6d642fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_5d2ad63e-b213-4c0b-a3ab-4c6a31f135f1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting arrangement remaining commitment</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a44d711d-c704-4175-be66-5e6185043472_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0d52684d-866d-4d22-8cb1-ff5ad2bb925c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bb7c1215-a3aa-49e3-bf99-19a0669730fe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and exercisable at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_a6c6589e-7937-42f9-8364-0c937c2c5b18_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostDomain" xlink:to="lab_us-gaap_CapitalizedContractCostDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3e60b307-23b3-4a6d-971a-51e7e500712f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_0d84b290-3169-4a9f-a882-8900cdd939ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_35c684e1-02f2-424b-9429-0a7f6f26edf1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_0c28e2ca-db51-4f52-8fc8-d1f7a1ed6f32_terseLabel_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum annual increase of shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_label_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_documentation_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:href="docs-20230331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:to="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5bf6f9ad-c324-4c48-84f6-cf4f26adc179_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afbb2931-9e87-445c-967c-c582723882a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ded529b2-6057-43de-b4b7-959d1b930f8f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_3beb33b8-e660-43c2-885a-5762bde35d68_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_485e4f96-13f2-412e-8c1b-28d8e6de3fc6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_686c2f05-7c40-428a-bb62-090755125894_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a003cc96-f845-416b-bbc7-5682d635a107_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Class A and Class B common stockholders, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_f8a6fbf3-7fa0-4d42-93ab-edd31ee32f45_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_253876cc-beb9-406d-bc4c-9f5b6d9ec12a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_ff426740-9ce0-43b3-aecf-3d017125f327_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_deb481ae-9465-40d7-85fb-bc6ae8bd6f25_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term, vested and expected to vest at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_57c262cf-059b-4295-b521-7dc0e826be80_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CommonStockVotingRightsNumberOfVotes_4ab97132-7a7d-4e3a-97f7-68d184bcdb17_terseLabel_en-US" xlink:label="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, number of votes per share</link:label>
    <link:label id="lab_docs_CommonStockVotingRightsNumberOfVotes_label_en-US" xlink:label="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes</link:label>
    <link:label id="lab_docs_CommonStockVotingRightsNumberOfVotes_documentation_en-US" xlink:label="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes" xlink:href="docs-20230331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CommonStockVotingRightsNumberOfVotes" xlink:to="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_e1e99d97-97d9-4130-9704-c6cd717e0071_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_f5fd0dfb-0f56-4f6d-9ac4-a366bd1a1631_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_e8685e12-17d2-4263-9973-9595c8aeb4bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ce6d6516-4ca7-44df-88f8-2167a9097808_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c189df75-ed30-476e-b99f-8f75c9d53048_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5f3fa593-a060-42d6-8191-c2dbb6ef0826_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fca16294-36fe-4fd0-863d-29e19d20ff90_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_84e61879-75af-4504-9fe9-67c56403b5a6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_6c92b144-3eb1-45e5-bd62-4e20bf77cc3d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_33e1a793-1c02-4bba-9d62-aff56c04de41_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b1acde96-1305-4118-b0e4-d60cb1025234_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_0b1d8db5-fa77-449e-80b9-f2b9640283e6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_1b60edaf-af36-459a-b05f-abdfb34cd837_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_bfb9b250-107a-4e11-8a6e-ec9625f4b2b1_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of common stock (in dollars per share)</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_WarrantsAndRightsOutstandingVestingPeriod_a3bfb91c-83d4-4f97-a800-386f8845b14b_terseLabel_en-US" xlink:label="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding, vesting period</link:label>
    <link:label id="lab_docs_WarrantsAndRightsOutstandingVestingPeriod_label_en-US" xlink:label="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Vesting Period</link:label>
    <link:label id="lab_docs_WarrantsAndRightsOutstandingVestingPeriod_documentation_en-US" xlink:label="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:href="docs-20230331.xsd#docs_WarrantsAndRightsOutstandingVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:to="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_8c85440f-5ecd-47b6-afed-583ac020fa30_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0361ecdc-6a10-42d9-8674-6f51193f8d47_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options and common stock warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetCurrent_b26165b4-4d72-4fa0-a8f2-f0cfc8727427_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract costs, current</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNetCurrent" xlink:to="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_87ed68a1-b226-4741-a3af-4537a85dce8c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3d7be592-bb58-49e5-be26-e751814cfe89_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b1992fd3-36b5-4e2f-b562-4fe6ac39b25e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a1f5b7b6-d63f-4569-8686-f8c60ea3ed24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0937d7d7-b243-4432-95bd-0ed9d6c82cdc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_9d07ccd2-a896-4ce8-a144-f99efbb6a15d_totalLabel_en-US" xlink:label="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost, cash equivalents and marketable securities</link:label>
    <link:label id="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_label_en-US" xlink:label="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Short Term Investments, Amortized Cost</link:label>
    <link:label id="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_documentation_en-US" xlink:label="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Short Term Investments, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:href="docs-20230331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:to="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_4345b74e-cb96-4687-9862-2e1527980dc9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Intangible Assets and Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b54d57d0-dd54-4655-885e-0b0e14a45ef6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e29278b5-6349-46df-82a5-beb3b3892c23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable, at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_0fdacedd-9d31-48ca-8cd2-37836fff7afd_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_af09852a-cbcb-4024-bcf0-ed433ec8587f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_71951169-5a1a-4f0d-b864-c2c5431e70ed_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_b6114a55-d64e-40ab-9970-b60accfafdd4_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_e54456b7-1bd7-4eef-b390-29fb9c8a68f3_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_2be4d340-7d01-44c0-8577-6a688a808bcf_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_a21805c6-d83a-4258-892d-ba55868ae551_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4e25b2f1-3e98-4b1b-aeb5-7f0f84808152_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_41d87970-2c67-41e2-83b4-8e0987e8cb59_terseLabel_en-US" xlink:label="lab_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options and common stock warrants (in shares)</link:label>
    <link:label id="lab_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_label_en-US" xlink:label="lab_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options and Warrants Exercised</link:label>
    <link:label id="lab_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_documentation_en-US" xlink:label="lab_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options and Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:href="docs-20230331.xsd#docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:to="lab_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_f4c62681-5bf8-4fed-b512-083a87638f77_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_731794a6-346d-409b-8e26-16234e83d3e5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_62eca267-fbf6-44aa-96dd-a2c4018466f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Consideration Allocation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_RebateLiabilitiesCurrent_d31c07de-88fa-4030-9f8d-11be161ace76_terseLabel_en-US" xlink:label="lab_docs_RebateLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate liabilities</link:label>
    <link:label id="lab_docs_RebateLiabilitiesCurrent_label_en-US" xlink:label="lab_docs_RebateLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate Liabilities, Current</link:label>
    <link:label id="lab_docs_RebateLiabilitiesCurrent_documentation_en-US" xlink:label="lab_docs_RebateLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RebateLiabilitiesCurrent" xlink:href="docs-20230331.xsd#docs_RebateLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_RebateLiabilitiesCurrent" xlink:to="lab_docs_RebateLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_OfficeSpaceLeaseInIrvingTexasMember_c3934145-625e-4ae3-8525-e8eae398b981_terseLabel_en-US" xlink:label="lab_docs_OfficeSpaceLeaseInIrvingTexasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Space Lease In Irving, Texas</link:label>
    <link:label id="lab_docs_OfficeSpaceLeaseInIrvingTexasMember_label_en-US" xlink:label="lab_docs_OfficeSpaceLeaseInIrvingTexasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Space Lease In Irving, Texas [Member]</link:label>
    <link:label id="lab_docs_OfficeSpaceLeaseInIrvingTexasMember_documentation_en-US" xlink:label="lab_docs_OfficeSpaceLeaseInIrvingTexasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Space Lease In Irving, Texas</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OfficeSpaceLeaseInIrvingTexasMember" xlink:href="docs-20230331.xsd#docs_OfficeSpaceLeaseInIrvingTexasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_OfficeSpaceLeaseInIrvingTexasMember" xlink:to="lab_docs_OfficeSpaceLeaseInIrvingTexasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_75a3bb8e-ecc6-4a62-a85a-ed783a6befe6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5aedde5-ebdd-4a15-8b07-713b437a9c3b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e06507b2-783b-441c-b4e0-c7288e4f3b78_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b1981728-ccbd-40d6-b1e8-07697e7988df_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_64a17ab6-f190-4fec-b421-7040014e54b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_25a2578d-7482-4033-b913-45581791c800_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_3f5ce366-d1d6-474b-87fa-4bfc055b9f7b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_690f3a15-c101-461a-8510-eb95859e4e28_terseLabel_en-US" xlink:label="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accrued expenses and other liabilities, current</link:label>
    <link:label id="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_label_en-US" xlink:label="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accrued Liabilities, Current [Table Text Block]</link:label>
    <link:label id="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_documentation_en-US" xlink:label="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:href="docs-20230331.xsd#docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:to="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d991b2aa-74a6-40f4-b934-70992f094ecf_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8f118e88-5448-49af-8248-a15b6b4a5479_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0a508cf9-9096-4e1a-8c7b-3eae4fb26bcf_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_5924e455-d20e-4117-92cf-d86189fafc1a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_8277aa81-63e6-40cc-b899-f98ae2496b6b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of temporary to permanent equity</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_label_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c8de89c9-204f-4a13-b150-3ea16d61d222_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementExtensionPeriod_c0e93cad-c7d9-4824-905d-59b509c11903_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, extension period</link:label>
    <link:label id="lab_docs_PartnershipAgreementExtensionPeriod_label_en-US" xlink:label="lab_docs_PartnershipAgreementExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement Extension Period</link:label>
    <link:label id="lab_docs_PartnershipAgreementExtensionPeriod_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementExtensionPeriod" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementExtensionPeriod" xlink:to="lab_docs_PartnershipAgreementExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_36372f86-4cfa-4d52-8ca7-2cc9bc2d9592_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_b365f55e-aa37-406c-a3c7-3e8e2a2f32c6_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_c91fe0f9-31ee-4977-abcf-27c10502d43a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_061531ed-3c2c-495f-b00d-1f1cfafa48cc_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_0e3395c2-2144-4fad-93fa-647bc37289c3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out consideration (up to)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo_b7d6aedf-067c-4d59-93e4-769065f12bdc_terseLabel_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year to two years</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo_label_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Two</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo_documentation_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" xlink:to="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_24d36440-f4a9-4c18-82bc-2f0a6264e2d7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7b53ba1e-7feb-4171-801a-9dd7dbb21366_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6cfc263e-3808-4d93-9b44-5737cf7bc75e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f210434b-8bca-479e-926b-d6deeb7f7455_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_0feebb5a-19e0-4a56-8c9b-7a284367bdba_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_7bb826f9-8670-40fd-81b2-6228d40c8a03_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_eaedc07c-96e8-4a91-9021-f11ec8ad0203_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial public offering price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_cbe0341c-cbb0-432b-9b79-5e00e4815e65_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e52d1f53-fbcd-4ed4-a24f-1f583c1a8f50_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out consideration liability, non-current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredTaxAssetsLeasingArrangements_557ae3e7-066c-4dd0-8cfc-1030fa7e4c91_terseLabel_en-US" xlink:label="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsLeasingArrangements" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_fc11ab10-4780-4519-90e7-5f05f30c926b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_e25bb350-a8dc-43b8-93d3-06f1f810a128_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d659ab0f-3fc9-45ff-a9ec-a62f87902522_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_67a21337-c885-40d8-8bec-86c539d43a9f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_136d6c0e-7a21-4951-af9e-5f3a61a43cde_terseLabel_en-US" xlink:label="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business consideration, held in escrow</link:label>
    <link:label id="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_label_en-US" xlink:label="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow</link:label>
    <link:label id="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_documentation_en-US" xlink:label="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:href="docs-20230331.xsd#docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:to="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_6cdd6093-c1f9-41db-93d4-d7ec15aec128_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod_2705ff09-bcce-4ac6-aadf-2b4eb65cdadc_terseLabel_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earnout consideration performance period</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod_label_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Performance Period</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod_documentation_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" xlink:to="lab_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8830bb0f-bb0d-44fc-b23d-364bbcff1e28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_10017b2a-d56c-4200-b4f6-a3cfba649b7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_200922d3-f632-4289-b084-9b55182591b4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3978ea46-634e-49c7-8210-9a58d6e27412_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_13ce1867-e693-457b-92cd-88865c5d5c19_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost, money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_42d1be6d-b648-4b86-9316-8bcdc17787f1_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fe5657fb-7ca3-4ed8-a742-932258ff1de8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b2ad07e0-f623-495d-84e3-1ebccc6b8d7b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_97efd489-5406-4c36-92e0-96f0b297c808_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and other tax liabilities</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dfe093c8-9c23-41b6-a5b5-d31f51636337_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from the beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_3112349d-fb53-42e1-9020-1d305125d2ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_793833ac-3a41-4156-8bdf-e08f543046fc_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_d1ca781a-c8a0-453c-a9df-c9b9f8bada51_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_db68f6d9-4db0-4591-a25b-c93d4bd54012_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_f2ccf2ce-2ddc-44d0-8dbd-812186b84367_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_642e28a7-2c5b-4b4b-879a-febd300cf377_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_7e7fcfb3-e749-4fbd-bf6d-48fa479e74c3_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6091cd6c-43b4-474a-b88d-efec49feb18e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1ba7b2f6-8f12-43cc-96cd-49e1f6281c11_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_968c0518-78ca-45d6-bb8c-5706d513f059_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_19fa5d05-fb4b-4aa5-ba1b-a8b8b54c8c25_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_d6be48aa-7eed-4e50-81e4-caefbf41a27a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1f4e6375-3ce0-4714-8ba3-f0f16bda0ef6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_3834160e-62ae-4934-aadc-b0dd030192cf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_EmployeeStockPurchasePlan2021Member_9e8eace7-89b5-4c39-bd7a-d0f8f1beceec_terseLabel_en-US" xlink:label="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP</link:label>
    <link:label id="lab_docs_EmployeeStockPurchasePlan2021Member_929caf00-3f43-4662-b620-5916c94dd83b_verboseLabel_en-US" xlink:label="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP</link:label>
    <link:label id="lab_docs_EmployeeStockPurchasePlan2021Member_label_en-US" xlink:label="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2021 [Member]</link:label>
    <link:label id="lab_docs_EmployeeStockPurchasePlan2021Member_documentation_en-US" xlink:label="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member" xlink:href="docs-20230331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_EmployeeStockPurchasePlan2021Member" xlink:to="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0be8bec8-0635-403c-9f26-26d2e65878a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares (in thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_d6cff03c-2aad-4987-a677-05bb47a0a25d_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_6a0ff28a-622e-4d65-a2d6-a72ecbceef41_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment_a3df9240-dc04-4554-9807-40c1e9a24c95_terseLabel_en-US" xlink:label="lab_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized research and development</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment_label_en-US" xlink:label="lab_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Expense, Capitalized Research And Development</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment_documentation_en-US" xlink:label="lab_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Expense, Capitalized Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" xlink:to="lab_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_351dc355-d2d4-47a3-b5fd-4e93eb509034_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7fc9319a-15b2-4feb-bff9-b99676d2427e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_7b8c2d57-6a2b-4a74-8c3d-051c7282d850_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_9cf56871-640b-4411-af06-21561ef5c81d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_805d4f8e-254e-4680-a78e-1c329faa31a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d63950af-2b19-4597-9adf-5146b3353bc1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_91293af1-3116-4150-a03d-ccc5e8c3e862_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a6c23cc8-9db9-4adb-b7f1-2ce3bee0f0e8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9eccf8e6-3314-4c85-924b-d32fd37b3280_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_0dba0893-ecf7-4457-b923-07eb476585fc_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_f5ebd351-c2e5-45d6-adf7-e6b217759475_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock to common stock</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostImpairmentLoss_72693a62-b479-4d83-80f7-c949afe9f6b3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract costs, impairment losses</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:to="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_49ebadf9-fec0-4a7a-a3a9-5bfd36d7cfb1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_bfe7786e-99ee-4fcb-99ac-89d825fc9ab9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_EscrowDepositsRelatedToSaleOfBusiness_0b697d14-7080-487c-9f52-4d674cf7547a_terseLabel_en-US" xlink:label="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts held in escrow related to sale of business</link:label>
    <link:label id="lab_docs_EscrowDepositsRelatedToSaleOfBusiness_label_en-US" xlink:label="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposits Related To Sale Of Business</link:label>
    <link:label id="lab_docs_EscrowDepositsRelatedToSaleOfBusiness_documentation_en-US" xlink:label="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposits Related To Sale Of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:href="docs-20230331.xsd#docs_EscrowDepositsRelatedToSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:to="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_8fd0d171-6785-4f3f-9de7-29cae946a745_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_f82532ec-67e5-4d59-a9c7-f95d2cf8ce10_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_34c71744-55c7-453c-a02f-200e3cf14bf0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_c4ec87d0-6de8-4e18-a5ec-3079f00b71a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on marketable securities, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_1171e4a9-8490-4c42-b99a-c0f86a6540e8_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SubscriptionMember_4d04cdd8-3b14-4cc7-826a-a0510d75276d_terseLabel_en-US" xlink:label="lab_docs_SubscriptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription</link:label>
    <link:label id="lab_docs_SubscriptionMember_label_en-US" xlink:label="lab_docs_SubscriptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription [Member]</link:label>
    <link:label id="lab_docs_SubscriptionMember_documentation_en-US" xlink:label="lab_docs_SubscriptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMember" xlink:href="docs-20230331.xsd#docs_SubscriptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SubscriptionMember" xlink:to="lab_docs_SubscriptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction_6459dfde-4d22-4de1-b70d-50fd1c4a9a31_terseLabel_en-US" xlink:label="lab_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase included in accrued expenses</link:label>
    <link:label id="lab_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Included In Accrued Expenses In Noncash Or Partial Noncash Transaction</link:label>
    <link:label id="lab_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction_documentation_en-US" xlink:label="lab_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Included In Accrued Expenses In Noncash Or Partial Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" xlink:href="docs-20230331.xsd#docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" xlink:to="lab_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_d5c6ab3b-2694-4e64-9cd7-2b742e2a333e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6ad99de2-1f3b-448b-a728-c9c54a7bb56a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_4549d841-3595-4717-8cc3-60b3c07d6159_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting interests threshold</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b4c1600-331b-4da1-ae37-142f73aaf06a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19ffdd7a-52e9-4abe-8364-623ed6ddc73d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted, exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09d0ec47-7d9b-4ef9-bdd3-3c746c006e35_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_02096f52-7f6c-43d4-864d-db791317cc61_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fbc447d0-8e8a-46b6-91f3-8eb69c59a732_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_067f8507-88f8-4441-b184-6e16cbaeb331_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate net proceeds from initial public offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_956ac223-1bd3-4479-bca1-85d0a043206b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SubscriptionHiringSolutionsMember_9d6b90ac-13e4-4508-9cd9-d91d65e8b344_terseLabel_en-US" xlink:label="lab_docs_SubscriptionHiringSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Hiring Solutions</link:label>
    <link:label id="lab_docs_SubscriptionHiringSolutionsMember_label_en-US" xlink:label="lab_docs_SubscriptionHiringSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Hiring Solutions [Member]</link:label>
    <link:label id="lab_docs_SubscriptionHiringSolutionsMember_documentation_en-US" xlink:label="lab_docs_SubscriptionHiringSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Hiring Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionHiringSolutionsMember" xlink:href="docs-20230331.xsd#docs_SubscriptionHiringSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SubscriptionHiringSolutionsMember" xlink:to="lab_docs_SubscriptionHiringSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1247f177-e377-474c-98a2-7bf110e981aa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_749be564-b7b0-4f11-aac5-a7a51011059b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_81a5c39c-1ee6-46bd-b801-cb8836a8dc87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_624538ab-6a1e-47b0-af25-89589013430c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Maturities of Available-For-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_067b3cd5-3947-45ce-8e67-1d65ed608b09_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_e68fedc3-1f34-40e2-8358-5c581872ab77_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_eb5df767-bfb2-4e11-8f78-4365e1a72fcf_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d993531d-9d23-448f-be85-fa562d294e57_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b67e06f-4303-4028-90c5-fc50f534d608_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_111d4ed1-e877-4f0b-9b79-393f95fc0ddb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_8c237e90-d1d9-423a-882a-c03575b706db_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_6d2e9ea1-66d3-4f59-8bbc-276a4300eb81_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_cfe4cd1a-aaf8-4c8b-b2ae-27cabf1940cf_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_31b3dfd5-8b33-455a-88d3-fe354f983d74_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash financing and investing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_bd356f3d-3463-4b2f-bcdf-22d02869f711_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_17a50f1a-cd13-479a-aa48-4b7ddf6596a7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_127bf957-0623-4cf6-8ba9-0129ed5b42be_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79cfee51-4cc2-4c67-9dff-151371dc4eb2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_9c7bc941-f578-4fb8-88fb-de8ae5bd5f55_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PerformanceBasedRestrictedStockUnitsMember_07f291c9-9d1b-41c8-ab9e-c893e87e4d6c_terseLabel_en-US" xlink:label="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:label id="lab_docs_PerformanceBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_docs_PerformanceBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:href="docs-20230331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_19b1d18a-d6ec-41a0-ada2-6063f956f079_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired, useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_23c3fd46-a5af-4181-983a-316ffc595e0a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 100,000 shares authorized as of March&#160;31, 2023 and 2022, respectively; zero shares issued and outstanding as of March&#160;31, 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2e187f99-923f-458a-9f86-b78fc9f184d8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in exchange for services</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_8bcd7072-d656-443b-813f-1861b0cca59a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_87013e99-c4c0-4c90-8877-bd53a4188f3b_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ec79af2-f55f-4d78-9596-7c92a2339b7e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b3076ac0-858e-4a40-8217-3407d9ee9759_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_d72b565a-8489-46a8-87a0-d59c1d860099_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5fc70c79-ffe5-450b-8631-c8ebc6710b69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares issued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b290f7d3-be6e-4845-8101-4c4d2969c4b9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f76c3760-f880-4fbf-82d8-16919a32a099_totalLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_68b507fd-cd59-4950-83a5-17e248d307d1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_b72341a3-0141-4918-85e9-c60532c1508d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_faeda359-6803-4370-8785-b52a1dc598fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_4820f97f-d9b0-4bab-b027-9f032be94945_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_7c82198f-0f84-4735-a91b-9940f246083f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_e930de4d-4296-4a10-aa27-792c80cd50b8_terseLabel_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities impairments loss</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_label_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Impairments Loss</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_documentation_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Impairments Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleImpairmentsLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:to="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_f2e689f5-5833-4fd6-8ec9-05e73cb18c03_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 162(m) limitation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_5471b755-91aa-412d-8c66-2d9d96a1f9c0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_40391d1d-39f7-4def-a47d-a9597e7582b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, period in force</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_a6f41d6c-e829-41ce-ab81-899f96f9b887_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_af83a5ca-3d90-47cd-851d-d490332041a9_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_09dd0de0-d68f-4492-8e68-b55d427b1fee_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_214f3b4d-ad30-4fc2-8d18-d0d350764842_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_871bd0fc-7908-4f11-bc59-cfa72ed16910_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_56526ba7-3571-4973-a18b-c60c6b6e2b1f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_5420e9c0-05cf-4c3a-988d-dfbe9c1053d5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_14b0e5aa-dc90-4f94-95c4-8ae1303c8903_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ce66082f-f8db-4380-9453-6ff1edb0b91c_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based payment (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_302a67df-a3d8-4877-83e5-6fcc47b6fac7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7dfa0382-0da1-4bcb-aacc-a86476d08a37_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1e631f7a-aa55-4e57-bd7b-ab0485d95ba0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_19c55ae6-be25-44a9-ba1b-2374ec2a4467_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions in the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_6fedb546-3389-4dc0-b6e3-7627b68410fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_670a46de-6847-4647-971b-5b579f00b7de_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3d84729b-786f-4c6c-b93e-ab45544ac893_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_d6a91bf0-ca48-4a37-a215-c9f410d773ac_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d7eb9a-d3f8-4898-83ed-3b820efc47b6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_50889565-fcb1-4432-aa3f-d617236ad016_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_06974a6d-b658-430d-8681-879fc8f2bf1c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Class A and Class B common stockholders, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_763d09bd-047e-4826-bab4-f4839ed95087_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_1ba0b434-65bc-4caa-86ca-08522aa55a01_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income and Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:to="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember_d6fdcda3-18b0-4862-9282-0ab5bbb84286_terseLabel_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest Less Than Threshold</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember_label_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest Less Than Threshold [Member]</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember_documentation_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest Less Than Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:href="docs-20230331.xsd#docs_IndividualsWithVotingInterestLessThanThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:to="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_a7f8aeaf-9879-450b-9065-a4b98dbccfb2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward split ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7170ffde-5238-47d3-b51e-7ddade5a7c96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_2897372c-aa75-431f-b9c3-3d2636132980_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of deferred offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_73716151-1dbe-4c43-b3d8-4d98e2a020f3_terseLabel_en-US" xlink:label="lab_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Class A and Class B common stockholders:</link:label>
    <link:label id="lab_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_label_en-US" xlink:label="lab_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic And Diluted Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_documentation_en-US" xlink:label="lab_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic And Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" xlink:href="docs-20230331.xsd#docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" xlink:to="lab_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_716178f7-ea82-4204-a95d-891ba6fb83d5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_OtherShareBasedAwardsMember_53a7ec40-f24b-4f03-a521-80a4db343cc1_terseLabel_en-US" xlink:label="lab_docs_OtherShareBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other share-based awards</link:label>
    <link:label id="lab_docs_OtherShareBasedAwardsMember_label_en-US" xlink:label="lab_docs_OtherShareBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Awards [Member]</link:label>
    <link:label id="lab_docs_OtherShareBasedAwardsMember_documentation_en-US" xlink:label="lab_docs_OtherShareBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember" xlink:href="docs-20230331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_OtherShareBasedAwardsMember" xlink:to="lab_docs_OtherShareBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_HostingArrangementPeriod_6eb2cb75-ed6a-473a-829d-00043c54c024_terseLabel_en-US" xlink:label="lab_docs_HostingArrangementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting arrangement period</link:label>
    <link:label id="lab_docs_HostingArrangementPeriod_label_en-US" xlink:label="lab_docs_HostingArrangementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Period</link:label>
    <link:label id="lab_docs_HostingArrangementPeriod_documentation_en-US" xlink:label="lab_docs_HostingArrangementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementPeriod" xlink:href="docs-20230331.xsd#docs_HostingArrangementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_HostingArrangementPeriod" xlink:to="lab_docs_HostingArrangementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_92f0df14-8261-4563-9523-2ede2bbe7078_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c60a69ef-4f17-48e8-90dd-3aad346115f7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_a74b2d39-366e-45f2-9b99-dc838fe09d67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_401be7ff-6848-4f74-ad41-45db9131aeed_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a39edb07-751b-4791-b04a-9df9c70f641f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_ea4df7c5-34c9-4da7-be62-ffd48ff6d8a7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_77677ce6-c5fe-4121-8ba9-601e81c18a75_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_77973c30-64a8-4869-9c18-6d811aef630e_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_01445689-0736-4a16-b808-55de7889f570_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_0741bfc9-1577-4cb9-9847-7842d95f5151_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_3a1e81f2-fd4f-4179-8997-6b041c58795b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_2031979d-e5b3-4540-8854-044690c28ee9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_47cad3b7-6fb3-425d-ad3c-43b277b8db7c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_b75afe46-88ea-4c94-97ad-aeafab0998d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_6dbe476f-bdc4-425f-b854-4fae7e5096dd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in exchange for services (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b1fd039b-32ef-465f-9797-b72d8fb7fe2c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period from the date of grant</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_929a420e-957b-4f42-b9ca-c8b97bdc20b2_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes and bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_fadf7de7-2daf-4663-aeae-1f83408204d1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_5681a698-81b5-47df-b022-2da251baeb75_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_300baec7-cde7-47ec-a952-b5c3750f89f9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_dcbfa434-4e63-44d6-b34a-53c012055ba1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a421bab3-1ea1-4900-8998-6224185f4be9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_IncreaseDecreaseInCapitalizedContractCost_f7831fbc-f09d-4a4e-b1c0-de941971c945_negatedTerseLabel_en-US" xlink:label="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract costs</link:label>
    <link:label id="lab_docs_IncreaseDecreaseInCapitalizedContractCost_label_en-US" xlink:label="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Capitalized Contract Cost</link:label>
    <link:label id="lab_docs_IncreaseDecreaseInCapitalizedContractCost_documentation_en-US" xlink:label="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Capitalized Contract Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:href="docs-20230331.xsd#docs_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:to="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_67565324-5fd4-4724-922e-beaadf31b454_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_FurnitureAndEquipmentMember_cf448b7f-aa90-4949-9c78-151df9616545_terseLabel_en-US" xlink:label="lab_docs_FurnitureAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_docs_FurnitureAndEquipmentMember_label_en-US" xlink:label="lab_docs_FurnitureAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Equipment [Member]</link:label>
    <link:label id="lab_docs_FurnitureAndEquipmentMember_documentation_en-US" xlink:label="lab_docs_FurnitureAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember" xlink:href="docs-20230331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_FurnitureAndEquipmentMember" xlink:to="lab_docs_FurnitureAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_593d0804-c656-4ac5-bbf6-57c866439ff1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Equity Instruments, Cash and Cash Equivalents, Unrealized and Realized Gains (Losses) [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_ad66e926-3cd4-40d1-8bf0-6e060695d1a7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_44696852-9394-4ad8-b5a5-20e2b29c8abe_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_84c56f71-f2e3-4b30-8da3-2921c8ba842b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_6028353b-4cf7-4d16-a1c0-81468487b93b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized stock-based compensation for internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_d7ca39a8-637f-4a9d-98f5-c997ee5b5c3e_terseLabel_en-US" xlink:label="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_label_en-US" xlink:label="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable And Accrued Liabilities, Current Disclosure [Text Block]</link:label>
    <link:label id="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_documentation_en-US" xlink:label="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable And Accrued Liabilities, Current Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:href="docs-20230331.xsd#docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:to="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_65f81c4c-d196-46b6-898b-5219ea1d78b6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_2cfdfe4c-0520-47e6-8d93-b194e01ea68d_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_51ad4be9-60c1-4e7e-a669-cc7403645d2f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_6e939478-d657-4e0b-9858-780e4d434469_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_ab5b483c-9f68-4b29-b166-f658cda4af5e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_9f63ae2c-5291-4b3f-9b0d-f47479c3da95_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_a2d654ee-fa5f-4aa4-ba50-df0422128606_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_fd85bc5a-7d85-4283-98f8-92f35a94330e_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithCustomerTerm_f0888751-8ab4-4caa-b077-ae9b3808d4e1_terseLabel_en-US" xlink:label="lab_docs_ContractWithCustomerTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual terms</link:label>
    <link:label id="lab_docs_ContractWithCustomerTerm_label_en-US" xlink:label="lab_docs_ContractWithCustomerTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Term</link:label>
    <link:label id="lab_docs_ContractWithCustomerTerm_documentation_en-US" xlink:label="lab_docs_ContractWithCustomerTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerTerm" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithCustomerTerm" xlink:to="lab_docs_ContractWithCustomerTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_6c3ed71a-edf5-4b38-a114-2c4959af4291_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAxis" xlink:to="lab_us-gaap_CapitalizedContractCostAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_ddbd9210-5781-4c0d-a08d-3efccc40b48c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer discretionary contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_bbe7b5a8-6564-4cdc-8e11-6438ce87ea2e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_afa5aa94-5505-4cfc-b9d9-139137b02b57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_26b7b50b-63f9-47b1-806a-c4c30c240cd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a017c0c7-f4e0-4b28-bd26-49f9e2ccdab1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_eee81802-60aa-43c5-9bb6-8993a385409c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0a90f81d-96ed-4fb4-93b7-c7b11314cbdf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_74e3ddeb-8f86-416b-9c6d-28b530f1569c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_88a7a2ef-a0c9-4c70-b73f-89a0111d5321_terseLabel_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_label_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_documentation_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:href="docs-20230331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:to="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_952c0b71-5720-4a27-a416-e1692faacb09_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_cf9ee1d0-1a4f-4222-bc8d-8e94a63d332d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_487f48d5-723f-4627-8a40-7a44b018e79f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ce09978-5286-4784-b2e0-6c67320d700f_negatedTerseLabel_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="docs-20230331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f4448ab7-4efd-46d5-8b54-450c86bdcee5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_df45f8ab-f8e0-461c-8961-3fb266ee95fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87a442b7-70eb-412e-abe0-cc6b0a752712_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_18dec564-f6d6-4c84-8235-580e1bca97ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_ef4c94a4-8998-48f1-a110-ae65cbe9fe11_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_47afef0a-0fca-4cdc-b4ea-81e536243e7c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d97062f5-5135-4e33-bdbf-e7079db29dd6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_de7d5606-1f21-43ce-ad4f-1ce2d59de519_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance_d2a76e65-d140-4159-85b9-59979dcdbb40_terseLabel_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out consideration liability, subject to performance</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance_label_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Subject to Performance</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance_documentation_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Subject to Performance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" xlink:to="lab_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_cf6b45d1-b464-4a31-8e2d-0e85cf51e924_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_8b1651d5-a3fe-446b-9df8-028714b6a073_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ba61e743-cb54-4c85-bc33-0e6a690b5ede_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7c4147d-dc5f-4b84-a832-833e5ad9bf48_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2065e196-5909-416c-a9f0-f435b7e6b9c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax withholding on shares under stock-based compensation awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_3b306497-619c-4c99-823b-711877580270_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02c7aa30-c078-4f21-87d9-46d1152efcd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_773ee848-0e94-4d0b-9b90-931eb735408a_terseLabel_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination contingent consideration liability payable period</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_label_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Payable Period</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_documentation_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Payable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:to="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_c9a1cfa5-8c23-4086-8694-b61f8c7a7234_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_b75a8547-52f5-4969-97d9-c51e0fc96f8a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_3a08a039-ff9c-41bf-99f1-40370737ea8e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_e4765779-6e55-4f14-9824-ab457fc21128_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1e8f4dff-7eda-4228-adca-b65926c5f6a4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_4049a774-94f9-4994-97af-809b31facdc7_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_7abe73f6-c1f2-423e-ad30-f5a47cd199e4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod_ec6a94ca-2f2a-41fc-8859-8faacf59c92e_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, revenue guarantee during noncancelable period, payment period</link:label>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod_label_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period, Payment Period</link:label>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period, Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" xlink:to="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_1940bc7c-11b2-4fde-b7c9-d612b674ed59_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_bb7167ba-a43d-441c-8753-a1434b882324_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_05111353-db69-4792-b699-007d0b5dfb37_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ccbd2223-77b8-4695-aed1-c98e8db60f75_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes at statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_fc504efb-4c0e-4dbd-bd3e-13e0ea63431c_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expenses</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_9f4025ae-89c5-4b36-8b0c-bc2ec0acfa28_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59f268b1-e96f-4b20-be4f-41748576b08f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ce9ae1e9-7bf8-4214-82be-24514f79021f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_5d86420b-0553-462a-9cf9-af0367bcf432_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_eb275807-8048-4afa-8853-9ad87e0d01f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation, net of amounts capitalized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ac56ae38-ae0f-4b75-810b-0490318dfb84_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant-date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_a0b72f76-9012-47c3-b592-5b3aefc8c823_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6435c093-d452-4898-9985-4660c38f095d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_dc7e110a-2957-460f-b007-9f6cd9b5a806_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_05ead38a-4fb2-44e8-a17e-232021c23cfe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_52ebbc40-f4cc-4372-8097-ee9f0477f747_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_79b9e8fe-059f-4e28-8621-3db6801acfa2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d2b3f90e-0839-4c31-bc36-6133d5862c38_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ad296030-3c54-4408-9790-3d715a21865b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_68b51a2a-8805-4601-9f52-cd0aabefcf09_terseLabel_en-US" xlink:label="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</link:label>
    <link:label id="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_label_en-US" xlink:label="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts [Member]</link:label>
    <link:label id="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_documentation_en-US" xlink:label="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:href="docs-20230331.xsd#docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:to="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e74a9831-11d8-44ec-9396-f0068228232b_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_f8c2a382-78b1-4b2a-bc02-24883b6001e1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_9f9c5ca3-4f6e-4f96-beaa-712b81b4d18f_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_3276fd2d-bab8-4ae8-9729-b9cce0a70a4e_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>docs-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4d1277b4-10a9-4732-8720-53d63c4cfd14,g:0c268704-e9e1-4ac2-87ff-5caa0e49a51f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.doximity.com/role/CoverPage" xlink:type="simple" xlink:href="docs-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_24c0442e-37ee-4bc5-a06d-0ca51e752774" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_fa6981ac-ff94-49bd-b8eb-b83dde660169" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24c0442e-37ee-4bc5-a06d-0ca51e752774" xlink:to="loc_dei_DocumentInformationTable_fa6981ac-ff94-49bd-b8eb-b83dde660169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d7d782c8-9fe8-4715-a08c-7d91502a6265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_fa6981ac-ff94-49bd-b8eb-b83dde660169" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d7d782c8-9fe8-4715-a08c-7d91502a6265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d7d782c8-9fe8-4715-a08c-7d91502a6265" xlink:to="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_c6057939-45d3-4de6-afd7-5d9b0b213d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:to="loc_us-gaap_CommonClassAMember_c6057939-45d3-4de6-afd7-5d9b0b213d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_12ddd459-c3be-4d14-be78-41f7fb366b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9db414d2-3474-4f68-aa61-85f58daa6323" xlink:to="loc_us-gaap_CommonClassBMember_12ddd459-c3be-4d14-be78-41f7fb366b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_fa6981ac-ff94-49bd-b8eb-b83dde660169" xlink:to="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ab9f2db5-56ef-4bb9-a67f-cf112358210d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentType_ab9f2db5-56ef-4bb9-a67f-cf112358210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_5d2d0fdb-af3c-4a45-bb44-5397b3446d24" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentAnnualReport_5d2d0fdb-af3c-4a45-bb44-5397b3446d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_29d3a7d7-6b54-4a33-88d3-caea2bbd6a47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentPeriodEndDate_29d3a7d7-6b54-4a33-88d3-caea2bbd6a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_68596625-0354-4601-8458-00da93333e1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_CurrentFiscalYearEndDate_68596625-0354-4601-8458-00da93333e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f0b4653d-5ff4-4671-8bb7-8ae8c48d8745" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentTransitionReport_f0b4653d-5ff4-4671-8bb7-8ae8c48d8745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_aeb6dcd6-b2a5-4e85-adee-cf7942da728e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityFileNumber_aeb6dcd6-b2a5-4e85-adee-cf7942da728e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b1666d7d-a53d-4791-98ac-f81a8daddd21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityRegistrantName_b1666d7d-a53d-4791-98ac-f81a8daddd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e33f2122-d138-44e4-8f2d-e9baba44690b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e33f2122-d138-44e4-8f2d-e9baba44690b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ceaee6af-40cc-447f-a45d-8d36bac76057" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityTaxIdentificationNumber_ceaee6af-40cc-447f-a45d-8d36bac76057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e334736d-010b-4caa-96b3-054afeab6113" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressAddressLine1_e334736d-010b-4caa-96b3-054afeab6113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_7d6358ac-af08-44b1-a1ea-fe467a132629" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressAddressLine2_7d6358ac-af08-44b1-a1ea-fe467a132629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_058e08fd-dc93-4d18-8790-b5adae1d1dc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressCityOrTown_058e08fd-dc93-4d18-8790-b5adae1d1dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_723d1fc6-f556-4b9f-99dd-a37db943c057" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressStateOrProvince_723d1fc6-f556-4b9f-99dd-a37db943c057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f8068ae7-8210-4179-b177-cab696f63239" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityAddressPostalZipCode_f8068ae7-8210-4179-b177-cab696f63239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_62422100-6faf-400a-8192-b59015ccf9ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_CityAreaCode_62422100-6faf-400a-8192-b59015ccf9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0354b478-180d-4031-94f4-0a2a3cdd8848" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_LocalPhoneNumber_0354b478-180d-4031-94f4-0a2a3cdd8848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0ef34e26-623b-4828-bf92-064b70e702a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_Security12bTitle_0ef34e26-623b-4828-bf92-064b70e702a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d4c1536d-dc95-40c8-89b5-30e07f69b3d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_TradingSymbol_d4c1536d-dc95-40c8-89b5-30e07f69b3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e449a792-31a4-492c-aec3-efc565f0ede0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_SecurityExchangeName_e449a792-31a4-492c-aec3-efc565f0ede0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_3f5f962b-6343-4de9-8c40-332165999e88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_3f5f962b-6343-4de9-8c40-332165999e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_267092ac-e958-4950-843c-4bac5d77d901" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityVoluntaryFilers_267092ac-e958-4950-843c-4bac5d77d901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_077eeaf6-4d23-4dbf-95b1-aac784e5a661" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityCurrentReportingStatus_077eeaf6-4d23-4dbf-95b1-aac784e5a661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5b0c572d-13fb-4222-9f97-7bf64ccced48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityInteractiveDataCurrent_5b0c572d-13fb-4222-9f97-7bf64ccced48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c22e6249-f266-430a-acac-5a7a8ccf2fb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityFilerCategory_c22e6249-f266-430a-acac-5a7a8ccf2fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c2aa75e1-b2ae-418c-a611-f94fb7104748" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntitySmallBusiness_c2aa75e1-b2ae-418c-a611-f94fb7104748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7baeb2d6-c011-43b6-8977-be7844f84804" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityEmergingGrowthCompany_7baeb2d6-c011-43b6-8977-be7844f84804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b50e7cc7-0671-49c4-8233-0307d7cedc26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b50e7cc7-0671-49c4-8233-0307d7cedc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_04794b22-379c-49bd-86ca-5d08bffe5053" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityShellCompany_04794b22-379c-49bd-86ca-5d08bffe5053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_7aefa8a8-c083-4d88-a827-53f5c8de674e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityPublicFloat_7aefa8a8-c083-4d88-a827-53f5c8de674e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1cd18517-7f28-441f-bae0-efdd5c3ce4cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1cd18517-7f28-441f-bae0-efdd5c3ce4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d58410d9-fa3e-4230-8df7-481875f96dd5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d58410d9-fa3e-4230-8df7-481875f96dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5ce04db9-7a2c-42b1-a8fa-125f86cf13aa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_EntityCentralIndexKey_5ce04db9-7a2c-42b1-a8fa-125f86cf13aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_1d7c32a3-a011-4673-98d2-71d431381f60" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentFiscalYearFocus_1d7c32a3-a011-4673-98d2-71d431381f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12bd9ed5-2165-4ac0-8f9e-5143cfc92e07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12bd9ed5-2165-4ac0-8f9e-5143cfc92e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e7da6fbf-3ba3-4a4e-a193-a7d33f09dea7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d11f54ca-beeb-49e4-8ec0-4029b5a164a4" xlink:to="loc_dei_AmendmentFlag_e7da6fbf-3ba3-4a4e-a193-a7d33f09dea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AuditInformation" xlink:type="simple" xlink:href="docs-20230331.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_AuditInformationAbstract_aab1aefd-7cd9-4e38-b23c-6012f0d28b37" xlink:href="docs-20230331.xsd#docs_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_80d09518-491a-4704-8537-21f0de873e61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_AuditInformationAbstract_aab1aefd-7cd9-4e38-b23c-6012f0d28b37" xlink:to="loc_dei_AuditorName_80d09518-491a-4704-8537-21f0de873e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_eb35dba5-a69c-4a7b-a760-7345ced7b886" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_AuditInformationAbstract_aab1aefd-7cd9-4e38-b23c-6012f0d28b37" xlink:to="loc_dei_AuditorLocation_eb35dba5-a69c-4a7b-a760-7345ced7b886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_8415dc7d-2a0b-4715-a123-8ef075f5f5e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_AuditInformationAbstract_aab1aefd-7cd9-4e38-b23c-6012f0d28b37" xlink:to="loc_dei_AuditorFirmId_8415dc7d-2a0b-4715-a123-8ef075f5f5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e43ad95c-1b58-44b9-9ac0-be902f5aa6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e43ad95c-1b58-44b9-9ac0-be902f5aa6ab" xlink:to="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0741349d-8c99-406d-91e4-1f9b6e4ee8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0741349d-8c99-406d-91e4-1f9b6e4ee8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_125156f4-ea72-47d6-8040-460b2672287f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_125156f4-ea72-47d6-8040-460b2672287f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e644cb25-4d58-46c9-bf61-5c45b7f53491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e644cb25-4d58-46c9-bf61-5c45b7f53491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bdc7574f-b2a4-405b-bec5-38b946389455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bdc7574f-b2a4-405b-bec5-38b946389455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent_88f53fae-ebaf-402e-98bb-5cbcb613176b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:to="loc_us-gaap_CapitalizedContractCostNetCurrent_88f53fae-ebaf-402e-98bb-5cbcb613176b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ba444b61-9b5e-476d-80e5-cb4db84c4142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_42832948-9c32-4fcd-9592-5980870e2aa6" xlink:to="loc_us-gaap_AssetsCurrent_ba444b61-9b5e-476d-80e5-cb4db84c4142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ed0acb85-ed8b-4faa-b0ea-25cb9899c07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ed0acb85-ed8b-4faa-b0ea-25cb9899c07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4e5c42ba-0054-4a20-8067-b65148d4674e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4e5c42ba-0054-4a20-8067-b65148d4674e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b7319c1e-06f2-4b2d-b0d1-8d04ed7afbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b7319c1e-06f2-4b2d-b0d1-8d04ed7afbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ccad9a20-7ff4-406d-ab36-90e7eb0d3fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ccad9a20-7ff4-406d-ab36-90e7eb0d3fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6847713b-5abe-45c9-b5ba-bb87da67f85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_Goodwill_6847713b-5abe-45c9-b5ba-bb87da67f85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_84b57b69-7e30-49ce-9001-4d7f2f87255e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_84b57b69-7e30-49ce-9001-4d7f2f87255e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fcfef7d5-6fd2-46d8-9442-6252e7e3b756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55aca8ce-2d00-4d15-a0c7-79d7fff98928" xlink:to="loc_us-gaap_Assets_fcfef7d5-6fd2-46d8-9442-6252e7e3b756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e43ad95c-1b58-44b9-9ac0-be902f5aa6ab" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_cd3d3518-0bcf-4332-bae3-e3df12326dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_cd3d3518-0bcf-4332-bae3-e3df12326dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_788098e5-4274-424a-b0cc-93396dbc07a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cd3d3518-0bcf-4332-bae3-e3df12326dc2" xlink:to="loc_us-gaap_AccountsPayableCurrent_788098e5-4274-424a-b0cc-93396dbc07a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_04c79c96-e15e-4e42-8818-53800a3becd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cd3d3518-0bcf-4332-bae3-e3df12326dc2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_04c79c96-e15e-4e42-8818-53800a3becd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fc918bba-79f6-4ea0-8d9b-06320feaf660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cd3d3518-0bcf-4332-bae3-e3df12326dc2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fc918bba-79f6-4ea0-8d9b-06320feaf660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_192fb466-d971-4f2b-9242-6c61c9a088fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cd3d3518-0bcf-4332-bae3-e3df12326dc2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_192fb466-d971-4f2b-9242-6c61c9a088fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7fcc264e-42b9-41d3-bdc7-995fb82ae2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cd3d3518-0bcf-4332-bae3-e3df12326dc2" xlink:to="loc_us-gaap_LiabilitiesCurrent_7fcc264e-42b9-41d3-bdc7-995fb82ae2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7445675d-d8a1-4b8b-a906-afe669d3b58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7445675d-d8a1-4b8b-a906-afe669d3b58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19722155-a829-4a4c-85a6-f581f7f9a252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19722155-a829-4a4c-85a6-f581f7f9a252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_7f9a7830-8d81-4950-9a4c-3ad063619e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_7f9a7830-8d81-4950-9a4c-3ad063619e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_440ee0b0-976e-4000-a141-638b37eca89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_440ee0b0-976e-4000-a141-638b37eca89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cf567f06-6081-41ee-b041-e3116be5b9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_Liabilities_cf567f06-6081-41ee-b041-e3116be5b9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e7659e70-03a7-485e-a4da-0b8e5c14d8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e7659e70-03a7-485e-a4da-0b8e5c14d8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_04176d9c-db4c-4325-93a4-19acfe544c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:to="loc_us-gaap_PreferredStockValue_04176d9c-db4c-4325-93a4-19acfe544c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a0779dee-cb42-4e52-9b2c-0c222594a913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:to="loc_us-gaap_CommonStockValue_a0779dee-cb42-4e52-9b2c-0c222594a913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4a5ae62b-b67c-4f95-9a6c-4f42c6a73abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4a5ae62b-b67c-4f95-9a6c-4f42c6a73abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e875d44c-1d40-436c-9de3-05da60ee60d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e875d44c-1d40-436c-9de3-05da60ee60d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7e1fe7ce-e4cf-431c-a5b8-b20cf939ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7e1fe7ce-e4cf-431c-a5b8-b20cf939ffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_91611039-ea3f-4d98-a606-b159351ea503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_05b830a1-fd86-4866-9715-220faafb366e" xlink:to="loc_us-gaap_StockholdersEquity_91611039-ea3f-4d98-a606-b159351ea503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_67f85290-ff99-4313-a224-10457a90499d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c92bac77-199a-4d79-bda9-8319dead3749" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_67f85290-ff99-4313-a224-10457a90499d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2ed227d1-bed2-437d-84c0-3473ccaf1001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2ed227d1-bed2-437d-84c0-3473ccaf1001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_15c8c7fa-cd74-47b2-a70e-ba54d743cf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_15c8c7fa-cd74-47b2-a70e-ba54d743cf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ba611f53-72b0-41ad-9626-a650aa5b1d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ba611f53-72b0-41ad-9626-a650aa5b1d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_cca7ecb6-bf81-4bbd-af64-7834763fd99c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_PreferredStockSharesIssued_cca7ecb6-bf81-4bbd-af64-7834763fd99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_3c682738-e190-49af-8e3c-6ec33d31ad19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_3c682738-e190-49af-8e3c-6ec33d31ad19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5f6ae9ad-ad8c-4e5a-b162-2aea490b5ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5f6ae9ad-ad8c-4e5a-b162-2aea490b5ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d068692a-7d4a-4b99-bec5-21ee71c11d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d068692a-7d4a-4b99-bec5-21ee71c11d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_093b059f-cb41-407d-8dbb-957b105ab34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_CommonStockSharesIssued_093b059f-cb41-407d-8dbb-957b105ab34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5c1dbf4f-05c7-429d-8357-83d5a9437eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_724ecc7b-c4bb-4223-b3af-356d46e513e1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5c1dbf4f-05c7-429d-8357-83d5a9437eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dff723d0-bd2c-4f7a-890f-583fc09bfb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dff723d0-bd2c-4f7a-890f-583fc09bfb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_e4dbd55e-c6c6-42ed-ac54-5034dc2dea36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_CostOfRevenue_e4dbd55e-c6c6-42ed-ac54-5034dc2dea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c553ca06-7ae9-497a-8b64-99aea51bdc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_GrossProfit_c553ca06-7ae9-497a-8b64-99aea51bdc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2111445e-4b9f-4d25-b7aa-03c971cde746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2111445e-4b9f-4d25-b7aa-03c971cde746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7ff5f3a3-a35e-40f6-99c5-e4f6f70316eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2111445e-4b9f-4d25-b7aa-03c971cde746" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7ff5f3a3-a35e-40f6-99c5-e4f6f70316eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_49d1a874-4302-4089-98d9-9bddafa450c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2111445e-4b9f-4d25-b7aa-03c971cde746" xlink:to="loc_us-gaap_SellingAndMarketingExpense_49d1a874-4302-4089-98d9-9bddafa450c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d9a6b9d3-6362-4a50-898e-16b863d8f3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2111445e-4b9f-4d25-b7aa-03c971cde746" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d9a6b9d3-6362-4a50-898e-16b863d8f3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_54b9513d-6204-4e62-819d-2e8aea712b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2111445e-4b9f-4d25-b7aa-03c971cde746" xlink:to="loc_us-gaap_OperatingExpenses_54b9513d-6204-4e62-819d-2e8aea712b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_98db3177-fc98-402c-b1ed-802ce8831693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_OperatingIncomeLoss_98db3177-fc98-402c-b1ed-802ce8831693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b7634c1e-ba32-4e9b-9bb3-3d2ac2ab0353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b7634c1e-ba32-4e9b-9bb3-3d2ac2ab0353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b7a52538-1dbb-43a0-b023-9383eda3efac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b7a52538-1dbb-43a0-b023-9383eda3efac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2ba68b43-e3dd-48b1-afdd-cd0f45f2a80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2ba68b43-e3dd-48b1-afdd-cd0f45f2a80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc4e627f-ddd8-489a-825f-f6981a0245f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_NetIncomeLoss_fc4e627f-ddd8-489a-825f-f6981a0245f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_78b20be6-2d1d-458f-a638-bb227ff676f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_78b20be6-2d1d-458f-a638-bb227ff676f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_b9fa89ce-3c10-424b-948b-b88ceda97fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_b9fa89ce-3c10-424b-948b-b88ceda97fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_66b6f7e7-174f-4a0c-bb5a-9b28d36880a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_66b6f7e7-174f-4a0c-bb5a-9b28d36880a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_31dd9e20-e1dd-4f8e-846e-89e58b26e418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_31dd9e20-e1dd-4f8e-846e-89e58b26e418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cbaf4e7f-b722-431b-a909-611c47ba0058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_EarningsPerShareAbstract_cbaf4e7f-b722-431b-a909-611c47ba0058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cb92ccc5-8555-4199-9986-392731d3d109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cbaf4e7f-b722-431b-a909-611c47ba0058" xlink:to="loc_us-gaap_EarningsPerShareBasic_cb92ccc5-8555-4199-9986-392731d3d109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b29640bc-7915-44d5-902e-f599827b4be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cbaf4e7f-b722-431b-a909-611c47ba0058" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b29640bc-7915-44d5-902e-f599827b4be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d3937c22-ada9-4129-ad7e-75bb92dde3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1bf5b7ae-c76e-43d3-9934-96964e7961cb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d3937c22-ada9-4129-ad7e-75bb92dde3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_da868f4e-d49a-4aad-8be6-e12790d5bbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d3937c22-ada9-4129-ad7e-75bb92dde3c1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_da868f4e-d49a-4aad-8be6-e12790d5bbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2571606-3102-44af-b5d0-27f762fbbf4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d3937c22-ada9-4129-ad7e-75bb92dde3c1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2571606-3102-44af-b5d0-27f762fbbf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5291eb95-5e81-4f81-a47e-b3ebdba0d420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0343cb75-e98f-4d9b-9619-a73b454484f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5291eb95-5e81-4f81-a47e-b3ebdba0d420" xlink:to="loc_us-gaap_NetIncomeLoss_0343cb75-e98f-4d9b-9619-a73b454484f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_03e326f7-1e59-40eb-a317-69d594bc919a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5291eb95-5e81-4f81-a47e-b3ebdba0d420" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_03e326f7-1e59-40eb-a317-69d594bc919a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1df661c3-f474-4c3c-a8e6-146c8f03c98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_03e326f7-1e59-40eb-a317-69d594bc919a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1df661c3-f474-4c3c-a8e6-146c8f03c98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8fb9f135-d422-48d0-bf78-282e17044f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5291eb95-5e81-4f81-a47e-b3ebdba0d420" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8fb9f135-d422-48d0-bf78-282e17044f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e7f7120d-6860-4092-86e5-1e8c70975269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_36573252-954b-47c2-b159-23582fd4a8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e7f7120d-6860-4092-86e5-1e8c70975269" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_36573252-954b-47c2-b159-23582fd4a8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5699df70-9bb4-4cd6-90d1-28c4eec061cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9d5b6c69-2eb3-4ebe-abbe-0b7c3124972f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5699df70-9bb4-4cd6-90d1-28c4eec061cd" xlink:to="loc_us-gaap_StatementTable_9d5b6c69-2eb3-4ebe-abbe-0b7c3124972f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_633c734d-6cd7-40c4-beda-c7e41e737b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9d5b6c69-2eb3-4ebe-abbe-0b7c3124972f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_633c734d-6cd7-40c4-beda-c7e41e737b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_633c734d-6cd7-40c4-beda-c7e41e737b30" xlink:to="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9ee84c1d-1735-4b50-b4e8-00a5b86de95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_CommonStockMember_9ee84c1d-1735-4b50-b4e8-00a5b86de95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7115c339-644a-4e88-beec-9d7ae4275ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7115c339-644a-4e88-beec-9d7ae4275ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c5217cd-2f0b-45a3-9d40-c915a29eef9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c5217cd-2f0b-45a3-9d40-c915a29eef9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5b4b4b69-15b2-4910-b9cd-42d682c4481f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f3021ce-cb6f-45f1-95a6-c72ee141889d" xlink:to="loc_us-gaap_RetainedEarningsMember_5b4b4b69-15b2-4910-b9cd-42d682c4481f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9d5b6c69-2eb3-4ebe-abbe-0b7c3124972f" xlink:to="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e78cfeeb-9c1d-497d-8e30-51f85501fffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e78cfeeb-9c1d-497d-8e30-51f85501fffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d5ed002b-5535-498a-be69-deaca497d66b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d5ed002b-5535-498a-be69-deaca497d66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5850164b-632e-4e34-a358-9b6ac297ff34" xlink:href="docs-20230331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5850164b-632e-4e34-a358-9b6ac297ff34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3357e39d-7250-4bec-bad5-714ac8da656b" xlink:href="docs-20230331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3357e39d-7250-4bec-bad5-714ac8da656b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_f9af1aba-8c47-4042-b041-960d0a41a09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_f9af1aba-8c47-4042-b041-960d0a41a09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1156ade8-c09b-4d0f-a3c0-e75a7aed7ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b86f5790-be4d-4a63-bb80-32646d7f0532" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1156ade8-c09b-4d0f-a3c0-e75a7aed7ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76518c6f-ed8d-4f72-ae93-7d0d9815cdd8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_3a9e43ba-a0af-4fde-8d73-210984f9608f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_SharesOutstanding_3a9e43ba-a0af-4fde-8d73-210984f9608f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3ee8af6c-63e2-4bab-8b50-6eb1031b6082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockholdersEquity_3ee8af6c-63e2-4bab-8b50-6eb1031b6082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b981d54b-197e-4cda-be25-6ad1ddcdc436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b981d54b-197e-4cda-be25-6ad1ddcdc436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_0e5a1ea5-e498-4263-9732-9b3644956ed0" xlink:href="docs-20230331.xsd#docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_0e5a1ea5-e498-4263-9732-9b3644956ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_8c857f51-1cd7-46ab-ba9d-d4585fa9e787" xlink:href="docs-20230331.xsd#docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_8c857f51-1cd7-46ab-ba9d-d4585fa9e787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e7e7cefe-9c3b-489c-bec7-91905d955aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e7e7cefe-9c3b-489c-bec7-91905d955aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30281934-9580-485a-9a27-04533b53d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30281934-9580-485a-9a27-04533b53d58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b261b7ff-98c6-469a-ac7b-95de4cc19d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b261b7ff-98c6-469a-ac7b-95de4cc19d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2276b646-3983-4cba-a26f-ad4eb49e3715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2276b646-3983-4cba-a26f-ad4eb49e3715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_7b9a1f90-d898-437c-ac0e-febb34af14dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_7b9a1f90-d898-437c-ac0e-febb34af14dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23cfb832-77d2-45e5-9cd3-1348d087faa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23cfb832-77d2-45e5-9cd3-1348d087faa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ed517bf2-217f-4085-ae82-ad4a8705640d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ed517bf2-217f-4085-ae82-ad4a8705640d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e2e90726-173e-45ae-8801-e91729bcb15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e2e90726-173e-45ae-8801-e91729bcb15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_6954e355-acc9-4fcf-bada-538fcfa7e4ca" xlink:href="docs-20230331.xsd#docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_6954e355-acc9-4fcf-bada-538fcfa7e4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9be6bcb3-7afd-470d-817e-996668e3737a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_9be6bcb3-7afd-470d-817e-996668e3737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a14b55bb-f985-405a-9020-cdab2f755cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a14b55bb-f985-405a-9020-cdab2f755cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_58454fea-077d-44a1-b5d6-508315f47ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_58454fea-077d-44a1-b5d6-508315f47ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0960bbd6-e5f2-476e-a44f-7273038755f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0960bbd6-e5f2-476e-a44f-7273038755f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_591945d8-9c80-447d-b834-1e38fe7c4606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_591945d8-9c80-447d-b834-1e38fe7c4606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e74e1975-f21d-4cd7-ba81-d32fc6f1e1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e74e1975-f21d-4cd7-ba81-d32fc6f1e1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1455cebb-7d66-4238-97b7-06f2c2e05087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1455cebb-7d66-4238-97b7-06f2c2e05087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bedb0c90-c46a-4ce4-b61b-3845a5c41ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bedb0c90-c46a-4ce4-b61b-3845a5c41ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_487b4b63-a780-4783-9875-dd25a56c3507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_487b4b63-a780-4783-9875-dd25a56c3507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_411cae91-34e0-4cd7-b52c-58bc6de93ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_NetIncomeLoss_411cae91-34e0-4cd7-b52c-58bc6de93ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_cb68b03d-3cbc-4db1-b0ac-542acbef9984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_SharesOutstanding_cb68b03d-3cbc-4db1-b0ac-542acbef9984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_61e418ab-6251-4dac-9bcb-8cb2508dcc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03f64ae8-fc3f-49c4-a9d4-da92cc91d89f" xlink:to="loc_us-gaap_StockholdersEquity_61e418ab-6251-4dac-9bcb-8cb2508dcc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="docs-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e19f72e5-b8b8-4d8c-9606-7c475e122a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e19f72e5-b8b8-4d8c-9606-7c475e122a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a90c4694-c608-41df-b367-cfa2db9fa6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e19f72e5-b8b8-4d8c-9606-7c475e122a2a" xlink:to="loc_us-gaap_NetIncomeLoss_a90c4694-c608-41df-b367-cfa2db9fa6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e19f72e5-b8b8-4d8c-9606-7c475e122a2a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ab8512f3-0585-497b-a70f-ca17485fb05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ab8512f3-0585-497b-a70f-ca17485fb05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4db3845e-c9e4-4416-a983-bb77ac45c034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4db3845e-c9e4-4416-a983-bb77ac45c034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8a350c37-d7b2-46d3-ab66-0104def11951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_ShareBasedCompensation_8a350c37-d7b2-46d3-ab66-0104def11951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ee1f4f90-4d4e-4fdb-b640-4ba202733526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ee1f4f90-4d4e-4fdb-b640-4ba202733526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_0d3a93e5-429a-4aa6-a3be-e8cf2e1d3a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_0d3a93e5-429a-4aa6-a3be-e8cf2e1d3a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d2e37a06-b496-4e27-a2a3-45ca8b1c1e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_GainLossOnInvestments_d2e37a06-b496-4e27-a2a3-45ca8b1c1e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_335a0fcc-1e27-4b3d-8f80-6f965b284872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_335a0fcc-1e27-4b3d-8f80-6f965b284872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ee63d93a-d433-42f1-beaa-bfef22ae6d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ee63d93a-d433-42f1-beaa-bfef22ae6d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_98d07591-db7d-4d78-bae1-887ab8acaffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_98d07591-db7d-4d78-bae1-887ab8acaffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dbe1224e-0fff-41d5-9f6a-351d34b86400" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_85e67e9d-3307-42bb-9b8b-b28ee9120b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_85e67e9d-3307-42bb-9b8b-b28ee9120b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_52b467ee-1e4d-4b9d-ad98-0f538c21616b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_52b467ee-1e4d-4b9d-ad98-0f538c21616b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IncreaseDecreaseInCapitalizedContractCost_3582229e-46d4-4f79-b994-e429dfce70f5" xlink:href="docs-20230331.xsd#docs_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:to="loc_docs_IncreaseDecreaseInCapitalizedContractCost_3582229e-46d4-4f79-b994-e429dfce70f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4a5880ad-5194-4f50-9e44-06003216a099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4a5880ad-5194-4f50-9e44-06003216a099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4b37bbeb-edf2-4b3c-a65b-c2141ca2a5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4b37bbeb-edf2-4b3c-a65b-c2141ca2a5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2585b385-141a-46cc-9386-5a353f4bb2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c3cab215-48d7-4115-8678-c912da986600" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2585b385-141a-46cc-9386-5a353f4bb2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ca59d0c-7cf4-4895-9411-06e162870db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e19f72e5-b8b8-4d8c-9606-7c475e122a2a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ca59d0c-7cf4-4895-9411-06e162870db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f35d9305-4ffd-4416-962a-3ed936232b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f35d9305-4ffd-4416-962a-3ed936232b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_75322520-028b-449f-8dee-8d84a46bb933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_75322520-028b-449f-8dee-8d84a46bb933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_214cbb28-6c82-4a44-86ff-01b5f9cd0fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_214cbb28-6c82-4a44-86ff-01b5f9cd0fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_e8446ac9-094b-4a00-8b55-e7c230d34a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_e8446ac9-094b-4a00-8b55-e7c230d34a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_002bde9a-e1fb-4f30-a386-6ef5ee67e7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_002bde9a-e1fb-4f30-a386-6ef5ee67e7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_7d13c71b-0987-4454-b182-18809a1f6161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_7d13c71b-0987-4454-b182-18809a1f6161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f425be6-45dc-4f02-8cba-a1554132b08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f425be6-45dc-4f02-8cba-a1554132b08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cd7d241b-f44e-40a9-a708-0b54ceee2533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cd7d241b-f44e-40a9-a708-0b54ceee2533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5728a7c-716d-4862-9a47-b4130fc42aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f356d5c-cca7-4a4b-8a3c-7d7c9ac6cb1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5728a7c-716d-4862-9a47-b4130fc42aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_71f8695a-02d0-42b0-80ef-bbc06b9b40d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_71f8695a-02d0-42b0-80ef-bbc06b9b40d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c18066dc-60fe-469d-b4a0-270da5715e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c18066dc-60fe-469d-b4a0-270da5715e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_18b71d3f-688a-4f4e-9919-f14d4c7ed56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:to="loc_us-gaap_ProceedsFromStockPlans_18b71d3f-688a-4f4e-9919-f14d4c7ed56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_03f36fe6-8172-4bc2-8eee-0fb3b5f9091c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_03f36fe6-8172-4bc2-8eee-0fb3b5f9091c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5530e53b-e630-4092-aaae-5aabf0900d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5530e53b-e630-4092-aaae-5aabf0900d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_a4127a1d-be16-4009-bab8-9cbd9498bfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_a4127a1d-be16-4009-bab8-9cbd9498bfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01faa3c5-24be-4a13-aa45-a59d4a10ec72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99cab189-68f5-4eff-811a-d4eb62ddc85c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01faa3c5-24be-4a13-aa45-a59d4a10ec72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e8dcf9e5-cb58-455b-bc3f-84f90e1f9913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e8dcf9e5-cb58-455b-bc3f-84f90e1f9913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e34ffcc-eaab-4c59-a850-b0ae2ee4b59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e34ffcc-eaab-4c59-a850-b0ae2ee4b59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6370f75-4eff-4937-891a-39b63c8d648c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6370f75-4eff-4937-891a-39b63c8d648c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_175a2307-47c8-4f3a-b0ce-bdea32c6f994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_175a2307-47c8-4f3a-b0ce-bdea32c6f994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_32d76284-ca2b-42b1-b6f4-4b8209aa38ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_175a2307-47c8-4f3a-b0ce-bdea32c6f994" xlink:to="loc_us-gaap_IncomeTaxesPaid_32d76284-ca2b-42b1-b6f4-4b8209aa38ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdc817c2-ae96-4221-b481-c62952c799c2" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_f10984f0-6267-4c35-89c6-8e195114fc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_f10984f0-6267-4c35-89c6-8e195114fc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuancesCostsIncurredButNotYetPaid_61f8f350-1e9b-4b34-adb2-e12c5d030410" xlink:href="docs-20230331.xsd#docs_StockIssuancesCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_docs_StockIssuancesCostsIncurredButNotYetPaid_61f8f350-1e9b-4b34-adb2-e12c5d030410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedAcquisitions_60bf75d9-b539-4f81-b050-632bbd429b0e" xlink:href="docs-20230331.xsd#docs_StockIssuedAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_docs_StockIssuedAcquisitions_60bf75d9-b539-4f81-b050-632bbd429b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_f35ed578-90ef-4677-aa7e-221e58da35f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_f35ed578-90ef-4677-aa7e-221e58da35f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EscrowDepositsRelatedToSaleOfBusiness_5d821438-eac6-49e6-ade0-c28845c00488" xlink:href="docs-20230331.xsd#docs_EscrowDepositsRelatedToSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_docs_EscrowDepositsRelatedToSaleOfBusiness_5d821438-eac6-49e6-ade0-c28845c00488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_0ee2a4b9-4505-4d48-9d58-9e062ce88b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_0ee2a4b9-4505-4d48-9d58-9e062ce88b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_be7aac12-cdfe-4a2a-be07-cbf9f410c3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_be7aac12-cdfe-4a2a-be07-cbf9f410c3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction_4267a87a-63c2-41a4-906d-94591cda4218" xlink:href="docs-20230331.xsd#docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_41c4d42b-56b2-4330-a33f-7880bb8b1cbc" xlink:to="loc_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction_4267a87a-63c2-41a4-906d-94591cda4218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/DescriptionofBusiness" xlink:type="simple" xlink:href="docs-20230331.xsd#DescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/DescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9c554a2c-4fe7-412c-bfbc-1e42d42701b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2ef1d07e-fbf4-4b59-9c4c-943a87abfa13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9c554a2c-4fe7-412c-bfbc-1e42d42701b3" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2ef1d07e-fbf4-4b59-9c4c-943a87abfa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummarySignificantAccountingPolicies" xlink:type="simple" xlink:href="docs-20230331.xsd#SummarySignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummarySignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7d1b11b3-60ce-4d74-8217-a7d767d293fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_1d94994e-8c73-4d96-bd42-eff9fa5c7c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d1b11b3-60ce-4d74-8217-a7d767d293fd" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_1d94994e-8c73-4d96-bd42-eff9fa5c7c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognition" xlink:type="simple" xlink:href="docs-20230331.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98cae4a2-cb4d-4a88-a982-0ec3fb1267f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_6aa6aff6-3696-45d0-ac2f-36f37897dced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98cae4a2-cb4d-4a88-a982-0ec3fb1267f5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_6aa6aff6-3696-45d0-ac2f-36f37897dced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/Investments" xlink:type="simple" xlink:href="docs-20230331.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5cb661cc-9cbb-4ff7-87be-507d508acb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_58eb4bb0-105f-42e2-ab8d-adb5bb82d25f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5cb661cc-9cbb-4ff7-87be-507d508acb0c" xlink:to="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_58eb4bb0-105f-42e2-ab8d-adb5bb82d25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="docs-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_172dd9a6-b596-4297-8be7-565fca1e3916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7acc90da-707b-41ad-8549-4e2136c96288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_172dd9a6-b596-4297-8be7-565fca1e3916" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7acc90da-707b-41ad-8549-4e2136c96288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="docs-20230331.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b129bc4d-49c6-4a04-b67e-1e248af69e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_cf0b455a-1292-409c-bf81-70a27c45463a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b129bc4d-49c6-4a04-b67e-1e248af69e2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_cf0b455a-1292-409c-bf81-70a27c45463a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="simple" xlink:href="docs-20230331.xsd#AccruedExpensesandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_469de45b-0de9-406d-878e-32f99d5bc7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_62317ee5-8e7e-4182-b9a3-92c6a6888b41" xlink:href="docs-20230331.xsd#docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_469de45b-0de9-406d-878e-32f99d5bc7eb" xlink:to="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_62317ee5-8e7e-4182-b9a3-92c6a6888b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinations" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b210a999-9cb2-42a8-a424-3d6323081e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_68798a7d-0152-4a00-b7e5-b219ba5a3e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b210a999-9cb2-42a8-a424-3d6323081e00" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_68798a7d-0152-4a00-b7e5-b219ba5a3e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssets" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ab7ec593-10a1-45df-9afa-0157bb7654be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8b62baf7-af31-44f1-b25a-56068f4354e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ab7ec593-10a1-45df-9afa-0157bb7654be" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8b62baf7-af31-44f1-b25a-56068f4354e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="docs-20230331.xsd#RedeemableConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_0cf49be8-54d1-422c-bbd0-bca988a5be27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityTextBlock_1db70e88-5a4a-4876-8417-10a0eab92b4f" xlink:href="docs-20230331.xsd#docs_TemporaryEquityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_0cf49be8-54d1-422c-bbd0-bca988a5be27" xlink:to="loc_docs_TemporaryEquityTextBlock_1db70e88-5a4a-4876-8417-10a0eab92b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/Equity" xlink:type="simple" xlink:href="docs-20230331.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b5005930-d4c8-49fe-a61f-01da4d96ae04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_176acc2a-6fa3-4030-b5c3-1a73243467a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b5005930-d4c8-49fe-a61f-01da4d96ae04" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_176acc2a-6fa3-4030-b5c3-1a73243467a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders" xlink:type="simple" xlink:href="docs-20230331.xsd#NetIncomePerShareAttributabletoCommonStockholders"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6aad03d5-456c-4e68-a533-52a9899fc37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_5c043c24-d688-4318-a8db-679c27a685af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6aad03d5-456c-4e68-a533-52a9899fc37a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_5c043c24-d688-4318-a8db-679c27a685af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxes" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_be63c1bc-8b90-4b59-a8b6-51d76ed057be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fefcaf58-6e76-4e7f-9cbd-8ef66b25a243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_be63c1bc-8b90-4b59-a8b6-51d76ed057be" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fefcaf58-6e76-4e7f-9cbd-8ef66b25a243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="docs-20230331.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df2ebf33-5ee2-4e1a-8a0f-05f80685e648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3d5f4408-d9c7-479e-ac5a-40f88c4f9969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df2ebf33-5ee2-4e1a-8a0f-05f80685e648" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3d5f4408-d9c7-479e-ac5a-40f88c4f9969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/Leases" xlink:type="simple" xlink:href="docs-20230331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2ffa592b-7699-4f98-b00c-1f8237f194a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_5d52d510-5f5f-46f1-9fd1-5d4865ba6f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ffa592b-7699-4f98-b00c-1f8237f194a5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_5d52d510-5f5f-46f1-9fd1-5d4865ba6f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/OtherIncomenet" xlink:type="simple" xlink:href="docs-20230331.xsd#OtherIncomenet"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/OtherIncomenet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_6fde4b0b-4d41-4ff5-a998-f24961f03f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_3d6edb84-bc6d-48ad-b5fd-b5a2e4bf4e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_6fde4b0b-4d41-4ff5-a998-f24961f03f66" xlink:to="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_3d6edb84-bc6d-48ad-b5fd-b5a2e4bf4e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="docs-20230331.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_58eefdc2-6bfc-43bf-850b-5f72b0813ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_293eac02-62a7-4e2c-8d93-29538b7324fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_58eefdc2-6bfc-43bf-850b-5f72b0813ddc" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_293eac02-62a7-4e2c-8d93-29538b7324fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="docs-20230331.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_48db88e8-1f0e-4f5b-8d91-a3e2ea41530a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_573fa67d-2219-4f3b-94d6-ac76e7d5b998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_48db88e8-1f0e-4f5b-8d91-a3e2ea41530a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_573fa67d-2219-4f3b-94d6-ac76e7d5b998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="docs-20230331.xsd#SummarySignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5c833dc4-96ee-4506-b702-2d6c1a9a9c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5c833dc4-96ee-4506-b702-2d6c1a9a9c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_287ca0ad-4f16-4d99-9b51-2c21e2ef85f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_287ca0ad-4f16-4d99-9b51-2c21e2ef85f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_7f02ad63-6284-4a1d-b2c1-1dd00aed5064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_FiscalPeriod_7f02ad63-6284-4a1d-b2c1-1dd00aed5064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a37ab3e3-a8ee-4036-9aa5-a90fefd5b345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_UseOfEstimates_a37ab3e3-a8ee-4036-9aa5-a90fefd5b345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_284c657f-7d71-4122-93d3-c2e3eef8e90f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_284c657f-7d71-4122-93d3-c2e3eef8e90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_04f79890-5ba4-4646-bb2f-21f1dd7cba85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_04f79890-5ba4-4646-bb2f-21f1dd7cba85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1aa2ec2e-2593-4c49-b232-b31167805438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1aa2ec2e-2593-4c49-b232-b31167805438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_d820ab88-04fd-473e-bb1b-08173ca860a8" xlink:href="docs-20230331.xsd#docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_d820ab88-04fd-473e-bb1b-08173ca860a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_c68398db-626a-47a4-9361-fcaf13d86cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_c68398db-626a-47a4-9361-fcaf13d86cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_93d9c71f-3faa-4a83-8e1b-9a45c1f1d788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_93d9c71f-3faa-4a83-8e1b-9a45c1f1d788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_4a6e9455-8bf0-4688-9fb1-554a3898422a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_4a6e9455-8bf0-4688-9fb1-554a3898422a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_53aba181-40a1-4abf-bf02-3f9898478dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_53aba181-40a1-4abf-bf02-3f9898478dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_259787f3-d546-4884-be5f-b5c9fc96d26c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_259787f3-d546-4884-be5f-b5c9fc96d26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e02af536-2b7d-4174-8cca-c3445142e434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e02af536-2b7d-4174-8cca-c3445142e434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_37cab555-bbf8-4ca6-a942-0b291ef2620c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_37cab555-bbf8-4ca6-a942-0b291ef2620c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_48be636e-0a0d-4498-b2cb-065259b9cda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_48be636e-0a0d-4498-b2cb-065259b9cda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_72fd552e-25d0-4347-9b4f-b1e3a33b9d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_72fd552e-25d0-4347-9b4f-b1e3a33b9d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_2f760fc4-4400-4c22-a0cf-fd7b2b8f584f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_2f760fc4-4400-4c22-a0cf-fd7b2b8f584f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_b8e9f161-8306-44f4-af1b-ec8d21a0486e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_b8e9f161-8306-44f4-af1b-ec8d21a0486e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_0ed33e4b-3ecc-4e3f-8bcc-a01b3775278b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_0ed33e4b-3ecc-4e3f-8bcc-a01b3775278b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_823eb30e-6b75-4bf0-b490-7808ef76ba01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_823eb30e-6b75-4bf0-b490-7808ef76ba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dc05ea39-b985-44c6-83ef-c8ff2e0a68ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a78190e-234f-45a7-9c20-edcaa85c5d39" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dc05ea39-b985-44c6-83ef-c8ff2e0a68ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="docs-20230331.xsd#SummarySignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_50b6e984-4462-44db-9f06-73eda4a311d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_087a5ccb-8a47-498a-8bbf-dc9a7793dcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50b6e984-4462-44db-9f06-73eda4a311d7" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_087a5ccb-8a47-498a-8bbf-dc9a7793dcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_144b2eef-b704-4ba5-840d-60027d07cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50b6e984-4462-44db-9f06-73eda4a311d7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_144b2eef-b704-4ba5-840d-60027d07cfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="docs-20230331.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3fb4643c-745f-4796-8521-77c70ca17201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ac26b39c-da25-463f-a213-0f195b7cb716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3fb4643c-745f-4796-8521-77c70ca17201" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ac26b39c-da25-463f-a213-0f195b7cb716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0746e6b8-ca3e-4606-9d8a-5cbd0a9516ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3fb4643c-745f-4796-8521-77c70ca17201" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0746e6b8-ca3e-4606-9d8a-5cbd0a9516ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsTables" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_48b0b393-d0ac-421e-abad-9ffa59878354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_c87a80e0-36f9-4ca2-b9fb-80f7c2194091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_48b0b393-d0ac-421e-abad-9ffa59878354" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_c87a80e0-36f9-4ca2-b9fb-80f7c2194091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_01897188-49cd-43e5-bbdc-f7fbc68b0527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_48b0b393-d0ac-421e-abad-9ffa59878354" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_01897188-49cd-43e5-bbdc-f7fbc68b0527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="docs-20230331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_00fe0cde-7b6c-419f-8a2e-c9cf15c7cc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_3d11ece9-ab48-4ca5-9fdb-150c223c6bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_00fe0cde-7b6c-419f-8a2e-c9cf15c7cc2f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_3d11ece9-ab48-4ca5-9fdb-150c223c6bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_332ba285-dc9c-4508-ab90-321be4af3887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_00fe0cde-7b6c-419f-8a2e-c9cf15c7cc2f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_332ba285-dc9c-4508-ab90-321be4af3887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_45e51992-44a3-4c68-864a-fcc6c1e1d925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_00fe0cde-7b6c-419f-8a2e-c9cf15c7cc2f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_45e51992-44a3-4c68-864a-fcc6c1e1d925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="docs-20230331.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_51dd13b6-20b3-4bf0-a8a6-790021ac2d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_736a4275-4759-41b2-bc9f-de9dd8dd04df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_51dd13b6-20b3-4bf0-a8a6-790021ac2d7a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_736a4275-4759-41b2-bc9f-de9dd8dd04df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="docs-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_fe057fc2-02d8-4b5b-9c5f-54fe314cada9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_60dd6b50-edde-4ea9-9a02-733bfb3268eb" xlink:href="docs-20230331.xsd#docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fe057fc2-02d8-4b5b-9c5f-54fe314cada9" xlink:to="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_60dd6b50-edde-4ea9-9a02-733bfb3268eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e97ffc4a-62bb-4494-ad54-5aeb4a5a4830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5efe07a8-47f8-4215-90d3-347bc6dafef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e97ffc4a-62bb-4494-ad54-5aeb4a5a4830" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5efe07a8-47f8-4215-90d3-347bc6dafef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_f243d75d-6a7e-4b25-bcc8-74e1ee4649ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e97ffc4a-62bb-4494-ad54-5aeb4a5a4830" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_f243d75d-6a7e-4b25-bcc8-74e1ee4649ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b81b9379-271a-4c62-a315-008a800a7b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e97ffc4a-62bb-4494-ad54-5aeb4a5a4830" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b81b9379-271a-4c62-a315-008a800a7b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5972f23-6983-44e0-ae04-8db17565eeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_f987220f-1d9c-4ad3-8271-8e80e3bbaa40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5972f23-6983-44e0-ae04-8db17565eeb1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_f987220f-1d9c-4ad3-8271-8e80e3bbaa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a418e780-662d-4312-9c49-6a250cef4f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5972f23-6983-44e0-ae04-8db17565eeb1" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a418e780-662d-4312-9c49-6a250cef4f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_21975cdc-3cf1-4d0d-b264-5e8feabed021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5972f23-6983-44e0-ae04-8db17565eeb1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_21975cdc-3cf1-4d0d-b264-5e8feabed021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityTables" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b93cac2b-f042-4705-8eb8-d358287016f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_98955959-abb3-47fb-a465-5fc4199b3481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b93cac2b-f042-4705-8eb8-d358287016f9" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_98955959-abb3-47fb-a465-5fc4199b3481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2940b7c9-11ab-457b-b78f-fd8acbf890b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b93cac2b-f042-4705-8eb8-d358287016f9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2940b7c9-11ab-457b-b78f-fd8acbf890b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4ccf9d5d-66a0-44cf-bb1a-335a24e6deba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b93cac2b-f042-4705-8eb8-d358287016f9" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4ccf9d5d-66a0-44cf-bb1a-335a24e6deba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_a0151d79-2189-44d7-a593-4f6761452aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b93cac2b-f042-4705-8eb8-d358287016f9" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_a0151d79-2189-44d7-a593-4f6761452aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6fb10442-9ddf-4188-bc1f-17baf2586412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b93cac2b-f042-4705-8eb8-d358287016f9" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6fb10442-9ddf-4188-bc1f-17baf2586412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_268db58b-ab17-4482-84e5-44cabd845e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b93cac2b-f042-4705-8eb8-d358287016f9" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_268db58b-ab17-4482-84e5-44cabd845e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables" xlink:type="simple" xlink:href="docs-20230331.xsd#NetIncomePerShareAttributabletoCommonStockholdersTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b04f2def-5b9f-4146-a216-7b2121687d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fc199ca-f37f-4556-b827-d7ec62f239ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b04f2def-5b9f-4146-a216-7b2121687d1b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fc199ca-f37f-4556-b827-d7ec62f239ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9fdc1c40-1d31-4eff-946d-7bad55f1f8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b04f2def-5b9f-4146-a216-7b2121687d1b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9fdc1c40-1d31-4eff-946d-7bad55f1f8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_51dc29e1-028d-45b8-8f5f-c96deea54856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_63079020-965f-41ef-a08d-1effcf8d989c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51dc29e1-028d-45b8-8f5f-c96deea54856" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_63079020-965f-41ef-a08d-1effcf8d989c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3f15c203-f1e0-4533-9819-3b70feb4b24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51dc29e1-028d-45b8-8f5f-c96deea54856" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3f15c203-f1e0-4533-9819-3b70feb4b24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_535dfb09-fb8a-462e-b4a5-356d89e13d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51dc29e1-028d-45b8-8f5f-c96deea54856" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_535dfb09-fb8a-462e-b4a5-356d89e13d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1e8883df-fc80-4fce-af86-51732c169ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51dc29e1-028d-45b8-8f5f-c96deea54856" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1e8883df-fc80-4fce-af86-51732c169ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesTables" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_24c34b03-5bf5-4817-b758-d1a95630f6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_fba33f52-2f12-45df-91ca-eaaac9a003a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_24c34b03-5bf5-4817-b758-d1a95630f6ad" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_fba33f52-2f12-45df-91ca-eaaac9a003a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c392ff6f-d89e-4c01-9eb8-e78b8d44f101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_24c34b03-5bf5-4817-b758-d1a95630f6ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c392ff6f-d89e-4c01-9eb8-e78b8d44f101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/OtherIncomenetTables" xlink:type="simple" xlink:href="docs-20230331.xsd#OtherIncomenetTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/OtherIncomenetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_62b053b6-0e95-4d76-be72-c57b58da426f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_ae459016-51a5-4399-8f7d-dbcf9853c69a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_62b053b6-0e95-4d76-be72-c57b58da426f" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_ae459016-51a5-4399-8f7d-dbcf9853c69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/DescriptionofBusinessDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#DescriptionofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/DescriptionofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d62eef36-2c91-41a2-b633-c918a81a33f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1559f673-6492-4b42-baff-b55d90a5429a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d62eef36-2c91-41a2-b633-c918a81a33f7" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1559f673-6492-4b42-baff-b55d90a5429a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_07c811e4-08aa-43b8-ab1a-29aa52b9b790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1559f673-6492-4b42-baff-b55d90a5429a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_07c811e4-08aa-43b8-ab1a-29aa52b9b790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_07c811e4-08aa-43b8-ab1a-29aa52b9b790" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_b1368bf8-f3b1-4414-be68-fdaa75688eae" xlink:href="docs-20230331.xsd#docs_InitialPublicOfferingIncludingOverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:to="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_b1368bf8-f3b1-4414-be68-fdaa75688eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_7d245644-fd64-45a6-9048-55cc67fac7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:to="loc_us-gaap_OverAllotmentOptionMember_7d245644-fd64-45a6-9048-55cc67fac7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_54429956-5183-4265-a27d-abcc6872ba75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41dd725b-abfb-4d07-a392-b1cac42b5e82" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_54429956-5183-4265-a27d-abcc6872ba75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1559f673-6492-4b42-baff-b55d90a5429a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_16a689ef-5940-4f8f-9586-5798f0440c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_16a689ef-5940-4f8f-9586-5798f0440c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_61de8e39-1110-4d66-926d-66af36c9dd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_61de8e39-1110-4d66-926d-66af36c9dd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_94cb9ebe-19d4-449a-8dab-58f0d038a66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_94cb9ebe-19d4-449a-8dab-58f0d038a66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_564a7ff8-927a-43d6-aaa4-a0c9f383a003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_564a7ff8-927a-43d6-aaa4-a0c9f383a003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_5e485d14-0940-445e-bbc1-f2d94cc810ce" xlink:href="docs-20230331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_docs_ConversionOfStockConversionRatio_5e485d14-0940-445e-bbc1-f2d94cc810ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_e8be8429-3bf9-425f-8338-15fd8ae63a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_DeferredOfferingCosts_e8be8429-3bf9-425f-8338-15fd8ae63a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_43b38984-152f-4697-92a8-84fe510e85de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ad59149e-32fd-4317-baeb-5373d8a83533" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_43b38984-152f-4697-92a8-84fe510e85de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f51a078d-f6ea-4729-a1f6-e6eaff646b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f51a078d-f6ea-4729-a1f6-e6eaff646b6c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a722002f-8afc-4586-a89d-f0bd9daa728d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:to="loc_srt_ProductOrServiceAxis_a722002f-8afc-4586-a89d-f0bd9daa728d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a722002f-8afc-4586-a89d-f0bd9daa728d" xlink:to="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionHiringSolutionsMember_0b3dee26-d917-4fe9-835f-dbf458edd2af" xlink:href="docs-20230331.xsd#docs_SubscriptionHiringSolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:to="loc_docs_SubscriptionHiringSolutionsMember_0b3dee26-d917-4fe9-835f-dbf458edd2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMarketingSolutionsMember_bbf28dc2-0fca-489d-9e7a-9346ac582090" xlink:href="docs-20230331.xsd#docs_SubscriptionMarketingSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_266d951f-d8b0-4809-83fa-9ea33000ad57" xlink:to="loc_docs_SubscriptionMarketingSolutionsMember_bbf28dc2-0fca-489d-9e7a-9346ac582090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_770e465e-f57c-4c38-80c3-d5a2ab55f497" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:to="loc_srt_RangeAxis_770e465e-f57c-4c38-80c3-d5a2ab55f497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_770e465e-f57c-4c38-80c3-d5a2ab55f497" xlink:to="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d4856a42-0fbc-4dff-a6f8-51f98e81dd4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:to="loc_srt_MinimumMember_d4856a42-0fbc-4dff-a6f8-51f98e81dd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_88989671-bbe7-4b25-af37-b8d972472b23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d916be73-1415-45e2-9f89-a17cd5911879" xlink:to="loc_srt_MaximumMember_88989671-bbe7-4b25-af37-b8d972472b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_70c0214e-baf4-45ef-b6a8-70b4950fb7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_70c0214e-baf4-45ef-b6a8-70b4950fb7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_70c0214e-baf4-45ef-b6a8-70b4950fb7cb" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_f9c896e0-a7a1-44ef-a909-0dd09941b4f0" xlink:href="docs-20230331.xsd#docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:to="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_f9c896e0-a7a1-44ef-a909-0dd09941b4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_953bab37-52d4-440e-bc70-e8c2a34490cf" xlink:href="docs-20230331.xsd#docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_dcf2533a-8f2d-46ba-9908-6ef4aa630bce" xlink:to="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_953bab37-52d4-440e-bc70-e8c2a34490cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_688945a3-b809-447e-a034-2bcc9aa5b994" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerTerm_9a97b9d6-b18d-4609-8172-59255b6e5bdf" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_docs_ContractWithCustomerTerm_9a97b9d6-b18d-4609-8172-59255b6e5bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fc67c9c0-8e90-4fd6-9486-8af70509404e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fc67c9c0-8e90-4fd6-9486-8af70509404e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_8511a627-2fe1-425d-9aea-6d2b39bbf052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_us-gaap_NumberOfReportingUnits_8511a627-2fe1-425d-9aea-6d2b39bbf052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_a65fddce-fa34-4848-b2a1-020307b1c3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b695e952-0416-48b0-8057-5b33512d51be" xlink:to="loc_us-gaap_AdvertisingExpense_a65fddce-fa34-4848-b2a1-020307b1c3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a03e7f6c-f086-45a2-b165-516af15954c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a03e7f6c-f086-45a2-b165-516af15954c8" xlink:to="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_feaa7bf4-141a-4624-b79a-139200df201d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:to="loc_srt_MajorCustomersAxis_feaa7bf4-141a-4624-b79a-139200df201d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d2ce8fcb-15c9-44c2-8389-3b711f29bcdd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_feaa7bf4-141a-4624-b79a-139200df201d" xlink:to="loc_srt_NameOfMajorCustomerDomain_d2ce8fcb-15c9-44c2-8389-3b711f29bcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CustomerAMember_1fe4ebcd-4250-4e45-b79a-544fec11ccac" xlink:href="docs-20230331.xsd#docs_CustomerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d2ce8fcb-15c9-44c2-8389-3b711f29bcdd" xlink:to="loc_docs_CustomerAMember_1fe4ebcd-4250-4e45-b79a-544fec11ccac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e58d1475-1093-4859-a292-05d7016133cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e58d1475-1093-4859-a292-05d7016133cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e58d1475-1093-4859-a292-05d7016133cb" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_05c7e258-9f74-4336-9ef5-44b006ca9c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_05c7e258-9f74-4336-9ef5-44b006ca9c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_2f79cfaa-1c8c-4e13-8b7d-877903336173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a8dd6637-18a6-436d-a8a1-c0da9ea9cb94" xlink:to="loc_us-gaap_AccountsReceivableMember_2f79cfaa-1c8c-4e13-8b7d-877903336173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e650014f-10b0-4c60-b3c8-3595ad96f656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e650014f-10b0-4c60-b3c8-3595ad96f656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_92fe7392-1ba7-49cb-856b-e2b753b89f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e650014f-10b0-4c60-b3c8-3595ad96f656" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_92fe7392-1ba7-49cb-856b-e2b753b89f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_a53ed4b0-52c1-4a90-b018-bec72234efc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_92fe7392-1ba7-49cb-856b-e2b753b89f6d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_a53ed4b0-52c1-4a90-b018-bec72234efc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_4ca382bd-6617-4a8d-bafc-491ca6c1ec70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b3242c4e-7e0b-4058-b997-568a98c6f6ba" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_4ca382bd-6617-4a8d-bafc-491ca6c1ec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_09fbfa24-6cd3-41bd-8215-ce477426890d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4ca382bd-6617-4a8d-bafc-491ca6c1ec70" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_09fbfa24-6cd3-41bd-8215-ce477426890d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ebb4e538-d1a0-4546-b1f0-07a209af2928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ebb4e538-d1a0-4546-b1f0-07a209af2928" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a6733aa-221d-4caf-8d62-84c431699ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a6733aa-221d-4caf-8d62-84c431699ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a6733aa-221d-4caf-8d62-84c431699ec1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_ff1dd5e1-766e-49ab-b3c1-531144a0d3f8" xlink:href="docs-20230331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:to="loc_docs_FurnitureAndEquipmentMember_ff1dd5e1-766e-49ab-b3c1-531144a0d3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_b7c06a9d-69a0-44d6-b5f9-fabfc70bf14a" xlink:href="docs-20230331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_b7c06a9d-69a0-44d6-b5f9-fabfc70bf14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_599bf4a1-2c09-4ba0-b96d-5d74c8b463ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4a1b3b3c-158a-4d04-926e-a533479b251b" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_599bf4a1-2c09-4ba0-b96d-5d74c8b463ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9c252af1-c465-49df-81dc-8f041c5dce74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:to="loc_srt_RangeAxis_9c252af1-c465-49df-81dc-8f041c5dce74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9c252af1-c465-49df-81dc-8f041c5dce74" xlink:to="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c53b58bd-3a06-4e0b-a4a9-b306c4e2e36c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:to="loc_srt_MinimumMember_c53b58bd-3a06-4e0b-a4a9-b306c4e2e36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a201abfd-500f-440a-9504-cef83a25a4a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9d54904-9434-433d-b9df-d82059c04c76" xlink:to="loc_srt_MaximumMember_a201abfd-500f-440a-9504-cef83a25a4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eff7953b-09ad-48c1-ad42-049af533809f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_163a3ef1-48b6-4136-989d-75eadfedb3bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eff7953b-09ad-48c1-ad42-049af533809f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_971e7fa9-a4b6-44b8-817e-c3165961822a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eff7953b-09ad-48c1-ad42-049af533809f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_971e7fa9-a4b6-44b8-817e-c3165961822a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db6ff80f-2211-4f5f-aa72-1a93a1bdf7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_80a24cf5-3716-4b5b-ae87-9d054951c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db6ff80f-2211-4f5f-aa72-1a93a1bdf7ae" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_80a24cf5-3716-4b5b-ae87-9d054951c726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80a24cf5-3716-4b5b-ae87-9d054951c726" xlink:to="loc_srt_ProductOrServiceAxis_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ef951fc1-b4fc-4eb9-ba0d-e750bdd6158e" xlink:to="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMember_8b35a796-4cca-4cf8-b53d-eaa297315c53" xlink:href="docs-20230331.xsd#docs_SubscriptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:to="loc_docs_SubscriptionMember_8b35a796-4cca-4cf8-b53d-eaa297315c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_fd2f2d5e-3f30-4486-af68-976bc210bec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0a6d4863-1f64-4eed-9006-09afda59cc3b" xlink:to="loc_us-gaap_ServiceOtherMember_fd2f2d5e-3f30-4486-af68-976bc210bec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_59c26ba2-0129-447c-b1b2-e6886f378b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80a24cf5-3716-4b5b-ae87-9d054951c726" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_59c26ba2-0129-447c-b1b2-e6886f378b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2adedb0-6e7b-4161-9432-9285d7334c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_59c26ba2-0129-447c-b1b2-e6886f378b7d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2adedb0-6e7b-4161-9432-9285d7334c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#RevenueRecognitionDeferredRevenueContractBalanceDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_60b47b26-4ff2-442f-99d6-9882e7ecd228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_35a42cc1-9ca6-4922-81e7-8de649820107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_60b47b26-4ff2-442f-99d6-9882e7ecd228" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_35a42cc1-9ca6-4922-81e7-8de649820107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3e13de9e-9169-4fdd-8cfa-240cb45f9bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_35a42cc1-9ca6-4922-81e7-8de649820107" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3e13de9e-9169-4fdd-8cfa-240cb45f9bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityAdditionsNet_6d7b8c38-557c-42ed-9760-0c8c3bf8be78" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerLiabilityAdditionsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_35a42cc1-9ca6-4922-81e7-8de649820107" xlink:to="loc_docs_ContractWithCustomerLiabilityAdditionsNet_6d7b8c38-557c-42ed-9760-0c8c3bf8be78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3b704a15-89fc-45cd-b899-9df253c0bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_35a42cc1-9ca6-4922-81e7-8de649820107" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3b704a15-89fc-45cd-b899-9df253c0bb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_6acfd6b4-dff8-4076-a7ea-1d0c84d2b988" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_35a42cc1-9ca6-4922-81e7-8de649820107" xlink:to="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_6acfd6b4-dff8-4076-a7ea-1d0c84d2b988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0d94c72f-5e18-4ab0-9e15-e1188eb0aaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_35a42cc1-9ca6-4922-81e7-8de649820107" xlink:to="loc_us-gaap_ContractWithCustomerLiability_0d94c72f-5e18-4ab0-9e15-e1188eb0aaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c8b7abd3-d7f0-4bbf-890f-4b214194dd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b09160f9-1a7d-4d40-8ca4-199e6242511a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c8b7abd3-d7f0-4bbf-890f-4b214194dd09" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b09160f9-1a7d-4d40-8ca4-199e6242511a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b09160f9-1a7d-4d40-8ca4-199e6242511a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b2e447e-e6a0-4325-89e6-47e5824c97d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f9b3ec3-9f1a-49bb-8744-2d5cd5714239" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b2e447e-e6a0-4325-89e6-47e5824c97d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_376ec73f-d1be-4c29-9a38-c464c2fe5e16" xlink:href="docs-20230331.xsd#docs_AMiONMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b2e447e-e6a0-4325-89e6-47e5824c97d9" xlink:to="loc_docs_AMiONMember_376ec73f-d1be-4c29-9a38-c464c2fe5e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b09160f9-1a7d-4d40-8ca4-199e6242511a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityAdditionsNet_cb6f7d7f-c305-4077-954b-03bf62613690" xlink:href="docs-20230331.xsd#docs_ContractWithCustomerLiabilityAdditionsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_docs_ContractWithCustomerLiabilityAdditionsNet_cb6f7d7f-c305-4077-954b-03bf62613690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_f4e6e3e2-e465-4bea-93d4-921d813e255c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_f4e6e3e2-e465-4bea-93d4-921d813e255c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CapitalizedContractCostAdditions_feb47b58-67a9-429b-9d93-96a77d99618a" xlink:href="docs-20230331.xsd#docs_CapitalizedContractCostAdditions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_docs_CapitalizedContractCostAdditions_feb47b58-67a9-429b-9d93-96a77d99618a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_2e0f8ed2-4aa9-4cf7-8b67-62d28ab02c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_2e0f8ed2-4aa9-4cf7-8b67-62d28ab02c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss_6d40a05c-36e3-4e73-80b1-58f1b451fb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1b6d6669-9cf0-4456-8ef4-0def0c66bcff" xlink:to="loc_us-gaap_CapitalizedContractCostImpairmentLoss_6d40a05c-36e3-4e73-80b1-58f1b451fb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_185ff094-aaf8-4a44-93fa-ffaabda42cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_185ff094-aaf8-4a44-93fa-ffaabda42cec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6df7311c-b68d-4bed-b161-d066c9e1c4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6df7311c-b68d-4bed-b161-d066c9e1c4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6df7311c-b68d-4bed-b161-d066c9e1c4cd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_2c4c51dd-cd7f-4f03-adcf-f256afa3eb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_2c4c51dd-cd7f-4f03-adcf-f256afa3eb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_17852ade-7799-42f9-bdc9-2788d046143b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3d07c3fa-452a-4853-b3e6-686c4481225c" xlink:to="loc_us-gaap_DebtSecuritiesMember_17852ade-7799-42f9-bdc9-2788d046143b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_18d1e4fa-5f18-4343-b4bd-c20c9feed098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:to="loc_us-gaap_FinancialInstrumentAxis_18d1e4fa-5f18-4343-b4bd-c20c9feed098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_18d1e4fa-5f18-4343-b4bd-c20c9feed098" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_90efdd9f-2908-4e27-8a14-662ca9b94334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CommercialPaperMember_90efdd9f-2908-4e27-8a14-662ca9b94334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5f0f40bc-614b-4660-9b78-2786d97ff8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5f0f40bc-614b-4660-9b78-2786d97ff8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_4c2aec78-668f-4f4b-9f5f-1d03ea7c507b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_4c2aec78-668f-4f4b-9f5f-1d03ea7c507b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_eaed6e5c-d757-4a3f-b8ed-b5681a34a76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CertificatesOfDepositMember_eaed6e5c-d757-4a3f-b8ed-b5681a34a76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_3417a9ff-c0de-4fbb-b06a-7d1702cb6725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_3417a9ff-c0de-4fbb-b06a-7d1702cb6725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_01158dc4-214a-4e17-82ea-dd16f5755028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_01158dc4-214a-4e17-82ea-dd16f5755028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_5ffa37c3-2785-465f-90a1-a472ea0b2fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_5ffa37c3-2785-465f-90a1-a472ea0b2fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_d30ed886-cb7b-468e-8222-61ed2d5c6d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53669ec4-4f7f-40d4-8dae-747b06d1d4d1" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_d30ed886-cb7b-468e-8222-61ed2d5c6d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a9d6aaa4-6900-4ac8-b4a3-696bc4b25847" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_6183bdab-8d32-461a-b9cc-5aa11fe2607e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_6183bdab-8d32-461a-b9cc-5aa11fe2607e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1d38050f-244b-40c9-a6aa-76b7586f2114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1d38050f-244b-40c9-a6aa-76b7586f2114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c59a31a7-7faf-4abf-b91f-c3f7ed11ed77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c59a31a7-7faf-4abf-b91f-c3f7ed11ed77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_16ec0d6f-77a5-4e52-8fa5-43d0abef831c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_16ec0d6f-77a5-4e52-8fa5-43d0abef831c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a69845bc-b32b-4d43-82d2-6f82a50cb534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a69845bc-b32b-4d43-82d2-6f82a50cb534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_27049967-4872-497b-87c1-a1e22c41182a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_27049967-4872-497b-87c1-a1e22c41182a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_e84e6071-1211-4f20-ab0a-c893f6f82d55" xlink:href="docs-20230331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_e84e6071-1211-4f20-ab0a-c893f6f82d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_6b9fe5a0-f63d-4b63-b875-2c92927d07f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e85ca90e-0e7e-4ef7-905f-84e1122f85c2" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_6b9fe5a0-f63d-4b63-b875-2c92927d07f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_68946410-5944-4cc9-8bf6-3e0020fc5d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a6140d94-ff95-46d5-b183-d9b5cc717084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_68946410-5944-4cc9-8bf6-3e0020fc5d4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a6140d94-ff95-46d5-b183-d9b5cc717084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo_c90ea676-0e42-45c0-b320-f4832e8d37f5" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_68946410-5944-4cc9-8bf6-3e0020fc5d4d" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo_c90ea676-0e42-45c0-b320-f4832e8d37f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_84b327f9-e3cc-451a-93e0-a691f5faa90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_68946410-5944-4cc9-8bf6-3e0020fc5d4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_84b327f9-e3cc-451a-93e0-a691f5faa90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_b20d36cd-4bd5-455e-a306-635c071cea67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_68946410-5944-4cc9-8bf6-3e0020fc5d4d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_b20d36cd-4bd5-455e-a306-635c071cea67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6270a4ae-c763-44da-8d21-fc758005a04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_6389c5a0-dce2-47b9-be0c-b7a2cdff2c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6270a4ae-c763-44da-8d21-fc758005a04d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_6389c5a0-dce2-47b9-be0c-b7a2cdff2c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_36db4251-8061-45b0-aab6-1a4f6e20661b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6270a4ae-c763-44da-8d21-fc758005a04d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_36db4251-8061-45b0-aab6-1a4f6e20661b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e73889d6-ed13-469a-8865-a180ebe5bc18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6270a4ae-c763-44da-8d21-fc758005a04d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e73889d6-ed13-469a-8865-a180ebe5bc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_f4d43148-5b13-4e5d-a950-94c00d1d4426" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleImpairmentsLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6270a4ae-c763-44da-8d21-fc758005a04d" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_f4d43148-5b13-4e5d-a950-94c00d1d4426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense_cba10ec7-aeb6-4b31-aa7f-7ceb53d57c41" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6270a4ae-c763-44da-8d21-fc758005a04d" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense_cba10ec7-aeb6-4b31-aa7f-7ceb53d57c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_cd18027f-09ea-44f9-8a3c-a32c8df2f632" xlink:href="docs-20230331.xsd#docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6270a4ae-c763-44da-8d21-fc758005a04d" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_cd18027f-09ea-44f9-8a3c-a32c8df2f632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3227d764-1466-4daa-b054-2f72d901e332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3227d764-1466-4daa-b054-2f72d901e332" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_789b5a6f-3c5f-413e-a36c-24b3d015e16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_789b5a6f-3c5f-413e-a36c-24b3d015e16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_789b5a6f-3c5f-413e-a36c-24b3d015e16a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6ee684b5-9197-4020-b948-cb9d4972b80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6ee684b5-9197-4020-b948-cb9d4972b80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5db8e60b-d5ac-46a3-b358-7a7fcb60ed91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5db8e60b-d5ac-46a3-b358-7a7fcb60ed91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4bd513a0-dcce-4efc-974b-7b3a4f0fd5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15fd039f-15c0-4d5c-a11f-c2ef758b223e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4bd513a0-dcce-4efc-974b-7b3a4f0fd5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e58144bc-ee9b-47e6-bc85-2a4508301d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e58144bc-ee9b-47e6-bc85-2a4508301d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b5e267d-2eec-497a-9895-d9ef8c480ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e58144bc-ee9b-47e6-bc85-2a4508301d00" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b5e267d-2eec-497a-9895-d9ef8c480ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_76c5b10c-082d-43b7-a0ae-ff8028611e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b5e267d-2eec-497a-9895-d9ef8c480ab2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_76c5b10c-082d-43b7-a0ae-ff8028611e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2fe16654-320c-4f48-9591-dc1ef3a1b45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2fe16654-320c-4f48-9591-dc1ef3a1b45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2fe16654-320c-4f48-9591-dc1ef3a1b45a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_311c3753-b792-45a6-b238-d668bd0e9ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_CommercialPaperMember_311c3753-b792-45a6-b238-d668bd0e9ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c84dcfae-1943-4956-80b3-b49a588e7786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c84dcfae-1943-4956-80b3-b49a588e7786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_bfdff927-3555-4a19-ba02-8a97cd8d388f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_bfdff927-3555-4a19-ba02-8a97cd8d388f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1fad8cc9-0caa-47c5-9c1c-4c620cd65209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1fad8cc9-0caa-47c5-9c1c-4c620cd65209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_2dca4c27-c7d2-4450-b309-b864f6b01a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_2dca4c27-c7d2-4450-b309-b864f6b01a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_dd3cc08a-e3e9-413c-954a-b2b218651a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_dd3cc08a-e3e9-413c-954a-b2b218651a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_09c0d3d6-f354-4318-8115-c0f86b4f6847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_284a8613-3b45-4217-a7d5-63efb10c552f" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_09c0d3d6-f354-4318-8115-c0f86b4f6847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c0bc946e-b58d-47c4-bcf7-2aced3c55ef1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_6e1a0daa-c6c2-424a-9f74-a684aadf912d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_6e1a0daa-c6c2-424a-9f74-a684aadf912d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_04e86f07-a2ca-4334-bea4-23b105b1fe51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_32e52c68-6998-4a17-8c6b-8c8c1b571d5c" xlink:to="loc_us-gaap_DebtSecuritiesMember_04e86f07-a2ca-4334-bea4-23b105b1fe51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5db9991b-eca2-433d-83bd-f61271da80d5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_73ded63e-5833-4f21-9f18-3d2a6ff34215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_73ded63e-5833-4f21-9f18-3d2a6ff34215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_182d4caf-51e5-41c0-b49f-2a29f37a6b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_73ded63e-5833-4f21-9f18-3d2a6ff34215" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_182d4caf-51e5-41c0-b49f-2a29f37a6b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2320c4f0-ccbd-47ae-9b99-2ca28c24420b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9b422103-3972-44c4-9921-877d4bee9d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9b422103-3972-44c4-9921-877d4bee9d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_71bc56c7-29f4-4fbe-bbda-f75d26b9c9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3a537673-c707-4977-9c93-fe591936bd3f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_71bc56c7-29f4-4fbe-bbda-f75d26b9c9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8851eecb-e3f2-47a1-bb12-d9533cce8345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_41a3b197-a579-42b1-ba13-1aa0851b04a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8851eecb-e3f2-47a1-bb12-d9533cce8345" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_41a3b197-a579-42b1-ba13-1aa0851b04a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_79667fc2-b739-4b3f-89e8-c6a6e12a3a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_41a3b197-a579-42b1-ba13-1aa0851b04a5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_79667fc2-b739-4b3f-89e8-c6a6e12a3a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b502b8bc-00a1-42d4-b4ec-fa6dbfbc3d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_41a3b197-a579-42b1-ba13-1aa0851b04a5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b502b8bc-00a1-42d4-b4ec-fa6dbfbc3d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9a61e36d-2398-44d7-94d5-2c7afb91cbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_41a3b197-a579-42b1-ba13-1aa0851b04a5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9a61e36d-2398-44d7-94d5-2c7afb91cbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c8c0f11c-15bf-49de-88e8-5a33ddd09902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_41a3b197-a579-42b1-ba13-1aa0851b04a5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c8c0f11c-15bf-49de-88e8-5a33ddd09902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_073c0f63-b49b-4c70-ad7b-86c6c5ec2431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8851eecb-e3f2-47a1-bb12-d9533cce8345" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_073c0f63-b49b-4c70-ad7b-86c6c5ec2431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6f57d430-5cd9-422d-b202-906ac80cd267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_12d29f15-27cb-40d8-917a-874166a7e01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6f57d430-5cd9-422d-b202-906ac80cd267" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_12d29f15-27cb-40d8-917a-874166a7e01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88e3fcd4-72b4-470b-88cb-bdb66af57452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_12d29f15-27cb-40d8-917a-874166a7e01d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88e3fcd4-72b4-470b-88cb-bdb66af57452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_88e3fcd4-72b4-470b-88cb-bdb66af57452" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_91e53cfd-0b0a-4816-b63d-aa8a91aa74fd" xlink:href="docs-20230331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_docs_FurnitureAndEquipmentMember_91e53cfd-0b0a-4816-b63d-aa8a91aa74fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_33860e70-6074-4907-9515-3c44508f8d1a" xlink:href="docs-20230331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_33860e70-6074-4907-9515-3c44508f8d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ed974154-3f52-40ba-bb9b-35d5789918b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ed974154-3f52-40ba-bb9b-35d5789918b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e57e8b06-cfd6-4c74-a49d-27f9bd6ed82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff960df5-00ec-44a5-abfd-a29b264f9eb8" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e57e8b06-cfd6-4c74-a49d-27f9bd6ed82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_12d29f15-27cb-40d8-917a-874166a7e01d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_377eaf63-8f66-4386-b52d-4bcf62556e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_377eaf63-8f66-4386-b52d-4bcf62556e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5643a6f-aa8d-4d8c-8262-d1771a69dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5643a6f-aa8d-4d8c-8262-d1771a69dc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_41f866a8-17d9-4208-9ad2-ee40a83d8dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4009cde0-9b65-4eff-a2bf-7f0e5fddcc22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_41f866a8-17d9-4208-9ad2-ee40a83d8dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#PropertyandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_002237b1-551f-4a23-a9d5-2c013d56778b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ea45baee-d449-43f7-9669-4bf47af818af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_002237b1-551f-4a23-a9d5-2c013d56778b" xlink:to="loc_us-gaap_Depreciation_ea45baee-d449-43f7-9669-4bf47af818af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_b6fcc936-dc87-4796-af6a-ab79c04a1105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_002237b1-551f-4a23-a9d5-2c013d56778b" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_b6fcc936-dc87-4796-af6a-ab79c04a1105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_1fd81e89-aa44-420f-b3f0-6efc296e057c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_002237b1-551f-4a23-a9d5-2c013d56778b" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_1fd81e89-aa44-420f-b3f0-6efc296e057c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_40728db9-63e5-4b0c-b174-316f0e0bc173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_002237b1-551f-4a23-a9d5-2c013d56778b" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_40728db9-63e5-4b0c-b174-316f0e0bc173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_df8ee77e-f6e3-48ba-9b59-b8808ffc5294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_df8ee77e-f6e3-48ba-9b59-b8808ffc5294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_371a1176-3c80-4644-88f6-ea7146fba2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_371a1176-3c80-4644-88f6-ea7146fba2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_c103bbc8-6d64-48ea-9753-4804d320c0ee" xlink:href="docs-20230331.xsd#docs_AccruedEmployeeStockPurchasePlanCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_c103bbc8-6d64-48ea-9753-4804d320c0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RebateLiabilitiesCurrent_00952109-3b65-4c49-9301-af1d0f88d70c" xlink:href="docs-20230331.xsd#docs_RebateLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_docs_RebateLiabilitiesCurrent_00952109-3b65-4c49-9301-af1d0f88d70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_217a4e05-f4bb-465e-b5c2-c85bf41ad010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_us-gaap_TaxesPayableCurrent_217a4e05-f4bb-465e-b5c2-c85bf41ad010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ec5aba3d-4c85-4e1b-bbc6-cc5c9c4b2663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ec5aba3d-4c85-4e1b-bbc6-cc5c9c4b2663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_28852382-290b-4eec-a168-0f53c4a2959d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_28852382-290b-4eec-a168-0f53c4a2959d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_935e76bd-f5a9-4e94-8774-562f5ea57913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_24e0c015-759f-45ef-8def-65c4d4f1ede7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_935e76bd-f5a9-4e94-8774-562f5ea57913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8cb49b7e-528d-4bbd-b070-daacb58c91eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8cb49b7e-528d-4bbd-b070-daacb58c91eb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a325310-2fbd-4177-977b-56817d722520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a325310-2fbd-4177-977b-56817d722520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a325310-2fbd-4177-977b-56817d722520" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_8cb68ff3-2559-4e01-9c92-636ad3c6d687" xlink:href="docs-20230331.xsd#docs_THMEDLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:to="loc_docs_THMEDLLCMember_8cb68ff3-2559-4e01-9c92-636ad3c6d687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_282147b6-95f7-4170-b628-caf46ea1cdb9" xlink:href="docs-20230331.xsd#docs_AMiONMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161b0756-6bcf-4e13-b809-e3fb39f14cdb" xlink:to="loc_docs_AMiONMember_282147b6-95f7-4170-b628-caf46ea1cdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c72048a9-723b-4d9c-984b-c49e11c42c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c72048a9-723b-4d9c-984b-c49e11c42c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c72048a9-723b-4d9c-984b-c49e11c42c58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_13402aab-150f-41d3-b8e2-5ec02238ba14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_13402aab-150f-41d3-b8e2-5ec02238ba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_9a3971ac-1b29-4938-a9a9-aef6c7c48271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:to="loc_us-gaap_TrademarksMember_9a3971ac-1b29-4938-a9a9-aef6c7c48271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c2c96295-5e8b-441a-bfa0-408a120a5732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab0dbffb-ec9f-44d0-ba12-79cf8429a53f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c2c96295-5e8b-441a-bfa0-408a120a5732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1c6bfa1b-1f99-46f0-83d3-9bc274529572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1c6bfa1b-1f99-46f0-83d3-9bc274529572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1f282dd5-4e49-4891-b2ac-feeef06b568a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1c6bfa1b-1f99-46f0-83d3-9bc274529572" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1f282dd5-4e49-4891-b2ac-feeef06b568a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0d974cde-decc-4591-ae2b-2c019a1ef5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1f282dd5-4e49-4891-b2ac-feeef06b568a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0d974cde-decc-4591-ae2b-2c019a1ef5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_848aab53-d589-4ebb-b48c-0877fa15f3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_848aab53-d589-4ebb-b48c-0877fa15f3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4ce524bf-1ea7-4933-a282-306aa43cb135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_848aab53-d589-4ebb-b48c-0877fa15f3ad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4ce524bf-1ea7-4933-a282-306aa43cb135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PortionOfCurativeTalentLLCMember_30bae1a0-3966-4a51-a4d9-f77b0600bd37" xlink:href="docs-20230331.xsd#docs_PortionOfCurativeTalentLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4ce524bf-1ea7-4933-a282-306aa43cb135" xlink:to="loc_docs_PortionOfCurativeTalentLLCMember_30bae1a0-3966-4a51-a4d9-f77b0600bd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_01db1b02-8732-424e-abb4-dda14f907d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_AwardTypeAxis_01db1b02-8732-424e-abb4-dda14f907d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_763d297f-0a0e-47cd-8800-68489b882c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_01db1b02-8732-424e-abb4-dda14f907d81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_763d297f-0a0e-47cd-8800-68489b882c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_72cc90c1-932c-47c1-80dd-db7e5603b704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_763d297f-0a0e-47cd-8800-68489b882c1d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_72cc90c1-932c-47c1-80dd-db7e5603b704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7fd33003-4f02-46f9-8876-74b888349e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7fd33003-4f02-46f9-8876-74b888349e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3d1f9920-b0cc-4a45-b306-a9cc4205c6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7fd33003-4f02-46f9-8876-74b888349e63" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3d1f9920-b0cc-4a45-b306-a9cc4205c6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_547dcf4b-c583-4d0d-a06d-83a016e91b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3d1f9920-b0cc-4a45-b306-a9cc4205c6e9" xlink:to="loc_us-gaap_SubsequentEventMember_547dcf4b-c583-4d0d-a06d-83a016e91b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b054b795-28ae-4a08-b9b7-aceb8266388e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_srt_StatementScenarioAxis_b054b795-28ae-4a08-b9b7-aceb8266388e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_57f84cde-16bb-40ad-832e-c7583b200aef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_b054b795-28ae-4a08-b9b7-aceb8266388e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_57f84cde-16bb-40ad-832e-c7583b200aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e861da32-f9cc-4dee-868a-b94fa6250bc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_57f84cde-16bb-40ad-832e-c7583b200aef" xlink:to="loc_srt_ScenarioForecastMember_e861da32-f9cc-4dee-868a-b94fa6250bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b38deb73-4dac-45fe-ae36-19d0ebe6d672" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2937db6b-6a58-4b1b-8928-cc22657e505d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2937db6b-6a58-4b1b-8928-cc22657e505d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c5cad28b-123c-4b56-873c-0d8c06177f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c5cad28b-123c-4b56-873c-0d8c06177f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_19ba1fcb-91b0-49da-b67f-a4f1748381c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_19ba1fcb-91b0-49da-b67f-a4f1748381c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4765c1e5-7da9-4cd2-b06e-2963428d957c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4765c1e5-7da9-4cd2-b06e-2963428d957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_72a99f66-c9b1-4214-94ac-90a161644799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_72a99f66-c9b1-4214-94ac-90a161644799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a58c158d-aa8e-4be3-a707-b8a41f5ef612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a58c158d-aa8e-4be3-a707-b8a41f5ef612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9190c124-356e-4856-95db-6636507a968b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9190c124-356e-4856-95db-6636507a968b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_413e8c02-7a3d-43a3-8206-e5dd77c92818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_413e8c02-7a3d-43a3-8206-e5dd77c92818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_289b6a72-c3d1-42b9-a9ee-c01c3618c503" xlink:href="docs-20230331.xsd#docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_289b6a72-c3d1-42b9-a9ee-c01c3618c503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93995d12-a507-4708-8a09-8395e13f678a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_93995d12-a507-4708-8a09-8395e13f678a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d193ce41-e0e8-4de2-bec9-3345b276be76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d193ce41-e0e8-4de2-bec9-3345b276be76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_00ff3758-a69a-4e7f-93c1-9ab9342d5983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_00ff3758-a69a-4e7f-93c1-9ab9342d5983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance_3cdb5960-4aa8-487b-9224-009927bca957" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance_3cdb5960-4aa8-487b-9224-009927bca957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod_ca971b07-8036-405e-bf9d-c9256305ab05" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod_ca971b07-8036-405e-bf9d-c9256305ab05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_b363e8ae-fbc9-4952-81f7-36cc306b8b2f" xlink:href="docs-20230331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_b363e8ae-fbc9-4952-81f7-36cc306b8b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities_f6b0f0dc-1aeb-4c44-bd9f-d5f82be3842e" xlink:href="docs-20230331.xsd#docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities_f6b0f0dc-1aeb-4c44-bd9f-d5f82be3842e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e17852a7-494b-436f-9aeb-d1a44df20551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e17852a7-494b-436f-9aeb-d1a44df20551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aaa55c36-a424-43a5-b2ca-fbafebf01bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aaa55c36-a424-43a5-b2ca-fbafebf01bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51cdfa29-9ed7-4f2c-a9fb-30cf3dd38ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51cdfa29-9ed7-4f2c-a9fb-30cf3dd38ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4553e62c-efa1-4980-9fda-80efe6c240eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_559549cc-6e03-4471-9e46-22bca5ba63d9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4553e62c-efa1-4980-9fda-80efe6c240eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsPurchaseConsiderationAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3fe0de18-d477-47c9-87ad-7564cf42c980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3fe0de18-d477-47c9-87ad-7564cf42c980" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_31b9d712-bf9d-4383-8ee8-a6e8d2af1f10" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_609f81ba-fe25-4de0-90b0-4737f61e74c7" xlink:href="docs-20230331.xsd#docs_THMEDLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:to="loc_docs_THMEDLLCMember_609f81ba-fe25-4de0-90b0-4737f61e74c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_cd195953-3266-49da-8385-62af5c4ff5ee" xlink:href="docs-20230331.xsd#docs_AMiONMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4fd3ac94-d5bb-40c6-95d8-4ec348d6cdd5" xlink:to="loc_docs_AMiONMember_cd195953-3266-49da-8385-62af5c4ff5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ef7566d-acad-4476-89d0-f7bed6b820b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ef7566d-acad-4476-89d0-f7bed6b820b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ef7566d-acad-4476-89d0-f7bed6b820b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b6e0dfbb-8362-4687-9b12-65fda2e0e3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b6e0dfbb-8362-4687-9b12-65fda2e0e3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55e6ec44-aa5a-4d4b-9a38-497f52506c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55e6ec44-aa5a-4d4b-9a38-497f52506c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_948b26e9-da98-41c3-a680-b3c2ce7c5360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7f03c8a-081a-48d7-83e6-8250574fe9ef" xlink:to="loc_us-gaap_TrademarksMember_948b26e9-da98-41c3-a680-b3c2ce7c5360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a6ec7a86-a4c7-44eb-aba0-bcf73f413cdf" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c1e0a071-714e-4a5b-9f43-83e1b6f435ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c1e0a071-714e-4a5b-9f43-83e1b6f435ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6a67ae70-23c7-4076-bc83-03cd7043295b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6a67ae70-23c7-4076-bc83-03cd7043295b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_542682f7-980e-4a35-bcd9-d673f328a908" xlink:href="docs-20230331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_542682f7-980e-4a35-bcd9-d673f328a908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2c03af74-dfd6-442e-9166-867fc40ec942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2c03af74-dfd6-442e-9166-867fc40ec942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e5b5ddfb-85ad-4d3e-99c0-56a26d3682ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_1a7bf185-044f-44ff-ad8e-3a817effcc62" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e5b5ddfb-85ad-4d3e-99c0-56a26d3682ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2232227e-eb60-4789-984c-9f724dbea1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2232227e-eb60-4789-984c-9f724dbea1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c3f46141-c230-42af-9485-e142262bc55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c3f46141-c230-42af-9485-e142262bc55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e595612f-ef9e-4d98-8f52-a684868bd528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_3f5fd31e-a5d8-459a-90a5-26d3fe36184b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e595612f-ef9e-4d98-8f52-a684868bd528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a391a52d-0782-4555-b735-c174bd07ebb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a391a52d-0782-4555-b735-c174bd07ebb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8c7cfbaa-b328-4796-912b-8267ea5be45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_Goodwill_8c7cfbaa-b328-4796-912b-8267ea5be45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_acf28531-c4ca-4565-9200-49e3c888041d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_24ce45c5-5909-4c58-95bd-decfb181f9c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_acf28531-c4ca-4565-9200-49e3c888041d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1" xlink:type="simple" xlink:href="docs-20230331.xsd#BusinessCombinationsPurchaseConsiderationAllocationDetails_1"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27eee6a1-f3ba-461a-829a-c98f15eea811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_441a95ff-7ecd-4972-9fbb-e5764739da72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27eee6a1-f3ba-461a-829a-c98f15eea811" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_441a95ff-7ecd-4972-9fbb-e5764739da72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e4bb9c9a-2d3c-41a6-a969-207744675b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_441a95ff-7ecd-4972-9fbb-e5764739da72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e4bb9c9a-2d3c-41a6-a969-207744675b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e4bb9c9a-2d3c-41a6-a969-207744675b34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_185b4783-928c-4621-a8a4-58a58e3c21c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_185b4783-928c-4621-a8a4-58a58e3c21c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_88d6e696-9a57-4dda-a135-6ba1f572bfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e795a69-b8f3-4c0a-be01-69bfb3fd7a5c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_88d6e696-9a57-4dda-a135-6ba1f572bfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_441a95ff-7ecd-4972-9fbb-e5764739da72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b862042b-fda2-45de-98cb-b1535048688a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b862042b-fda2-45de-98cb-b1535048688a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10ff3435-c832-4505-9a0f-59a30397586c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10ff3435-c832-4505-9a0f-59a30397586c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df79c53b-4b77-46b5-bfea-f1e4bb9cdb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83560fc1-3c80-4404-ac67-6518c05b7089" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df79c53b-4b77-46b5-bfea-f1e4bb9cdb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ef454d20-0ed3-4686-a432-410b6afb51f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0dfcc21c-4841-4a7b-b3ef-a8f9a186df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ef454d20-0ed3-4686-a432-410b6afb51f1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0dfcc21c-4841-4a7b-b3ef-a8f9a186df9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0fa45f55-273d-4a7c-b784-a3fb08755184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ef454d20-0ed3-4686-a432-410b6afb51f1" xlink:to="loc_us-gaap_Goodwill_0fa45f55-273d-4a7c-b784-a3fb08755184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8d67f26c-0748-4561-9f49-52a048ff8c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ef454d20-0ed3-4686-a432-410b6afb51f1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8d67f26c-0748-4561-9f49-52a048ff8c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_45ff3e97-7569-44a9-b8e5-26404caf42c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_45ff3e97-7569-44a9-b8e5-26404caf42c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7d5f8e68-48e7-40e5-b977-485b8c3c2a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7d5f8e68-48e7-40e5-b977-485b8c3c2a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2d1c7b91-5efb-40bc-a289-cfeff5f028e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2d1c7b91-5efb-40bc-a289-cfeff5f028e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dace9460-884a-4946-b6d6-8438f342e840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dace9460-884a-4946-b6d6-8438f342e840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_feeb9b6e-b99a-4392-9e3b-ca6f904efec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_feeb9b6e-b99a-4392-9e3b-ca6f904efec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5de51dbb-7358-4e5d-908f-7cdbbec8235c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5de51dbb-7358-4e5d-908f-7cdbbec8235c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a1264038-baf2-462f-ac89-72406b5c8a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed40f1f1-0460-4bbb-a971-13b222aa7b4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a1264038-baf2-462f-ac89-72406b5c8a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IntangibleAssetsChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2a815780-cad3-4bee-9864-19165877eb09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3aff4015-4f42-409c-b44e-45429fe19e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2a815780-cad3-4bee-9864-19165877eb09" xlink:to="loc_us-gaap_GoodwillRollForward_3aff4015-4f42-409c-b44e-45429fe19e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ab4c991b-1ad7-4f15-834c-4b00f4f0fcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3aff4015-4f42-409c-b44e-45429fe19e7a" xlink:to="loc_us-gaap_Goodwill_ab4c991b-1ad7-4f15-834c-4b00f4f0fcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_40c52840-601a-4e5c-ba56-6faade2da29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3aff4015-4f42-409c-b44e-45429fe19e7a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_40c52840-601a-4e5c-ba56-6faade2da29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4e597903-4324-45e1-bf23-9e1b309c9326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3aff4015-4f42-409c-b44e-45429fe19e7a" xlink:to="loc_us-gaap_Goodwill_4e597903-4324-45e1-bf23-9e1b309c9326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#RedeemableConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_c05529fd-c0b0-47d8-be0a-0d85ce191874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_cc29c464-0e63-48d2-8dad-e00fbb6ac393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_c05529fd-c0b0-47d8-be0a-0d85ce191874" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_cc29c464-0e63-48d2-8dad-e00fbb6ac393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_cc29c464-0e63-48d2-8dad-e00fbb6ac393" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_669fc2d2-11fd-4827-abf1-d60c2b3cf3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d086ea0d-0c8b-45d1-a24e-3cdeb7f2679e" xlink:to="loc_us-gaap_ClassOfStockDomain_669fc2d2-11fd-4827-abf1-d60c2b3cf3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_bfc3da27-9269-4353-9c53-078f121ada5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_669fc2d2-11fd-4827-abf1-d60c2b3cf3f2" xlink:to="loc_us-gaap_CommonClassBMember_bfc3da27-9269-4353-9c53-078f121ada5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_cc29c464-0e63-48d2-8dad-e00fbb6ac393" xlink:to="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_1d8ad57c-d09d-4c05-87b6-0fcc2a069b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_1d8ad57c-d09d-4c05-87b6-0fcc2a069b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_147ccbc5-5adb-4492-828d-8eefefe4c20d" xlink:href="docs-20230331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_docs_ConversionOfStockConversionRatio_147ccbc5-5adb-4492-828d-8eefefe4c20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_b2f14927-9548-4d4a-8ff6-bf9e3e80f60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_b2f14927-9548-4d4a-8ff6-bf9e3e80f60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_6a01ece7-9999-45ff-9d4d-47400ead05e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_6a01ece7-9999-45ff-9d4d-47400ead05e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_da6b3325-3546-4d22-911a-1db1a402f511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_682f04ef-419c-435b-adc3-7fe246f87df6" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_da6b3325-3546-4d22-911a-1db1a402f511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c571531-b024-4ed2-9c33-a6c6d9cbce72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c571531-b024-4ed2-9c33-a6c6d9cbce72" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_48e4cfcd-0812-4a8a-8105-f8679777cb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_48e4cfcd-0812-4a8a-8105-f8679777cb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9fbbe649-275d-480e-a7f4-6ddc8c3c0548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48e4cfcd-0812-4a8a-8105-f8679777cb23" xlink:to="loc_us-gaap_ClassOfStockDomain_9fbbe649-275d-480e-a7f4-6ddc8c3c0548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9fbbe649-275d-480e-a7f4-6ddc8c3c0548" xlink:to="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_2f5a3dbc-a62c-4af3-8087-a8a7a18fbaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:to="loc_us-gaap_CommonClassAMember_2f5a3dbc-a62c-4af3-8087-a8a7a18fbaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_21876727-c693-4b3c-81e4-a7bb721acf25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockMember_e1269517-35fc-4b0d-aece-f066ae228a0f" xlink:to="loc_us-gaap_CommonClassBMember_21876727-c693-4b3c-81e4-a7bb721acf25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_89696d67-eda8-4e83-a70f-42e3bd088e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_89696d67-eda8-4e83-a70f-42e3bd088e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_89696d67-eda8-4e83-a70f-42e3bd088e07" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithUSNewsWorldReportLPMember_8dce26fc-8eff-42f0-a7b9-6b6f33ce61ef" xlink:href="docs-20230331.xsd#docs_ContractWithUSNewsWorldReportLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:to="loc_docs_ContractWithUSNewsWorldReportLPMember_8dce26fc-8eff-42f0-a7b9-6b6f33ce61ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_USNewsWarrantMember_7c446686-4578-4185-b17b-1e6b35ade2fa" xlink:href="docs-20230331.xsd#docs_USNewsWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_f6db2759-46d8-43bc-989c-6c16ea1d15b4" xlink:to="loc_docs_USNewsWarrantMember_7c446686-4578-4185-b17b-1e6b35ade2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f2eb6cc5-690c-4542-be92-cc56de9b2411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_PlanNameAxis_f2eb6cc5-690c-4542-be92-cc56de9b2411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f2eb6cc5-690c-4542-be92-cc56de9b2411" xlink:to="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_38d69f68-e97f-4cae-bced-06c2b9016c8e" xlink:href="docs-20230331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_EquityIncentivePlan2010Member_38d69f68-e97f-4cae-bced-06c2b9016c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_f45bca0c-d2ea-40d7-97f3-2f6d77ad76ab" xlink:href="docs-20230331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_f45bca0c-d2ea-40d7-97f3-2f6d77ad76ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_141ec2e7-e9ee-4725-8f39-c4c9d4d86831" xlink:href="docs-20230331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_141ec2e7-e9ee-4725-8f39-c4c9d4d86831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_1b4a9c6e-4d88-4a6a-aa01-d34c29704400" xlink:href="docs-20230331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_15a3f2e9-9cf5-486f-a249-39b354410045" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_1b4a9c6e-4d88-4a6a-aa01-d34c29704400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ec00bad-ae54-464b-8ff5-9294bb3d6341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_AwardTypeAxis_1ec00bad-ae54-464b-8ff5-9294bb3d6341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1ec00bad-ae54-464b-8ff5-9294bb3d6341" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_123a8e65-2bd4-45fd-9081-fd04793c4522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_123a8e65-2bd4-45fd-9081-fd04793c4522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e5f71b19-3689-4f65-b88b-556c3774ef7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e5f71b19-3689-4f65-b88b-556c3774ef7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_aeebcbe5-426b-465a-9d1f-036a0e76fab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_us-gaap_PerformanceSharesMember_aeebcbe5-426b-465a-9d1f-036a0e76fab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_5d1f9fee-a607-452b-a5b8-c9a21b11b6e7" xlink:href="docs-20230331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7ea28ac-ab4b-45e7-93c8-06b5b66e12cd" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_5d1f9fee-a607-452b-a5b8-c9a21b11b6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_12d8a862-65c3-494c-8031-b3fdcaa04ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_12d8a862-65c3-494c-8031-b3fdcaa04ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_12d8a862-65c3-494c-8031-b3fdcaa04ef6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_6005c739-26a7-4890-b8f2-8e184e29b472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_6005c739-26a7-4890-b8f2-8e184e29b472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_3d955e92-6b0c-4abe-a81b-d14be80ed50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_3d955e92-6b0c-4abe-a81b-d14be80ed50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_d29cd31e-a815-44e1-b49b-4cc2a76d1cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_d29cd31e-a815-44e1-b49b-4cc2a76d1cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1276503e-f567-4990-ae8c-8e571788cb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1276503e-f567-4990-ae8c-8e571788cb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_3c2c78f4-7f4a-4a65-bc41-e57a35f79d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_74fc00b1-f9ce-48f6-bbd9-26d5e17fc85b" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_3c2c78f4-7f4a-4a65-bc41-e57a35f79d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_9e6ace9d-7413-4cd6-9edf-3d7579496364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_VestingAxis_9e6ace9d-7413-4cd6-9edf-3d7579496364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_dae5172d-6011-4c7c-ab7c-b8e6b7d73acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_9e6ace9d-7413-4cd6-9edf-3d7579496364" xlink:to="loc_us-gaap_VestingDomain_dae5172d-6011-4c7c-ab7c-b8e6b7d73acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember_6f565470-a311-4546-ba55-9701cdf1ef2d" xlink:href="docs-20230331.xsd#docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_dae5172d-6011-4c7c-ab7c-b8e6b7d73acb" xlink:to="loc_docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember_6f565470-a311-4546-ba55-9701cdf1ef2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_5eb5d436-5d3f-4c77-8b5d-551d9748202c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_GranteeStatusAxis_5eb5d436-5d3f-4c77-8b5d-551d9748202c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_5eb5d436-5d3f-4c77-8b5d-551d9748202c" xlink:to="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_c6d9c990-9ebb-48e1-bec4-b2889c6da184" xlink:href="docs-20230331.xsd#docs_IndividualsWithVotingInterestLessThanThresholdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:to="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_c6d9c990-9ebb-48e1-bec4-b2889c6da184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestAtThresholdMember_6b40e255-0f8e-4178-9a87-8de0460a36a5" xlink:href="docs-20230331.xsd#docs_IndividualsWithVotingInterestAtThresholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_9cf07a7d-f5c4-40a9-b32c-1db96d4e76bc" xlink:to="loc_docs_IndividualsWithVotingInterestAtThresholdMember_6b40e255-0f8e-4178-9a87-8de0460a36a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_20d414b1-a77c-4f0b-978c-2a11e8de58dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_srt_TitleOfIndividualAxis_20d414b1-a77c-4f0b-978c-2a11e8de58dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b85de43b-126e-4562-86f6-00b4128d3bc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_20d414b1-a77c-4f0b-978c-2a11e8de58dd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b85de43b-126e-4562-86f6-00b4128d3bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_b720ac2d-93cf-43dd-965c-f4a6d70596c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b85de43b-126e-4562-86f6-00b4128d3bc0" xlink:to="loc_srt_ChiefExecutiveOfficerMember_b720ac2d-93cf-43dd-965c-f4a6d70596c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a92265f-7103-4df2-9393-6d09af071faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6ddfb3b6-9e3b-49c4-b6f0-f07320967078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6ddfb3b6-9e3b-49c4-b6f0-f07320967078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a072aa81-d446-46b3-8a8f-d060631a4a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a072aa81-d446-46b3-8a8f-d060631a4a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d805933d-6731-4c56-8dca-fa72a0265d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d805933d-6731-4c56-8dca-fa72a0265d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_71e65682-fad2-45e6-a51e-f3ce2e7930a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_71e65682-fad2-45e6-a51e-f3ce2e7930a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_889abe43-0456-4fe9-8194-c44434ae586f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_889abe43-0456-4fe9-8194-c44434ae586f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2dc079a3-f339-4108-9b82-1689ec4bdb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2dc079a3-f339-4108-9b82-1689ec4bdb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes_fd226595-faf2-49e1-99f6-8772701edb7e" xlink:href="docs-20230331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_CommonStockVotingRightsNumberOfVotes_fd226595-faf2-49e1-99f6-8772701edb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_546d53a7-9263-497c-a92e-b3432d685f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_546d53a7-9263-497c-a92e-b3432d685f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_bb740761-1fb8-4058-b729-802f4776bda1" xlink:href="docs-20230331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ConversionOfStockConversionRatio_bb740761-1fb8-4058-b729-802f4776bda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_35bada68-e83d-4a10-b802-0aebda122e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_35bada68-e83d-4a10-b802-0aebda122e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_463571e2-971e-40b2-8eaa-7ccb038c3534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_463571e2-971e-40b2-8eaa-7ccb038c3534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_77aa86fc-b0c3-4640-970d-366e7213da71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_77aa86fc-b0c3-4640-970d-366e7213da71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_aade58e9-0f9c-4e9f-b572-0604c3303130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_aade58e9-0f9c-4e9f-b572-0604c3303130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_69c8323c-b6e9-4c6b-b090-1f8b50599c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_69c8323c-b6e9-4c6b-b090-1f8b50599c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_92360adf-d923-44b6-b1d0-2910a4a28644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_92360adf-d923-44b6-b1d0-2910a4a28644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b13f25b5-1c62-4939-bbcd-a05a1c49fd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b13f25b5-1c62-4939-bbcd-a05a1c49fd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_649f2b46-20ee-48ca-be05-b987ead2d280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_649f2b46-20ee-48ca-be05-b987ead2d280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a7c6c585-c4c0-4854-b451-9466b1acfb45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a7c6c585-c4c0-4854-b451-9466b1acfb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ClassOfWarrantOrRightExercisesInPeriod_f2320e7b-34dd-442c-93cb-a1ecf1198cc0" xlink:href="docs-20230331.xsd#docs_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ClassOfWarrantOrRightExercisesInPeriod_f2320e7b-34dd-442c-93cb-a1ecf1198cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue_6efe52c4-dd07-4168-ad13-e2efb663a2b9" xlink:href="docs-20230331.xsd#docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue_6efe52c4-dd07-4168-ad13-e2efb663a2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d6df749c-984e-4c2e-8d77-46539cb8c5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d6df749c-984e-4c2e-8d77-46539cb8c5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6eb8614d-d439-4dd5-81a4-a9757daa1ec2" xlink:href="docs-20230331.xsd#docs_WarrantsAndRightsOutstandingVestingPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6eb8614d-d439-4dd5-81a4-a9757daa1ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_121de308-6a16-4d53-88e5-a223cf6239b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_121de308-6a16-4d53-88e5-a223cf6239b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_76357a6e-7631-4b13-b240-43d7060eb638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_76357a6e-7631-4b13-b240-43d7060eb638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f5bb5cd9-cea2-4db4-a4da-f738ee92067b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f5bb5cd9-cea2-4db4-a4da-f738ee92067b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_786901d0-e42e-44ab-a9da-700526aee21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_786901d0-e42e-44ab-a9da-700526aee21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8644998c-b8c4-4943-9640-194461288ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8644998c-b8c4-4943-9640-194461288ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_0ed252a9-da1f-42ce-a3cd-ba027e26eb48" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_0ed252a9-da1f-42ce-a3cd-ba027e26eb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_2b71d9a9-23f1-43bc-a532-5b6d06bbb8e4" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_2b71d9a9-23f1-43bc-a532-5b6d06bbb8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d60f3efc-145a-4625-bdd9-8e70713307d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d60f3efc-145a-4625-bdd9-8e70713307d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5627846e-b237-4477-9375-5740d1b20366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5627846e-b237-4477-9375-5740d1b20366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d9604a06-0c3f-4210-81a7-e6b2c540edc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d9604a06-0c3f-4210-81a7-e6b2c540edc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_2160dc8a-d415-46f5-a797-6e5abc8656b7" xlink:href="docs-20230331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_2160dc8a-d415-46f5-a797-6e5abc8656b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_25b4a97f-7d51-4772-8bf5-b11ea56215a2" xlink:href="docs-20230331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_25b4a97f-7d51-4772-8bf5-b11ea56215a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_86d199db-7de8-466a-8560-ef098c4589de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_86d199db-7de8-466a-8560-ef098c4589de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_3b17693b-f810-4831-957c-a5aa7aca2062" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_3b17693b-f810-4831-957c-a5aa7aca2062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98d92b9e-d05b-4c7b-a4ac-92cfb2da68d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98d92b9e-d05b-4c7b-a4ac-92cfb2da68d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9f12c979-13f8-4622-9a7d-ddf20d8a8d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9f12c979-13f8-4622-9a7d-ddf20d8a8d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cd0fc9d8-9bcf-4509-873a-0b43fffbd15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cd0fc9d8-9bcf-4509-873a-0b43fffbd15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10d521a-1711-4869-9439-84418116c2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a10d521a-1711-4869-9439-84418116c2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aa446f38-f4fa-47a9-9431-891d667dc11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aa446f38-f4fa-47a9-9431-891d667dc11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_152e6171-06fc-46a6-9bf3-d7f3413740b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_152e6171-06fc-46a6-9bf3-d7f3413740b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_daf50b06-1848-4997-8c98-78f0a01d8d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_daf50b06-1848-4997-8c98-78f0a01d8d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_1e84c03b-07dd-4034-a5b1-429f4977938b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_1e84c03b-07dd-4034-a5b1-429f4977938b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3460660e-59ce-4136-a4c6-0e715a940339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3460660e-59ce-4136-a4c6-0e715a940339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_67da31d1-8166-4aa1-96c3-657f0e8a1c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08e3ffad-812e-4411-b213-d988f19378b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_67da31d1-8166-4aa1-96c3-657f0e8a1c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityCommonStockReservedforIssuanceDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_20c81340-fb26-47a6-b7b8-12953519b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57bfc797-44f7-4273-bf39-73601705930b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_20c81340-fb26-47a6-b7b8-12953519b82f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57bfc797-44f7-4273-bf39-73601705930b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b69e33ef-bd69-4dba-8b66-fd0b48893d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57bfc797-44f7-4273-bf39-73601705930b" xlink:to="loc_us-gaap_PlanNameAxis_b69e33ef-bd69-4dba-8b66-fd0b48893d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b69e33ef-bd69-4dba-8b66-fd0b48893d40" xlink:to="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_a1cd03c6-fad7-4c4c-9680-506167917bf0" xlink:href="docs-20230331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_EquityIncentivePlan2010Member_a1cd03c6-fad7-4c4c-9680-506167917bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_a6232ee5-a0d5-47e1-a15c-f818035b93c3" xlink:href="docs-20230331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_a6232ee5-a0d5-47e1-a15c-f818035b93c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_2ddc4839-960d-4005-ba90-a81e5401bc02" xlink:href="docs-20230331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_2ddc4839-960d-4005-ba90-a81e5401bc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_fc43810e-b9c5-47a8-af51-29c0a2e57f86" xlink:href="docs-20230331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_875ac4dd-27b7-4e9b-9d8b-ae6c7eaf3455" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_fc43810e-b9c5-47a8-af51-29c0a2e57f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57bfc797-44f7-4273-bf39-73601705930b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7b6024d9-827e-4b20-9067-c05aef28d4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7b6024d9-827e-4b20-9067-c05aef28d4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_257c4c4d-e837-4d85-b0c5-60cd279b977e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_257c4c4d-e837-4d85-b0c5-60cd279b977e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bf4ff25c-d6e7-4ed5-bc2c-b079d053d8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bf4ff25c-d6e7-4ed5-bc2c-b079d053d8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_76df89f6-a79c-4cea-b4ce-36c33952d339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_76df89f6-a79c-4cea-b4ce-36c33952d339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f002fdba-06ae-4657-a49f-c528c925b0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e85e1be9-f6e4-4e28-bd7c-4f3798704c26" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f002fdba-06ae-4657-a49f-c528c925b0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockOptionActivityDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd441328-e0c2-4bbe-b2fd-5a3d7775b7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd441328-e0c2-4bbe-b2fd-5a3d7775b7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5807d33f-0d1d-4a0f-bade-dccf3d2086ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd441328-e0c2-4bbe-b2fd-5a3d7775b7f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5807d33f-0d1d-4a0f-bade-dccf3d2086ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18c9f309-39e5-4fb6-98ac-17e48cd9a7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd441328-e0c2-4bbe-b2fd-5a3d7775b7f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18c9f309-39e5-4fb6-98ac-17e48cd9a7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_f8964d70-f210-4de7-b016-420919756925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd441328-e0c2-4bbe-b2fd-5a3d7775b7f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_f8964d70-f210-4de7-b016-420919756925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_83e114d4-6f14-4cef-8864-cea51879719d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd441328-e0c2-4bbe-b2fd-5a3d7775b7f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_83e114d4-6f14-4cef-8864-cea51879719d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8f8198e9-ea55-4eac-b836-5c1b34bfc2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8f8198e9-ea55-4eac-b836-5c1b34bfc2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0b805f85-2563-4aef-bc48-d778bcdabb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0b805f85-2563-4aef-bc48-d778bcdabb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6713bd20-b081-4fc9-a261-6f4b7097f0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6713bd20-b081-4fc9-a261-6f4b7097f0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2d2ef474-0908-46a8-91c7-6655bbe0c3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6713bd20-b081-4fc9-a261-6f4b7097f0b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2d2ef474-0908-46a8-91c7-6655bbe0c3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_92a582da-2ebb-4cd6-9926-7bfb835333ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6713bd20-b081-4fc9-a261-6f4b7097f0b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_92a582da-2ebb-4cd6-9926-7bfb835333ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ca69d87e-99d2-4cda-a8e1-d3900b4a5108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6713bd20-b081-4fc9-a261-6f4b7097f0b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ca69d87e-99d2-4cda-a8e1-d3900b4a5108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee8d83aa-fbb1-43fc-850c-c6aacc92e7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6713bd20-b081-4fc9-a261-6f4b7097f0b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee8d83aa-fbb1-43fc-850c-c6aacc92e7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_976bc7cf-bed8-4c3f-bf95-6ab4667b057a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_976bc7cf-bed8-4c3f-bf95-6ab4667b057a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e9d42185-4cce-478c-9c7f-e16262843cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e9d42185-4cce-478c-9c7f-e16262843cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bc8bf6-c660-4711-8494-34517a2402da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c77b4139-312e-40ac-9fde-49be01863f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c77b4139-312e-40ac-9fde-49be01863f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2fa73b1f-c521-47f6-b276-5412ff020c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2fa73b1f-c521-47f6-b276-5412ff020c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ec764f6a-c5f6-4789-831d-4ef6023c0c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ec764f6a-c5f6-4789-831d-4ef6023c0c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8563be58-a373-4038-8a5c-83d81a43400b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8563be58-a373-4038-8a5c-83d81a43400b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4966e6e8-b86c-4cce-83f1-0def8d76a6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4966e6e8-b86c-4cce-83f1-0def8d76a6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5444f350-8485-41a7-8bb5-2ef9797ad7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_65f8ce56-2c53-44fa-89e8-4076012da6a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5444f350-8485-41a7-8bb5-2ef9797ad7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityStockOptionsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3555f153-9013-4559-899b-154803b12b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3555f153-9013-4559-899b-154803b12b93" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bad13742-cd80-4866-b8e6-395413e376c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:to="loc_srt_RangeAxis_bad13742-cd80-4866-b8e6-395413e376c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bad13742-cd80-4866-b8e6-395413e376c4" xlink:to="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db523b74-dca9-4ffc-92df-91f521d2b550" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:to="loc_srt_MinimumMember_db523b74-dca9-4ffc-92df-91f521d2b550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d34c3320-e1a4-4783-a0df-ed8976125649" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_71966782-33d4-4ea7-ba1e-555ad4b02c27" xlink:to="loc_srt_MaximumMember_d34c3320-e1a4-4783-a0df-ed8976125649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_445e1f84-1d42-40f9-881f-726c568b32f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:to="loc_us-gaap_AwardTypeAxis_445e1f84-1d42-40f9-881f-726c568b32f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73491d40-3305-411e-933d-71f5eaa0827a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_445e1f84-1d42-40f9-881f-726c568b32f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73491d40-3305-411e-933d-71f5eaa0827a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_53b7b656-e456-4ce8-956f-623e1c42e943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73491d40-3305-411e-933d-71f5eaa0827a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_53b7b656-e456-4ce8-956f-623e1c42e943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d7757dfc-1773-417f-8f89-c402d361d728" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_3746dcc2-3fd1-4253-b076-171952ec7b44" xlink:href="docs-20230331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_3746dcc2-3fd1-4253-b076-171952ec7b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0f935ef0-d0fc-4115-88ef-6661484a0b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0f935ef0-d0fc-4115-88ef-6661484a0b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_addfd607-a17f-4529-9119-a6086f283aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_addfd607-a17f-4529-9119-a6086f283aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6490d556-7217-40fb-910f-0c2890b19b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6490d556-7217-40fb-910f-0c2890b19b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_33219604-1c90-4f1c-b38e-8cb684abff92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_33219604-1c90-4f1c-b38e-8cb684abff92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b3d9b0cf-cd61-462b-914c-3687023802e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b3d9b0cf-cd61-462b-914c-3687023802e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6eb11ced-e082-4659-9215-e0391a7e8dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50cc2ee-8162-484a-a646-e70ab02c1e13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6eb11ced-e082-4659-9215-e0391a7e8dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityRestrictedStockUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4cce4372-377f-4c18-ac40-2b94513e98fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7dd62798-4156-44c9-af2b-b2305eae1cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4cce4372-377f-4c18-ac40-2b94513e98fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7dd62798-4156-44c9-af2b-b2305eae1cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4f3a2703-a342-402d-94e6-b46502324d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7dd62798-4156-44c9-af2b-b2305eae1cd8" xlink:to="loc_us-gaap_AwardTypeAxis_4f3a2703-a342-402d-94e6-b46502324d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4b85994-bbf8-455a-ac69-1ea429464f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4f3a2703-a342-402d-94e6-b46502324d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4b85994-bbf8-455a-ac69-1ea429464f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4e19fdb2-4177-4a35-bd6e-3d0762c398e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4b85994-bbf8-455a-ac69-1ea429464f3f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4e19fdb2-4177-4a35-bd6e-3d0762c398e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7dd62798-4156-44c9-af2b-b2305eae1cd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f173cd2c-88b4-4e4d-bfe1-216dac156599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f173cd2c-88b4-4e4d-bfe1-216dac156599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84f80dc5-ac19-4425-8493-9e495a0e3c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84f80dc5-ac19-4425-8493-9e495a0e3c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4789785e-984f-44d0-87d6-033db1f3c9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4789785e-984f-44d0-87d6-033db1f3c9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d0e439a-b0c3-4fb8-9ad5-c62a5c0be306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d0e439a-b0c3-4fb8-9ad5-c62a5c0be306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8f46e7df-2411-4a47-bcad-0783ebd454a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_57b81b8a-b1d6-4655-8e3e-d8ed57499676" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8f46e7df-2411-4a47-bcad-0783ebd454a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3dd07fad-c5df-414e-afce-7ee0d2eb802d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_99e35cdb-318a-45d0-8c50-10cd48399aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_99e35cdb-318a-45d0-8c50-10cd48399aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2b3e1b9f-6bab-45a2-8346-ee8095418d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2b3e1b9f-6bab-45a2-8346-ee8095418d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_18261aaf-e95f-4278-a32e-87bab768972c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_18261aaf-e95f-4278-a32e-87bab768972c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_df82f942-ec4e-4929-9cb3-bddb7ba82155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_df82f942-ec4e-4929-9cb3-bddb7ba82155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_76984394-0429-4758-a6ca-c1892ecc1f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e25f0b2d-2a88-4659-acb3-703604a9ca26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_76984394-0429-4758-a6ca-c1892ecc1f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityPerformanceBasedRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2b0039ba-7c59-4873-8336-c543a7148504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38ee5138-1c74-4f46-b14c-7663322500a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2b0039ba-7c59-4873-8336-c543a7148504" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38ee5138-1c74-4f46-b14c-7663322500a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2fe249cd-6ea3-46df-baf5-5093b0add7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38ee5138-1c74-4f46-b14c-7663322500a4" xlink:to="loc_us-gaap_AwardTypeAxis_2fe249cd-6ea3-46df-baf5-5093b0add7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec5407f0-5b1e-4bd4-8341-c8444101a9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2fe249cd-6ea3-46df-baf5-5093b0add7c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec5407f0-5b1e-4bd4-8341-c8444101a9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_a6cc277c-71c0-43b8-85db-6dbac6a2b54d" xlink:href="docs-20230331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec5407f0-5b1e-4bd4-8341-c8444101a9f7" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_a6cc277c-71c0-43b8-85db-6dbac6a2b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38ee5138-1c74-4f46-b14c-7663322500a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e97f89b4-966b-484f-94dc-1d60092269f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e97f89b4-966b-484f-94dc-1d60092269f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_023b1e71-e766-48d0-be2c-1957cc5eaab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_023b1e71-e766-48d0-be2c-1957cc5eaab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d806761a-7a63-4254-b3b9-f20c6eab4363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d806761a-7a63-4254-b3b9-f20c6eab4363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d1e098a5-fe10-475c-b626-ad9ba7421ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d1e098a5-fe10-475c-b626-ad9ba7421ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d34739c9-2ef2-49c7-854c-b976e379412c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86955bae-297e-40e5-be1b-b4292d74b082" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d34739c9-2ef2-49c7-854c-b976e379412c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4a96d3d-1172-4863-be8e-125ca8f0da71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c219f9ef-9685-406f-a031-89ffcb7d1b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c219f9ef-9685-406f-a031-89ffcb7d1b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1764e2ef-473e-4438-9e58-7b11833154d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1764e2ef-473e-4438-9e58-7b11833154d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a4e59bf2-f4fa-4992-a59e-9910a904d067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a4e59bf2-f4fa-4992-a59e-9910a904d067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_97632df7-7079-4fa6-aa06-b27b04751508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_97632df7-7079-4fa6-aa06-b27b04751508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b72e4811-425f-4b6d-af62-208a7d27a9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c0fbf7-aa43-4f1e-93ba-7e0a918bb433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b72e4811-425f-4b6d-af62-208a7d27a9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EquityStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_72e1bd2c-40e7-4a21-a7e7-bf77e846abec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_800cb3db-7ab7-461e-ba32-ea4343127e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_72e1bd2c-40e7-4a21-a7e7-bf77e846abec" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_800cb3db-7ab7-461e-ba32-ea4343127e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_404492a7-3582-453c-8b35-8c627a2304fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_800cb3db-7ab7-461e-ba32-ea4343127e6b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_404492a7-3582-453c-8b35-8c627a2304fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_404492a7-3582-453c-8b35-8c627a2304fa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c46457c1-e747-487c-b9dd-94174cf19939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_CostOfSalesMember_c46457c1-e747-487c-b9dd-94174cf19939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc66f465-f8b8-4fda-93f7-de3dc66fae67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc66f465-f8b8-4fda-93f7-de3dc66fae67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_8b5130bd-b4d4-4a09-90a5-822060a61460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_8b5130bd-b4d4-4a09-90a5-822060a61460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fe6ded76-bd2f-4f83-9a0d-f97bfae73fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1014f923-b13e-402c-901e-3ad01274495c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_fe6ded76-bd2f-4f83-9a0d-f97bfae73fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b6a9d501-d963-442e-9537-9583af5af9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_800cb3db-7ab7-461e-ba32-ea4343127e6b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b6a9d501-d963-442e-9537-9583af5af9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_276d8041-6389-4ba7-8c0b-22b1c40109b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b6a9d501-d963-442e-9537-9583af5af9f6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_276d8041-6389-4ba7-8c0b-22b1c40109b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1c964843-ac53-44fb-b38e-af4618b73980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4225ed31-2076-4712-a4f0-e18bd70a9ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1c964843-ac53-44fb-b38e-af4618b73980" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4225ed31-2076-4712-a4f0-e18bd70a9ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b5c36be9-9344-4205-a132-56d282be6f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4225ed31-2076-4712-a4f0-e18bd70a9ccb" xlink:to="loc_us-gaap_AwardTypeAxis_b5c36be9-9344-4205-a132-56d282be6f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b5c36be9-9344-4205-a132-56d282be6f50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_04af12a9-3b1f-4add-987a-cf5f99eaf9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:to="loc_us-gaap_EmployeeStockOptionMember_04af12a9-3b1f-4add-987a-cf5f99eaf9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_693726ec-7b06-44fe-b51e-72f13c99a1f8" xlink:href="docs-20230331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b323297-98a1-4ee1-a9e3-f86900f02538" xlink:to="loc_docs_OtherShareBasedAwardsMember_693726ec-7b06-44fe-b51e-72f13c99a1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_4225ed31-2076-4712-a4f0-e18bd70a9ccb" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_53606dba-9120-4d71-a490-732774de6c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_NetIncomeLoss_53606dba-9120-4d71-a490-732774de6c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dac0c586-0167-491a-a3ba-d13a47dc6058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dac0c586-0167-491a-a3ba-d13a47dc6058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_e68b5709-a1a5-4e3e-aa72-345daf945dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_e68b5709-a1a5-4e3e-aa72-345daf945dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9fb2530d-589a-4ce6-b6ea-f3ead4e0364e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9fb2530d-589a-4ce6-b6ea-f3ead4e0364e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_9b4ba245-234e-48b9-b7a8-3d29777fa32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c980342c-7e6e-401b-86be-3dfad066f6b5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_9b4ba245-234e-48b9-b7a8-3d29777fa32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_87c9c292-8077-4050-aedd-3eab2ed49ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_87c9c292-8077-4050-aedd-3eab2ed49ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1d656355-37fd-45f4-bc09-4c68f7a3e9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1d656355-37fd-45f4-bc09-4c68f7a3e9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_adb21063-9b63-40b8-ac45-55107f49e508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_adb21063-9b63-40b8-ac45-55107f49e508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2d1d2fe-a54d-4fab-92cc-28f0cfc77380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_7b23f202-1735-4170-8a83-21be67c8c530" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2d1d2fe-a54d-4fab-92cc-28f0cfc77380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:href="docs-20230331.xsd#docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_7b9e50b2-476e-4968-852f-66bbf3db9569" xlink:to="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a1e680b0-b362-4ed1-bb45-37a9e8b56ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:to="loc_us-gaap_EarningsPerShareBasic_a1e680b0-b362-4ed1-bb45-37a9e8b56ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7d395e74-19b4-40e9-b614-87f329a35790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract_d36d14e9-b8ce-4040-85cd-71cd17312fc6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7d395e74-19b4-40e9-b614-87f329a35790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a69a971c-92a9-448f-95fa-fdbeac2231e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6df5a84d-a548-4cd0-a763-e2d46f3a632f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a69a971c-92a9-448f-95fa-fdbeac2231e6" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6df5a84d-a548-4cd0-a763-e2d46f3a632f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b41f10bd-e0c1-4447-8b07-166668869b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6df5a84d-a548-4cd0-a763-e2d46f3a632f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b41f10bd-e0c1-4447-8b07-166668869b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b41f10bd-e0c1-4447-8b07-166668869b44" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_c58adfb3-0c58-4ff2-8581-441f94f4884e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_c58adfb3-0c58-4ff2-8581-441f94f4884e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_d8e25671-9409-447e-963f-283e2df8df90" xlink:href="docs-20230331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:to="loc_docs_OtherShareBasedAwardsMember_d8e25671-9409-447e-963f-283e2df8df90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_50641ce5-c601-4af3-ba3a-cb2e91c64c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac4f720a-40a0-4f09-9111-380a06dc288e" xlink:to="loc_us-gaap_WarrantMember_50641ce5-c601-4af3-ba3a-cb2e91c64c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad648e4f-a9ca-43dc-9ed2-e5794e9087dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6df5a84d-a548-4cd0-a763-e2d46f3a632f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad648e4f-a9ca-43dc-9ed2-e5794e9087dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e61455e1-4ee8-4fe9-9bb9-a4dc37abb84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad648e4f-a9ca-43dc-9ed2-e5794e9087dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e61455e1-4ee8-4fe9-9bb9-a4dc37abb84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_91b2a03d-15c9-4b3e-85f7-ac103f1af3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5ec8014b-5f1b-43ee-aa38-a9530bbd0e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_91b2a03d-15c9-4b3e-85f7-ac103f1af3b3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5ec8014b-5f1b-43ee-aa38-a9530bbd0e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bdd32713-cabb-485b-870e-67b115bd886d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5ec8014b-5f1b-43ee-aa38-a9530bbd0e18" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bdd32713-cabb-485b-870e-67b115bd886d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_33e8651c-0741-4783-8cd6-af6cc07d1fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5ec8014b-5f1b-43ee-aa38-a9530bbd0e18" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_33e8651c-0741-4783-8cd6-af6cc07d1fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_d1b0af6e-aaf2-496c-8c9b-d9872e019785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5ec8014b-5f1b-43ee-aa38-a9530bbd0e18" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_d1b0af6e-aaf2-496c-8c9b-d9872e019785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_155cc5dd-8c51-4f11-a4e6-bb44959ba179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_91b2a03d-15c9-4b3e-85f7-ac103f1af3b3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_155cc5dd-8c51-4f11-a4e6-bb44959ba179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a02f06b4-3894-4c60-814b-cb8abe007596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_155cc5dd-8c51-4f11-a4e6-bb44959ba179" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a02f06b4-3894-4c60-814b-cb8abe007596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_8a1e36b0-0640-45d8-9731-c93104dd32aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_155cc5dd-8c51-4f11-a4e6-bb44959ba179" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_8a1e36b0-0640-45d8-9731-c93104dd32aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_434ea99c-bb0e-4b43-9719-53e5a6a8bac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_155cc5dd-8c51-4f11-a4e6-bb44959ba179" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_434ea99c-bb0e-4b43-9719-53e5a6a8bac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_35e6dba2-a9ac-429e-8f75-c9e28e971503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_91b2a03d-15c9-4b3e-85f7-ac103f1af3b3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_35e6dba2-a9ac-429e-8f75-c9e28e971503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_23bf33f3-b48c-4fe0-af44-6f34a104c2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_23bf33f3-b48c-4fe0-af44-6f34a104c2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d0d52305-84ad-462f-8f16-d740f94cdbac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d0d52305-84ad-462f-8f16-d740f94cdbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f873e7fd-de09-4f57-a4c7-3769a1342140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f873e7fd-de09-4f57-a4c7-3769a1342140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_f2f14790-6e9c-4acb-a71d-39b6e8423a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_f2f14790-6e9c-4acb-a71d-39b6e8423a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ec57630e-860b-4daa-9935-f151c00f927b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ec57630e-860b-4daa-9935-f151c00f927b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_f8dedfd8-a6bb-4120-aa5d-d8d5774edb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_f8dedfd8-a6bb-4120-aa5d-d8d5774edb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f6e29ac0-5262-409b-9ec3-f93f0fcdfc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f6e29ac0-5262-409b-9ec3-f93f0fcdfc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b3367622-8e3e-4307-94b7-12bb55132e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c5e425-cd7c-4dfc-b898-a675d6e81cf9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b3367622-8e3e-4307-94b7-12bb55132e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c1b76d89-eb44-424a-b45e-2cc5cedbb92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1b76d89-eb44-424a-b45e-2cc5cedbb92d" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_46c9051a-eb5a-4e91-aad4-e45cc42c86ed" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_46c9051a-eb5a-4e91-aad4-e45cc42c86ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c32537ad-02b5-41dc-82ad-8b4f3cd45016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c32537ad-02b5-41dc-82ad-8b4f3cd45016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_267c4b7e-4f40-45fc-add4-13e2e9a43427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_267c4b7e-4f40-45fc-add4-13e2e9a43427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsLeasingArrangements_ec878a15-7ed9-48ff-a6b6-1c866ff06b70" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_docs_DeferredTaxAssetsLeasingArrangements_ec878a15-7ed9-48ff-a6b6-1c866ff06b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_547dad03-5d1e-4f4d-8675-65342755d612" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_547dad03-5d1e-4f4d-8675-65342755d612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_da63df2e-273b-4a85-90b3-837209617dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_da63df2e-273b-4a85-90b3-837209617dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_62b784e7-b5cd-4545-90bf-9a25a7b6a498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_62b784e7-b5cd-4545-90bf-9a25a7b6a498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment_4dbd97ec-a89e-42d0-898d-e376bc470d79" xlink:href="docs-20230331.xsd#docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment_4dbd97ec-a89e-42d0-898d-e376bc470d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_268ead8e-a0b1-463c-8363-89b87bd9bc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_268ead8e-a0b1-463c-8363-89b87bd9bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f9ab9521-9c01-4b43-953f-7a4ae5915be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f9ab9521-9c01-4b43-953f-7a4ae5915be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_8fba0fca-bd46-4fd5-9aeb-6c69e0d79d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_ac544a94-3477-4d6e-a4fe-154da47a81b1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_8fba0fca-bd46-4fd5-9aeb-6c69e0d79d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_c5e7ebda-e02c-4709-9501-0dc4345776b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1b76d89-eb44-424a-b45e-2cc5cedbb92d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_c5e7ebda-e02c-4709-9501-0dc4345776b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_51d6baae-34fd-4ec7-b223-a88e44bec1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_c5e7ebda-e02c-4709-9501-0dc4345776b2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_51d6baae-34fd-4ec7-b223-a88e44bec1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_229bd2a4-ccd0-42d4-b356-229c9498a8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_c5e7ebda-e02c-4709-9501-0dc4345776b2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_229bd2a4-ccd0-42d4-b356-229c9498a8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b51da5df-a9bf-47a6-902c-908db7509901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_c5e7ebda-e02c-4709-9501-0dc4345776b2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b51da5df-a9bf-47a6-902c-908db7509901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_459e92c9-8534-4c93-99f4-7c045da5e928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_c5e7ebda-e02c-4709-9501-0dc4345776b2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_459e92c9-8534-4c93-99f4-7c045da5e928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4969ecd4-af82-490f-80c8-1865ca77d71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1b76d89-eb44-424a-b45e-2cc5cedbb92d" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4969ecd4-af82-490f-80c8-1865ca77d71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bed2e7ea-032a-4b04-a236-28d11f0fb9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_7b0fe50b-edbb-44ad-bd0a-6befd32406d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bed2e7ea-032a-4b04-a236-28d11f0fb9e4" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_7b0fe50b-edbb-44ad-bd0a-6befd32406d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_65660ad5-fe1b-4bec-be34-fdf1abf28722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_7b0fe50b-edbb-44ad-bd0a-6befd32406d2" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_65660ad5-fe1b-4bec-be34-fdf1abf28722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_65660ad5-fe1b-4bec-be34-fdf1abf28722" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_a88c524e-5bd2-4512-a404-70abeb109799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:to="loc_us-gaap_DomesticCountryMember_a88c524e-5bd2-4512-a404-70abeb109799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f5e860e7-7dc2-42bf-ba91-71848375de72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fdc8d645-362a-4beb-b609-d253653b310d" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f5e860e7-7dc2-42bf-ba91-71848375de72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_7b0fe50b-edbb-44ad-bd0a-6befd32406d2" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_12169096-dd2b-4de7-ab3c-189b426e9fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_12169096-dd2b-4de7-ab3c-189b426e9fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_66f612dc-66f4-45c3-8bdf-8ce3e35387d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_66f612dc-66f4-45c3-8bdf-8ce3e35387d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_cdff8d8f-5124-4b76-b9b2-fba6f5f9010e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_cdff8d8f-5124-4b76-b9b2-fba6f5f9010e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_e7a4201b-0893-4719-8d34-5d8042a7d0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_e7a4201b-0893-4719-8d34-5d8042a7d0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_a7c8b34d-0a73-4c41-b2c3-9a9714950af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_a7c8b34d-0a73-4c41-b2c3-9a9714950af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_03013f91-ec8f-45bf-b5ba-9cdeb42d9f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_03013f91-ec8f-45bf-b5ba-9cdeb42d9f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8a9173a1-0f80-4d1e-a539-5d3eaf16ee08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_d4abb762-9f9e-4109-83b6-e82f5772dd4d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8a9173a1-0f80-4d1e-a539-5d3eaf16ee08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_48870868-9196-4eb5-ac94-9bdda7def0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_48870868-9196-4eb5-ac94-9bdda7def0b1" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1493faca-fceb-4ddd-bc39-d33e26237d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1493faca-fceb-4ddd-bc39-d33e26237d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_d26d0e4e-0dee-4f81-b7e4-37fc3dd3a79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_d26d0e4e-0dee-4f81-b7e4-37fc3dd3a79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9fa25857-a201-4b4b-8998-a875cfa4a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9fa25857-a201-4b4b-8998-a875cfa4a38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_e3765536-5bc0-43bb-b1b6-8102df38f986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_e3765536-5bc0-43bb-b1b6-8102df38f986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ed61f3f0-9845-4401-8a53-c5beb96abd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ed61f3f0-9845-4401-8a53-c5beb96abd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ff8baf0c-7071-415a-9ebb-d58ed1b8c401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3003c561-1a33-4f50-b2d5-026785019479" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ff8baf0c-7071-415a-9ebb-d58ed1b8c401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f3ca31b-d295-4a00-a200-06aa118e05f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_b8f19a34-bad4-46df-a83a-28cabbfa8d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f3ca31b-d295-4a00-a200-06aa118e05f2" xlink:to="loc_us-gaap_OtherCommitmentsTable_b8f19a34-bad4-46df-a83a-28cabbfa8d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6cd30960-128d-4df7-acb3-4efaa4c5d035" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_b8f19a34-bad4-46df-a83a-28cabbfa8d99" xlink:to="loc_srt_RangeAxis_6cd30960-128d-4df7-acb3-4efaa4c5d035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6cd30960-128d-4df7-acb3-4efaa4c5d035" xlink:to="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_78b9e120-bdf1-46d8-ad39-3c51d11f5ecd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:to="loc_srt_MinimumMember_78b9e120-bdf1-46d8-ad39-3c51d11f5ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a0e24b5-b069-4ec4-964a-31d084ac3d75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ba4f29d9-24dc-48c6-b61e-d6aa7d57ffc3" xlink:to="loc_srt_MaximumMember_8a0e24b5-b069-4ec4-964a-31d084ac3d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_b8f19a34-bad4-46df-a83a-28cabbfa8d99" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementExtensionPeriod_82684f1a-b50e-4cb1-a8d0-477fa641dac6" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementExtensionPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementExtensionPeriod_82684f1a-b50e-4cb1-a8d0-477fa641dac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_8ddf2c48-ba9a-4c3d-947d-37fcd71648e3" xlink:href="docs-20230331.xsd#docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_8ddf2c48-ba9a-4c3d-947d-37fcd71648e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_c2c15ed2-dc91-4e93-be83-d9ce9c60127a" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_c2c15ed2-dc91-4e93-be83-d9ce9c60127a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_fbe7caf0-e982-40fb-8dbf-9fb0166b2454" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_fbe7caf0-e982-40fb-8dbf-9fb0166b2454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod_853b25a2-35f5-485b-bf4d-2a1e2d8dca32" xlink:href="docs-20230331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod_853b25a2-35f5-485b-bf4d-2a1e2d8dca32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementPeriod_899c2c49-c596-4bce-8c18-a39a53b53ac7" xlink:href="docs-20230331.xsd#docs_HostingArrangementPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_HostingArrangementPeriod_899c2c49-c596-4bce-8c18-a39a53b53ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementAnnualCommitment_63d67730-eddf-4888-84f1-3dfa60df57b8" xlink:href="docs-20230331.xsd#docs_HostingArrangementAnnualCommitment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_docs_HostingArrangementAnnualCommitment_63d67730-eddf-4888-84f1-3dfa60df57b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_8f706233-f1fa-4fd8-b2ce-24f5478b34e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_us-gaap_OtherCommitment_8f706233-f1fa-4fd8-b2ce-24f5478b34e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_8971146f-ce7b-4aeb-be75-504450c6b649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3f104bc2-c628-4f64-975a-455b5ef67f93" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_8971146f-ce7b-4aeb-be75-504450c6b649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ca6d29fc-a30a-45ad-ac8a-8f7741130917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_33b73605-7e0a-4266-bf39-11d08f7367df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ca6d29fc-a30a-45ad-ac8a-8f7741130917" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_33b73605-7e0a-4266-bf39-11d08f7367df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_fd877024-9a34-48c8-91db-8a28cfdecd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_33b73605-7e0a-4266-bf39-11d08f7367df" xlink:to="loc_us-gaap_LeaseContractualTermAxis_fd877024-9a34-48c8-91db-8a28cfdecd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_43df4072-3bf7-4231-8add-eebbe2ee2dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_fd877024-9a34-48c8-91db-8a28cfdecd1d" xlink:to="loc_us-gaap_LeaseContractualTermDomain_43df4072-3bf7-4231-8add-eebbe2ee2dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OfficeSpaceLeaseInIrvingTexasMember_f070d7bc-78cf-4e74-b006-59254d950810" xlink:href="docs-20230331.xsd#docs_OfficeSpaceLeaseInIrvingTexasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_43df4072-3bf7-4231-8add-eebbe2ee2dff" xlink:to="loc_docs_OfficeSpaceLeaseInIrvingTexasMember_f070d7bc-78cf-4e74-b006-59254d950810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_33b73605-7e0a-4266-bf39-11d08f7367df" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_262b204c-ac92-4de6-ad2f-b1ee99de6401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_262b204c-ac92-4de6-ad2f-b1ee99de6401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9633799a-d2be-4788-9ba2-cabc7d2a5f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9633799a-d2be-4788-9ba2-cabc7d2a5f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_73c3bbe1-0fdb-472e-b893-c6a6d3387823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ec6f9e45-7dc1-42e3-9a14-5ef244f80264" xlink:to="loc_us-gaap_OperatingLeaseLiability_73c3bbe1-0fdb-472e-b893-c6a6d3387823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_db9054d7-e8ab-446f-896c-b7447b5e375a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_18de664a-67b5-42e7-9ae6-15e780d09a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db9054d7-e8ab-446f-896c-b7447b5e375a" xlink:to="loc_us-gaap_OperatingLeaseCost_18de664a-67b5-42e7-9ae6-15e780d09a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_4d8472a7-570f-4502-b7b8-5d5874f46764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db9054d7-e8ab-446f-896c-b7447b5e375a" xlink:to="loc_us-gaap_VariableLeaseCost_4d8472a7-570f-4502-b7b8-5d5874f46764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9b854a32-5c5f-4d60-928a-0e3d88f52cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db9054d7-e8ab-446f-896c-b7447b5e375a" xlink:to="loc_us-gaap_LeaseCost_9b854a32-5c5f-4d60-928a-0e3d88f52cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2796f226-24de-41d1-b0fe-5688dd67a928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_04c3d844-23b8-46c4-8aac-673aa3518fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2796f226-24de-41d1-b0fe-5688dd67a928" xlink:to="loc_us-gaap_OperatingLeasePayments_04c3d844-23b8-46c4-8aac-673aa3518fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d1527255-4812-44f4-affb-68e96e799deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f1b72069-2813-4164-af1a-3b1ef92966b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1527255-4812-44f4-affb-68e96e799deb" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f1b72069-2813-4164-af1a-3b1ef92966b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4d385315-2d20-4d10-b936-2a4359e817cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1527255-4812-44f4-affb-68e96e799deb" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4d385315-2d20-4d10-b936-2a4359e817cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c719ba94-e964-4819-a680-7ece8a86c571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c719ba94-e964-4819-a680-7ece8a86c571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_52dc4296-e76a-49ba-9615-1a976cf8fa90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_52dc4296-e76a-49ba-9615-1a976cf8fa90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c55b1975-9794-472f-901f-2f90a67092f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c55b1975-9794-472f-901f-2f90a67092f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9c1440a8-73b0-4ce3-870b-12bdd4553320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9c1440a8-73b0-4ce3-870b-12bdd4553320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1d6ada0e-3a25-4872-95c4-a3f99211d2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1d6ada0e-3a25-4872-95c4-a3f99211d2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a8ffdba8-9e33-4531-a33b-0d9c8fcb539a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a8ffdba8-9e33-4531-a33b-0d9c8fcb539a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_490cdc5b-e5f0-471a-b8ea-79600373211e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_490cdc5b-e5f0-471a-b8ea-79600373211e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_40a7abe5-6aca-4087-88ba-5ffb78f8a6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_40a7abe5-6aca-4087-88ba-5ffb78f8a6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_24849cba-f341-49e0-aeda-c0a128f2535c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a2399aa-062e-4d63-9910-ec14880e9401" xlink:to="loc_us-gaap_OperatingLeaseLiability_24849cba-f341-49e0-aeda-c0a128f2535c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="docs-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.doximity.com/role/OtherIncomenetDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#OtherIncomenetDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/OtherIncomenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_66110dcd-e5de-4236-97b3-0e669feb4341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_01a4e912-015a-41b2-beb1-24f6d729be99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_66110dcd-e5de-4236-97b3-0e669feb4341" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_01a4e912-015a-41b2-beb1-24f6d729be99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_a96d49b6-1a7b-4352-9e55-c9fcca6b19d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_66110dcd-e5de-4236-97b3-0e669feb4341" xlink:to="loc_us-gaap_GainLossOnInvestments_a96d49b6-1a7b-4352-9e55-c9fcca6b19d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_9abf2fff-e2ab-4857-9e5e-dcc9268a1f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_66110dcd-e5de-4236-97b3-0e669feb4341" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_9abf2fff-e2ab-4857-9e5e-dcc9268a1f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_512c2a9e-26c2-490b-bb38-55ea43aad034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_66110dcd-e5de-4236-97b3-0e669feb4341" xlink:to="loc_us-gaap_OtherNonoperatingExpense_512c2a9e-26c2-490b-bb38-55ea43aad034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_965d6ed7-8049-463f-8221-fa4c7e9f7702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_66110dcd-e5de-4236-97b3-0e669feb4341" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_965d6ed7-8049-463f-8221-fa4c7e9f7702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#EmployeeBenefitPlanDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_fa67608b-a44f-47e4-b080-15d7a326ebcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_bd6766d2-bf38-4baa-846a-d0054a0396c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_fa67608b-a44f-47e4-b080-15d7a326ebcc" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_bd6766d2-bf38-4baa-846a-d0054a0396c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="docs-20230331.xsd#SegmentandGeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SegmentandGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_188f84f9-8d06-409d-a55f-4d7b85592322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_d39dd2bd-dec6-414b-be68-2087e8fcb5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_188f84f9-8d06-409d-a55f-4d7b85592322" xlink:to="loc_us-gaap_NumberOfOperatingSegments_d39dd2bd-dec6-414b-be68-2087e8fcb5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_526e893b-1b18-49a4-a642-0bae09ed231a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_188f84f9-8d06-409d-a55f-4d7b85592322" xlink:to="loc_us-gaap_NumberOfReportableSegments_526e893b-1b18-49a4-a642-0bae09ed231a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>docs-20230331_g1.jpg
<TEXT>
begin 644 docs-20230331_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **Y
MSXI?&#X6?!'PK)XX^+WQ TGPWI,3;3?:Q?) C/C(1=QR[G!PJY8]A7E7AO\
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M^._"^G>-?!VM6^HZ3JUE%=Z;?VLFZ.X@D4.DBGN"I!_&M"@ HHHH ***\O\
MBC^VG^RQ\%?'7_"L_BG\:]'T;7S DXTFZ:0S&-P2K!54Y! /Y4 >H45X<?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ[X[313J^JZ1H=U9V\>FV8VX:6:[FB02-O0K&"20ZDE01GX$_: _Y6)O#_\
MV']"_P#37#74_P#!5+]C#]HWP[^TOJO_  4'_8P\5WM[JNEM;+XML/#\^[4=
M%N8+*%1((QGS87M?(9XL$[7)*M&Y*@'WO^SM^U!X2_:+T#Q3K^F>$M>\,_\
M"(>)9M$UJQ\66L=K<P7$5M;W$A95=U5%$^W=NP=A8$J03Y-:_P#!5#X=^+]
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M$GA%/%$L6H:Q:/+*\YE*DJDGF22;-F]@(T.Q"6VCGG\XOB)_RLC6W_8<TO\
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MOSXEL;:$2"<RA/+\BXER1Y39SMZC&><?"W[&:JO_  7\^( 50!_PD'B@\?\
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M%R41_P#@G%XO9E!*ZII)4D=#]OA'\B:^K?#/_(N:?_UXQ?\ H KY3_X+C_\
M*.'QA_V$])_].$% '(_\$ ;:TO?V!+^SO[>.:";QSJ2313(&1T,%L"K \$$<
M$&OD;_@G?<ZAX;_X+2ZUX>_9IE8^#)O%/B*"]@TUB;,Z*AN#'G;QY2R"#RV_
MO>6!][F?]EC]CCXC_M"?\$F=?\:? ?QUXKL?%VD>,=0DET#3?$UZEEKUDEO
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW^.FL?'CP9^T1<:QJ'B#3[FTU>SU?PNGDRK-,DY9?+G4HPEC4CG&-PQSD)\
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MM=,U%]-%K*;8'*)(HD<,RDL-PVY7:-N06;T2B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5:LU]J%V6=G+S3L!O;+'&       !73T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN?\)_
M%;X:>._$FM>$/!/CS2M7U/PX\2:]9Z;?),^GO+OV)+L)V.?+?Y3R-O('%7/&
MGC?P;\./"]WXV^('BK3]$T?3T#WVJ:K>)!;VZE@H+R.0J@LP R>I [T :E%<
M3\+OVE/V>_C=J=SHOP<^-OA;Q3>6< GN[;0-=@NWAC+!0[B)B5&2!D]Z=X[_
M &C/@7\,?$'_  BOC_XJ:-I6H+ D]Q;75X ;6%VVI+.1Q!&Q! >0JI((!X-
M':44V.2.:-9H9%='4%64Y!!Z$&G4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5]TUH?T&T445_"Q_? 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJFJZ/:ZQ&D5U)*H1LCRI2I_2J7_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
MX%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_
M (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4
M;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q7XK?\%)OV5M2_9@_:-U
M%+5(SX=\4W$^J>''C<9CC=\R0,O53&[;1V*[3G.0/UL^+_B#X:? [X;:O\5?
MB%KMW::3HUH9[E_M;%G/18T&?F=V*JH[LP%?G_\ L@? WQ1_P4M_:9UC]J+X
M\:;*?!&BW?DV.E32%XYV7YH;!2WWHXU8/*?XF8#'[QL?MG@]C\7PT\;GN(ER
MX*G#EG=:SGO3A#5>_=^B3UM>Z_#/&?+\'Q.L#D&'CS8ZI/FIV>E.GM4G/1^Y
M9;;MK2_*T_A"OHG_ ()L_LB>(_VG_CYIVJ76FL/"7A:^@OO$=[(OR2;&WQVJ
M_P!YI&7!'9-QZX!_2$_\$M?V%3JO]L_\**MO.W[MG]IW7E9_ZY>;LQ[;<5\@
M_"VS;_@FW_P49O/@UXHO;F#P!XUDCCL;IIV55MIG;['.S=S#*7@=CQ@R-Z5^
MLS\5</QEDF/PF00G#%QI.4544?>2TGR<LI7E&+O&^[MI9,_(8>$F)X*SW 8S
MB&<*F$E64).FY>ZWK#GYHQM"4E:5ME?6[1^H%%8__"#Z1_S\WO\ X%M1_P (
M/I'_ #\WO_@6U?QT?VB;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q
M16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
M@6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO
M_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4
M ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1
M_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16
M/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#
MZ1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?E<X3I3<)JS6C3W370_6*=2%6"G!W35TULT]F@HHHJ2PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM/C1[72I;HLV"L1&5]^:I?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!
ML45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!
ML45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+0!?UG6=)\.Z/=>(->U&&SL;&V>XO+NXD"1PQ(I9W
M9CP% !)/H*_,B_G\7_\ !8']M1;"S>\L_A7X,;)< ILL]_+>UQ=,F!W1%Z'R
MSGL_^"GO[67C;XS^,K+]@K]G_3+F;5-3OXH?$XM9 SS2DADLLKPJK_K)3T&T
M D!7%?47['OP!TC]DCX*V'PO\.^$+FXO3_I.OZJ H:_O& WOZA!@*B]E49R<
MD_KV41CX=\-+.:J_X4,7%K#Q>]*F])5FNCDM(>6NJ<DOQO.)2\2.)WDM%_\
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M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
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MD.EZ%X6T V$7VEW3-Q.3EI-J*RJF=H,A;&0I%'P%\._^"B'V"_\  WQ7^/\
MX!N-.FGE2W\8:'X9GBUH6S$X"PEUM8I@IPLF)%4X)23'/OM% &-\._A_X3^%
M/@32?AMX%TI;'1]$L([/3K56+;(D4 98\LQZECDL222236S110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2CVLK.7=V3NU=E%%%?G9^D!1110 4444 %%%% !1110 4444 %%%% !1110
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MKVD9_P"/6]C^6:+'4#=\RYY*,I[UZ+<W-O9V\EY>7"111(7EED<*J*!DL2>
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M\2N*%FU17RW!R:H)[5JRT=9KK&&T//73WD7:***_(#]E"BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_!./_@O8^H^*4_90_P""EFFMX)\>:;<_V>OBW4K(V5O<SJ=OE:A$P464^?\
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M:<*D?B@]U_FO,[:BBBOA#U HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /G;_@I!_P %'_@[_P $
MX/@[%X_\?VLFL:_K$DD'A/PG:7"QS:G,B@NS.0?*@3<N^7#;=Z@*S, ?QG^)
M_P#P<:_\%-/&_B>76/!7C_P]X-T\RDP:1HOA2TN45,\*TEZDSL<8R05R>0!T
MI?\ @XV^)WBCQM_P4SU_P5K-S*=/\&^'=*T[1X&)V+'-:1WLC@=,F2Y8$]3L
M4?PBO@^O[Q\(O"/A'#<(X7,LRPL,17Q$(U&ZD5.,8S7-&,8RO%6BU=VNW?6U
MDORWB#/\PGF$Z-&;A&#:T=FVM&VUKN?L3_P3K_X.3_$OB7Q]IOPC_;TT71X+
M+5+A+:T^(.C6_P!E6TE8A5-[!DIY9)YFCV!."4(RR_L-'(DJ++$X96 *LIR"
M/45_'A7]/'_!''XG>*/B]_P3,^$7C7QC<RSZ@/#LNG23SDEY8[*[GLHG8GEB
M8[="2>3G/>ORWZ0/AGD/"^'P^=9135*%2?LYTU\/,XN4917V=(R32TVLEK?W
M.$\ZQ6.G/#8A\S2NGUM=)I]]U8^F****_F ^V"BBB@ HHHH **** "BBB@ H
MHHH ***CO();FTEMH+R2W>2-E2XA"EXB1@,H<,N1U&01QR".* )**^2_V!M1
M\<Q?MC?M->"O&'Q.\0>)X-!\0:#%I4WB"_\ .:WADMKJ4QHJA8XU!?&U%4<#
MC-:/QB^)FK_'/_@H3X>_8DL]:OK3PKX>\$S^+O'<.FWDEN^JN94@M;*22(JX
MA5I$E= 0)-RJV5!! /J.BOESX8_$^]_9]_X*!ZW^QM?:U=3>#O$G@./Q?X,B
MU&]><Z/+'+)!=V<<DK,_DL(GG5"2L>"% 5L#G?V.K>;_ (*&_"[QC^TU\2O$
M^OVK>(?$NH6'PZ33-:N;0>&=-M\16\UND3JHNC('DDE()<A5/R#;0!]BT5X'
M_P $V?VE?%7[3_[+]EXI^(KQ/XK\/ZM=^'O%4T*!4GO;5@#* , %XWB<@  ,
M[8 &*]\H **** "BBB@ HHHH **** "O"_VC/^"F'["7[)WB$^$/CW^TIH.B
MZPHS-H]ND]_=P9 (\V"TCEDBR""-ZKD=,UXW_P %U?V_O%/[#7[)D-E\*M4:
MR\<>/[Z32M!U"/A].MT3==7:?]-$5HT0]5>=7'W,5_.=J>IZEK6HSZQK&H3W
M=W=3--=75S*9))I&)+.S,268DDDGDDU_0GA+X(1X\RUYMF=>5+#-N,%"W/-K
M1N\DU&*>GPMMI[6U^1S_ (F>5U_J]"*E/=WV5]E96UZ[G]2O[.?_  4O_82_
M:Q\0CPA\!/VE-!UK6&&8='N$GL+N? )/E07<<4DN "3L5L#KBO=*_CVTS4]2
MT748-8T?4)[2[M9EFM;JVE,<D,BG*NK*058$ @CD$5^KW[/W_!P_\='_ &;=
M!\ >*9/"W_"9:7&VGZCXN\2WVZ;4%4_NKCRBR*)-A16D<L'=&8@9KW.-_HWY
MCEM6E4X=JNM3D[2C4<5*&E^;F22E'2SM%23MHTW;QO\ B(>$P&#G7S&G+W=O
M9QE)N[M915VGYMV[M=?VJDD2)&EE<*J@EF8X 'J:\/\ C1_P4;_8]^!OFVGB
M;XP6.I:A%D'2O#G^GS[AU5C%E(V]I'6OR_U;]HJY_:BE-W^UC_P4_P#!?A_2
M)&S-I2Z^;T8SU2RTX?9S_P "=6_6O1_A9\0O^#>[X.&*_P#B+^U?-XYU"/!9
M[[0-7:U#9QE8+2TY'^R[2"OF*/A)@LIUS)XG%37_ "[PF'J27_@V4>5KO9)G
MA2XZXSSUVRC T\-3?_+S%U%%_P#@J+YT^UVT>M^,O^"S'QB^+&M/X+_8\_9I
MO+Z[DXAN=2MY;^Y*GC=]EM>$(]3(Z^HXK*'[&7_!4_\ ;&(N?VD/C(_A71+G
MF32[R_"@H>F+&RQ&2!VE96]:[+0O^"\/_!'CX5:,GASX:^/9;+3X\;++P_\
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M<"&^TR5T,<GEN59621"4>)U>-QC<IP, 'R[\3_!>H_%__@LWIUIH3L+7PG\
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M"*I?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
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M:/L7C?\ Z#=E_P" Q_QK8HKRSUC'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V*I:UXC\/>&[?[9XBUZRL(O^>M[=)$OYL0*J,)3ERQ5V3.<*<>:3LO,
MJ?8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-<7XG_;-_9+\';E\0?M(>"X
MG3[\,/B*WFD'U2-F;]*\[\3_ /!6C]A'PWNCB^,,NIRKUBTS0;Q\_1VB5#_W
MU7NX3A3B?'_[M@:T_-4YM??:QX&,XMX5R_\ WG'T8>3J03^Z]SWC[%XW_P"@
MW9?^ Q_QH^Q>-_\ H-V7_@,?\:^0O$__  7-_9>TS=%X8^'OC35)%Z/)9VUO
M$WXF=F_\=KA-3_X+K:_KMR=-^&7[*DUU,?\ 5M<^('F8^G[J*WS_ ./5]+AO
M"CQ Q2YE@917><H0M_X%)/\  ^8Q7B[X=X67*\?&3[0C.=__  &+7XGWQ]B\
M;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-?G_\ \/"O^"JGQ(^3X<?L@?8H'_U=
MTO@O49,?]M9I!'^E&?\ @N[\3>@;0+63_L#6>S^<PKK_ .(69E0_WW'X2AY3
MKJ_W13./_B+&68C_ ''+\7B/.%"5OODXV1^@'V+QO_T&[+_P&/\ C7QO_P %
MG?C;\0OAC\!]'^%UAXA2(^.+Z:*_>TC*,]G;JC219SD!WEB!]5#*>&-</_P[
MW_X*K?$CY_B-^U_]B@D_UEJWC347Q_VRAC$?ZUYE^UQ_P2B^,7P*^#%Y\<=0
M^+Q\9W&F3H=7L8M.EWV]JV0]P)7E9G"-LW#:,*S,2 IKZC@KA7@W*N*\)5Q6
M<4:TU-<M.$)M2GM#W_A5I6:NM6K=3Y7CCBWC7-N$L91PF35J,)0?-4G."<8:
M.?N+WG>-T[.Z3OT/CBBBBO[!/XQ/U,_X(Q?&SXA?$[X#ZQ\+K_Q DI\#W\,5
MA)=QEV2SN%=HXLYR0CQ2@>BE5'"BOLC[%XW_ .@W9?\ @,?\:^0_^"(OP4U?
MP%^SYK7Q9UJ+RF\;:HAL(\\M:6GF1K(?3,KSC'HH/>OM2OX"\3E@%Q[CU@[<
MG/TVYN5>T_\ )^8_T-\+7F#\/LO>-OS^SZ[\G,_9_P#E/E^1C_8O&_\ T&[+
M_P !C_C1]B\;_P#0;LO_  &/^-;%%?"'WY@:CH'B;6+&73-6O--NK:=-LUO<
M6.]'7T*G@BOC']O?_@B7\*_VN_#\VJZ'+::/XE@A/]FZA;QD/&>2(]Q^_'G_
M )9N<#)VM'G-?=M%>EE&<9ID.80QV7U94JL'=2B[/_)I[-.Z:T::,<1AZ&*I
M.E6BI1?1GX1_ ?\ ;=_X*!?\$//B-;_LW_M3>%M2\0_#)IRNG6\P,OV6'/,N
MFSO@ #[QMG(0GE=FXR']A/V:OVEO /[7?PPM/B]^S]\6]&U_1KGY93! 5GLY
ML M!<1-AX91D95@#@@C*D$])\>?V>?@M^TY\/+SX5_';X>:?XCT.]0B2UOHO
MFC;M)&XP\3CJ'0AAZU^/W[37_!,_]N'_ ((X_$J[_:]_X)T?$'6=>\#P R:U
MIHC\^ZL;526,5_;*-E[:@<^<JAH^6*Q[1(?V-5N%/%M<M?DP.</:7PX?$O\
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MC_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!
MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !
MC_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\
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M^@W9?^ Q_P :M:5!K\,CG6+^"92OR"*+:0:O44 %%%% !1110 4444 %%%%
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MQ(S;1?6XY('030C)!&1D@;_TQT76M(\2:/:^(/#^IP7MC?6Z3V=Y:RAXYXG
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M?0B(,0?K7CT/[''Q@\<2K=?%7XO;\G=L$TUXR^WSE%7\,@5P?[5?BK_@GO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGLNR6R7DDD>IDV191P]@EA,MHQI4UK:*W?=O=OS;;"BBBO+/6"BBB@ HHHH
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M]A'X37V7TG6]:L6/11<1R(/P9,_^/5S=S^PEXBT:4W?@KXNM%)_")+-X2/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% &!XS'PO^(?A6_\
M#^-EL=3TG5+9K>_L;I=R31L.0?3U!&"" 000#7YL:_9_$_\ X)#_ +2:^-?A
MU?S^(_A=XEN!'/:M+Q-$"3]GE/1+J($F.3&'&>QD0?J-_9VG_P#/C#_WZ%<_
M\4O@]\.?C-X"U+X:_$3PO;7^DZI;F*YA:,!E[JZ,.4=3AE8<@@&OM>#N+?\
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M@OC#_6*E4PF-I^QQU#W:U)]'_/'O"6Z:O:]KM6;L_P#"8^&/^@U!_P!]4?\
M"8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0KXH^Y*?_"8^&/^@U!_
MWU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z
M#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )
MCX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?
M_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@
M"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_
M0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y
M\8?^_0H I_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3
M_P#GQA_[]"@"G_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[
M.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"
MC^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQ
MA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_
M .?&'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[
M3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/
M[.T__GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'
M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX
M8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]
M4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U
M!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_
M *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX
M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
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M .?&'_OT*?%;6T!)@MT0GJ40#- #Z*** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^3O\ @L/X1^!6H_LK
M7/C#XIVS1Z[IUTD'@R\M%7[0;V3GR<G[T+(C-(#T6/</F"U^4^N_&'XL>)_#
M.G^"_$7Q*UV]T?2K86^FZ7<ZK*]O;1#.%2,MM &<#CH .@ K]!O^"]W]M_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/!_U&XMR77(LZJ<J_P"7>)2K1].?245Z)LX[X2?MW_LD?&WRH/ GQRT0W<N
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %>9_MC_  <U#X__ +,/
MC/X2:-M-_JND$Z<CL 'NH76>%"3T!DB0$]LYKTRBNO 8VOEN.I8NB[3IRC./
MK%IK\4<F88*AF6 JX.NKPJ1E"7I)-/\ !G\[6I:;J.C:C<:/J]C-:W=I.\-U
M;7$922*1259&4\JP(((/((J"OV<_:R_X)@_L]?M4ZW+XYN1=^&/$\X_TG6M%
M5-MV0, SPL-LA']X%'. "Q  'C'@?_@@Y\,]+UQ+WX@_'O6-9L$<,;'3=%CL
M6< _=:1I9N#T.%!]"*_L?+?'/@G$Y<JV+G*E5MK3Y)2UZ\LHIQ:[-N/FD?Q7
MF?@)QUA<R='"0A5I7TJ<\8JW3FC)J2?=)2\FSQO_ ((H? GQ#XQ_:-N/CE-8
M21Z+X0TZ>*.\9<++?7$9B6)3W(B>5FQ]W*9^\*_5NN>^%OPJ^'OP5\$67PZ^
M%_A:VT?1[!-MO9VRGJ>KLQ)9W)Y+L2Q/4FNAK^8O$#BZ7&O$<\P4.2"2A!/=
M0C=J_2[;;=MKVN[7/ZF\.^#H\#\,PRYSYZC;G.2V<Y63M?6R225]7:]E>P44
M45\4?<A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
ME/[5WQE\<_#;P[HW@CX+3^&O^%@^,]4^P>$HO%US)'I\9C0S7$]QY7[PQI$A
M4!,DR2PK_%7JU>0?M2?L*?LS?MDQ6;?'OP-<:G=Z9:R0:3?VVL7-O)8AR"S1
MB.0(6)"DEE;.U<@@ 4 -_9DLOV](=7U6;]L36?A7+8_9HQHD'PZ@U#S#*6/F
M-,]WM 4*%"A022Q)(V@-QGPO^/\ \>_VN;/QS\2?V=/$V@Z+X:\+Z]=Z+X.A
MU31FNSXFNK55,MQ/()4\FU>1A'&(P)  SLQX2N-_8YTGX\_L[_%;XH?L'>)O
MB#J7B_1]!\(V_B#X8Z_JLF^]M[*Y,T"VDK_Q;)8]J= /+8@*K*B6?^"&B6L?
M_!.KPO%$NV9=:U87BD8*R?;9>#[[=M 'N?[(W[2GAO\ :T^ 6A_&[PYITE@V
MHQO#JFDS/NDT^]B<QSV[' SM=3@D#<I5L#.*]*KXR_X(A+>2?LZ_$+4&!^PW
M?QIUR;23_";<Q6@RO^SO#].X-?9M !1110 454U74+K3XT>UTJ6Z+-@K$1E?
M?FJ7_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM6M*U6]U"1TNM$GM0JY#2D8;VXH O4444 %%%%
M !1110 4444 %>0_%CPW^VVOQCL_%'P*^)'@1O!TFE+;ZEX7\7Z1<>9%<AV)
MN8;BV^=B5*C8Y"C:>,MD>O44 <-\)/@]<^!M;UOXB^-/$46N>,/$_P!G76M7
M@LOLT"00!A!:6T)=S%!'YDK ,[NSS2,S'< /-O"W[+_QD^ DOCGPI^S+XK\.
M6/AKQUK5QK%J-<CG,_A6_N45;F2VCB!6[B+*)$A9X!&V1N93@?05% '#_LW?
M #P-^R]\%-!^!OPZCE_LS0K4QBXN"#-=3,Q>6>0C@N\C,QQP,X&  *[BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_M._M:_#?]L.T_8N_;,L?#.L3^)]"GU;P1XT\)6LEO'=" ,TL$\3G"L%1SD
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M>)R?TKWNODW_ ((Q?\F=W7_90=>_]*S0!TWQBU/_ (**?$O7=9O_ -ER_P#
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MG.1[1X9D\3RZ';OXRM+"#4MN+J/3+EY8-V>J,Z(V",'!'&<9.,F_10 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M</'^LP>&?"?QET*ZU:ZN5@@T5KP17S2%&<#[-)ME *H[ E<84\\5\\_\%/\
M7/BK\$?BU\'OVQ='^&=WXU\$?#B^U-_%V@V2[I+,W,"11Z@%P1F)?,(=AA&
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M2]^&6M:5\1/ $B#Q!X#:YMGN)DD4-#/:3O)'#/#(I!5V:/&1N"[ESYU\'O\
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M ;XA_LQ67[3ND)JHM;[5TT2#PS]F4ZG)K3R+$FF)'N"M.[LNWY@NU@[%5#$
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M&FMVN@>-1 L=VUW&?LFJJB[4\XH"T<B@!1( V54*5. 5^)O^'/W[=O\ ;?\
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MH,Y-=K67XO\  W@KX@Z1_8'C[P?I>N6'FB3[%K&GQW,.\9PVR12N1DX.,\T
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MX@_M#>#[N-_#'AOX7VGAG6=5MW!M[G5WN$N&A$@^5VA@C3S "2C% V#Q5?\
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MJJ.     .E '@W_!4C4M/TS_ ()^?%274;V*!9?"TL,;2R!0\CLJH@SU))
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MO?L2^&-!\;_&OX(^$O!OAWP1I%I"WB#X@Z#HD%A::G/'YK20J\<2&Z\E2GS
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
3 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_3a.jpg
<TEXT>
begin 644 image_3a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ") .D# 2(  A$! Q$!_\0
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M+3U9S/P4^(>O_%,0:A-*UE9:7!]@U*VD@0-/J"\2L#C(4<8Q@9S7L%<YX)\
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M569]RL$3*+_=''(]SS7&?!KQA?\ C+0-1GU"1I9;74KFT0S1"*?8DC*OFHH
M5L < "N_HL+E16DMIW><K=R('4!%"*?+/J,CG\<T+;3"2-C=NRK'M92JX=O[
MQXX/L.*LU0UW6[/PYI%WJ=_,(+.UC,DDC= !18=B2.TN$2 -?2N48EV*(/,'
MH<#C\,4C6=P8Y%%_*&:3<K[$RB_W1QT]SS7G'P8^*-U\1->\<6]W<VK+IM_#
M':VMN/F@@>VBD D/=MSL3Z'CM7J=%A615DMIV><K>2()% 10BGRSZCCG\<TH
MMIA)&QNW*K'L9-BX9O[QXZ^PX]JLTC':I."<#.!WHL.Q5CM+A4@#7TCF,DNQ
M1!YH]#QQ^&*MUY?X \>ZMKGCC4M)UMKG3+B,22VVFSV'DB2#S&5)%<Y+\*,X
MQS7J%.U@2L%%%% PHHJFVKV2:FFGFYC^VNA<09^;:.] %RBBB@ HHKG[[Q]X
M>TW5TTNZU:W@U!Y%B6!R=Q=CA5Z=22* /'];_;Q^"/ACXF:_X%UOQO9Z-K&B
M?+=RWOR6PDSAHED[R*>JXXP:L?\ #=_[/O\ T5KPS_X%_P#UJ\0\(_"SP7XJ
M_P""E?QCL]:\(:#K%G_PBVGWHM[_ $R">/[0[1EY=KJ1O;)RW4Y.37U!_P ,
MU_"+_HE?@K_PGK/_ .-T <=_PW?^S[_T5KPS_P"!?_UJRO%'[9/[-OC+P[J.
MAZM\5?#D^FZA UO<1)J#1%XV&&&Y<,.#U!%>C?\ #-?PB_Z)7X*_\)ZS_P#C
M=<3\1_AW\&?AX^GPR?"'P7>7-Z)FC0Z'91*%CC+OEC$1G"G [F@"QX!_;(^#
M_CSXD:)\.O!OBN+Q-K%]:2SP/IY:>&-(E)822D\-A<@'.:]UKX3N?#'A#0/^
M"B'P+NO!OAK2_#6G:GX/U.[:'2]/BLQ(2DF&=8U&6QQS7W90 5R?Q'\"/\0]
M$32_[;O=&M_-62;[''"_GJ#GRW$B,"A[C'/0UUE4=7URPT&V%QJ%U':0E@H:
M0XR?04 0>&M'N-!TF.SNM4N-8F5F8W=TD:.V3D#;&JJ .@  Z5JU%:W4-];Q
MSV\JS0R ,CH<AAZBI: "H+U;A[:06KQQSD?(TJEE!]P*GK,F\2Z7;QWKR7\*
M+9.([@EO]4Q&0#[X(XH R_"/A.U\"V5\\M[)=W=_=/=W=Y<8!DD8^@   &%
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M@=>>X&/QKPC_ (6S^VC_ -"'\*?_  .N_P#X[1_PMG]M'_H0_A3_ .!UW_\
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M] HH]E#L')$X_3_AW;:3"8K,PVT98LPCBQN8]2>>2?4\U:_X0]_^?I?^^/\
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-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169986854416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 19, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Doximity, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-2485512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 3rd St.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">549-4330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DOCS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s Definitive Proxy Statement relating to the 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#8217;s fiscal year ended March&#160;31, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001516513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,441,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,224,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989271104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987036544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 158,027<span></span>
</td>
<td class="nump">$ 112,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent', window );">Marketable securities</a></td>
<td class="nump">682,972<span></span>
</td>
<td class="nump">685,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $887 and $359 as of March&#160;31, 2023 and 2022, respectively</a></td>
<td class="nump">107,047<span></span>
</td>
<td class="nump">81,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">22,289<span></span>
</td>
<td class="nump">19,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetCurrent', window );">Deferred contract costs, current</a></td>
<td class="nump">5,118<span></span>
</td>
<td class="nump">5,512<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">975,453<span></span>
</td>
<td class="nump">904,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,279<span></span>
</td>
<td class="nump">8,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="nump">34,907<span></span>
</td>
<td class="nump">48,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">13,819<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">31,836<span></span>
</td>
<td class="nump">7,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">67,940<span></span>
</td>
<td class="nump">18,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,654<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,136,888<span></span>
</td>
<td class="nump">991,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,272<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">31,245<span></span>
</td>
<td class="nump">25,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">105,238<span></span>
</td>
<td class="nump">84,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">1,752<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">139,507<span></span>
</td>
<td class="nump">111,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">13,885<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent earn-out consideration liability, non-current</a></td>
<td class="nump">15,942<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, non-current</a></td>
<td class="nump">1,240<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">170,772<span></span>
</td>
<td class="nump">112,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 100,000 shares authorized as of March&#160;31, 2023 and 2022, respectively; zero shares issued and outstanding as of March&#160;31, 2023 and 2022, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March&#160;31, 2023 and 2022, respectively; 193,941 and 192,398 shares issued and outstanding as of March&#160;31, 2023 and 2022, respectively</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">762,150<span></span>
</td>
<td class="nump">702,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(14,083)<span></span>
</td>
<td class="num">(15,294)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">217,855<span></span>
</td>
<td class="nump">191,107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">966,116<span></span>
</td>
<td class="nump">878,594<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,136,888<span></span>
</td>
<td class="nump">$ 991,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169988073408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 887<span></span>
</td>
<td class="nump">$ 359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">193,941,000<span></span>
</td>
<td class="nump">192,398,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">193,941,000<span></span>
</td>
<td class="nump">192,398,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987028720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 419,052<span></span>
</td>
<td class="nump">$ 343,548<span></span>
</td>
<td class="nump">$ 206,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">53,490<span></span>
</td>
<td class="nump">39,787<span></span>
</td>
<td class="nump">31,196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">365,562<span></span>
</td>
<td class="nump">303,761<span></span>
</td>
<td class="nump">175,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">80,186<span></span>
</td>
<td class="nump">62,350<span></span>
</td>
<td class="nump">43,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">123,523<span></span>
</td>
<td class="nump">92,129<span></span>
</td>
<td class="nump">62,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">36,745<span></span>
</td>
<td class="nump">35,746<span></span>
</td>
<td class="nump">16,492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">240,454<span></span>
</td>
<td class="nump">190,225<span></span>
</td>
<td class="nump">122,398<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">125,108<span></span>
</td>
<td class="nump">113,536<span></span>
</td>
<td class="nump">53,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">8,048<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="nump">4,466<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">133,156<span></span>
</td>
<td class="nump">114,005<span></span>
</td>
<td class="nump">57,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">20,338<span></span>
</td>
<td class="num">(40,778)<span></span>
</td>
<td class="nump">7,559<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">112,818<span></span>
</td>
<td class="nump">154,783<span></span>
</td>
<td class="nump">50,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Undistributed earnings attributable to participating securities, basic</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Undistributed earnings attributable to participating securities, diluted</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Class A and Class B common stockholders, basic</a></td>
<td class="nump">112,818<span></span>
</td>
<td class="nump">133,257<span></span>
</td>
<td class="nump">21,556<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Class A and Class B common stockholders, diluted</a></td>
<td class="nump">$ 112,818<span></span>
</td>
<td class="nump">$ 133,257<span></span>
</td>
<td class="nump">$ 21,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to Class A and Class B common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">193,176<span></span>
</td>
<td class="nump">163,484<span></span>
</td>
<td class="nump">74,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">213,425<span></span>
</td>
<td class="nump">191,017<span></span>
</td>
<td class="nump">95,134<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169986861296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 112,818<span></span>
</td>
<td class="nump">$ 154,783<span></span>
</td>
<td class="nump">$ 50,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Change in unrealized gain (loss) on available-for-sale-securities, net of tax benefit (provision) of $(425), $5,199, and $0, respectively</a></td>
<td class="nump">1,211<span></span>
</td>
<td class="num">(15,273)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 114,029<span></span>
</td>
<td class="nump">$ 139,510<span></span>
</td>
<td class="nump">$ 50,189<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994299920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent', window );">Change in unrealized gain (loss) on available-for-sale-securities, tax benefit (provision)</a></td>
<td class="num">$ (425)<span></span>
</td>
<td class="nump">$ 5,199<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169983788448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 81,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 81,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,566,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">1,136<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 14,954<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (13,886)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">8,897<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">8,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock in exchange for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock in exchange for services</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(258,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(2,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition', window );">Common stock warrant expense</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock in connection with an acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in connection with an acquisition</a></td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">50,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,210<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 66,743<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">30,357<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">36,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</a></td>
<td class="num">(76,287,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering</a></td>
<td class="num">$ (81,458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">29,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">12,612<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">12,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax withholding on shares under stock-based compensation awards</a></td>
<td class="num">(817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(2,698)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,698)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition', window );">Common stock warrant expense</a></td>
<td class="nump">2,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering</a></td>
<td class="nump">81,458<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">81,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon initial public offering, net of offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,506,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon initial public offering, net of offering costs</a></td>
<td class="nump">548,452<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">548,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock in connection with the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock in connection with the employee stock purchase plan</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(15,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">154,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,783<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 878,594<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">702,589<span></span>
</td>
<td class="num">(15,294)<span></span>
</td>
<td class="nump">191,107<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">43,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised', window );">Exercise of stock options and common stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,842,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised', window );">Exercise of stock options and common stock warrants</a></td>
<td class="nump">$ 9,929<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">9,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">3,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax withholding on shares under stock-based compensation awards</a></td>
<td class="num">$ (3,822)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,822)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,675,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(86,072)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(86,070)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition', window );">Common stock warrant expense</a></td>
<td class="nump">5,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock in connection with the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock in connection with the employee stock purchase plan</a></td>
<td class="nump">4,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">1,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">112,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,818<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 966,116<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 762,150<span></span>
</td>
<td class="num">$ (14,083)<span></span>
</td>
<td class="nump">$ 217,855<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Stock Options and Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Stock Options and Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987933616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 112,818<span></span>
</td>
<td class="nump">$ 154,783<span></span>
</td>
<td class="nump">$ 50,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">10,283<span></span>
</td>
<td class="nump">5,040<span></span>
</td>
<td class="nump">3,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">13,226<span></span>
</td>
<td class="num">(41,247)<span></span>
</td>
<td class="nump">4,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation, net of amounts capitalized</a></td>
<td class="nump">47,834<span></span>
</td>
<td class="nump">31,442<span></span>
</td>
<td class="nump">7,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">2,027<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on marketable securities, net</a></td>
<td class="nump">3,115<span></span>
</td>
<td class="nump">4,332<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Loss on sale of marketable securities</a></td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of deferred contract costs</a></td>
<td class="nump">8,785<span></span>
</td>
<td class="nump">9,755<span></span>
</td>
<td class="nump">6,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">1,454<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of acquisition:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(26,242)<span></span>
</td>
<td class="num">(31,017)<span></span>
</td>
<td class="num">(20,452)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(3,448)<span></span>
</td>
<td class="num">(9,089)<span></span>
</td>
<td class="num">(1,833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_IncreaseDecreaseInCapitalizedContractCost', window );">Deferred contract costs</a></td>
<td class="num">(8,462)<span></span>
</td>
<td class="num">(9,609)<span></span>
</td>
<td class="num">(9,384)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="num">(195)<span></span>
</td>
<td class="nump">8,664<span></span>
</td>
<td class="nump">7,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">17,527<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">38,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(213)<span></span>
</td>
<td class="num">(1,107)<span></span>
</td>
<td class="num">(2,583)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">179,602<span></span>
</td>
<td class="nump">126,575<span></span>
</td>
<td class="nump">82,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisition, net of cash acquired</a></td>
<td class="num">(53,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(31,682)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,701)<span></span>
</td>
<td class="num">(1,912)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Internal-use software development costs</a></td>
<td class="num">(4,483)<span></span>
</td>
<td class="num">(3,785)<span></span>
</td>
<td class="num">(4,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(190,560)<span></span>
</td>
<td class="num">(1,317,193)<span></span>
</td>
<td class="num">(78,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">83,139<span></span>
</td>
<td class="nump">47,919<span></span>
</td>
<td class="nump">40,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sales of marketable securities</a></td>
<td class="nump">107,182<span></span>
</td>
<td class="nump">633,802<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(59,923)<span></span>
</td>
<td class="num">(640,574)<span></span>
</td>
<td class="num">(70,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">553,905<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of stock options and common stock warrants</a></td>
<td class="nump">9,926<span></span>
</td>
<td class="nump">12,612<span></span>
</td>
<td class="nump">8,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock in connection with the employee stock purchase plan</a></td>
<td class="nump">4,759<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(3,822)<span></span>
</td>
<td class="num">(817)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(85,324)<span></span>
</td>
<td class="num">(2,698)<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,982)<span></span>
</td>
<td class="num">(1,468)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(74,461)<span></span>
</td>
<td class="nump">560,415<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">45,218<span></span>
</td>
<td class="nump">46,416<span></span>
</td>
<td class="nump">17,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">112,809<span></span>
</td>
<td class="nump">66,393<span></span>
</td>
<td class="nump">48,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">158,027<span></span>
</td>
<td class="nump">112,809<span></span>
</td>
<td class="nump">66,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="nump">5,231<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">5,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash financing and investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock to common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">81,458<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_StockIssuancesCostsIncurredButNotYetPaid', window );">Unpaid deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_StockIssuedAcquisitions', window );">Common stock issued in acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized stock-based compensation for internal-use software development costs</a></td>
<td class="nump">865<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_EscrowDepositsRelatedToSaleOfBusiness', window );">Amounts held in escrow related to sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Fair value of contingent earn-out consideration included in purchase consideration</a></td>
<td class="nump">21,134<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">14,759<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction', window );">Repurchase included in accrued expenses</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_EscrowDepositsRelatedToSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Escrow Deposits Related To Sale Of Business</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_EscrowDepositsRelatedToSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_IncreaseDecreaseInCapitalizedContractCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Capitalized Contract Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_IncreaseDecreaseInCapitalizedContractCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase Included In Accrued Expenses In Noncash Or Partial Noncash Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_StockIssuancesCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issuances Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_StockIssuancesCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_StockIssuedAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued, Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_StockIssuedAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991371440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of Business</a></td>
<td class="text">Description of Business<div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doximity,&#160;Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, monitor their work schedules, and manage their careers. The Company&#8217;s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company&#8217;s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company completed its initial public offering (&#8220;IPO&#8221;), in which the Company issued and sold 22,505,750 shares of its Class A common stock at $26.00 per share, including 3,495,000 shares issued upon the exercise of the underwriters&#8217; option to purchase additional shares. The Company received proceeds of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs. In connection with the IPO, all 76,286,618 shares of the Company&#8217;s outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred offering costs, which consist of direct incremental legal, consulting, banking, and accounting fees relating to the Company&#8217;s planned initial public offering, were capitalized. Upon the consummation of the IPO, $5.5 million of deferred offering costs were offset against proceeds. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Split</span></div>On June&#160;8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation effecting a 2-for-1 forward split of the Company&#8217;s issued and outstanding stock, including outstanding stock-based instruments and redeemable convertible preferred stock. The par value of the common and redeemable convertible preferred stock was not adjusted as a result of the stock split. As such, the Company has reclassified amounts from additional paid-in capital to common stock. All issued and outstanding shares of common stock, stock-based instruments, redeemable convertible preferred stock, and per-share amounts included in the accompanying consolidated financial statements have been adjusted to reflect this stock split for all periods presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991263344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales. The Company&#8217;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.162%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-bottom:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of assessing the concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company&#8217;s services directly or indirectly through marketing agencies.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is primarily derived from the sale of subscriptions for the following solutions:</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Marketing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#8217;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Hiring Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Providing customers access to the Company&#8217;s professional tools where recruiters can access the Company&#8217;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, through the following five steps:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the contract with a customer</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the terms and conditions of its contracts and the Company&#8217;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#8217;s rights regarding the services to be transferred and the payment terms for the services, it has determined that the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#8217;s ability and intent to pay, which is based on a variety of factors, including the customer&#8217;s payment history or, in the case of a new customer, the customer&#8217;s credit and financial information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual terms for Marketing Solutions contracts are generally 12 months or less. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions contracts are cancellable with a customary notice period. The Company does not  refund prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment was not made. The contractual term for Hiring Solutions contracts is generally 12 months. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the customers&#8217; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#8217;s Awareness modules may include a sponsored article, short animated videos or other short-form content that is presented to the targeted member.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period, subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Determine the transaction price </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#8217;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Allocate the transaction price to performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price (&#8220;SSP&#8221;). The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of SSP is based on historical sales of standalone services. The Company estimates the SSP for arrangements where standalone sales do not provide sufficient </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evidence of the SSP. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Recognize revenue when or as the Company satisfies a performance obligation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#8217;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#8217;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract, while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#8217;s contracts do not contain significant financing components. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#8217;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes sales compensation that is considered to be incremental and recoverable costs of obtaining a contract with a customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales compensation earned for the renewal of Marketing Solutions contracts is commensurate with compensation earned for a new or expansion Marketing Solutions contract, whereas compensation for the renewal of Hiring Solutions subscription contracts is earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#8217;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. The portion of deferred compensation expected to be recognized within one year of the balance sheet date is recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Amortization of deferred contract costs are included in cost of revenue and sales and marketing expense in the consolidated statements of operations. Sales compensation that is not considered incremental costs are expensed in the same period as they are earned. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Marketable Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2023 and 2022 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#8217; equity on the consolidated balance sheets. The Company&#8217;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net, and any remaining unrealized losses are recorded to other comprehensive income (loss). If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#8217;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations, payment history and the customer&#8217;s current financial condition. The Company had no material bad debt write offs for the years ending March&#160;31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. Maintenance and repairs are expensed as incurred. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal-Use Software Development Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, including the selection of valuation methodologies, estimates of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates. Acquisition costs, such as legal and consulting fees, are expensed as incurred. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in cost of revenue and sales and marketing expense. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates the recoverability of the Company&#8217;s long-lived assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#8217;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU and PSU is based on the fair value of the Company&#8217;s Class A common stock, which is traded on the NYSE, on the date of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP (&#8220;ESPP rights&#8221;), and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#8217;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the Company granted stock options and warrants which were valued using the Black-Scholes pricing model, and after the IPO, the Company has granted warrants and ESPP rights which were valued using the Black-Scholes pricing model. The assumptions used in the Black-Scholes models are determined as follows: </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the awards. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Prior to the IPO, when there was no public market for the Company&#8217;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. After the IPO, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. Prior to the IPO, the Company estimated the expected term for awards granted to employees using the simplified method as the Company&#8217;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For awards granted to non-employees, the Company used the contractual term as the expected term. For ESPP rights, the expected term is equivalent to the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Per Share of the Company&#8217;s Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Because the Company&#8217;s common stock was not publicly traded until the completion of the IPO, the Company&#8217;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#8217;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#8217;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. After the IPO, the Company used the closing stock price of the Company&#8217;s Class A common stock, which is traded on the NYSE. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is or contains a lease at inception. All of the Company&#8217;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. As none of the Company&#8217;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the two-class method to compute basic and diluted net income per share attributable to common stockholders when shares meet the definition of participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the automatic conversion of the Company&#8217;s outstanding redeemable convertible preferred stock to Class B common stock in connection with the IPO, the Company had redeemable convertible preferred stock. The redeemable convertible preferred stock was considered to be a participating security because the holders were each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#8217;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate. Redeemable convertible preferred stock was therefore included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, and common stock warrants. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#8217;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of expenses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to cloud hosting, personnel-related expenses for the Company&#8217;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delivery and support of the Company&#8217;s platform. Cost of revenue also includes the amortization of internal-use software development costs, editorial and other content-related expenses, and allocated overhead. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the Company&#8217;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Expenses </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations. Advertising expense was $2.6 million, $2.8 million, and $2.6 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. Most amendments within this guidance </span></div>are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance on April 1, 2022, and the adoption of this guidance did not have a material impact on the consolidated financial statements. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers,</span> as if it had originated the contracts. Previously, the Company recognized contract assets and contract liabilities at the acquisition date based on fair value estimates, which had resulted in a reduction to unearned revenue on the balance sheet, and therefore, a reduction to revenues that would have otherwise been recorded as an independent entity. The Company adopted this guidance on April 1, 2022, using the prospective approach. The adoption is applicable to business combinations occurring on or after April 1, 2022, including the Company&#8217;s acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians completed on April 1, 2022 (the &#8220;AMiON&#8221; Acquisition). See Note 8&#8212;Business Combinations for additional discussion regarding the AMiON acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169990612880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Disaggregation </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subscription</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">389,739&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">319,298&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">192,256&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">419,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company&#8217;s deferred revenue balances were as follows (in thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions, net, during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">345,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from the beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(83,231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(82,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from contracts invoiced during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(335,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(261,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">105,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the additions, net, during the period was $2.9 million of additions due to the AMiON acquisition which closed on April&#160;1, 2022. See Note 8 &#8212; Business Combinations for additional information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unbilled revenue balances were $2.2 million and $1.4 million as of March&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div>The Company capitalized $8.5 million, $9.6 million, and $9.4 million of contract acquisition costs for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. Amortization of deferred contract costs was $8.8 million, $9.8 million, and $6.9 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. Deferred contract costs are periodically analyzed for impairment. There were no impairment losses relating to deferred contract costs during the fiscal years ended March&#160;31, 2023, 2022, and 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991228032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">701,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">682,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">828,104&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,924)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">809,247&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the contractual maturities of the Company&#8217;s available-for-sale debt securities were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">360,143&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due in one year to two years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">315,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">682,972&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities because certain borrowers have the right to call or prepay certain obligations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">129,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">549,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">705,798&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">728,556&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and 2022, the Company has recognized accrued interest of $2.8 million and $2.1 million, respectively, which is included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzE3MDQyNDMwMjMzNTky_1995d277-8431-4487-a901-191b21f55f52">prepaid expenses and other current assets</span> in the consolidated balance sheets. </span></div>The unrealized losses associated with the Company&#8217;s debt securities were $18.9 million and $20.5 million as of March&#160;31, 2023 and 2022, respectively. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did not recognize any impairment on these securities as of March&#160;31, 2023 and 2022. The Company did not recognize any credit losses related to the Company&#8217;s debt securities during the fiscal years ended March&#160;31, 2023 and 2022. The fair value related to the debt securities with unrealized loss for which no credit losses were recognized was $653.4 million and $684.7 million as of March&#160;31, 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993387984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy for the Company&#8217;s assets and liabilities measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">444,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,748&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">243,224&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">682,972&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">566,023&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">243,224&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">809,247&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contingent earn-out consideration liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total contingent earn-out consideration liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">155,130&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">550,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended March&#160;31, 2023 and 2022, the Company had no transfers between levels of the fair value hierarchy.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Earn-out Consideration Liability</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the contingent earn-out consideration liability (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.525%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions in the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent earn-out consideration liability relates to the AMiON acquisition, which closed on April 1, 2022. The fair value of the liability is remeasured at each reporting date until the related contingency is resolved, with any changes to the fair value recognized as <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzE3MDQyNDMwMjMyMTQz_3e9d7d07-1cf9-455d-9196-8ee9cf5d4f4c">sales and marketing expense</span> in the consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of the contingent earn-out consideration liability, the Company used the discounted cash flow method. The significant inputs used in the fair value measurement of the contingent earn-out consideration liability are the discount rate and the timing and amounts of the future payments, which are based upon estimates of future achievement of the performance metrics. As these inputs are not based on observable market data, they represent a Level 3 measurement within the fair value hierarchy. Changes in the significant inputs used would significantly impact the fair value of the contingent earn-out consideration liability.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8&#8212;Business Combinations for additional discussion regarding the AMiON acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991228032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,854&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(13,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense on property and equipment for the fiscal years ended March&#160;31, 2023, 2022, and 2021 was $5.5 million, $4.0 million and $2.6 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $4.8 million, $3.5 million and $2.2 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2023, 2022, and 2021, the Company capitalized $5.3 million, $4.3 million, and $4.6 million, respectively, of internal-use software development costs, which are included in property and equipment, net on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No impairment was recognized on property and equipment during the years ended March&#160;31, 2023, 2022, and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991263344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">Accrued Expenses and Other Current Liabilities<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,733&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued payroll, bonus, and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employee contributions under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Rebate liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of contingent earn-out consideration liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable And Accrued Liabilities, Current Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991239120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Curative Talent Acquisition </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company completed the acquisition of THMED, LLC (subsequently renamed Curative Talent, LLC, &#8220;Curative&#8221;), which was accounted for as a business combination. Curative provides temporary and permanent healthcare staffing services to hospitals, medical groups, and other healthcare facilities across the United States. The acquisition-date fair value of the consideration transferred was $34.7 million, consisting of $33.6 million in cash and 689,656 shares of common stock valued at $1.1 million. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the future benefits as a result of the acquisition that will enhance the Company&#8217;s product available to both new and existing customers and increase the Company&#8217;s competitive position. Goodwill is deductible for income tax purposes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition-related costs were $1.2 million and were recorded as general and administrative expense in the Company&#8217;s consolidated statements of operations during the fiscal year ended March&#160;31, 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired are comprised of customer relationships with an estimated useful life of 10 years. The fair value assigned to the customer relationship was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the Company&#8217;s consolidated financial statements from the acquisition date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company sold a portion of Curative Talent&#8217;s business for total consideration of $4.7 million, of which $4.2 million has been received in cash and the remaining $0.5 million was held in escrow, subject to standard representations </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and warranties. The net assets of this business were not material. The Company recognized a gain on sale for the total consideration during the fiscal year ended March&#160;31, 2021 as a result of this sale. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AMiON Acquisition </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2022, the Company completed the acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians (&#8220;the AMiON acquisition&#8221;) to further expand our physician cloud platform. The acquisition-date fair value of the consideration was $74.6 million, consisting of $53.5 million in cash and $21.1 million in fair value of contingent earn-out consideration.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the definitive agreement for the AMiON acquisition, the Company will pay contingent earn-out consideration of up to $24.0 million, of which $4.0 million is a minimum guarantee and the remaining $20.0 million is subject to the achievement of certain operational performance metrics over the next four years. The contingent earn-out consideration is payable in cash in annual installments over the next four years, with approximately $6.0&#160;million settled in the first quarter of fiscal 2024. The contingent earn-out consideration is classified as a liability, the short-term portion of which is included in accrued expenses and other current liabilities and the long-term portion is in contingent earn-out consideration liability, non-current in the consolidated balance sheets. See Note 5&#8212;Fair Value Measurements for additional information regarding the valuation of the contingent earn-out consideration liability. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in May 2022, 93,458 RSUs with a grant date fair value of $32.99 per share were granted to the eligible employees joining the Company in connection with the AMiON acquisition. The shares will vest on a quarterly basis over four years based on continued service. The aggregate grant date fair value of these RSUs is accounted for as post-acquisition stock-based compensation expense and is recognized on a straight-line basis over the requisite service period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AMiON acquisition was accounted for as a business combination. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill generated from the AMiON acquisition represents the future benefits from the development of future customer relationships and the assembled workforce. Goodwill from this business combination is deductible for income tax purposes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired are comprised of customer relationships, trademarks, and developed technology with estimated useful lives of 9 years, 3 years, and 18 months, respectively. The fair value assigned to the customer relationships was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the consolidated financial statements from the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition-related costs were not material and were recorded as general and administrative expense in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate operating results and pro forma results of operations for AMiON have not been presented as the effect of this acquisition was not material to the Company&#8217;s financial results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991217840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets was $4.8 million, $1.0 million and $1.1 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021 respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, future amortization expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill were as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67,940&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the Company&#8217;s goodwill balance of $18.9 million during the fiscal year ended March&#160;31, 2022. No impairment charges on goodwill were recorded during the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991301536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_TemporaryEquityTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text">Redeemable Convertible Preferred StockUpon completion of the IPO in June 2021, all shares of the Company&#8217;s redeemable convertible preferred stock outstanding, totaling 76,286,618, were automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. The carrying value of redeemable convertible preferred stock of $81.5 million was reclassified into stockholders&#8217; equity. As of March&#160;31, 2023 and 2022, there were no shares of redeemable convertible preferred stock issued or outstanding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991244976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, the Company&#8217;s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and preferences, including voting rights, designated from time to time by the board of directors. As of March&#160;31, 2023 and 2022, there were no shares of preferred stock issued and outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock and Creation of Dual-Class Structure </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company&#8217;s 85,523,836 shares of then-existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of March&#160;31, 2023, there were 120,682,472 shares of Class A common stock, and 73,258,344 shares of Class B common stock outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;12, 2022, the Company&#8217;s board of directors authorized a program to repurchase up to $70 million of the Company&#8217;s Class A common stock. As of September 30, 2022, the Company repurchased and retired 2,150,982 shares of Class A common stock for an aggregate purchase price of $70 million, thereby completing this share repurchase program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;28, 2022, the Company&#8217;s board of directors authorized an additional program to repurchase up to $70 million of the Company&#8217;s Class A common stock. The repurchases may be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. As of March&#160;31, 2023, the Company repurchased and retired 523,647 shares of Class A common stock for an aggregate purchase price of $16.0 million, and $54.0 million remained available and authorized for repurchases under this program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Warrants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News &amp; World Report, L.P., or U.S. News. The warrant expires 10 years from the date of grant. As of March&#160;31, 2023, the warrant was fully vested. During the fiscal year ended March&#160;31, 2023, the warrant for 125,000 shares were exercised with an intrinsic value of $4.0 million. The remaining warrant for 125,000 shares was outstanding as of March&#160;31, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company issued a warrant to U.S. News (the &#8220;U.S. News Warrant&#8221;) to purchase 516,000 shares of Class A common stock with an exercise price of $12.56 per share in connection with the execution of a commercial agreement with the U.S. News (the &#8220;Commercial Agreement&#8221;). The U.S. News Warrant expires 10 years from the date of grant. The first tranche of the U.S. News Warrant vested on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $76.50, volatility of 46.9%, risk-free interest rate of 1.61%, contractual term of 10 years, and an expected dividend of 0%. The fair value of the warrant is recognized as expense in cost of revenue in the consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. During the fiscal years ended March&#160;31, 2023 and 2022, $5.4 million and $2.6 million were recognized as stock-based compensation expense relating to the U.S. News Warrant, respectively. As of March&#160;31, 2023, unamortized compensation expense, net of estimated forfeitures, related to the unvested warrants was $26.8 million, which is expected to be recognized over the remaining vesting period of 5.0 years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2010 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2010, the Company&#8217;s board of directors and stockholders approved the adoption of the 2010 Equity Incentive Plan (the &#8220;2010 Plan&#8221;). The 2010 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. Options may </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be granted at a price per share not less than 100% of the fair market value at date of grant. If the incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2010 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. Stock awards may also be granted for services performed by external consultants and vest according to an award-specific schedule as approved by the board of directors. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Stock Option and Incentive Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s board of directors approved the adoption of the 2021 Stock Option and Incentive Plan (the &#8220;2021 Plan&#8221;), which became effective upon the Company&#8217;s initial public offering and supersedes the 2010 Plan. The 2010 Plan continues to govern the terms of outstanding awards that were granted under the 2010 Plan. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. A total of 22,500,000 shares of Class A common stock was initially reserved for the 2021 Plan. The number of shares reserved and available for issuance for the 2021 Plan will automatically increase each April 1, beginning on April 1, 2022, by the lesser of 5% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee. Any shares of Class B common stock that would have otherwise been returned to the Company&#8217;s 2010 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan after being automatically converted from shares of Class B common stock to Class A common stock. The 2010 Plan and the 2021 Plan are collectively referred to as the &#8220;Plans&#8221; in the notes to the consolidated financial statements, unless otherwise noted.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s board of directors approved the adoption of the ESPP, which became effective upon the Company&#8217;s initial public offering. A total of 4,500,000 shares of Class A common stock was initially reserved for the ESPP. The number of shares reserved and available for issuance for the ESPP will automatically increase each April 1, beginning on April 1, 2022 and continuing through April 1, 2031, by the lesser of 6,750,000 shares of Class A common stock, 1% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. During fiscal 2018, the Company granted 4,682,582 options outside of the Plans, of which 2,027,917 options were exercised and 2,654,665 were outstanding as of March&#160;31, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has shares of common stock reserved for issuance as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2010 Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 Plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Awards outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding outside the Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,560&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted generally vest over four years with service-based, performance-based, and/or market-based conditions and expire ten years from the date of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activities within the Plans as well as outside of the Plans were as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,983&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.15&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,293,545&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options forfeited or expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,407&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">627,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and exercisable as of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,897&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">354,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and expected to vest as of March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">603,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the fiscal years ended March&#160;31, 2023, 2022, and 2021 was $118.4 million, $521.6 million, and $52.6 million respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of options granted for the fiscal years ended March&#160;31, 2022 and 2021 was $10.73 and $3.18 respectively. The Company has not granted any stock options since the first quarter of fiscal 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested stock options was $37.0 million, which is expected to be recognized over a weighted-average period of 2.92 years. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$18.41 - $21.41</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$2.06 - $10.51</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46.5% - 47.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.1% - 58.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.77% - 1.02%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.26% - 1.02%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 6.09</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 8.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based and/or Market-Based Options </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the board of directors of the Company granted 1,792,000 options to the Chief Executive Officer with an exercise price of $0.97 per share under the 2010 Plan (the &#8220;2018 CEO Grant&#8221;) with a liquidity-event performance-based vesting condition based on the occurrence of a qualifying liquidity event, including an IPO, as well as stock price target after the consummation of the IPO. In September 2020, the 2018 CEO Grant was modified to extend the stock price target achievement cutoff date. The fair value of the 2018 CEO Grant was determined using a Monte Carlo simulation approach on the modification date. The achievement of the qualifying event was not considered to be probable prior to the Company&#8217;s IPO. Upon the Company's IPO, the liquidity-event performance-based condition was met. During the fiscal years ended March&#160;31, 2023 and 2022, $0.2 million and $1.7 million was recognized as stock-based compensation expense relating to the 2018 CEO Grant. As of March&#160;31, 2023, this option was fully vested.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had 480,000 unvested options with performance-based and service-based vesting conditions. The performance conditions are satisfied upon meeting certain financial performance targets. During the fiscal year ended March&#160;31, 2023, 200,000 options vested and 280,000 options were forfeited. There were no unvested options remaining as of March&#160;31, 2023. The stock-based compensation expense related to these performance options was $1.7 million for the fiscal year ended March&#160;31, 2022 and was immaterial for the fiscal years ended March&#160;31, 2023 and 2021. There is no remaining unrecognized compensation expense as of March&#160;31, 2023. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units (&#8220;RSUs&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RSUs granted by the Company generally vest over four years based on continued service.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">534&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68.23&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,951&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs vested during the fiscal years ended March&#160;31, 2023 and 2022 was $11.4 million and $2.5 million, respectively. No RSUs were granted before fiscal 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested RSUs was $59.3 million, and is expected to be recognized over a weighted-average period of approximately 3.04 years. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units (&#8220;PSUs&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs have service-based and performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes PSU activity (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80.00&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of PSUs vested during the fiscal year ended March&#160;31, 2023 $0.4 million. No PSUs vested during the fiscal year ended March&#160;31, 2022 and no PSUs were granted before fiscal 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested PSUs that are probable of vesting was $3.0 million, and is expected to be recognized over a weighted-average period of approximately 0.76 years. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in&#160;thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,634&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,979&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">600&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,834&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991209664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share Attributable to Common Stockholders</a></td>
<td class="text">Net Income Per Share Attributable to Common Stockholders<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Numerator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(21,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(28,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112,818&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133,257&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,556&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Denominator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">193,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,027&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,290&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,612&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">213,425&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">191,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,088&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">464&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991277376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s income before income taxes was generated in the United States for the fiscal year ended March 31, 2023, 2022, and 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for (benefit from) income taxes consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(34,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(41,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s provision for (benefit from) income taxes (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes at statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,076)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(14,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(71,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities were as follows (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accruals and deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research &amp; development credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Capitalized research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,839&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51,131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,899)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,932)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which include California research and development credits, California alternative minimum tax credits, and capital loss carryforwards. The Company concluded, based upon the preponderance of positive evidence (i.e., a strong earnings history exclusive of the loss that created the future deductible amount, a history of taxable income in recent periods, the taxable loss is a result of excess tax benefit on stock exercises as a result of a non-recurring event (IPO), and the current forecast of income before taxes for the United States going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets could be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance was $5.2 million and $4.7 million as of March&#160;31, 2023 and 2022, respectively, relating to the California research and development tax credits, California alternative minimum tax credits, and capital loss carryforwards. The valuation allowance increased by $0.5 million during the fiscal year ended March&#160;31, 2023 primarily due to capital loss carryforwards. The valuation allowance increased by $1.8 million during the fiscal year ended March&#160;31, 2022 primarily due to the increase in California research and development credits generated during the year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had net operating loss, or NOL, carryforwards for state tax purposes of $15.3 million and no NOL carryforwards for federal tax purposes. Portions of the NOL carryforwards will expire at various dates beginning in the tax year ending March&#160;31, 2035. As of March&#160;31, 2023, the Company had research and development tax credit carryforwards for federal and state tax purposes of $7.4 million and $9.0 million, respectively. The federal research and development tax credit carryforwards will expire beginning in the year ending March&#160;31, 2042. The California state research and development tax credit carryforwards do not expire. The other state research and development tax credit carryforwards will expire at various dates beginning in the year ending March&#160;31, 2032. Based on an assessment of the Company&#8217;s historical ownership changes through March&#160;31, 2023, the Company does not anticipate a current limitation on the tax attributes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and 2022, the Company had unrecognized tax benefits, or UTBs, of $7.9 million and $6.2 million, respectively. If realized, $5.9 million would impact the effective tax rate while the remainder would reduce deferred tax assets subject to a full valuation allowance. The Company does not expect any material changes to its UTBs within the next 12 months.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions related to a lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties were not material during the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state jurisdictions. With limited exceptions, all tax years for which the Company has filed a tax return remain subject to examination.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994459904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum Guarantees</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News for six years. This agreement can be terminated after three years by either party. Under this amended agreement, the Company pays the U.S. News a portion of the revenue generated with the end customers, subject to annual minimum guarantees. As of March 31, 2023, the remaining annual minimum guarantees ranged from $3.0 million to $6.2 million, and the total minimum guarantee for the remaining noncancelable periods was $6.6 million, of which $3.0 million is expected to be paid within 1 year. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Commitments </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a web hosting arrangement for 3 years ending December&#160;31, 2024, with an annual commitment of $5.2 million. As of March&#160;31, 2023, the total remaining commitment was $5.2 million. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company&#8217;s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company&#8217;s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no material claims under these indemnification provisions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material effect on its results of operations, financial position, or cash flows. No loss contingencies were recorded for the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993434592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has non-cancelable operating leases for the rental of office space with various expiration dates through 2030. During the fiscal year ended March 31, 2023, the office space lease in Irving, Texas with an approximately 8-year term commenced and a related right-of-use asset and lease liability of $14.8 million was recognized. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.64</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.37</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,637&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991263344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock', window );">Other Income, net</a></td>
<td class="text">Other Income, net<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,148&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">301&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Realized loss on sale of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Realized gain on sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,466&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991327616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">Employee Benefit PlanThe Company sponsors a 401(k)&#160;savings plan. All U.S. employees are eligible to participate in the 401(k)&#160;plan after meeting certain eligibility requirements. Participants may elect to have a portion of their salary deferred and contributed to the 401(k)&#160;plan up to the limit allowed by applicable income tax regulations. The Company matched a portion of employee contributions to the 401(k) plan totaling $2.1 million, $2.1 million, and $1.3 million for the fiscal years ended March&#160;31, 2023, 2022 and 2021, respectively. Both employee contributions and the Company&#8217;s matching contributions are fully vested upon contribution.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991244976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">Segment and Geographic Information<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company&#8217;s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company&#8217;s performance. As such, the Company has determined that it has one operating and reportable segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s long-lived assets were based in the United States as of March&#160;31, 2023 and 2022. No country outside of the United States accounted for more than 10% of total revenue for the fiscal years ended March&#160;31, 2023, 2022, and 2021. Substantially all of the Company&#8217;s revenue was derived in the United States for the fiscal years ended March&#160;31, 2023, 2022, and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987117648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Year</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its </span></div>estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.</span></div>Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is primarily derived from the sale of subscriptions for the following solutions:</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Marketing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#8217;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Hiring Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Providing customers access to the Company&#8217;s professional tools where recruiters can access the Company&#8217;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, through the following five steps:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the contract with a customer</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the terms and conditions of its contracts and the Company&#8217;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#8217;s rights regarding the services to be transferred and the payment terms for the services, it has determined that the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#8217;s ability and intent to pay, which is based on a variety of factors, including the customer&#8217;s payment history or, in the case of a new customer, the customer&#8217;s credit and financial information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual terms for Marketing Solutions contracts are generally 12 months or less. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions contracts are cancellable with a customary notice period. The Company does not  refund prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment was not made. The contractual term for Hiring Solutions contracts is generally 12 months. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the customers&#8217; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#8217;s Awareness modules may include a sponsored article, short animated videos or other short-form content that is presented to the targeted member.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period, subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Determine the transaction price </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#8217;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Allocate the transaction price to performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price (&#8220;SSP&#8221;). The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of SSP is based on historical sales of standalone services. The Company estimates the SSP for arrangements where standalone sales do not provide sufficient </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evidence of the SSP. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Recognize revenue when or as the Company satisfies a performance obligation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#8217;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#8217;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract, while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#8217;s contracts do not contain significant financing components. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#8217;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes sales compensation that is considered to be incremental and recoverable costs of obtaining a contract with a customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales compensation earned for the renewal of Marketing Solutions contracts is commensurate with compensation earned for a new or expansion Marketing Solutions contract, whereas compensation for the renewal of Hiring Solutions subscription contracts is earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. </span></div>Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#8217;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. The portion of deferred compensation expected to be recognized within one year of the balance sheet date is recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Amortization of deferred contract costs are included in cost of revenue and sales and marketing expense in the consolidated statements of operations. Sales compensation that is not considered incremental costs are expensed in the same period as they are earned.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock', window );">Cash and Cash Equivalent and Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Marketable Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2023 and 2022 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#8217; equity on the consolidated balance sheets. The Company&#8217;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net, and any remaining unrealized losses are recorded to other comprehensive income (loss). If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.</span></div>The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">Accounts Receivable and Allowance for Doubtful AccountsAccounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#8217;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations, payment history and the customer&#8217;s current financial condition.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table></div>When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. Maintenance and repairs are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Internal-Use Software Development Costs</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal-Use Software Development Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. </span></div>Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text">Business CombinationsWhen the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, including the selection of valuation methodologies, estimates of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates. Acquisition costs, such as legal and consulting fees, are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill Intangible Assets and Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in cost of revenue and sales and marketing expense. </span></div>Management evaluates the recoverability of the Company&#8217;s long-lived assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#8217;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU and PSU is based on the fair value of the Company&#8217;s Class A common stock, which is traded on the NYSE, on the date of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP (&#8220;ESPP rights&#8221;), and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#8217;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the Company granted stock options and warrants which were valued using the Black-Scholes pricing model, and after the IPO, the Company has granted warrants and ESPP rights which were valued using the Black-Scholes pricing model. The assumptions used in the Black-Scholes models are determined as follows: </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the awards. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Prior to the IPO, when there was no public market for the Company&#8217;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. After the IPO, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. Prior to the IPO, the Company estimated the expected term for awards granted to employees using the simplified method as the Company&#8217;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For awards granted to non-employees, the Company used the contractual term as the expected term. For ESPP rights, the expected term is equivalent to the offering period. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. </span>Fair Value Per Share of the Company&#8217;s Common Stock&#8212;Because the Company&#8217;s common stock was not publicly traded until the completion of the IPO, the Company&#8217;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#8217;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#8217;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. After the IPO, the Company used the closing stock price of the Company&#8217;s Class A common stock, which is traded on the NYSE.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is or contains a lease at inception. All of the Company&#8217;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. As none of the Company&#8217;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. </span></div>The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share Attributable to Common Stockholders</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the two-class method to compute basic and diluted net income per share attributable to common stockholders when shares meet the definition of participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the automatic conversion of the Company&#8217;s outstanding redeemable convertible preferred stock to Class B common stock in connection with the IPO, the Company had redeemable convertible preferred stock. The redeemable convertible preferred stock was considered to be a participating security because the holders were each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#8217;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate. Redeemable convertible preferred stock was therefore included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, and common stock warrants. </span></div>The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. </span></div>The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#8217;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Contingencies</a></td>
<td class="text">Legal ContingenciesThe Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text">Cost of Revenue <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of expenses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to cloud hosting, personnel-related expenses for the Company&#8217;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with </span>delivery and support of the Company&#8217;s platform. Cost of revenue also includes the amortization of internal-use software development costs, editorial and other content-related expenses, and allocated overhead.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the Company&#8217;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Expenses</a></td>
<td class="text">Advertising Expenses Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Recently Adopted</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. Most amendments within this guidance </span></div>are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance on April 1, 2022, and the adoption of this guidance did not have a material impact on the consolidated financial statements. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers,</span> as if it had originated the contracts. Previously, the Company recognized contract assets and contract liabilities at the acquisition date based on fair value estimates, which had resulted in a reduction to unearned revenue on the balance sheet, and therefore, a reduction to revenues that would have otherwise been recorded as an independent entity. The Company adopted this guidance on April 1, 2022, using the prospective approach. The adoption is applicable to business combinations occurring on or after April 1, 2022, including the Company&#8217;s acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians completed on April 1, 2022 (the &#8220;AMiON&#8221; Acquisition). See Note 8&#8212;Business Combinations for additional discussion regarding the AMiON acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalent And Marketable Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987881008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net</a></td>
<td class="text">The Company&#8217;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.162%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-bottom:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* Less than 10%</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">The estimated useful life of each asset category is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,854&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(13,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987021360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subscription</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">389,739&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">319,298&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">192,256&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">419,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Changes in Deferred Revenue Balance</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company&#8217;s deferred revenue balances were as follows (in thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions, net, during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">345,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from the beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(83,231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(82,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from contracts invoiced during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(335,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(261,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">105,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989421472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">701,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">682,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">828,104&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,924)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">809,247&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">129,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">549,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">705,798&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">728,556&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Contractual Maturities of Available-For-Sale Debt Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the contractual maturities of the Company&#8217;s available-for-sale debt securities were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">360,143&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due in one year to two years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">315,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">682,972&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities because certain borrowers have the right to call or prepay certain obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991348144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy for the Company&#8217;s assets and liabilities measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">444,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,748&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">243,224&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">682,972&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">566,023&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">243,224&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">809,247&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contingent earn-out consideration liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total contingent earn-out consideration liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">155,130&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">550,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy for the Company&#8217;s assets and liabilities measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">444,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">439,748&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">243,224&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">682,972&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">566,023&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">243,224&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">809,247&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contingent earn-out consideration liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total contingent earn-out consideration liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">155,130&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">550,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the contingent earn-out consideration liability (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.525%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions in the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991403184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">The estimated useful life of each asset category is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,854&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(13,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991239120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock', window );">Schedule of accrued expenses and other liabilities, current</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,733&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued payroll, bonus, and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employee contributions under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Rebate liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of contingent earn-out consideration liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991211120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase Consideration Allocation</a></td>
<td class="text">The purchase consideration allocation was as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The purchase consideration allocation was as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademark</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, future amortization expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169991319552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, future amortization expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill were as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67,940&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169990274112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Common Stock Reserved for Issuance</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has shares of common stock reserved for issuance as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2010 Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 Plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Awards outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding outside the Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,560&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activities within the Plans as well as outside of the Plans were as follows: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,983&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.15&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,293,545&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options forfeited or expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,407&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">627,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and exercisable as of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,897&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">354,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and expected to vest as of March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">603,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock Options Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$18.41 - $21.41</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$2.06 - $10.51</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46.5% - 47.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.1% - 58.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.77% - 1.02%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.26% - 1.02%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 6.09</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 8.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Restricted Stock Unit Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">534&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68.23&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,951&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in&#160;thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,634&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,979&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">600&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,834&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Performance-Based Units Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes PSU activity (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80.00&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169986972624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Numerator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(21,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(28,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112,818&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133,257&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,556&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Denominator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">193,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,027&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,290&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,612&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">213,425&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">191,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,088&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">464&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169986947856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for (benefit from) income taxes consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(34,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(41,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s provision for (benefit from) income taxes (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes at statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,076)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(14,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(71,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities were as follows (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accruals and deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research &amp; development credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Capitalized research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,839&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51,131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,899)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,932)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions related to a lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140170072576528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.64</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.37</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,637&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987893920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Income, Net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,148&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">301&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Realized loss on sale of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Realized gain on sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,466&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989155072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 08, 2021</div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Capitalized deferred offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Forward split ratio</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=docs_InitialPublicOfferingIncludingOverAllotmentOptionMember', window );">Initial Public Offering Including Over Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold in initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,505,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Initial public offering price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate net proceeds from initial public offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold in initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,286,618<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ConversionOfStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ConversionOfStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=docs_InitialPublicOfferingIncludingOverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=docs_InitialPublicOfferingIncludingOverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987944864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies- Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense | $</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember', window );">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">13 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=docs_SubscriptionHiringSolutionsMember', window );">Subscription, Hiring Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ContractWithCustomerTerm', window );">Contractual terms</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=docs_SubscriptionMarketingSolutionsMember', window );">Subscription, Marketing Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ContractWithCustomerTerm', window );">Contractual terms</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=docs_SubscriptionHiringSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=docs_SubscriptionHiringSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=docs_SubscriptionMarketingSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=docs_SubscriptionMarketingSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989396448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details) - Customer A - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=docs_CustomerAMember', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=docs_CustomerAMember', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=docs_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=docs_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169990164944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies- Property, Plant and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember', window );">Furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember', window );">Furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember', window );">Computers and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internal-use software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989008624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 419,052<span></span>
</td>
<td class="nump">$ 343,548<span></span>
</td>
<td class="nump">$ 206,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=docs_SubscriptionMember', window );">Subscription</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">389,739<span></span>
</td>
<td class="nump">319,298<span></span>
</td>
<td class="nump">192,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember', window );">Service, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 29,313<span></span>
</td>
<td class="nump">$ 24,250<span></span>
</td>
<td class="nump">$ 14,641<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=docs_SubscriptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=docs_SubscriptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169983743104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Deferred Revenue Contract Balance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 84,985<span></span>
</td>
<td class="nump">$ 83,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ContractWithCustomerLiabilityAdditionsNet', window );">Additions, net, during the period</a></td>
<td class="nump">439,503<span></span>
</td>
<td class="nump">345,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from the beginning balance</a></td>
<td class="num">(83,231)<span></span>
</td>
<td class="num">(82,534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance', window );">Revenue recognized from contracts invoiced during the period</a></td>
<td class="num">(335,821)<span></span>
</td>
<td class="num">(261,014)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 105,436<span></span>
</td>
<td class="nump">$ 84,985<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerLiabilityAdditionsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Additions, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerLiabilityAdditionsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169984755216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ContractWithCustomerLiabilityAdditionsNet', window );">Additions, net, during the period</a></td>
<td class="nump">$ 439,503,000<span></span>
</td>
<td class="nump">$ 345,041,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled revenue</a></td>
<td class="nump">2,200,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CapitalizedContractCostAdditions', window );">Capitalized contract acquisition costs</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of deferred contract costs</a></td>
<td class="nump">8,785,000<span></span>
</td>
<td class="nump">9,755,000<span></span>
</td>
<td class="nump">6,883,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostImpairmentLoss', window );">Deferred contract costs, impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ContractWithCustomerLiabilityAdditionsNet', window );">Additions, net, during the period</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CapitalizedContractCostAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Contract Cost, Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CapitalizedContractCostAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerLiabilityAdditionsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Additions, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerLiabilityAdditionsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_AMiONMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169984521728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 728,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(18,924)<span></span>
</td>
<td class="num">(20,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">682,972<span></span>
</td>
<td class="nump">708,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cost or Amortized Cost, money market funds</a></td>
<td class="nump">158,027<span></span>
</td>
<td class="nump">112,809<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost', window );">Cost or Amortized Cost, cash equivalents and marketable securities</a></td>
<td class="nump">828,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Fair Value, cash equivalents and marketable securities</a></td>
<td class="nump">809,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cost or Amortized Cost, money market funds</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value, money market funds</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,758<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost', window );">Cost or Amortized Cost, cash equivalents and marketable securities</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Fair Value, cash equivalents and marketable securities</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">701,829<span></span>
</td>
<td class="nump">705,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(18,924)<span></span>
</td>
<td class="num">(20,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">682,972<span></span>
</td>
<td class="nump">685,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">7,271<span></span>
</td>
<td class="nump">7,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">7,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">27,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">27,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">78,609<span></span>
</td>
<td class="nump">9,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">78,489<span></span>
</td>
<td class="nump">9,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities | Corporate notes and bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">119,241<span></span>
</td>
<td class="nump">129,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(778)<span></span>
</td>
<td class="num">(1,796)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">118,512<span></span>
</td>
<td class="nump">128,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities | Sovereign bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">7,744<span></span>
</td>
<td class="nump">8,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(360)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">8,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities | U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">461,584<span></span>
</td>
<td class="nump">549,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(17,509)<span></span>
</td>
<td class="num">(18,260)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 444,087<span></span>
</td>
<td class="nump">$ 531,641<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents and Short Term Investments, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989476752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">$ 360,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo', window );">Due in one year to two years</a></td>
<td class="nump">315,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Asset-backed securities</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 682,972<span></span>
</td>
<td class="nump">$ 708,062<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993988624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss', window );">Accrued interest</a></td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList', window );">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Prepaid expenses and other current assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized losses related to debt securities</a></td>
<td class="nump">$ 18,924,000<span></span>
</td>
<td class="nump">20,494,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss', window );">Debt securities impairments loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense', window );">Debt securities credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance', window );">Fair value of debt securities which no credit losses were recognized</a></td>
<td class="nump">$ 653,400,000<span></span>
</td>
<td class="nump">$ 684,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-Sale, Allowance for Credit Loss, Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Impairments Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DebtSecuritiesAvailableForSaleImpairmentsLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, With No Credit Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL121698322-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267856-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes accrued interest, after allowance for credit loss, on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169982390768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">$ 682,972<span></span>
</td>
<td class="nump">$ 708,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">682,972<span></span>
</td>
<td class="nump">685,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">7,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">27,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate notes and bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">118,512<span></span>
</td>
<td class="nump">128,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember', window );">Sovereign bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">8,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government and agency securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">444,087<span></span>
</td>
<td class="nump">531,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">809,247<span></span>
</td>
<td class="nump">708,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out consideration liability</a></td>
<td class="nump">21,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total contingent earn-out consideration liability</a></td>
<td class="nump">21,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="nump">22,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">682,972<span></span>
</td>
<td class="nump">685,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial paper | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">78,489<span></span>
</td>
<td class="nump">9,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="nump">20,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Asset-backed securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">7,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Certificates of deposit | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">27,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Corporate notes and bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">118,512<span></span>
</td>
<td class="nump">128,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Sovereign bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">8,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. government and agency securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">444,087<span></span>
</td>
<td class="nump">531,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">566,023<span></span>
</td>
<td class="nump">550,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total contingent earn-out consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="nump">20,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">439,748<span></span>
</td>
<td class="nump">530,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Commercial paper | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">126,275<span></span>
</td>
<td class="nump">20,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Asset-backed securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Certificates of deposit | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Corporate notes and bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Sovereign bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | U.S. government and agency securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">439,748<span></span>
</td>
<td class="nump">530,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">243,224<span></span>
</td>
<td class="nump">157,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total contingent earn-out consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">243,224<span></span>
</td>
<td class="nump">155,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Commercial paper | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">78,489<span></span>
</td>
<td class="nump">9,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Asset-backed securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">7,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Certificates of deposit | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">27,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Corporate notes and bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">118,512<span></span>
</td>
<td class="nump">128,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Sovereign bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">8,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | U.S. government and agency securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">4,339<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out consideration liability</a></td>
<td class="nump">21,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total contingent earn-out consideration liability</a></td>
<td class="nump">21,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Commercial paper | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Asset-backed securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Certificates of deposit | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Corporate notes and bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Sovereign bonds | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | U.S. government and agency securities | Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Cash equivalents and marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169986857296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions in the period</a></td>
<td class="nump">21,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending fair value</a></td>
<td class="nump">$ 21,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Sales and marketing<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994105120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Total Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 24,854<span></span>
</td>
<td class="nump">$ 16,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(13,575)<span></span>
</td>
<td class="num">(8,470)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,279<span></span>
</td>
<td class="nump">8,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">2,816<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember', window );">Computers and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">745<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internal-use software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 20,405<span></span>
</td>
<td class="nump">$ 15,057<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993958448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of internal-use software development costs</a></td>
<td class="nump">4,800,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAdditions', window );">Capitalized internal-use software development costs</a></td>
<td class="nump">5,300,000<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions made to capitalized computer software costs during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987068768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Accrued commissions</a></td>
<td class="nump">$ 5,733<span></span>
</td>
<td class="nump">$ 6,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll, bonus, and related expenses</a></td>
<td class="nump">8,739<span></span>
</td>
<td class="nump">8,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_AccruedEmployeeStockPurchasePlanCurrent', window );">Employee contributions under employee stock purchase plan</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_RebateLiabilitiesCurrent', window );">Rebate liabilities</a></td>
<td class="nump">3,348<span></span>
</td>
<td class="nump">4,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Sales and other tax liabilities</a></td>
<td class="nump">1,504<span></span>
</td>
<td class="nump">785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of contingent earn-out consideration liability</a></td>
<td class="nump">5,920<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">5,412<span></span>
</td>
<td class="nump">4,263<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 31,245<span></span>
</td>
<td class="nump">$ 25,270<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_AccruedEmployeeStockPurchasePlanCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Employee Stock Purchase Plan, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_AccruedEmployeeStockPurchasePlanCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_RebateLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rebate Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_RebateLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169988890736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,863,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Portion Of Curative Talent, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale of business consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow', window );">Sale of business consideration, held in escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember', window );">THMED, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">689,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Value of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember', window );">THMED, LLC | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets acquired, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 74,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="nump">53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out consideration liability</a></td>
<td class="nump">21,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent earn-out consideration (up to)</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Contingent earn-out consideration liability, minimum guarantee</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance', window );">Contingent earn-out consideration liability, subject to performance</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod', window );">Contingent earnout consideration performance period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod', window );">Business combination contingent consideration liability payable period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Subsequent Event | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities', window );">Contingent consideration liability settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangibles, useful life</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangibles, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangibles, useful life</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability Payable Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Subject to Performance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment For Contingent Consideration Liability, Operating And Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=docs_PortionOfCurativeTalentLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=docs_PortionOfCurativeTalentLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_AMiONMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169988820016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Purchase Consideration Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 67,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember', window );">THMED, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,280<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,915<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_AMiONMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994452016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 38,600<span></span>
</td>
<td class="nump">$ 9,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(6,764)<span></span>
</td>
<td class="num">(1,971)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">31,836<span></span>
</td>
<td class="nump">7,909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">37,069<span></span>
</td>
<td class="nump">9,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 1,531<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169990338448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">67,940,000<span></span>
</td>
<td class="nump">18,915,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169983741264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Future Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 4,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">4,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">4,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">4,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">4,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">11,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 31,836<span></span>
</td>
<td class="nump">$ 7,909<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989159872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Changes in Carrying Amount of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of period</a></td>
<td class="nump">$ 18,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">49,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of period</a></td>
<td class="nump">$ 67,940<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994104256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 08, 2021</div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Reclassifications of temporary to permanent equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,286,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ConversionOfStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ConversionOfStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90193-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169975833552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">5 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 08, 2021 </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 30, 2010</div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 12, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,941,000<span></span>
</td>
<td class="nump">192,398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount | $</a></td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,647<span></span>
</td>
<td class="nump">2,150,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program, period in force</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="nump">$ 86,072<span></span>
</td>
<td class="nump">$ 2,698<span></span>
</td>
<td class="nump">$ 2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,834<span></span>
</td>
<td class="nump">$ 31,442<span></span>
</td>
<td class="nump">7,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,407,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,407,000<span></span>
</td>
<td class="nump">26,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,400<span></span>
</td>
<td class="nump">$ 521,600<span></span>
</td>
<td class="nump">$ 52,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.73<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized compensation expense, option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period from the date of grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense excluding option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested equity instruments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized compensation expense, option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Options unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Options forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,792,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense excluding option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested equity instruments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan | Individuals With Voting Interest Less Than Threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock', window );">Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan | Individuals With Voting Interest At Threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock', window );">Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold', window );">Voting interests threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period from the date of grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding', window );">Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member', window );">2021 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding', window );">Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease', window );">Maximum annual increase of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member', window );">Options outstanding outside the Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,682,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,027,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,027,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,654,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,654,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_ContractWithUSNewsWorldReportLPMember', window );">Contract With U.S. News &amp; World Report, L.P.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price called by warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ClassOfWarrantOrRightExercisesInPeriod', window );">Warrants exercised in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue', window );">Warrants exercised in period , intrinsic value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U.S. News Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price called by warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_WarrantsAndRightsOutstandingVestingPeriod', window );">Warrants and rights outstanding, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense excluding option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U.S. News Warrant | Share-Based Payment Arrangement, Subsequent to Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_WarrantsAndRightsOutstandingVestingPeriod', window );">Warrants and rights outstanding, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U.S. News Warrant | Measurement Input, Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U.S. News Warrant | Measurement Input, Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U.S. News Warrant | Measurement Input, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U.S. News Warrant | Measurement Input, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U.S. News Warrant | Measurement Input, Expected Dividend Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,523,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CommonStockVotingRightsNumberOfVotes', window );">Common stock, number of votes per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,682,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,682,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_CommonStockVotingRightsNumberOfVotes', window );">Common stock, number of votes per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,258,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,258,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ClassOfWarrantOrRightExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Exercises in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ClassOfWarrantOrRightExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Exercises in Period, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockVotingRightsNumberOfVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number Of Votes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockVotingRightsNumberOfVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ConversionOfStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ConversionOfStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_WarrantsAndRightsOutstandingVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding, Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_WarrantsAndRightsOutstandingVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestLessThanThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestLessThanThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestAtThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestAtThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=docs_ContractWithUSNewsWorldReportLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=docs_ContractWithUSNewsWorldReportLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169984346832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity - Common Stock Reserved for Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares)</a></td>
<td class="nump">641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">22,407,000<span></span>
</td>
<td class="nump">26,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">62,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">19,752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant (in shares)</a></td>
<td class="nump">31,112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Units outstanding (in shares)</a></td>
<td class="nump">2,157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member', window );">2021 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant (in shares)</a></td>
<td class="nump">6,243,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member', window );">Options outstanding outside the plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">2,654,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987931152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">26,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(3,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options forfeited and expired (in shares)</a></td>
<td class="num">(859)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">22,407<span></span>
</td>
<td class="nump">26,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Vested and exercisable, at end of period (in shares)</a></td>
<td class="nump">11,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, at end of period (in shares)</a></td>
<td class="nump">21,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 4.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">2.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired (in dollars per share)</a></td>
<td class="nump">4.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">4.39<span></span>
</td>
<td class="nump">$ 4.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, vested and exercisable at period end (in dollars per share)</a></td>
<td class="nump">2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, vested and expected to vest at period end (in dollars per share)</a></td>
<td class="nump">$ 4.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual term, outstanding</a></td>
<td class="text">6 years 6 months 21 days<span></span>
</td>
<td class="text">7 years 7 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term, vested and exercisable at period end</a></td>
<td class="text">5 years 7 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term, vested and expected to vest at period end</a></td>
<td class="text">6 years 6 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="nump">$ 627,187<span></span>
</td>
<td class="nump">$ 1,293,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, vested and exercisable at period end</a></td>
<td class="nump">354,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at period end</a></td>
<td class="nump">$ 603,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993840320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock Options Valuation Assumptions (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">46.50%<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">58.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">0.77%<span></span>
</td>
<td class="nump">0.26%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">1.02%<span></span>
</td>
<td class="nump">1.02%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Fair value of common stock (in dollars per share)</a></td>
<td class="nump">$ 18.41<span></span>
</td>
<td class="nump">$ 2.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Fair value of common stock (in dollars per share)</a></td>
<td class="nump">$ 21.41<span></span>
</td>
<td class="nump">$ 10.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987143744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(324)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">1,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 68.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">34.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">51.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">44.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 40.08<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169982166384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Performance-Based Restricted Stock Units Activity (Details) - Performance-Based Restricted Stock Units - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">213,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(11,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(8,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">206,000<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 80.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">34.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">80.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">38.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 34.68<span></span>
</td>
<td class="nump">$ 80.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994408352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 47,834<span></span>
</td>
<td class="nump">$ 31,442<span></span>
</td>
<td class="nump">$ 7,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">9,634<span></span>
</td>
<td class="nump">4,979<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">12,583<span></span>
</td>
<td class="nump">7,065<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">16,939<span></span>
</td>
<td class="nump">8,108<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 8,678<span></span>
</td>
<td class="nump">$ 11,290<span></span>
</td>
<td class="nump">$ 2,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994111104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 112,818<span></span>
</td>
<td class="nump">$ 154,783<span></span>
</td>
<td class="nump">$ 50,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Undistributed earnings attributable to participating securities, basic</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Undistributed earnings attributable to participating securities, diluted</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Class A and Class B common stockholders, basic</a></td>
<td class="nump">112,818<span></span>
</td>
<td class="nump">133,257<span></span>
</td>
<td class="nump">21,556<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Class A and Class B common stockholders, diluted</a></td>
<td class="nump">$ 112,818<span></span>
</td>
<td class="nump">$ 133,257<span></span>
</td>
<td class="nump">$ 21,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares)</a></td>
<td class="nump">193,176<span></span>
</td>
<td class="nump">163,484<span></span>
</td>
<td class="nump">74,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Dilutive effect of assumed exercise of common stock warrants (in shares)</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares)</a></td>
<td class="nump">213,425<span></span>
</td>
<td class="nump">191,017<span></span>
</td>
<td class="nump">95,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract', window );"><strong>Net income per share attributable to Class A and Class B common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment (in shares)</a></td>
<td class="nump">20,027<span></span>
</td>
<td class="nump">27,290<span></span>
</td>
<td class="nump">20,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=docs_OtherShareBasedAwardsMember', window );">Other share-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment (in shares)</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic And Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=docs_OtherShareBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=docs_OtherShareBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169990220624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">1,088<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="nump">76,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=docs_OtherShareBasedAwardsMember', window );">Other share-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">572<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=docs_OtherShareBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=docs_OtherShareBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169988902848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Tax Expense Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current provision:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 3,515<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 1,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3,498<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">7,013<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred provision (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">11,834<span></span>
</td>
<td class="num">(34,852)<span></span>
</td>
<td class="nump">4,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1,491<span></span>
</td>
<td class="num">(6,395)<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">13,325<span></span>
</td>
<td class="num">(41,247)<span></span>
</td>
<td class="nump">4,987<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">$ 20,338<span></span>
</td>
<td class="num">$ (40,778)<span></span>
</td>
<td class="nump">$ 7,559<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989147824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income taxes at statutory rate</a></td>
<td class="nump">$ 27,963<span></span>
</td>
<td class="nump">$ 23,941<span></span>
</td>
<td class="nump">$ 12,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">6,757<span></span>
</td>
<td class="nump">5,503<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="num">(5,076)<span></span>
</td>
<td class="num">(8,332)<span></span>
</td>
<td class="num">(1,845)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Stock-based compensation</a></td>
<td class="num">(14,841)<span></span>
</td>
<td class="num">(71,780)<span></span>
</td>
<td class="num">(5,796)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">1,878<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Section 162(m) limitation</a></td>
<td class="nump">4,782<span></span>
</td>
<td class="nump">7,260<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">752<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">$ 20,338<span></span>
</td>
<td class="num">$ (40,778)<span></span>
</td>
<td class="nump">$ 7,559<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989332544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue', window );">Accruals and deferred revenue</a></td>
<td class="nump">$ 2,744<span></span>
</td>
<td class="nump">$ 1,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">1,733<span></span>
</td>
<td class="nump">32,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research &amp; development credit carryforwards</a></td>
<td class="nump">7,230<span></span>
</td>
<td class="nump">12,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DeferredTaxAssetsLeasingArrangements', window );">Operating lease liabilities</a></td>
<td class="nump">3,968<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense', window );">Acquisition and other related expense</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation expense</a></td>
<td class="nump">6,492<span></span>
</td>
<td class="nump">3,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross', window );">Unrealized loss</a></td>
<td class="nump">4,785<span></span>
</td>
<td class="nump">5,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">19,825<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">47,075<span></span>
</td>
<td class="nump">55,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(5,236)<span></span>
</td>
<td class="num">(4,731)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net of valuation allowance</a></td>
<td class="nump">41,839<span></span>
</td>
<td class="nump">51,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(2,734)<span></span>
</td>
<td class="num">(1,899)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease right-of-use assets</a></td>
<td class="num">(3,506)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(692)<span></span>
</td>
<td class="num">(398)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(6,932)<span></span>
</td>
<td class="num">(2,573)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 34,907<span></span>
</td>
<td class="nump">$ 48,558<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Acquisition and Other Related Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Deferred Expense, Capitalized Research And Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169975661088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 5,236,000<span></span>
</td>
<td class="nump">$ 4,731,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Net operating loss carryforwards, state</a></td>
<td class="nump">15,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Net operating loss carryforwards, federal</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">7,913,000<span></span>
</td>
<td class="nump">$ 6,188,000<span></span>
</td>
<td class="nump">$ 3,162,000<span></span>
</td>
<td class="nump">$ 2,475,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact the effective tax rate</a></td>
<td class="nump">5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Tax credit carryforwards, research</a></td>
<td class="nump">7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Tax credit carryforwards, research</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169990215680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 6,188<span></span>
</td>
<td class="nump">$ 3,162<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions related to the current year</a></td>
<td class="nump">2,210<span></span>
</td>
<td class="nump">2,995<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions related to prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions related to prior years</a></td>
<td class="num">(472)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions related to a lapse of statute</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 7,913<span></span>
</td>
<td class="nump">$ 6,188<span></span>
</td>
<td class="nump">$ 3,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993843520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 08, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_PartnershipAgreementExtensionPeriod', window );">Partnership agreement, extension period</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted', window );">Partnerships agreement, period before termination is permitted</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod', window );">Partnership agreement, revenue guarantee during noncancelable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod', window );">Partnership agreement, revenue guarantee during noncancelable period, payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_HostingArrangementPeriod', window );">Hosting arrangement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_HostingArrangementAnnualCommitment', window );">Hosting arrangement annual commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Hosting arrangement remaining commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany', window );">Partnership agreement, annual revenue guarantee to partnering company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany', window );">Partnership agreement, annual revenue guarantee to partnering company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_HostingArrangementAnnualCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Hosting Arrangement, Annual Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_HostingArrangementAnnualCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_HostingArrangementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Hosting Arrangement, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_HostingArrangementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement, Annual Revenue Guarantee To Partnering Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement Extension Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period, Payment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partnerships Agreement Period Before Termination Is Permitted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993674576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 13,819<span></span>
</td>
<td class="nump">$ 1,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">15,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=docs_OfficeSpaceLeaseInIrvingTexasMember', window );">Office Space Lease In Irving, Texas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=docs_OfficeSpaceLeaseInIrvingTexasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=docs_OfficeSpaceLeaseInIrvingTexasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169993601376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,592<span></span>
</td>
<td class="nump">$ 1,159<span></span>
</td>
<td class="nump">$ 2,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 2,696<span></span>
</td>
<td class="nump">$ 1,273<span></span>
</td>
<td class="nump">$ 2,515<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169994011648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</a></td>
<td class="nump">$ 718<span></span>
</td>
<td class="nump">$ 1,107<span></span>
</td>
<td class="nump">$ 2,569<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169987903344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">7 years 21 days<span></span>
</td>
<td class="text">1 year 7 months 20 days<span></span>
</td>
<td class="text">1 year 4 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">4.18%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169989504576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 2,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">2,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">18,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(2,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 15,637<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169984268800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income</a></td>
<td class="nump">$ 9,287<span></span>
</td>
<td class="nump">$ 2,148<span></span>
</td>
<td class="nump">$ 301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized loss on sale of marketable securities</a></td>
<td class="num">(1,093)<span></span>
</td>
<td class="num">(1,231)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Realized gain on sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(448)<span></span>
</td>
<td class="num">(533)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 8,048<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
<td class="nump">$ 4,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140170072611488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer discretionary contribution amount</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140170072565024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>docs-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:docs="http://www.doximity.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="docs-20230331.xsd" xlink:type="simple"/>
    <context id="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie97abaadc2504001892e499621c9a22d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie515b3edc3ec46ef8e0798e729e1c42d_I20230519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-19</instant>
        </period>
    </context>
    <context id="i429c89ea5d0c416f85960bc2a4c84894_I20230519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-19</instant>
        </period>
    </context>
    <context id="i73fa6205d93043c89ed98735725c4862_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2663b241eb57491e938b976279a54ef3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i553913e079194069a9a91da8d0544cb1_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5b796d52a1c24138acd0adc60a1d55b6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i51bee6fa91384d2b859a47c7b4a2bdf1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i239eff19d97e41b9b0482aa745e705a8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8ac170db1b65461e92998fa288b22bb1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2aec2a3cf466470d83a702d7d3b279e8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i46d6f06521b34618831102060f160822_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic816ea61c72b4526baf4f08dda97575f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibca3ba7268b644c385960bab4881daa4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie2a4a27e961b4732a69f4329e75908ce_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0c7aad5f38d74f8ea3efd5af5a079c17_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id3f4e1f1e9ef42a596eb67129ffa34b2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iee132da446eb4ed08a23cdf121ea6b0c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ff263310c7e4813b992a8d0b1ad53cc_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0955332a233f4c018f259ff874af4f61_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i351c61ddd53e415fb0132c3f28ec7e27_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4eb2e149b8ed4edea42e1794b79eead8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifccc74565273499782a3a98a62beb0f7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i64036fdea8df4afda807a5cece385147_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i49e68429295e421e87c13df53148e23a_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i713bedb0e69c494c8ed7f90198455f80_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i84d98fc03def4365a7f3fa504e96b220_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd694dc2e48a4412a000d9b02c10f96e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i419e8bf8b3aa40158f8de4af142458a2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i448d1c798e6544a99cf0cf2663a4894b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iccdb5f0a810d4eebb2bafe0d42b2c742_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib6eef4e680704bceaea439b7961166cd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i279a208c32804584b31bfd94d3dd86ac_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaae932e69d134ab791bd1c42fff0771b_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iccbddb5d88f943d18b1e2bca79988299_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id9c60a7a5216441aacc21b7da53bdeb8_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="ib2e9777aeaf94d178823baaa223076df_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic9cad1e062b649388bc8309807dd70ec_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia35ab93e92f745bf8d13e1856e15688d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a7a508b84f14a2c89f8f76f79912495_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMarketingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66fbd0824ee44aa4999edf05fdba61a6_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionHiringSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id95916c6936340cdade0aa07aaf2b43c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i395392694ee54a58a68d60da43cd9346_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i193acb95329a49ffa11b381f072505f0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i13475fef7778429390ef0860c7b05a45_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibf3ecb7779284d14862d24d80dc3241e_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4bc3bbea93e64ae99dfb98af6a33b945_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0728b940a9f64fc9bf1ed1b456fbfb6a_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i396b959629334256bafddb8623b58bbb_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8189eaf3c5a341eb905e447cbdc1e660_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iad7a18fbd0c14f8ba371333c97190a67_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd6a54410372468a8511243ad114dbe9_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2ad31f043cf54368a2e28a707d138b65_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1c10798df81841449d5dbfb26d76969d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id6779a54192f451097a27ad596eba040_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie833f8b08d684b3bb2c16e4a4497f123_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i201f487ed07e45f08dc9cea2b1958064_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic9331d77b340451ca2423fed1eb629d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia473d08e40b3424da33538edeca5a18a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8e08c2c5bc6c4949a1de1927437917b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7961eb9eb71b4575b98a42d5964377ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if06de78b66e74d5080cb4950adc00e7e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i946014a5671d4e999aa1c822257039c4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idfbd7fea093845f382923f9f0125016c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7e31cc3adeec45e18d64bd94c7d49110_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0010efa975ea4d45a2dbde4069444622_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2da9dd48330643cea24f08da15d08f08_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5a55bf9be127468b8145b679c3cf838e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie3fd684df0de4636aa6962e405af5eea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e3f89117d4a4f85908606a734310a23_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id941a7f003394c1fb37f82255dbe3a41_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie594ea2a3b124a90b0be930db8daf27e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic6537334aae64a1692c21c4e30957279_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i973077bac51d46c88beba9ea2d79c88b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iffc1194235564259b4e5b6767a113b31_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5c8099fd0c864406be81e7c53be8b1d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i80bd4f5f67e2484cb7851cf004cdfad5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i36192b7a614641d2838f423484ca11ba_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1239324fd29a4d1993d7b6b495489a13_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i66936efbaed5446aa82b9ca004d420ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iec0fbdefb9f344138749e5e674d592cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie6c235234c42491f8e4131aaefe2d585_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i98667fb3a0514e69a891a6c081d597f0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i094e2dbabb8e4569979ac9d1ad7c84d9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0963b486b6ee4c8e9ddec603fe52aa57_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ife6e57af6f2b4495abe15bf65ff24f3e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5b3c5e95b7974760b927c85be52fe69e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i58e4533ec3b849e492c02f5e01cd9d6a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i09e67dedfef14071b24d1b252a8bbef3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1801570f9a834b549ef10690ad07160d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifcf35ce1750d4d47b705f6c8963f102c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib56e571af58f495b8ff9277d066ea6b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied4d9be5d4554ad18ecaefd25a72b9a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id00a28ee4e38426aa959a32377ae4867_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2ce81717c598448da1d06f768af2f4ba_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if0b8ad77a8b54ef28439d747d79868d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifae67aa06b9f4fdd9689aa90c7f5dc18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id70c3b9155fa4014bd5667ee3349735b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i98636d2454d045d09a3f9d68e1038e6d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9831b78d3b4c462b8337fda154bdd3ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if458aec6fca44eddbd86df4028e655b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2b84df18f95a4433bdee213a281e943c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6ea633cae78847bd9a91472bbef8eaeb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7bde8858ac6a4a3eb52f9c270d702920_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2286649f7330456ea7cbe19b6772994e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3ff5a0797ef9423a9741628a3da70909_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i47804551dcb6422893826946bddd57c2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic05928ff03824eacb3dec61c64f97f64_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib75f9bcdbb0d429ea39c456129fe42b7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8f27c894e80643b7bb1023a488f98851_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3a9950d0144847e69bf21ab85c40dee1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8af851fc24a442e8aee600463f49f4bb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0d09321a4a9a437083a3c246e5205811_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05788cb1cd704a9aa7f2c4a233d58bfc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07b39367e3554a54949428ce5c073cd4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib5d7ef86da204a758e391dfe903e1498_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i266a23a458034fcab5ce09b2e8f653a3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d2e893789f44ff5b5960e5ae1657eee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if00cf42cc410455b9902a0c72c79d686_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56cca9f8ee3e46cd915bfb9e19b9f84d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i935023b9804f4655be2ead76741d2746_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i86a6490c23ed4240aa47bc61b8c3cc1d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic4ea9461173a44349f0685c96d1dcce1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7aa9ca7e9e934914903f4b7ed4c4ec8c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1c19be996cea4d049a4bb47f817d6982_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibabb2f6f89e14ad0ac35698b41047d5f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8d946978d3a54bbcb36b85d5855cebd0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d38645272f547daad9432aae576444c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c236f2898f14fbfa92c2686609c680c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e816f48c9cd41c8ba78b4ddd652f74f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idb93a4838e9c497484028bc965359528_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7538ba3acbdc47ac862773381252a6f1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie236fc059a234762bbc16ada70ba77e4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i92af9636372c49d2a9396d3c6194fe71_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieda7830848534f8f99c833d0078f6325_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3d87a52b74e641e5a5e5d658f483a695_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia3300bb0e530443a969df765b1b31393_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i02c06a11eaaf4c74901e4c3250b6056e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2667c5bdf5084cac925ae49f37d0694b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f3d74c12b094566806aae4a3ee77109_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f39a5b24bf14e7e8210e52e2c38875c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i005f944628624d14994ceacb3670c691_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i24c46d6de0854211be7d105d64fb8545_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic6b38e693ec6459a8eb430afd06d1251_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic9c77e864c11452c9c2ce068c5c61f23_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i28a659e594ee4fce9a6eb802ff0c4752_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d5a6f37cf644c71865652f7c26ad37b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8c5538d593e0408abf61ba5d1091154b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ida82cc5649fa4f7d87b92b1e33c7bbf4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i491fd2bcc91649b49adbc5e628f544ad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i909ed7ebdc6e40c2b4891ea6cce48b16_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe2e05eecb8e45dab3610612e9815a2f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5378ae045e224699baa5bf281d6856b8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2b07362e43874a6594d73dabd00c8bd4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5254616f1e114acbae4ffe43531c2c3e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1f9cc7883e82437ebb578096cb2a8fd6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0eba1ae8f23b43768d9773249e2d7a88_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3fb568cd7f51427db6f63dfe746772cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i028db93b3eea4709b1441884e9e13e7c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4b800cd958594616ba0a181f993bd05f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i69297980cac1443bb352fff016d929b6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="ie68ef9f8618c452ea229d8ad30b5bf6a_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i792a31a0059348cda0386afa68fcd936_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="iab8cf2152e6a45f19fde2dadc29bceb1_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ia7176555421542a3996fd5fb7b63446f_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="iedea9d7e7d2f4459ae223d71da4c8b3e_D20230401-20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="i33d40acad4a14920a7156beb462b2eb5_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i7e291345f6a64a58aaf2f650b1ba9147_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i078c5a28b0454db6b490e4fff852e96e_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i0f275888ff1e48c7a97763a827fcee54_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="ifffbf1b0e78f4ac596aeef622400a7dd_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="ic7a96ee455094c298ce4724ad93c884e_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i96330e2ec3d34bf5b8ce4bf07abe50a2_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i9dd1e4f4b78c402ab313d73be32dece7_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="icd29a5137477430b8f27c6edb2086fbe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a6d175e49204bda81ef5fb379cd9fea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8a6c090726294b758ee283e14aedd42c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iea1fb9c634ba4816850d26fbc19237a3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia5fc25c9a4e64fa18623717924e129f3_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8232534e9744410f8e611d99b9e84386_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="ib0806f84593344d893e74652c3b10250_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="i20facf15f91a4b51a59cf495eff488b0_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="ibf068271d669438eafc6af652e833d08_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="id4aeaddbe31d41d99ae6142cc71b26ca_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9ddd079c5de94e16b92910b68fa5ba6d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3443fdd6919e400180bc0aa7089b7a55_I20220512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2022-05-12</instant>
        </period>
    </context>
    <context id="i10df40a9fbe74c14b3193c4c8faa6cfd_D20220512-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2022-05-12</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5e8f6b95c6e94f2d8a158e8e14a0d188_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i073baaa025aa4391ae3be3ed0f9b6b8b_D20221028-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2022-10-28</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i185f2fc156dc487daa4da85b1135e893_D20221028-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2022-10-28</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i8dd14ac8c2ad476a91aae55b5e50e12b_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i60ed2d73233c4b148efb0ab0281f05c5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99dac51b2929424c872d9593a38b3a9c_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ic83bcd7a1cdd424a827ac1b242d45d64_D20211001-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">docs:ShareBasedPaymentArrangementSubsequentToTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i79cbc3050a9f4e728de0f2541e8414d5_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i39c41ee9b35d4ca198dae8381879c81d_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ic5f71bd088ee4c3fa9152d5f8241176d_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib20f32b4eb624a099afa796abcc7e5e7_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7c602ccebaef4e4fb1436ee5279c5deb_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i31ff09070ac64dc9a6c3517e07569162_D20211001-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="id7a2d89272fb4cd08d7941569bcdac06_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if0b910594e0447b48176dee4458443bc_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0dcfc10564a84d99afdf2868944eaf6f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i329535dcf29942da975d098642b9ca8c_D20100401-20100430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestLessThanThresholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-04-01</startDate>
            <endDate>2010-04-30</endDate>
        </period>
    </context>
    <context id="i8f5a97d0329f49aba3a9c73948197302_D20100401-20100430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestAtThresholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-04-01</startDate>
            <endDate>2010-04-30</endDate>
        </period>
    </context>
    <context id="i9add1738f524485aa3f0e69e33348404_D20100401-20100430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-04-01</startDate>
            <endDate>2010-04-30</endDate>
        </period>
    </context>
    <context id="i4731ee97e9044ac481efdbc35006ea21_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i237ab3fe7b4848009fc6504e611304a8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EmployeeStockPurchasePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i392549f122de4599a31a1bc930b60d7c_D20170401-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i5f2625bab237468f82960faeaa65ecd8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7716737ca7654b41b69b01245e63ae37_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3b225b55e25041dca4b2711a6a9a0a19_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ida806691cbf34206b1424fc5e64367de_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if1179d128dab4059b72b6142b8bc8b8d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1dfa57621a8d47a2a7dc41b2f9ba12c7_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i991245b0925a47909f34aedbdca61682_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id87182a9d8de4d7fbe7b3181cb3305b0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i26986aac2225480487211e3064de5fd8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic468072a804447168766f95eca229ba8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4652006ba32649869cae91401685e771_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i974d976e0f864a8ea9541b7b73048e70_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa33e8ecd9a84ebfae3604c0b6afa814_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia38954e2b9174a84b2206f208d8b037c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9ada4a0cc2124109ba680255244c2035_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie09eece225b24d259739810162abac64_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1e2a2f066c684b6dbfa470b1af8ddf0e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if594047406484611a6549a4cd2fd4424_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i999bcffa27f543c7af8d4b487ac793aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id3057033fffd40dbb4f5e5ee0064bd42_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i775865ed2f994ca4b21733ec560d2c8a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3b047f5f9ca746b7b52daa842f8517c4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i49f50d35db5d4553b776c905f48f0eb1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i455bb77bdffd4042986f586a60bc3c32_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63c582bee6244ae9bf6eba0489faaa89_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic806ae5f2fb3486d8a36fbf8855115c8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0ef8644397db461d970fc87d9283f043_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id81f09cb89e346d9b6bab4046c526ee3_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i74e15aef3d274c7b9ac433e9e2fe446b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icb2ef783dd62482f9546438633e5ef6a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2705eaddbac94b21a48222ef233d1bae_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1643d43bb3664592a6b37cafbac8f20c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7528701bd71f4ef1b51847193823879c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaa288c7de6084883bc844573b299fa09_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8811c0f4a5d34a13b7ee23df9071c2f2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i28297a7cc3e04248b1ee658ba91be269_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i01d3afc740f4462684bea44adc594e9c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9f982a6f25a441579e268bbeafa0e133_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic706608c6ad1415d94545d91154d4ff2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia75bd356b16a493fbe592c7374ec7564_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2251c5f98a1541d58cc80a3e18e94e7c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie28e082f86864f4680a3d75aa82cec9b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i03a2e271385b4f50b853a1db39b70580_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i20ee62022dbc4678aa4e1eda92d558d6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i68d0cfc8bce14eb0bbdb2d1d8791664f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i76d02cec04034dcebafb0e2d3f74bd25_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7d9e728004f0418fb411e0ffbf42921b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17ea570245b84a03b7cfc4320cff3431_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i76934d327b4e4c10a7eaeee01e5c0d44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idbca9608b0944cceac22ef5ca0e4cb5a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i906daea421694946be847efacad3faf2_D20211008-20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-10-08</startDate>
            <endDate>2021-10-08</endDate>
        </period>
    </context>
    <context id="ic9b04179a332405c949f34abf3c2def8_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic9d45f1ab6dd4164bda35547de20a2ec_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i40c5d3ad3fc5494998c4463ceb353d93_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">docs:OfficeSpaceLeaseInIrvingTexasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>docs:reporting_unit</measure>
    </unit>
    <unit id="vote">
        <measure>docs:vote</measure>
    </unit>
    <unit id="segment">
        <measure>docs:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18wLTEtMS0xLTE4MTc2OQ_14825969-ef68-4c44-951d-aa7072e9aa80">0001516513</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18xLTEtMS0xLTE4MTc2OQ_54f865a6-c8b2-4419-8afe-eb31e28ca229">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18yLTEtMS0xLTE4MTc2OQ_fccd0138-8c6d-4472-a6a7-a4ae361d2c4f">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M180L2ZyYWc6MWExNDY0Y2M4YzU1NGMwNTg4NWFiNDFlOGM4ZDcxMWQvdGFibGU6YTg3YzQ1NTI0NzkwNDQ3ZWFmMTBlM2NmYjkxNWMyZjMvdGFibGVyYW5nZTphODdjNDU1MjQ3OTA0NDdlYWYxMGUzY2ZiOTE1YzJmM18zLTEtMS0xLTE4MTc2OQ_72e8846f-9b5c-4bb4-9fa6-a2a2aab17469">false</dei:AmendmentFlag>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzE3MDQyNDMwMjMzNTky_1995d277-8431-4487-a901-191b21f55f52">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzE3MDQyNDMwMjMyMTQz_3e9d7d07-1cf9-455d-9196-8ee9cf5d4f4c">http://fasb.org/us-gaap/2022#SellingAndMarketingExpense</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <dei:DocumentType
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YWQzZTQ5OTY4ZmNiNGU1NjhkMDBkNTY3NzdmNDMyNTMvdGFibGVyYW5nZTphZDNlNDk5NjhmY2I0ZTU2OGQwMGQ1Njc3N2Y0MzI1M18wLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjM3NzFjZTJiYTExNjRiNWQ5OGM2NzkwMjFiYTg1NmY2Xzk_b73cd804-8335-47da-9c77-9f319c58f1c9">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18wLTAtMS0xLTE4MTc2OQ_f68636e5-26e2-49c1-8cb6-d4ed76e177c4">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18xLTEtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjkxYjNmMzg0MDNjZDRmNGU5YjllMTk2MTUzZjVlYzY5XzMw_5c05c867-a98f-46af-85b4-b8569d272a92">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18xLTEtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjkxYjNmMzg0MDNjZDRmNGU5YjllMTk2MTUzZjVlYzY5XzMw_4faf9a47-a690-4044-b13f-ea994a4550fc">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6NGNjYzE0ZjgxZmUzNDFhMTk4MmMwNzhhNWY5OTY4N2MvdGFibGVyYW5nZTo0Y2NjMTRmODFmZTM0MWExOTgyYzA3OGE1Zjk5Njg3Y18zLTAtMS0xLTE4MTc2OQ_15d63cb7-6565-4339-9852-32cde39dcb85">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc3_482a5b25-af2e-4590-8d15-e0ccd46f4b20">001-40508</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6Mjg1YTA1ZDhjMThhNDQwYWJlZDFlOGNiYTZhNzk0ZWEvdGFibGVyYW5nZToyODVhMDVkOGMxOGE0NDBhYmVkMWU4Y2JhNmE3OTRlYV8wLTAtMS0xLTE4MTc2OQ_c9e331b2-4098-4e3e-be54-3f9f0e4f6f97">Doximity, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8wLTAtMS0xLTE4MTc2OQ_b37e3da0-18e1-4e5e-a9ef-99118b7b9d97">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8wLTItMS0xLTE4MTc2OQ_fb6b7127-7ceb-4336-9640-c72599e0df57">27-2485512</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzU_d1d73885-7be9-4583-8b32-800f326cc4be">500 3rd St.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzg_89a4b2ce-4754-4bd5-8c2c-665b8a5c5524">Suite 510</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzEx_43971792-df2c-4050-95f7-02b57f2f4b4d">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzE1_9ec32fda-0b95-49f7-8bd7-fa2c840a45d8">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl8zLTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOjIzMjY3OTExNWIyYzRiY2FhY2IzNDY4YjEwY2UwMmIyXzE4_e61bd4b6-3233-4218-9ae1-90d19ae2b58a">94107</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl80LTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOmU4NjlhNGYzMzQ2NjQwOGVhNDI4Y2E0MWI3YTA3YTAwXzU_f03454fa-13aa-4149-80d5-d06963f4b9b7">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MzE2NjhjZTMyNTBjNGI3NDg1YTM3ZTllMjAxOTZlMmYvdGFibGVyYW5nZTozMTY2OGNlMzI1MGM0Yjc0ODVhMzdlOWUyMDE5NmUyZl80LTAtMS0xLTE4MTc2OS90ZXh0cmVnaW9uOmU4NjlhNGYzMzQ2NjQwOGVhNDI4Y2E0MWI3YTA3YTAwXzg_37ac0ed1-adbc-4b7c-9699-045c16bb9dd3">549-4330</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MjY2MThlMTIzMTIxNGZmNGJkMDk4ZmE3ZWY2NmZlOGIvdGFibGVyYW5nZToyNjYxOGUxMjMxMjE0ZmY0YmQwOThmYTdlZjY2ZmU4Yl8xLTAtMS0xLTE4MTc2OQ_4ff3f1fc-d8c5-4a5a-b917-f3e109f6d55f">Class A common stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MjY2MThlMTIzMTIxNGZmNGJkMDk4ZmE3ZWY2NmZlOGIvdGFibGVyYW5nZToyNjYxOGUxMjMxMjE0ZmY0YmQwOThmYTdlZjY2ZmU4Yl8xLTItMS0xLTE4MTc2OQ_d56ab647-8004-41f5-8bc7-702e02d943d2">DOCS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6MjY2MThlMTIzMTIxNGZmNGJkMDk4ZmE3ZWY2NmZlOGIvdGFibGVyYW5nZToyNjYxOGUxMjMxMjE0ZmY0YmQwOThmYTdlZjY2ZmU4Yl8xLTQtMS0xLTE4MTc2OQ_d86b5923-441c-4029-9e1d-14a3158d2c61">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8xNzA0MjQzMDIzNzA2Ng_b6dafcc6-42c0-4a85-a234-4aa6da334b5e">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDcz_0d96d208-ad38-4874-8dc2-aacf62238c0b">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc1_9a744b32-719e-4167-ba47-709d76dc2a91">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc4_02b91258-5f5f-4e0a-899c-b2f474e22a00">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YjgxOWM1ZWU2YTVlNDhjZDlkOTc0YjlhMDU2Yjg0MDMvdGFibGVyYW5nZTpiODE5YzVlZTZhNWU0OGNkOWQ5NzRiOWEwNTZiODQwM18wLTAtMS0xLTIyMTUzNQ_29d5ae6b-a090-4515-b962-1f2f85e65b6e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YjgxOWM1ZWU2YTVlNDhjZDlkOTc0YjlhMDU2Yjg0MDMvdGFibGVyYW5nZTpiODE5YzVlZTZhNWU0OGNkOWQ5NzRiOWEwNTZiODQwM18xLTQtMS0xLTE4MTc2OQ_7847df68-ea86-4f69-a890-4c15d2fdc40d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGFibGU6YjgxOWM1ZWU2YTVlNDhjZDlkOTc0YjlhMDU2Yjg0MDMvdGFibGVyYW5nZTpiODE5YzVlZTZhNWU0OGNkOWQ5NzRiOWEwNTZiODQwM18yLTQtMS0xLTE4MTc2OQ_0c8d5ee6-a5ea-4260-b786-809f6f511b25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDgy_2d2df387-d30e-4b41-adc5-d65c58fb75da">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8xNzA0MjQzMDIzNzA2OA_65ce7f9d-2457-4e13-9201-436e5d6f4f66">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ie97abaadc2504001892e499621c9a22d_I20220930"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8yNTUx_62bc883d-c380-4d00-a4d9-d9fb4cfc01c9"
      unitRef="usd">3630000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie515b3edc3ec46ef8e0798e729e1c42d_I20230519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDgw_6e1563e0-3e50-4dd2-877c-1489bb8e01a5"
      unitRef="shares">121441605</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i429c89ea5d0c416f85960bc2a4c84894_I20230519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8yNjI1_47ea480a-606b-443a-a729-fe33dcdcf61a"
      unitRef="shares">73224944</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xL2ZyYWc6ZTYwZDQzZjkzYWFkNGQ5YjhjM2RiMWY2MmNlMWY5NzgvdGV4dHJlZ2lvbjplNjBkNDNmOTNhYWQ0ZDliOGMzZGIxZjYyY2UxZjk3OF8zMDc0_c6ddda64-2c65-42d0-9560-3529bfa758a8">Portions of the registrant&#x2019;s Definitive Proxy Statement relating to the 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#x2019;s fiscal year ended March&#160;31, 2023.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184Mi9mcmFnOmI0NGJjYTY4M2E1ZDQ1MDliN2I4MWQ1M2M3M2ZhMTlhL3RhYmxlOjgwOWMzYTQyM2FhMTQ0Y2I4M2U0MmZhNTJlODAxYTUxL3RhYmxlcmFuZ2U6ODA5YzNhNDIzYWExNDRjYjgzZTQyZmE1MmU4MDFhNTFfMS0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjozYTA0Mjg0ODA4NDE0ODQxODFlNzBjYWExYjc1M2VlOF83MQ_5889e625-e9fb-41a1-91f4-ebabf3da59e9">34</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NS9mcmFnOjg2MzQzZDJlY2ExOTQwMmI4MWNmMzgzNTJlOGM4MjRkL3RhYmxlOmI5NmEwOGQyYzk1YjQyNGE4YTZmNjc5YWE0NTYxNmQ1L3RhYmxlcmFuZ2U6Yjk2YTA4ZDJjOTViNDI0YThhNmY2NzlhYTQ1NjE2ZDVfMC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjo4MmFkNjFjMWE1ZjY0ODFiODEzNTcyODVmMGQwMjRiN184_7799a6e0-842d-4b6c-85b5-314f0b88a6ad">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NS9mcmFnOjg2MzQzZDJlY2ExOTQwMmI4MWNmMzgzNTJlOGM4MjRkL3RhYmxlOmI5NmEwOGQyYzk1YjQyNGE4YTZmNjc5YWE0NTYxNmQ1L3RhYmxlcmFuZ2U6Yjk2YTA4ZDJjOTViNDI0YThhNmY2NzlhYTQ1NjE2ZDVfMS0wLTEtMS0xODE3Njk_bf177f68-4df4-4105-842f-bf27b3f61e47">San Francisco, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNC0xLTEtMS0xODE3Njk_091bb7cd-ac2d-4788-bad9-66bcebcfc1f9"
      unitRef="usd">158027000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNC0zLTEtMS0xODE3Njk_38a64866-ed39-4d32-8f48-f25f3a342a08"
      unitRef="usd">112809000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNS0xLTEtMS0xODE3Njk_c1ba2836-a81d-4e58-9ac3-408b132025b7"
      unitRef="usd">682972000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNS0zLTEtMS0xODE3Njk_65f48971-aa8c-4266-84eb-79f92a230490"
      unitRef="usd">685304000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjo2ODg1ZmNlYjVkMWM0ZGI2YTBjODczYmZiMjBiNDgzM182Nw_9571158f-210d-4377-b52e-da630da49826"
      unitRef="usd">887000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjo2ODg1ZmNlYjVkMWM0ZGI2YTBjODczYmZiMjBiNDgzM183NA_65cddf5d-8f68-4a9b-8139-c78ffc2298fa"
      unitRef="usd">359000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0xLTEtMS0xODE3Njk_2092b295-fccf-490a-a5dd-487832ce281b"
      unitRef="usd">107047000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNi0zLTEtMS0xODE3Njk_6467d9e7-1c58-4fe4-84c8-7e3e43db5008"
      unitRef="usd">81073000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNy0xLTEtMS0xODE3Njk_ffb94a4f-b786-4c4e-b24a-66fedb2a1cb5"
      unitRef="usd">22289000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfNy0zLTEtMS0xODE3Njk_d4a7b47a-c1ea-4fd9-a3a5-981f1855b5e3"
      unitRef="usd">19439000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOC0xLTEtMS0xODE3Njk_1e7c2c49-2095-422c-8131-77a3efb43eab"
      unitRef="usd">5118000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOC0zLTEtMS0xODE3Njk_47a28143-28da-4804-b7db-527341ae444d"
      unitRef="usd">5512000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOS0xLTEtMS0xODE3Njk_425b6d7b-3b0d-492f-8b34-796ff71dc177"
      unitRef="usd">975453000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfOS0zLTEtMS0xODE3Njk_6c37419f-0d81-4ede-baef-01e48aea484e"
      unitRef="usd">904137000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTAtMS0xLTEtMTgxNzY5_2b66059e-2853-4528-8042-c77616219c7e"
      unitRef="usd">11279000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTAtMy0xLTEtMTgxNzY5_81f12817-5aa0-4152-b2c1-b195089e3c9f"
      unitRef="usd">8488000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTEtMS0xLTEtMTgxNzY5_dcc1e831-9da5-4b28-81f3-452aba2d381b"
      unitRef="usd">34907000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTEtMy0xLTEtMTgxNzY5_fbf80563-8a5d-48a2-bc3c-ffcb71de7f2e"
      unitRef="usd">48558000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTItMS0xLTEtMTgxNzY5_35f4d038-66c4-4e92-83cf-b3baadf104b2"
      unitRef="usd">13819000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTItMy0xLTEtMTgxNzY5_94de1d21-f8c1-4b57-b798-6e9d5530ab8a"
      unitRef="usd">1087000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTMtMS0xLTEtMTgxNzY5_6602bd95-b9d5-498f-8e90-d45cef31f978"
      unitRef="usd">31836000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTMtMy0xLTEtMTgxNzY5_23ba2989-8e22-4467-9cb7-a523774e87ff"
      unitRef="usd">7909000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTQtMS0xLTEtMTgxNzY5_442c044e-62fa-4360-83b0-31c0396834df"
      unitRef="usd">67940000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTQtMy0xLTEtMTgxNzY5_f86aee44-5527-45b5-b4ce-1370e7b0d66c"
      unitRef="usd">18915000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTUtMS0xLTEtMTgxNzY5_f5d47564-5d06-4677-8439-bf064999174f"
      unitRef="usd">1654000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTUtMy0xLTEtMTgxNzY5_1ba95601-ddf8-4e12-81d9-4697f2fd88ca"
      unitRef="usd">2263000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTYtMS0xLTEtMTgxNzY5_50ff7e53-81d2-499e-af92-36e335d72bfd"
      unitRef="usd">1136888000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTYtMy0xLTEtMTgxNzY5_d80b3499-936d-401c-a20b-3b0d76b5ddff"
      unitRef="usd">991357000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTktMS0xLTEtMTgxNzY5_9b344f7e-f462-44e5-a820-2ecf08992ae5"
      unitRef="usd">1272000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMTktMy0xLTEtMTgxNzY5_7db26c5a-b24b-49c7-b7fb-a0185be6a95f"
      unitRef="usd">463000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjAtMS0xLTEtMTgxNzY5_be7c2b02-403b-47aa-ac18-b41ebadca37d"
      unitRef="usd">31245000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjAtMy0xLTEtMTgxNzY5_e0ac82ac-e6e4-4dff-be83-f71b9c48fd1b"
      unitRef="usd">25270000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjEtMS0xLTEtMTgxNzY5_37faa8b9-6bd3-4e29-b72e-8e3cbaf448c0"
      unitRef="usd">105238000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjEtMy0xLTEtMTgxNzY5_d011d061-37b8-45f2-9b9c-de7527c977d3"
      unitRef="usd">84907000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjItMS0xLTEtMTgxNzY5_44abe5be-e4c9-416a-a31e-7dc30fb0d130"
      unitRef="usd">1752000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjItMy0xLTEtMTgxNzY5_b957994b-174f-4a86-992f-c8946a96f503"
      unitRef="usd">642000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjMtMS0xLTEtMTgxNzY5_9f961239-3190-4131-8fa1-641cacc62c18"
      unitRef="usd">139507000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjMtMy0xLTEtMTgxNzY5_9b3fc70e-ae90-4000-a6f3-16f9ec368fbb"
      unitRef="usd">111282000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjQtMS0xLTEtMTgxNzY5_1ebd124a-6734-464c-a2de-57e1b0d643b5"
      unitRef="usd">198000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjQtMy0xLTEtMTgxNzY5_6626dbd1-296c-4c65-bee9-3133bea92823"
      unitRef="usd">78000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjUtMS0xLTEtMTgxNzY5_d52abf40-f7e8-4a7b-bc12-2f1050445deb"
      unitRef="usd">13885000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjUtMy0xLTEtMTgxNzY5_f7816941-a177-4b1c-bb8c-e550dd0f54b2"
      unitRef="usd">447000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMS0xLTEtMTgzNTI3_2c733f7a-eb6c-47a9-b614-bbd7ce22af47"
      unitRef="usd">15942000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMy0xLTEtMTgzNTI3_c7727590-f31d-4795-956a-bb9023996e02"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMS0xLTEtMTgxNzY5_c47e4a0b-129b-4562-b603-d5c05e694457"
      unitRef="usd">1240000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjYtMy0xLTEtMTgxNzY5_7e49cbd3-052e-42f1-9737-4712a7082a52"
      unitRef="usd">956000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjctMS0xLTEtMTgxNzY5_1926be9b-cb8a-4f8d-8e6f-9f4482f96db7"
      unitRef="usd">170772000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjctMy0xLTEtMTgxNzY5_53966fb4-3851-440f-a756-7c56e9553ac9"
      unitRef="usd">112763000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjgtMS0xLTEtMTgxNzY5_ea0ff6e4-8006-4078-b665-ac0e29fdddd3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMjgtMy0xLTEtMTgxNzY5_c86d50d4-150a-4f34-a63b-7d14cb0feb46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfMjE_7662ac03-570d-4cc6-9352-50e1f9485b17"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfMjE_88ae7282-24dc-47e4-a8ce-b2ca8eaea4a2"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MDQ1_2b482f6f-6a9a-4bf7-aec9-2c3586570428"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MDQ1_628a09d6-af0b-48ac-bb21-0f151bbebe47"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_89f67ee7-b472-420f-8793-8b7239c94e71"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_8dd38866-198d-40d3-a1bf-f5eaaa3b83df"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_cf4f1870-8c9f-405b-ac27-8827e7ccdbef"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMC0xLTEtMTgxNzY5L3RleHRyZWdpb246YWU1NzhiMWY4Y2FiNDUyYmExZmE2YWEwY2NkOTNkYTFfNTQ5NzU1ODE0MTAx_e5552c09-6639-4d49-b511-ed49fff50e47"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMS0xLTEtMTgxNzY5_038614f8-9f55-498f-ae7a-b0531d52fa8a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzItMy0xLTEtMTgxNzY5_60d0ee2e-0a05-494f-ab62-637baf0f22d5"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMzg_88c4f8ed-0a27-4815-9f3f-13ecb96659b1"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMzg_ec8d5391-fd89-4f74-8084-e0ab82fffeb4"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfNTI_77ae495d-8a5f-4776-a86c-c35a6dde4b1e"
      unitRef="shares">1500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfNTI_c5b4d041-a136-4295-b6c9-91502207780d"
      unitRef="shares">1500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTEx_56e7ae30-ece5-4091-bd0d-d32eebf6e2a4"
      unitRef="shares">193941000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTEx_97ec36ff-1758-4528-a0ca-4ba83b309371"
      unitRef="shares">193941000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTE4_07207aac-b33a-4029-9e6d-69df94ba2b1e"
      unitRef="shares">192398000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMC0xLTEtMTgxNzY5L3RleHRyZWdpb246MWI5NzdiMjdmZGNiNDMwZjgzNmRhYWNmYjEwYzU2N2RfMTE4_56235399-254d-492b-bf76-392564269282"
      unitRef="shares">192398000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMS0xLTEtMTgxNzY5_a6f851c1-4988-42e9-812d-9af53c8f86db"
      unitRef="usd">194000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzMtMy0xLTEtMTgxNzY5_d0b2f775-ad80-4634-a292-df3f157f6109"
      unitRef="usd">192000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzQtMS0xLTEtMTgxNzY5_b4b7fd7e-a5e6-45da-af05-f0e5276932f5"
      unitRef="usd">762150000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzQtMy0xLTEtMTgxNzY5_c02effc7-0aaf-4cd2-87d1-bd7bc22f1d8d"
      unitRef="usd">702589000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzUtMS0xLTEtMTgxNzY5_b5d1e7af-c57f-4126-9f0d-8b63dc4eb8f2"
      unitRef="usd">-14083000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzUtMy0xLTEtMTgxNzY5_2e65f0ec-de17-4871-8521-b7792f2a4ae3"
      unitRef="usd">-15294000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzYtMS0xLTEtMTgxNzY5_b1f9f0c9-eba6-4c5e-8c80-6424fd41a4ac"
      unitRef="usd">217855000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzYtMy0xLTEtMTgxNzY5_cf85269a-c91d-4855-98f6-1d94c28b5d46"
      unitRef="usd">191107000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzctMS0xLTEtMTgxNzY5_a7ef52f7-8e13-4c3a-bc2e-6aa6bc958486"
      unitRef="usd">966116000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzctMy0xLTEtMTgxNzY5_4bda6501-3c72-4753-8ab7-7ff2527f7d09"
      unitRef="usd">878594000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzgtMS0xLTEtMTgxNzY5_2687e19b-74d9-42b9-abe4-600ed0d7fd8d"
      unitRef="usd">1136888000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184OC9mcmFnOjYzMDc2N2VkMzA3MDQ0OTc5N2YwZTJhZjEyMDQyZjA2L3RhYmxlOjM1ZGUwM2YwNGVlNzQ3NWNhZjA2ZTlmNTJjYzIxMjFiL3RhYmxlcmFuZ2U6MzVkZTAzZjA0ZWU3NDc1Y2FmMDZlOWY1MmNjMjEyMWJfMzgtMy0xLTEtMTgxNzY5_99fd4ef6-b7b9-45d0-990d-659a9fdbe266"
      unitRef="usd">991357000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMi0xLTEtMS0xODE3Njk_8fb1a422-0b5c-4ea7-8177-780db18a58a0"
      unitRef="usd">419052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMi0zLTEtMS0xODE3Njk_acdddf1c-1872-4055-a64a-9ac7a8fae6fa"
      unitRef="usd">343548000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMi01LTEtMS0xODE3Njk_bac6ec42-f483-4f52-9798-7d8799eb87e0"
      unitRef="usd">206897000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMy0xLTEtMS0xODE3Njk_b2c4c690-7436-41d2-a1a3-eb9d9763bea8"
      unitRef="usd">53490000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMy0zLTEtMS0xODE3Njk_4abb291d-25af-4e84-b19b-206288ad058a"
      unitRef="usd">39787000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMy01LTEtMS0xODE3Njk_e14c384b-8abc-495d-b079-3067eddd4d5b"
      unitRef="usd">31196000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNC0xLTEtMS0xODE3Njk_1168b126-8869-47fc-80e0-5a439f06c60a"
      unitRef="usd">365562000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNC0zLTEtMS0xODE3Njk_8175c619-b918-409c-a5da-860a637967af"
      unitRef="usd">303761000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNC01LTEtMS0xODE3Njk_3d5d59fc-d903-46e4-92cb-30de9afd6f87"
      unitRef="usd">175701000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNi0xLTEtMS0xODE3Njk_f60c1195-a89a-4dfc-ac4a-731c5b501654"
      unitRef="usd">80186000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNi0zLTEtMS0xODE3Njk_fed572f4-b26a-405a-ad2f-b85ac848f7cd"
      unitRef="usd">62350000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNi01LTEtMS0xODE3Njk_fe6b04a9-d868-4f23-814f-6f456b488bca"
      unitRef="usd">43873000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNy0xLTEtMS0xODE3Njk_f766e87b-97d9-4a6a-b82b-2d0963e75b6d"
      unitRef="usd">123523000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNy0zLTEtMS0xODE3Njk_1dcdffbb-6035-426b-a577-bf16a39c6c5d"
      unitRef="usd">92129000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfNy01LTEtMS0xODE3Njk_cb84a2ff-d2d1-4f21-9784-f921d66e3171"
      unitRef="usd">62033000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOC0xLTEtMS0xODE3Njk_b94f1705-a6f9-40c9-afd1-72ff70e6041d"
      unitRef="usd">36745000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOC0zLTEtMS0xODE3Njk_c81a1a56-0fac-41ee-8bb2-7f02ddfe5a7b"
      unitRef="usd">35746000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOC01LTEtMS0xODE3Njk_034ae70e-979e-49e4-9cee-92b78fad0c50"
      unitRef="usd">16492000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOS0xLTEtMS0xODE3Njk_f8bb73e4-af9f-48c1-a696-6a91442447e7"
      unitRef="usd">240454000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOS0zLTEtMS0xODE3Njk_401aa987-1c6e-45d3-8bc6-8c5d23827301"
      unitRef="usd">190225000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfOS01LTEtMS0xODE3Njk_bb0e8df2-cbec-4ac2-aea8-9770acc5c193"
      unitRef="usd">122398000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTAtMS0xLTEtMTgxNzY5_ca1e121b-744e-42f7-9756-40cb520bdede"
      unitRef="usd">125108000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTAtMy0xLTEtMTgxNzY5_506ee365-c953-4a64-847f-fbb3b722e733"
      unitRef="usd">113536000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTAtNS0xLTEtMTgxNzY5_0d4d188f-60d7-4684-b092-d9ad8eb08e98"
      unitRef="usd">53303000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTEtMS0xLTEtMTgxNzY5_1698de17-98cd-4d1e-b6dc-51f4e1a65143"
      unitRef="usd">8048000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTEtMy0xLTEtMTgxNzY5_5bb56e54-7ffc-41f5-9436-66da146a3502"
      unitRef="usd">469000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTEtNS0xLTEtMTgxNzY5_4331df10-b4a4-4885-a9f2-123cba66d79e"
      unitRef="usd">4466000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTItMS0xLTEtMTgxNzY5_c85d9945-cdc1-4def-9d0e-abf846ea61db"
      unitRef="usd">133156000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTItMy0xLTEtMTgxNzY5_9f11d196-508c-4f5a-9ce0-373969412ddb"
      unitRef="usd">114005000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTItNS0xLTEtMTgxNzY5_87121884-b1c0-4e0a-96fa-c13a88c41b1a"
      unitRef="usd">57769000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTMtMS0xLTEtMTgxNzY5_1b455efb-e8f0-40c3-961d-5e59c54cb9eb"
      unitRef="usd">20338000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTMtMy0xLTEtMTgxNzY5_1597f2be-0098-4034-a01f-bfb56cc01dd9"
      unitRef="usd">-40778000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTMtNS0xLTEtMTgxNzY5_7edff81e-f1d6-4fb5-9d2d-ff17ffc0d0b9"
      unitRef="usd">7559000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTQtMS0xLTEtMTgxNzY5_f981371d-7e36-4cd1-b327-dbf188ff0eb1"
      unitRef="usd">112818000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTQtMy0xLTEtMTgxNzY5_6f3af263-9887-409e-9e86-2904b87c1efc"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTQtNS0xLTEtMTgxNzY5_a45ecdba-edcf-456f-b7b0-ad79532066d5"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMS0xLTEtMTgxNzY5_6194d07a-0346-4624-968e-cc08a611f6f7"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMS0xLTEtMTgxNzY5_b2b62bf4-625f-47af-ac4a-99651309eadc"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMy0xLTEtMTgxNzY5_1275d853-6671-4468-946f-cb2f687908cc"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtMy0xLTEtMTgxNzY5_ea04b119-b564-4b86-8f89-4b3d091e5198"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtNS0xLTEtMTgxNzY5_b99eab24-b151-4550-89e0-d1555123b3c9"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTUtNS0xLTEtMTgxNzY5_e226fd08-6306-41ce-b739-a91e35ae6fa0"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMS0xLTEtMTgxNzY5_60a5de1a-eb3a-43d2-a1b5-5add4b3e0448"
      unitRef="usd">112818000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMS0xLTEtMTgxNzY5_ddf66632-cf4a-429e-af67-ea06668a78f5"
      unitRef="usd">112818000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMy0xLTEtMTgxNzY5_158da3b9-4b47-468c-960f-d2d6909a3154"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtMy0xLTEtMTgxNzY5_63a71c4f-627a-40ac-8018-e05496f0ea7d"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtNS0xLTEtMTgxNzY5_25d9a3c4-5a3e-4029-b06c-fc8d00d96761"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTYtNS0xLTEtMTgxNzY5_952ea8b4-1d6a-4be9-891d-4e232ffba5a3"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTgtMS0xLTEtMTgxNzY5_d07512d5-fe25-4eec-9849-b8c40d212341"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTgtMy0xLTEtMTgxNzY5_171411b5-5e85-4f0b-bf7c-9d8c26b649cd"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTgtNS0xLTEtMTgxNzY5_6f48f1a8-bd5b-431a-a443-20c87ab92223"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTktMS0xLTEtMTgxNzY5_a4ddbae1-eb7d-40a8-96f0-b33bbe3be5f2"
      unitRef="usdPerShare">0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTktMy0xLTEtMTgxNzY5_13d3a21d-2dc5-4c46-a847-8fa568f008a9"
      unitRef="usdPerShare">0.70</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMTktNS0xLTEtMTgxNzY5_075ef360-2ca4-442d-abf5-fafb42a1656f"
      unitRef="usdPerShare">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjEtMS0xLTEtMTgxNzY5_747a15aa-4ef8-4c64-b4ac-9bf8aaef584c"
      unitRef="shares">193176000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjEtMy0xLTEtMTgxNzY5_ec1ecfee-7872-4988-b2a0-49116f752030"
      unitRef="shares">163484000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjEtNS0xLTEtMTgxNzY5_f0bc3d6a-b09d-42c0-b8c0-647b97f733de"
      unitRef="shares">74342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjItMS0xLTEtMTgxNzY5_9d84a15b-63d0-412a-9c16-f8670abb265c"
      unitRef="shares">213425000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjItMy0xLTEtMTgxNzY5_c83ac2d6-45a6-437d-a110-78f404adda72"
      unitRef="shares">191017000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185MS9mcmFnOjE1N2MwMDdkM2IyODRjYzQ4Y2EzZWQ4YWE5YjUzNWJlL3RhYmxlOjczZDZjNTJmMDRjYTQ1OTNhMTVjMjIyNjJmMDJjODAxL3RhYmxlcmFuZ2U6NzNkNmM1MmYwNGNhNDU5M2ExNWMyMjI2MmYwMmM4MDFfMjItNS0xLTEtMTgxNzY5_903007cd-ccad-40eb-bd3d-e63c5ea0842c"
      unitRef="shares">95134000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfMi0xLTEtMS0xODE3Njk_cc1d69e2-fc65-4de7-b8dc-89502c02fba1"
      unitRef="usd">112818000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfMi0zLTEtMS0xODE3Njk_7402711e-c116-47ce-ab7a-4568d3661860"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfMi01LTEtMS0xODE3Njk_d92b1787-81b1-49bd-a17b-8111f713b8d0"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjpmOGRmMmQ0ODRmOGU0MGQ1YTQwZjkyMDVlMjBiMGU5Nl83_ec0cecdf-6a87-43bc-b561-586796212b92"
      unitRef="usd">425000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjpmOGRmMmQ0ODRmOGU0MGQ1YTQwZjkyMDVlMjBiMGU5Nl8xMQ_efd9d56b-787c-4780-bf40-ab7a0d43e975"
      unitRef="usd">-5199000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0wLTEtMS0xODE3NjkvdGV4dHJlZ2lvbjpmOGRmMmQ0ODRmOGU0MGQ1YTQwZjkyMDVlMjBiMGU5Nl8xOQ_2a937127-68e7-4369-90ce-4dd4e51a514d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0xLTEtMS0xODE3Njk_110942dc-9eea-43e0-a336-0060fc497406"
      unitRef="usd">1211000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC0zLTEtMS0xODE3Njk_b8241599-5488-41da-817f-aea43a941958"
      unitRef="usd">-15273000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNC01LTEtMS0xODE3Njk_3122fb58-95da-4ab0-bfc3-1af2e80c2256"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNi0xLTEtMS0xODE3Njk_c1f63267-644b-4a1c-92d8-6fb1c5426202"
      unitRef="usd">114029000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNi0zLTEtMS0xODE3Njk_31cea890-3bce-4cda-95ed-a274f4486f38"
      unitRef="usd">139510000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185NC9mcmFnOjVjY2Q2YjdmZGI1OTQ3MjdhOGJlODYyNTY3MDVhMjU2L3RhYmxlOmNlZWE4MTIyMzI2MzQ2ZTBhNzQ1ZTI0ZTg4MTY1NzIyL3RhYmxlcmFuZ2U6Y2VlYTgxMjIzMjYzNDZlMGE3NDVlMjRlODgxNjU3MjJfNi01LTEtMS0xODE3Njk_764ce5e8-8089-4784-a790-b481cdfe35f2"
      unitRef="usd">50189000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xLTEtMS0xODE3Njk_d2986681-63f0-4985-9841-c515e51c297b"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0zLTEtMS0xODE3Njk_2cb9f8c4-25f8-474e-94cf-fcf07277651c"
      unitRef="usd">81458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i51bee6fa91384d2b859a47c7b4a2bdf1_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi02LTEtMS0xODE3Njk_9b96cf61-bf31-4172-bfd8-cfa6af5bff72"
      unitRef="shares">68566000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i51bee6fa91384d2b859a47c7b4a2bdf1_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi04LTEtMS0xODE3Njk_db839a1d-f9fd-4c6e-9a6b-9181a2ef272b"
      unitRef="usd">68000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i239eff19d97e41b9b0482aa745e705a8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xMC0xLTEtMTgxNzY5_e76f8522-fe85-43a1-8983-2ff200a1afe4"
      unitRef="usd">14954000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ac170db1b65461e92998fa288b22bb1_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xMi0xLTEtMTgxNzY5_f020f78a-beca-4289-9844-2eecd750a579"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2aec2a3cf466470d83a702d7d3b279e8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xNC0xLTEtMTgxNzY5_0f7b0253-265c-4625-b7e2-8e4f5d3e0f5e"
      unitRef="usd">-13886000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMi0xNi0xLTEtMTgxNzY5_d6cd867a-5680-4adc-9df4-0ff7fffcbd73"
      unitRef="usd">1136000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMy0xMC0xLTEtMTgxNzY5_252d74a9-a945-4f4f-9efa-ea66f94cdc23"
      unitRef="usd">7398000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMy0xNi0xLTEtMTgxNzY5_891998cc-7d5e-4e46-8c6c-5b0c22a17676"
      unitRef="usd">7398000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC02LTEtMS0xODE3Njk_7b37ad01-ae1c-4a6b-88df-2295e803b3af"
      unitRef="shares">13890000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC04LTEtMS0xODE3Njk_9f44c4d4-7dda-47dd-bd20-ea51b378663a"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC0xMC0xLTEtMTgxNzY5_264e00ed-7868-40b5-b6da-fc254b74fd36"
      unitRef="usd">8883000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNC0xNi0xLTEtMTgxNzY5_7ff99185-d9a3-4461-bd77-dfc2bc1da80d"
      unitRef="usd">8897000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS02LTEtMS0xODMxNTc_bd463ccb-fee6-48b4-a236-24aef6b70c87"
      unitRef="shares">22000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xMC0xLTEtMTgzMTU3_570dffc8-15d3-4e7e-9978-6a7c3ac11a29"
      unitRef="usd">34000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xNi0xLTEtMTgzMTU3_22b1fe58-cbcc-4c3c-8cb4-fc2d47710724"
      unitRef="usd">34000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi02LTEtMS0xODMxNjY_e622e645-9683-43e7-acaf-f889538f73a5"
      unitRef="shares">258000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xMC0xLTEtMTgzMTY2_f1f92c72-c9ca-4328-b4d7-6a3fc68a2815"
      unitRef="usd">2022000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xNi0xLTEtMTgzMTY2_906d0a8d-a0be-47d7-bf0b-8903214f2798"
      unitRef="usd">2022000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xMC0xLTEtMTgxNzY5_cd2583e8-38cd-4329-b8b4-8f4ad5da11c6"
      unitRef="usd">49000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNS0xNi0xLTEtMTgxNzY5_6c48d6f9-851d-4a03-a45f-658f9df7544a"
      unitRef="usd">49000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i46d6f06521b34618831102060f160822_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xMi0xLTEtMTgxNzY5_41cf89d7-335a-4670-9a57-15252715001b"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNi0xNi0xLTEtMTgxNzY5_5e6a2710-991a-451e-8436-483f98e30e91"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy02LTEtMS0xODE3Njk_c477b7fe-3b7a-43b8-baa3-5aa61565038e"
      unitRef="shares">690000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ibb975eb3d9b743c2a6f9dd8f52f67079_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy04LTEtMS0xODE3Njk_5a6a85cf-707c-4d66-9047-983b5da0c9ed"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ia03de047cda04f77bab1b71c6cb39c0a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy0xMC0xLTEtMTgxNzY5_f5d53cbf-194d-49a9-ad78-b24109df589f"
      unitRef="usd">1061000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfNy0xNi0xLTEtMTgxNzY5_59e68907-bd8d-4f0a-aadd-13f494f64834"
      unitRef="usd">1062000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="ic816ea61c72b4526baf4f08dda97575f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOC0xNC0xLTEtMTgxNzY5_273fb652-fd69-4d7a-be88-bec3afc30e0c"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOC0xNi0xLTEtMTgxNzY5_9cc02920-742a-4070-a223-23b596ee114f"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xLTEtMS0xODE3Njk_0a36fabe-8d39-4d31-a219-cb7c55d777e1"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0zLTEtMS0xODE3Njk_d7d0da30-8c80-48c4-b969-a98584817fb2"
      unitRef="usd">81458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ie2a4a27e961b4732a69f4329e75908ce_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS02LTEtMS0xODE3Njk_57056945-ab4c-475f-acd5-f25183e6b9ef"
      unitRef="shares">82910000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie2a4a27e961b4732a69f4329e75908ce_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS04LTEtMS0xODE3Njk_746f186f-7bc7-4e60-b505-cf3d53300148"
      unitRef="usd">83000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c7aad5f38d74f8ea3efd5af5a079c17_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xMC0xLTEtMTgxNzY5_0c6097b4-fad2-40ea-9877-0c07154cd04e"
      unitRef="usd">30357000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id3f4e1f1e9ef42a596eb67129ffa34b2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xMi0xLTEtMTgxNzY5_73afcf2b-91cd-4349-b424-b21538107827"
      unitRef="usd">-21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee132da446eb4ed08a23cdf121ea6b0c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xNC0xLTEtMTgxNzY5_117e3759-46a1-48d9-b49d-143d11cb2bd6"
      unitRef="usd">36324000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfOS0xNi0xLTEtMTgxNzY5_87f3da4f-ef2f-43f5-83ee-0a5ddc3efe84"
      unitRef="usd">66743000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTAtMTAtMS0xLTE4MTc2OQ_26b646c1-444e-4b19-9aac-704649fccec5"
      unitRef="usd">29341000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTAtMTYtMS0xLTE4MTc2OQ_53beda1c-f441-4b63-9507-4bdfdec613b3"
      unitRef="usd">29341000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtNi0xLTEtMTgxNzY5_4dbe35ae-28b0-4e83-970c-60382197229f"
      unitRef="shares">10823000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtOC0xLTEtMTgxNzY5_7301ad51-cef6-4849-9735-ab167bb5e4fa"
      unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtMTAtMS0xLTE4MTc2OQ_2a6d9929-26bc-45e1-804c-a260faf625c0"
      unitRef="usd">12601000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTEtMTYtMS0xLTE4MTc2OQ_79d64c17-de48-41e2-a06e-d9b9c0c3543d"
      unitRef="usd">12612000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTQtNi0xLTEtMTgzMTgx_90f00eeb-55c0-4d49-9e6a-96d24944ed91"
      unitRef="shares">24000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTAtMS0xLTE4MzE5Mg_b018637f-2c4f-40a5-9923-b60e82407a81"
      unitRef="usd">817000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTYtMS0xLTE4MzE5Mg_33ccbb72-f8d0-4ff7-984e-2f3194485e04"
      unitRef="usd">817000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTMtNi0xLTEtMTgxNzY5_9155f88d-f2a6-42c2-a38b-872365dd1f22"
      unitRef="shares">181000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTMtMTAtMS0xLTE4MTc2OQ_c6b2c5bb-2dbb-4b70-b949-b4b03d258bef"
      unitRef="usd">2698000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTMtMTYtMS0xLTE4MTc2OQ_dd1c9a51-217b-43a3-8263-f66f3579d26a"
      unitRef="usd">2698000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTQtMTAtMS0xLTE4MTc2OQ_5876b501-4ef4-44d3-b178-0dc36c3167e4"
      unitRef="usd">2598000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTQtMTYtMS0xLTE4MTc2OQ_f71e4dc3-f8fc-4910-84e0-a97fb7ebc532"
      unitRef="usd">2598000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1ff263310c7e4813b992a8d0b1ad53cc_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTItMS0xLTE4MTc2OQ_7c66d0d9-5c7e-454b-92e2-60f06d277260"
      unitRef="usd">-15273000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTUtMTYtMS0xLTE4MTc2OQ_9932ecde-96f1-4fc1-9dc2-37900e4110fc"
      unitRef="usd">-15273000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <docs:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMS0xLTEtMTgzMjAy_7767442b-4028-4912-8603-ae2a97a9b2fc"
      unitRef="shares">76287000</docs:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <docs:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMy0xLTEtMTgzMjAy_ea6fdf45-79b9-491d-af76-de62bd7ac81f"
      unitRef="usd">81458000</docs:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktNi0xLTEtMTgzMjAy_4f48cb4d-5da8-4f8e-b334-c73241bad49c"
      unitRef="shares">76287000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktOC0xLTEtMTgzMjAy_8c2550fc-a7c8-40de-ac4c-19d8b0e06ed3"
      unitRef="usd">76000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMTAtMS0xLTE4MzIwMg_6087eb58-604a-4152-88c6-95f906c6c7e2"
      unitRef="usd">81382000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTktMTYtMS0xLTE4MzIwMg_d5e890fc-8f6a-4685-9131-5467f2cc81dc"
      unitRef="usd">81458000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtNi0xLTEtMTgxNzY5_06289ea1-7915-4e01-b31d-c0e482c48fc7"
      unitRef="shares">22506000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtOC0xLTEtMTgxNzY5_71595bc3-5701-48df-9177-80e4abb7b3f0"
      unitRef="usd">22000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtMTAtMS0xLTE4MTc2OQ_b5f164b2-8ec7-44bf-b8b8-629369547b0c"
      unitRef="usd">548430000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTYtMTYtMS0xLTE4MTc2OQ_44370dda-82ad-4eca-8f26-83d63eb72957"
      unitRef="usd">548452000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i812191652aba43ccae61e9dccf6d9f0d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMjEtNi0xLTEtMTgzMjE2_a127d4f3-eb60-4610-b5b9-3be0672a48f1"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9f04e4da258d47a887f1b0abed11e01e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMjEtMTAtMS0xLTE4MzIxNg_10cfbeb2-902a-4ff6-a4e4-5629ce4f87dc"
      unitRef="usd">1395000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMjEtMTYtMS0xLTE4MzIxNg_36a85e3a-ee06-4385-898d-98c8ecec254b"
      unitRef="usd">1395000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="i0955332a233f4c018f259ff874af4f61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTctMTQtMS0xLTE4MTc2OQ_c26de2ff-cabd-41bd-ba3f-7edb91e79e8b"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTctMTYtMS0xLTE4MTc2OQ_61fb2b1a-bb6d-4cf1-b0ce-893f5070aa25"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMS0xLTEtMTgxNzY5_32bb07f2-d7ae-4475-88a6-62331506f18e"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMy0xLTEtMTgxNzY5_1f2ebe6a-9698-47f3-82cf-20c22abeaf71"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtNi0xLTEtMTgxNzY5_64db7d82-48a5-456b-bec2-f8c8dc9d4b91"
      unitRef="shares">192398000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtOC0xLTEtMTgxNzY5_afdb01f5-b250-46e2-9210-8a13f0826240"
      unitRef="usd">192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4eb2e149b8ed4edea42e1794b79eead8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTAtMS0xLTE4MTc2OQ_fe05266b-91b7-45a8-8f50-609cc3c0ac89"
      unitRef="usd">702589000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifccc74565273499782a3a98a62beb0f7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTItMS0xLTE4MTc2OQ_0475c1aa-f8ed-4ca7-9035-7663b12fb547"
      unitRef="usd">-15294000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i64036fdea8df4afda807a5cece385147_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTQtMS0xLTE4MTc2OQ_a21d728b-8b7d-4f0a-b2ac-2189e9454e19"
      unitRef="usd">191107000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE1MjVlNjU4Y2YzMzRkMmJhYzgzZWMyMTNlYzdhZWUwL3RhYmxlcmFuZ2U6MTUyNWU2NThjZjMzNGQyYmFjODNlYzIxM2VjN2FlZTBfMTgtMTYtMS0xLTE4MTc2OQ_03dc5441-d002-4649-bd3d-10d38ed348cd"
      unitRef="usd">878594000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xLTEtMS0xODE3Njk_32bb07f2-d7ae-4475-88a6-62331506f18e"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0zLTEtMS0xODE3Njk_1f2ebe6a-9698-47f3-82cf-20c22abeaf71"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi02LTEtMS0xODE3Njk_64db7d82-48a5-456b-bec2-f8c8dc9d4b91"
      unitRef="shares">192398000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i351c61ddd53e415fb0132c3f28ec7e27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi04LTEtMS0xODE3Njk_afdb01f5-b250-46e2-9210-8a13f0826240"
      unitRef="usd">192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4eb2e149b8ed4edea42e1794b79eead8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xMC0xLTEtMTgxNzY5_fe05266b-91b7-45a8-8f50-609cc3c0ac89"
      unitRef="usd">702589000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifccc74565273499782a3a98a62beb0f7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xMi0xLTEtMTgxNzY5_0475c1aa-f8ed-4ca7-9035-7663b12fb547"
      unitRef="usd">-15294000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i64036fdea8df4afda807a5cece385147_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xNC0xLTEtMTgxNzY5_a21d728b-8b7d-4f0a-b2ac-2189e9454e19"
      unitRef="usd">191107000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMi0xNi0xLTEtMTgxNzY5_03dc5441-d002-4649-bd3d-10d38ed348cd"
      unitRef="usd">878594000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMy0xMC0xLTEtMTgxNzY5_14ca2f80-c34c-44d5-bfda-9aaac717f581"
      unitRef="usd">43343000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMy0xNi0xLTEtMTgxNzY5_18a62d93-40e5-4633-8b01-0f6d27b5bc8f"
      unitRef="usd">43343000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <docs:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised
      contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC02LTEtMS0xODE3Njk_63716984-1c0c-4c3f-a272-cc0d84afa432"
      unitRef="shares">3842000</docs:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
    <docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
      contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC04LTEtMS0xODE3Njk_7b0871a6-bd82-4e63-9292-832ccae78761"
      unitRef="usd">4000</docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
    <docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
      contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC0xMC0xLTEtMTgxNzY5_428b17ac-4799-4642-be87-a452f378a19e"
      unitRef="usd">9925000</docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
    <docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNC0xNi0xLTEtMTgxNzY5_ffc6876d-4baa-4703-8c9b-2f6f8db606a1"
      unitRef="usd">9929000</docs:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNS02LTEtMS0xODE3Njk_73df6528-a94f-463b-a2b5-1cd3d67ebdd3"
      unitRef="shares">223000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNi0xMC0xLTEtMTgxNzY5_49a19a96-9867-4eb1-b8fd-44041d2bcb97"
      unitRef="usd">3822000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNi0xNi0xLTEtMTgxNzY5_874c6468-a552-4522-81ee-ac2af487ba22"
      unitRef="usd">3822000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy02LTEtMS0xODE3Njk_5841436a-baaa-4d14-8e23-2701604bb84d"
      unitRef="shares">2675000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy04LTEtMS0xODE3Njk_6d338a07-6e59-4a1f-a2d1-e0daf7099e42"
      unitRef="usd">2000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i49e68429295e421e87c13df53148e23a_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy0xNC0xLTEtMTgxNzY5_4f099301-0409-41db-8391-17f11f9a1838"
      unitRef="usd">86070000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfNy0xNi0xLTEtMTgxNzY5_e2c19f1a-1748-4e1c-8797-2291d542912f"
      unitRef="usd">86072000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfOC0xMC0xLTEtMTgxNzY5_327cfff2-a8f1-49ba-adce-571abab9d591"
      unitRef="usd">5356000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfOC0xNi0xLTEtMTgxNzY5_3c8e1747-b6bc-46dc-afab-681f42198ace"
      unitRef="usd">5356000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i20415eb849ac4c62acd0fa48b37d0bd1_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTItNi0xLTEtMTgxNzY5_579143f9-1e10-47ec-b5ea-6648db68cf0a"
      unitRef="shares">153000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i04f1e2c1a8804d498ad698c9415cc5fa_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTItMTAtMS0xLTE4MTc2OQ_9da16923-3d00-4c3a-b115-96d1d7ed49ba"
      unitRef="usd">4759000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTItMTYtMS0xLTE4MTc2OQ_fa41a259-5c1d-41d3-a33c-258ae8c058d7"
      unitRef="usd">4759000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i713bedb0e69c494c8ed7f90198455f80_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTEtMTItMS0xLTE5NjY3Nw_733a804f-5650-4882-b67f-42589c1948d0"
      unitRef="usd">1211000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTEtMTYtMS0xLTE5NjY3Nw_93d5a5f2-35af-4077-b2e0-0221e09d4a2d"
      unitRef="usd">1211000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i49e68429295e421e87c13df53148e23a_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTMtMTQtMS0xLTE4MTc2OQ_24d3c47f-da5e-45bf-a1cb-3a9898f63163"
      unitRef="usd">112818000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTMtMTYtMS0xLTE4MTc2OQ_c94e43b5-eec7-4295-97bc-e4658c8d2bec"
      unitRef="usd">112818000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMS0xLTEtMTgxNzY5_8d4f9b9f-40fb-4562-870a-89c76c5db416"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMy0xLTEtMTgxNzY5_f759e864-72f9-404c-9e2e-2462fa1ada7e"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i84d98fc03def4365a7f3fa504e96b220_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtNi0xLTEtMTgxNzY5_4cd6421f-8aed-461f-9bf4-5cbcecdb9034"
      unitRef="shares">193941000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i84d98fc03def4365a7f3fa504e96b220_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtOC0xLTEtMTgxNzY5_74b36622-a13a-4018-8675-0aea5fff6411"
      unitRef="usd">194000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd694dc2e48a4412a000d9b02c10f96e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTAtMS0xLTE4MTc2OQ_8e7b6b5b-87ee-414e-844f-5074035dffb4"
      unitRef="usd">762150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i419e8bf8b3aa40158f8de4af142458a2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTItMS0xLTE4MTc2OQ_7116885c-7058-4f96-a54d-6f5784501cb7"
      unitRef="usd">-14083000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i448d1c798e6544a99cf0cf2663a4894b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTQtMS0xLTE4MTc2OQ_5a49f1d9-7df5-4ac2-aee0-e8305264db54"
      unitRef="usd">217855000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M185Ny9mcmFnOmVlODg1YmYxOTFiMTQwMGJiMzAzMmQ0Y2MzNzEwNTk4L3RhYmxlOjE2MTc3Yzk4ODk2ODRiZGE4NWFjMDJlNTBmNjFlZTYyL3RhYmxlcmFuZ2U6MTYxNzdjOTg4OTY4NGJkYTg1YWMwMmU1MGY2MWVlNjJfMTQtMTYtMS0xLTE4MTc2OQ_ea50d7eb-7db8-4a3f-b240-bb0387fd35af"
      unitRef="usd">966116000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMtMS0xLTEtMTgxNzY5_82b39ca5-2b32-4225-9013-3e4d980c2d2f"
      unitRef="usd">112818000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMtMy0xLTEtMTgxNzY5_df10be92-729d-4f8d-91a7-7fe01f1ff852"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMtNS0xLTEtMTgxNzY5_358f945b-2538-4510-86b5-3b36d291e131"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzUtMS0xLTEtMTgxNzY5_79bf1ae3-77b2-4bea-8a6a-0da1a6e1550e"
      unitRef="usd">10283000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzUtMy0xLTEtMTgxNzY5_2a52b0fb-cf3c-4cec-9854-362edf52b8e0"
      unitRef="usd">5040000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzUtNS0xLTEtMTgxNzY5_3a1a73e6-fa4a-4449-9a78-938db3c7d358"
      unitRef="usd">3702000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzYtMS0xLTEtMTgxNzY5_ab6bf352-5c24-484b-ac9c-391021e6e5b7"
      unitRef="usd">13226000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzYtMy0xLTEtMTgxNzY5_f24ad12b-f388-415f-9cdd-a9a6ae7b03fd"
      unitRef="usd">-41247000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzYtNS0xLTEtMTgxNzY5_213cb383-9e57-4ecf-954a-6b605aa950c3"
      unitRef="usd">4987000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzctMS0xLTEtMTgxNzY5_02e880f4-f67e-4479-8591-b16f1e6bdfb5"
      unitRef="usd">47834000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzctMy0xLTEtMTgxNzY5_868c649e-1696-45a9-945e-77ae1b7f4ad3"
      unitRef="usd">31442000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzctNS0xLTEtMTgxNzY5_c4fdd910-1bd8-4ce8-a0bd-7629fdff9b6d"
      unitRef="usd">7252000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzgtMS0xLTEtMTgxNzY5_e4406d3d-df1e-49cf-a596-def3d5a23e46"
      unitRef="usd">2027000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzgtMy0xLTEtMTgxNzY5_eea8c926-0cb3-4e9f-9685-551a5cf92bcf"
      unitRef="usd">1159000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzgtNS0xLTEtMTgxNzY5_60f4e22d-e1bf-41f1-992f-6af007a6693f"
      unitRef="usd">2433000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEwLTEtMS0xLTE4MTc2OQ_45db474e-36cd-4d92-b62a-6745b42509e0"
      unitRef="usd">-3115000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEwLTMtMS0xLTE4MTc2OQ_f3414f01-4dae-4855-b6ec-1b6846dd106f"
      unitRef="usd">-4332000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEwLTUtMS0xLTE4MTc2OQ_3e88bb26-d7e8-4ae1-abac-f9e5570c42c2"
      unitRef="usd">-197000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzExLTEtMS0xLTE4MTc2OQ_5a786e3e-0639-4889-a5d1-fe281b0b9839"
      unitRef="usd">-1093000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzExLTMtMS0xLTE4MTc2OQ_b2c7545e-7879-4cd8-8ba0-8d60eb017dee"
      unitRef="usd">-1231000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzExLTUtMS0xLTE4MTc2OQ_1c981509-4c3e-4ef1-b809-4d382c12c537"
      unitRef="usd">0</us-gaap:GainLossOnInvestments>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEyLTEtMS0xLTE4MTc2OQ_e7c4b39b-2040-4f0b-a30e-f3275ec11b50"
      unitRef="usd">8785000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEyLTMtMS0xLTE4MTc2OQ_b880e45a-9d59-4b35-995f-c9be73fac57b"
      unitRef="usd">9755000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEyLTUtMS0xLTE4MTc2OQ_7d0398db-1964-415d-8b22-5f6dd18f4b24"
      unitRef="usd">6883000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEzLTEtMS0xLTE4MTc2OQ_0f0f2517-24e8-47b5-9351-ff2ba84d979c"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEzLTMtMS0xLTE4MTc2OQ_09e3c50f-805a-463b-b7fb-e11d801b1296"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzEzLTUtMS0xLTE4MTc2OQ_e2a140e1-b2a6-419b-b5d9-afbffa31ec45"
      unitRef="usd">4698000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE0LTEtMS0xLTE4MTc2OQ_963ed918-4451-40fb-8320-c44bd28cbe5e"
      unitRef="usd">-1454000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE0LTMtMS0xLTE4MTc2OQ_7cdcd060-52d1-4bed-901d-5f067138a2fe"
      unitRef="usd">-410000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE0LTUtMS0xLTE4MTc2OQ_f4c09089-2c8b-457e-840d-47b19ec52908"
      unitRef="usd">-403000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE2LTEtMS0xLTE4MTc2OQ_f276dce2-2620-488e-b266-9b94769433bb"
      unitRef="usd">26242000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE2LTMtMS0xLTE4MTc2OQ_6ebb5d55-7033-4227-85d6-259b2949f3e4"
      unitRef="usd">31017000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE2LTUtMS0xLTE4MTc2OQ_ff3e5225-c575-4a7e-bec1-3b0bbc5836c0"
      unitRef="usd">20452000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE3LTEtMS0xLTE4MTc2OQ_e99e2da4-7cdf-4ecc-95c1-f74672ee3440"
      unitRef="usd">3448000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE3LTMtMS0xLTE4MTc2OQ_70b93f96-326e-4555-8006-7ba19bc8fa11"
      unitRef="usd">9089000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE3LTUtMS0xLTE4MTc2OQ_9258a470-f21e-4a29-b6cb-250bc16ebe83"
      unitRef="usd">1833000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <docs:IncreaseDecreaseInCapitalizedContractCost
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE4LTEtMS0xLTE4MTc2OQ_519a86d0-1386-4028-ad5a-03819588029c"
      unitRef="usd">8462000</docs:IncreaseDecreaseInCapitalizedContractCost>
    <docs:IncreaseDecreaseInCapitalizedContractCost
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE4LTMtMS0xLTE4MTc2OQ_01256442-e70d-44c5-bc41-956654ba4dea"
      unitRef="usd">9609000</docs:IncreaseDecreaseInCapitalizedContractCost>
    <docs:IncreaseDecreaseInCapitalizedContractCost
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE4LTUtMS0xLTE4MTc2OQ_b2b2af21-6239-4e28-ac45-0dc3b534b2c4"
      unitRef="usd">9384000</docs:IncreaseDecreaseInCapitalizedContractCost>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE5LTEtMS0xLTE4MTc2OQ_ca2f3969-c523-4d76-bfdf-d0ba15d2f68c"
      unitRef="usd">-195000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE5LTMtMS0xLTE4MTc2OQ_0830f3be-1e7c-4f05-9c2a-12b899501317"
      unitRef="usd">8664000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzE5LTUtMS0xLTE4MTc2OQ_9af216e6-b9ed-4ed1-962c-c78757380f69"
      unitRef="usd">7285000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIwLTEtMS0xLTE4MTc2OQ_d6874c0f-3a9c-4436-bedd-0b9389817622"
      unitRef="usd">17527000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIwLTMtMS0xLTE4MTc2OQ_c621e4cd-19c1-48f9-a052-8a884df3a653"
      unitRef="usd">1828000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIwLTUtMS0xLTE4MTc2OQ_b93ffac9-7395-4d58-98ec-1e2d1d25b95e"
      unitRef="usd">38571000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIxLTEtMS0xLTE4MTc2OQ_a1e0e62d-96a8-47aa-855b-ca527f214b34"
      unitRef="usd">-213000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIxLTMtMS0xLTE4MTc2OQ_489d6894-5975-4819-924e-82520924f896"
      unitRef="usd">-1107000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIxLTUtMS0xLTE4MTc2OQ_f06b2144-d4be-4dc5-bd1e-bdfbd4e432c5"
      unitRef="usd">-2583000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIzLTEtMS0xLTE4MTc2OQ_5bc3be43-f6aa-40dc-83bc-090419a17d7b"
      unitRef="usd">179602000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIzLTMtMS0xLTE4MTc2OQ_65edb959-0977-474b-8967-e2a5bcd547a0"
      unitRef="usd">126575000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzIzLTUtMS0xLTE4MTc2OQ_1463437a-6576-4069-8db3-4b449d4534bb"
      unitRef="usd">82973000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTEtMS0xLTE4MzU0OA_e4412851-5907-4db7-bfed-a64ce55d0650"
      unitRef="usd">53500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTMtMS0xLTE4MzU0OA_06d0dcf5-ae1d-4495-bbd9-d4fd7c4a36f5"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTUtMS0xLTE4MzU0OA_bcb18908-f803-425d-963d-a39b113887ae"
      unitRef="usd">31682000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTEtMS0xLTE4MTc2OQ_514f7aeb-77c0-4245-83c4-732e0d4b524c"
      unitRef="usd">1701000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTMtMS0xLTE4MTc2OQ_d48bc891-3046-4d37-ac4d-dc28d91ac137"
      unitRef="usd">1912000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI1LTUtMS0xLTE4MTc2OQ_45d3e4ca-f264-44ff-9f5f-cf2b9e0c070c"
      unitRef="usd">245000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI2LTEtMS0xLTE4MTc2OQ_50b9e809-f9f3-496b-a182-48b920dc4f1d"
      unitRef="usd">4483000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI2LTMtMS0xLTE4MTc2OQ_9db769cc-d53c-4316-a3ac-27e65c914d0a"
      unitRef="usd">3785000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI2LTUtMS0xLTE4MTc2OQ_a4c8995f-5f13-45db-af6e-6e0ebea1ec1e"
      unitRef="usd">4365000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI3LTEtMS0xLTE4MTc2OQ_abf2e77b-e3ad-4d2c-bf9e-3a4ed9796761"
      unitRef="usd">190560000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI3LTMtMS0xLTE4MTc2OQ_b60aad48-1b2e-4746-aec7-810c3b8c1b85"
      unitRef="usd">1317193000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI3LTUtMS0xLTE4MTc2OQ_1a11c9bd-cd2d-4cf0-a1bc-7af417022597"
      unitRef="usd">78880000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI4LTEtMS0xLTE4MTc2OQ_cee55311-1f89-4c09-ad48-75d3e585164b"
      unitRef="usd">83139000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI4LTMtMS0xLTE4MTc2OQ_2c04ea6a-663e-447d-96a4-01da59e4e72b"
      unitRef="usd">47919000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI4LTUtMS0xLTE4MTc2OQ_0d982c1d-2b58-4eb2-9229-d70a4a0a9ec7"
      unitRef="usd">40537000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI5LTEtMS0xLTE4MTc2OQ_4a0e5577-1f21-410f-9a3f-e07ede3c7f20"
      unitRef="usd">107182000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI5LTMtMS0xLTE4MTc2OQ_590889b0-7e58-4b93-9164-314f9abd265a"
      unitRef="usd">633802000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzI5LTUtMS0xLTE4MTc2OQ_52d20c74-2bd9-4a0d-a717-39b56f646298"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMxLTEtMS0xLTE4MTc2OQ_6b7e9ce1-21cb-4bdb-8e20-9eed6c9103e8"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMxLTMtMS0xLTE4MTc2OQ_ae93b11b-18a6-4b86-844c-f5dc7beb5ac8"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMxLTUtMS0xLTE4MTc2OQ_4c022a44-cebe-4f5e-aba1-46afb3f7138d"
      unitRef="usd">4230000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMyLTEtMS0xLTE4MTc2OQ_4b76542e-f5b8-415b-bc60-1d535dd70e52"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMyLTMtMS0xLTE4MTc2OQ_0f753e4a-728a-406f-afb6-22be18d9ad25"
      unitRef="usd">-595000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMyLTUtMS0xLTE4MTc2OQ_67464bf1-81ad-4a80-9db4-87e50f9a058d"
      unitRef="usd">12000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMzLTEtMS0xLTE4MTc2OQ_16915ef5-1a33-4e60-805b-01d003a96d6b"
      unitRef="usd">-59923000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMzLTMtMS0xLTE4MTc2OQ_38302aab-788e-4e2b-b015-3bd097a65e5c"
      unitRef="usd">-640574000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzMzLTUtMS0xLTE4MTc2OQ_b501ca1d-d408-4925-9865-23df74d9773c"
      unitRef="usd">-70417000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM1LTEtMS0xLTE4MTc2OQ_f126f4f8-8d28-4c09-bf9b-150b39c213b1"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM1LTMtMS0xLTE4MTc2OQ_918de7a7-68d1-45aa-adb7-19030fb6d20e"
      unitRef="usd">553905000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM1LTUtMS0xLTE4MTc2OQ_444eea67-a1fd-478d-a852-fac2e424bc3d"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM2LTEtMS0xLTE4MTc2OQ_f19a4e7e-a1fb-408f-9dd9-bfd575dbb2e1"
      unitRef="usd">9926000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM2LTMtMS0xLTE4MTc2OQ_a10f21e4-b0ca-44fb-88e7-b68c6633449a"
      unitRef="usd">12612000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM2LTUtMS0xLTE4MTc2OQ_e1f28da8-0206-436a-827a-ff0b567e7bb1"
      unitRef="usd">8897000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromStockPlans
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM3LTEtMS0xLTE4MTc2OQ_fcbcc300-890f-4034-8591-9698fa6a4e8e"
      unitRef="usd">4759000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM3LTMtMS0xLTE4MTc2OQ_ada29e54-0984-46e5-b2a9-81f92fac9e35"
      unitRef="usd">1395000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM3LTUtMS0xLTE4MTc2OQ_68cbd6e7-5f9e-4969-aefb-bbd95ae7bc24"
      unitRef="usd">0</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM4LTEtMS0xLTE4MTc2OQ_f5a14a51-eea0-4960-8e12-f2eef5fc9669"
      unitRef="usd">3822000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM4LTMtMS0xLTE4MTc2OQ_a243967e-6708-4095-a2f0-11ceb0b872af"
      unitRef="usd">817000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM4LTUtMS0xLTE4MTc2OQ_9556e2b0-5cae-4130-90b7-d71c08080ba7"
      unitRef="usd">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM5LTEtMS0xLTE4MTc2OQ_d7c113fb-598b-450a-87b2-96ea75cfff90"
      unitRef="usd">85324000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM5LTMtMS0xLTE4MTc2OQ_94a05bd6-6111-4f86-99e0-431c0ae9850d"
      unitRef="usd">2698000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzM5LTUtMS0xLTE4MTc2OQ_3cff5482-02f9-4d68-9fd1-2c814af6ae55"
      unitRef="usd">2022000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQwLTEtMS0xLTE4MTc2OQ_703ef5b4-35f3-4736-a789-ba864ff7cd2e"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQwLTMtMS0xLTE4MTc2OQ_2d540c92-f0c0-4a6b-97c0-2030d687fa16"
      unitRef="usd">3982000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQwLTUtMS0xLTE4MTc2OQ_32aae6de-20c9-4ee4-8ea9-635ae350e585"
      unitRef="usd">1468000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQyLTEtMS0xLTE4MTc2OQ_f3504caf-18ae-405e-acc5-3af50f12921d"
      unitRef="usd">-74461000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQyLTMtMS0xLTE4MTc2OQ_292f4d7b-06e2-4f93-bd4a-30fd8afed2d7"
      unitRef="usd">560415000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQyLTUtMS0xLTE4MTc2OQ_3399e234-b0e0-4e9b-b562-50a4bf0f4ff6"
      unitRef="usd">5407000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQzLTEtMS0xLTE4MTc2OQ_d59ad872-6d85-4288-96cc-cfa7b2194f5b"
      unitRef="usd">45218000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQzLTMtMS0xLTE4MTc2OQ_76377477-a1d6-4594-8e9b-568f23e7e5ac"
      unitRef="usd">46416000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQzLTUtMS0xLTE4MTc2OQ_6f576216-1be9-4c86-bfe7-0c5d7eb1fe89"
      unitRef="usd">17963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ0LTEtMS0xLTE4MTc2OQ_b32d04de-859e-4f60-ad4e-cbadb36047d8"
      unitRef="usd">112809000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ0LTMtMS0xLTE4MTc2OQ_e96475da-292f-4610-8298-9b80aa051ced"
      unitRef="usd">66393000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ0LTUtMS0xLTE4MTc2OQ_123f5e48-d269-4a41-aaa0-8bc3c8dbedb1"
      unitRef="usd">48430000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ1LTEtMS0xLTE4MTc2OQ_9bd9f1c2-c973-453b-893a-662f9fdffdd4"
      unitRef="usd">158027000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ1LTMtMS0xLTE4MTc2OQ_f24de2aa-0211-4716-9a0d-c6723a768684"
      unitRef="usd">112809000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmM2IyYTA1YjNjMjM0ODAzODY3ZmVkMDQ5NmRmNWI5ZS90YWJsZXJhbmdlOmYzYjJhMDViM2MyMzQ4MDM4NjdmZWQwNDk2ZGY1YjllXzQ1LTUtMS0xLTE4MTc2OQ_5be30c7a-807b-447d-bccc-308104ebfb27"
      unitRef="usd">66393000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzEtMS0xLTEtMTgxNzY5_6a64b86b-1719-4fc6-b392-d99e1cab4906"
      unitRef="usd">5231000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzEtMy0xLTEtMTgxNzY5_7d723e83-e564-455d-b178-26afbdfcb5a2"
      unitRef="usd">206000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzEtNS0xLTEtMTgxNzY5_09e5bee6-30e9-46e7-b02e-9b621b5363c2"
      unitRef="usd">5972000</us-gaap:IncomeTaxesPaid>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzMtMS0xLTEtMTgxNzY5_8e65ba79-0671-4b05-851f-6d5cdc144083"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzMtMy0xLTEtMTgxNzY5_decc3f4d-293b-45fb-9d73-2e6136504ca5"
      unitRef="usd">81458000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzMtNS0xLTEtMTgxNzY5_7521e0b9-a047-4cdb-ab46-9138e57a87e0"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <docs:StockIssuancesCostsIncurredButNotYetPaid
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzQtMS0xLTEtMTgxNzY5_ab996cec-2686-4605-bd32-fb0f5b6bee77"
      unitRef="usd">0</docs:StockIssuancesCostsIncurredButNotYetPaid>
    <docs:StockIssuancesCostsIncurredButNotYetPaid
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzQtMy0xLTEtMTgxNzY5_3b43c8a3-0e07-423c-8782-b36d3ac6e34c"
      unitRef="usd">0</docs:StockIssuancesCostsIncurredButNotYetPaid>
    <docs:StockIssuancesCostsIncurredButNotYetPaid
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzQtNS0xLTEtMTgxNzY5_1b0e125e-a05e-4f49-b24f-fbe6f2ea9ed1"
      unitRef="usd">782000</docs:StockIssuancesCostsIncurredButNotYetPaid>
    <docs:StockIssuedAcquisitions
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzUtMS0xLTEtMTgxNzY5_6687468d-913c-40ac-9e7f-fa514d558dc2"
      unitRef="usd">0</docs:StockIssuedAcquisitions>
    <docs:StockIssuedAcquisitions
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzUtMy0xLTEtMTgxNzY5_acd44801-ba37-4d08-8c46-07fa273b4d82"
      unitRef="usd">0</docs:StockIssuedAcquisitions>
    <docs:StockIssuedAcquisitions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzUtNS0xLTEtMTgxNzY5_7fe17522-f615-467f-9415-5c035e515c03"
      unitRef="usd">1062000</docs:StockIssuedAcquisitions>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzYtMS0xLTEtMTgxNzY5_4405cf5a-6294-4286-93d1-a2aefcbf4327"
      unitRef="usd">865000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzYtMy0xLTEtMTgxNzY5_c07f0ddb-7b50-4f37-8141-e0f71a32c86a"
      unitRef="usd">497000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzYtNS0xLTEtMTgxNzY5_b3d7796b-585b-4368-bc41-8988114ec85d"
      unitRef="usd">195000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <docs:EscrowDepositsRelatedToSaleOfBusiness
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzctMS0xLTEtMTgxNzY5_9a71c06a-eb1a-4032-b8a6-66d55cd27536"
      unitRef="usd">0</docs:EscrowDepositsRelatedToSaleOfBusiness>
    <docs:EscrowDepositsRelatedToSaleOfBusiness
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzctMy0xLTEtMTgxNzY5_4dbe2f4e-7dad-4363-b551-e09bd66c1dd7"
      unitRef="usd">0</docs:EscrowDepositsRelatedToSaleOfBusiness>
    <docs:EscrowDepositsRelatedToSaleOfBusiness
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzctNS0xLTEtMTgxNzY5_746042e1-7b75-4cd9-9db2-a3c397e9f3b6"
      unitRef="usd">470000</docs:EscrowDepositsRelatedToSaleOfBusiness>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMS0xLTEtMjAwMjIx_59d08c23-378c-465f-842a-a6599f35ce82"
      unitRef="usd">21134000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMy0xLTEtMjAwMjIx_c1df7ca2-856e-4506-9823-f31991db000b"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktNS0xLTEtMjAwMjIx_0fdda81d-9451-4030-b009-8e52a61c3683"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMS0xLTEtMTgxNzY5_18b87bef-0d12-42a1-b523-505ca4679463"
      unitRef="usd">14759000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktMy0xLTEtMTgxNzY5_4be4146e-2bac-4a71-ad4a-51740fc42c1c"
      unitRef="usd">1151000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzktNS0xLTEtMTgxNzY5_da474e81-3e7d-4445-bee5-3ea9f441ca64"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzExLTEtMS0xLTIxMzUwNA_bf33cc64-fa2b-4793-8f69-6d74146f1c3f"
      unitRef="usd">748000</docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction>
    <docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzExLTMtMS0xLTIxMzUwNA_342b00d2-872f-4d38-bfc1-57671f910a28"
      unitRef="usd">0</docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction>
    <docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDAvZnJhZzpjNzEzOTRkMTM3ZWQ0NGI3YmM3YTBlZDAwZmM5NzhhNC90YWJsZTpmODJlODA2Yjk5YTY0NTBjODIyNzk3YzhhMjJlZTFkOC90YWJsZXJhbmdlOmY4MmU4MDZiOTlhNjQ1MGM4MjI3OTdjOGEyMmVlMWQ4XzExLTUtMS0xLTIxMzUwNA_f1bbc3da-2419-4aa6-873c-9b341a7beae5"
      unitRef="usd">0</docs:RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzI3MzA_b00bdede-498c-4d77-b9a0-457b8138e6b8">Description of Business&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Doximity,&#160;Inc. (the &#x201c;Company&#x201d;) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, monitor their work schedules, and manage their careers. The Company&#x2019;s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company&#x2019;s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company completed its initial public offering (&#x201c;IPO&#x201d;), in which the Company issued and sold 22,505,750 shares of its Class A common stock at $26.00 per share, including 3,495,000 shares issued upon the exercise of the underwriters&#x2019; option to purchase additional shares. The Company received proceeds of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs. In connection with the IPO, all 76,286,618 shares of the Company&#x2019;s outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred offering costs, which consist of direct incremental legal, consulting, banking, and accounting fees relating to the Company&#x2019;s planned initial public offering, were capitalized. Upon the consummation of the IPO, $5.5 million of deferred offering costs were offset against proceeds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Split&lt;/span&gt;&lt;/div&gt;On June&#160;8, 2021, the Company&#x2019;s board of directors and stockholders approved an amendment to the Company&#x2019;s amended and restated certificate of incorporation effecting a 2-for-1 forward split of the Company&#x2019;s issued and outstanding stock, including outstanding stock-based instruments and redeemable convertible preferred stock. The par value of the common and redeemable convertible preferred stock was not adjusted as a result of the stock split. As such, the Company has reclassified amounts from additional paid-in capital to common stock. All issued and outstanding shares of common stock, stock-based instruments, redeemable convertible preferred stock, and per-share amounts included in the accompanying consolidated financial statements have been adjusted to reflect this stock split for all periods presented.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="iccdb5f0a810d4eebb2bafe0d42b2c742_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzExMjM_27dda943-0632-4333-8adb-5f82ba97377d"
      unitRef="shares">22505750</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ib6eef4e680704bceaea439b7961166cd_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzExNjQ_1ea9c095-272d-413a-89b7-6f35f7dd8ddd"
      unitRef="usdPerShare">26.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i279a208c32804584b31bfd94d3dd86ac_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzExODg_549508fb-67c0-43c1-98de-dd0f2e2972f4"
      unitRef="shares">3495000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="iccdb5f0a810d4eebb2bafe0d42b2c742_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzEzMTU_a798e9d7-8f40-4fb3-bab6-a718783cb0a7"
      unitRef="usd">548500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="iaae932e69d134ab791bd1c42fff0771b_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzE0NDE_bfa02f78-b0d6-4797-a5c2-1dcaa34666fb"
      unitRef="shares">76286618</us-gaap:ConversionOfStockSharesConverted1>
    <docs:ConversionOfStockConversionRatio
      contextRef="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzE2MDg_4466d40d-6c5d-4dea-b150-ac631b35e765"
      unitRef="number">1</docs:ConversionOfStockConversionRatio>
    <us-gaap:DeferredOfferingCosts
      contextRef="iccbddb5d88f943d18b1e2bca79988299_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzE4NDk_4fba6dff-9850-42b9-b3fb-f534fb5a19a5"
      unitRef="usd">5500000</us-gaap:DeferredOfferingCosts>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="id9c60a7a5216441aacc21b7da53bdeb8_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDYvZnJhZzo5MWI2NzcwMzI2OWE0MTVkYjE2NWUwMzIzMGMzMWVkYS90ZXh0cmVnaW9uOjkxYjY3NzAzMjY5YTQxNWRiMTY1ZTAzMjMwYzMxZWRhXzIwODA_7b068928-7040-4ca0-96cf-57eb5f7637cd"
      unitRef="number">2</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYx_76dd35a9-91fa-41de-833a-c71f9f90bba1">Summary of Significant Accounting Policies&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal Year &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year ends on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#x2019;s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#x2019;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales. The Company&#x2019;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the purpose of assessing the concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company&#x2019;s services directly or indirectly through marketing agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue is primarily derived from the sale of subscriptions for the following solutions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Marketing Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#x2019;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Hiring Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Providing customers access to the Company&#x2019;s professional tools where recruiters can access the Company&#x2019;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, through the following five steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the contract with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers the terms and conditions of its contracts and the Company&#x2019;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#x2019;s rights regarding the services to be transferred and the payment terms for the services, it has determined that the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#x2019;s ability and intent to pay, which is based on a variety of factors, including the customer&#x2019;s payment history or, in the case of a new customer, the customer&#x2019;s credit and financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual terms for Marketing Solutions contracts are generally 12 months or less. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions contracts are cancellable with a customary notice period. The Company does not  refund prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payment was not made. The contractual term for Hiring Solutions contracts is generally 12 months. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the customers&#x2019; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#x2019;s Awareness modules may include a sponsored article, short animated videos or other short-form content that is presented to the targeted member.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period, subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Determine the transaction price &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#x2019;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#x2019;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Allocate the transaction price to performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price (&#x201c;SSP&#x201d;). The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of SSP is based on historical sales of standalone services. The Company estimates the SSP for arrangements where standalone sales do not provide sufficient &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;evidence of the SSP. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Recognize revenue when or as the Company satisfies a performance obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#x2019;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#x2019;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract, while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#x2019;s contracts do not contain significant financing components. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#x2019;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes sales compensation that is considered to be incremental and recoverable costs of obtaining a contract with a customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales compensation earned for the renewal of Marketing Solutions contracts is commensurate with compensation earned for a new or expansion Marketing Solutions contract, whereas compensation for the renewal of Hiring Solutions subscription contracts is earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#x2019;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. The portion of deferred compensation expected to be recognized within one year of the balance sheet date is recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Amortization of deferred contract costs are included in cost of revenue and sales and marketing expense in the consolidated statements of operations. Sales compensation that is not considered incremental costs are expensed in the same period as they are earned. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#x2019;s anticipated life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2023 and 2022 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#x2019; equity on the consolidated balance sheets. The Company&#x2019;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net, and any remaining unrealized losses are recorded to other comprehensive income (loss). If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#x2019;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations, payment history and the customer&#x2019;s current financial condition. The Company had no material bad debt write offs for the years ending March&#160;31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3-5 years &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. Maintenance and repairs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Internal-Use Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, including the selection of valuation methodologies, estimates of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates. Acquisition costs, such as legal and consulting fees, are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets, and Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in cost of revenue and sales and marketing expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management evaluates the recoverability of the Company&#x2019;s long-lived assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#x2019;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RSU and PSU is based on the fair value of the Company&#x2019;s Class A common stock, which is traded on the NYSE, on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP (&#x201c;ESPP rights&#x201d;), and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#x2019;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the IPO, the Company granted stock options and warrants which were valued using the Black-Scholes pricing model, and after the IPO, the Company has granted warrants and ESPP rights which were valued using the Black-Scholes pricing model. The assumptions used in the Black-Scholes models are determined as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Prior to the IPO, when there was no public market for the Company&#x2019;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. After the IPO, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The expected term represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding. Prior to the IPO, the Company estimated the expected term for awards granted to employees using the simplified method as the Company&#x2019;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For awards granted to non-employees, the Company used the contractual term as the expected term. For ESPP rights, the expected term is equivalent to the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividend Yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Per Share of the Company&#x2019;s Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Because the Company&#x2019;s common stock was not publicly traded until the completion of the IPO, the Company&#x2019;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#x2019;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#x2019;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. After the IPO, the Company used the closing stock price of the Company&#x2019;s Class A common stock, which is traded on the NYSE. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract is or contains a lease at inception. All of the Company&#x2019;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#x2019;s incremental borrowing rate. As none of the Company&#x2019;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income Per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the two-class method to compute basic and diluted net income per share attributable to common stockholders when shares meet the definition of participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the automatic conversion of the Company&#x2019;s outstanding redeemable convertible preferred stock to Class B common stock in connection with the IPO, the Company had redeemable convertible preferred stock. The redeemable convertible preferred stock was considered to be a participating security because the holders were each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#x2019;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate. Redeemable convertible preferred stock was therefore included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#x2019;s losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, and common stock warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#x2019;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of expenses &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related to cloud hosting, personnel-related expenses for the Company&#x2019;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;delivery and support of the Company&#x2019;s platform. Cost of revenue also includes the amortization of internal-use software development costs, editorial and other content-related expenses, and allocated overhead. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expense is primarily comprised of personnel-related&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; associated with the Company&#x2019;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Expenses &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations. Advertising expense was $2.6 million, $2.8 million, and $2.6 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. Most amendments within this guidance &lt;/span&gt;&lt;/div&gt;are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance on April 1, 2022, and the adoption of this guidance did not have a material impact on the consolidated financial statements. &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers,&lt;/span&gt; as if it had originated the contracts. Previously, the Company recognized contract assets and contract liabilities at the acquisition date based on fair value estimates, which had resulted in a reduction to unearned revenue on the balance sheet, and therefore, a reduction to revenues that would have otherwise been recorded as an independent entity. The Company adopted this guidance on April 1, 2022, using the prospective approach. The adoption is applicable to business combinations occurring on or after April 1, 2022, including the Company&#x2019;s acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians completed on April 1, 2022 (the &#x201c;AMiON&#x201d; Acquisition). See Note 8&#x2014;Business Combinations for additional discussion regarding the AMiON acquisition.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYz_d6d5b4a6-5b6d-472f-845d-8b9c9f4504eb">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUz_86c40266-1107-4661-8994-3da4343a36a8">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY1_a5774b1d-7e1c-4ce3-b5fb-9534276c1294">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal Year &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year ends on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:FiscalPeriod>
    <us-gaap:UseOfEstimates
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUw_160b6d87-5884-4c90-a0be-e317f4768872">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#x2019;s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its &lt;/span&gt;&lt;/div&gt;estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment.</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU0_b81186ef-2195-4d3b-b597-e8fd05280565">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#x2019;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.&lt;/span&gt;&lt;/div&gt;Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYy_5d1fc432-1c1e-4418-bdf9-ac6b97ea1a49">The Company&#x2019;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib2e9777aeaf94d178823baaa223076df_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTphMmNmNWExN2E3ZDI0YWY1ODY4NmM0ZTIzYWUzODQ5Yy90YWJsZXJhbmdlOmEyY2Y1YTE3YTdkMjRhZjU4Njg2YzRlMjNhZTM4NDljXzMtNS0xLTEtMTgxNzY5_dfd08fd8-576d-4b49-ba5a-59b5bca14294"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic9cad1e062b649388bc8309807dd70ec_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTphMmNmNWExN2E3ZDI0YWY1ODY4NmM0ZTIzYWUzODQ5Yy90YWJsZXJhbmdlOmEyY2Y1YTE3YTdkMjRhZjU4Njg2YzRlMjNhZTM4NDljXzMtNy0xLTEtMTgxNzY5_007c19a6-f01e-4133-a29b-7618f59f80f3"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia35ab93e92f745bf8d13e1856e15688d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTphMmNmNWExN2E3ZDI0YWY1ODY4NmM0ZTIzYWUzODQ5Yy90YWJsZXJhbmdlOmEyY2Y1YTE3YTdkMjRhZjU4Njg2YzRlMjNhZTM4NDljXzMtOS0xLTEtMTgxNzY5_6cb70dfa-ee90-4ebb-bb4c-3180af020e4a"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ2_f0d21dac-0981-49c3-80e4-c50d589145f0">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue is primarily derived from the sale of subscriptions for the following solutions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Marketing Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#x2019;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Hiring Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Providing customers access to the Company&#x2019;s professional tools where recruiters can access the Company&#x2019;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, through the following five steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the contract with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers the terms and conditions of its contracts and the Company&#x2019;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#x2019;s rights regarding the services to be transferred and the payment terms for the services, it has determined that the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#x2019;s ability and intent to pay, which is based on a variety of factors, including the customer&#x2019;s payment history or, in the case of a new customer, the customer&#x2019;s credit and financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual terms for Marketing Solutions contracts are generally 12 months or less. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions contracts are cancellable with a customary notice period. The Company does not  refund prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payment was not made. The contractual term for Hiring Solutions contracts is generally 12 months. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the customers&#x2019; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#x2019;s Awareness modules may include a sponsored article, short animated videos or other short-form content that is presented to the targeted member.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period, subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Determine the transaction price &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#x2019;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#x2019;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Allocate the transaction price to performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price (&#x201c;SSP&#x201d;). The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of SSP is based on historical sales of standalone services. The Company estimates the SSP for arrangements where standalone sales do not provide sufficient &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;evidence of the SSP. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Recognize revenue when or as the Company satisfies a performance obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#x2019;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#x2019;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract, while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#x2019;s contracts do not contain significant financing components. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#x2019;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes sales compensation that is considered to be incremental and recoverable costs of obtaining a contract with a customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales compensation earned for the renewal of Marketing Solutions contracts is commensurate with compensation earned for a new or expansion Marketing Solutions contract, whereas compensation for the renewal of Hiring Solutions subscription contracts is earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. &lt;/span&gt;&lt;/div&gt;Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#x2019;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. The portion of deferred compensation expected to be recognized within one year of the balance sheet date is recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Amortization of deferred contract costs are included in cost of revenue and sales and marketing expense in the consolidated statements of operations. Sales compensation that is not considered incremental costs are expensed in the same period as they are earned.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <docs:ContractWithCustomerTerm
      contextRef="i6a7a508b84f14a2c89f8f76f79912495_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzUyMjM_d08ddba2-3c14-47af-8e20-b1971ebe25d1">P12M</docs:ContractWithCustomerTerm>
    <docs:ContractWithCustomerTerm
      contextRef="i66fbd0824ee44aa4999edf05fdba61a6_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQzOTgwNDY2MjExNzg_de183213-679e-4050-a881-22e63efa8bfa">P12M</docs:ContractWithCustomerTerm>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="id95916c6936340cdade0aa07aaf2b43c_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzE1NDc4_1f42e863-5c9c-4de3-abbc-62bc15ee51b9">P7M</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i395392694ee54a58a68d60da43cd9346_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzE1NDg0_fd296dd2-1110-4a08-b9e8-cdc4536c2fdb">P13M</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i193acb95329a49ffa11b381f072505f0_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzE1NjQ0_84b96427-a133-4e0c-85cb-e7253c083032">P4Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY2_03fa56cd-23b7-434c-bf91-adc5e9ca4446">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#x2019;s anticipated life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <docs:CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU1_30140036-8ccf-4351-b1cc-6cdb2cf133af">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2023 and 2022 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#x2019; equity on the consolidated balance sheets. The Company&#x2019;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net, and any remaining unrealized losses are recorded to other comprehensive income (loss). If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net.</docs:CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDYw_8db3595a-f8e2-496a-95da-b5d030687487">Accounts Receivable and Allowance for Doubtful AccountsAccounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#x2019;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations, payment history and the customer&#x2019;s current financial condition.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY3_a2b28875-930b-4cd6-96dd-091b92fbb30c">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3-5 years &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. Maintenance and repairs are expensed as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU3_57202aa8-ca0a-4515-828e-a47dfc685e30">The estimated useful life of each asset category is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3-5 years &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;24,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(13,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i13475fef7778429390ef0860c7b05a45_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzAtMS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZWI2M2ZkZjcyODE1NDI3NWEzNjM2NjliZDE5ZTk5YmVfNA_e0785d1d-f78c-4735-b67f-c15629006aa1">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ibf3ecb7779284d14862d24d80dc3241e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzAtMS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZWI2M2ZkZjcyODE1NDI3NWEzNjM2NjliZDE5ZTk5YmVfNw_b4c6e9b0-8dfb-4d7a-b9ba-778e6b5da190">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4bc3bbea93e64ae99dfb98af6a33b945_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzEtMS0xLTEtMTgxNzY5_28af3399-73d0-453f-a2a4-8f159fbd78a8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0728b940a9f64fc9bf1ed1b456fbfb6a_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90YWJsZTpkYjY0NDA0YTlkODQ0MGRmOTM5ZDYyNWE2YmNhNDkzZC90YWJsZXJhbmdlOmRiNjQ0MDRhOWQ4NDQwZGY5MzlkNjI1YTZiY2E0OTNkXzItMS0xLTEtMTgxNzY5_186f40c6-cb6f-4938-90ac-e3d1dc58bf5a">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY0_150ba5b9-4407-486d-8c60-da13ff97aacf">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Internal-Use Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. &lt;/span&gt;&lt;/div&gt;Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life.</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUy_bcb648b9-844f-41a8-8a7c-63e37a077f69">Business CombinationsWhen the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, including the selection of valuation methodologies, estimates of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates. Acquisition costs, such as legal and consulting fees, are expensed as incurred.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY4_24e971dd-68ef-44d6-815e-c67e7238e2a7">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets, and Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in cost of revenue and sales and marketing expense. &lt;/span&gt;&lt;/div&gt;Management evaluates the recoverability of the Company&#x2019;s long-lived assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzIzODQ0_4e7c26f6-f61e-4398-8661-5411a36f1b8c"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDcw_bb3d69dc-b302-4b7a-8331-41dd7ac9bbdb">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#x2019;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RSU and PSU is based on the fair value of the Company&#x2019;s Class A common stock, which is traded on the NYSE, on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP (&#x201c;ESPP rights&#x201d;), and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#x2019;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the IPO, the Company granted stock options and warrants which were valued using the Black-Scholes pricing model, and after the IPO, the Company has granted warrants and ESPP rights which were valued using the Black-Scholes pricing model. The assumptions used in the Black-Scholes models are determined as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Prior to the IPO, when there was no public market for the Company&#x2019;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. After the IPO, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The expected term represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding. Prior to the IPO, the Company estimated the expected term for awards granted to employees using the simplified method as the Company&#x2019;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For awards granted to non-employees, the Company used the contractual term as the expected term. For ESPP rights, the expected term is equivalent to the offering period. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividend Yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. &lt;/span&gt;Fair Value Per Share of the Company&#x2019;s Common Stock&#x2014;Because the Company&#x2019;s common stock was not publicly traded until the completion of the IPO, the Company&#x2019;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#x2019;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#x2019;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. After the IPO, the Company used the closing stock price of the Company&#x2019;s Class A common stock, which is traded on the NYSE.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDY5_2a275a73-e28c-4e95-86c2-5a2cef0a21e6">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract is or contains a lease at inception. All of the Company&#x2019;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#x2019;s incremental borrowing rate. As none of the Company&#x2019;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. &lt;/span&gt;&lt;/div&gt;The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDcy_60371118-ce80-4eb4-abaf-4d4cf37ebf89">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income Per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the two-class method to compute basic and diluted net income per share attributable to common stockholders when shares meet the definition of participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the automatic conversion of the Company&#x2019;s outstanding redeemable convertible preferred stock to Class B common stock in connection with the IPO, the Company had redeemable convertible preferred stock. The redeemable convertible preferred stock was considered to be a participating security because the holders were each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#x2019;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate. Redeemable convertible preferred stock was therefore included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#x2019;s losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, and common stock warrants. &lt;/span&gt;&lt;/div&gt;The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ4_ca08d927-4859-4b42-9772-ca08d440ee0c">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#x2019;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ3_e0a83139-1de7-4037-bf04-bc1ef03f3c5c">Legal ContingenciesThe Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above.</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDUx_664d0c17-0575-4fa9-9bfc-81277d5d1c4c">Cost of Revenue &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of expenses &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related to cloud hosting, personnel-related expenses for the Company&#x2019;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with &lt;/span&gt;delivery and support of the Company&#x2019;s platform. Cost of revenue also includes the amortization of internal-use software development costs, editorial and other content-related expenses, and allocated overhead.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDcx_e4d4dfdd-9906-4854-bc99-a7e99b3acae0">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expense is primarily comprised of personnel-related&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; associated with the Company&#x2019;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDQ5_cecfad04-0358-43e3-bf30-a12ba0ebbd72">Advertising Expenses Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzM3NzIx_4a1e8d47-ce87-4fb6-9b34-d39308029ce7"
      unitRef="usd">2600000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzM3NzI1_d72f34b2-8222-45d6-b9f0-a217790b9d76"
      unitRef="usd">2800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzM3NzMz_d4512b05-aa3d-4b4b-a7d8-5e2118488077"
      unitRef="usd">2600000</us-gaap:AdvertisingExpense>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMDkvZnJhZzpjZjY5ZGQ0ZWNhOTU0ODg5OTg3MjNiNzNkNjg2NTNlYi90ZXh0cmVnaW9uOmNmNjlkZDRlY2E5NTQ4ODk5ODcyM2I3M2Q2ODY1M2ViXzQxMDU5_2a629518-89d9-42ab-a88e-fe8f2212462a">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. Most amendments within this guidance &lt;/span&gt;&lt;/div&gt;are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance on April 1, 2022, and the adoption of this guidance did not have a material impact on the consolidated financial statements. &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers,&lt;/span&gt; as if it had originated the contracts. Previously, the Company recognized contract assets and contract liabilities at the acquisition date based on fair value estimates, which had resulted in a reduction to unearned revenue on the balance sheet, and therefore, a reduction to revenues that would have otherwise been recorded as an independent entity. The Company adopted this guidance on April 1, 2022, using the prospective approach. The adoption is applicable to business combinations occurring on or after April 1, 2022, including the Company&#x2019;s acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians completed on April 1, 2022 (the &#x201c;AMiON&#x201d; Acquisition). See Note 8&#x2014;Business Combinations for additional discussion regarding the AMiON acquisition.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzc1NA_51c534fb-00d1-44f1-8242-09211fa2233c">Revenue Recognition &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Disaggregation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subscription&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;389,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;319,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;192,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;29,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;14,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;419,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;343,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;206,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company&#x2019;s deferred revenue balances were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;84,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions, net, during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;345,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from the beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(83,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(82,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from contracts invoiced during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(335,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(261,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;105,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;84,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the additions, net, during the period was $2.9 million of additions due to the AMiON acquisition which closed on April&#160;1, 2022. See Note 8 &#x2014; Business Combinations for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unbilled revenue balances were $2.2 million and $1.4 million as of March&#160;31, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Contract Costs&lt;/span&gt;&lt;/div&gt;The Company capitalized $8.5 million, $9.6 million, and $9.4 million of contract acquisition costs for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. Amortization of deferred contract costs was $8.8 million, $9.8 million, and $6.9 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. Deferred contract costs are periodically analyzed for impairment. There were no impairment losses relating to deferred contract costs during the fiscal years ended March&#160;31, 2023, 2022, and 2021.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzc1NQ_1b80c3ad-1251-45ee-895f-acb7246f2a36">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subscription&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;389,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;319,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;192,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;29,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;14,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;419,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;343,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;206,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i396b959629334256bafddb8623b58bbb_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzItMS0xLTEtMTgxNzY5_b7c0828d-a0f6-463c-abe0-c59962490eb4"
      unitRef="usd">389739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8189eaf3c5a341eb905e447cbdc1e660_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzItMy0xLTEtMTgxNzY5_cc6b5c25-750f-41b3-b081-5573b247cb59"
      unitRef="usd">319298000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad7a18fbd0c14f8ba371333c97190a67_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzItNS0xLTEtMTgxNzY5_3d2c72ab-9a31-4985-9304-feb9c4a9b264"
      unitRef="usd">192256000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd6a54410372468a8511243ad114dbe9_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzMtMS0xLTEtMTgxNzY5_feb28cf3-3c37-4479-831d-c84133290a80"
      unitRef="usd">29313000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ad31f043cf54368a2e28a707d138b65_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzMtMy0xLTEtMTgxNzY5_a1396396-43c1-4c8e-b343-b2a7a8ed798d"
      unitRef="usd">24250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c10798df81841449d5dbfb26d76969d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzMtNS0xLTEtMTgxNzY5_9691c3cb-f459-44a0-bb94-fed9c6e9131c"
      unitRef="usd">14641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzQtMS0xLTEtMTgxNzY5_f19b9734-a397-4851-8cf3-cab2c9ac12a3"
      unitRef="usd">419052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzQtMy0xLTEtMTgxNzY5_6bf1bad5-e3d7-4c2a-bc56-e3d9e139833f"
      unitRef="usd">343548000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo5ZGY2YzNjYTVmYzY0YThlODdkYmRjMzhmYTk0MmUxMy90YWJsZXJhbmdlOjlkZjZjM2NhNWZjNjRhOGU4N2RiZGMzOGZhOTQyZTEzXzQtNS0xLTEtMTgxNzY5_621d9a48-4a74-49f1-898d-78fcca1ad49f"
      unitRef="usd">206897000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzc1Mw_4d216acb-427b-4f9c-8e2e-d7e7182bdb4e">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company&#x2019;s deferred revenue balances were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;84,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions, net, during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;345,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from the beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(83,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(82,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from contracts invoiced during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(335,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(261,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;105,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;84,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzItMS0xLTEtMTgxNzY5_3a4bf063-e8a2-4b28-b025-c041ea021ee2"
      unitRef="usd">84985000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzItMy0xLTEtMTgxNzY5_86027be8-a0d0-43dc-bc3a-18dfd6ebb41d"
      unitRef="usd">83492000</us-gaap:ContractWithCustomerLiability>
    <docs:ContractWithCustomerLiabilityAdditionsNet
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzMtMS0xLTEtMTgxNzY5_b0f2dc73-ef12-4647-9b31-d65110f8f0c0"
      unitRef="usd">439503000</docs:ContractWithCustomerLiabilityAdditionsNet>
    <docs:ContractWithCustomerLiabilityAdditionsNet
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzMtMy0xLTEtMTgxNzY5_2c6e4a3a-2a1c-4ac5-bbff-f6cb8608d79e"
      unitRef="usd">345041000</docs:ContractWithCustomerLiabilityAdditionsNet>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzQtMS0xLTEtMTgxNzY5_51f80ff6-12ae-4065-a339-1556a84925ce"
      unitRef="usd">83231000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzQtMy0xLTEtMTgxNzY5_8114df23-38e6-4324-a774-f6ba335d0335"
      unitRef="usd">82534000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzUtMS0xLTEtMTgxNzY5_6449b0bd-629a-46fc-bf49-473ace740729"
      unitRef="usd">335821000</docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance>
    <docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzUtMy0xLTEtMTgxNzY5_119f8b6f-0b38-4e6d-a4cc-459c784a338f"
      unitRef="usd">261014000</docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzYtMS0xLTEtMTgxNzY5_cb34bd68-cbc6-4c70-9fa6-149fc0a9149a"
      unitRef="usd">105436000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90YWJsZTo1Njc4MjUwNGQ3NzY0YzdiOWU1ZDdiYzlkYmM1MjZjYS90YWJsZXJhbmdlOjU2NzgyNTA0ZDc3NjRjN2I5ZTVkN2JjOWRiYzUyNmNhXzYtMy0xLTEtMTgxNzY5_5e7c7450-b85e-4469-86c2-463800759849"
      unitRef="usd">84985000</us-gaap:ContractWithCustomerLiability>
    <docs:ContractWithCustomerLiabilityAdditionsNet
      contextRef="id6779a54192f451097a27ad596eba040_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzU0OTc1NTgxNDk0Mg_bdbc5e62-20ad-4b9d-a74d-8c7011caec6d"
      unitRef="usd">2900000</docs:ContractWithCustomerLiabilityAdditionsNet>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzI1Nw_34ac65ba-81bc-4c30-93da-0d2396fb9430"
      unitRef="usd">2200000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzI2MQ_bbc8ac1d-46eb-4d2c-b81a-fd296939488b"
      unitRef="usd">1400000</us-gaap:UnbilledReceivablesCurrent>
    <docs:CapitalizedContractCostAdditions
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzM1Ng_233ae87f-a94c-4fdd-994e-cffac1e656cb"
      unitRef="usd">8500000</docs:CapitalizedContractCostAdditions>
    <docs:CapitalizedContractCostAdditions
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzM2MA_e3693386-2295-4a45-af96-727008a3902b"
      unitRef="usd">9600000</docs:CapitalizedContractCostAdditions>
    <docs:CapitalizedContractCostAdditions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzM2OA_ffcadd51-25d0-4977-a546-884e18d38e17"
      unitRef="usd">9400000</docs:CapitalizedContractCostAdditions>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzUwMg_287f923b-752f-4b9b-b445-fb80fbd27f99"
      unitRef="usd">8800000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzUwNg_e1a79273-98b8-4bb3-bcad-b8aa4bed4950"
      unitRef="usd">9800000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzUxNA_c1957978-597b-40df-b5f3-f43054aeb4fe"
      unitRef="usd">6900000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostImpairmentLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzY1MQ_26054433-8382-4740-8308-f48bfc5e3882"
      unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzY1MQ_54ea6070-4335-4cc1-ad7a-7d14fcd5d475"
      unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTIvZnJhZzo5NjE5MzVkYjI4NzI0ZjQzODBiNzUyOTllNjI2NDZjMS90ZXh0cmVnaW9uOjk2MTkzNWRiMjg3MjRmNDM4MGI3NTI5OWU2MjY0NmMxXzY1MQ_8c30f994-c1d7-47b0-863b-252ea0efaa9c"
      unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzEzNjM_fd5d68e5-88c0-47b7-828e-d22492c2a2de">Investments&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;461,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;444,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;701,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;682,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;828,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;809,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the contractual maturities of the Company&#x2019;s available-for-sale debt securities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;360,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due in one year to two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;315,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;682,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual maturities may differ from contractual maturities because certain borrowers have the right to call or prepay certain obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;129,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;549,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;705,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;728,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and 2022, the Company has recognized accrued interest of $2.8 million and $2.1 million, respectively, which is included in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzE3MDQyNDMwMjMzNTky_1995d277-8431-4487-a901-191b21f55f52"&gt;prepaid expenses and other current assets&lt;/span&gt; in the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;The unrealized losses associated with the Company&#x2019;s debt securities were $18.9 million and $20.5 million as of March&#160;31, 2023 and 2022, respectively. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did not recognize any impairment on these securities as of March&#160;31, 2023 and 2022. The Company did not recognize any credit losses related to the Company&#x2019;s debt securities during the fiscal years ended March&#160;31, 2023 and 2022. The fair value related to the debt securities with unrealized loss for which no credit losses were recognized was $653.4 million and $684.7 million as of March&#160;31, 2023 and 2022, respectively.</us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzEzNjY_bd72ca16-de7c-42d7-abe2-a42d16afeca8">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;461,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;444,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;701,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;682,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;828,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;809,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;129,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;549,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;705,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;728,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie833f8b08d684b3bb2c16e4a4497f123_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzUtMS0xLTEtMTgxNzY5_6c871946-c4a7-4971-b286-18fe2dc54410"
      unitRef="usd">126275000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie833f8b08d684b3bb2c16e4a4497f123_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzUtOS0xLTEtMTgxNzY5_84b8acb4-4e29-4cde-b560-a9d2fa0d15e6"
      unitRef="usd">126275000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
      contextRef="i201f487ed07e45f08dc9cea2b1958064_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzctMS0xLTEtMTgxNzY5_1f48c1ec-93fe-40a3-b5cc-0a8cdff3a428"
      unitRef="usd">126275000</docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i201f487ed07e45f08dc9cea2b1958064_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzctOS0xLTEtMTgxNzY5_7a6f4888-e1bc-42b0-a20b-7152f0e6319b"
      unitRef="usd">126275000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktMS0xLTEtMTgxNzY5_de98e034-748b-43a6-9f8f-4f743a3202e4"
      unitRef="usd">7271000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktMy0xLTEtMTgxNzY5_31e23da6-1275-463e-9a8a-6e5599b654e8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktNS0xLTEtMTgxNzY5_cf42e447-30e3-476f-b346-a614f317ae19"
      unitRef="usd">71000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic9331d77b340451ca2423fed1eb629d3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzktOS0xLTEtMTgxNzY5_5b6220bb-5b6d-430b-b43c-166dc288ada7"
      unitRef="usd">7200000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTEtMS0xLTE4MTc2OQ_2b9ad826-f785-472b-bc13-7a7e040a2941"
      unitRef="usd">27380000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTMtMS0xLTE4MTc2OQ_964babe7-a0ad-45f1-a6f3-04b1d267aac9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTUtMS0xLTE4MTc2OQ_9aea716d-d434-44d7-92ff-14e671e7f7c1"
      unitRef="usd">80000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia473d08e40b3424da33538edeca5a18a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEwLTktMS0xLTE4MTc2OQ_8df7fbf7-aa06-481a-ad78-6b8e60cad2bf"
      unitRef="usd">27300000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTEtMS0xLTE4MTc2OQ_cc88affa-b367-4cf5-be48-7bb6aa760bf1"
      unitRef="usd">78609000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTMtMS0xLTE4MTc2OQ_7bc12f8a-6bc9-42ab-80da-d64c4c3da5e3"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTUtMS0xLTE4MTc2OQ_7483de85-04d0-4fc8-815c-6a0be8ae0aac"
      unitRef="usd">126000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8e08c2c5bc6c4949a1de1927437917b1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzExLTktMS0xLTE4MTc2OQ_2f3e3514-28bb-4526-bebc-5273b606740d"
      unitRef="usd">78489000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTEtMS0xLTE4MTc2OQ_51f0ca85-cf2f-4f3a-b254-e7488523c96b"
      unitRef="usd">119241000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTMtMS0xLTE4MTc2OQ_0e58b3eb-e896-4849-8ea9-c008bdd34381"
      unitRef="usd">49000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTUtMS0xLTE4MTc2OQ_86077c45-5590-4bbe-a6f1-630c1a55f764"
      unitRef="usd">778000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7961eb9eb71b4575b98a42d5964377ab_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEyLTktMS0xLTE4MTc2OQ_eab9f4f4-4fab-40ee-9304-94506c73aa4f"
      unitRef="usd">118512000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTEtMS0xLTE4MTc2OQ_9c6e02af-eb0e-4180-a4f6-059657b32b3e"
      unitRef="usd">7744000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTMtMS0xLTE4MTc2OQ_e6e70e0c-f866-4d87-9c0b-7a7bbb09c216"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTUtMS0xLTE4MTc2OQ_cf2164f1-e950-4318-aa2d-8200e30bd5f9"
      unitRef="usd">360000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if06de78b66e74d5080cb4950adc00e7e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzEzLTktMS0xLTE4MTc2OQ_863d5111-d170-4412-897d-854ef940bae2"
      unitRef="usd">7384000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i946014a5671d4e999aa1c822257039c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTEtMS0xLTE4MTc2OQ_1e07de40-0d94-430f-9af9-f9e72dec1564"
      unitRef="usd">461584000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i946014a5671d4e999aa1c822257039c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTMtMS0xLTE4MTc2OQ_7711e2c0-72e4-4e86-aa16-9c8c5892ae0b"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i946014a5671d4e999aa1c822257039c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTUtMS0xLTE4MTc2OQ_af1c15a9-0f76-4335-bafb-cc3db9c77f2f"
      unitRef="usd">17509000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i946014a5671d4e999aa1c822257039c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE0LTktMS0xLTE4MTc2OQ_09ac4199-b135-4955-bc7d-8c01c960adcf"
      unitRef="usd">444087000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="idfbd7fea093845f382923f9f0125016c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTEtMS0xLTE4MTc2OQ_66feef11-56d4-4a7c-991e-3afcff0c3291"
      unitRef="usd">701829000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idfbd7fea093845f382923f9f0125016c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTMtMS0xLTE4MTc2OQ_c5211c87-0fa6-456f-94c9-e59cea480995"
      unitRef="usd">67000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idfbd7fea093845f382923f9f0125016c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTUtMS0xLTE4MTc2OQ_f4226dd1-5a9b-480a-8d2e-c90d43349732"
      unitRef="usd">18924000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="idfbd7fea093845f382923f9f0125016c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE1LTktMS0xLTE4MTc2OQ_f3c6c264-9210-4b36-8938-715ee8315b8c"
      unitRef="usd">682972000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTEtMS0xLTE4MTc2OQ_fae0ceed-2e0f-41ca-a2ad-c463815f9fcd"
      unitRef="usd">828104000</docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTMtMS0xLTE4MTc2OQ_a73e74c1-a066-40f2-80e4-0b03af8ae10e"
      unitRef="usd">67000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTUtMS0xLTE4MTc2OQ_2f6b7f89-553a-4e37-9199-c7adea01d9bb"
      unitRef="usd">18924000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZToyZDk2ZDYzZDQxYzI0NjNkODM5NzQ4MzIxZTE2ZWUzZC90YWJsZXJhbmdlOjJkOTZkNjNkNDFjMjQ2M2Q4Mzk3NDgzMjFlMTZlZTNkXzE2LTktMS0xLTE4MTc2OQ_101649c7-4e59-4dea-b95b-fb170d381f30"
      unitRef="usd">809247000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzEzNjQ_318ade29-98b3-4fd7-8c92-f261e8eb33c1">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the contractual maturities of the Company&#x2019;s available-for-sale debt securities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;360,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due in one year to two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;315,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;682,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual maturities may differ from contractual maturities because certain borrowers have the right to call or prepay certain obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzEtMS0xLTEtMTgxNzY5_228e8971-8421-470a-9705-07e46b11478e"
      unitRef="usd">360143000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <docs:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzItMS0xLTEtMTgxNzY5_ebc88183-a963-4e41-9da7-accd5c2085c1"
      unitRef="usd">315629000</docs:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzMtMS0xLTEtMjI1OTgw_29739e9d-98e3-43a9-87f8-0e9b4b83f087"
      unitRef="usd">7200000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTpiN2ZkNDQ3N2FmOGE0ODYzYmIxMTIxN2NkNjg3NDUyZi90YWJsZXJhbmdlOmI3ZmQ0NDc3YWY4YTQ4NjNiYjExMjE3Y2Q2ODc0NTJmXzMtMS0xLTEtMTgxNzY5_f6c8863f-bf97-4e5b-b24e-d5755769cd00"
      unitRef="usd">682972000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtMS0xLTEtMTgxNzY5_81ea811b-c770-41b8-a4df-ce115b2dc23d"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtMy0xLTEtMTgxNzY5_8ab3b642-20a5-4234-8330-9bb23ed168c3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtNS0xLTEtMTgxNzY5_1d5431f9-5545-4367-99be-f543e485cd3a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7e31cc3adeec45e18d64bd94c7d49110_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzMtOS0xLTEtMTgxNzY5_96cc9ff6-95a4-4b8c-9801-7140ea935d7b"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtMS0xLTEtMTgxNzY5_10d95439-7c42-4777-b424-91b928ab9fed"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtMy0xLTEtMTgxNzY5_9cd16e71-0170-49ab-aab6-4a97f10753c1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtNS0xLTEtMTgxNzY5_2d56ba7b-4485-4fda-a9ee-b44f12888886"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0010efa975ea4d45a2dbde4069444622_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzUtOS0xLTEtMTgxNzY5_a2024f7f-86e9-41f9-a95b-0c030c7d08db"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctMS0xLTEtMTgxNzY5_987816b7-2c85-425d-90fb-c6a8989b9f99"
      unitRef="usd">22758000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctMy0xLTEtMTgxNzY5_f841dc66-6d7a-4dcd-a3d8-9be00d8fc491"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctNS0xLTEtMTgxNzY5_ace10521-ccd7-43e4-aca2-f2fe97d56392"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2da9dd48330643cea24f08da15d08f08_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzctOS0xLTEtMTgxNzY5_a7a960c8-a567-49a3-9fd0-268329982e2b"
      unitRef="usd">22758000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktMS0xLTEtMTgxNzY5_776c0074-a3bf-4b71-8e22-889a91da76d8"
      unitRef="usd">7791000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktMy0xLTEtMTgxNzY5_1c31e6f7-cfe5-43b7-bd31-85e44f78ed12"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktNS0xLTEtMTgxNzY5_a727ab56-6ce1-4242-ab48-0641436932ec"
      unitRef="usd">51000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5a55bf9be127468b8145b679c3cf838e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzktOS0xLTEtMTgxNzY5_2d93c7c5-fbc7-45a9-9043-fd379909eaf8"
      unitRef="usd">7740000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTEtMS0xLTE4MTc2OQ_be8276f5-173f-49bd-8ec1-3334c7cb028f"
      unitRef="usd">9436000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTMtMS0xLTE4MTc2OQ_5addab6d-53dc-4068-aea4-5c1ef02ddf32"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTUtMS0xLTE4MTc2OQ_3a6418f1-b06e-44b4-9bd1-88e3c52e5759"
      unitRef="usd">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie3fd684df0de4636aa6962e405af5eea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzExLTktMS0xLTE4MTc2OQ_b0a5ad98-fbda-4e37-b04e-64a6778e3d82"
      unitRef="usd">9383000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTEtMS0xLTE4MTc2OQ_50d76136-8017-4967-9944-f0d6a83ae460"
      unitRef="usd">129900000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTMtMS0xLTE4MTc2OQ_0cf495a0-e1f4-4cfd-9c19-67bb578c19e8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTUtMS0xLTE4MTc2OQ_fd93a516-8a71-40c0-a855-997ebd81a498"
      unitRef="usd">1796000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0e3f89117d4a4f85908606a734310a23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEyLTktMS0xLTE4MTc2OQ_01b3031e-bc82-4a3c-943b-d9fe0ade3034"
      unitRef="usd">128104000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTEtMS0xLTE4MTc2OQ_917b8e43-b27c-430e-bd7a-501d86e5ad2c"
      unitRef="usd">8770000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTMtMS0xLTE4MTc2OQ_09a495b8-337a-486e-959d-3808ec335869"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTUtMS0xLTE4MTc2OQ_3f279640-7367-4465-a687-4a1523b4cf85"
      unitRef="usd">334000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id941a7f003394c1fb37f82255dbe3a41_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzEzLTktMS0xLTE4MTc2OQ_5708e305-6d0b-4347-a087-e3df7263d754"
      unitRef="usd">8436000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTEtMS0xLTE4MTc2OQ_ff3f80ff-2362-4426-b821-ee52628acd85"
      unitRef="usd">549901000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTMtMS0xLTE4MTc2OQ_c21d1712-d4cc-4d61-b417-ae60f8d01bab"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTUtMS0xLTE4MTc2OQ_c740ce21-380e-44cb-961d-1758a3b2f5a6"
      unitRef="usd">18260000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie594ea2a3b124a90b0be930db8daf27e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE0LTktMS0xLTE4MTc2OQ_928fd192-fdc2-4bc9-a7ab-d5e55262fd4c"
      unitRef="usd">531641000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ic6537334aae64a1692c21c4e30957279_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTEtMS0xLTE4MTc2OQ_039b69f7-d3eb-4250-b60f-c377e94a3d4a"
      unitRef="usd">705798000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic6537334aae64a1692c21c4e30957279_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTMtMS0xLTE4MTc2OQ_4eea023a-c538-497c-89b5-6f3445f09133"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic6537334aae64a1692c21c4e30957279_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTUtMS0xLTE4MTc2OQ_975f5c7e-753a-42fc-89c4-a37138a7f5d8"
      unitRef="usd">20494000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic6537334aae64a1692c21c4e30957279_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE1LTktMS0xLTE4MTc2OQ_ae854317-69da-4625-977c-d0638ff8846f"
      unitRef="usd">685304000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTEtMS0xLTE4MTc2OQ_eeb89aca-05fe-44df-8a0d-572298e89097"
      unitRef="usd">728556000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTMtMS0xLTE4MTc2OQ_cf0b08e3-3648-401c-a76b-9363d8b6141e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTUtMS0xLTE4MTc2OQ_93b66b5a-44bf-4be0-a7c4-2b8f556f16b7"
      unitRef="usd">20494000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90YWJsZTo1YjE4MDkwNTJkOTE0N2NhYTE5ZDU4MmQyYjUxNTI4MC90YWJsZXJhbmdlOjViMTgwOTA1MmQ5MTQ3Y2FhMTlkNTgyZDJiNTE1MjgwXzE2LTktMS0xLTE4MTc2OQ_b9d52ad5-c0fc-4512-84fd-4d390fad80ac"
      unitRef="usd">708062000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzQyNQ_abf905a1-e980-458a-b1dd-483e66e5c8af"
      unitRef="usd">2800000</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzQzMg_292b6fb6-bf7a-4082-9143-f1eeabd5856e"
      unitRef="usd">2100000</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzYyMw_7e56bc25-fbb6-4629-b1d9-6863e9c6e4a3"
      unitRef="usd">18900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzU0OTc1NTgxNTU4MQ_2f9b9126-4bbb-423d-b043-8e925dccac90"
      unitRef="usd">20500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <docs:DebtSecuritiesAvailableForSaleImpairmentsLoss
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzgzNg_47a95a4a-63c3-43d8-89a8-348308335b7c"
      unitRef="usd">0</docs:DebtSecuritiesAvailableForSaleImpairmentsLoss>
    <docs:DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzkxMQ_867ebd16-7d48-4df2-a369-b08c684aefcd"
      unitRef="usd">0</docs:DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense>
    <docs:DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzkxMQ_bd710ccf-1d3b-421a-ac18-c02161ca2732"
      unitRef="usd">0</docs:DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense>
    <docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzExMzE_e46d6e2a-3362-4bbb-9539-ee457b8def94"
      unitRef="usd">653400000</docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance>
    <docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTUvZnJhZzo3NDBkNTE0OTBiOTg0ZTExOGU2NGE1MGU3OTFjZDFiYS90ZXh0cmVnaW9uOjc0MGQ1MTQ5MGI5ODRlMTE4ZTY0YTUwZTc5MWNkMWJhXzU0OTc1NTgxNTYzMg_f0ccb01f-bb55-4106-a087-b2036c354ce3"
      unitRef="usd">684700000</docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzI4OA_45644628-d297-4420-9686-99fea06bbf55">Fair Value Measurements &lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value hierarchy for the Company&#x2019;s assets and liabilities measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;444,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;243,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;682,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;566,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;243,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;809,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;155,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;550,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;157,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal years ended March&#160;31, 2023 and 2022, the Company had no transfers between levels of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Earn-out Consideration Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the contingent earn-out consideration liability (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent earn-out consideration liability relates to the AMiON acquisition, which closed on April 1, 2022. The fair value of the liability is remeasured at each reporting date until the related contingency is resolved, with any changes to the fair value recognized as &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzE3MDQyNDMwMjMyMTQz_3e9d7d07-1cf9-455d-9196-8ee9cf5d4f4c"&gt;sales and marketing expense&lt;/span&gt; in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the fair value of the contingent earn-out consideration liability, the Company used the discounted cash flow method. The significant inputs used in the fair value measurement of the contingent earn-out consideration liability are the discount rate and the timing and amounts of the future payments, which are based upon estimates of future achievement of the performance metrics. As these inputs are not based on observable market data, they represent a Level 3 measurement within the fair value hierarchy. Changes in the significant inputs used would significantly impact the fair value of the contingent earn-out consideration liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 8&#x2014;Business Combinations for additional discussion regarding the AMiON acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzI4OQ_5456d553-11c5-4aa3-9853-554ea25186de">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value hierarchy for the Company&#x2019;s assets and liabilities measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;444,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;243,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;682,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;566,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;243,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;809,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;155,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;550,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;157,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzI4OQ_974a8f25-7531-453f-8541-ae2e9958b6ef">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value hierarchy for the Company&#x2019;s assets and liabilities measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;126,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;78,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;118,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;444,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;439,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;243,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;682,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;566,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;243,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;809,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;155,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;550,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;157,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i973077bac51d46c88beba9ea2d79c88b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtMS0xLTEtMTgxNzY5_07798b4b-7b8d-46bf-a41d-19a5f8834b1a"
      unitRef="usd">126275000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iffc1194235564259b4e5b6767a113b31_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtMy0xLTEtMTgxNzY5_72869743-3c0f-4d05-8581-f17a528cdc43"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5c8099fd0c864406be81e7c53be8b1d0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtNS0xLTEtMTgxNzY5_f36169e7-f497-4beb-b2c6-8076c3e80985"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i80bd4f5f67e2484cb7851cf004cdfad5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzUtNy0xLTEtMTgxNzY5_63e23e0a-e5ce-49cd-9e18-1ac58195753b"
      unitRef="usd">126275000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i36192b7a614641d2838f423484ca11ba_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctMS0xLTEtMTgxNzY5_7059b162-15ea-45fa-aeda-c1d1cf5b3b79"
      unitRef="usd">126275000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1239324fd29a4d1993d7b6b495489a13_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctMy0xLTEtMTgxNzY5_95109d9e-63e9-4e86-aa1c-16ec32f6890e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i66936efbaed5446aa82b9ca004d420ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctNS0xLTEtMTgxNzY5_381a68d5-a38e-4d99-9bbc-f60d116e940f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iec0fbdefb9f344138749e5e674d592cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzctNy0xLTEtMTgxNzY5_5571d39f-6b7a-48d3-b775-27ac39c66202"
      unitRef="usd">126275000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie6c235234c42491f8e4131aaefe2d585_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktMS0xLTEtMTgxNzY5_e7451eb2-d4eb-412c-b2be-dbc8588d5eb3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i98667fb3a0514e69a891a6c081d597f0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktMy0xLTEtMTgxNzY5_ab559f83-8f4f-4fa3-a641-9ee7716578c4"
      unitRef="usd">7200000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i094e2dbabb8e4569979ac9d1ad7c84d9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktNS0xLTEtMTgxNzY5_4c587f4c-c5b4-4fa7-a6f6-ede46c7a7d8e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0963b486b6ee4c8e9ddec603fe52aa57_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzktNy0xLTEtMTgxNzY5_db94ab70-0d00-4ee2-8ba4-23d16c0fa333"
      unitRef="usd">7200000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ife6e57af6f2b4495abe15bf65ff24f3e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTEtMS0xLTE4MTc2OQ_df48cbf8-3b46-49cb-bf1d-57eef320cde5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5b3c5e95b7974760b927c85be52fe69e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTMtMS0xLTE4MTc2OQ_9249106c-759c-4828-9a57-d0bfc8666169"
      unitRef="usd">27300000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i58e4533ec3b849e492c02f5e01cd9d6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTUtMS0xLTE4MTc2OQ_28d1a948-4bc3-42ae-849e-5bc8304fc5c8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i09e67dedfef14071b24d1b252a8bbef3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEwLTctMS0xLTE4MTc2OQ_8c8bc0e2-1750-485d-9b02-df72819f92bd"
      unitRef="usd">27300000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1801570f9a834b549ef10690ad07160d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTEtMS0xLTE4MTc2OQ_2fabd0a3-8cd1-4765-9af4-facf06a4ef34"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifcf35ce1750d4d47b705f6c8963f102c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTMtMS0xLTE4MTc2OQ_f6fd39c3-3e72-4845-9c77-8802a15646ac"
      unitRef="usd">78489000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib56e571af58f495b8ff9277d066ea6b9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTUtMS0xLTE4MTc2OQ_57cfac91-e72c-4641-bc58-6dc8ff195370"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ied4d9be5d4554ad18ecaefd25a72b9a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzExLTctMS0xLTE4MTc2OQ_6e898113-d3a2-47ee-b451-0bb3a772a18d"
      unitRef="usd">78489000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id00a28ee4e38426aa959a32377ae4867_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTEtMS0xLTE4MTc2OQ_0a1f0ce1-97b6-4cb1-a82c-f80d69f33c7a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2ce81717c598448da1d06f768af2f4ba_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTMtMS0xLTE4MTc2OQ_0d212d82-8a0c-4fce-901c-e275ac01361b"
      unitRef="usd">118512000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if0b8ad77a8b54ef28439d747d79868d3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTUtMS0xLTE4MTc2OQ_d12a815b-dadc-456e-8574-cbdb3ed83499"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifae67aa06b9f4fdd9689aa90c7f5dc18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEyLTctMS0xLTE4MTc2OQ_d5771531-1487-4399-bde8-923fb3610fad"
      unitRef="usd">118512000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id70c3b9155fa4014bd5667ee3349735b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTEtMS0xLTE4MTc2OQ_3b416796-3535-4495-9c87-294da1861c84"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i98636d2454d045d09a3f9d68e1038e6d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTMtMS0xLTE4MTc2OQ_e9a2cde3-2740-43cc-9a43-1ec094da1f55"
      unitRef="usd">7384000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9831b78d3b4c462b8337fda154bdd3ed_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTUtMS0xLTE4MTc2OQ_938db677-c75c-4fe5-9479-1c9a7c5e4415"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if458aec6fca44eddbd86df4028e655b9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzEzLTctMS0xLTE4MTc2OQ_b3adbdd2-e9b0-4a00-a9a8-b6141c6147ff"
      unitRef="usd">7384000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2b84df18f95a4433bdee213a281e943c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTEtMS0xLTE4MTc2OQ_c4b19f1c-bced-4203-9120-444d2e58ea8e"
      unitRef="usd">439748000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6ea633cae78847bd9a91472bbef8eaeb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTMtMS0xLTE4MTc2OQ_0de5e289-9832-4039-afdc-441c7e20c206"
      unitRef="usd">4339000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7bde8858ac6a4a3eb52f9c270d702920_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTUtMS0xLTE4MTc2OQ_51db7f6e-2691-42fa-908e-8eea8395da03"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2286649f7330456ea7cbe19b6772994e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE0LTctMS0xLTE4MTc2OQ_0a0f3ce7-7178-48fe-8700-5a780eec7daa"
      unitRef="usd">444087000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3ff5a0797ef9423a9741628a3da70909_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTEtMS0xLTE4MTc2OQ_db67fdd7-4d6c-4c0f-8cab-7c8546deb288"
      unitRef="usd">439748000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i47804551dcb6422893826946bddd57c2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTMtMS0xLTE4MTc2OQ_0002f8a1-2192-4123-bfef-8c661ca51251"
      unitRef="usd">243224000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic05928ff03824eacb3dec61c64f97f64_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTUtMS0xLTE4MTc2OQ_d6089724-c558-4d29-b816-c1252e73d357"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib75f9bcdbb0d429ea39c456129fe42b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE2LTctMS0xLTE4MTc2OQ_ffde4c8a-bab2-4f45-86c3-b78956ff1f4e"
      unitRef="usd">682972000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8f27c894e80643b7bb1023a488f98851_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTEtMS0xLTE4MTc2OQ_5a7feee9-8476-418d-9b0d-35a2de48d1e7"
      unitRef="usd">566023000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3a9950d0144847e69bf21ab85c40dee1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTMtMS0xLTE4MTc2OQ_6215e164-7f00-46a0-b714-f7a1af90ab20"
      unitRef="usd">243224000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8af851fc24a442e8aee600463f49f4bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTUtMS0xLTE4MTc2OQ_c636270e-1ba2-44b8-bd34-488043b50e43"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0d09321a4a9a437083a3c246e5205811_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzE3LTctMS0xLTE4MTc2OQ_905e89df-1d0e-4bd7-bb5d-2905455b3b30"
      unitRef="usd">809247000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8f27c894e80643b7bb1023a488f98851_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTEtMS0xLTE5Njk4Mg_8e469b39-a85d-4779-91de-1d29cee297da"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3a9950d0144847e69bf21ab85c40dee1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTMtMS0xLTE5Njk4Mg_a9fbdc74-e25a-4c15-a257-25601e1159bc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8af851fc24a442e8aee600463f49f4bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTUtMS0xLTE5Njk4Mg_e9da28de-70d1-4911-af37-1f6d7c75b8c4"
      unitRef="usd">21862000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0d09321a4a9a437083a3c246e5205811_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIwLTctMS0xLTE5Njk4Mg_69fa5363-5364-4a9e-816e-58338d272c80"
      unitRef="usd">21862000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8f27c894e80643b7bb1023a488f98851_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTEtMS0xLTE5Njk5Nw_c1d1e4c2-4890-48b3-9e23-8f745c69d4af"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3a9950d0144847e69bf21ab85c40dee1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTMtMS0xLTE5Njk5Nw_a64604a7-0400-4deb-a97e-b7c06ce7e8b5"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8af851fc24a442e8aee600463f49f4bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTUtMS0xLTE5Njk5Nw_0b8f9442-0d79-40d6-8a89-d0223e17cedd"
      unitRef="usd">21862000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0d09321a4a9a437083a3c246e5205811_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTowMTlhMTYzZjNiMjM0YjE3OWYyMDY5ZWFlODA0ZDkxNi90YWJsZXJhbmdlOjAxOWExNjNmM2IyMzRiMTc5ZjIwNjllYWU4MDRkOTE2XzIxLTctMS0xLTE5Njk5Nw_83fa6398-d874-4cf9-9b79-b035769360dc"
      unitRef="usd">21862000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i05788cb1cd704a9aa7f2c4a233d58bfc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtMS0xLTEtMTgxNzY5_99848eaa-507b-4f54-ace6-08aaed94e7c7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i07b39367e3554a54949428ce5c073cd4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtMy0xLTEtMTgxNzY5_77c70e15-80c2-41eb-9af2-3e7ff1f0b46d"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib5d7ef86da204a758e391dfe903e1498_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtNS0xLTEtMTgxNzY5_d6515d2e-9146-4cc4-b1d1-f616d0229de1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i266a23a458034fcab5ce09b2e8f653a3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzMtNy0xLTEtMTgxNzY5_cbe5f570-4b94-4e38-aeaf-c3b61bc61156"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6d2e893789f44ff5b5960e5ae1657eee_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtMS0xLTEtMTgxNzY5_7013a966-ec64-4123-9f7e-cd023eb60fde"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if00cf42cc410455b9902a0c72c79d686_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtMy0xLTEtMTgxNzY5_0e371c78-cd6d-4b03-94aa-9d5e19702654"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i56cca9f8ee3e46cd915bfb9e19b9f84d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtNS0xLTEtMTgxNzY5_88424a2e-601d-42dd-aab3-c3d4aeb1be18"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i935023b9804f4655be2ead76741d2746_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzUtNy0xLTEtMTgxNzY5_77bbd1aa-15f9-470e-9725-426a6a35cf1c"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i86a6490c23ed4240aa47bc61b8c3cc1d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctMS0xLTEtMTgxNzY5_378b26af-c6b8-43df-9ae7-0c2042ebbb19"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic4ea9461173a44349f0685c96d1dcce1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctMy0xLTEtMTgxNzY5_728e9521-fd3f-4d47-a8d8-144a5d7cd7c6"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7aa9ca7e9e934914903f4b7ed4c4ec8c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctNS0xLTEtMTgxNzY5_1d7e359b-a499-48a7-b8d2-b0593d04dcb5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1c19be996cea4d049a4bb47f817d6982_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzctNy0xLTEtMTgxNzY5_39d838d2-e07f-4878-9871-e4090092c46e"
      unitRef="usd">22758000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ibabb2f6f89e14ad0ac35698b41047d5f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktMS0xLTEtMTgxNzY5_889ea33d-53a7-487e-a457-28308a91d173"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8d946978d3a54bbcb36b85d5855cebd0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktMy0xLTEtMTgxNzY5_93a48e7d-4d66-4de3-bea4-09ebbbb29c40"
      unitRef="usd">7740000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5d38645272f547daad9432aae576444c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktNS0xLTEtMTgxNzY5_cfe42484-8d98-4fa7-8c1e-700abdd503d6"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4c236f2898f14fbfa92c2686609c680c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzktNy0xLTEtMTgxNzY5_45c09285-a8c9-4688-a6f8-b3c8736d7a76"
      unitRef="usd">7740000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0e816f48c9cd41c8ba78b4ddd652f74f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTEtMS0xLTE4MTc2OQ_ab6927a1-be3e-4712-af41-2063f9702a96"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="idb93a4838e9c497484028bc965359528_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTMtMS0xLTE4MTc2OQ_547afea8-c551-40a6-b96b-44a1249ea765"
      unitRef="usd">9383000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7538ba3acbdc47ac862773381252a6f1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTUtMS0xLTE4MTc2OQ_5b9b39d5-7950-46db-a838-19483010dc05"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie236fc059a234762bbc16ada70ba77e4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzExLTctMS0xLTE4MTc2OQ_5dbe12f8-fc2f-40b1-9b65-a6d5ca7553fa"
      unitRef="usd">9383000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i92af9636372c49d2a9396d3c6194fe71_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTEtMS0xLTE4MTc2OQ_9590ac9b-2b52-4253-95bd-11de8a0468a2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ieda7830848534f8f99c833d0078f6325_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTMtMS0xLTE4MTc2OQ_521f44a8-bab8-4787-8cf6-db83a241f470"
      unitRef="usd">128104000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3d87a52b74e641e5a5e5d658f483a695_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTUtMS0xLTE4MTc2OQ_682a419f-5f62-4e4b-b1e8-ec54ab02f648"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia3300bb0e530443a969df765b1b31393_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEyLTctMS0xLTE4MTc2OQ_efa9bf79-62e8-4c73-8208-42ff9269f496"
      unitRef="usd">128104000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i02c06a11eaaf4c74901e4c3250b6056e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTEtMS0xLTE4MTc2OQ_6d529e4e-2ecd-438e-bb1b-0cf088789502"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2667c5bdf5084cac925ae49f37d0694b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTMtMS0xLTE4MTc2OQ_1ddcb8a5-061b-4836-94d9-723abf684707"
      unitRef="usd">8436000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4f3d74c12b094566806aae4a3ee77109_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTUtMS0xLTE4MTc2OQ_4a5013c2-e162-4893-ab9b-e988dbb22349"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4f39a5b24bf14e7e8210e52e2c38875c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzEzLTctMS0xLTE4MTc2OQ_7da0c029-e0a5-4552-aae4-a88913620123"
      unitRef="usd">8436000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i005f944628624d14994ceacb3670c691_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTEtMS0xLTE4MTc2OQ_dcb06d1c-44f7-44e4-bc94-def37109c547"
      unitRef="usd">530174000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i24c46d6de0854211be7d105d64fb8545_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTMtMS0xLTE4MTc2OQ_ccee33a2-b950-4fec-baa3-a1cfc75d1aa2"
      unitRef="usd">1467000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic6b38e693ec6459a8eb430afd06d1251_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTUtMS0xLTE4MTc2OQ_6ef67497-6ff0-42de-ab0c-8e649d4b85ab"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic9c77e864c11452c9c2ce068c5c61f23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE0LTctMS0xLTE4MTc2OQ_e2401974-0da2-4b98-91dc-12d68e33c87b"
      unitRef="usd">531641000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i28a659e594ee4fce9a6eb802ff0c4752_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTEtMS0xLTE4MTc2OQ_c97fa619-9249-4ee4-8d76-abf81a4673c4"
      unitRef="usd">530174000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6d5a6f37cf644c71865652f7c26ad37b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTMtMS0xLTE4MTc2OQ_4973935e-56c1-4214-9d08-22ae770827d3"
      unitRef="usd">155130000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8c5538d593e0408abf61ba5d1091154b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTUtMS0xLTE4MTc2OQ_bb6f1532-602d-4c79-8b69-5a832fd8693e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ida82cc5649fa4f7d87b92b1e33c7bbf4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE1LTctMS0xLTE4MTc2OQ_c48259bd-f095-41b7-a41c-112d4eb3d34b"
      unitRef="usd">685304000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i491fd2bcc91649b49adbc5e628f544ad_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTEtMS0xLTE4MTc2OQ_37d213e7-1cb9-497e-b5d6-ba8957d106db"
      unitRef="usd">550246000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i909ed7ebdc6e40c2b4891ea6cce48b16_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTMtMS0xLTE4MTc2OQ_320518f5-07cc-44b3-a8d1-28d6a4e7850b"
      unitRef="usd">157816000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ibe2e05eecb8e45dab3610612e9815a2f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTUtMS0xLTE4MTc2OQ_a15d4ef9-a45b-45f9-ab70-1cd1e02fafa3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5378ae045e224699baa5bf281d6856b8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTo5ZTU4NGIzOWIyODk0OTczYjU2Y2M4MDk4ODgyYTA3Yi90YWJsZXJhbmdlOjllNTg0YjM5YjI4OTQ5NzNiNTZjYzgwOTg4ODJhMDdiXzE2LTctMS0xLTE4MTc2OQ_30be2a34-948a-4561-9469-14a40f6283c8"
      unitRef="usd">708062000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90ZXh0cmVnaW9uOjM2NWNhODQyMTdkMzQ0NDk5ZTY3MzM1NGU0NWQyNmY2XzE3MDQyNDMwMjMyMTQy_bc979538-af5a-4e9e-9822-350a739e513b">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the contingent earn-out consideration liability (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzEtMy0xLTEtMTg0MTkx_1cfce055-b9f8-47e2-9f94-7a3e2975922f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzItMy0xLTEtMTg0MTkx_ac2dcb6c-b2cf-4710-8228-d787d26349ba"
      unitRef="usd">21134000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzMtMy0xLTEtMTg0MTkx_024b4d85-fec8-45b4-be28-1f2862cdeb63"
      unitRef="usd">728000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMTgvZnJhZzozNjVjYTg0MjE3ZDM0NDQ5OWU2NzMzNTRlNDVkMjZmNi90YWJsZTpmYTA4NjI0NGJkZTY0MTU1YTI2MzdkMzY3YjBiMzQ5Zi90YWJsZXJhbmdlOmZhMDg2MjQ0YmRlNjQxNTVhMjYzN2QzNjdiMGIzNDlmXzUtMy0xLTEtMTg0MTkx_3118e2b1-bb22-4828-bd99-172556306e09"
      unitRef="usd">21862000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzg3OA_ade653aa-91dd-4477-a61e-b78cf03c00a9">Property and Equipment, Net&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;24,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(13,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense on property and equipment for the fiscal years ended March&#160;31, 2023, 2022, and 2021 was $5.5 million, $4.0 million and $2.6 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $4.8 million, $3.5 million and $2.2 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended March&#160;31, 2023, 2022, and 2021, the Company capitalized $5.3 million, $4.3 million, and $4.6 million, respectively, of internal-use software development costs, which are included in property and equipment, net on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No impairment was recognized on property and equipment during the years ended March&#160;31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2b07362e43874a6594d73dabd00c8bd4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzItMS0xLTEtMTgxNzY5_61e67341-635e-40c9-a900-cd5ed3ccc1af"
      unitRef="usd">2816000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5254616f1e114acbae4ffe43531c2c3e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzItMy0xLTEtMTgxNzY5_2e083b3d-50c1-4596-ba8e-5176aab519d1"
      unitRef="usd">336000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1f9cc7883e82437ebb578096cb2a8fd6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzMtMS0xLTEtMTgxNzY5_a13bcd7b-6139-4fd6-855a-e177b6fd09be"
      unitRef="usd">745000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0eba1ae8f23b43768d9773249e2d7a88_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzMtMy0xLTEtMTgxNzY5_c862c1fa-491c-4e51-abfa-5da4618a5e25"
      unitRef="usd">769000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3fb568cd7f51427db6f63dfe746772cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzQtMS0xLTEtMTgxNzY5_c9efcc09-cdcc-4e8d-a496-bfa261aabd64"
      unitRef="usd">888000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i028db93b3eea4709b1441884e9e13e7c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzQtMy0xLTEtMTgxNzY5_9ea6a8b2-4607-442e-bd00-188deef8094d"
      unitRef="usd">796000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4b800cd958594616ba0a181f993bd05f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzUtMS0xLTEtMTgxNzY5_9e4869b5-020f-463b-bd00-17fe702ece8b"
      unitRef="usd">20405000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i69297980cac1443bb352fff016d929b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzUtMy0xLTEtMTgxNzY5_362840ce-008f-45e4-849b-7b441272b520"
      unitRef="usd">15057000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzYtMS0xLTEtMTgxNzY5_fcc45e85-28b7-489c-aea7-2370dc1d80ef"
      unitRef="usd">24854000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzYtMy0xLTEtMTgxNzY5_971020c9-23ad-4e34-8a43-237b21d34630"
      unitRef="usd">16958000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzctMS0xLTEtMTgxNzY5_e9229497-a862-4bdd-9626-9ff86af01e4a"
      unitRef="usd">13575000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzctMy0xLTEtMTgxNzY5_a497d905-9f87-4960-9d14-4b3ee00f7f63"
      unitRef="usd">8470000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzgtMS0xLTEtMTgxNzY5_ab9b03ea-af9c-4d23-943e-6f8217dde42e"
      unitRef="usd">11279000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90YWJsZTowOGMzNjhkMzBjMzA0ZGE0OWYyZTEyZmNhYTY2NDg4OS90YWJsZXJhbmdlOjA4YzM2OGQzMGMzMDRkYTQ5ZjJlMTJmY2FhNjY0ODg5XzgtMy0xLTEtMTgxNzY5_b61ee80c-334b-439b-8406-63b0a5386d0d"
      unitRef="usd">8488000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzIyMA_8e479955-3f6c-439a-9415-03d7e4104385"
      unitRef="usd">5500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzIyNA_7e12c00d-8a32-42c0-815c-1185a4186ac2"
      unitRef="usd">4000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzIzMQ_64b39fd0-7f08-4097-b246-2715e40455b4"
      unitRef="usd">2600000</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzM0Nw_13b77d66-d39a-486f-8da7-e3f5fddd6d9e"
      unitRef="usd">4800000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzM1MQ_acfa76e2-236d-4906-9c42-efae0ba1bb4c"
      unitRef="usd">3500000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzM1OA_2d21aba8-2724-4232-a945-3a15878d0ef5"
      unitRef="usd">2200000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzYyMw_486cd01d-3976-46e0-9aaa-f188568ec7b8"
      unitRef="usd">5300000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzYyNw_e89dd8fb-fadb-48e0-9186-3b2d539849ee"
      unitRef="usd">4300000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1XzYzNQ_a1f3dcd1-5ce1-445d-b216-c2b00cbd4f0f"
      unitRef="usd">4600000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzc4NA_683af5ed-e2f1-48b2-8611-1d76361862c5"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzc4NA_bc241482-f789-4c93-855d-dd89c15c2b67"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjEvZnJhZzpiZTEzMmNhODY5YTg0MmM1YTY3N2ZmMGFhOTBiZjk5NS90ZXh0cmVnaW9uOmJlMTMyY2E4NjlhODQyYzVhNjc3ZmYwYWE5MGJmOTk1Xzc4NA_df6f2634-6e5f-4b7a-838f-2073b042a82a"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90ZXh0cmVnaW9uOjZkMTgyNWNjMDM2NzQxZDk4N2YyZDNiZjBjNzliNGYyXzE1Mg_9c3c2245-c55c-4b4a-9318-1fcc22277b91">Accrued Expenses and Other Current Liabilities&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued commissions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued payroll, bonus, and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Employee contributions under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Rebate liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current portion of contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;25,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock>
    <docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90ZXh0cmVnaW9uOjZkMTgyNWNjMDM2NzQxZDk4N2YyZDNiZjBjNzliNGYyXzE1Mw_ffe70cad-20b6-40c3-a764-1a4cb06af93c">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued commissions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued payroll, bonus, and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Employee contributions under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Rebate liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current portion of contingent earn-out consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;25,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzItMS0xLTEtMTgxNzY5_4e763433-0af4-41a2-a935-67a9fe8c826e"
      unitRef="usd">5733000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzItMy0xLTEtMTgxNzY5_e794419d-9a89-4e6c-9cde-25beef751643"
      unitRef="usd">6653000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzMtMS0xLTEtMTgxNzY5_2b11ffda-2c9b-4d26-b18c-82f137f26352"
      unitRef="usd">8739000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzMtMy0xLTEtMTgxNzY5_873f1e5e-576e-41b0-8020-7e1c846a5cd3"
      unitRef="usd">8015000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <docs:AccruedEmployeeStockPurchasePlanCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzQtMS0xLTEtMTgxNzY5_40cb720e-cb4a-4378-a344-b2123b14b03b"
      unitRef="usd">589000</docs:AccruedEmployeeStockPurchasePlanCurrent>
    <docs:AccruedEmployeeStockPurchasePlanCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzQtMy0xLTEtMTgxNzY5_c40ede64-869b-4932-ba97-fb529c4ccf5a"
      unitRef="usd">621000</docs:AccruedEmployeeStockPurchasePlanCurrent>
    <docs:RebateLiabilitiesCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzUtMS0xLTEtMTgxNzY5_fb9b25a2-af1a-4e14-a99c-7d646e753335"
      unitRef="usd">3348000</docs:RebateLiabilitiesCurrent>
    <docs:RebateLiabilitiesCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzUtMy0xLTEtMTgxNzY5_575e3713-a8b3-4dda-b5cf-e34950c28cc4"
      unitRef="usd">4933000</docs:RebateLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzYtMS0xLTEtMTgxNzY5_8560a462-77ea-4ef4-b52b-8da6a9c924d4"
      unitRef="usd">1504000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzYtMy0xLTEtMTgxNzY5_9bad3815-8ecf-4852-bb76-ef17d296cd27"
      unitRef="usd">785000</us-gaap:TaxesPayableCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMS0xLTEtMTk3MDI0_e32a95b6-8f1f-46d7-8a17-51220bea026f"
      unitRef="usd">5920000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMy0xLTEtMTk3MDI0_ca9d63a5-cde5-40c1-9c7e-5e22d40fe672"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMS0xLTEtMTgxNzY5_3406e0f6-0651-4c88-95ec-d7cd1ecf3b71"
      unitRef="usd">5412000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzctMy0xLTEtMTgxNzY5_e0e8d898-a0d9-43b6-8c70-9e731bed955f"
      unitRef="usd">4263000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzgtMS0xLTEtMTgxNzY5_2f5f460d-f953-43d3-99ff-42a10718d497"
      unitRef="usd">31245000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjQvZnJhZzo2ZDE4MjVjYzAzNjc0MWQ5ODdmMmQzYmYwYzc5YjRmMi90YWJsZTpmODQ3Yjc0OTIyNjY0ZGIyYTVmZWU2ZWM1NzJmNDhhMC90YWJsZXJhbmdlOmY4NDdiNzQ5MjI2NjRkYjJhNWZlZTZlYzU3MmY0OGEwXzgtMy0xLTEtMTgxNzY5_6e244c55-3490-44db-bca7-4313ff4fbde0"
      unitRef="usd">25270000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzI2Mzk_d3e16d5c-f138-4a3f-b8ed-b73098528260">Business Combinations&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Curative Talent Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2020, the Company completed the acquisition of THMED, LLC (subsequently renamed Curative Talent, LLC, &#x201c;Curative&#x201d;), which was accounted for as a business combination. Curative provides temporary and permanent healthcare staffing services to hospitals, medical groups, and other healthcare facilities across the United States. The acquisition-date fair value of the consideration transferred was $34.7 million, consisting of $33.6 million in cash and 689,656 shares of common stock valued at $1.1 million. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net assets acquired, excluding goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the future benefits as a result of the acquisition that will enhance the Company&#x2019;s product available to both new and existing customers and increase the Company&#x2019;s competitive position. Goodwill is deductible for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s acquisition-related costs were $1.2 million and were recorded as general and administrative expense in the Company&#x2019;s consolidated statements of operations during the fiscal year ended March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired are comprised of customer relationships with an estimated useful life of 10 years. The fair value assigned to the customer relationship was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the Company&#x2019;s consolidated financial statements from the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company sold a portion of Curative Talent&#x2019;s business for total consideration of $4.7 million, of which $4.2 million has been received in cash and the remaining $0.5 million was held in escrow, subject to standard representations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and warranties. The net assets of this business were not material. The Company recognized a gain on sale for the total consideration during the fiscal year ended March&#160;31, 2021 as a result of this sale. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AMiON Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;1, 2022, the Company completed the acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians (&#x201c;the AMiON acquisition&#x201d;) to further expand our physician cloud platform. The acquisition-date fair value of the consideration was $74.6 million, consisting of $53.5 million in cash and $21.1 million in fair value of contingent earn-out consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the definitive agreement for the AMiON acquisition, the Company will pay contingent earn-out consideration of up to $24.0 million, of which $4.0 million is a minimum guarantee and the remaining $20.0 million is subject to the achievement of certain operational performance metrics over the next four years. The contingent earn-out consideration is payable in cash in annual installments over the next four years, with approximately $6.0&#160;million settled in the first quarter of fiscal 2024. The contingent earn-out consideration is classified as a liability, the short-term portion of which is included in accrued expenses and other current liabilities and the long-term portion is in contingent earn-out consideration liability, non-current in the consolidated balance sheets. See Note 5&#x2014;Fair Value Measurements for additional information regarding the valuation of the contingent earn-out consideration liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, in May 2022, 93,458 RSUs with a grant date fair value of $32.99 per share were granted to the eligible employees joining the Company in connection with the AMiON acquisition. The shares will vest on a quarterly basis over four years based on continued service. The aggregate grant date fair value of these RSUs is accounted for as post-acquisition stock-based compensation expense and is recognized on a straight-line basis over the requisite service period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The AMiON acquisition was accounted for as a business combination. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net assets acquired, excluding goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill generated from the AMiON acquisition represents the future benefits from the development of future customer relationships and the assembled workforce. Goodwill from this business combination is deductible for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired are comprised of customer relationships, trademarks, and developed technology with estimated useful lives of 9 years, 3 years, and 18 months, respectively. The fair value assigned to the customer relationships was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the consolidated financial statements from the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition-related costs were not material and were recorded as general and administrative expense in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate operating results and pro forma results of operations for AMiON have not been presented as the effect of this acquisition was not material to the Company&#x2019;s financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzQ5OQ_6434946c-5e8d-4339-8a84-f6700b0289d9"
      unitRef="usd">34700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzUxNw_e1c34ba2-12ad-4a4e-9ffb-2b095a4c6060"
      unitRef="usd">33600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzUzMg_a549fb50-d6e4-43dc-aa47-b7053e5bbce5"
      unitRef="shares">689656</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i00be10cbe91f4cd68abcf253993667ef_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU2OA_86963a5f-bdef-424c-97db-5fd8ac233a48"
      unitRef="usd">1100000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzI2NDA_52fe1a10-1e8f-437a-a326-287fca4cd580">The purchase consideration allocation was as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net assets acquired, excluding goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The purchase consideration allocation was as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net assets acquired, excluding goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzEtMS0xLTEtMTgxNzY5_01c23fe3-ab34-4267-b625-d1f5bb0c40cd"
      unitRef="usd">1972000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzItMS0xLTEtMTgxNzY5_329f5853-7e80-47fa-a9e0-e1f140ea7eaa"
      unitRef="usd">4075000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <docs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzMtMS0xLTEtMTgxNzY5_05f6928a-0c88-4fb3-babe-4f82aabbe6c3"
      unitRef="usd">1503000</docs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzQtMS0xLTEtMTgxNzY5_8c173f96-a461-4006-8322-809f1fdc2989"
      unitRef="usd">10280000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzUtMS0xLTEtMTgxNzY5_f3af1af7-aaa7-4813-b328-be9e69edc803"
      unitRef="usd">17830000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzgtMS0xLTEtMTgxNzY5_29c193df-3c53-4600-9846-507d96857473"
      unitRef="usd">2030000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzktMS0xLTEtMTgxNzY5_3df7a004-8e0e-4502-bfe7-9c1b667bb96b"
      unitRef="usd">15800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzEwLTEtMS0xLTE4MTc2OQ_9cfbc1bf-8307-4511-8e5c-ab47019c4e94"
      unitRef="usd">18915000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4898f87402b94fdc96d8b0443cb6d3b6_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo4MTAwMjZkZjhkZmI0NmJjYTlkMmM1NjhkMzY4M2MzOC90YWJsZXJhbmdlOjgxMDAyNmRmOGRmYjQ2YmNhOWQyYzU2OGQzNjgzYzM4XzExLTEtMS0xLTE4MTc2OQ_59fde3ea-97d2-4ee5-b144-387751fb4bfc"
      unitRef="usd">34715000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie68ef9f8618c452ea229d8ad30b5bf6a_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzExNzI_1bce92d3-2181-4d98-be57-ab4aa426999a"
      unitRef="usd">1200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i792a31a0059348cda0386afa68fcd936_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE0MTk_d1c6419d-e560-4742-b688-d040ab0d80a0">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="iab8cf2152e6a45f19fde2dadc29bceb1_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE5MjA_993e5a9d-f51f-4cd6-845c-d8610505f038"
      unitRef="usd">4700000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ia7176555421542a3996fd5fb7b63446f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE5MzM_14349588-f9a3-4d26-8877-b4b1437d3a91"
      unitRef="usd">4200000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <docs:DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow
      contextRef="iab8cf2152e6a45f19fde2dadc29bceb1_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzE5ODA_877815eb-1595-489c-8cb8-40f6ac395df5"
      unitRef="usd">500000</docs:DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDM4Nw_35d167fe-ff94-42bb-bab7-d4362e2c513f"
      unitRef="usd">74600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQwNQ_6ffae8b7-17e2-4581-b490-81364e32911b"
      unitRef="usd">53500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQyNA_b186d683-96e3-4221-a112-1cb80fac7493"
      unitRef="usd">21100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ0Mg_0c0736e2-c3f1-4999-bc39-a6a3c808ec16"
      unitRef="usd">24000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ2MA_253676ef-605d-402b-87d9-bc373042a29d"
      unitRef="usd">4000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <docs:BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ3OQ_eb931412-545d-4503-aba0-6926346bb502"
      unitRef="usd">20000000</docs:BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance>
    <docs:BusinessCombinationContingentConsiderationLiabilityPerformancePeriod
      contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDUxMA_ac1f2dee-c5d4-4887-8455-eda26d858887">P4Y</docs:BusinessCombinationContingentConsiderationLiabilityPerformancePeriod>
    <docs:BusinessCombinationContingentConsiderationLiabilityPayablePeriod
      contextRef="ib3a6de5c6ac44fe09dffd924bac89eae_D20220401-20220401"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDQ5NQ_dccab3da-b08a-42dc-b89b-ba7d7c3677cd">P4Y</docs:BusinessCombinationContingentConsiderationLiabilityPayablePeriod>
    <docs:PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities
      contextRef="iedea9d7e7d2f4459ae223d71da4c8b3e_D20230401-20230630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDg1MA_12a2e71a-77d5-4965-ab03-e42ad9138928"
      unitRef="usd">6000000</docs:PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i33d40acad4a14920a7156beb462b2eb5_D20220501-20220531"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDUyMg_aab91aa1-8899-47fb-bc59-ceb1c6e6ac4d"
      unitRef="shares">93458</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i33d40acad4a14920a7156beb462b2eb5_D20220501-20220531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDUzMw_59915b70-59d6-46c5-bba6-decd398e9fe2"
      unitRef="usdPerShare">32.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7e291345f6a64a58aaf2f650b1ba9147_D20220501-20220531"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU0Nw_3081d624-2f5c-4b12-87ae-3aa66a6830e8">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzItMS0xLTEtMTg0NDAw_af0e5381-9bb8-4b2b-b2ad-8289bde0f726"
      unitRef="usd">447000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i078c5a28b0454db6b490e4fff852e96e_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzQtMS0xLTEtMTg0NDAw_fb3d8538-8bd3-47df-b1a3-efa2f00d56fb"
      unitRef="usd">27200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0f275888ff1e48c7a97763a827fcee54_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzUtMS0xLTEtMTg0NDAw_d24381a7-2530-4322-a3d5-472584f41ff3"
      unitRef="usd">820000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ifffbf1b0e78f4ac596aeef622400a7dd_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzYtMS0xLTEtMTg0NDAw_cdc620d8-5cb1-4722-99a6-ceb0e8971b4f"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzctMS0xLTEtMTg0NDAw_bdcb9c31-38d8-4666-8864-f5cc0c1c18c9"
      unitRef="usd">29167000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzEwLTEtMS0xLTE4NDQwMA_7bf056dd-178f-412f-aa37-d5a29d014023"
      unitRef="usd">2925000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzExLTEtMS0xLTE4NDQwMA_e9fdea84-d7ad-46a6-817f-a4abd479ffc7"
      unitRef="usd">633000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzEzLTEtMS0xLTE4NDQwMA_4fc6139f-58a2-43d9-9430-c2e7fed23c1e"
      unitRef="usd">25609000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzE0LTEtMS0xLTE4NDQwMA_40719c1f-ad07-4408-b7e6-bd345f3c64a7"
      unitRef="usd">49025000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ic5f4a711ecba45a3ba8d5e659f736f4f_I20220401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90YWJsZTo0NGM2ZjkzOGFiNDM0NGIxOGMxYWMzMzhkZjViNzU5My90YWJsZXJhbmdlOjQ0YzZmOTM4YWI0MzQ0YjE4YzFhYzMzOGRmNWI3NTkzXzE1LTEtMS0xLTE4NDQwMA_7fac0ac0-a3d0-404b-ab4b-271f25482646"
      unitRef="usd">74634000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic7a96ee455094c298ce4724ad93c884e_D20220401-20220401"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU1OQ_1b971f2d-20e6-494a-9ffe-420bd9870263">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i96330e2ec3d34bf5b8ce4bf07abe50a2_D20220401-20220401"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU2OQ_9274d753-2a7b-40f9-a532-d9958ca9fa19">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9dd1e4f4b78c402ab313d73be32dece7_D20220401-20220401"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMjcvZnJhZzpjZTg4ZWU4YTU1YTA0MjgxODI0MWZkMTFjZTU5YjRmMi90ZXh0cmVnaW9uOmNlODhlZThhNTVhMDQyODE4MjQxZmQxMWNlNTliNGYyXzU0OTc1NTgyMDU4MQ_23329aa0-9bfa-47a9-b529-e1696f711453">P18M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE3MDQyNDMwMjMxNzYy_4838ad3a-be71-41c8-91b9-7b5925d2e748">Intangible Assets&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;37,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for intangible assets was $4.8 million, $1.0 million and $1.1 million for the fiscal years ended March&#160;31, 2023, 2022, and 2021 respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, future amortization expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;49,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no changes to the Company&#x2019;s goodwill balance of $18.9 million during the fiscal year ended March&#160;31, 2022. No impairment charges on goodwill were recorded during the fiscal years ended March&#160;31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzQxMg_2367d31b-80d4-4c86-bb9e-c223e085855e">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;37,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icd29a5137477430b8f27c6edb2086fbe_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzItMS0xLTEtMTg0MjI5_043c64ef-9ae1-4f65-80dc-87b1a4ccc4ef"
      unitRef="usd">37069000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0a6d175e49204bda81ef5fb379cd9fea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzItMy0xLTEtMTg0MjI5_89c2624a-abb2-45d9-998c-efb265bd9f1f"
      unitRef="usd">9869000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8a6c090726294b758ee283e14aedd42c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzMtMS0xLTEtMTg0MjI5_1700d091-55df-4e93-aceb-dc53ae2db359"
      unitRef="usd">1531000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iea1fb9c634ba4816850d26fbc19237a3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzMtMy0xLTEtMTg0MjI5_e42acc92-c3f2-42ef-acee-f1ea586b813d"
      unitRef="usd">11000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzQtMS0xLTEtMTg0MjI5_1fecddce-1179-4a85-a4f2-2a6c7aa24502"
      unitRef="usd">38600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzQtMy0xLTEtMTg0MjI5_01d62023-8d20-40bb-8242-e9fe8061b8b1"
      unitRef="usd">9880000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzUtMS0xLTEtMTg0MjI5_ff87a2b0-dd7c-4d1c-ab96-7a1119f26229"
      unitRef="usd">6764000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzUtMy0xLTEtMTg0MjI5_505194dc-64d1-4618-9826-cc8e25098b5e"
      unitRef="usd">1971000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzYtMS0xLTEtMTg0MjI5_c7d4c970-f8d6-491e-9ccf-dae32a67d930"
      unitRef="usd">31836000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZToyNzI3OTQ4MGJkZmM0NTI3OGJlZjc3MzYzMWE0MDc0Ny90YWJsZXJhbmdlOjI3Mjc5NDgwYmRmYzQ1Mjc4YmVmNzczNjMxYTQwNzQ3XzYtMy0xLTEtMTg0MjI5_6d0f47c0-dd25-4941-a611-70d56dca0264"
      unitRef="usd">7909000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzEzOA_97604919-97c9-4ed4-9cf4-2e81fe37eb9d"
      unitRef="usd">4800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE0Mg_74f57751-ce4d-4eec-8275-e94181f8ec1c"
      unitRef="usd">1000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE0OQ_b3994181-ec19-433f-a4b1-506c26c44e24"
      unitRef="usd">1100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzQxMw_2fdd9da1-f8e6-425d-b233-bbafa6e6859d">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, future amortization expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzEtMS0xLTEtMTg0MjI5_71ae1440-05df-41a3-9bac-98fcfb552dfc"
      unitRef="usd">4519000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzItMS0xLTEtMTg0MjI5_cb98e790-c509-4cb4-9f9f-57202d181552"
      unitRef="usd">4245000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzMtMS0xLTEtMTg0MjI5_7a07dfdb-f20c-47c7-9d87-8a3f94b8a943"
      unitRef="usd">4012000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzQtMS0xLTEtMTg0MjI5_99dfe820-2e13-436d-be89-6195004f87f9"
      unitRef="usd">4010000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzUtMS0xLTEtMTg0MjI5_886f25fa-36b3-4f44-a1d6-14b8b1647aa7"
      unitRef="usd">4010000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzYtMS0xLTEtMTg0MjI5_513ba979-fb40-40d1-93af-bd9efce01f7c"
      unitRef="usd">11040000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTplYWZhMTdiMjk5NmQ0NTExODk2ODM0ZWQxYzRmNmVkOC90YWJsZXJhbmdlOmVhZmExN2IyOTk2ZDQ1MTE4OTY4MzRlZDFjNGY2ZWQ4XzctMS0xLTEtMTg0MjI5_9c93cf58-3429-466f-af9e-bb587f87bea5"
      unitRef="usd">31836000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzE3MDQyNDMwMjMxNzYx_df43a753-1833-44aa-b75e-a6831d89b86e">&lt;div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;49,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTo5ZjMxZjA5YmNlYzE0MmY2OWE2ZjBmZDhlMTY4ODM4NC90YWJsZXJhbmdlOjlmMzFmMDliY2VjMTQyZjY5YTZmMGZkOGUxNjg4Mzg0XzEtMS0xLTEtMTg0NjUy_5d2bceef-abf7-4d7c-aaf5-bbac00300655"
      unitRef="usd">18915000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTo5ZjMxZjA5YmNlYzE0MmY2OWE2ZjBmZDhlMTY4ODM4NC90YWJsZXJhbmdlOjlmMzFmMDliY2VjMTQyZjY5YTZmMGZkOGUxNjg4Mzg0XzItMS0xLTEtMTg0NjUy_253c373d-9daf-4136-963f-3b05c1ceef48"
      unitRef="usd">49025000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90YWJsZTo5ZjMxZjA5YmNlYzE0MmY2OWE2ZjBmZDhlMTY4ODM4NC90YWJsZXJhbmdlOjlmMzFmMDliY2VjMTQyZjY5YTZmMGZkOGUxNjg4Mzg0XzMtMS0xLTEtMTg0NjUy_8750e275-676e-45eb-8563-3a94cb4a2a51"
      unitRef="usd">67940000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNTAwOA_c7e1bb7a-d98f-4c48-9833-281c5df072be"
      unitRef="usd">18900000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNDY0OQ_77becd1a-da90-49ec-9372-6c5547cdd5aa"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNDY0OQ_c169e340-0140-4dd0-9845-abaa1a3c94eb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M184NzAvZnJhZzpmNzViYjNiMTg3N2I0MThkYTY4Njc5ZjhkYzgxMDhhYy90ZXh0cmVnaW9uOmY3NWJiM2IxODc3YjQxOGRhNjg2NzlmOGRjODEwOGFjXzU0OTc1NTgxNDY0OQ_f02cdb63-0840-46a9-ae61-931863027a73"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <docs:TemporaryEquityTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU4NzQ_5bc858e4-5df5-429f-bf11-59b3df9110b8">Redeemable Convertible Preferred StockUpon completion of the IPO in June 2021, all shares of the Company&#x2019;s redeemable convertible preferred stock outstanding, totaling 76,286,618, were automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. The carrying value of redeemable convertible preferred stock of $81.5 million was reclassified into stockholders&#x2019; equity. As of March&#160;31, 2023 and 2022, there were no shares of redeemable convertible preferred stock issued or outstanding.</docs:TemporaryEquityTextBlock>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="ia5fc25c9a4e64fa18623717924e129f3_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzMwMw_ff237fea-d1a7-4a3c-90fc-dbc2a35f36fe"
      unitRef="shares">76286618</us-gaap:ConversionOfStockSharesIssued1>
    <docs:ConversionOfStockConversionRatio
      contextRef="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzQwMQ_863f7749-5551-4c57-815a-cbdc535a07f6"
      unitRef="number">1</docs:ConversionOfStockConversionRatio>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzQ4MQ_194ecf77-7fee-42b1-82f1-8a61fa4c8115"
      unitRef="usd">81500000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_67df02df-d2f4-4e2b-a53a-94a0fbaf0350"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_85273c17-ab18-492a-a07b-ecc50b108da5"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_a3cf076c-a95a-4277-89ba-4e9e30dc3286"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzAvZnJhZzpmMDQyZjE3MzU1NGM0NWM5YTY5MjdhN2VhYTRlYTFjYy90ZXh0cmVnaW9uOmYwNDJmMTczNTU0YzQ1YzlhNjkyN2E3ZWFhNGVhMWNjXzU0OQ_ef380972-2cdb-4b8f-99e0-c5bfc63fd2f9"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc2_4f0c14c4-b6a2-4c4b-9951-f7ebf5a9b581">Equity&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the IPO, the Company&#x2019;s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and preferences, including voting rights, designated from time to time by the board of directors. As of March&#160;31, 2023 and 2022, there were no shares of preferred stock issued and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock and Creation of Dual-Class Structure &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company&#x2019;s board of directors and stockholders approved an amendment to the Company&#x2019;s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company&#x2019;s 85,523,836 shares of then-existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of March&#160;31, 2023, there were 120,682,472 shares of Class A common stock, and 73,258,344 shares of Class B common stock outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;12, 2022, the Company&#x2019;s board of directors authorized a program to repurchase up to $70 million of the Company&#x2019;s Class A common stock. As of September 30, 2022, the Company repurchased and retired 2,150,982 shares of Class A common stock for an aggregate purchase price of $70 million, thereby completing this share repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;28, 2022, the Company&#x2019;s board of directors authorized an additional program to repurchase up to $70 million of the Company&#x2019;s Class A common stock. The repurchases may be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. As of March&#160;31, 2023, the Company repurchased and retired 523,647 shares of Class A common stock for an aggregate purchase price of $16.0 million, and $54.0 million remained available and authorized for repurchases under this program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News &amp;amp; World Report, L.P., or U.S. News. The warrant expires 10 years from the date of grant. As of March&#160;31, 2023, the warrant was fully vested. During the fiscal year ended March&#160;31, 2023, the warrant for 125,000 shares were exercised with an intrinsic value of $4.0 million. The remaining warrant for 125,000 shares was outstanding as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the Company issued a warrant to U.S. News (the &#x201c;U.S. News Warrant&#x201d;) to purchase 516,000 shares of Class A common stock with an exercise price of $12.56 per share in connection with the execution of a commercial agreement with the U.S. News (the &#x201c;Commercial Agreement&#x201d;). The U.S. News Warrant expires 10 years from the date of grant. The first tranche of the U.S. News Warrant vested on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $76.50, volatility of 46.9%, risk-free interest rate of 1.61%, contractual term of 10 years, and an expected dividend of 0%. The fair value of the warrant is recognized as expense in cost of revenue in the consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. During the fiscal years ended March&#160;31, 2023 and 2022, $5.4 million and $2.6 million were recognized as stock-based compensation expense relating to the U.S. News Warrant, respectively. As of March&#160;31, 2023, unamortized compensation expense, net of estimated forfeitures, related to the unvested warrants was $26.8 million, which is expected to be recognized over the remaining vesting period of 5.0 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2010 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2010, the Company&#x2019;s board of directors and stockholders approved the adoption of the 2010 Equity Incentive Plan (the &#x201c;2010 Plan&#x201d;). The 2010 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. Options may &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;be granted at a price per share not less than 100% of the fair market value at date of grant. If the incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2010 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. Stock awards may also be granted for services performed by external consultants and vest according to an award-specific schedule as approved by the board of directors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Stock Option and Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company&#x2019;s board of directors approved the adoption of the 2021 Stock Option and Incentive Plan (the &#x201c;2021 Plan&#x201d;), which became effective upon the Company&#x2019;s initial public offering and supersedes the 2010 Plan. The 2010 Plan continues to govern the terms of outstanding awards that were granted under the 2010 Plan. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. A total of 22,500,000 shares of Class A common stock was initially reserved for the 2021 Plan. The number of shares reserved and available for issuance for the 2021 Plan will automatically increase each April 1, beginning on April 1, 2022, by the lesser of 5% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#x2019;s compensation committee. Any shares of Class B common stock that would have otherwise been returned to the Company&#x2019;s 2010 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan after being automatically converted from shares of Class B common stock to Class A common stock. The 2010 Plan and the 2021 Plan are collectively referred to as the &#x201c;Plans&#x201d; in the notes to the consolidated financial statements, unless otherwise noted.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s board of directors approved the adoption of the ESPP, which became effective upon the Company&#x2019;s initial public offering. A total of 4,500,000 shares of Class A common stock was initially reserved for the ESPP. The number of shares reserved and available for issuance for the ESPP will automatically increase each April 1, beginning on April 1, 2022 and continuing through April 1, 2031, by the lesser of 6,750,000 shares of Class A common stock, 1% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#x2019;s compensation committee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. During fiscal 2018, the Company granted 4,682,582 options outside of the Plans, of which 2,027,917 options were exercised and 2,654,665 were outstanding as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has shares of common stock reserved for issuance as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2010 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Awards outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares available for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding outside the Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options granted generally vest over four years with service-based, performance-based, and/or market-based conditions and expire ten years from the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activities within the Plans as well as outside of the Plans were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Remaining Contractual Term &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,293,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;627,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and exercisable as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;354,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;603,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options exercised during the fiscal years ended March&#160;31, 2023, 2022, and 2021 was $118.4 million, $521.6 million, and $52.6 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of options granted for the fiscal years ended March&#160;31, 2022 and 2021 was $10.73 and $3.18 respectively. The Company has not granted any stock options since the first quarter of fiscal 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested stock options was $37.0 million, which is expected to be recognized over a weighted-average period of 2.92 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$18.41 - $21.41&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$2.06 - $10.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46.5% - 47.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38.1% - 58.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.77% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.26% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 6.09&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 8.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-Based and/or Market-Based Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2018, the board of directors of the Company granted 1,792,000 options to the Chief Executive Officer with an exercise price of $0.97 per share under the 2010 Plan (the &#x201c;2018 CEO Grant&#x201d;) with a liquidity-event performance-based vesting condition based on the occurrence of a qualifying liquidity event, including an IPO, as well as stock price target after the consummation of the IPO. In September 2020, the 2018 CEO Grant was modified to extend the stock price target achievement cutoff date. The fair value of the 2018 CEO Grant was determined using a Monte Carlo simulation approach on the modification date. The achievement of the qualifying event was not considered to be probable prior to the Company&#x2019;s IPO. Upon the Company's IPO, the liquidity-event performance-based condition was met. During the fiscal years ended March&#160;31, 2023 and 2022, $0.2 million and $1.7 million was recognized as stock-based compensation expense relating to the 2018 CEO Grant. As of March&#160;31, 2023, this option was fully vested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company had 480,000 unvested options with performance-based and service-based vesting conditions. The performance conditions are satisfied upon meeting certain financial performance targets. During the fiscal year ended March&#160;31, 2023, 200,000 options vested and 280,000 options were forfeited. There were no unvested options remaining as of March&#160;31, 2023. The stock-based compensation expense related to these performance options was $1.7 million for the fiscal year ended March&#160;31, 2022 and was immaterial for the fiscal years ended March&#160;31, 2023 and 2021. There is no remaining unrecognized compensation expense as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RSUs granted by the Company generally vest over four years based on continued service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes RSU activity (in&#160;thousands, except per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;68.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;51.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;44.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;40.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of RSUs vested during the fiscal years ended March&#160;31, 2023 and 2022 was $11.4 million and $2.5 million, respectively. No RSUs were granted before fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested RSUs was $59.3 million, and is expected to be recognized over a weighted-average period of approximately 3.04 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-Based Restricted Stock Units (&#x201c;PSUs&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PSUs have service-based and performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes PSU activity (in&#160;thousands, except per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;80.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;80.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of PSUs vested during the fiscal year ended March&#160;31, 2023 $0.4 million. No PSUs vested during the fiscal year ended March&#160;31, 2022 and no PSUs were granted before fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested PSUs that are probable of vesting was $3.0 million, and is expected to be recognized over a weighted-average period of approximately 0.76 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;47,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iccbddb5d88f943d18b1e2bca79988299_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE3Ng_adbae9f8-6357-4355-9a28-40f8ca7b7470"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iccbddb5d88f943d18b1e2bca79988299_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzIzOA_8c5f371f-ac60-4b14-9d9a-79847db9cfef"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_3365ebaa-6b3e-4571-a079-7e4968f895e7"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_a5b412dc-f71d-4d9a-bd09-7b6a8e3c21f5"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_ce8321b8-16b0-41c8-a9d5-1c3417e12eb9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzM4Mg_f3b5b505-665e-4584-8a0f-5f6d1de9b52c"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8232534e9744410f8e611d99b9e84386_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzg5OA_858a1cd1-d2c0-4f25-9623-8da883567420"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8232534e9744410f8e611d99b9e84386_I20210608"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzk1MA_04a180bf-a498-454b-8acb-914f45af39fe"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <docs:CommonStockVotingRightsNumberOfVotes
      contextRef="i8232534e9744410f8e611d99b9e84386_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzk1Nw_7c525f08-a629-402b-a993-cb78a8bd7b8f"
      unitRef="vote">1</docs:CommonStockVotingRightsNumberOfVotes>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib0806f84593344d893e74652c3b10250_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzk4MA_13de073c-14cf-41f8-9b70-9f73fbd720ff"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib0806f84593344d893e74652c3b10250_I20210608"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwMzI_04beab98-a748-4f3c-9e20-be39d7008fd6"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <docs:CommonStockVotingRightsNumberOfVotes
      contextRef="ib0806f84593344d893e74652c3b10250_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwMzk_22aded0c-95fd-41bf-9fa0-5c16fe8a616a"
      unitRef="vote">10</docs:CommonStockVotingRightsNumberOfVotes>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i20facf15f91a4b51a59cf495eff488b0_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzExOTA_61e7b3db-8d80-421a-bcd7-a6731f9f5c03"
      unitRef="shares">85523836</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <docs:ConversionOfStockConversionRatio
      contextRef="ibf068271d669438eafc6af652e833d08_D20210608-20210608"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzOTA_c116aeee-5df9-4a32-964e-1f517c4c78c6"
      unitRef="number">1</docs:ConversionOfStockConversionRatio>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id4aeaddbe31d41d99ae6142cc71b26ca_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE0NDU_64d3baf0-aadd-4402-80be-41a6ea924ac7"
      unitRef="shares">120682472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9ddd079c5de94e16b92910b68fa5ba6d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE0ODQ_c42e4171-3459-42c0-a239-7f0f67e18f09"
      unitRef="shares">73258344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i3443fdd6919e400180bc0aa7089b7a55_I20220512"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODg3NQ_fe983f00-1604-40b4-93a1-efd881ee1e21"
      unitRef="usd">70000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i10df40a9fbe74c14b3193c4c8faa6cfd_D20220512-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODg5MA_86580530-8e6c-4212-be5e-b9f0b354a54b"
      unitRef="shares">2150982</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i10df40a9fbe74c14b3193c4c8faa6cfd_D20220512-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODkwNg_efc56988-009a-49ba-bcf1-ad4d1c3ae38b"
      unitRef="usd">70000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i5e8f6b95c6e94f2d8a158e8e14a0d188_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODk0Mg_b6c8b2fd-070c-47d0-bfa8-56af5a03901c"
      unitRef="usd">70000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i073baaa025aa4391ae3be3ed0f9b6b8b_D20221028-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgyODk1Nw_d2eae321-bc90-4c67-87af-fbe56c1b80f3">P12M</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i185f2fc156dc487daa4da85b1135e893_D20221028-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg0MDY3OA_bb96cec0-2b7b-4bed-a6a5-985a2128f5fc"
      unitRef="shares">523647</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i185f2fc156dc487daa4da85b1135e893_D20221028-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg0MDY4NA_7bd4fd8b-ee7e-4fc4-b114-adfaa4f93a0a"
      unitRef="usd">16000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU3MDg_46df02ad-d96d-4262-bd66-456ff68b1bba"
      unitRef="usd">54000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE2MDk_3ce70d82-1e91-456b-b103-7c10eb9d25e3"
      unitRef="shares">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE2NTk_51f470c5-1e13-49ad-8fe3-58f666d1cfea"
      unitRef="usdPerShare">0.72</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="ifafb0ab9c27944ad9b69d4c4824fce2b_I20170331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE4NzU_7eb0384e-4d22-4fce-9d6c-454fb5e98d89">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <docs:ClassOfWarrantOrRightExercisesInPeriod
      contextRef="i8dd14ac8c2ad476a91aae55b5e50e12b_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY4Nzc_157832ce-b4a0-4591-9d29-3ced4e53dbcb"
      unitRef="shares">125000</docs:ClassOfWarrantOrRightExercisesInPeriod>
    <docs:ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue
      contextRef="i8dd14ac8c2ad476a91aae55b5e50e12b_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY4OTU_8377129b-f993-4283-a1de-7e06eec39f09"
      unitRef="usd">4000000</docs:ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i60ed2d73233c4b148efb0ab0281f05c5_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5Mjk_01020cd0-34c0-49e5-8cd6-ed1a0bdce86a"
      unitRef="shares">125000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NDI_9b5a2c6c-022d-4e92-94d7-0c5bda462b6d"
      unitRef="shares">516000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NTE_fbf948ea-fe35-4474-96ef-608552572b1c"
      unitRef="usdPerShare">12.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NjI_5719ef90-7478-4f42-9a55-846f6102ef3c">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <docs:WarrantsAndRightsOutstandingVestingPeriod
      contextRef="ic83bcd7a1cdd424a827ac1b242d45d64_D20211001-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5NzQ_ec02d173-eb53-400b-ab83-8b45cad36d89">P6Y</docs:WarrantsAndRightsOutstandingVestingPeriod>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i99dac51b2929424c872d9593a38b3a9c_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDY5OTE_ad797445-a07e-49c6-8f9a-05ead718264a"
      unitRef="usd">34700000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i79cbc3050a9f4e728de0f2541e8414d5_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMDU_2e061854-b906-4d31-9444-ed7687ca6aed"
      unitRef="number">76.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i39c41ee9b35d4ca198dae8381879c81d_I20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMTM_49d46bfb-99e3-4bec-9f4e-39cfe690670b"
      unitRef="number">0.469</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ic5f71bd088ee4c3fa9152d5f8241176d_I20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMjE_c9b7fd02-a273-4e9c-b25d-0eef8e335506"
      unitRef="number">0.0161</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="ib20f32b4eb624a099afa796abcc7e5e7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMzI_bb51a151-7913-4db7-acce-9c8a88b2cc5a">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i7c602ccebaef4e4fb1436ee5279c5deb_I20211031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwMzc_d4b10cb9-8bdf-4c72-97df-e2cc2c02b64e"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <docs:WarrantsAndRightsOutstandingVestingPeriod
      contextRef="i31ff09070ac64dc9a6c3517e07569162_D20211001-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcwNTY_604767fb-a760-4161-ae01-0c1596d23514">P6Y5M23D</docs:WarrantsAndRightsOutstandingVestingPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id7a2d89272fb4cd08d7941569bcdac06_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcxMzE_1dac9974-f60e-4bfc-afb2-99658a4b4fb4"
      unitRef="usd">5400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if0b910594e0447b48176dee4458443bc_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU3NTY_1f389041-5d55-45d1-b5bb-de386421f201"
      unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i0dcfc10564a84d99afdf2868944eaf6f_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcxNDg_a3d31839-a448-4753-ba1d-a7727e4a78d7"
      unitRef="usd">26800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id7a2d89272fb4cd08d7941569bcdac06_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NDcxNTU_a055de36-a38f-43a6-91ce-1c7ebbb24fde">P5Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock
      contextRef="i329535dcf29942da975d098642b9ca8c_D20100401-20100430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1MzI_e8502f10-4719-4920-8a3d-b66c073347f3"
      unitRef="number">1</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold
      contextRef="i8f5a97d0329f49aba3a9c73948197302_D20100401-20100430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1Mzg_ca1d3ded-b9c0-45b8-bc17-9072116541cc"
      unitRef="number">0.10</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock
      contextRef="i8f5a97d0329f49aba3a9c73948197302_D20100401-20100430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1NDU_34161ebd-630e-4898-bd26-061845d65db8"
      unitRef="number">1.10</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9add1738f524485aa3f0e69e33348404_D20100401-20100430"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1NTg_a132a8f0-1af6-4abf-94ca-1ea5cff67df0">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i9add1738f524485aa3f0e69e33348404_D20100401-20100430"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1Njk_b892236e-44d9-4b5a-b739-474e2885becd">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i4731ee97e9044ac481efdbc35006ea21_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1ODI_31e6be1a-2064-47bb-9383-75de06d3610d"
      unitRef="shares">22500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding
      contextRef="i4731ee97e9044ac481efdbc35006ea21_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1ODc_15fd666a-6fd5-4c50-996d-515a8975afef"
      unitRef="number">0.05</docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk1OTk_1d8b8116-9d14-462d-9985-41e36d0d1954"
      unitRef="shares">4500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease
      contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk2MTE_a7c9d4f4-0a1d-4138-b965-186138359441"
      unitRef="shares">6750000</docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease>
    <docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding
      contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTk2MTY_fe208d8d-1750-40f6-9f8c-260817c95b37"
      unitRef="number">0.01</docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i392549f122de4599a31a1bc930b60d7c_D20170401-20180331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzcwOTQ_7e7b1d19-ba6e-40fd-9524-61936e0cc62a"
      unitRef="shares">4682582</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised
      contextRef="i5f2625bab237468f82960faeaa65ecd8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzcxODA_e76f506b-26f1-456f-8dea-105e288889b6"
      unitRef="shares">2027917</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5f2625bab237468f82960faeaa65ecd8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTQ4OTk_781671c4-e888-4b5b-9010-f10eb92c972e"
      unitRef="shares">2654665</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc4_e4369ad0-a4d9-491c-89e0-4a61766d9d6d">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has shares of common stock reserved for issuance as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2010 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Awards outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares available for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding outside the Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzItMS0xLTEtMTgxNzY5_13b34918-ab9f-46a2-aa37-379e89a52adf"
      unitRef="shares">641000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7716737ca7654b41b69b01245e63ae37_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzQtMS0xLTEtMTgxNzY5_38ff5511-8ab7-4035-abbc-5276b497aa1c"
      unitRef="shares">19752000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i3b225b55e25041dca4b2711a6a9a0a19_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzctMS0xLTEtMTgxNzY5_1f50f6c2-cddf-4fa4-b125-0dfd758081ff"
      unitRef="shares">2157000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i3b225b55e25041dca4b2711a6a9a0a19_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzktMS0xLTEtMTgxNzY5_00a34fb5-50dc-4e0e-94f1-83582e007109"
      unitRef="shares">31112000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i237ab3fe7b4848009fc6504e611304a8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzEwLTEtMS0xLTE4MTc2OQ_f3fa6447-2895-4471-af1d-3b17de7d6e86"
      unitRef="shares">6243000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5f2625bab237468f82960faeaa65ecd8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzExLTEtMS0xLTE4MTc2OQ_f2a51d7a-74cf-4d7c-b5a4-7da0b98c1a58"
      unitRef="shares">2655000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTozZjI3ZGYwYjEzMTE0YzFlOWNjMDBlZWRhMWU1NjgxYi90YWJsZXJhbmdlOjNmMjdkZjBiMTMxMTRjMWU5Y2MwMGVlZGExZTU2ODFiXzEyLTEtMS0xLTE4MTc2OQ_2b40f47e-8115-4300-ad2a-88f68e3bdefd"
      unitRef="shares">62560000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ida806691cbf34206b1424fc5e64367de_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU0MzI_0e70a8a3-b81a-482e-a423-6fa3b2eb7811">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ida806691cbf34206b1424fc5e64367de_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2NTU0NDU_af1e6252-34d9-45a8-9e9e-7858a8a9c2a7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTcz_5999c7a4-4c5a-486c-a41f-a7c0933117d6">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activities within the Plans as well as outside of the Plans were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Remaining Contractual Term &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,293,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;627,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and exercisable as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;354,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;603,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtMS0xLTEtMTgxNzY5_f53ae775-9378-463d-bf8e-0a1ddf949263"
      unitRef="shares">26983000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtMy0xLTEtMTgxNzY5_e5961a26-fa1a-4da6-a336-65fdf554ff25"
      unitRef="usdPerShare">4.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtNS0xLTEtMTgxNzY5_d2cd35c7-3992-43d7-ade7-10d99d74ee48">P7Y7M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzEtNy0xLTEtMTgxNzY5_94a1de4d-a91c-46ae-aa9a-291b443446e3"
      unitRef="usd">1293545000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzMtMS0xLTEtMTgxNzY5_94380f2d-3e0f-4073-9aa3-ca2079905dc9"
      unitRef="shares">3717000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzMtMy0xLTEtMTgxNzY5_37d4df40-2104-4eb5-a95a-13adf31d76cc"
      unitRef="usdPerShare">2.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzQtMS0xLTEtMTgxNzY5_5924b631-62c8-4503-b21f-3487084f7d3a"
      unitRef="shares">859000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzQtMy0xLTEtMTgxNzY5_532d730a-10bb-47e6-87fe-4781c6ca267e"
      unitRef="usdPerShare">4.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtMS0xLTEtMTgxNzY5_c8b270e9-1202-4489-b071-c863c7f4c540"
      unitRef="shares">22407000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtMy0xLTEtMTgxNzY5_13a3edc7-c275-4e29-a201-dfcac0176f3e"
      unitRef="usdPerShare">4.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtNS0xLTEtMTgxNzY5_3a99546b-5fc8-4032-9e58-762635eb157c">P6Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzUtNy0xLTEtMTgxNzY5_bf1d37f0-c64f-4f7a-a684-4bc348cdc129"
      unitRef="usd">627187000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtMS0xLTEtMTgxNzY5_87b46269-c03b-4775-9735-ab172b832fff"
      unitRef="shares">11897000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtMy0xLTEtMTgxNzY5_9f854387-2457-49e2-9e0c-60f55a5f2c28"
      unitRef="usdPerShare">2.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtNS0xLTEtMTgxNzY5_c604a645-cd98-4af8-bfb0-2fb1cf32aa54">P5Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzYtNy0xLTEtMTgxNzY5_15d4aa33-bdd2-4538-9fe5-06f22a63d4db"
      unitRef="usd">354546000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctMS0xLTEtMTgxNzY5_454288f5-5965-44eb-850b-363375e01832"
      unitRef="shares">21472000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctMy0xLTEtMTgxNzY5_f5f1c62b-6745-4d1a-971c-517f6d35f596"
      unitRef="usdPerShare">4.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctNS0xLTEtMTgxNzY5_45ebdf2b-217b-4387-8d25-6fc2872ef086">P6Y6M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo4ZDRhZDU2MWQ4ODU0NzkxODQ3YzU4NDA3NTU1ZTE2Ny90YWJsZXJhbmdlOjhkNGFkNTYxZDg4NTQ3OTE4NDdjNTg0MDc1NTVlMTY3XzctNy0xLTEtMTgxNzY5_ddea5d5d-3147-406c-8538-e7586cb0c9f7"
      unitRef="usd">603118000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc2Nzk_fc47c08b-2a43-47c5-9469-3ed5f60d6df9"
      unitRef="usd">118400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc2ODM_4f7dd8e2-16f9-491e-b99d-e47c3edcfafe"
      unitRef="usd">521600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc2OTE_90e5d171-ea10-4cac-bc52-5cd9359291fa"
      unitRef="usd">52600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc4MjA_43868b52-dc5c-48b6-bb1b-f0a4342d0da7"
      unitRef="usdPerShare">10.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzc4Mjg_24180c8b-6a34-42c6-abde-c50da6e34aaf"
      unitRef="usdPerShare">3.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzIxOTkwMjMyOTA4NzY_1330e990-4064-40f7-91dd-52affd2ea1b7"
      unitRef="usd">37000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzIxOTkwMjMyOTA5NTA_f991c394-1474-4c7e-bed0-6b2f0c3051b5">P2Y11M1D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc1_17d8a4b6-6300-462e-9713-3cfd44d36248">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$18.41 - $21.41&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$2.06 - $10.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46.5% - 47.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38.1% - 58.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.77% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.26% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 6.09&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 8.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="if1179d128dab4059b72b6142b8bc8b8d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItMy0xLTEtMTgxNzY5L3RleHRyZWdpb246ZjcyN2JlNTUzMWE1NDQxMmIzNDVmYTE5NjA4NmM4NDZfNA_ac3cf56c-413e-4859-80b4-cd385ccaa00d"
      unitRef="usdPerShare">18.41</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i1dfa57621a8d47a2a7dc41b2f9ba12c7_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItMy0xLTEtMTgxNzY5L3RleHRyZWdpb246ZjcyN2JlNTUzMWE1NDQxMmIzNDVmYTE5NjA4NmM4NDZfOQ_379db484-5050-4748-be09-48d66746ff0b"
      unitRef="usdPerShare">21.41</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i991245b0925a47909f34aedbdca61682_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MzBiZjI4MGVmYjJiNDIwYzhmODMxMWRmODgwZThkN2NfNA_3b9ce8e6-151f-49f6-bd0f-9efad59be3e9"
      unitRef="usdPerShare">2.06</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="id87182a9d8de4d7fbe7b3181cb3305b0_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzItNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MzBiZjI4MGVmYjJiNDIwYzhmODMxMWRmODgwZThkN2NfOQ_5aea01bd-4123-461b-8f50-1650f521fb7d"
      unitRef="usdPerShare">10.51</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246MTMwM2E4MTQ4MWNhNDYyZThlZmY0YTgyNzNiMTY0MzhfNA_1eeb047e-5aba-4839-81fd-8f00b34a2bdd"
      unitRef="number">0.465</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246MTMwM2E4MTQ4MWNhNDYyZThlZmY0YTgyNzNiMTY0MzhfOQ_177459c2-a2c2-4485-9f42-e77c4fff5310"
      unitRef="number">0.470</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246OGU1MmI1YWU1ZjE0NDJiNThmMjU4ZjljZjU0MGZjYjZfNA_345ab64c-5a9f-4892-ac18-13ebdddf0b6c"
      unitRef="number">0.381</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzMtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246OGU1MmI1YWU1ZjE0NDJiNThmMjU4ZjljZjU0MGZjYjZfOQ_29654c3c-be0a-4469-beb1-67e99774e4c5"
      unitRef="number">0.583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246YWNhMzcxYzk5YjRiNGMzN2FiM2ZkMGUwOWZjNDc2Y2RfNA_73f71a2e-5bbf-4ee3-b808-92af9d0c8b0e"
      unitRef="number">0.0077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246YWNhMzcxYzk5YjRiNGMzN2FiM2ZkMGUwOWZjNDc2Y2RfOQ_a1bb5fcc-0c75-4016-8f4e-27e730055296"
      unitRef="number">0.0102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MjkwOWMwYTgxYjQyNGI3M2E1M2M2NDI2OGQ5ZTIwYmNfNA_47c9f039-c615-4788-aed3-ac118c4313c2"
      unitRef="number">0.0026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzQtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246MjkwOWMwYTgxYjQyNGI3M2E1M2M2NDI2OGQ5ZTIwYmNfOQ_b1cc0b90-b52f-4a01-8e25-1d58a717e2f7"
      unitRef="number">0.0102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if1179d128dab4059b72b6142b8bc8b8d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246NmI5NGJjODQ3MDhmNDBkMWI5YWQ2NTBmZTcxMmU0ZTZfNA_a087c582-3250-4b31-b662-9a144619d55b">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1dfa57621a8d47a2a7dc41b2f9ba12c7_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtMy0xLTEtMTgxNzY5L3RleHRyZWdpb246NmI5NGJjODQ3MDhmNDBkMWI5YWQ2NTBmZTcxMmU0ZTZfOQ_3777d643-dd61-46ea-8a16-ceaaff67e9e5">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i991245b0925a47909f34aedbdca61682_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZmYwOWQ5MTRkNTdmNDMyYzgwOWVhMjI2NWJjNWNkZTZfNA_d9f05050-715d-46e8-8d24-2be64936b0c7">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id87182a9d8de4d7fbe7b3181cb3305b0_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzUtNS0xLTEtMTgxNzY5L3RleHRyZWdpb246ZmYwOWQ5MTRkNTdmNDMyYzgwOWVhMjI2NWJjNWNkZTZfOQ_aaac64f4-5b18-4591-bc62-0d7476e9f118">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzYtMy0xLTEtMTgxNzY5_4435949c-5990-4955-8607-b5ab400b3546"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2YzllODVjZGZhNTU0OWZhYmNhOWE4YmVlZWUzMjZlMS90YWJsZXJhbmdlOjZjOWU4NWNkZmE1NTQ5ZmFiY2E5YThiZWVlZTMyNmUxXzYtNS0xLTEtMTgxNzY5_81d9c01d-2943-4147-b110-72e14d070f65"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4652006ba32649869cae91401685e771_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzgyOTE_50c8f264-e049-4408-b72b-4774f9f95959"
      unitRef="shares">1792000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i4652006ba32649869cae91401685e771_D20180301-20180331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzgzNTk_62130acd-36a3-4d36-80c7-6d530b55ad44"
      unitRef="usdPerShare">0.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i974d976e0f864a8ea9541b7b73048e70_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzkwNTc_9da5dd05-cb68-463f-bfc4-fab262d361de"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifa33e8ecd9a84ebfae3604c0b6afa814_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjMzMA_2637e545-5690-425f-87b6-e5da3cc7a301"
      unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="ia38954e2b9174a84b2206f208d8b037c_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjE1OQ_6db040a7-1571-4790-9184-163ff343b3f8"
      unitRef="shares">480000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjE4Ng_3bf57d88-7cb3-4521-bc4d-692dd4947c15"
      unitRef="shares">200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjE5Ng_d0b4711d-be58-4f29-b14c-6d6916326592"
      unitRef="shares">280000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i9ada4a0cc2124109ba680255244c2035_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjIwNQ_2c6f5fc0-ae2d-4608-b0a5-eeb51c3c258b"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie09eece225b24d259739810162abac64_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg4MzE2NQ_bc7e97a2-1b50-4c0b-abc8-847bbbf53a1d"
      unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1e2a2f066c684b6dbfa470b1af8ddf0e_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjIxOA_094533ba-753d-4110-93c3-50789e61109c"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i05b21cc9abb74765aca07e3d85d3ad5a_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjIxOA_5c04ed98-1d5d-4b4a-8020-db7c762319c2"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i9ada4a0cc2124109ba680255244c2035_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjczMQ_4a5ca088-a603-482c-bce6-9d3e58fcecf7"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgzODQxOA_a461eade-0e84-4764-bd06-453a44c54e49">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc3_861458d4-988d-41fe-9f30-3771eca90e11">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes RSU activity (in&#160;thousands, except per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;68.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;51.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;44.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;40.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i999bcffa27f543c7af8d4b487ac793aa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzEtMS0xLTEtMTgxNzY5_b07a5948-cb2b-4cc2-959c-bd2c305c7c84"
      unitRef="shares">534000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i999bcffa27f543c7af8d4b487ac793aa_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzEtMy0xLTEtMTgxNzY5_21b9a513-5151-433a-9ca9-718b584c4d99"
      unitRef="usdPerShare">68.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzItMS0xLTEtMTgxNzY5_afa10ce1-13cb-4043-9a19-da47d39ef0a5"
      unitRef="shares">1863000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzItMy0xLTEtMTgxNzY5_11dde486-eb10-44c1-bc6a-8ad18b91f0e5"
      unitRef="usdPerShare">34.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzMtMS0xLTEtMTgxNzY5_32e19c68-3271-44bd-96b3-d385513b5290"
      unitRef="shares">324000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzMtMy0xLTEtMTgxNzY5_32a3a51f-0a9d-468f-8634-b8ad3e915284"
      unitRef="usdPerShare">51.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzQtMS0xLTEtMTgxNzY5_66c0b326-a903-44c4-a9af-17d92ef38f64"
      unitRef="shares">122000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzQtMy0xLTEtMTgxNzY5_b88fc543-92bf-4cb9-8890-15e3d9919463"
      unitRef="usdPerShare">44.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id3057033fffd40dbb4f5e5ee0064bd42_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzUtMS0xLTEtMTgxNzY5_8f27767a-b5a5-4134-8e75-5be6f6832f6c"
      unitRef="shares">1951000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id3057033fffd40dbb4f5e5ee0064bd42_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo1ZmNiN2Y5OWUwOWY0Y2YzOWRlMWQ1MTY5NGE4ZTExMi90YWJsZXJhbmdlOjVmY2I3Zjk5ZTA5ZjRjZjM5ZGUxZDUxNjk0YThlMTEyXzUtMy0xLTEtMTgxNzY5_600e5ed8-8881-4545-8eb4-f877d746a609"
      unitRef="usdPerShare">40.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTI1_3a567e48-6907-4684-bc4a-f5a568054625"
      unitRef="usd">11400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i775865ed2f994ca4b21733ec560d2c8a_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTgzODQ1NQ_96de06b2-865b-40bf-8f8d-a687bed8b9d5"
      unitRef="usd">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="id3057033fffd40dbb4f5e5ee0064bd42_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzExMDUy_bce5605a-6e66-43d4-ad22-cf55157f99ef"
      unitRef="usd">59300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="if594047406484611a6549a4cd2fd4424_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzExMTM3_d39a7a9e-2666-464b-a765-e5682d9573f9">P3Y14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzE3MDQyNDMwMjk5NzMz_3c450589-ff8f-4450-be64-88b589963721">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes PSU activity (in&#160;thousands, except per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;80.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;80.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3b047f5f9ca746b7b52daa842f8517c4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzEtMS0xLTEtMjAxMzEx_9de790a3-5e5f-4a9a-9025-02adef01f2f9"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3b047f5f9ca746b7b52daa842f8517c4_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzEtMy0xLTEtMjAxMzEx_1d082e8d-84ae-4d10-a16f-7f4e29c41d26"
      unitRef="usdPerShare">80.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzItMS0xLTEtMjAxMzEx_f5332daa-d1ef-4764-b971-b4c3237060ae"
      unitRef="shares">213000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzItMy0xLTEtMjAxMzEx_3b1d666d-e682-4288-bdf8-f8ff7e43c0c4"
      unitRef="usdPerShare">34.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzMtMS0xLTEtMjAxMzEx_87a0ce47-cd2b-4bc1-8587-a0bed28eef8f"
      unitRef="shares">11000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzMtMy0xLTEtMjAxMzEx_45833060-84b4-4dcd-a56d-f1a8df7c0ead"
      unitRef="usdPerShare">80.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzQtMS0xLTEtMjAxMzEx_3560ea94-611e-4e9e-8170-c41dddb4d67d"
      unitRef="shares">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzQtMy0xLTEtMjAxMzEx_ede0ccc5-f9cb-41cd-8d08-f35a49a73b34"
      unitRef="usdPerShare">38.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i49f50d35db5d4553b776c905f48f0eb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzUtMS0xLTEtMjAxMzEx_4f8755a2-5c3b-40fc-9142-45888312424e"
      unitRef="shares">206000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i49f50d35db5d4553b776c905f48f0eb1_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTowZTIwY2E3ZTZkNmU0NDI1OTlkOWNkZjdjYjJlOWE3Ny90YWJsZXJhbmdlOjBlMjBjYTdlNmQ2ZTQ0MjU5OWQ5Y2RmN2NiMmU5YTc3XzUtMy0xLTEtMjAxMzEx_32e9f850-d4af-49cc-96d5-1b6125a62546"
      unitRef="usdPerShare">34.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg4MjgzMQ_06c5a8cc-52f6-45c2-8cea-79a9bed4786b"
      unitRef="usd">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i455bb77bdffd4042986f586a60bc3c32_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEwOTk1MTE2OTcwNjM_7e4b280b-e0b4-4f09-9688-799843938ac8"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i49f50d35db5d4553b776c905f48f0eb1_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg1MDQ2MA_20f528ed-2a0f-4a7b-a2f7-3fbdedaad424"
      unitRef="usd">3000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzU0OTc1NTg3MjI2Mw_12e03629-7e5a-42ca-be13-cd426ae5501e">P0Y9M3D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90ZXh0cmVnaW9uOjUxZDI2Yjc1ZWM2YzQ3YTJhNTE5ZTNkM2I4YmRjODQwXzEzNTc0_138c219c-1667-433f-bd20-e7b3549d5283">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;47,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i63c582bee6244ae9bf6eba0489faaa89_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzItMS0xLTEtMTgxNzY5_e1d4e8de-9cf4-45b8-a1fe-396664b4040a"
      unitRef="usd">9634000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic806ae5f2fb3486d8a36fbf8855115c8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzItMy0xLTEtMTgxNzY5_596bbfa8-154a-412d-b94d-1f852466ec7f"
      unitRef="usd">4979000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0ef8644397db461d970fc87d9283f043_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzItNS0xLTEtMTgxNzY5_a52f94ae-de96-4fc4-b594-09567fbed704"
      unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id81f09cb89e346d9b6bab4046c526ee3_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzMtMS0xLTEtMTgxNzY5_deb3979c-9d1a-4534-8b0d-57ffb0b6a44b"
      unitRef="usd">12583000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i74e15aef3d274c7b9ac433e9e2fe446b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzMtMy0xLTEtMTgxNzY5_85da68cd-14f4-4a8f-baf8-1975cd2bbd73"
      unitRef="usd">7065000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icb2ef783dd62482f9546438633e5ef6a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzMtNS0xLTEtMTgxNzY5_20be871d-7dba-4c2a-9576-a0053870e419"
      unitRef="usd">1975000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2705eaddbac94b21a48222ef233d1bae_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzQtMS0xLTEtMTgxNzY5_4ce6d607-44d1-4e5f-a856-330d99bbafd8"
      unitRef="usd">16939000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1643d43bb3664592a6b37cafbac8f20c_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzQtMy0xLTEtMTgxNzY5_e2cd6d3d-117c-4bee-8568-feff13eb1901"
      unitRef="usd">8108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7528701bd71f4ef1b51847193823879c_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzQtNS0xLTEtMTgxNzY5_b44d08e8-20b8-43c6-b7dc-01d2a6e3fc10"
      unitRef="usd">1998000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaa288c7de6084883bc844573b299fa09_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzUtMS0xLTEtMTgxNzY5_27e32fcc-e771-4569-b50b-3d6201099614"
      unitRef="usd">8678000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8811c0f4a5d34a13b7ee23df9071c2f2_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzUtMy0xLTEtMTgxNzY5_72b77369-6009-41ec-a285-b7cc8a7d8f0c"
      unitRef="usd">11290000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i28297a7cc3e04248b1ee658ba91be269_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzUtNS0xLTEtMTgxNzY5_415ea19f-94dd-4f3a-844d-7d73a2ca3429"
      unitRef="usd">2679000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzYtMS0xLTEtMTgxNzY5_aa1bd0cc-8d16-43bd-b9c8-6bf5b9b4bbac"
      unitRef="usd">47834000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzYtMy0xLTEtMTgxNzY5_aafac36e-50e8-4cc4-83d4-aba0dcb6b8b4"
      unitRef="usd">31442000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzMvZnJhZzo1MWQyNmI3NWVjNmM0N2EyYTUxOWUzZDNiOGJkYzg0MC90YWJsZTo2NDRiNjEyNmZmNGE0MjM2OGY0ODBkMWQzZjJkMGNlYS90YWJsZXJhbmdlOjY0NGI2MTI2ZmY0YTQyMzY4ZjQ4MGQxZDNmMmQwY2VhXzYtNS0xLTEtMTgxNzY5_62550e4f-e4d9-49cc-b545-80bbb7ddfefa"
      unitRef="usd">7252000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90ZXh0cmVnaW9uOmE4OTM4ZjZjYTk2NDQyZThiN2E0YTNlMTNlODQ1OGI0XzQ1Ng_686cf917-6118-4554-bae0-a355909add2e">Net Income Per Share Attributable to Common Stockholders&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Numerator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;112,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;154,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;50,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: undistributed earnings attributable to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(21,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(28,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Class A and Class B common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;112,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;133,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Denominator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;193,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;163,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;74,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;213,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;191,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;95,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income per share attributable to Class A and Class B common stockholders:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90ZXh0cmVnaW9uOmE4OTM4ZjZjYTk2NDQyZThiN2E0YTNlMTNlODQ1OGI0XzQ1Nw_591fc06e-8e1b-4eb7-b57b-8260f7ecb941">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Numerator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;112,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;154,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;50,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: undistributed earnings attributable to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(21,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(28,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Class A and Class B common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;112,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;133,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Denominator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;193,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;163,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;74,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;213,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;191,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;95,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income per share attributable to Class A and Class B common stockholders:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzMtMS0xLTEtMTgxNzY5_82d4203e-836e-45c9-9305-e2f5b963c074"
      unitRef="usd">112818000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzMtMy0xLTEtMTgxNzY5_e8257fc7-6896-498b-a361-bde552b720e5"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzMtNS0xLTEtMTgxNzY5_913eb524-b7ff-460a-b2b4-c9efad19d9c4"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMS0xLTEtMTgxNzY5_80e51203-0bae-452b-89fb-36124c5940f6"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMS0xLTEtMTgxNzY5_92a4ada9-7cb5-40ba-b5dd-9520d432ee62"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMy0xLTEtMTgxNzY5_8a438024-363b-4928-b810-14912007f968"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtMy0xLTEtMTgxNzY5_b7dd40ca-bf45-4d8e-86af-e595f9dfbb73"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtNS0xLTEtMTgxNzY5_0a02b962-2378-4e08-9d1a-e2c8baa42234"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzQtNS0xLTEtMTgxNzY5_ab7a355a-fe63-47be-946d-a133955abfd8"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMS0xLTEtMTgxNzY5_b3ce84f8-883c-4f0d-af0c-5a261d041f4f"
      unitRef="usd">112818000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMS0xLTEtMTgxNzY5_ffec26d0-e52e-4f47-a539-3968971940d6"
      unitRef="usd">112818000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMy0xLTEtMTgxNzY5_5ac55c1d-1c16-4b6a-8ff0-b812f7c0d5e5"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtMy0xLTEtMTgxNzY5_b0570a3b-a8c4-47da-b012-bee678695b83"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtNS0xLTEtMTgxNzY5_4d6fa71f-be8f-4792-8fb8-bddbe93ee26f"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzUtNS0xLTEtMTgxNzY5_b60fbf32-bc47-496d-825c-c2b74327d6ca"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzctMS0xLTEtMTgxNzY5_ec73a09a-00c3-40e4-88af-97dc3fdcfe0b"
      unitRef="shares">193176000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzctMy0xLTEtMTgxNzY5_ee558472-13f4-44a9-82b4-e7440e946905"
      unitRef="shares">163484000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzctNS0xLTEtMTgxNzY5_92e4e3af-30ea-45be-b087-1aba1feb5906"
      unitRef="shares">74342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ida806691cbf34206b1424fc5e64367de_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzgtMS0xLTEtMTgxNzY5_2159ad76-53e3-4d6a-896c-5ea82781c2b2"
      unitRef="shares">20027000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i26986aac2225480487211e3064de5fd8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzgtMy0xLTEtMTgxNzY5_15b22ee2-1191-41f9-934b-4f1a409b21de"
      unitRef="shares">27290000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic468072a804447168766f95eca229ba8_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzgtNS0xLTEtMTgxNzY5_7740a41e-adc6-495e-95a2-15bbf0ea17ba"
      unitRef="shares">20612000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEwLTEtMS0xLTE4MTc2OQ_1a3d4cbf-ee00-4dc8-80ce-bcebbb93c515"
      unitRef="shares">139000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEwLTMtMS0xLTE4MTc2OQ_d9badefc-7106-412b-acb9-88a4e6f56e00"
      unitRef="shares">234000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEwLTUtMS0xLTE4MTc2OQ_13135670-2ebe-4e8d-b5d9-8e04d1b4664e"
      unitRef="shares">180000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i01d3afc740f4462684bea44adc594e9c_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzExLTEtMS0xLTE4MTc2OQ_28330cad-a0dd-4e9c-8798-375717e03acc"
      unitRef="shares">83000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9f982a6f25a441579e268bbeafa0e133_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzExLTMtMS0xLTE4MTc2OQ_e850a945-5285-494e-b6e1-258fd763882f"
      unitRef="shares">9000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic706608c6ad1415d94545d91154d4ff2_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzExLTUtMS0xLTE4MTc2OQ_f137846a-0325-4472-bcbc-181603dfe484"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEyLTEtMS0xLTE4MTc2OQ_840d83b8-ef91-4610-93f8-fc4a2a495aef"
      unitRef="shares">213425000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEyLTMtMS0xLTE4MTc2OQ_f43effd4-b473-4996-99fa-47961d84f626"
      unitRef="shares">191017000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEyLTUtMS0xLTE4MTc2OQ_2b227f7b-a2ad-4c7a-908d-ed783a396d16"
      unitRef="shares">95134000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEzLTEtMS0xLTE4MTc2OQ_61620a1d-d637-492d-87a0-a7141b359125"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEzLTMtMS0xLTE4MTc2OQ_90438e02-d316-4d04-8b29-4420425fc2ec"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzEzLTUtMS0xLTE4MTc2OQ_54c53143-1db9-415a-8a90-67c50ae993ea"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzE0LTEtMS0xLTE4MTc2OQ_5e1d9d77-577f-41d5-9ae5-a21dcc83d84e"
      unitRef="usdPerShare">0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzE0LTMtMS0xLTE4MTc2OQ_6718982c-500b-4a15-87de-f8040bb88d56"
      unitRef="usdPerShare">0.70</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZTo0ODczYzYzZjEyMTI0MGIxOTdjNTMzY2M3N2EzOGM4MC90YWJsZXJhbmdlOjQ4NzNjNjNmMTIxMjQwYjE5N2M1MzNjYzc3YTM4YzgwXzE0LTUtMS0xLTE4MTc2OQ_4dab04d0-d528-429d-a54e-78cdec709fc5"
      unitRef="usdPerShare">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90ZXh0cmVnaW9uOmE4OTM4ZjZjYTk2NDQyZThiN2E0YTNlMTNlODQ1OGI0XzQ1OA_e3c0be24-711f-4351-befb-14cf16da9749">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia75bd356b16a493fbe592c7374ec7564_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzItMS0xLTEtMTgxNzY5_dedbecab-5e0b-44d3-b529-40147ba48a9e"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2251c5f98a1541d58cc80a3e18e94e7c_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzItMy0xLTEtMTgxNzY5_2bd3cf5c-7ba7-4da9-9211-163f8d496798"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie28e082f86864f4680a3d75aa82cec9b_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzItNS0xLTEtMTgxNzY5_e4522ae6-76cd-4e9e-87f4-5b7e22e98f9a"
      unitRef="shares">76287000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i03a2e271385b4f50b853a1db39b70580_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzUtMS0xLTEtMTgxNzY5_15ff4573-9fe5-49f1-8dd3-5ef1d2b4b765"
      unitRef="shares">572000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i20ee62022dbc4678aa4e1eda92d558d6_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzUtMy0xLTEtMTgxNzY5_4fb7b400-bdc3-4fe0-8827-6df54c77074d"
      unitRef="shares">217000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i68d0cfc8bce14eb0bbdb2d1d8791664f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzUtNS0xLTEtMTgxNzY5_a18204a1-fa30-48b3-ba76-0adc264f23f7"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i76d02cec04034dcebafb0e2d3f74bd25_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzYtMS0xLTEtMTgxNzY5_10a04a05-aefb-4c7f-835a-04349afa2d8a"
      unitRef="shares">516000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7d9e728004f0418fb411e0ffbf42921b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzYtMy0xLTEtMTgxNzY5_42ddd7dd-fed2-4474-a7e5-b924b9fc750b"
      unitRef="shares">247000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i17ea570245b84a03b7cfc4320cff3431_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzYtNS0xLTEtMTgxNzY5_4c8c7445-2bc1-4594-9ea6-280db5dc4ddb"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzctMS0xLTEtMTgxNzY5_a7c32fe2-3f47-4c2a-b780-8277e474aea8"
      unitRef="shares">1088000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzctMy0xLTEtMTgxNzY5_24941fd2-61a9-4cf3-a9c0-09e64173b0bb"
      unitRef="shares">464000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzYvZnJhZzphODkzOGY2Y2E5NjQ0MmU4YjdhNGEzZTEzZTg0NThiNC90YWJsZToyMjg0NmQzODZiYTM0ZTJmYjdjNzYwYzg3NzhmMGQ0Yi90YWJsZXJhbmdlOjIyODQ2ZDM4NmJhMzRlMmZiN2M3NjBjODc3OGYwZDRiXzctNS0xLTEtMTgxNzY5_1e2b00dc-38e9-4279-baa0-b69ed979d905"
      unitRef="shares">76287000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODk_58941de5-5589-4fe5-9670-4a053f806829">Income Taxes&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s income before income taxes was generated in the United States for the fiscal year ended March 31, 2023, 2022, and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s provision for (benefit from) income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred provision (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(34,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;13,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(41,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#x2019;s provision for (benefit from) income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income taxes at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;23,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(14,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(71,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accruals and deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;32,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research &amp;amp; development credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Acquisition and other related expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Capitalized research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;19,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;47,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;55,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;41,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;51,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;48,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which include California research and development credits, California alternative minimum tax credits, and capital loss carryforwards. The Company concluded, based upon the preponderance of positive evidence (i.e., a strong earnings history exclusive of the loss that created the future deductible amount, a history of taxable income in recent periods, the taxable loss is a result of excess tax benefit on stock exercises as a result of a non-recurring event (IPO), and the current forecast of income before taxes for the United States going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets could be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance was $5.2 million and $4.7 million as of March&#160;31, 2023 and 2022, respectively, relating to the California research and development tax credits, California alternative minimum tax credits, and capital loss carryforwards. The valuation allowance increased by $0.5 million during the fiscal year ended March&#160;31, 2023 primarily due to capital loss carryforwards. The valuation allowance increased by $1.8 million during the fiscal year ended March&#160;31, 2022 primarily due to the increase in California research and development credits generated during the year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had net operating loss, or NOL, carryforwards for state tax purposes of $15.3 million and no NOL carryforwards for federal tax purposes. Portions of the NOL carryforwards will expire at various dates beginning in the tax year ending March&#160;31, 2035. As of March&#160;31, 2023, the Company had research and development tax credit carryforwards for federal and state tax purposes of $7.4 million and $9.0 million, respectively. The federal research and development tax credit carryforwards will expire beginning in the year ending March&#160;31, 2042. The California state research and development tax credit carryforwards do not expire. The other state research and development tax credit carryforwards will expire at various dates beginning in the year ending March&#160;31, 2032. Based on an assessment of the Company&#x2019;s historical ownership changes through March&#160;31, 2023, the Company does not anticipate a current limitation on the tax attributes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and 2022, the Company had unrecognized tax benefits, or UTBs, of $7.9 million and $6.2 million, respectively. If realized, $5.9 million would impact the effective tax rate while the remainder would reduce deferred tax assets subject to a full valuation allowance. The Company does not expect any material changes to its UTBs within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions related to a lapse of statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and penalties were not material during the fiscal years ended March&#160;31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal and various state jurisdictions. With limited exceptions, all tax years for which the Company has filed a tax return remain subject to examination.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODg_17f00e17-2f39-4489-b7fa-a8c0d4ece478">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s provision for (benefit from) income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred provision (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(34,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;13,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(41,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzMtMS0xLTEtMTgxNzY5_9120ec20-9dba-47d5-bcaf-9d06b450e2a8"
      unitRef="usd">3515000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzMtMy0xLTEtMTgxNzY5_d530afc3-a337-4e70-b537-1a2bcac14286"
      unitRef="usd">160000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzMtNS0xLTEtMTgxNzY5_ead033e1-f96d-4a6d-a5a6-80f4c0215674"
      unitRef="usd">1302000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzQtMS0xLTEtMTgxNzY5_8598d93d-d6c2-4c0f-b107-feaf3b27a940"
      unitRef="usd">3498000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzQtMy0xLTEtMTgxNzY5_9039c910-ab86-40ed-a912-dd566206cd21"
      unitRef="usd">309000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzQtNS0xLTEtMTgxNzY5_0f2352c0-3e63-469b-92d2-4776744b600a"
      unitRef="usd">1270000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzUtMS0xLTEtMTgxNzY5_275a5ad7-5753-433c-ba34-2e61bc67c509"
      unitRef="usd">7013000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzUtMy0xLTEtMTgxNzY5_fda8cd17-cbcc-45b6-91a7-e12f0558a013"
      unitRef="usd">469000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzUtNS0xLTEtMTgxNzY5_03832ef5-53fc-467f-873b-0750f28ecb11"
      unitRef="usd">2572000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzctMS0xLTEtMTgxNzY5_fc3b273d-4a6b-466a-8203-6eb11088b14b"
      unitRef="usd">11834000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzctMy0xLTEtMTgxNzY5_8688549f-62be-4a1a-b00e-855cf6197ad6"
      unitRef="usd">-34852000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzctNS0xLTEtMTgxNzY5_b2a80c8d-93ae-4965-af4a-458d94fde261"
      unitRef="usd">4862000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzgtMS0xLTEtMTgxNzY5_d272ea6e-1e8f-4498-bf9b-38a52e017271"
      unitRef="usd">1491000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzgtMy0xLTEtMTgxNzY5_e7577c78-a219-4236-9eb1-bb3c0c7593d2"
      unitRef="usd">-6395000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzgtNS0xLTEtMTgxNzY5_4b6b9599-47df-42b0-925e-ceb44f8c5e27"
      unitRef="usd">125000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzktMS0xLTEtMTgxNzY5_d3a832f5-b86a-4c27-b22a-5dc308797aed"
      unitRef="usd">13325000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzktMy0xLTEtMTgxNzY5_f78d216a-d33f-47e5-b0bb-3341069d0d8f"
      unitRef="usd">-41247000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzktNS0xLTEtMTgxNzY5_32ae4164-5e3f-435b-b920-87d2b660022e"
      unitRef="usd">4987000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzEwLTEtMS0xLTE4MTc2OQ_c3b001a2-f23b-4909-a78e-087735c3f13c"
      unitRef="usd">20338000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzEwLTMtMS0xLTE4MTc2OQ_6991e4ce-c94e-4cf6-9f1b-704c7a30449f"
      unitRef="usd">-40778000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTphYmM5NDk0NDhmNzM0OWQ3ODExMGExMzA1OWI0ZDQ5Yy90YWJsZXJhbmdlOmFiYzk0OTQ0OGY3MzQ5ZDc4MTEwYTEzMDU5YjRkNDljXzEwLTUtMS0xLTE4MTc2OQ_f38571e5-669c-47e7-a13e-87dae54cb029"
      unitRef="usd">7559000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODU_4c7b043b-b1ec-441c-b774-139f27aad220">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#x2019;s provision for (benefit from) income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income taxes at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;23,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(14,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(71,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzItMS0xLTEtMTgxNzY5_e679044d-d051-4480-93f4-c0aef99aa921"
      unitRef="usd">27963000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzItMy0xLTEtMTgxNzY5_49c24781-3719-420b-8dd2-d05a4f1bfdb5"
      unitRef="usd">23941000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzItNS0xLTEtMTgxNzY5_7b9f2e1a-6ec5-4a71-a446-d5ad962c5f2a"
      unitRef="usd">12131000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzMtMS0xLTEtMTgxNzY5_01c4014b-a04a-4751-80eb-f580ba710896"
      unitRef="usd">6757000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzMtMy0xLTEtMTgxNzY5_ba12b397-bd81-489f-af7b-527fcfd05b72"
      unitRef="usd">5503000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzMtNS0xLTEtMTgxNzY5_9c79f5b8-7d2d-4c2a-9549-ddbc5fc81e22"
      unitRef="usd">2532000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzQtMS0xLTEtMTgxNzY5_6cf21d76-192e-441c-92b8-f51c887d003e"
      unitRef="usd">5076000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzQtMy0xLTEtMTgxNzY5_736386ba-f999-4630-9e10-441858333fee"
      unitRef="usd">8332000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzQtNS0xLTEtMTgxNzY5_da1f6f62-ab9d-4f80-b437-4dc2c28970b6"
      unitRef="usd">1845000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzUtMS0xLTEtMTgxNzY5_6ebd1b0a-8696-489c-88b7-3ed8c8ba3b02"
      unitRef="usd">-14841000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzUtMy0xLTEtMTgxNzY5_49ca38a2-8739-4efe-ab09-b45074b4b6ab"
      unitRef="usd">-71780000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzUtNS0xLTEtMTgxNzY5_a4dd26d5-2cdb-4bfd-bcdf-56550ff3ea32"
      unitRef="usd">-5796000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzYtMS0xLTEtMTgxNzY5_926fd6cb-d86f-427b-8986-a3c3a4436dbd"
      unitRef="usd">504000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzYtMy0xLTEtMTgxNzY5_02f951db-1273-44aa-92de-5e499ea4b407"
      unitRef="usd">1878000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzYtNS0xLTEtMTgxNzY5_0a2259e3-1277-4604-aeb2-ee6c2d15bb0d"
      unitRef="usd">171000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzctMS0xLTEtMTgxNzY5_aedf0099-e16e-4b59-80d7-bb4adf9990b9"
      unitRef="usd">4782000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzctMy0xLTEtMTgxNzY5_b06d4b51-348f-462b-82b3-727b1e79f33b"
      unitRef="usd">7260000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzctNS0xLTEtMTgxNzY5_80c39c5d-5eac-44c1-a5d7-0bf8689220bd"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzgtMS0xLTEtMTgxNzY5_bdf832ca-acec-4aa6-b188-d962f3ccd81c"
      unitRef="usd">249000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzgtMy0xLTEtMTgxNzY5_e2f25e1f-8675-47f0-b1a6-64d44dda88e3"
      unitRef="usd">752000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzgtNS0xLTEtMTgxNzY5_eda2c2d8-0f87-46af-b581-00da1c8949c6"
      unitRef="usd">366000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzktMS0xLTEtMTgxNzY5_89d68d36-b22a-4625-bd51-ec7f90d3fcfe"
      unitRef="usd">20338000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzktMy0xLTEtMTgxNzY5_2a957e8c-9e01-4187-bac5-972711977db0"
      unitRef="usd">-40778000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTo5YzA2YzQ0ZTJmNzY0M2E4OTBjZmM0NGNhNzM4MGIwZC90YWJsZXJhbmdlOjljMDZjNDRlMmY3NjQzYTg5MGNmYzQ0Y2E3MzgwYjBkXzktNS0xLTEtMTgxNzY5_b9306eeb-11bd-4ac8-a42c-702e381ee13f"
      unitRef="usd">7559000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2ODY_bbfd55a8-9d6c-46ea-8b8e-099584e0c001">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accruals and deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;32,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research &amp;amp; development credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Acquisition and other related expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Capitalized research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;19,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;47,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;55,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;41,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;51,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;48,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzMtMS0xLTEtMTgxNzY5_4240c572-ea9a-403c-96a6-31d3591f6f02"
      unitRef="usd">2744000</docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue>
    <docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzMtMy0xLTEtMTgxNzY5_4e562d23-3b87-4827-9036-edfd198e086a"
      unitRef="usd">1760000</docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzQtMS0xLTEtMTgxNzY5_96cf8d95-7911-4195-a4a9-a653968e3b10"
      unitRef="usd">1733000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzQtMy0xLTEtMTgxNzY5_79267418-8890-43d2-b20e-205f031fa2ed"
      unitRef="usd">32215000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzUtMS0xLTEtMTgxNzY5_31f3e478-b9b2-4bb9-98f9-7a86ae837352"
      unitRef="usd">7230000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzUtMy0xLTEtMTgxNzY5_e003d54b-d19e-47ee-8e3f-98164fe0624b"
      unitRef="usd">12310000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <docs:DeferredTaxAssetsLeasingArrangements
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzYtMS0xLTEtMTgxNzY5_0ae1a505-ec46-420b-8f82-2a39140757b7"
      unitRef="usd">3968000</docs:DeferredTaxAssetsLeasingArrangements>
    <docs:DeferredTaxAssetsLeasingArrangements
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzYtMy0xLTEtMTgxNzY5_195b51d2-b6eb-484d-bdef-bd046efc2ad5"
      unitRef="usd">276000</docs:DeferredTaxAssetsLeasingArrangements>
    <docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzctMS0xLTEtMTgxNzY5_024f6998-a52b-4c34-8cf5-589c1405166b"
      unitRef="usd">298000</docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense>
    <docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzctMy0xLTEtMTgxNzY5_4a1ec83c-e671-442a-9332-dd46e68f90d7"
      unitRef="usd">255000</docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzgtMS0xLTEtMTgxNzY5_8d116200-c79c-4a0c-b3c0-f2ad91ea2c42"
      unitRef="usd">6492000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzgtMy0xLTEtMTgxNzY5_f0a09e42-9c16-404d-90d7-7c44117f2d38"
      unitRef="usd">3847000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzktMS0xLTEtMTgxNzY5_f95c0915-b3a7-4364-916c-6ffde504c965"
      unitRef="usd">4785000</us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzktMy0xLTEtMTgxNzY5_90479674-a19c-4281-8e19-135ded7e8295"
      unitRef="usd">5199000</us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross>
    <docs:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTEtMS0xLTIxNTg0Ng_ef23ae0c-9fc3-48a7-9c57-a4464355e73c"
      unitRef="usd">19825000</docs:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment>
    <docs:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTMtMS0xLTIxNTg0Ng_2ae27e30-7b5f-4be3-8519-08ab529d6dbe"
      unitRef="usd">0</docs:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTEtMS0xLTE4MTc2OQ_af2640e4-016b-421a-a345-9c0acd5969ed"
      unitRef="usd">47075000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEwLTMtMS0xLTE4MTc2OQ_3ea65120-8d50-4def-a8fd-ed9aeed97923"
      unitRef="usd">55862000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzExLTEtMS0xLTE4MTc2OQ_502aa125-c759-4735-b4d1-9e5068d2b9d7"
      unitRef="usd">5236000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzExLTMtMS0xLTE4MTc2OQ_afc32f80-0fe9-4dc3-973e-ea5baa6342ee"
      unitRef="usd">4731000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEyLTEtMS0xLTE4MTc2OQ_4822554b-339e-4988-bf98-b4134362db3c"
      unitRef="usd">41839000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzEyLTMtMS0xLTE4MTc2OQ_7f147a32-e729-40c0-a052-062038439e11"
      unitRef="usd">51131000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE0LTEtMS0xLTE4MTc2OQ_51073d74-9a17-4c94-8213-bb11d985c301"
      unitRef="usd">2734000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE0LTMtMS0xLTE4MTc2OQ_acfffaa7-ae9e-4f89-a2bc-b416ccf7d0cc"
      unitRef="usd">1899000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE1LTEtMS0xLTE4MTc2OQ_c65054b8-814b-48b5-a432-c181bc47bbfd"
      unitRef="usd">3506000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE1LTMtMS0xLTE4MTc2OQ_20d66787-9ca9-4e00-ad25-82d8378f46d4"
      unitRef="usd">276000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE2LTEtMS0xLTE4MTc2OQ_4e5b41ff-36d5-4958-a4a1-f934b293bdc1"
      unitRef="usd">692000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE2LTMtMS0xLTE4MTc2OQ_70863aff-f092-44cb-bddf-6ebf49590607"
      unitRef="usd">398000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE3LTEtMS0xLTE4MTc2OQ_7dbc8256-cce7-4db1-8125-8224a2bc9915"
      unitRef="usd">6932000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE3LTMtMS0xLTE4MTc2OQ_013fa4cb-6543-4fb5-9d62-46ab347565c3"
      unitRef="usd">2573000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE4LTEtMS0xLTE4MTc2OQ_ac689b6d-78a2-42c9-89d2-b75cdd036427"
      unitRef="usd">34907000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpmNDRhMDU2YTVlNmM0NGFjYjUyNjMwYzE1MGViOWRiZi90YWJsZXJhbmdlOmY0NGEwNTZhNWU2YzQ0YWNiNTI2MzBjMTUwZWI5ZGJmXzE4LTMtMS0xLTE4MTc2OQ_6b5cb945-7a29-4ccf-aa05-215a6b529f0c"
      unitRef="usd">48558000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzE3MDc_0000c060-5a83-4d7b-85d2-a6871fa8ca1b"
      unitRef="usd">5200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzE3MTQ_d793e062-6b08-4f10-8885-a7bac8bb43f3"
      unitRef="usd">4700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzE4ODE_627d56f0-9cb0-4cc3-9886-cdc6ca3a85aa"
      unitRef="usd">500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzU0OTc1NTgyODkzNw_6ffca0bd-f754-4777-bc22-42f514fac1d9"
      unitRef="usd">1800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzIyMTA_13cebefa-322f-41dc-82ac-0919a1f17f72"
      unitRef="usd">15300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzIyMTc_55e9a969-679a-4656-b427-0470177a6be2"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i76934d327b4e4c10a7eaeee01e5c0d44_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzI1MzM_ef243bb4-d7b6-45b3-b4e0-e1f618b7c187"
      unitRef="usd">7400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="idbca9608b0944cceac22ef5ca0e4cb5a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzI1NDA_cc52520a-3bec-4170-9b54-71a35f63e8c3"
      unitRef="usd">9000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzMwNDM_14b11123-a3d2-47b8-8fce-d2930c16a9fb"
      unitRef="usd">7900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzMwNTA_f4f7a260-951b-473d-a09f-4a0b6f364f02"
      unitRef="usd">6200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzMwODE_b91ebb49-ec54-45d4-92b8-a7349ff9f49a"
      unitRef="usd">5900000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90ZXh0cmVnaW9uOjg5NzgwNWVhYWVlNDQwNWE4ZDc2N2U1MzYyOTZkNzc1XzM2OTA_89124b72-1df7-411a-9fbf-b69477d058d4">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions related to a lapse of statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzItMS0xLTEtMTgxNzY5_c23bbfaa-db34-4d77-a1e5-e7e018139da6"
      unitRef="usd">6188000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzItMy0xLTEtMTgxNzY5_472c59cd-a554-43c7-9f1f-5cfefc1f919a"
      unitRef="usd">3162000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5b796d52a1c24138acd0adc60a1d55b6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzItNS0xLTEtMTgxNzY5_2ac82521-f1c9-4077-b6b7-edb87f373225"
      unitRef="usd">2475000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzMtMS0xLTEtMTgxNzY5_4ca5a788-2662-407e-983f-29457d38cbc2"
      unitRef="usd">2210000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzMtMy0xLTEtMTgxNzY5_9c45f7f3-bb91-44d6-b388-5a30e940b05d"
      unitRef="usd">2995000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzMtNS0xLTEtMTgxNzY5_59fdfb90-09a2-48b0-b462-81948ad6d331"
      unitRef="usd">687000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzQtMS0xLTEtMTgxNzY5_0ab2738b-2494-4bee-a1bb-4ce97ee59e7d"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzQtMy0xLTEtMTgxNzY5_e228b9b7-b3ec-40f7-8c39-c09bf77bcfc6"
      unitRef="usd">36000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzQtNS0xLTEtMTgxNzY5_6d0a6084-6b13-48b8-848e-49044ea78cce"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzUtMS0xLTEtMTgxNzY5_68367bcf-f32a-45e5-9370-175a4b8cfbaf"
      unitRef="usd">472000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzUtMy0xLTEtMTgxNzY5_e55879c8-f7d6-4567-a3f8-667d5ca0a3e2"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzUtNS0xLTEtMTgxNzY5_0dde245f-98a2-4432-9a14-b37b11c26e29"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzYtMS0xLTEtMTgxNzY5_394f4040-c774-4152-ab7d-4a08bc80e608"
      unitRef="usd">13000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzYtMy0xLTEtMTgxNzY5_8bc2afd9-d1ce-4c40-87a1-a30e2e355e19"
      unitRef="usd">5000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzYtNS0xLTEtMTgxNzY5_3d832438-678a-4409-abb8-71443d07e0c0"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzctMS0xLTEtMTgxNzY5_c1a96cc9-b92b-4ac9-b446-e7f77c6f704e"
      unitRef="usd">7913000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzctMy0xLTEtMTgxNzY5_39a40b1d-6b57-476e-8926-0df1b74e85fa"
      unitRef="usd">6188000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xMzkvZnJhZzo4OTc4MDVlYWFlZTQ0MDVhOGQ3NjdlNTM2Mjk2ZDc3NS90YWJsZTpiYzA3MTBjZTY5MTA0MGIxOGM2YmMwNzM4ZGI5YjYyMS90YWJsZXJhbmdlOmJjMDcxMGNlNjkxMDQwYjE4YzZiYzA3MzhkYjliNjIxXzctNS0xLTEtMTgxNzY5_d75613c9-2c19-4418-b65e-7fb0741a452e"
      unitRef="usd">3162000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM4NDg_f193ed4e-fdf3-4314-873c-6190e303f322">Commitments and Contingencies&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Minimum Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News for six years. This agreement can be terminated after three years by either party. Under this amended agreement, the Company pays the U.S. News a portion of the revenue generated with the end customers, subject to annual minimum guarantees. As of March 31, 2023, the remaining annual minimum guarantees ranged from $3.0 million to $6.2 million, and the total minimum guarantee for the remaining noncancelable periods was $6.6 million, of which $3.0 million is expected to be paid within 1 year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Commitments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a web hosting arrangement for 3 years ending December&#160;31, 2024, with an annual commitment of $5.2 million. As of March&#160;31, 2023, the total remaining commitment was $5.2 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company&#x2019;s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company&#x2019;s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no material claims under these indemnification provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material effect on its results of operations, financial position, or cash flows. No loss contingencies were recorded for the fiscal years ended March&#160;31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <docs:PartnershipAgreementExtensionPeriod
      contextRef="i906daea421694946be847efacad3faf2_D20211008-20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzY5MA_01b9a164-7ae6-45f7-b5f3-310a57c130c6">P6Y</docs:PartnershipAgreementExtensionPeriod>
    <docs:PartnershipsAgreementPeriodBeforeTerminationIsPermitted
      contextRef="i906daea421694946be847efacad3faf2_D20211008-20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzczMw_9d5645d4-7467-472b-8ca6-80b1678fd4c8">P3Y</docs:PartnershipsAgreementPeriodBeforeTerminationIsPermitted>
    <docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany
      contextRef="ic9b04179a332405c949f34abf3c2def8_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzE2NDkyNjc0NTg4Njk_e0d4dfc1-d37d-4df8-92d6-2f7051bc8f69"
      unitRef="usd">3000000</docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany>
    <docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany
      contextRef="ic9d45f1ab6dd4164bda35547de20a2ec_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNjAyMQ_705519ff-a19c-4d2a-8136-4ae68a496cf5"
      unitRef="usd">6200000</docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany>
    <docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzE2NDkyNjc0NTg4ODc_e68bebd5-ad8b-4b9f-89db-47a8712f691a"
      unitRef="usd">6600000</docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod>
    <docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany
      contextRef="ic9b04179a332405c949f34abf3c2def8_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzE2NDkyNjc0NTg4NjM_12fbdb24-7a1b-485f-9b2b-0b8bfa1ef9ba"
      unitRef="usd">3000000</docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany>
    <docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNjA5Ng_1982f9be-268a-4498-ac23-e0b20be3256b">P1Y</docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod>
    <docs:HostingArrangementPeriod
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNDA4Mw_26c683f4-fb2c-4821-8ed1-715514390575">P3Y</docs:HostingArrangementPeriod>
    <docs:HostingArrangementAnnualCommitment
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNDEyMw_b2f41dbf-fb9c-4fc0-afd7-4621c9f082da"
      unitRef="usd">5200000</docs:HostingArrangementAnnualCommitment>
    <us-gaap:OtherCommitment
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzU0OTc1NTgyNDE2NQ_5d451e35-3cbd-4930-8b2f-7cf328c8c770"
      unitRef="usd">5200000</us-gaap:OtherCommitment>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM3Njk_8ab4038a-3609-4f87-8e69-fff15ce31c62"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM3Njk_998965a2-6bc4-4b5a-bfcf-f157b46f7458"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDIvZnJhZzo0NjM1NjExYmQxZjA0YmMxYWI5N2YxZmE1NGRkYzczYy90ZXh0cmVnaW9uOjQ2MzU2MTFiZDFmMDRiYzFhYjk3ZjFmYTU0ZGRjNzNjXzM3Njk_b68f5250-49a8-4613-9935-b9addb69e292"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzUwMQ_15cfbfe2-a032-4916-b7ea-ee816ea9e116">Leases&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has non-cancelable operating leases for the rental of office space with various expiration dates through 2030. During the fiscal year ended March 31, 2023, the office space lease in Irving, Texas with an approximately 8-year term commenced and a related right-of-use asset and lease liability of $14.8 million was recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in measurement of lease liabilities&#x2014;Operating cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzU0OTc1NTgxNDg3OA_619b58af-a61b-4769-a073-b4c7b8247af9">P8Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i40c5d3ad3fc5494998c4463ceb353d93_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzU0OTc1NTgxNTI2OA_749c006c-df7e-4533-a771-4b90e01d9d64"
      unitRef="usd">14800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i40c5d3ad3fc5494998c4463ceb353d93_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzU0OTc1NTgxNTI2OA_e4a338a1-6ced-43c7-a45d-761b639c89b2"
      unitRef="usd">14800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzQ5OA_59770b2d-1919-4943-92f9-c734338259e3">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in measurement of lease liabilities&#x2014;Operating cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzItMS0xLTEtMTgxNzY5_458b19e2-9bf1-4f75-9a81-32187019a5f7"
      unitRef="usd">2592000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzItMy0xLTEtMTgxNzY5_1ef23b2b-c593-48aa-b2c7-2e1c6d451782"
      unitRef="usd">1159000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzItNS0xLTEtMTgxNzY5_4b7d3204-bc6e-41bb-9eee-2ca728066c33"
      unitRef="usd">2372000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzMtMS0xLTEtMTgxNzY5_60d77c73-627b-452b-81cf-7be8f75822d1"
      unitRef="usd">104000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzMtMy0xLTEtMTgxNzY5_8bb59f07-db9d-4311-88d0-56846574f193"
      unitRef="usd">114000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzMtNS0xLTEtMTgxNzY5_f5b150a1-1abd-4e49-a669-ce3addc60c87"
      unitRef="usd">143000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzQtMS0xLTEtMTgxNzY5_f2d42105-9763-442c-b69d-8c630ee0e9c2"
      unitRef="usd">2696000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzQtMy0xLTEtMTgxNzY5_86fec0fc-a1b0-49f1-a6f4-3137c49b99bf"
      unitRef="usd">1273000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTowZjcyOTIzZWUzNDc0ZjFhYmY4OWE2NGMwMGNmZDNiZC90YWJsZXJhbmdlOjBmNzI5MjNlZTM0NzRmMWFiZjg5YTY0YzAwY2ZkM2JkXzQtNS0xLTEtMTgxNzY5_e039f5da-f80e-4fb0-9dd2-d84b2fbb0906"
      unitRef="usd">2515000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTplZTgzNjBjMjkyNjY0NDk2OGQ5MTk4OWRkZjJlNGYzNy90YWJsZXJhbmdlOmVlODM2MGMyOTI2NjQ0OTY4ZDkxOTg5ZGRmMmU0ZjM3XzItMS0xLTEtMTgxNzY5_0e655d9f-4107-47c7-84ba-1e68c3393467"
      unitRef="usd">718000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTplZTgzNjBjMjkyNjY0NDk2OGQ5MTk4OWRkZjJlNGYzNy90YWJsZXJhbmdlOmVlODM2MGMyOTI2NjQ0OTY4ZDkxOTg5ZGRmMmU0ZjM3XzItMy0xLTEtMTgxNzY5_f40c0987-fe44-4b1a-96d2-e46fff89ad8c"
      unitRef="usd">1107000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTplZTgzNjBjMjkyNjY0NDk2OGQ5MTk4OWRkZjJlNGYzNy90YWJsZXJhbmdlOmVlODM2MGMyOTI2NjQ0OTY4ZDkxOTg5ZGRmMmU0ZjM3XzItNS0xLTEtMTgxNzY5_6b4383d5-dcd9-4b0e-86d1-ca76fc1efd30"
      unitRef="usd">2569000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzItMS0xLTEtMTgxNzY5_6746c32b-bb2f-4962-9d76-21298e9fd523">P7Y21D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzItMy0xLTEtMTgxNzY5_e75aa950-0f2e-46fc-89a4-d88ae6efd460">P1Y7M20D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzItNS0xLTEtMTgxNzY5_b344e25f-8a0c-448a-a5cb-aaf16edee654">P1Y4M13D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzMtMS0xLTEtMTgxNzY5_9d920ee1-848b-4927-a31e-b7e973cd6186"
      unitRef="number">0.0418</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i2663b241eb57491e938b976279a54ef3_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzMtMy0xLTEtMTgxNzY5_0fab0fd0-83de-4997-959c-16cc85f7cb89"
      unitRef="number">0.0395</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ibca3ba7268b644c385960bab4881daa4_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpiYmFmZmFlYzRiMDI0NjU0OWI5YmEwZWVkNDg2YWJmYS90YWJsZXJhbmdlOmJiYWZmYWVjNGIwMjQ2NTQ5YjliYTBlZWQ0ODZhYmZhXzMtNS0xLTEtMTgxNzY5_eca04cf9-2236-48b1-89d7-feccb74ac4df"
      unitRef="number">0.0395</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90ZXh0cmVnaW9uOmI3OTgwMzM5YmQzMjRmZWM4MjQ2OGMxZTQ5YWM4MTVjXzUwMA_fce82d3b-8e23-4022-b7de-e2e0be9018bb">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzEtMS0xLTEtMTgxNzY5_73742150-8172-428a-9676-0d3c431bb24e"
      unitRef="usd">2238000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzItMS0xLTEtMTgxNzY5_e33b3ce1-713a-4991-a068-7b613afa9715"
      unitRef="usd">2411000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzMtMS0xLTEtMTgxNzY5_adb61d6a-2c22-4a2e-9233-5d801fb3aa8e"
      unitRef="usd">2458000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzQtMS0xLTEtMTk3MjQx_313d750f-33c0-4f33-a18c-ad1c5f7357a7"
      unitRef="usd">2497000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzUtMS0xLTEtMTk3MjQx_3b272ddb-c46c-42bc-9079-ea296de5cfe3"
      unitRef="usd">2605000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzYtMS0xLTEtMTk3MjQx_60dcb94f-f5bf-4528-a4ef-3d2ff168a4d2"
      unitRef="usd">6052000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzQtMS0xLTEtMTgxNzY5_3805b16d-28fc-4c3d-b265-861ca2989bc8"
      unitRef="usd">18261000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzUtMS0xLTEtMTgxNzY5_31b61f1c-9d35-40dd-b514-655f19dc00d8"
      unitRef="usd">2624000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i73fa6205d93043c89ed98735725c4862_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDUvZnJhZzpiNzk4MDMzOWJkMzI0ZmVjODI0NjhjMWU0OWFjODE1Yy90YWJsZTpmNjFjMDZiODlkNTQ0MzQxYWVhODc0MDRjMWI4NGU2Ni90YWJsZXJhbmdlOmY2MWMwNmI4OWQ1NDQzNDFhZWE4NzQwNGMxYjg0ZTY2XzYtMS0xLTEtMTgxNzY5_56506d3f-683c-4aa2-bd91-998856ded0d3"
      unitRef="usd">15637000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90ZXh0cmVnaW9uOmIzNGM0NDM4ODgyNzRlNmE5ZTQyOTJkYTY4YjY0ZDVjXzE3MDQyNDMwMjMwODUz_5d8e0fb4-c39b-4ebb-84c8-06917f03b3da">Other Income, net&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Realized loss on sale of marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Realized gain on sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90ZXh0cmVnaW9uOmIzNGM0NDM4ODgyNzRlNmE5ZTQyOTJkYTY4YjY0ZDVjXzI0MTg5MjU1ODExNDI5_f5589fe9-867d-427d-a192-ff0cfd2cea60">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Realized loss on sale of marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Realized gain on sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzItMS0xLTEtMjIyNDM5_6131ae5f-d93c-462a-aeee-9b981eae2aa0"
      unitRef="usd">9287000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzItMy0xLTEtMjIyNDM5_a42eba63-16e3-4dd7-8b34-1c6e3317cd22"
      unitRef="usd">2148000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzItNS0xLTEtMjIyNjA5_1ba0e892-d4ad-4ae7-ae3c-144f80e8596c"
      unitRef="usd">301000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GainLossOnInvestments
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzMtMS0xLTEtMjIyNDM5_18f5a886-5544-49d5-8927-7f1a0cfdb4cb"
      unitRef="usd">-1093000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzMtMy0xLTEtMjIyNDM5_cb1d325e-eec6-406c-b02d-02e44ca9b525"
      unitRef="usd">-1231000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzMtNS0xLTEtMjIyNjA5_8699844b-2ec2-47a5-afaf-e81ef2d96653"
      unitRef="usd">0</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMS0xLTEtMjI2MjYw_7a0dafa9-4014-43f0-8c26-da04f7f0a567"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMy0xLTEtMjI2MjYw_ea49fe20-0780-4871-ab70-67688340592a"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtNS0xLTEtMjI2MjYw_6c3252cb-91c0-478a-bd34-511480aaa5b5"
      unitRef="usd">4698000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMS0xLTEtMjIyNDM5_78bb92a3-a6de-4f60-a4ff-3d459e93fc8b"
      unitRef="usd">146000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtMy0xLTEtMjIyNDM5_6d21e4d6-3c17-473e-9ab8-506726a95b85"
      unitRef="usd">448000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzQtNS0xLTEtMjIyNjA5_89a6f4ca-2b22-404d-8a83-a0f6111b38df"
      unitRef="usd">533000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzUtMS0xLTEtMjIyNDM5_fab23384-ac8e-425f-9279-f4dc654d29f0"
      unitRef="usd">8048000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzUtMy0xLTEtMjIyNDM5_412b753c-8ee3-469c-aace-af4af88332f8"
      unitRef="usd">469000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M181NDk3NTU4MTQ4NTgvZnJhZzpiMzRjNDQzODg4Mjc0ZTZhOWU0MjkyZGE2OGI2NGQ1Yy90YWJsZToyMmZjNmI4YzQ1ZTQ0M2E0YWQyODY1YTNjZWZjYTYyOC90YWJsZXJhbmdlOjIyZmM2YjhjNDVlNDQzYTRhZDI4NjVhM2NlZmNhNjI4XzUtNS0xLTEtMjIyNjA5_21509117-dff0-4661-b418-c6b9bc4d4215"
      unitRef="usd">4466000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzYxNA_1574103d-84eb-4a69-b0d9-9d9d10e7c0a7">Employee Benefit PlanThe Company sponsors a 401(k)&#160;savings plan. All U.S. employees are eligible to participate in the 401(k)&#160;plan after meeting certain eligibility requirements. Participants may elect to have a portion of their salary deferred and contributed to the 401(k)&#160;plan up to the limit allowed by applicable income tax regulations. The Company matched a portion of employee contributions to the 401(k) plan totaling $2.1 million, $2.1 million, and $1.3 million for the fiscal years ended March&#160;31, 2023, 2022 and 2021, respectively. Both employee contributions and the Company&#x2019;s matching contributions are fully vested upon contribution.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzQzNw_80801b12-926a-411a-801e-1dc44e5c3977"
      unitRef="usd">2100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i553913e079194069a9a91da8d0544cb1_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzQ0MQ_ede52ec9-6f25-48ca-b377-6191d3ebfd73"
      unitRef="usd">2100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i9a65581073804c1b92ffbd93440bd08f_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNDgvZnJhZzpkMGZhNjQ5ZTI2YTg0ZTM5ODE4ZDliNTJiYTM3NDY1Ny90ZXh0cmVnaW9uOmQwZmE2NDllMjZhODRlMzk4MThkOWI1MmJhMzc0NjU3XzQ0OQ_592653a2-573d-478e-9e95-4193ca7a9586"
      unitRef="usd">1300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNTEvZnJhZzo4NTJmNDIwMGFlZGI0OTE1YjdjNzAyMjdiYzA0YWJkNS90ZXh0cmVnaW9uOjg1MmY0MjAwYWVkYjQ5MTViN2M3MDIyN2JjMDRhYmQ1XzEwMTc_b341100b-0952-42f8-a9ad-9718959fa3dd">Segment and Geographic Information&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company&#x2019;s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company&#x2019;s performance. As such, the Company has determined that it has one operating and reportable segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of the Company&#x2019;s long-lived assets were based in the United States as of March&#160;31, 2023 and 2022. No country outside of the United States accounted for more than 10% of total revenue for the fiscal years ended March&#160;31, 2023, 2022, and 2021. Substantially all of the Company&#x2019;s revenue was derived in the United States for the fiscal years ended March&#160;31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNTEvZnJhZzo4NTJmNDIwMGFlZGI0OTE1YjdjNzAyMjdiYzA0YWJkNS90ZXh0cmVnaW9uOjg1MmY0MjAwYWVkYjQ5MTViN2M3MDIyN2JjMDRhYmQ1XzYyOQ_44b93239-f235-4476-8d3e-a2731d338a29"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxYjUxZDkyZDNhYzQzMTc5ZTJmOGJkZmFjMjRhMzUzL3NlYzpiMWI1MWQ5MmQzYWM0MzE3OWUyZjhiZGZhYzI0YTM1M18xNTEvZnJhZzo4NTJmNDIwMGFlZGI0OTE1YjdjNzAyMjdiYzA0YWJkNS90ZXh0cmVnaW9uOjg1MmY0MjAwYWVkYjQ5MTViN2M3MDIyN2JjMDRhYmQ1XzYyOQ_96e43419-8c74-4ef2-ab9c-1735d71657a9"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>104
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M+RYNKM$^^G%]CG[?^X3V4)*CFZ4H)<OG\GBBX,UZ_"3>O.6L?@L9>,M?K#A
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M+GJ^<\7@T;Q2#E W9I1]V0*]-/2Z\L9@AR.,AW0Z;14.M2N<FFSE5CO_K3I
M,S=RVA<GD>]CW#TQ,=B%$-5@4ELE0U^S]]_2!M6:DP8VL@3A&3X@F,X'#(;&
M\X')U@<P_?416L-=DDL0NPL8Z!P$X*&H/^C5-TJLJF]BMT(ID5672\X O3:
MWQ<"U,/F1G]F:SZK3O\%4$L#!!0    ( ,U NE9DF05T0 ,   0+   8
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&ULK99M;],P$,>_BA40VJ2Q//5QM)&Z
M;@@D'BHZX 7BA9M<&VM.'&RG!3X]YR0+S98^"?JBM9.[OW]W/=LWV@AYKV(
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MIP; [PLA].M-_8+=R=CD'U!+ P04    " #-0+I68X^><%\#  #S"0  &
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MBE%V%,^+HKOD2I?PHIGH6QD*$Z"_KSE7;QTS07W/&_T'4$L#!!0    ( ,U
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MG(F&@;6WEP% QS:]3-'<&F=L51R&U/1KJR*\-V8=+E4,)(3=)-37GV /K&S
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M?]%_R'G[8W;Q5_J'GOIC]K_I_]$#/\!0(TC4?/NW[CH#L;H85Z)\YH7#".\
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M)!G S6Q<>CL=\1NWXR&7L^S(;Y%C%B-:X(TFVC> @LA\A@R6][V"J]1D&48
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MRGDT*BDDV2OSR4T6TSD0G$'C<0QN9%6\7OQ=4,&J1+(AMF\6Z>=*@!P5N&L
M/Y&ODZK_$PNAFN]\C6(YCIE"/W.M?G!'3[\?YK\@BV%Y! -&2=[X@3GT[+N;
MG]*"#<<<*14E9HWP*T^=9?0\DFPU-[+N]>Z3K:&OW/9^,\[(!2;\O9MKD4^$
MSR&J64]?Y!=T]&#HLDB^O0%H>0NTO'-H>0^T:-7KAWLP-Q::Y!M42%\?+;M.
M<>\\?\?4AY8-\V/V+],VY^1G[%G[=(,)W5JA)O(>@L!4,/?A+X$4]<A3HG"5
M3,C.\!AADJ.K"N,#]5M.E 3O8\H1-T0<<$BGD@<<1MK0/ZY5HYWA"2YZ#BXV
M[:1C1EDZK_E)F=FJF;((-LY_O ]$5U/R_+W'%PX:7T)2 Y'<2F7;@Z<?5V4W
MT.+:X,<6LD?R!UPOHLCTWJ-XIA_JD):XAN_8F/IG>1Q%%O<ZJEQX2,X$?3/%
MR3K8C_.ZVH.[8_;A^E=7Z3+_Q0XQ7OCK%T2RH6VR+9 ,CDROTI;)()L\"]_%
MI>8C<Z&ZZ4TH%I]<1<=E3DXYA&I(:5E3;#K=',VH&#>S)>9U!)Z1'QG#6KI!
MMC/3O_-N[LQOU4-4F;N801$LA@EMGJ;%;U7]9/]D,1=192S\91BI0Q0BT9!S
MD?*2+(&;<J9U([[7ET-U>(,GY^J&*N$E,)-T']T0H]T*+9RP5H5-Q8?6([^)
M1L+<:XZXT>M>6*EQB[%/E9,"2$]&O#QFDM"2T!"VI>Q*8P=Q7Q99-Z0;\&5C
MWI(9&39:$B3)^GA6X^?:6.KPN:2WCH?146[J\?%7'>F783A#RAW !4TE3<&/
MIM\UR$6R/!F YUSPQ)PLSC^'"B.NX(Q.]T(*6\5L8EM!OOXF?,7DB2O*(ZTW
M>OS,*$[*CC;0'6 PQ"5YWF\>OW#W)"YV\74<+JWS0D;TWNFJJ+:TVT;Z/X,+
MGD<M 1SD#8DP4O]$-CRV2*L$HRLNW%A3\A[)L&!K:#S+;%;G325'U;#0C0W:
M_Y23MY2BG^Y4B23\U] C*37,T9@^*?O)HZ\;D:+=4[%SV4MT@-&AT/+'9?93
M^A<AI/-FS94*<;J8/TT2NVW2H*IJ5)YS V)"GU5B D[JDL.;?D*"]QA"D=,B
MBP+/026.[QMW;:Z:MI7O]6DY4',%&56?Q*2"RNO!6JS50KZW3^L'3Z_ODP#C
M4 CKSE$OS<%]UTM<44S7UZYYU$:B[,^7+.>U,Y5(NUI\Y66LT/CDHW&CFC8Z
M40LN@:P)NA\(5LJPKFD!FB?I<>%(\S"!+28/170V:E2^]TE8!+Y]Y!$-'#^%
M*<8\(IEC&,Z_-X'31E=*J5+\!@EV>K/IZ(O&V,!DV14"%!+F=)88Z8R?AM;M
MM6F-EL,A%^5FN]R%H;VHSG&R4"4.'3!/ZZK\UQDN0N5.GW^*ARH&2/*:T6!@
MQ\.3AN>HMN#?J05WYHS[#@S&FQ<<.JU&XG33OS8NM5QHFR$3K6_S.OG=-'Z.
MX*,%''^?'W_] J-99(.3ZSH,)2(#NO',MP;]X&$YO]YG9PIBEL/7)KZ3AHE@
MVUUIZ%>B[4UBU&ECU^RW17&D_4 >-VLS-=O%($"Y*Y^CT*J5:N"9+MP2P-OO
M^:LJ.%D]VCY6BFY[YAA^O)-O>F4_#U\Y8GTAOFL[[66:=6B^2[RL?, 7%-&3
M($2T243&Y60N75)ECKR$&X--+TH!_-@P O@8'&]2LU"^'[O62B0_FV8FP%,^
M<BNAVT<>ZY#/S(K)YV%V3(8Z>@R85K]$(QXUYL8T8I)1F,<=G!%,R6IDV#%_
MY:L4):7?F,.XY3H?S'L@8FI#@/-A*W_A)@QHO:D4#$4VK7SGPS$^E(RS5W(:
M&:1CNZ.)1G DS\EW%SF5S%E]6&%5%2W\6.R8UC\0#"/Z+[FK'/$%4"-R%<OD
M_>-1W[OQAQ.M)+SJPR680,&CIP)[AJC_F->7V?=*'(^_JDX@4V'HG>V73_O7
M+Y_:COXIZ+]D(=&_K'2_S?O\]4ORWC;FVE05?R]WW;\ZNSB+_HI>]5=G5Q??
M7%V>/:4WP^.O7^[SC?E1JO.(^M;TZK/E7[XZ$['N?NF;/9;$UTN1>. ?MX:,
M\!8/T.?KING=+]C@T+0?^7BO_P]02P,$%     @ S4"Z5N>5!]'8 P  D@@
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MX8XWI;U5^]^QCV?B\%)5FO8)^TXW/O<@;8Q556],#"HANS?_V>?AB<$L>,6
M]0:LY=TY:EE><<N7<ZWVH)TVH;E%&VIK3>2$=$6YLYJ^"K*SRUN\1]D@W&*J
M<BE<IN9C2\#N\SCM0=8="'L%)&1PK:0M#/PF,\R> XR)T4"+'6BMV9N(UUR/
M( I]8 &+WL"+AC"C%B_Z19@[K2K8$%=-[4"IM@5LVB2CAK]66]/*_SZ6@0X_
M/H[OCLZ%J7F*"X_.AD%]C][R_;MP&ER^P3X>V,=OH?_7(OUO$#C(KH3A>:XQ
MY\_$J:+#9RQFH'9@"TJ?*ND4"YG#J9 D48WA,C-G%_!!F)27\"=RW34!4 G3
M8JBA>S#W".&NV9I4B[IU=0+1+/'/H\2MPL1GR8Q68<)\-IG"9W*J@25^%!)"
M3+( PMB?QB%\49;\Z9[I"<1D'$R8@XDC?Q([&!9,_5ER_ECP-2^Y3-' IN R
MIW<;!9)"57/Y\/[=C(7GE\8=:]2:@CC@;P^&>]0(W/29,"_RL#(N5\=B7V,N
MI'2YZ\&(X"SVD]G$+2(_3ABLLJPMC/%!HO4A:[0S<!1KU$)E$$>)/PDB"G+B
M!Y2&0ZET5]5_B'/;X\YD^\+C*?EA47A&"^9/HOCL5?NT3YE+T;T2*<E?DCF-
MHHE/*2,\-@W]("1 *O[S&,-@XL?1]#':CS(M&]<A??+Y+X/>4\)/V"BA"[ L
M7==0B@<KTD>PJM5?78O/G^BF_]$(TW7XOA!4B;14QG6QA%6M10E=8=@([A#A
MD[((,VB+SRYAW1@Z.<:XIM@*R3LG-/X&E]1W0G;SD'8C^'*D@QJY):ZO=A!%
MPX9HJ'7@)!S%CX)C3>2T'&F?($V-[30K'T9P=>C5H<LWREAS[-H9/YD3=./E
M[30T5.M&VFYD#-)AX*ZZ.?.HWDUK(D?-9:#$'9D&H_.)![J;@-W&JKJ=.EME
MZ7IMEP7]-*!V"O1]IRCM_<8Y&'Y#EO\"4$L#!!0    ( ,U NE9GDNC(( 4
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M-$#^"2#/9[>R-)EF;\L4TEV "5K5F^9WIMWXCR+><C5F@><PW_6#1_""WM7
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M9T:S%XZHHJASV+7A4GD4$"ES)#C3:#4($7$;$RR/'G QNG-T1VZ_5&)*4<E
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M@L__+ 52V]("/%\8-(KQ@@YHO[5>_A]02P,$%     @ S4"Z5C*P0,KA P
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M+5^J;W7;Y>J+9_!WF4 PJ5S@56C*Z$1]E6@NJGS#7^Y.\ZK*U_QS)6-41+0
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M=X'.EXIR9[MP"H86>/XW4$L#!!0    ( ,U NE:;Y+4DV@D  )<;   9
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M!BP P:U00N#">ZVJ;E^@L(W?X7.1@@:V"9+WP1_AV /Q(R\I@0B$4\0PR8X
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MVH!8%S,_8?4@Z!D%":E$8075Y=@#(WRZ?C9]YL&]@ZYN:<MMB#H#?<)#%&F
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M._@$7*QS+A'4%+N*:<J@,@*46N_8>O(:=WQA0]U[E?T=#$8.."1K&I];X.7
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M.!=%;MT_.GO$*=%\@QW1GR@;=8,OP/.MM9W[!RYPLLU'VMZK_P502P,$%
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MRM($\*\%?0VA=@)TOE3*[A;.0/M]-?T/4$L#!!0    ( ,U NE8.]7$'9 ,
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M+W-H965T,S$N>&ULK5?;;MLX$/V5@1L4,<#$$G5UFAA(TLL6V !%DW8?%OM
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MO;0+8'XB0;9-QSIHWR*'_P)02P,$%     @ S4"Z5I?Y&1!# P  8P<  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S,N>&ULC55M;]LX#/XKA%<<6L"MWQ,W
MEP1HNPTW8!N"M=L^'.Z#8M.Q,%GR)+E9[]>/LA.W!9+<?;$EBGS(AR*I^5;I
M'Z9&M/"K$=(LO-K:=A8$IJBQ8>9*M2CII%*Z89:V>A.85B,K>Z-&!'$83H*&
M<>DMY[ULI9=SU5G!):XTF*YIF'ZZ1:&V"R_R]H(O?%-;)PB6\Y9M\![MUW:E
M:1>,*"5O4!JN)&BL%MY--+M-G7ZO\(WCUKQ8@V.R5NJ'VWPH%U[H D*!A74(
MC'Z/>(="." *X^<.TQM=.L.7ZSWZ^YX[<5DS@W=*?.>EK1=>[D&)%>N$_:*V
M?^&.3^;P"B5,_X7MH)N2QZ(S5C4[8]HW7 Y_]FN7AQ<&>7C$(-X9Q'W<@Z,^
MRK?,LN5<JRUHITUH;M%3[:TI."[=I=Q;3:><[.QRI>E^M7T")DMX][/C+67<
M^O"9ZN'\@:T%FHMY8,F3TP^*'>KM@!H?08UB^*2DK0V\DR66KP$""G&,,]['
M>1N?1/S$]!4DD0]Q&"<G\)*1=]+C)?_!VX>58-*^I@]_WZR-U50Q_QSB/B"G
MAY%=%\U,RPI<>-0F!O4C>LL_WD23\,\3<:=CW.DI].4]=679"015P>&[.Q3Q
M2<S#$3_4"&@LI\+'$CJ#52= \*KWC*RH@1E#15+0^4;I)^"&)% I07UN9O"^
MTY+;3F,?'8ZI32XS>$*F#=RIINTLTLII&%79+2/U9'?\0=*99.*2?#^?EOA(
M@V2 *I2Q9M3_B-2<M1(E\*;5ZA&=CH'[6FD"<E&_(J%II+BAQ>4&A#,%TFI>
MYQ2?^T$ZJHIFD7'I(#!+^1G(.H1S+DFB.D-FYF(&-\;I4-%2GO95ZS[QT;R<
M0>SGT83^23(YEIMIFL%T<GV,:Y[G,+V>_._4Q:&?AAE$F1]F4WA0E@EH#R8
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MXP7H?JVU.VR\@?&Q6_X/4$L#!!0    ( ,U NE;H]<LN400  /(*   9
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MT,T]VPRL.M9WVTY9.EMJLZ!?$]1N ZWOE;+G@0O0_>RL_@502P,$%     @
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M^A#(<U^UC^\(5AHG4*BL"%&OOQ*C80L!@&[%J-M!.4YBD2!+G,P^#NITPH6
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M+JBM1NT.T/Y,$7=6"V>@;]0G?P-02P,$%     @ S4"Z5OO6<DU&!@  =!
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M"6W ^Z52=G=#!H8_&L[_!%!+ P04    " #-0+I6-Y,CI<@#  !3"0  &0
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M\CHMO09'O/KD0:1ZI<A/:0SQH;V+#&H:P9;&;6 %_#5/KX@WN"2!%_A-\_F
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MNK>^4[DI;A+<W?#R0N:!RB5+%>&P0%/OJH_1*<L[CO)%BZRX)I@+K452-%=
M8Y!F /Z_$$)O7XR#^J9I\A]02P,$%     @ S4"Z5DZIX]61!   JQP  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULQ9GO3^,V&,?_%2M#TYUT(TU:
M6F!M)6ANNI,&0U2WO9BFR21/6XO$SFRGY:;]\;.=-JDA&"I9ZAN:'WX^]O.U
MG\=Y\'C#^*-8 4CT5.143(*5E.5E&(IT!046IZP$JMXL&"^P5+=\&8J2 \Z,
M49&'<:\W# M,:# =FV=W?#IFE<P)A3N.1%44F'^_AIQM)D$4[![<D^5*Z@?A
M=%SB)<Q!?BOON+H+&TI&"J"",(HX+";!5729Q#UM8%K\3F C]JZ1=N6!L4=]
M\S6;!#T](L@AE1J!U<\:9I#GFJ3&\<\6&C1]:L/]ZQW]%^.\<N8!"YBQ_ ^2
MR=4D. ]0!@M<Y?*>;;[ UJ$SS4M9+LQ?M-FV[04HK81DQ=98C: @M/[%3ULA
M]@SZHU<,XJU!_,P@CE\QZ&\-^N\U&&P-!D:9VA6C0X(EGHXYVR"N6RN:OC!B
M&FOE/J%ZWN>2J[=$V<GIO)YOQ!9H3I:4+$B*J417:<HJ*@E=HCN6DY2 ^ G=
M8LZQGB;T(0&)22X^HA-$*+HA>:XF48Q#J8:DP6&Z[?ZZ[CY^I?LH1C>,RI5
MGVD&F0T(E2^-0_'.H>O82;S!_!3UHT\H[L5]]&V>H \G']4*+1G7[OQ=42([
MQCE[/S7>43LPR?LQ43?&<KK?S&+?</NO<&]5?.U/&6=47:>@ E0*Q#B:K3!=
M@IXKJQFA*2ES0'_^JH#HJX1"_-4UB77O@^[>=6JZ%"5.81*HW". KR&8_OA#
M-.S]W*6T3UCB"6:I/FA4'[CHT]NJ> "N0Z=97D@O+X'^>WO!7=?LH6'K[+R>
M1N-PO2^4L_=#A?($LX0Z:X0Z<PIUE:U!B2&T0/"DMBP!2J*3+E5JT,6>*O'I
M\)DN76W.[3:)FV-Y,6R\&#J]F.,<!)JQHB!";WL"J9T'S:L'D7)22O/DMP4R
ML4@S]/FIQ/7V^(5P[?F<Y57=:J92'E<[7F?"= [BT%CS"4L\P2SQ1XWXHZ-F
MN)%/U7W"$D\P2_7S1O5S=^ 6.HG]B\TG6@F<L*Q+/#=D@+X#YEUK?>8T/%0H
M3S!+J(M&J NGCS>$DJ(J5%9+8 &<0_8B4:B]_Q'D*XG 9 S=ZD6NN <*&YR[
M<X9S<(>N7I^PQ!/,FI2HUW[<]HZ:-;;=>Q+>*RWQ1;.EWZLK(A^IXPW*"!6F
M/.B4RVEZL%R>:+9<<2M7[$X@^.F8"<0]NH,7LD]:XHMFSTQ;6D7'K:TBK\65
M5UKBBV9+W]97D;O >F\.<5.BOBN)>"VR?-%LO=HR*W+76?NUR*<7F:!3.B?P
MX,7GDY;XHMEBMM5>-#QNW'LM]+S2$E\T6_JVUHN<1<UTMU55:MN2P(ONI>MF
M1+$KZKU6:+YHMEIMC1:YZRL[ZCN^$CK5\UEZS;S2$E\T6\^VE(LNCAOX7JLU
MK[3$%\W^UWU;K\7.HN1]@?\&PQGX;MM#U?)%J]4*]TYQ"N!+<QHFD%EA]?E'
M\[0Y<;LRYTS/GE]'ETE];M9BZF,\E1R61-4$.2P4LG<Z4ELLKT_&ZAO)2G-6
M],"D9(6Y7 '.@.L&ZOV",;F[T1TTYY/3_P%02P,$%     @ S4"Z5O1C[[O\
M @  $PP  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N>&ULK9==;]HP%(;_
MBI5ITR:UY+. .H@$9%,KK1,";;N8=F&2$[":V)EMH/OWLYV0A2Y$K90;8COG
M?>+SQHX/DR/CCV('(-%3GE$QM792%K>V+>(=Y%@,6 %4W4D9S[%47;ZU1<$!
M)T:49[;G.$,[QX1:X<2,+7DX87N9$0I+CL0^SS'_,X>,':>6:YT&5F2[DWK
M#B<%WL(:Y+=BR57/KBD)R8$*PBCBD$ZMF7L;C76\"?A.X"@:;:0SV3#VJ#OW
MR=1R](0@@UAJ E:7 RP@RS1(3>-WQ;3J1VIALWVB?S:YJUPV6,""93]((G=3
M:VRA!%*\S^2*'>^@RN=&\V*6"?.+CE6L8Z%X+R3+*[&:04YH><5/E0\-@3N\
M(/ J@?=<$%P0^)7 ?ZD@J 2!<:9,Q?@088G#"6='Q'6THNF&,=.H5?J$ZM>^
MEES=)4HGPW7YNA%+D2!;2E(28RK1+([9GDI"MVC),A(3$-=HW0A8F*D!%V@%
M:KT)*(-=YRUB'.6,@T:NX !T#WJH(NKX&,@!;S*X0E_5NGX?@<0D$Q_0=4U%
MLV9GP6BL^!R;E;(BXG%B2Y6[SL".JSSG99[>A3Q=#STP*G<"?:()).< 6YE6
M.^>=G)M[G<0'S ?(=Z^0YWA^RX06+Y=[+?+HY7*W(QN_7@>^X047>-6;:C.V
M4Z@_2[>BP#%,+;,.^ &L\-T;=^A\;#.E3UC4$^S,L* V+#!T_X)A_R]*]/.+
MBD'W$G+QJ\W(H$\C^X1%/<'.C+RIC;SI7'GG1G)EY!4J@.LQ=>ZT^=C)>ZV/
M?<*B$N8ZAJ9/W$/H#%RUO0\M!@UK@X:=!K5\.=M<Z82\UI4^85%/L#/S1K5Y
MH[ZWZ:A/(_N$13W!SHP<UT:.>]ZFX];-,*XW0VE0:Y0^TII14>?<7INYW2B7
M5'VQ-66G0&:7E>=_/5I7MC-3T#T;GZN*MRQ0_V'*<ED=SUM"!<H@54AG,%)?
M!EZ6H&5'LL(491LF59%CFCM5M0/7 >I^RI@\=?0#ZO\!X5]02P,$%     @
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M\>$&G9Z<H1-$&?I2\(4D+)=]5VE^YA0W:[B,:B[! 2Y^@&[U.85$[UD.^3:
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MI5I8P^VT6>2F7L0[LXCKH3M&Y4:@WVD&V3&!K3)NT_8.:=]XHXQWF%\BW[U
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M7S2_S\HR6]4?ESR:\[PR$+\O,G%7N#^HWET__%\%T_\!4$L#!!0    ( ,U
MNE;$IJJ3LP(  *T'   9    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;*V5
M44_;,!#'OXJ5H0DD2M*D38&UD: =&@](B [V,.W!3:^-A1,7^]+"M]\Y2;,
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MP%AH:JP$X2OIY,\2E=1AH:F!$*2NI)0_2UW8U#*=@JN5@JN5,%=;PNR]]KW
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M=@46;C,9N$3M+"8%]M3W,RB"NW=?:)+2G&2*P"(Z;97ANB.@P4V"(3%$V'?
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MFT !\.I@7TTDR\NS\2.3ZJ1=#G= 8N#:0%W?,":?)OJXW7Q>6?X'4$L#!!0
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M[U#\?IJF^?.-<@6/:?9C_7"&_P=02P,$%     @ S4"Z5AJ3+C(F!@  P#0
M !D   !X;"]W;W)K<VAE971S+W-H965T-3@N>&ULM9MK<YLX%(;_BL;;V6EG
MVA@$-G8V\8P3M-O.)&VFE]W/"B@V4XQ<28[3F?WQ*RX!9+!JMJ=?$F[G$;Q'
M'/$B<['GXJM<,Z;0TR;-Y.5HK=3V?#R6T9IMJ#SC6Y;I/0]<;*C2JV(UEEO!
M:%P$;=(Q=ISI>$.3;+2X*+;=B<4%WZDTR=B=0'*WV5#Q_8JE?'\Y<D?/&SXF
MJ[7*-XP7%UNZ8I^8^K*]$WIM7%/B9,,RF? ,"?9P.5JZY\3S\X#BB+\3MI>M
M991?RCWG7_.5=_'ER,G/B*4L4CF"ZG^/[)JE:4[2Y_&M@H[J-O/ ]O(S_<_B
MXO7%W%/)KGGZ3Q*K]>5H-D(Q>Z"[5'WD^[>LNJ!)SHMX*HN_:%\=ZXQ0M).*
M;ZI@?0:;)"O_TZ=*B%: ZQ\)P%4 /C7 JP*\4P/\*L _-6!2!127/BZOO1 N
MI(HN+@3?(Y$?K6GY0J%^$:WU2K*\HWQ20N]-=)Q:7.VDWB(ENN:;^R2C>?8D
M>H/N=B):ZP3H[;I3Q$P4>] R37E4+KX,F:))*E_IH[]\"M'+%Z_0"Y1DZ/.:
M[R3-8GDQ5OH,\W;&474V5^79X"-G<TO%&?+<UP@[V.L)O[:'+[<ZW"G#<4]X
M>'KK?>'D]-8=,WRLLU*G!M>IP07/.\*[2>A]DB8J81)1J>]D%I_W25I2_'Y*
M7FC.Y99&['*D*XEDXI&-%K__YDZ=/_H$AH2%D# "!#-2X=6I\&STQ5^<Q_LD
M3?OD+R,G161>EA\7TV#NZP[PV-;5RA^J:[=)=S9W)V:3!*A)0S"_%LRW"O;Y
M[2T)7Z.;F^L^R:RQ0WLL)"R$A!$@F)& 29V B;5X+*5D2M>-Z-LN$4<*QP0R
M#9"P$!)&@&!&&J9U&J;6^^":RC728R&*\@6FD_%(4Y:IWK'1BAJ:#TA8" DC
MTV[UF@>X+EZ&SD&M<V#5>1E%?*=EU<^N$=,:WZ>L3V$K9*C"D+ 0$D9*V+2E
ML.\$DWZ%9[7",ZO"']2:B?PYA/5W7FOT4&DA82$DC,PZTKH3Q^N7=EY+.[<7
MB>(Q7ZLK6%H^@*^3;:_(5LY0D2%A(22,S+LB.WCF]*OL.HW5<>P/)5S1M.K"
M]<C8:U*LG*$Z@])"4!JI:(;4P<P[)G7+5;H@WJ7"0"D-20M!:02*9B:D\9*N
MU1\U ^26?L]'Q^*AA$:1V+$8I4VV>I,$ZC!!:2$HC52T]NV G:-W0^,>7;M]
M?,_48=EYC=A3E.[B)%NAE<5=VLF#M0>UH: T4M',H77F'!._<:*NW8K:O+L]
M=+"ZH%84E$8JFJ&N\<[ 5+>QF:[5/E5CZO;Y;6'4?EO8JSBHZ02EA: T4M':
M/L?S@Z.*-X[2M5O*Y6WRX7VOM*#^$906@M((%,W,0.,UW>"GWZVXH%83E!:"
MT@@4S4Q&8TM=NR\]T?G;*8/S,>O<V[X?F.]?0] F"13-E+FQJ*[=HY[NG4 ]
MJMNU@GCN3CM2@]I/*)HYZ]/85.S S/N NE106@A*(U T,R&-F<56;[8(V0,3
MNKOK$O/(LEUO?;$C!B?#[>GV^&"")P1MDT#13)%;DYUV@UJ^7_R!$[4S!JO<
M=7M3SSL4&782\U?,8N+&B.)?9D3MY,'2=\T>GDR=^:'XH X3BF:*WQA1_/^-
MJ#UTL+I=L^?/G6[] '684#13W<:(8E@C:L<-5GS243SPIYY_J#BHPX2BF8HW
M1A2?8$31O^CTZ0L[<+#FH X5E$:@:&9J&H>*?]ZA8E"'"DH+06D$BF8FHW&H
MV.Y0!]P?H"85=^<J<8 =Y[ F@=I4*)JI=6-3L=VF/M>DSRQ:9SSEJ^]OKO1P
M$*-WF:+9*LEG/I9'Y[#M\,'Z@TZP@M((%,W\-5UC<3V[Q3VE/GF@]A:4%H+2
M"!3-3$9C;SV[O3V]/ME!@U/2-;DS?%B=0)LD4#13Z<;C>C^8A'VN3H+&;$/%
MUWZ504TN*"T$I1$HFIF.UH]ZO9^O0J"V%Y06@M((%,U,1N../;L['E"%0+UR
M16N_R@\ZSTB@31(H6JGTN/7Q1_YMSRT5JR23*&4/&N^<!?K21/FY3+FB^+;X
M'N2>*ZUXL;AFNB")_ "]_X%S];R2?V)2?[2T^ ]02P,$%     @ S4"Z5A$=
MJZ0" P  O L  !D   !X;"]W;W)K<VAE971S+W-H965T-3DN>&ULM59=3]LP
M%/TK5H8FD(!\M?E@;20H0D-B&X*Q/4Q[<-O;QB*Q,]MMV7[];">$M$TKD,)+
M&SOW')][?.W<P8KQ1Y$"2/249U0,K53*XLRVQ22%'(M35@!5;V:,YUBJ(9_;
MHN" IP:49[;G.(&=8T*M9&#F;GDR8 N9$0JW'(E%GF/^]P(RMAI:KO4\<4?F
MJ=03=C(H\!SN03X4MUR-[)IE2G*@@C"*.,R&UKE[-G(-P$3\(+ 2C6>D4QDS
M]J@'U].AY6A%D,%$:@JL_I8P@BS33$K'GXK4JM?4P.;S,_N525XE,\8"1BS[
M2:8R'5J1A:8PPXM,WK'59Z@2ZFN^"<N$^46K,C94P9.%D"ROP$I!3FCYCY\J
M(QH M[<#X%4 [[4 OP+X)M%2F4GK$DN<##A;(:ZC%9M^,-X8M,J&4+V-]Y*K
MMT3A9')-):9S,LX G0L!4J 3M#5WC+ZJ@CJ\!(E))HY4R,/])3H\.$('B%#T
M/64+@>E4#&RI)&EB>U(M?U$N[^U8_@OFI\AWCY'G>'X+?/1ZN+<.MY41M1M>
M[89G^/P=?%>$$@DG-ZJRIMLVH%\W*AY=2\C%[[9<2_)>.[D^D&>BP!,86NK$
M">!+L)*/']S ^=26>4=D:S[XM0_^/O9F5>"J N:<B=8-+IGZADE?&LO$CP+'
M&=C+9C;;47$4O02MJ>S5*GM[5=Z $&?J(I@L\D6&I=HRG#,NR3^L;X@VK25?
MT%!Q$H1!;T-K2Y0;AVZ[V'XMMO]62RG(-I']K>5]-_*##9';46'LQ.T:@UIC
ML%?CR-PWP-7]G!D/14J*UDW?R_/62N^(;"WEL$XY?,\3'W;I0T=D:SY$M0]1
M9R<^VB[0T GBC0+=CHJC8$>!QK7*>*_*;S)5U4EJK:WR]E*\=4\Z(EO+UG5>
M/L[.>U9GQ=Z1%5VQK7O1:%3<SBJTHFI^;MR^[VY4:%O4YBUO-UHKW=>JCF-.
MJ$ 9S!3(.0T5FI>M8CF0K##=UIA)=9>:QU2UU\!U@'H_8TP^#W0#5S?LR7]0
M2P,$%     @ S4"Z5F& ]!F\ @  4P@  !D   !X;"]W;W)K<VAE971S+W-H
M965T-C N>&ULK59M;]HP$/XK5C9-K;0UKZ0O"Y&@6;=^Z%2UZO9AV@>3'&#5
ML3/;D&Z_?K834BB!H:E\(/;YGN?N.8<[DIJ+1SD'4.BII$P.G;E2U87KRGP.
M)98GO *F3Z9<E%CIK9BYLA* "PLJJ1MX7NR6F# G3:SM5J0)7RA*&-P*)!=E
MB<7O,5!>#QW?61GNR&RNC,%-DPK/X![40W4K],[M6 I2 I.$,R1@.G1&_D46
M&W_K\(U +=?6R"B9</YH-M?%T/%,0D A5X8!Z\<2+H%20Z33^-5R.EU( UQ?
MK]BOK':M98(E7'+ZG11J/G3.'%3 %"^HNN/U%VCU# Q?SJFTWZAN? >A@_*%
M5+QLP3J#DK#FB9_:.JP!_'@'(&@!P4M M ,0MH#P4$#4 B);F4:*K4.&%4X3
MP6LDC+=F,PM;3(O6\@DSUWZOA#XE&J?2:Z8PFY$)!322$I1$']!7+ 0VUX&.
M,E"84'FLK0_W&3IZ>YRX2H<U8#=O0XR;$,&.$'Z ;CA3<XD^L0**30)7Y]LE
M':R2'@=[&6^P.$&A_QX%7A#V)'1Y.#SH@6>'P_T]:L+N"D++%^[@^\QY41-*
M$68%VKZ/C,B<<KD0@'Z,)E()_5/YV7<+392H/XII'Q>RPCD,'=T?)(@E..F[
M-W[L?>RKX&N29:]$ME'=J*MNM(\]'95<*/('VR[#IX@\%QC; O>5LJ$<6$K3
M.)=I=.:93^(NUZNT[>=[/7Y9CY^_Z;>A;=!I&^S5MGIS^B0TR'@M9'QZ'O5H
MV';TS\[]P;:(O;G\YRW&G=+X(*6(E!4F0L\=U2<ZWJKS2[7_],CV>32YNVOM
MM@0QLV-+HIPOF&J:6&?M)N/(#H07]K&>F,V >Z9IQJWN,3/")*(PU93>R:G.
M1S0CK-DH7MFF/N%*CPB[G.NI#\(XZ/,IYVJU,0&Z_Q'I7U!+ P04    " #-
M0+I6CA%XI\<"  "1"0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6RM
MEEUOVC 4AO^*E553*W7-=X .(K6P;KV85/5CNYAV89(#L>K$S'9(MU\_VTDS
M"FFHT&Z(/\[[^CF'Q/:X8OQ19  2/>6T$!,KDW)U;MLBR2#'XHRMH% S"\9S
M+%67+VVQXH!3(\JI[3E.9.>8%%8\-F,W/!ZS4E)2P U'HLQSS']? F75Q'*M
MYX%;LLRD'K#C\0HOX0[DP^J&JY[=NJ0DAT(05B .BXEUX9Y/1SK>!'PC4(F-
M-M*9S!E[U)WK=&(Y&@@H)%([8/58PQ0HU48*XU?C:;5+:N%F^]G]RN2N<IEC
M 5-&OY-49A-K:*$4%KBD\I957Z#))]1^":/"_**JB74LE)1"LKP1*X*<%/43
M/S5UV!"XP2L"KQ%X;Q7XC< WB=9D)JT9EC@><U8AKJ.5FVZ8VABURH84^E^\
MDUS-$J63\74A<;$D<PKH0@B0 GU 5Z4LN>KGC$OR!YMR?WI2[XT =#P#B0D5
M)RKNX6Z&CH].T!$B!;K/6"EPD8JQ+167=K>3AN&R9O!>8?B*^1GRW5/D.9[?
M(9^^7>Z]E-NJ&FU)O+8DGO'S7_'[S%A:$4J1R@;MUF=&1$*9T!7Z<3$7DJLW
M\6=7TO4J0?<J^NL\%RN<P,12GY\ O@8K?O_.C9R/727X3V8O"N*W!?'[W&-5
MUZ KP5H5&I7>+=9Q$+JCL;W>!.^U/A \:,&#?>!A%WBMBC;!O2#< N^U/A \
M;,'#?>!1%WBX"^ZXWA9XK_6!X%$+'NT#'W2!1UW@SA9XK_6!X(,6?+ /?-@%
M/G@+>*_U@>##%GS8"WZ?@3J]%Q)X%_YP!]]UG6";OW>% _E'+?^HEW]C@\5F
M@SU%!<BN7$8[VXWO#OUH*Y?=J,'(^;<IU8SVQH&I+ROJ"%F20B *"R5SS@9*
MS^L+0-V1;&7.T#F3ZD0VS4S=F8#K #6_8$P^=_2QW-["XK]02P,$%     @
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MVIG=B]5>N,D!K"9QQC8P(^V/7]M)4\*$ )+WIL3![W-LSJOCCTYVE+WR-8!
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MK"JW3\Z4VP^SR$4YBRQB1S6'1$ONJ&:BFH5J-JHYI=:(GL%Q]*#E=53S42U
MM1#5!*I%J"8IK1D]51T^?WCIU:W#DE2')1 Z%Z526[V3A]1,5+-0S48U!]5<
M5/-0S4>U -5"5!.H%J&:I+1F0E7U^,E+U^,G:#T>U4Q4LU#-1C4'U5Q4\U#-
M1[4 U4)4$Z@6H9JDM&:L5?7XB;H>?XBF8DV%8NIW6 &F,YS03CRJF:AFH9J-
M:LZ9'^9(^YK$:=<YLXL>AX=J/JH%J!:BFD"U"-4DI36#J.K13]0]>NO+PR(]
MG%&5ZU#=I9N5EMTGS:OBG>&$]N51S40U"]5L5'/._(#S"?[I=$++\:CFHUJ
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M/"=?:;]MLFRSVC^\3^+;)"TVR/_^;I-/#LL_% -\WJ2_[[_,M_\'4$L#!!0
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M]$Y/JZX!MJT*0H'76)0VV=2> )I-@7Y9O%_,YYU,+*W62R8VU6);:DUNM96
MP4N_+VP:C)E5M=B66A-^;5B@V;'\^/LB['!Y?MNNSLP-Z8WM9W@66)L6:%R;
M7S@/#EMH_&^FFA*-55=A2ZV)IO85L+^Q4,=I0H#8$K"3R^GNKYLV;</,JEIL
M2ZW)M+8A</S24Z15-V-5+;:EUOP.7?L99%RR?X]3+A6;'_$"/PR#;S+?7'7O
M[\96O8=[MO6A-JH^8+9))8>,K*6\=S64;RYVVOLYG0BZT[LA2RH$S?7AEN"$
M,%5 WE]3*AY/U 9+M0,7_0]02P,$%     @ S4"Z5L"7Q"\M!0  )!@  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C8N>&ULM5E1;^(X$/XK%E>=NA(EV($
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M1K^! IC21:B^\]4WR EU#9[/0YG^1:N\;[N!_(54/,H':PLB%F>_]"UWQ-8
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M<N:2# JF@^.9)CK9ZQ?%T5(WGTYW4%T+W.F1/;I6@\ZDB]ME FY;<\#/5&E
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M+W-H965T-C<N>&ULQ5AM;]LV$/XKA#H4+=!8HOS:U#:0N"E68,&"!.L^#/W
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ML^Z(5F8ULOV*;/\59-EC$]D"C49ULL,CKGT?U_ZHZ^<ZJ+@.6KG><OU %@J
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M;&JZK)NF>J+%QC4J3T*;ML<-<]-HHK0'S/Y*"'V86 --ZYK\!%!+ P04
M" #-0+I6JA(F/G@#   ,#@  &0   'AL+W=O<FMS:&5E=',O<VAE970V.2YX
M;6RUEVMOVC 4AO^*E4U3)PUR@Y!V@%1ZV?:A4U74]K-)#F UL:EMH/WWLYTT
M7 (N1=T7R,7G]?OX<G+<73+^)*8 $KWD&14]9RKE[,QU13*%'(LFFP%5;\:,
MYUBJ6SYQQ8P#3DU0GKF!YT5NC@EU^EWS[);WNVPN,T+AEB,QSW/,7P>0L67/
M\9VW!W=D,I7Z@=OOSO $AB#O9[=<W;F52DIRH((PBCB,>\ZY?W;AMW2 :?%
M8"G6KI%&&3'VI&_^I#W'TXX@@T1J":S^%G !6::5E(_G4M2I^M2!Z]=OZM<&
M7L&,L( +ECV25$Y[3NR@%,9XGLD[MOP-)5!;ZR4L$^87+<NVGH.2N9 L+X.5
M@YS0XA^_E .Q%N!'>P*",B#8#FCM"0C+@-" %LX,UB66N-_E;(FX;JW4](49
M&Q.M: C5TSB47+TE*D[VKY[G1+ZB!KH%;A8%3: Q4..2HCL0DI-$JLNA9,D3
MNJ=$"G2N!U['G%R"Q"03WS\2W4!?D8O$%',075<J NW#34JW@\)ML,>M'Z ;
M1N54H"N:0KHIX"KTBC]XXQ\$5L4;S)LH]'^@P O"'88N#@\/+';":CI"HQ?N
MT?L[ST? $1NCX=XA*A1:NQ7TMC\3,YQ SU'[6@!?@-/_]L6/O)^[\#Y); .V
M5<&V;.K] 4P(I81.U$;,]-)!)X26:^/[+O)"+C)R.C\MU(+P/*_K+M:1K)T>
MB=2ND-I6I%\<4[WDWP%IUT "/ZR36/LZDB2J2"(KR8/:O^^#1#60AN_70>K-
M5BTVW'4J=QVK.Y7"QT .,-BI&XSK_JR='3G0<8426U%4)OO %HCK*\>+ZD#U
M9IL[9</I:>7TU)J<'LTW$=(&.E\ 5Q]Y9)8[4A\>0->8</2 LSGLLGWZF3GK
MD\0VQL#W5A],[XBLE;(LPUR@F<K>9OIVSEXIW5Z;EWA[ZNS='XNW5@_X!V>P
M Z'*"L-?HPI;S2C<!K-V?"Q8L (+#DUH!W(%M4U4GRQKG\<RK:H%W_I]WDJ#
M!V*%.Z8K;K8ZVVC_HS3P5[6!;R\.=J3% _D*W7AK-<;;>"W;5BQ,NVMU=0Y\
M8HX; B5L3F518E9/JR/-N2GDMYX/]%''U.LKF>*<I I(E4X$RF"L)+UF1QGB
MQ=&CN)%L9JKW$9/J+& NI^JX!EPW4._'C,FW&]U!=0#L_P-02P,$%     @
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MH77%/]T/[-%C\(_9TNT[R8_<Z-R6_;#0ML)S6PZ 15'XBBU/YV][_ #^.Y1
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M ]3G:\;D\22_0?GKR^Q?4$L#!!0    ( ,U NE9J;Q6#QP,  .\2   9
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MW#)%4I*7IFYH 4DIB"(@T>>7)"]32-%*<&I<"PUD:\Q7J/-V'V)0F.3R([I
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MNXN5)=YVL>U LJWIZYZ95%VB>=RHSA^X!JCU@C'Y.M ;]/\ETO\!4$L#!!0
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M%9SYF30&\'PIA'X9F%-E]U^$^?]02P,$%     @ S4"Z5E)*)31%!   YA<
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MY&*.(:FZ-ZL'1A95MW(O#?8^U6.&[2PH"\#UG93F:6!?T#;(T;]02P,$%
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M&\S),OM9M_^DW3]Z9?\P(C=2F%*3SR*'_"F!C\7T%47KBB;13L8;JH[)(/Q
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MN^-7]:\N>4QFSC1<2?&3+TTQ#88!64+.&F'NY.8;;!-*K-Y""NVN9-/N3=.
M+!IM9+D-1@<EK]H[>]Z^B)T 2@\$T&T =;Y;D'-YS0S+)DINB+*[4<T.7*HN
M&LWQRGZ5>Z/P*<<XD]T IJ3)&;EEIE'<<)S(G+AE<L/9G(MV\?0:#.-"?R(G
MA%?DH9"-9M523T*#-JQ8N-@B+ULD/8"\9>J<].+/A$:T1Q[OK\GIR:=_94+,
MHDN%=JE0I]L[GLJOB[DV"K_V;Y^U5J+OE[ E,-8U6\ TP']<@UI#D'W\$*?1
MER,&>YW!WC'U#//M^SRU48F+LE6TSBCM#2?AVL/J=ZS^>ZS$QVJCTEU6/X[]
MK*1C)>^Q4A\K\;"2 WFE'2M]CS7PL5(/:S3PLP8=:_ >:^AC#?99:93X6<..
M-3S*>B@ FVIN0/F(PSTB JF?..J(H^-$:9@@>8-E#T2X>J_9"S9<XZWIT9Z%
M>$C3 W].'+VUG^BHBQO0>DQX63<&EMA8\ 6 -MZF$NTY.*.IK2BO@YT&&!]U
M,+.%7AFR9J(!V_O:=R'>>I_73;Q7M'&2]O[_X\*=SFQ/.>Q]*UYI9.08%YT/
M4$"U!T<[,;)VS7HN#;9^-RSPL 5E-^#S7$KS.K']OSN^L[]02P,$%     @
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MC0=P_5C@G0JD >#[L1!ZU3 #M+>T]!]02P,$%     @ S4"Z5NZ,**QY @
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MM[=J\PW:?,X=7ZFX\5^R";;G%Q$I5\8JT8(Q L%D^-/'M@X[@.00(&T!Z4O
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M!.Y&',$<@ <,B2+S'MQY'P6K]U2P_B_M\ ]02P,$%     @ S4"Z5I>*NQS
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M&!8U:A-34$JLH#WF7)CJ!"H3)^?< JT'#S$Q!:7OLNZ_:_1G0.A./BPU<\<
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MXG?5KLH\'T/93%UIOMS]?V[WW[\O_P)02P,$%     @ S4"Z5E(UQJ.* @
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M1=:*(FM%D;7ZG[+^&,?#/XY?GFEOVN$Y/UO^/''S"U!+ 0(4 Q0    ( ,U
MNE8'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N
M>&UL4$L! A0#%     @ S4"Z5KHG@;#N    *P(  !$              ( !
MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ S4"Z5IE<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " #-0+I6J-)VQ8P(  !U-P  &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ S4"Z5H)G47-! @
MQ04  !@              ("!SQ   'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( ,U NE;8+[>Y\08  &(=   8              " @483
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #-0+I69)D%
M=$ #   $"P  &               @(%M&@  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ S4"Z5CF6/>4M!@  )1L  !@
M ("!XQT  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,U
MNE9CCYYP7P,  /,)   8              " @48D  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " #-0+I6",FAP]$"  #Y!@  &
M        @(';)P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ S4"Z5FPT720=#   ^W   !@              ("!XBH  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( ,U NE8Y:6O%\PH  )XU   8
M              " @34W  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " #-0+I6A-N20=<%  #E#   &0              @(%>0@  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( ,U NE9>"023\2<
M $:&   9              " @6Q(  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ S4"Z5N>5!]'8 P  D@@  !D              ("!
ME'   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #-0+I6
M9Y+HR" %  #<#   &0              @(&C=   >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( ,U NE9O"JR/'08  !(1   9
M      " @?IY  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ S4"Z5LHK7F3< P  ^@D  !D              ("!3H   'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #-0+I6)].G'1$#   1!P
M&0              @(%AA   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( ,U NE:DR-!?\ D  '<=   9              " @:F'  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ S4"Z5C*P0,KA
M P  )PD  !D              ("!T)$  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " #-0+I6H:!IZ  #  #D!@  &0
M@('HE0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ,U
MNE8)DGRT&Q(  -8]   9              " @1^9  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ S4"Z5FU6>7U<!   #@L  !D
M         ("!<:L  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " #-0+I6F^2U)-H)  "7&P  &0              @($$L   >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( ,U NE9;.;6B: 8  &X/
M   9              " @16Z  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ S4"Z5OR3K0H\!   M D  !D              ("!M,
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #-0+I6HF=$
MY+@"   1!@  &0              @($GQ0  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( ,U NE;X&K$&-@,  #P'   9
M  " @1;(  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
MS4"Z5OZD6$.- P  XP@  !D              ("!@\L  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " #-0+I6C^Z3I.HI  #-D@  &0
M            @(%'SP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( ,U NE8 ]!8#\P,  &L)   9              " @6CY  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ S4"Z5@[U<0=D P
MP <  !D              ("!DOT  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " #-0+I6I%F"X 0%   @#0  &0              @($M
M 0$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ,U NE;R
MC:UBSP0  )<4   9              " @6@& 0!X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ S4"Z5I?Y&1!# P  8P<  !D
M     ("!;@L! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,U NE:O\QNVE@0  +0+   9              "
M@2\A 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ S4"Z
M5OO6<DU&!@  =!   !D              ("!_"4! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " #-0+I6-Y,CI<@#  !3"0  &0
M        @(%Y+ $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( ,U NE:\*G-9R0(  !0&   9              " @7@P 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ S4"Z5MDY3:(X!   =1(
M !D              ("!>#,! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " #-0+I63JGCU9$$  "K'   &0              @('G-P$
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( ,U NE;T8^^[
M_ (  !,,   9              " @:\\ 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ S4"Z5DN?0N?K @  S L  !D
M ("!XC\! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #-
M0+I6?<VWI!\#   R#0  &0              @($$0P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( ,U NE;LQQPT&P,  +P(   9
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M970U,2YX;6Q02P$"% ,4    " #-0+I6QXDN*L(.  #.JP  &0
M    @(&O7 $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M ,U NE;1AG+6&0,  ,0'   9              " @:AK 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ S4"Z5M9I0EBQ P  :A$  !D
M             ("!^&X! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    " #-0+I6@:0GX/P"  !*"0  &0              @('@<@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( ,U NE873GI35@,
M /X)   9              " @1-V 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ S4"Z5M9"?$GR"P  J)T  !D              ("!
MH'D! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " #-0+I6
M&I,N,B8&  # -   &0              @(')A0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( ,U NE81':ND @,  +P+   9
M      " @2:, 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ S4"Z5F& ]!F\ @  4P@  !D              ("!7X\! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " #-0+I6CA%XI\<"  "1"0
M&0              @(%2D@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+
M 0(4 Q0    ( ,U NE9Z-C+*?0(  ,H%   9              " @5"5 0!X
M;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ S4"Z5OQ!U1H&
M!   81@  !D              ("!!)@! 'AL+W=O<FMS:&5E=',O<VAE970V
M,RYX;6Q02P$"% ,4    " #-0+I6OKS*L%@B  "R9 ( &0
M@(%!G $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( ,U
MNE;;>2*@100  (T;   9              " @="^ 0!X;"]W;W)K<VAE971S
M+W-H965T-C4N>&UL4$L! A0#%     @ S4"Z5L"7Q"\M!0  )!@  !D
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M=#<P+GAM;%!+ 0(4 Q0    ( ,U NE8M[Q&)+P4  (D9   9
M  " @178 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @
MS4"Z5FIO%8/' P  [Q(  !D              ("!>]T! 'AL+W=O<FMS:&5E
M=',O<VAE970W,BYX;6Q02P$"% ,4    " #-0+I6;,!$FG(#  !7#   &0
M            @(%YX0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4
M Q0    ( ,U NE;T[,22X0,  '<,   9              " @2+E 0!X;"]W
M;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ S4"Z5FM5$S%H!
M41   !D              ("!.ND! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX
M;6Q02P$"% ,4    " #-0+I64DHE-$4$  #F%P  &0              @('9
M[0$ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( ,U NE8-
M;YY[=0,  "P+   9              " @57R 0!X;"]W;W)K<VAE971S+W-H
M965T-S<N>&UL4$L! A0#%     @ S4"Z5HN40&=>!   YQL  !D
M     ("! ?8! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,U NE9^I:CCNP(  ,H'   9              "
M@34& @!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ S4"Z
M5F!8..X4 P  L0D  !D              ("!)PD" 'AL+W=O<FMS:&5E=',O
M<VAE970X-"YX;6Q02P$"% ,4    " #-0+I6[HPHK'D"  ">!@  &0
M        @(%R# ( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0
M   ( ,U NE9XN)6Q.@(  "T%   9              " @2(/ @!X;"]W;W)K
M<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ S4"Z5O"N;3E4 P  LA4
M  T              ( !DQ$" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #-
M0+I6EXJ[',     3 @  "P              @ $2%0( 7W)E;',O+G)E;'-0
M2P$"% ,4    " #-0+I67YO.8*,&  !_.   #P              @ '[%0(
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ S4"Z5E(UQJ.* @  N3(  !H
M             ( !RQP" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ S4"Z5H/1K $N @  1#$  !,              ( !C1\" %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&     %X 7@#)&0  ["$"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>279</ContextCount>
  <ElementCount>470</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>80</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Summary Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummarySignificantAccountingPolicies</Role>
      <ShortName>Summary Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Net Income Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Other Income, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/OtherIncomenet</Role>
      <ShortName>Other Income, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Summary Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.doximity.com/role/SummarySignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Summary Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables</Role>
      <ShortName>Summary Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/SummarySignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/RevenueRecognition</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/Investments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/FairValueMeasurements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/BusinessCombinations</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/IntangibleAssets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/Equity</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Net Income Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Other Income, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/OtherIncomenetTables</Role>
      <ShortName>Other Income, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/OtherIncomenet</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/DescriptionofBusinessDetails</Role>
      <ShortName>Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/DescriptionofBusiness</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Summary of Significant Accounting Policies- Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies- Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails</Role>
      <ShortName>Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Summary of Significant Accounting Policies- Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies- Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue Recognition - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Revenue Recognition - Deferred Revenue Contract Balance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails</Role>
      <ShortName>Revenue Recognition - Deferred Revenue Contract Balance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails</Role>
      <ShortName>Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails</Role>
      <ShortName>Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails</Role>
      <ShortName>Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Property and Equipment, Net - Total Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net - Total Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Property and Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property and Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Business Combinations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsNarrativeDetails</Role>
      <ShortName>Business Combinations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Business Combinations - Purchase Consideration Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails</Role>
      <ShortName>Business Combinations - Purchase Consideration Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Intangible Assets - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets - Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Intangible Assets - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Intangible Assets - Changes in Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>Intangible Assets - Changes in Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Redeemable Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/RedeemableConvertiblePreferredStock</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityNarrativeDetails</Role>
      <ShortName>Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Equity - Common Stock Reserved for Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails</Role>
      <ShortName>Equity - Common Stock Reserved for Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Equity - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityStockOptionActivityDetails</Role>
      <ShortName>Equity - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Equity - Stock Options Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Equity - Stock Options Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Equity - Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails</Role>
      <ShortName>Equity - Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Equity - Performance-Based Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Equity - Performance-Based Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Equity - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails</Role>
      <ShortName>Equity - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Income Taxes - Schedule of Income Tax Expense Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Schedule of Income Tax Expense Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/CommitmentandContingencies</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Leases - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Other Income, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/OtherIncomenetDetails</Role>
      <ShortName>Other Income, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/OtherIncomenetTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Employee Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EmployeeBenefitPlanDetails</Role>
      <ShortName>Employee Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="docs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Segment and Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SegmentandGeographicInformationDetails</Role>
      <ShortName>Segment and Geographic Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="docs-20230331.htm">docs-20230331.htm</File>
    <File>docs-20230331.xsd</File>
    <File>docs-20230331_cal.xml</File>
    <File>docs-20230331_def.xml</File>
    <File>docs-20230331_lab.xml</File>
    <File>docs-20230331_pre.xml</File>
    <File>ex-107xcraigoverpeckofferl.htm</File>
    <File>exhibit191-insidertradingp.htm</File>
    <File>exhibit211-listofsubsidiar.htm</File>
    <File>exhibit231-consentfy23.htm</File>
    <File>exhibit31133123.htm</File>
    <File>exhibit31233123.htm</File>
    <File>exhibit32133123.htm</File>
    <File>exhibit32233123.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>docs-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1117">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>109
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "docs-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1117,
    "http://xbrl.sec.gov/dei/2022": 39
   },
   "contextCount": 279,
   "dts": {
    "calculationLink": {
     "local": [
      "docs-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "docs-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "docs-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "docs-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "docs-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "docs-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 708,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 6
   },
   "keyCustom": 53,
   "keyStandard": 417,
   "memberCustom": 24,
   "memberStandard": 53,
   "nsprefix": "docs",
   "nsuri": "http://www.doximity.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.doximity.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Description of Business",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.doximity.com/role/DescriptionofBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Summary Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.doximity.com/role/SummarySignificantAccountingPolicies",
     "shortName": "Summary Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.doximity.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.doximity.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.doximity.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Property and Equipment, Net",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Business Combinations",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.doximity.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Intangible Assets",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.doximity.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Redeemable Convertible Preferred Stock",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.doximity.com/role/RedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.doximity.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Equity",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.doximity.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Net Income Per Share Attributable to Common Stockholders",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders",
     "shortName": "Net Income Per Share Attributable to Common Stockholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.doximity.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Commitment and Contingencies",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.doximity.com/role/CommitmentandContingencies",
     "shortName": "Commitment and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.doximity.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Other Income, net",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.doximity.com/role/OtherIncomenet",
     "shortName": "Other Income, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Employee Benefit Plan",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.doximity.com/role/EmployeeBenefitPlan",
     "shortName": "Employee Benefit Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Segment and Geographic Information",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.doximity.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Summary Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies",
     "shortName": "Summary Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Summary Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables",
     "shortName": "Summary Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.doximity.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.doximity.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.doximity.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Property and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Business Combinations (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.doximity.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.doximity.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Equity (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.doximity.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Net Income Per Share Attributable to Common Stockholders (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables",
     "shortName": "Net Income Per Share Attributable to Common Stockholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.doximity.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.doximity.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Other Income, net (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.doximity.com/role/OtherIncomenetTables",
     "shortName": "Other Income, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "docs:ConversionOfStockConversionRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Description of Business (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.doximity.com/role/DescriptionofBusinessDetails",
     "shortName": "Description of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "iccbddb5d88f943d18b1e2bca79988299_I20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Summary of Significant Accounting Policies- Narrative (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies- Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ib2e9777aeaf94d178823baaa223076df_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails",
     "shortName": "Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ib2e9777aeaf94d178823baaa223076df_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i13475fef7778429390ef0860c7b05a45_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Summary of Significant Accounting Policies- Property, Plant and Equipment (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails",
     "shortName": "Summary of Significant Accounting Policies- Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i13475fef7778429390ef0860c7b05a45_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
     "shortName": "Revenue Recognition - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i396b959629334256bafddb8623b58bbb_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Revenue Recognition - Deferred Revenue Contract Balance (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails",
     "shortName": "Revenue Recognition - Deferred Revenue Contract Balance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ibca3ba7268b644c385960bab4881daa4_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "docs:ContractWithCustomerLiabilityAdditionsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Revenue Recognition - Narrative (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails",
     "shortName": "Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails",
     "shortName": "Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Investments - Narrative (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.doximity.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i0d09321a4a9a437083a3c246e5205811_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails",
     "shortName": "Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Property and Equipment, Net - Total Property and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
     "shortName": "Property and Equipment, Net - Total Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Property and Equipment, Net - Narrative (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails",
     "shortName": "Property and Equipment, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalesCommissionCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalesCommissionCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Business Combinations - Narrative (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
     "shortName": "Business Combinations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "iab8cf2152e6a45f19fde2dadc29bceb1_I20201031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Business Combinations - Purchase Consideration Allocation (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
     "shortName": "Business Combinations - Purchase Consideration Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i4898f87402b94fdc96d8b0443cb6d3b6_I20200401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Intangible Assets - Intangible Assets, Net (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails",
     "shortName": "Intangible Assets - Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Intangible Assets - Narrative (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.doximity.com/role/IntangibleAssetsNarrativeDetails",
     "shortName": "Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Intangible Assets - Future Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails",
     "shortName": "Intangible Assets - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Intangible Assets - Changes in Carrying Amount of Goodwill (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
     "shortName": "Intangible Assets - Changes in Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "docs:ConversionOfStockConversionRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Redeemable Convertible Preferred Stock (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails",
     "shortName": "Redeemable Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i54d5c9e860f9491ca63d3803144f4a8d_D20210601-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationsOfTemporaryToPermanentEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "iccbddb5d88f943d18b1e2bca79988299_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.doximity.com/role/EquityNarrativeDetails",
     "shortName": "Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "iccbddb5d88f943d18b1e2bca79988299_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Equity - Common Stock Reserved for Issuance (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
     "shortName": "Equity - Common Stock Reserved for Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i3b225b55e25041dca4b2711a6a9a0a19_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Equity - Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.doximity.com/role/EquityStockOptionActivityDetails",
     "shortName": "Equity - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i26986aac2225480487211e3064de5fd8_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Equity - Stock Options Valuation Assumptions (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
     "shortName": "Equity - Stock Options Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i26986aac2225480487211e3064de5fd8_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i999bcffa27f543c7af8d4b487ac793aa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Equity - Restricted Stock Unit Activity (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
     "shortName": "Equity - Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i999bcffa27f543c7af8d4b487ac793aa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i3b047f5f9ca746b7b52daa842f8517c4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Equity - Performance-Based Restricted Stock Units Activity (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
     "shortName": "Equity - Performance-Based Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2d7d4d4a7bc44e968f6a9f33a8f5a18b_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Equity - Stock-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails",
     "shortName": "Equity - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i63c582bee6244ae9bf6eba0489faaa89_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails",
     "shortName": "Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails",
     "shortName": "Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Income Taxes - Schedule of Income Tax Expense Benefit (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails",
     "shortName": "Income Taxes - Schedule of Income Tax Expense Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.doximity.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i2663b241eb57491e938b976279a54ef3_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i906daea421694946be847efacad3faf2_D20211008-20211008",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:PartnershipAgreementExtensionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Commitment and Contingencies (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.doximity.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i906daea421694946be847efacad3faf2_D20211008-20211008",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:PartnershipAgreementExtensionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.doximity.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i5b796d52a1c24138acd0adc60a1d55b6_I20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i5b796d52a1c24138acd0adc60a1d55b6_I20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Leases - Components of Lease Expense (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails",
     "shortName": "Leases - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "i73fa6205d93043c89ed98735725c4862_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeExpenseNonoperatingNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Other Income, net (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.doximity.com/role/OtherIncomenetDetails",
     "shortName": "Other Income, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeExpenseNonoperatingNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Employee Benefit Plan (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.doximity.com/role/EmployeeBenefitPlanDetails",
     "shortName": "Employee Benefit Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Segment and Geographic Information (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.doximity.com/role/SegmentandGeographicInformationDetails",
     "shortName": "Segment and Geographic Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20230331.htm",
      "contextRef": "ia69a715ac2514211984fe60a2d2034ac_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 80,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "docs_AMiONMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AMiON",
        "label": "AMiON [Member]",
        "terseLabel": "AMiON"
       }
      }
     },
     "localname": "AMiONMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition",
        "label": "APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition",
        "terseLabel": "Common stock warrant expense"
       }
      }
     },
     "localname": "APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable And Accrued Liabilities, Current Disclosure",
        "label": "Accounts Payable And Accrued Liabilities, Current Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_AccruedEmployeeStockPurchasePlanCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Employee Stock Purchase Plan, Current",
        "label": "Accrued Employee Stock Purchase Plan, Current",
        "terseLabel": "Employee contributions under employee stock purchase plan"
       }
      }
     },
     "localname": "AccruedEmployeeStockPurchasePlanCurrent",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021",
        "label": "Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021 [Member]",
        "terseLabel": "Options outstanding outside the Plans",
        "verboseLabel": "Options outstanding outside the plans"
       }
      }
     },
     "localname": "ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.doximity.com/20230331",
     "xbrltype": "stringItemType"
    },
    "docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability Payable Period",
        "label": "Business Combination, Contingent Consideration, Liability Payable Period",
        "terseLabel": "Business combination contingent consideration liability payable period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPayablePeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_BusinessCombinationContingentConsiderationLiabilityPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Performance Period",
        "label": "Business Combination, Contingent Consideration, Liability, Performance Period",
        "terseLabel": "Contingent earnout consideration performance period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPerformancePeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Subject to Performance",
        "label": "Business Combination, Contingent Consideration, Liability, Subject to Performance",
        "terseLabel": "Contingent earn-out consideration liability, subject to performance"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilitySubjectToPerformance",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_CapitalizedContractCostAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized Contract Cost, Additions",
        "label": "Capitalized Contract Cost, Additions",
        "terseLabel": "Capitalized contract acquisition costs"
       }
      }
     },
     "localname": "CapitalizedContractCostAdditions",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents and Short Term Investments, Amortized Cost",
        "label": "Cash and Cash Equivalents and Short Term Investments, Amortized Cost",
        "totalLabel": "Cost or Amortized Cost, cash equivalents and marketable securities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalent And Marketable Securities",
        "label": "Cash, Cash Equivalent And Marketable Securities [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalent and Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_ClassOfWarrantOrRightExercisesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of Warrant or Right, Exercises in Period",
        "label": "Class of Warrant or Right, Exercises in Period",
        "terseLabel": "Warrants exercised in period (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisesInPeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of Warrant or Right, Exercises in Period, Intrinsic Value",
        "label": "Class of Warrant or Right, Exercises in Period, Intrinsic Value",
        "terseLabel": "Warrants exercised in period , intrinsic value"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisesInPeriodIntrinsicValue",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase",
        "label": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase",
        "terseLabel": "Maximum annual increase of shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding",
        "label": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding",
        "terseLabel": "Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "docs_CommonStockVotingRightsNumberOfVotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number Of Votes",
        "label": "Common Stock, Voting Rights, Number Of Votes",
        "terseLabel": "Common stock, number of votes per share"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberOfVotes",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "docs_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Software",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computers and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_ContractWithCustomerLiabilityAdditionsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Additions, Net",
        "label": "Contract With Customer, Liability, Additions, Net",
        "terseLabel": "Additions, net, during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAdditionsNet",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance",
        "label": "Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance",
        "negatedTerseLabel": "Revenue recognized from contracts invoiced during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_ContractWithCustomerTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Term",
        "label": "Contract With Customer, Term",
        "terseLabel": "Contractual terms"
       }
      }
     },
     "localname": "ContractWithCustomerTerm",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_ContractWithUSNewsWorldReportLPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With U.S. News &amp; World Report, L.P.",
        "label": "Contract With U.S. News &amp; World Report, L.P. [Member]",
        "terseLabel": "Contract With U.S. News &amp; World Report, L.P."
       }
      }
     },
     "localname": "ContractWithUSNewsWorldReportLPMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_ConversionOfStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion Of Stock, Conversion Ratio",
        "label": "Conversion Of Stock, Conversion Ratio",
        "terseLabel": "Conversion of stock conversion ratio"
       }
      }
     },
     "localname": "ConversionOfStockConversionRatio",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "docs_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer A",
        "label": "Customer A [Member]",
        "terseLabel": "Customer A"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Expense",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Expense",
        "terseLabel": "Debt securities credit losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossExpense",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Two",
        "label": "Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Two",
        "terseLabel": "Due in one year to two years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DebtSecuritiesAvailableForSaleImpairmentsLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Impairments Loss",
        "label": "Debt Securities, Available-for-sale, Impairments Loss",
        "terseLabel": "Debt securities impairments loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleImpairmentsLoss",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available For Sale, With No Credit Allowance",
        "label": "Debt Securities, Available For Sale, With No Credit Allowance",
        "terseLabel": "Fair value of debt securities which no credit losses were recognized"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleWithNoCreditAllowance",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts",
        "label": "Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts [Member]",
        "terseLabel": "Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts"
       }
      }
     },
     "localname": "DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Acquisition and Other Related Expense",
        "label": "Deferred Tax Assets, Acquisition and Other Related Expense",
        "terseLabel": "Acquisition and other related expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsAcquisitionAndOtherRelatedExpense",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Deferred Expense, Capitalized Research And Development",
        "label": "Deferred Tax Assets, Deferred Expense, Capitalized Research And Development",
        "terseLabel": "Capitalized research and development"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopment",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DeferredTaxAssetsLeasingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leasing Arrangements",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue",
        "terseLabel": "Accruals and deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow",
        "terseLabel": "Sale of business consideration, held in escrow"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_EarningsPerShareBasicAndDilutedEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic And Diluted Earnings Per Share",
        "label": "Earnings Per Share, Basic And Diluted Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to Class A and Class B common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEarningsPerShareAbstract",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "docs_EmployeeStockPurchasePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2021",
        "label": "Employee Stock Purchase Plan 2021 [Member]",
        "terseLabel": "2021 ESPP",
        "verboseLabel": "2021 ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2021Member",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_EquityIncentivePlan2010Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan 2010",
        "label": "Equity Incentive Plan 2010 [Member]",
        "terseLabel": "2010 Plan",
        "verboseLabel": "2010 Plan"
       }
      }
     },
     "localname": "EquityIncentivePlan2010Member",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_EscrowDepositsRelatedToSaleOfBusiness": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Escrow Deposits Related To Sale Of Business",
        "label": "Escrow Deposits Related To Sale Of Business",
        "terseLabel": "Amounts held in escrow related to sale of business"
       }
      }
     },
     "localname": "EscrowDepositsRelatedToSaleOfBusiness",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_FurnitureAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture and Equipment",
        "label": "Furniture and Equipment [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndEquipmentMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_HostingArrangementAnnualCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hosting Arrangement, Annual Commitment",
        "label": "Hosting Arrangement, Annual Commitment",
        "terseLabel": "Hosting arrangement annual commitment"
       }
      }
     },
     "localname": "HostingArrangementAnnualCommitment",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_HostingArrangementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hosting Arrangement, Period",
        "label": "Hosting Arrangement, Period",
        "terseLabel": "Hosting arrangement period"
       }
      }
     },
     "localname": "HostingArrangementPeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_IncreaseDecreaseInCapitalizedContractCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Capitalized Contract Cost",
        "label": "Increase (Decrease) In Capitalized Contract Cost",
        "negatedTerseLabel": "Deferred contract costs"
       }
      }
     },
     "localname": "IncreaseDecreaseInCapitalizedContractCost",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_IndividualsWithVotingInterestAtThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individuals With Voting Interest At Threshold",
        "label": "Individuals With Voting Interest At Threshold [Member]",
        "terseLabel": "Individuals With Voting Interest At Threshold"
       }
      }
     },
     "localname": "IndividualsWithVotingInterestAtThresholdMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_IndividualsWithVotingInterestLessThanThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individuals With Voting Interest Less Than Threshold",
        "label": "Individuals With Voting Interest Less Than Threshold [Member]",
        "terseLabel": "Individuals With Voting Interest Less Than Threshold"
       }
      }
     },
     "localname": "IndividualsWithVotingInterestLessThanThresholdMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_InitialPublicOfferingIncludingOverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Public Offering Including Over Allotment Option",
        "label": "Initial Public Offering Including Over Allotment Option [Member]",
        "terseLabel": "Initial Public Offering Including Over Allotment Option"
       }
      }
     },
     "localname": "InitialPublicOfferingIncludingOverAllotmentOptionMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_OfficeSpaceLeaseInIrvingTexasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Space Lease In Irving, Texas",
        "label": "Office Space Lease In Irving, Texas [Member]",
        "terseLabel": "Office Space Lease In Irving, Texas"
       }
      }
     },
     "localname": "OfficeSpaceLeaseInIrvingTexasMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_OtherShareBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Share-Based Awards",
        "label": "Other Share-Based Awards [Member]",
        "terseLabel": "Other share-based awards"
       }
      }
     },
     "localname": "OtherShareBasedAwardsMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement, Annual Revenue Guarantee To Partnering Company",
        "label": "Partnership Agreement, Annual Revenue Guarantee To Partnering Company",
        "terseLabel": "Partnership agreement, annual revenue guarantee to partnering company"
       }
      }
     },
     "localname": "PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_PartnershipAgreementExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement Extension Period",
        "label": "Partnership Agreement Extension Period",
        "terseLabel": "Partnership agreement, extension period"
       }
      }
     },
     "localname": "PartnershipAgreementExtensionPeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period",
        "label": "Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period",
        "terseLabel": "Partnership agreement, revenue guarantee during noncancelable period"
       }
      }
     },
     "localname": "PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period, Payment Period",
        "label": "Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period, Payment Period",
        "terseLabel": "Partnership agreement, revenue guarantee during noncancelable period, payment period"
       }
      }
     },
     "localname": "PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriodPaymentPeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnerships Agreement Period Before Termination Is Permitted",
        "label": "Partnerships Agreement Period Before Termination Is Permitted",
        "terseLabel": "Partnerships agreement, period before termination is permitted"
       }
      }
     },
     "localname": "PartnershipsAgreementPeriodBeforeTerminationIsPermitted",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment For Contingent Consideration Liability, Operating And Financing Activities",
        "label": "Payment For Contingent Consideration Liability, Operating And Financing Activities",
        "terseLabel": "Contingent consideration liability settled"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_PerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-Based Restricted Stock Units",
        "label": "Performance-Based Restricted Stock Units [Member]",
        "terseLabel": "Performance-Based Restricted Stock Units"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_PortionOfCurativeTalentLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion Of Curative Talent, LLC",
        "label": "Portion Of Curative Talent, LLC [Member]",
        "terseLabel": "Portion Of Curative Talent, LLC"
       }
      }
     },
     "localname": "PortionOfCurativeTalentLLCMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_RebateLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebate Liabilities, Current",
        "label": "Rebate Liabilities, Current",
        "terseLabel": "Rebate liabilities"
       }
      }
     },
     "localname": "RebateLiabilitiesCurrent",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase Included In Accrued Expenses In Noncash Or Partial Noncash Transaction",
        "label": "Repurchase Included In Accrued Expenses In Noncash Or Partial Noncash Transaction",
        "terseLabel": "Repurchase included in accrued expenses"
       }
      }
     },
     "localname": "RepurchaseIncludedInAccruedExpensesInNoncashOrPartialNoncashTransaction",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts",
        "label": "Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts [Member]",
        "terseLabel": "Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts"
       }
      }
     },
     "localname": "SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Accrued Liabilities, Current",
        "label": "Schedule Of Accrued Liabilities, Current [Table Text Block]",
        "terseLabel": "Schedule of accrued expenses and other liabilities, current"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price",
        "terseLabel": "Fair value of common stock (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock",
        "terseLabel": "Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold",
        "terseLabel": "Voting interests threshold"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "docs_ShareBasedPaymentArrangementSubsequentToTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Subsequent to Tranche One",
        "label": "Share-Based Payment Arrangement, Subsequent to Tranche One [Member]",
        "terseLabel": "Share-Based Payment Arrangement, Subsequent to Tranche One"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementSubsequentToTrancheOneMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_StockIssuancesCostsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issuances Costs Incurred But Not Yet Paid",
        "label": "Stock Issuances Costs Incurred But Not Yet Paid",
        "terseLabel": "Unpaid deferred offering costs"
       }
      }
     },
     "localname": "StockIssuancesCostsIncurredButNotYetPaid",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_StockIssuedAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued, Acquisitions",
        "label": "Stock Issued, Acquisitions",
        "terseLabel": "Common stock issued in acquisition"
       }
      }
     },
     "localname": "StockIssuedAcquisitions",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Stock Options and Warrants Exercised",
        "label": "Stock Issued During Period, Shares, Stock Options and Warrants Exercised",
        "terseLabel": "Exercise of stock options and common stock warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Stock Options and Warrants Exercised",
        "label": "Stock Issued During Period, Value, Stock Options and Warrants Exercised",
        "terseLabel": "Exercise of stock options and common stock warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_StockOptionAndIncentivePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option and Incentive Plan 2021",
        "label": "Stock Option and Incentive Plan 2021 [Member]",
        "terseLabel": "2021 Plan",
        "verboseLabel": "2021 Plan"
       }
      }
     },
     "localname": "StockOptionAndIncentivePlan2021Member",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_SubscriptionHiringSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription, Hiring Solutions",
        "label": "Subscription, Hiring Solutions [Member]",
        "terseLabel": "Subscription, Hiring Solutions"
       }
      }
     },
     "localname": "SubscriptionHiringSolutionsMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_SubscriptionMarketingSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription, Marketing Solutions",
        "label": "Subscription, Marketing Solutions [Member]",
        "terseLabel": "Subscription, Marketing Solutions"
       }
      }
     },
     "localname": "SubscriptionMarketingSolutionsMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_SubscriptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription",
        "label": "Subscription [Member]",
        "terseLabel": "Subscription"
       }
      }
     },
     "localname": "SubscriptionMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_THMEDLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "THMED, LLC",
        "label": "THMED, LLC [Member]",
        "terseLabel": "THMED, LLC"
       }
      }
     },
     "localname": "THMEDLLCMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities",
        "label": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities",
        "negatedTerseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities",
        "label": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities",
        "negatedTerseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_TemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity",
        "label": "Temporary Equity [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTextBlock",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_USNewsWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. News Warrant",
        "label": "U.S. News Warrant [Member]",
        "terseLabel": "U.S. News Warrant"
       }
      }
     },
     "localname": "USNewsWarrantMember",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_WarrantsAndRightsOutstandingVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants and Rights Outstanding, Vesting Period",
        "label": "Warrants and Rights Outstanding, Vesting Period",
        "terseLabel": "Warrants and rights outstanding, vesting period"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingVestingPeriod",
     "nsuri": "http://www.doximity.com/20230331",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r313",
      "r651",
      "r733",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r407",
      "r595",
      "r614",
      "r633",
      "r634",
      "r648",
      "r661",
      "r668",
      "r731",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r407",
      "r595",
      "r614",
      "r633",
      "r634",
      "r648",
      "r661",
      "r668",
      "r731",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r313",
      "r651",
      "r733",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r310",
      "r597",
      "r649",
      "r667",
      "r726",
      "r727",
      "r733",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r310",
      "r597",
      "r649",
      "r667",
      "r726",
      "r727",
      "r733",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r400",
      "r407",
      "r438",
      "r439",
      "r440",
      "r571",
      "r595",
      "r614",
      "r633",
      "r634",
      "r648",
      "r661",
      "r668",
      "r724",
      "r731",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r400",
      "r407",
      "r438",
      "r439",
      "r440",
      "r571",
      "r595",
      "r614",
      "r633",
      "r634",
      "r648",
      "r661",
      "r668",
      "r724",
      "r731",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r408",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r255",
      "r408",
      "r682",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r255",
      "r408",
      "r682",
      "r683",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r703",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r13",
      "r666"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $887 and $359 as of March\u00a031, 2023 and 2022, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Amortization of premium on marketable securities, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r16",
      "r637"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Accrued commissions"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r94",
      "r208"
     ],
     "calculation": {
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r216",
      "r610",
      "r622",
      "r626"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r23",
      "r26",
      "r161",
      "r563",
      "r617",
      "r618",
      "r685",
      "r686",
      "r687",
      "r695",
      "r696",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets acquired, useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r8",
      "r666"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r695",
      "r696",
      "r697",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Tax withholding on shares under stock-based compensation awards"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r125",
      "r126",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Expenses"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r217",
      "r317",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r48",
      "r80",
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r656",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r178",
      "r187",
      "r212",
      "r236",
      "r297",
      "r301",
      "r306",
      "r325",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r495",
      "r498",
      "r522",
      "r666",
      "r729",
      "r730",
      "r784"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r204",
      "r218",
      "r236",
      "r325",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r495",
      "r498",
      "r522",
      "r666",
      "r729",
      "r730",
      "r784"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses",
        "terseLabel": "Unrealized losses related to debt securities"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails",
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r76",
      "r321",
      "r607"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r77",
      "r608"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r488",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r139",
      "r140",
      "r488",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r148",
      "r149",
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r148",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Value of shares issued"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent earn-out consideration (up to)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "terseLabel": "Contingent earn-out consideration liability, minimum guarantee"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r147",
      "r150",
      "r494"
     ],
     "calculation": {
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent earn-out consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r147",
      "r151"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Current portion of contingent earn-out consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r147",
      "r151"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent earn-out consideration liability, non-current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r141",
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r141",
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired, excluding goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAdditions": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions made to capitalized computer software costs during the period.",
        "label": "Capitalized Computer Software, Additions",
        "terseLabel": "Capitalized internal-use software development costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r194",
      "r196"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Amortization of internal-use software development costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization of deferred contract costs"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostAxis": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Axis]",
        "terseLabel": "Capitalized Contract Cost [Axis]"
       }
      }
     },
     "localname": "CapitalizedContractCostAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostDomain": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Domain]",
        "terseLabel": "Capitalized Contract Cost [Domain]"
       }
      }
     },
     "localname": "CapitalizedContractCostDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedContractCostImpairmentLoss": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Impairment Loss",
        "terseLabel": "Deferred contract costs, impairment losses"
       }
      }
     },
     "localname": "CapitalizedContractCostImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNetCurrent": {
     "auth_ref": [
      "r344"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.",
        "label": "Capitalized Contract Cost, Net, Current",
        "terseLabel": "Deferred contract costs, current"
       }
      }
     },
     "localname": "CapitalizedContractCostNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r50",
      "r206",
      "r636"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1": {
       "order": 1.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cost or Amortized Cost, money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Fair Value, money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r684"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "totalLabel": "Fair Value, cash equivalents and marketable securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r44",
      "r50",
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r44",
      "r176"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r236",
      "r259",
      "r264",
      "r272",
      "r276",
      "r283",
      "r284",
      "r325",
      "r364",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r522",
      "r635",
      "r681",
      "r692",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r107",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class Of Warrant Or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price called by warrants (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Common stock warrants (in shares)",
        "verboseLabel": "Common stock warrants (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrant outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r736",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds that is excluded from cash and cash equivalents.",
        "label": "Commercial Paper, Not Included with Cash and Cash Equivalents [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperNotIncludedWithCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r19",
      "r181",
      "r191"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r99",
      "r357",
      "r358",
      "r629",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "totalLabel": "Total (in shares)",
        "verboseLabel": "Number of shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r695",
      "r696",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r666"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March\u00a031, 2023 and 2022, respectively; 193,941 and 192,398 shares issued and outstanding as of March\u00a031, 2023 and 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Benefit Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EmployeeBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r27",
      "r221",
      "r223",
      "r228",
      "r604",
      "r611"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r64",
      "r65",
      "r173",
      "r174",
      "r313",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r64",
      "r65",
      "r173",
      "r174",
      "r313",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r64",
      "r65",
      "r173",
      "r174",
      "r313",
      "r628",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r185",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r64",
      "r65",
      "r173",
      "r174",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r66",
      "r173",
      "r175",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r64",
      "r65",
      "r173",
      "r174",
      "r313",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r159",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Changes in Deferred Revenue Balance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r384",
      "r385",
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r384",
      "r385",
      "r396"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue, current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r384",
      "r385",
      "r396"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, non-current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedTerseLabel": "Revenue recognized from the beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r52",
      "r53",
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r52",
      "r53",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Conversion of stock, shares converted (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r52",
      "r53",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Conversion of stock, shares issued (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r656",
      "r658",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate notes and bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r32",
      "r236",
      "r325",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r522",
      "r729"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r770"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal, State and Local, Tax Expense (Benefit)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r694",
      "r770",
      "r772"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current provision:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r694",
      "r770",
      "r772"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r63",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r320",
      "r338",
      "r339",
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes accrued interest, after allowance for credit loss, on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r710"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1": {
       "order": 2.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss",
        "totalLabel": "Cost or Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "auth_ref": [
      "r710"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "terseLabel": "Cash equivalents and marketable securities",
        "totalLabel": "Fair Value",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent": {
     "auth_ref": [
      "r710"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r694",
      "r771",
      "r772"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r765"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r48",
      "r136",
      "r473",
      "r481",
      "r482",
      "r694"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred provision (benefit):"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r3",
      "r4",
      "r179",
      "r186",
      "r467"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r711"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Capitalized deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r694",
      "r771",
      "r772"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Research &amp; development credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r768"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r768"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Net operating loss carryforwards, federal"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Net operating loss carryforwards, state"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r132",
      "r134",
      "r769"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Tax credit carryforwards, research"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross": {
     "auth_ref": [
      "r769"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss",
        "terseLabel": "Unrealized loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r469"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails",
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r134",
      "r769"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employer discretionary contribution amount"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r48",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r48",
      "r295"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r395",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r113",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Common Stock Reserved for Issuance"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r91",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sale of business consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to Class A and Class B common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r229",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r256",
      "r259",
      "r272",
      "r275",
      "r276",
      "r280",
      "r510",
      "r511",
      "r605",
      "r612",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r229",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r259",
      "r272",
      "r275",
      "r276",
      "r280",
      "r510",
      "r511",
      "r605",
      "r612",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r59",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerator"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r764",
      "r766"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll, bonus, and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized stock-based compensation for internal-use software development costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unamortized compensation expense, weighted average period of recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r763"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized compensation expense excluding option"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r763"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized compensation expense, option"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r103",
      "r199",
      "r225",
      "r226",
      "r227",
      "r239",
      "r240",
      "r241",
      "r244",
      "r252",
      "r254",
      "r282",
      "r329",
      "r383",
      "r445",
      "r446",
      "r447",
      "r477",
      "r478",
      "r509",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r563",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r513",
      "r514",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r373",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r514",
      "r568",
      "r569",
      "r570",
      "r646",
      "r647",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r513",
      "r514",
      "r516",
      "r517",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r373",
      "r401",
      "r406",
      "r514",
      "r568",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r373",
      "r401",
      "r406",
      "r514",
      "r569",
      "r646",
      "r647",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r373",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r514",
      "r570",
      "r646",
      "r647",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r168",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Additions in the period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending fair value",
        "periodStartLabel": "Beginning fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r373",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r568",
      "r569",
      "r570",
      "r646",
      "r647",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r519",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsContingentEarnOutConsiderationLiabilityDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r322",
      "r323",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r341",
      "r342",
      "r343",
      "r375",
      "r380",
      "r500",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r644",
      "r706",
      "r707",
      "r708",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangibles, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r210",
      "r353"
     ],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Less: accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r351",
      "r352",
      "r353",
      "r354",
      "r598",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r85",
      "r602"
     ],
     "calculation": {
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Intangible assets, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r85",
      "r598"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/IntangibleAssetsFutureAmortizationExpenseDetails",
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Year"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r34",
      "r73",
      "r679"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.doximity.com/role/OtherIncomenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Loss on sale of marketable securities",
        "terseLabel": "Realized loss on sale of marketable securities"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.doximity.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r497",
      "r691"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.doximity.com/role/OtherIncomenetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on sale of business",
        "terseLabel": "Realized gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.doximity.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r209",
      "r346",
      "r603",
      "r645",
      "r666",
      "r713",
      "r720"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails",
      "http://www.doximity.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r348",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r79",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill Intangible Assets and Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r48",
      "r347",
      "r349",
      "r350",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r409",
      "r411",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [
      "r409",
      "r411",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r31",
      "r236",
      "r297",
      "r300",
      "r305",
      "r308",
      "r325",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r522",
      "r643",
      "r729"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r28",
      "r177",
      "r182",
      "r193",
      "r297",
      "r300",
      "r305",
      "r308",
      "r606",
      "r643"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r237",
      "r459",
      "r465",
      "r472",
      "r479",
      "r483",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r238",
      "r253",
      "r254",
      "r296",
      "r457",
      "r480",
      "r484",
      "r613"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for (benefit from) income taxes",
        "totalLabel": "Provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r224",
      "r453",
      "r454",
      "r465",
      "r466",
      "r471",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r766"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income taxes at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r766"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Section 162(m) limitation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r766"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r766"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r766"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "Research and development credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r45",
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r596",
      "r690"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisition:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r690",
      "r780"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r276"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Dilutive effect of assumed exercise of common stock warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r260",
      "r261",
      "r263",
      "r276",
      "r412"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based payment (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/OtherIncomenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "auth_ref": [
      "r88",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "terseLabel": "Internal-Use Software Development Costs"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Contractual Maturities of Available-For-Sale Debt Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment.",
        "label": "Investments in Debt and Equity Instruments, Cash and Cash Equivalents, Unrealized and Realized Gains (Losses) [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r555",
      "r665"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Contingencies"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r15",
      "r236",
      "r325",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r496",
      "r498",
      "r499",
      "r522",
      "r642",
      "r729",
      "r784",
      "r785"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r180",
      "r189",
      "r666",
      "r693",
      "r709",
      "r777"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r205",
      "r236",
      "r325",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r496",
      "r498",
      "r499",
      "r522",
      "r666",
      "r729",
      "r784",
      "r785"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total contingent earn-out consideration liability"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r725"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Loss contingency"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Measurement Input, Expected Dividend Rate"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Measurement Input, Expected Term"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Measurement Input, Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Measurement Input, Share Price"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r44",
      "r46",
      "r49"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r29",
      "r49",
      "r183",
      "r192",
      "r203",
      "r219",
      "r222",
      "r227",
      "r236",
      "r243",
      "r247",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r269",
      "r297",
      "r300",
      "r305",
      "r308",
      "r325",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r511",
      "r522",
      "r643",
      "r729"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r256",
      "r257",
      "r271",
      "r276",
      "r297",
      "r300",
      "r305",
      "r308",
      "r643"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income attributable to Class A and Class B common stockholders, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r258",
      "r265",
      "r266",
      "r267",
      "r268",
      "r271",
      "r276"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net income attributable to Class A and Class B common stockholders, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r57",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r249",
      "r255",
      "r280",
      "r318",
      "r319",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r445",
      "r446",
      "r447",
      "r475",
      "r476",
      "r477",
      "r478",
      "r490",
      "r491",
      "r492",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r599",
      "r600",
      "r601",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash financing and investing activities"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r297",
      "r300",
      "r305",
      "r308",
      "r643"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r549",
      "r665"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r545"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r545"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r545"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r546",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in measurement of lease liabilities\u2014Operating cash flows"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r691"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r554",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r553",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Hosting arrangement remaining commitment"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r157",
      "r158",
      "r160"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Change in unrealized gain (loss) on available-for-sale-securities, net of tax benefit (provision) of $(425), $5,199, and $0, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent": {
     "auth_ref": [
      "r157",
      "r158",
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities, Tax, Portion Attributable to Parent",
        "negatedTerseLabel": "Change in unrealized gain (loss) on available-for-sale-securities, tax benefit (provision)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r157",
      "r158",
      "r160",
      "r220",
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other intangibles"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities, non-current"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.doximity.com/role/OtherIncomenetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "negatedTerseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock": {
     "auth_ref": [
      "r230",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Other Nonoperating Income and Expense [Text Block]",
        "terseLabel": "Other Income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeAndExpenseTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/OtherIncomenet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.doximity.com/role/OtherIncomenetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "totalLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r52",
      "r53",
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Given",
        "terseLabel": "Fair value of contingent earn-out consideration included in purchase consideration"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r688",
      "r689"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payments of deferred offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r38",
      "r72",
      "r232"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r39",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisition, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Develop Software",
        "negatedTerseLabel": "Internal-use software development costs"
       }
      }
     },
     "localname": "PaymentsToDevelopSoftware",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r6",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r6",
      "r666"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 100,000 shares authorized as of March\u00a031, 2023 and 2022, respectively; zero shares issued and outstanding as of March\u00a031, 2023 and 2022, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r684"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r41",
      "r124"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options and common stock warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r72",
      "r232",
      "r233"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r36",
      "r72",
      "r232"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuance of common stock in connection with the employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r98",
      "r630",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r93",
      "r207"
     ],
     "calculation": {
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r95",
      "r190",
      "r609",
      "r666"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r95",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTables",
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "auth_ref": [
      "r102",
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "terseLabel": "Reclassifications of temporary to permanent equity"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable convertible preferred stock"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r128",
      "r195",
      "r792"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r105",
      "r188",
      "r621",
      "r626",
      "r666"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r199",
      "r239",
      "r240",
      "r241",
      "r244",
      "r252",
      "r254",
      "r329",
      "r445",
      "r446",
      "r447",
      "r477",
      "r478",
      "r509",
      "r617",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r293",
      "r294",
      "r299",
      "r303",
      "r304",
      "r310",
      "r311",
      "r313",
      "r394",
      "r395",
      "r597"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r313",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r552",
      "r665"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Aggregate net proceeds from initial public offering"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued and sold in initial public offering"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Initial public offering price (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r139",
      "r140",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r58",
      "r61",
      "r259",
      "r264",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r81",
      "r84",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsTables",
      "http://www.doximity.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r645",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]",
        "terseLabel": "Performance-Based Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Schedule of Other Income, Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/OtherIncomenetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Purchase Consideration Allocation"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r409",
      "r411",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r114",
      "r118",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Stock Options Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r664",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsTables",
      "http://www.doximity.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r66",
      "r173",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r297",
      "r298",
      "r302",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceOtherMember": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.",
        "label": "Service, Other [Member]",
        "terseLabel": "Service, Other"
       }
      }
     },
     "localname": "ServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation, net of amounts capitalized"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of vested equity instruments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r115",
      "r116"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "verboseLabel": "Units outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Vested and exercisable, at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, vested and exercisable at period end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Options forfeited and expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited or expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r417",
      "r418"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Options outstanding (in shares)",
        "verboseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares (in thousands)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and expected to vest at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest, at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, vested and expected to vest at period end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options granted, exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r416",
      "r435",
      "r436",
      "r437",
      "r438",
      "r441",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration period from the date of grant"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and exercisable at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Average remaining contractual term, vested and exercisable at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Options unvested (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "terseLabel": "Options forfeited (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Average remaining contractual term, outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Average remaining contractual term, vested and expected to vest at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Options vested (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r108",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Internal-use software development costs"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SovereignDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by foreign government (not within the country of domicile of the entity).",
        "label": "Sovereign Debt Securities [Member]",
        "terseLabel": "Sovereign bonds"
       }
      }
     },
     "localname": "SovereignDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r236",
      "r259",
      "r264",
      "r272",
      "r276",
      "r283",
      "r284",
      "r325",
      "r364",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r522",
      "r635",
      "r681",
      "r692",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r22",
      "r103",
      "r199",
      "r225",
      "r226",
      "r227",
      "r239",
      "r240",
      "r241",
      "r244",
      "r252",
      "r254",
      "r282",
      "r329",
      "r383",
      "r445",
      "r446",
      "r447",
      "r477",
      "r478",
      "r509",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r563",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r282",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r6",
      "r7",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock in connection with an acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r21",
      "r103",
      "r104",
      "r105",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Conversion of stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock in connection with the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Issuance of common stock in exchange for services (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock upon initial public offering, net of offering costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Vesting of restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r22",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock in connection with an acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r22",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock in connection with the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "terseLabel": "Issuance of common stock in exchange for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock upon initial public offering, net of offering costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Stock repurchase program, period in force"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase and retirement of common stock (in shares)",
        "terseLabel": "Repurchase and retirement of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r6",
      "r7",
      "r103",
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase and retirement of common stock",
        "terseLabel": "Repurchase and retirement of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r71",
      "r666",
      "r693",
      "r709",
      "r777"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Forward split ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r537",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r537",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r537",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r0",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Sales and other tax liabilities"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r2",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r364",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Redeemable convertible preferred stock issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Redeemable convertible preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r322",
      "r323",
      "r375",
      "r380",
      "r500",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r706",
      "r707",
      "r708",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. government and agency securities"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables, Current",
        "terseLabel": "Unbilled revenue"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r270",
      "r273",
      "r274"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "negatedTerseLabel": "Undistributed earnings attributable to participating securities, basic"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r270",
      "r273",
      "r274",
      "r680"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted",
        "negatedTerseLabel": "Undistributed earnings attributable to participating securities, diluted"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r452",
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails",
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions related to a lapse of statute"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r285",
      "r286",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r550",
      "r665"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Common stock warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrants and rights outstanding"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrant, measurement input"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants and rights outstanding, term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r258",
      "r276"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r256",
      "r276"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2793-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2814-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL121698322-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267856-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r669": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r671": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r672": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r673": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r674": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r675": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r676": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r677": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r678": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2740-109256",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131251-203054",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>110
<FILENAME>0001516513-23-000036-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001516513-23-000036-xbrl.zip
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MTZH+F[=68JO>/)% XX6WWK$(D;1)AB"UR#DS;A)="7,PQ3/3@IID2G- SF)
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M3-&_[949P8M8[B4.!KN'T-T]I$^EOOG=*CN_??G(4=/)Y#YG35!*C."5E8<
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MY'']G6/Y-M#T3*PV:_F(6383*U0/;1'JSM5X&P^J.BW=89.NS*4JCSAFX^B
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MSSIWH@M)X''TB#B-O Z)79%#G;"B<N4J[D#+9I?D:,(KT,E>(P[-Z81UON3
ME'D"G@"!+0+N#L8_)$?L1B$EB:P:9KW0">@++-O2\4Z[=Y(F*F)?S,RHL@E6
M.@'6!+%9Q49R?\I@:ZB@1%>1D;L9,ZP"H%7%CH]770PP#?&VQR+8*4W2Q9HS
MC6QO>"]7<?Y@])Q?T&_SC*DH2;'"IX-4\XE\G3>.+7NR_SG[+S+=DN?##M-@
M"LA6+5UQ7^RG2![&C@F5B1X7;-^"5SY8\6JO*M(GO"R0H"IY3NN!O#I^'A]_
MY)#G;"W+LIN'9+9['1D5]V2>D7XE;TNUL\\#L('ID] FN<&TU .PD:VPK:Y=
MO>R"U2IE<31'K\9D/E*M$M#H&<=:WL.*#@]'Y#AKI42$%K]0RY;M.5YI]PO*
M**$LVY:C"8 ^D+$@+G',[68V"Y_8KA:]@!_Y,CY[Q47J3=/@9O$GY-6L5+^8
M0,0V*E,BTU\5/XS>8L5360_LI-N<DQ#DQKE+2=O0O5+52-Z!1!5;MQTXJLPX
M3$<*>0U2-M4(.X E?,#^(,L7*JK84!YX*WJZ"]Q#TI:0BWS#6T&Y7V0EV& ,
MEI(6Z; ?9)@4KM&Q9_BX5F3)L9^_=F'O&1YSY^,7LZ0KA"X*>Q7S*^5>U[3I
M]/_S1"-015N9]EO;Q2157M[OS]$I,^G%@^>?=[*%5V3Y$&3(V"I"=,?_^LH9
MTT"KS!+Y2I)QM!WF>2E1FVH+4RKE-&"4-V6/SUVA6+G8T<"+"A$:J;SK)?Y^
M7-.>E!M:H5XP9.A]:6#%JJKI\TVH,VA=NI&4>UK0FO%Q32OCO*R(2ZK$8DPS
M%25?39^)8PA\US8%K[<K6+GQCN"DIIAPMIV\D!X.X.HVXM0JG=$P&05Z13<7
M26=!IG4^@PAV&S8X()3E+BJH$+#&MN!<[&W$\32B^K1 [WCGX\U,U[^)Y^E>
M[# <DCX^&8=QEK5CO   'G) ">CP!L$Y3[Y!=%,TEFY;DC1_^YP/OB9'E -_
ME>D5(Y!".<Z:-.66J;@0@;TNBRKU'%R;:@[G/-UN=7<(,L"^UMN*@=L*QP@I
MT$PMU"M,CYU]-&KXQ.(N^9=6^P?A@P.A*[660&3BSK;5MI."@S!_O> M6!T9
M*L 8#U8TK#J*G8U?7? >LJ E,SP[H[U,]V/-)6:@G?7@U5]VM;"L=UMZY0T[
MEH+?,C(RQ!CNR0D ]),LGLMF?AKXA ^1C<AAF7&\=NGP:YH,CI _^CIS3,T(
M62DM*.N%H]$?*1=GB/#QT1^7@8T;VX=G>D)C[*_HXZG X03&<G1@Q2<41[[C
M5PBLY(L///KC@YZ>Q)IEJO/[-,;7>)W?&SE.SX]7?_BGOY(=*,>/!-:5[9.6
MD2U\G KT=Y;NYW'5%% TI[<7+*; !C=Y*VP?I3X*""1SONB*;D/'39NZ\T0G
MH>>E:""H21P=7,%Q:>N4O9L0<T6]2E[D5I$BW@U\I(636H1%VW=_ L(!L$5O
M/HD'0WM)NVPH*"+_5Q18Z'LN>4.6"7UT*745L(*:M0L)5?@)X-$UCPLI'(^O
M]O=J:VX2D=:*Z/8E-/ [4N">N:9BZ6HZV<6VBY+[:4>;,VTU)2W/=8WZ+9G:
M3XTME5IZ )F/03U];R*# O,BQ^.6@?&@SKW8<-$0 BB+=85P.^@&UAQI44$:
M78<_V\/<AHQ$1M)C6;;KJC1@S5_4YSR<[30$N5F[O]XAF[391]!FSS3I<V49
M[@C;<%P5]SJ*_0.VWZ!(RJ7-3D H_4!!Y>/)'!\#H )QU0H"Z^$4%I+<"[5R
M]DB*]FOLR6[%H %N=M!/BOEHFFV%175&VXV=/:B(ZFQ)6Z*ZEK]IJZ\KCKWY
M.;5"))<TZ<8%E<BO)#IPULNE--BB6B(N[;1",H4L)](Q/HF%+:R]W>SJR[*Z
M+ERV<LK^ _A'4G&Z&6^>NUNEMJ;]]]'WWUO6_R'1<8RI>16Y] ;C\.D&/1C[
MZ#1RZV\$: %?4J8H;HR BM$1'!D 7.I05 L-8/;P)VF,STQWWMI1_)3&0!;K
MNBJ9@DSK6<6,T9*JQIL%C>"Q$I@XI0R^GP_@.@__'6,OI=PQ K5%4V0S@^UI
M<Q*2YO*V!@4,<<_]T2H5 M=JT1A[8U+K*"K] +BG1F1JTS&8+%90;$,D=-8C
MW]!J  &S.NWQHYZQ0]3=L3(8^Q%&LMI<77'BPB=TW88W?PQ'8@+E?1QACYI3
M#C8U]GTFO7:M]A2YE13VYO&S)P,O_;@R]O2+!X].2<:><'+B1; @.,(;<I0G
MX:A"<9+]==VPCT'W-= /J7YR*TF_.509QI;)C'-EW3;YJ9HG"&^V+(ALW*4(
MR35<*#IFU*#R>[%6O$FN.3O7&,@](Y%<M!$(P2?*AKB8" +D7X4=IP&B+4,+
M#B2\,%:EH$70/!B*N/O;M$!J[U6Z-5"%WX@X5^+$&6.9=F<,Y4Q018MC(CJ'
MD-TJ&ZV:%F8(+1VP$]>XX%:N6M7I=GU+6V_:@;]F!UIIA,&TQ3$XY@X,<CMW
MM,1EV!3>#5)ECBV*FG&&^UIBB\$^IM1)6DF4-E[4!'U-@DI"#<CK*OE!7GFQ
M2_XN.34@"5*UD7"X!('';<L&#R!-P!+.2>)>5J_VM[-'S\0RE8(>ABV".[RT
M6)*@5G6;<X'%6E8"A5'T\4K *<-*%D5OA% '8R&0HL;FUO2@'7Z^,Y?<AF9<
MXEQ:-V(A%6\)ZM"CJA!56:O*:AFT)A[Z9$LVHQ-6N&VZD^I=/EH]8C&)ZA?V
M)X@1)%)%+P^C6>82?+H*!0=*,$GO.+)6YV,?,E;4:4A0<D8TU^M\2S,!.!R_
M6*_%HQBT0=ZD9F5?Y,Z3U[<H-Y(,<%S#POVZ%61NF;&Q%YB[)2.0TGI$_#.W
MHL'<(S?XEEF&OVN6\GYD:3EH)"\4R2V#G:(8.=!0-8?'D>A/F@5)@."97.IS
MW'1$.]4$7'<A_"3M&$Z!-['WS%*)43.?A4?Z(*Y#][]X&:=Q-Z#T*+G"L988
M.3 >W\\XH,6@MK'@OHW=OZ@?>!_S=0A6(&;+3) 5L*#6J))A8+[P[?5P8Q);
M@P,J>JB']V;#JK32L0@QT- ]&%X>4Y?*70+P\0P5,AJ:TB\1G!>MV[M;CI#X
MGQLEI%(D0KHS)Q\5!0[64PLRB#GX?;CNY2_W:%N?@.=[*\TR[@L;@(F3)\4I
MQ)C]_N@ B!6(>1\C%Y)(F1#TP@MQS)=R>&?H!E J%(1Y=$N%4DG-H8F!(O@B
M[Z@ 61K,D:Z1/:%/M<F+4FY!;?G[1X[ #.5714B<S>*PT:RW ;<<5(:^PA<%
MD+CL'5TSUIM&S6BCVDS &*'/YS[^A];(%[P:W4NZ6J%S#%-5]T+J/JUU>"Z%
MS@O?>;5B;I6=XC_1%QQYY$!XB/A=N[DH#TEMFFH?E@"P.\<3S#$]IHE1A5+L
M)B5RHDJ$L4]'5B'Q-A7JQMHM^)CKI8L;[5MD:6;A9N3:"!+3.I]W6@N @NRT
MV:$86$"M3B%>\ABR$.AD$R@OEX>[YA+53I7')<+3X8JH?_+L[-5?S)$(R]UR
M%G8>5X?NW-G"1TU08M4T;B/ES"&+!%6 =[Q.&P6$^YB$USN\_:<M<UI;!H"I
MO.RP9K9[OC68!EN=SUY].V,H8MZ>4*"Z#Y9 Z<FE6//^"&2]'G, X"B=)46U
M$GY.$ANFTZ3WT]<S1WRCGL&.'/$).7F;)7HR(2=/8"S'1TY.JOKW4-5OG(^_
M*FK$0&''M71\U",N 1AF8WC<9%?,:PV8]@&(AFX33E^NG,B;M40Y?91PZZR8
M,.998;< 8<:?JKFP"#"HC6'V!</JUE7MRZ+ZX,(8$#>9)B<F[\_,4$;RH6-)
M.9&,R4(R;5Q%JX!2$G1A,]]RXV>?2<RMFL."<D,N%=LTXGGJJ_K>IDK4G@KF
MS"8$D>^=$/NBUC9M+LF/=TV/HD'D7C8/BEAQR7GR#U^\"9Y<<N.A1:QCE-4C
MNL(H>6O^9[]D6.N20^$RIU32!?('S'%$NQ1>"B=A/.3W'NVN6\;1[\Q^>[T]
M>P5<\JE SIIN3L=*(L,*ACVC/(,NQP:T$\@(;OUOX>,B5'7&3H,%DJ[KO*4_
MD"GTI$IRW_!/1,)0U<5.[Q:M@2VR1.<-O06&+EBNW E=>(16/_,EUW"ZMV"@
MENX).T^DP5QM'IJP\\7II@Y B/"+'%"B/SQ*3O:;5MBQI]XZY7%:*1(G.EOO
MT;Z['Z?:VRTI:39(5!R/N^&>&=^S;IF9!L_B!ASM;NL:(662#<2LT4+4@IZ2
MJ)D=OI58<OLA)BW6]B$FK8WTF:F]Z4%L.:+$H$]1ZS$L8>>,5$@IW9J(2ACQ
M=IZT)-^+WDE >;3D _B!+@>#4>D\PL,"TE&+ECS0A0I+32 #//#BVO_-7CTF
MP]B; &L,*67[T!\E&$XEDN')()A?B8/^2)^U- XN2[%^L![Y_NO5QLF6S;V)
M*F?OPNM]T$$Y9 SII59$'@Y5#4=L:]_)=G@)B>%V#F_H8+*>HY#5BP7C>>RC
MBT7+YN=W+]]<7,RDTCV77,V0PL5JQ9 )6A;5=8PH[>F'B$93.""P77(!T*#.
M0[_+4K $V=T:SR'#G8U;3B_9)I8>+BB[X#0S^A>+.R$C\C2$*%.RV#KGG;=;
MZ2<@.:())GUJ9^AS7<$?50J^2EZDOX@-])8F-NWU1SQ*3&2<M2+E$J !@+IQ
M9::'QL+!W^)-=1;VU#+]Q?4Y'0/3!#:A%]/8>.:$,%<4<(1<3M 9 U9FG*^>
M)<K'D&4@;TH7ZZCCB^>%42@?T%A,>Q&P:AA5!H[33J]S:(M1*EL&:%,5)0?*
M87H:SF"I;.0AR N?-0PNM)LHA5-#YV6ZD=,T/B0#D^Y0N=2(@V;)I7-;3G%-
M5N^)[=BW3(9,$MHTZ8J7Z)C;L[<[-S8FP!874BN+SX6]J8D]LICUV=,[ [U0
MB]5ILHK\;!'W\8LHH*742$ 2&W!I@12&/V2[+102>JP"_F%V:E03=3L6O$G*
M/\FYA'*$XP'0$:,\=HIVTXN11F44?>+[WGDF\Q931"\='^)?V5<O $D$/9.G
M(<))9!101K\SX 9DLLBPH_16Y ;PG6@H>89+&^].,8[0E6N8P%F/V%0.++W#
MMXB5TK'6C QI2V[?.@5YZ&Z,"=6#M<^39W0::OV+D60R%)N\[S,&AT4=I824
M-R U06@HCY1Y"M$IIGY"?0QN3V-]^9S[H17ISLYEFQB/RZA@/%NAOA 6FIT?
M:#G93"@E3$Q/ *LB%H"E2*=XI@WP&%E/-Q7; =!1^"*EE84:ZY9\:WI/W-D2
MY8[YXE(Z6W&[S:$UM '5Z@BCT?%8V$)1$ 3@NR""SRPT\1N]S9-$5/\(QQ'-
M-&]#, YS\&;ZY4%<YC!SL"04)7@5%^VJH;BA*4&E$P,LT2B5JT&85S$& DO[
M-P%$!_9,HQAGT&>?6MVV9*#/K+A)*D9&OB,JH\6T'>'DL)I?N?9_-4H5(K!)
M,GF90]0(3Y2+,U*9NF'%.YXI%?S<2<$_L\;CZ3Y;>C/<ZF2C-"/DX/=T^U@J
M(-VG+1\V5KE5-%.<ROIJI 4*BA$YQK@?KVT5QSL2H-7B)(MYFHCV(JZ?/F#Z
MYJ99\<>P+W]B13"OZ3YG\]T9_R&;?Y3HW?U"YGT[O-S.85Y.NDO\;],D;Z//
M^ T&=V88-2M">1O?S2-D=V-\MN<3@8_!/ MTS)8+_:MT7:U_2KB^0B%IN;+/
MF#"9M>-O\A9.=QN][BOG*/@IQ H[\$ P[:TF"Y=)2@++[7=!6<WXVFB:(UJ*
M0+\XLX+DF-(I8DGRS0U>R1^^01EWH&'>7V:^ICM<^LZFO;U>^G2)\#4)Z+SB
M"D)>/NELE"XN-<.WD:+(L(WC,C\?[/=<NN@X2KH&O! L^0J'CT55ST!_0WTI
M,U#!D8OBAW])ON<";._23_ZE1P[DK<HAD$K<@$RBK\U7DZ-Z3)X)OUA?'34F
MNB];?.9H4QG'N"T>)LN0T&6#+(:C>ZO2.AKK3L6:1T2GOFZ(0Z]VJ,E>"UNT
ME^,SS!FIA75U[8W)K.Y6#8KKE!)__^R2W+VS$E9 <WI%N!DJ1*R_M"!FTB%]
M"]+];+7VJXOE##Z4'9W R+>0M\\F,/()C&4"(]^'$Z1WQA_S$/GJT"FBG3+,
MD]*QYE%D3)@WS?(C_R+EVFNK.K1Z1MHZ*>Y:.PZDE2WKT%DRKZI+:2V O!L@
M7<)K#D5>9X(4LX9\#6,[)T3QD0EYW:>*Q?\Z61W _6*B2C%^>@CYF&##O/DU
M(NCM&?H@<RPJ&!ZHW<_K'HI+>W3$&-XAS^]O1?V<I(OXHYB#>=EQEQ3?SD>Q
M5<)0HLM#\X)0&LTR.V >6@7@]IR\+\6),8V3L2L)0H4$D,&:^WU,^@WC!D2&
M9=]]TH$(#^]VZQ 8S'Y*N6ZTK2)<*T=8&H:\"'L@.?IXOA+$])M1LYLIA#(M
M@#0I"&@JIG>CA]15RFR%29%VI91Y1E/2C_%$I Y^;K9Y4;6_1=>=KNC (P89
MC[9_9A32?N1,PKZA;':F@'JUZZ_<$-S+*Z&<E0?0>Z(F&D[M<!3:ES.&:(?A
M15I@C>=22X"FYNF\\'TV2(1:5C;]IF'*=.-#$ V:3UC_IT'=Y(#1['#D,+Q_
M].Y&6NN43.E#\8?LQDEFB!135%"Q#_R4S>RV]"7;G7S7:&I]HHMYE;A?*5@<
M?%8O  "4#PAT3=X>B/&L"$:F6G#=&($W#9%!+)$Z\>YG#?9/=]9VI=$YR,6D
M 7(IE/;D!O ;S7@!P)O4Q]D2X/(,";9>/TN./?DVU^6JXB749K&Z[O0G6RO*
M(3J<"O"CN*:]E[O6-I=U,I?V;W$S.<E3#A1SV)-<3FR8(I),:7(7L5="^8;>
M?-*QAR9\615YI9W@>K'I?OJ((W<1+WLO#!<_8A TT(P/KWZW;< ?A!4.-[(X
MY-U+^@SI%>^I6$K"=)1/TOH_WZI[JG)%IE(^$N<UFQZKGG97[2?VE7)".5X"
M3N,@.W^HLH'BNWC)E[[Z_DPU#X+0_;Z%35]'UUUIV:46Q%),LR7SL"![**4U
M\PR"*>CI5BZF+!_R5]+KGO52)62]6,F.-8"=TR[RE?ZAW:LQQ6N]&^VUFHER
MK$=<GWNTCIA)+5)V?[,I9@HSEF&/]93^)V\LKAK U5. _ZB>[G]5<ZD[/3;E
MC<\R%6+>['7U$%.8K$VNUIXE+F??%(-W$?_N?+=W^(&N<<=$DSTM*,JH5WD>
M])H2"TL*P(8T166.*JO/>8W5Z#XR2O\'D26.G010OB9XLTU>@H(I96HW(<&-
MAQZ0%;YU^!S6XZJJ0#';*NO^*D>)-HM\.#RD3%5O)%DI$#71?T#W.G=Z$ODL
M$Q_FZQ3()+E/*]QQV%H_[6W^^W0D?0.CR+]BQ-(=9D\:D!>9P!][Z"[UH]N\
ME>!;\(0XG.)S?H)]Q+&&1P7E58>G* "D6)X)MH;A'D.'H/=PU 97V>]H*3S^
M%-UG#QJS$=TY=P$YTW;',S;RF , D?>!#<& 4!+>9^ JA?'U+BTXCAZZ'9N=
MZ9U5Z8^\4-2&DA48>VIHXV-^%/)'>G=_"UOVLR69=@UW]K*M+R=(*@5NVLY
MR(K]&)G%D)\S@K1BW)(8[SV[D1%+WG!L6O0V 3A2Z6"M+6PH#N("<MCK0J F
MLY@(TSN((]7!Y](7[_:;&*:E(H550#$10_/MW.K\;/@(/G!'<QL=1K,P\H=>
MQ,7/A3R>)+XN=F=+QZ#E-%S''PD4ZK;$P8>5#4*O:+->9F<JX$O^OZ^/Y[&.
MPEL#_C=Y*U-\'U5R!%W<!\0SV_EAV#M'WRV-QC%%=LVDF8UV%HK*  R2*^'
MJEZE:)&39M76T%P0>I%45&]Z=/F2_4#KFQL7$40X_C=UI3]@''\)?G34O7+-
MW0)1(A"@V$:-7M+?_SQY!7^1-(H/E!;@F=O)&)U_E/4Y!^^Z]!,+!;%*D=P(
MFCY/:PZ-TL(S+ZM EJ.*.&XCO9'$) H70$8]G'*NJ]T6%8/^]Q=) DE1)_0
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M_,SU!Q*=5O@ILZ$).DM:;T1DVU=YZGNLS9*KRB?<L?>L/8]"4&/"E:SB5GF
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M5\\'7;EF-!^+<ZF99E.A\=D8"35KXU)8=F3"!+IVOHP>\%\=>6VXOZ]/5I9
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MZ)QW(;'CJ5<-VM83&NW;V).82.E;LB 6&R\KUA=S1"#V&P&:PO**3$<2:?^
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M]!4(>>,F+8PUW\AT9KZ+MO(9>^;%F"S8$SCQ (Q 2W>S3&439:.%*J(4LBR
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M#ND/.J.'VUETL')K#9)AAW%Z8Z;@X<8'C9X:O7;A9KZP/:,64'Q$<U/4LJR
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M[\JZD?DNB$QER@&1:W &<7H#G58;Z2P"U5&WKP>/,\(B(-C+E_29IQ7P2ZZ
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M\*PZGX7OX<&#0>3>I.OJJ,M7>&O+9R8JZ]RU%!VDFHE@JJ1S+<DSTCD?UMB
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MT:?#GXJ[3<7[@]8;LR#C=9<7;*$^P^P#(<SGS#.7WL#U@_+NCB&?+98".DT
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M%A_F=1,I;*R*4QNMY4[2G3'/PWP'8: H-<D],'!5M6=#W45:<4?-?3GA!W8
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M7F/OT=&7S&,/3Z620]$6WM[SM634\!=A-_\F<M$R8^5]D4:(<SN(N !?V$J
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M,2!K\<NNSQBA940592T RS#<RU@]<UXK5ZQ1_:WR1B-]B_"$;4AJ/XY3<UX
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MCJ:<1BGC"1:R$7XPU4(8W0&'#\W)A@EX]R7HW)7'GZ+0F[*/A$HG5T2:>=C
M(G#.QJ(4B*?3$4A_1-4\&!D$)>%J^@1#!%#&U:32/(S>%GKBA-T<7+?5P/B\
MFX[(-W@YR;ZW YK;;V'6"/<U@%G> 'MGKA>6/"M]= ,K9HF"5;L+5EIB7^Y"
MM:LE+^"H?^T[X5^;JF\C"@%K7W=&V/]0[R 30(H_P]BU>DI))B/2^^:. @-F
MF=()H7$PTC)1^AQLSUWF(\:ZG@)<;I?R_C)Z@9O:EI1#9*>%ZSHVYL0\($.
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MG+8M<>0:CH'8]"OKNUU^$!KS33C*ZC%NI^4%_F-8*,-64 -"7+=-?8MXXF)
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M%KI/E0B AR-X2YA2.8S"RL>A2*UOW1BAPP^#47<$*8:E]&WE]Y):53U[E1F
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M;PKF/O4DCW#=M'B*K(CO"V&O%8QECPNLN56^;KUL3E525GF.;WZ7 -U=C]=
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M^2!)/P@'2OD<,0&NC<U%[-R3\3\C")*&#4,CI%B1=0BV*(UK?];MQ?X,,@=
MS.W"'^&6Y@HH]QF_9F*MPU:X)?YA]W#J6(;/7=GG9(Y:IE>_K=<UZ+9NCT,P
M2J7P[P^W)2)>?2I""Z@&;%_MJKX'?P2AF263[=,AGD+&49"8;%'LPCD_)O90
MU' =%BMS7:6O\PP\6Y-2^'NCE(OB'0#[WF".\&+AED5Z-8&K2])<LMAW!((5
MA Z/SBAN*?[Q;/6GBCLL!3H( P$BH^ 1A6_?3%6A4 \'O*D).&A0VBC;S8Y2
M'^*9B;6311^AZ]OJJ$U/*V*I8]/S*BDD)$D2.):'0R/^+)L$+H1):DB<,1YI
M++]P$63P6T49T0'!&.U@FB0X0'8^9R<U)]IA<.-%7#;$!VK,%ZB\(5';;*&7
MSV[ 1(BB3^O;UQCV:O>-O*=+4\\TFJ71)IKT^Q-XY0QXY=^>P"M/X)6/Y%T^
M<O *.)1N<E)DB_"C2^;DP_TAZ7V#'^+1%-MF[?Q7#'OUENH5@V20T)YL*I#J
M"OPX;6^,$3G*ZY":K#NNPY%%G071K3B9 >(;D^%F/N4H'&>AIA^(".V.'HWW
MF9RKLG1+X4"K^2P<BP5V0JEX"*N69B?":]?:'IM&KJN2BPE* ,")L]^*PSZ?
M+HETT>LUBW/I<-Q4]6%DZCKHET!VCWSQ_\O>FS"WC63IHG\%X7'-M2,@-O?%
M?ET1*B\UJBE9;LONNJX7+SI ,BG"!@$6%LFL7__.DIE(@"!%4@M!"A,QW6T1
M2.1R\NSG.YR?$9E*B!:E\*87<'6W_F1:7\.50"*%I],QLR!;EL,25/4G6D%O
MLODMO(2%\BEI9C.I8V[OP5X>;H1+.XG42FH/N\04D*\Z=J+1O.("!H"R%U5*
M.I5%+R=C9P\]5:5S(3Q-9$O>$JQ/._GNCKYSG 4I%%[7[6BWF=[R!5XU.W98
M*W/[*"PF@^/D%7,C=IQI"NW&.:4X ?U/@"(^94!E8],S&#SDB%07>6W5WS(&
MZ:HYKNO,NL)S95[HU,;6T"JPQEF JFPL<6FI/^Z2UR3O8=>%0XP[PI8\81IG
MFW;**E-*"8<]0QY)C$-[BTT(?UV*RBQN'%+N^U2H7;1511S=",99-'$95?*2
MJ3I'RQX)8F=F=J4\=0J"*S ;&BL/^IAZ';,#8#]D?QDCDFJQ$JJU3:%N&#[X
M+U#I88_$6.'9A)3#D'*S,:$5I"4$'!-6;C"L8M7]#]**.(,7%B+T%&Q,3"T:
MJ#"$.UID*\&N)<+Z.F>X+,=%9$??Z-VC.S>A2VN5<24S)+%6@/^2IW#U:8YF
M9TA7'X*C4@=U5H5$@=XJ0^]P_.Y9$%YU453_EM1U"40I0T!XU!I=U R_I(Y=
MEBF%H,C2/X J^!JNA# N@K^Q,A['Y=;?I!\VYWJ7LHS=OM1YX2A$SD7F9JH<
MZW1/<)=2'26]";H,R\2T5: RU':+N5W1D9A.BHSOA1%WI'J*-U7"S*J4$B=V
MK!>HQ@KJ,@Q_ K)I=ZPW[S]9'[%C3*/;QN<IO>6ER;RE3X8<]I*:I!93[)O.
M$7&H N8:RI< !MCJPTTK\HOG_<Y<][[R<ZJUI]$ (9U!ZEI?W#(8(T!E /O-
M_&5&C&-@;"FMJ# 0]WL,M\L >J):8HU?([N[(,!&/H7<0)(^C=8J"%*4D7T$
M4]0H"&"WC+--I$G&XEW)T6/N\IOY.\=Q(4^I^8I._B<K1 >ATGVXD9A;MO3:
MT;V3(1'>N&4$NMS><;=7XXS,Q$!*/%.S6(&:8/1Y8U<U6XEZ[AFP-6I3FG9
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M5#,VCWE$'Y(X*LCAKYP,I$I* VDBM]'W9'GO\[E%?,SI%QDR0N&\%7PQ68\
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M/6>2Z4C-(K; ?<WEA#.R/750,G2;@D-T)Z!6>A3+ITX@>+]N"M!#36)9SZ:
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M>2!K.78TL(M;(LS:2F&/R 3KG&+9$S!KH5I>,*(W%638CY$'RL?U+4:PSI!
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MZ]N6D$.<7;F\8SE6!9/V1/;.7R9SZJ+"5CK>( )-(Z1LQ#:N\P:JJY<_-".
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M]1?N2U['\P:\C:@,W%F+ZZM5A_K58!N%,[.WGIH$\W)#52&(IX1UWAIS(U*
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M-;'_A8'RCYZRFK67!31W6D##&CG8_  ^A0WM@,#D[4@EX/^Y/]EG,!?<C%N
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M!'0\%):((8V63,88L#)3P$V^,D=&7)LA=E0E0# *Z!A79PBW8#+AWB&@-)A
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M]2BO19BN&T[Y-'0=;\5$&QM-U-(3S4]+/M9&5-AY$+D8;'\5"H]R;%,P6$0
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MA@%(H0B01F"BK*)>H.>!S'N=K[U>[WP:+?/1JNC1<HY(R3E 2J;YFHX C4P
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MJ -480-,B)$$49AQBGDB&4^PANMDSG" "E\0O@;RNR6X)8,+AJR6#U/+Z5M
MS8-DR*)T 1B]!>P5D @[H'1@45!!<I>XL16M$&==IJ:LY@U@ULZG:N?L6'*#
M@Q ,:"<AH#PUNV*%@0LD("8"1U 51J]"VOD*:!>VXI.F7=:MVIEN.M!LUZP^
M:_9U*[-)+MD#N-[Z=W'G]]K;Y;YGYWUQ.#1G*I>A1@0G/-#,<T"9TZE5@X$
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M=-!$119UQJIT8?L*+G<:OC^(%)83O<T%I*IMPC^6M/9U >&%1TGQU.5BW&5
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M"AU&F-#HB\(W;%&MS"L4<V<$JL[2'H% 3\PM9@1:#@+-Y)0%HJBXBO4R(E"
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M,$#NL!"8IU$!K([%[&R?7+U70>7/$+TR4GKFNK ,T:L T3/9,*4(]M9YH'A
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MPO#QNO3[A=/R8[J=U?=!ZCN6?B_55R"FF+$$,)%(,:0+,900 LBHOMH884B
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M;CHOTOU4TCUK*L^A!"81"^+,->*1>*2548A20X( 1"<TC:5[1?3@90:/4KK
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M-.+ G: \U[!H*CP?<EX"OM9!NA^>;Q3I?GS*,4X0Y=IY;0ABF$O$ U.YR%9
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MR-;JF02+TZ* TJ-3TP)*#P-*LTS4^L"YAL5QE@$3!34=:<\EPBI9JH"G!EU
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M(YPG;G6X_5:M0A/F]NG5"V\S=E[;IL"9?-ZJP'C#('9>\BZE^W!><]B(@>.
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M#1H4V:36UA9%";#\,SG_W,.KV6YKX<*:W1/O_6T^&0U\85B#^58T&I?ICE8
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MH+%KGKU8; 61OM6?!O6G_'SU,8_6MN D7_OQV&NC1I3S6D_MYH/^@: 3U+K
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M(":+UC6^<VUM=+^$AK[!V>Z=L[ *SL",[5"GZZ88;IE47N92P0]@%JT/Q"^
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M%-=+%!(M)Q\+;O 0K63,VZBTYLH%8PV8+IIO:H(,Q-))?J74?$X*0Q21:H/
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M\HAH] %QIB-R8( 0]@EKK;01>'%1A7+4L;0:3J547KB0!-;<6V^HL)&;Q%3
MTG!7R,@JJ?E,5(&$X)VV F$)R@TNI$2&!X,49=8EJ;G":FU#-SA[="F:HN1+
MJ^0\L:"X)]1APX64&HPZ:+EE,2I%L"EF?$7T>R:FP*W A'F*(LDQ!6T8LLXX
M%(W6P3E*&3?%C+\*#3=6.,I=(CRJ"/N-HZ"1>@9L3I2[)2NEYC,Q!14L]I@:
M%#'8<BX$11G D=7:$"8I)I0MGQE_31D+']<_K%<'.:S0/8[=89VQ8 ]BUY^7
MZA5WB#-@D0SGDFI)>2#<&.ZCS9?<%?;2E'*8JP-?>$ZP 7P0+ /QB/.DX ]
M+N<-AR4&/Q/XIQ<<O!#!<(.H90J)EI./!0<;N.<RR!"Q%IP2XJ(*!(L@>7+P
M2DEA6"DUGPDV9.K F*7(U>G3*7KDK 6/A/CDE<@M%>C:!FEPJ8J2OU@E]](Q
M':5AN<.=,%9'QQFV*6030$7)1%P5_9Y-8(A)*FX4DBGAW/PH(NNP1[#;W 0.
M$&Y=26!X!1INO%)12^X)X8+"/ZF/6&HOO"2)E@2&E5+SV00&RC$QBB,<P)9S
M9S0R)'A$:) :#+S7RF6V3AJ2DR52\T4F,*Q&FY[C>?5G'Y/,\&J+:U-MI3!1
M&!XC3SX:*Z/3F(*A\UR)4EQ[=2"-S E >*.2E<0@0[E!>8^1#DH"?4F:6/!'
MF.<+"T#<4Y=6Z CEU<*##,+*Q)1/DG.OB):BKMGBJ;2!J9(EL5+P,!.X )^&
M&28B$M(3<&P(1R9@C2BU42FLJ0IL;8,(T2#LT>6["CR\.'@ ST<P'81A$7.L
M<V8-<58$@@TAXGF3J$K(XQ'(,!/R<$XF(AA%$M.0D[D-TDX:)*QF- 6=PUR+
MSJ\HR/!RD"%83;T7DIMD>5(!7&=#'<E>M'(NE4H2*P4/,Z$2SS45Q@64L!&(
M$Z>0Y<0C0FC@T;' N%O;D%HTV./O>CP3/"PH:V/YHR?338[KG(T[A53NV%II
M-,4W##8B]$[S(^M->A08+MM2_N,GK<U+,1#<D!2H\]X0,!*.&QN<%U%2G03G
MMC2)7AT#0><$GI@*E+"H$/'.(/ S(W(B2.2L-B(G/\B08^D"-RA?<#/81VK8
M3SYL*Q!;('91I9&PB4%%%[R,''OJN#8D6@E\BFM'9('858+8F> =HU@0L)8(
M*Y\S#!W+W;8)HCI(RZ/2 KL<O%,-30K$%H@M$/L$W0<CC5C$Z)V.7 3KF 1J
M0V@TF@A+2V7[54'7F0"H)2+PF$SN.N@0%_EO3F'@LX%$3)--=N']!PNZ%G0M
MZ'JM,1Q3VD;,1:3@)1KCK!4N44V"U$*ZTE5@I2!V)HC,,)A/RS@R7%N 6$E0
M[O6)"+<<)TDU\WIM0V'=P)*^"(BM0\S_K*.L\-_0_KHQF5;K]!BTR<_^&SXT
MF=2Q[1^TNY.QFYO8=W0Z&+;3^>BE=C?$+BB<KI%YH4I.\)VT? N4K7M0#0]C
ME=I95:KS:/N#*L+(0M6T?7\XVD!&&A5H,:N#T%F=&_67WO:.8=3GU:$-5;=7
M#?LPEA3A 2X.SV+L5IWX-78&52^-?L.V^]57VSF-U6$[]O/CS]<O9>-RH3.Z
MM+NGMA:@ZTL['CO/V8\GO4$[?^!-/W;@DU_C+V?M,#R$F=?P=>U;XYW 5U^Q
M#B3F='C[5[Z[ASYFZ/E).Z;QU'I=^_.P/QG-B3V(R/6C_8)L@L&^L9TS>SY8
M^^?-6<(4QP]7%'Y]>C5NG6%*3S;#T4(#?.?ZVGFO !QB/W\*QF279BS583_;
MOO]J.^($"88&9CUG1)E(DW8A64^Y98+MJ[6-W?J\!G3@;3:;__JG7=F9=(>#
M>O@W1/":1#V_EJCYN+;S]W9S>W>O46VWWJXO_7!;.[OO/E2[.]7;G=:'G3^V
MMS9WWVU5OVVW-EMOMS?_J#[LP@O-=ZW=#_.4?PHQ1T1'&FP<!<\H!LMS31UN
M-4@&-MYS3[6^!]X]O\VJG_BF/83?]W=8OK?U[ _RO?9WMM]%O=-A5K5!&V1\
MM"1_M*UK=]K#\YOK=\.(3U7!E,8J(D#X!<EW08WF*4IL:0 FRZW?WZI)+<>Y
MBQIE(W9[D\_^!M;NKVSL)K\.K+89[>"T'\-.]\_,=+/U_=4.VH./W9Z#]?B:
MD6*[>W(*HX#A>/A6/8%=&->OG9[_LJ(T]O/?A]@?_]6UG\SISE&3MCZU#G>V
MWI\W=\.7YL5[^.X7&"/,Y*))6K]_Q*U/[\];QWL4*"EKPN=:6\VSYE$3/O_^
M?-]YHXQ@&DR; $(:341&4XJ8P%8Q$P5A;JV*0&=.LHZ#L[#4PO[]5(#,FGJ=
M3N^LYFFC@__38Y@"/&10DRI_:$'V!U6[._KGE3+$B3+X&\K0F2A#]3_U=WJG
M,,(P^-\WM^+D758,%F@\O GKJDDZ+%3'G@SBF\E??IGT(VUWZ^G67_KEYB]D
M?C?%T.L?'+U]Q5/6\8BKC--!QK\\?GN]?FO*XQB]I^FZH.+6M_$Z^>_OAUL>
MW:?USD,E8IVJNPWU!YDQ/TR4>]HVM-_)OQG9WN>)?N@[&>3?1L[0'FA0]>[*
M%ZHF;M -?W9!%[N6.43V:P3M[&8(NG+A;KW(M7@UN4NR&7DU4<C[S?VE1!FI
ME,Q13J(3BAL2#=/.*$F5L8+'=.=;O9>L;$S%<CFD3^WAX0P#&]RD8(.;A.V2
M4=;/>N%'/"?'>[N;O'6TC5MY++M[N+G[D>SM;M/F129P>VSOZ-<V$#GQ>3K^
M>/SYL+EU0)M'[_'>,3S[Z/VWUNY?A\VCO8L6?0]C">WF[]L7K:W.,9"]8?.J
M<3W\QI=O^[DV1\1"(&=2[CL2*3+)<*0LB]0H82A-3YCA_AW-*@FLMZKU)HRT
MUID)*3V!Q_3"<UB,4@7A,0[L4P#G+;BY/1B<QL%K.+UY+O3<GD5/V/W@G?3(
M49]RXW>,P%/6*"BM I6,&V?7-BAI$+9,A<U> :-^6WOM&1^?EU&7DK0K@H^_
MVW;WC]Y@L-W-Y][YO#O'-N%C@P*+]X+%YBPL8LH=#UJ@%#V02N$X<A%@D:1<
MX=.'Z"1;VU!4KTZUVJ<(V3SNDZ^ Y[[KAB6*B=PW=^+U1$P6N3(OQ?XIEJRD
M6 3#,&=>FQB,5DPH*CP'%*SC*4]H]NX13RENP6/LW\=9^\<(T9$Z@G(+!L0U
MF#X7C$$$-E](AF7$IG8+]/-G=#U5Q.7[^5S?/>P:OY)')Y?^M/ ^YW]UZE0^
M1NS549K-9GNG55G_?Z?M4:)4HSH[;/O#RG=Z@Q@J^.[F2;_=J4:G('2]VKV9
MU#5.\[KZ@?:@RH@P.O.N;!X2/*X?3WK]/,@JP,\#2 WAF?F+H_&$JSGX\2-
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MDHMGO(CR*KMSEN=Z19 Z=REF*C2 /3V+L,/WN8D=I8[))"V)]ES0:"DU0=O
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M]2^-D\;NX36HN_;7LT-XUN/KQDVC56\>PER<9*-,8G28JXB$=1:@. -?D:0
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MP+W?<;96)=CUX"+]#( U.Q2.S"<R<$'.CKKG<-/07P<WQ<?3LSM9B*W. %<
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M;&5HA:H(Y?=\R[LF>:M3>?,@Q=4I4>53]L_@/SGPDK>;+ACG=L#*E;U'^/^
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MC(Y285!2YFFN=N"C+(B->%;;[?CN2:S!K->J::]MG9WU6NY\P--WULU\F2<
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M8'!8!%^F0,+<(6',TV'41DXD1R)F2&#"Y1;#&&D5J),2 ]C'?&)BIMW)IN0
M/LOY>3SS]5-]T9EU^EJT>7P\A<TT9V95=H6INY(E4CUS_-^YJ+!_L ? 9SS=
M>W_HF<.86(H290YQ@PVR2D<$+J-BPK-$F,_\O.N,38M@8AEZ)WXGTEU0M*#H
M8CO>!4_G@J?U43R5QI#(?43>\)@;T4ID$G%(@?.D+,.<F^QDXW6EQO'TR8=_
M!4H+E*XPE+YDF*( Z%P ]-,H@":FA2)1("F-SU%*A2QLD3DD8:. 31'3BJ-
MB&F1)BUX<]UY-5W;22GZW)/W1O(_V+/X(<(=?:O=JCKVE:YKVY\.82-WF(.W
MY$@$">7$(Z<41X291)6U :9\E;JNW;9*:_5KMM:[)Q'7_=1N8TZU. #,FCT;
M=%H;Q'EAY/;L_*S;NZP^E+L5ULZZ$YL=/KZM6^G=]KK;H2W58$OOMM*[;:X3
M5WJWE=YMI7?;+!S3W;M&"-@YM[9-;T*!TR,=D-<<Q'@M88K9G9O==]0>B%YL
MW65>J@3VGK/W&H(;7;%_M45A3#B/IW&UC^MT!Z[SZ_'!21TWWC6.&E=U7G^W
M>W'P=B2X<=P^KF\?'#>V/[3K)_MP#QAK\[.HOVN<Y.OMTQU6!U]R__C7+W]?
M[8ZG:$:I#.8\H( %R>VZ,3(L<>2QC<D8:TUF@Z9JW<AG\R\^2;V6(P1<\''U
M\7'J/),%'Q<7'T<35+GQE"M-$%-5W1QV2(= ,UQ:GHA+P0G 1[9N^+2*9 L^
M%GQ\\8=>B&.N@H^+AH]CV;K*F40CL4A&+Q '1P)9SB4*P@8CJ1>)YJ8#=)VP
MY<#'*14M+C*@5>GM]PXMUFN=>):/3:X/1H;G&X5K\85]YLG%U;%?4&UZJ#:A
M.S4F'I:..V1QYFI2X!IK'!U*0F,'"X^UD9DM08EIU2 L:0'22BOYO!R_HN1S
M4?)1U\Y90ATS"KD _AW7)B&;E$."JN03++)3=&U3K L\K<XC1<D73\GGY;T4
M)9^'DH_Y)\8KDX332 4:,@6!149P@T)PX)MX32*E54<!MH+\BXOLA'R(_5BE
M3-A. 'WZ)[:[IR>Q<U;SO1A:9V-%@JM-Y/24 HUY^1[PPMO!6ERO5<&JZ6'5
MA+[*TB=*@I*(&!H'29R& G0E0;S6*F#,8C9(L)*%HVTE57M>'D=1[1FK]JBO
MH9AD6CJ+DLD<;I)A9"+!6<FUT(RQ%$&U]3J;8(84U5X%U9Z7GU%4>[:J/>9A
M!$N23)(BZPQX&$ECY#A3B =//=5&82<SB[+F"\*L^BI..+K^"W*V'_,CGN3C
MPDHY7M=YQIR=B@>JOA]3P_7QR/;BKWFYWMY9K9VO/O;[\(7KD]X36)974>TX
M+SB;T(]91A>(PQ9I:62.BGJDM5.(Q:"]=I8Y3 '...#9^(%N:42S"E@P.P:(
M@@4+C043DM\LTY;F)JS@M<04P<C!!NP;@15WW$GKUC8565<:%RQ822R8@MM2
ML& )L6#,S;$\!"J#0-0'A[A+ 3D?$A(@'S@E%BVK3DN5>4YPLIRA/$61WQ[9
MSN><R57[Q[;/![7O-A?&VXXO+:U>^OQDL#J[G6MR6?C 5K\?S_I_7B_6UO5:
M%7AZ$CSMC[LMALH4I'<H:)G[8RB'M-$26>:9Y9S)X + $WYVC]P28UU8Q9[7
MZ<F3%+L8)5/4^E$'!=-D! %[A%#%$.?6(D-#1")R8Z(%%P6K*O8Z@=BNZ/VJ
MZ/V\CE;*ACX[U1[S-\ >H\)$EE5;(2XQ1S8ZBF*4G@8BG,.Y=XQ:I-:4K^%D
M)0[4D4CZ[Y.?:NW62>OL%1ZM+*"[T>AF'J)S&(]KQV&)7#$_IH=1?MSIL#$D
MC(U!D<B(N!,&:1P4<H[;D#,]L#.Y5872BY1<6F*DR^EV% 6?N8*/E8A@&4"M
M"6(\=\B6U"%-'4.**D>B,HFQ? "R3N7X^4=1\%51\'GY%]]7\-3Z&@.ZBKUN
MT>TGZO:8@Z&Q9\:+@$2TF3+7$V0%;-[8)2VU :#.$<.* );^LD#:_0K.-?;.
MCF*OG%^\L$-1K<)6R%3$N3"G7R#G29#S>=Q?<"%I1KU%UF>6;FLE<D1KE)DR
M$O,^:)(;&_%IL<B78.7B:>^\O(6BO<_5WE%G(-)$120)::D$XBIAT%Y08<D#
MYP&64$<&SH!XMJ]?M'=AM7=>KD#1WF=J[YBY'X.EG@:-<-+Y/,$FY& E$<;!
M$J\--UZN;3(YGKU4SA.6L'7L_=:^I5/7;&9F56"]M(Y=/HS_,NY?:1.D#@R\
M*DIM#M<*Y((@*'J5# XL^12GU3AVBFKTPG'>@J$%0Q>[;*B@Z3S0=-3?I=8(
M%;5')L*2<0)F,VB"0$91!5ND4L'A*;2-+4!:@'3U@70A8@P%/F<'GV,!!V<8
MEC$Z1(@+")P(C2RG'BE,(],D1L+2E)K&+@"$/J)I;/X["WJK,TB6O=<-<Z@L
M/'>I/.WV6_D#;WJQ;7.%X&USRO^]W[9T^*CX]BO6P8.=GSW\E6^VW1QT,GNA
MOJ8&W^\5>O?G4>]Z-*?V<T2N%^T79!,,]HUM7]C+_MK/]Y\2'G%X<47A[J.S
M\> 3IC2S)QQ,-.!+MU>M_QN0X-C+GX(QV8492^VHEV'X7RU'G"#!T,"LYXPH
M$VG2+B3K*;=,L$.UMEDU'\[$Z6\S@O_G9[NT3]+)E(LP_(?:U<Y?2R:W]MO>
M^WNWOMO<7Z_M-MYN+/QP&WO-G8^UYE[M[5[CX][ON]M;S9WMVF^[C:W&V]VM
MWVL?F_!"?:?1_#A)^4<0<[ 3<T*"BYQ0#<MG"->442JI35Z+J"49F!/PG1BV
M\N:> K8Q$.\Q\QR$P'HKG2&.41&\\&)M?OV\QRHG,B%NR[I6&] []DLK[^W]
M0^=2$,)J9(+TB,MHD78Z(FR,T#QBCS%9E5;>N:J_V\D'7!E#PU ZJF;<MI*/
MBAVV?2LAM8O8B_#>L %XU6U[8"S]4,OMM27JKZWHAE:RM*RFCQO0<SLOFQ7K
M6+U5J5CI4EVZ5,^I2_4KR%/='M^PWCQ&;'Z\L]5CY.F'DWNF/\(I)3 ,8IYL
ML85AR_O>N6WWAX3V0\GHQ7\B6.+/211?S9#O2H9N%4M64BR"89@SKTT,1BLF
M%!6>:TD/=[^=/A"ZOO]FS$F"7ZY?&T9P,[5O[Y^8W:=KL;O^Q(>!P+V&X.[I
M26,;[KW]B>XWP;>J KJ_'<-X+QO']8O]JQU2?_=G:^^O#ZV#UDAP]V0?/KMS
MT6@>'#7^^E0%B/?_:K0:S5U:O_KUN-[\=''PUZXX>/??DXD-PCCEV,.RHFB-
M11P\:V2DE8B1P(3)A,"X:BNB^+,)9Q:O,*R UTJ"%Y62.<I)=$)Q0Z)AVADE
MJ3)6\)A8!5[?2$@OX+6@X#5&ZQF%I($RQ%Q.A=54(8.91#&D0(R.6,O<LW5=
M+515ZY3\B:6P)1NY&^MIS!']SN=:N]OOU[SM]2Y!+2YL+[RRYDAS-,"N0]9C
M,+9WO1J_PV*\O;L6!:RF!U83FB(9Z9,.1B!E2,Y"@M\LMP99*9B1.C)'< 56
M[-E=&DO=S<+J]7-MDZ+7+ZW78QV1#)6*$XVT-AAQ%BAR%$<$X)TP(\G2&-8V
M&5VG9+QORM*7Y"R%%7+3HO'_LR>GOTQHTC@%H^0U\(?,S"C9[?S1ZV8N].N5
M I=J^W:5"H)-#\$F=$H!D&*1*XV<<11QYPPR.AFD+/A/43-885J1 [%%<J,*
M.="26"9%N>>IW&/%_ABS(+A#@9B(N(H1@:^10,.)Y"EB2;D#MX.N,[)(VOV:
M@B1[MP&2:/OQ;II0B8_,]8#J=YA_F+*M7B\3) \)"PH\30N>)K0[P#82*[!
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M#CI^=@'T_VGUXZ"AQ=<S^,"@=]?75K_J1G]J>V?733=SDZS;K0J>8;"_? N
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M]KC1_,P;QU\.(PX\)$]08#D],22-P#^0"$PB+(CS.DFSMLF^T3T\R^+3Q"0
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MD0]7TU[$7Q2GF+*PYW(:X!W&](6?\@ [QUH>2W,LQHB2+(/WR 9!P%(8 9>
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M0VMW+H?-VZ8!(.D6YM.[^-G4FP" VE^:OR\ZWXUS_-SY&W,MP^;W7^""!&[
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MA%B]OE@M1 !=3=>9:@3$IK)'=-VFA!J>2R@-%)/YC)F&CF*E67>*U1MH[+,
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MCX(4?@+3BY.<]\D;\_EZ:APX]V'R.@S!I/9YW#''7V-JRN,UD1)+4UXK"D_
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M3.Y,KA].3GB]STBLS @NAB#6C*?<DR<0(=P#Q]E,"-<1(5P1PMW6R3\YA/L
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M3C\[XJANV.10SP7^_,O_ U!+ P04    " #-0+I6VH2<M)0N  "ZY $ %0
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MW$N?'&:MVAN7+93L @K].$'18.F;P6"#M:?C_'X^2?_Z-!G1ZLY>_K]SPNC
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M.PBB=J2NK;$TJ41OT;,ZPZ86FR7R/8-F3@<L%K57O/4!5&^-94<(N=MV[B.
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M9W^,2104BQ/=PZ_U\'.[4EW8=WK;LM7/@I>S+XOVK0,0SD1#H9+.M3NB).;
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MQBDB8EJ#8-%DRPSW2IBB':8='33<0O8HM=6%G98]BM9Y!:Y0\F!YC 0+#85
MVEEDH'5A3CKRVCQIO;1.0UH+V*.44 =N6O9!6DOH)^DBJ:F>HPU,$$&;[%E(
M]?A,NUH[1VDFD!Q)=$E;OB,5W07W*)74D:.6S976T?P-H.@TBN ,*[+>WJS9
M)1&\8%G)DFP1*/"^<G2MIZ1'KZ5N#+5LX[26Z)^??3H=?\6+@_XWB]V:-Z=
MN(6NKAOY=?5^9JV32R^#B[40?I%)(J>E>4?*>@CJHQ1:4_Y:-I):YP59"7L0
M,4>> H4/V@*]+:A9M"(R10XBF*1%POM*,;:>SU8"?92::\A=RR96EZA?SS[B
MI)Z"3?!CK6_V&6LQ\#/\=3RE4&/VNKR'+V]JLS6B:=G-/^U=U-'68J1UT7>^
M5A2FB3MG2?AM4N;>VKW;:*\CY.-6X2[Y;-EYZQ(_8;P"/-!"), @F-+(%WZ
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MU9/YR4T,Q@I9&): M1JF9[X8R:"FT%L?LY&MJR/W-)0?K\2AZ>7 ]Y)>X6P
M*@@P,C/NO"03&\.B4X8EX73,W&&,A^Q<T1!^A U-R.UARO[[>)S_')Z>#GQR
M-'@ %I6D]]@%RX*0%)E+ZQ!,)(.U+MI\^>PC4L=6YCR<*>@2_FJUIB*]4>1@
MZ 2D5FM8D)Q<C8 J>>^Y;GXUM:>A')'H#H'L'C:D-TZ/!XO)@:_-4>NAJ,;(
M( )G,15'CK%0*;>>PK[+WGQ=M-8K*8?>FT^)&+(3DL42,M/**^81/?F5Z#,%
M6Z*('[WY.M"_9F^^36C82ZNU=0#^Z,VW,94;]US;AH>]"$93" TI:);-_!I
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M=H0_7IW#$="2]V7K,XMYC+BUJ1=O^XT3&1I?HI_#A]JH!(:3^9[6ZW(MU77
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MG\OUL@O4??S*?>GS/+SC^IF-#/H</7JP1M^[RQ;(T>F,2D;@HM9+:B/ F6*
ML:BX<%G&W=Z=7@)Q-OBII^?-/D9HS)=WGX98?OB&Z:;6T?Y2RC#A9'E(1BM8
M2"+7/%ARTV6F/QF=H*A@LF7:FR;<> ;"\9R2WLTV;J_SC8[J__GKBKY^IF_G
MOYC_O.KC Y9_J___[<-/=[K[U[_^]>]Y_&WXF43\]S3^_->YXA;%V ^ZPW[
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M!8':%F=V(LHKZ%Q_,,_.S(X;K^9Z2/]X@'[ZSS"Z6410T^G-Y\7/.B> [/J
M9BD@!TFTD@1")X=G3%K!BU)U1AV%AI&5E"+WFD+$P7Z/.GT:B&8IT7D(CAL!
MRJD P2@#:%F(3"2.7#8.$DZ7!K)2B+CGXW\,PTFU)3ZPXWV[I8&TRF32)<B2
M.2BA97W=9(!;8H; 9*/:K<"C)X"7>5N]!STWE)N>SLKGE!ZR3JS;AAOW?:#F
M+3>(%Y]O/@]8\5)C89!9'07/N0;G*)0VQO!J"!9UZZYMQY/NU2R&,R?..66:
M["%I^#:7-.1<<FWK&WB=>J<%Q1J<^]KJUYF:*1K")2Z1A71O2^0\B'-.^2GK
M)%W;%&ZY%1CE6=;: /G+%'>Q0G$79P58$LXS<IFC.9LDXSUE>UL>YT":'G)5
M^I=SN0E(*;@W3 %/GH$J/$&4CFR3HB'+Q%+\69\>S\CVMCC.@31]C;.+V^6,
M^YR1M4<D'T29:TE-@90-159&U&6O4AW<8BE&=DRLCK%HLQQZD>9U+H#3$Z.'
M.0B]N(4/>UP.#$;.Z[1L9$[4)#GR!@5%3<BDY\&BR\T;Q?0NU.M< &=#DQXZ
M7K9+KLK6:IM+ FZMK)TX"KCBZDAI)K(T/%OAWG(I3\OFDQC[U+F4M5+[0Y5K
MD3P4,I=6"3IW'*OCKLV\RR%(KQ67**U).W7ZW5(+?_? R\^:W,O6XZXZ;]P6
M80[BMB1_!Q@->ZP\>/3Q^Z<<J/Q5\W707(^&M!0L&4O'I91UF"@&"S%P!*UU
MR*KN@F*GH.+4!GRFCTE;^^VCL,9V6][_W Z4B%K(:!7D%.K@3MI5O,B%7/^B
M!<\B:MVB$\FCAQZW]\C!:A^WT%G#EY-S((O[B5L@4B4I!0/D@<2Q3M9TNP*8
MG;>&"VW43K6)VXSW\*$7:+R#==;#:[/'<\65TLB+4\ S[2>*%0_.\0)6F*2-
MBU*4UFDACP"\3E^HNRU.\;+HD,FKN\C44R%*'_*<IIRE TWVO;PXEHU/D0]P
MB&Q6*D]B,=KRF:XY#@B>=G^P=-)B",P)&UXM;[=4Z)PY;?<Q;0]T?939OL@@
MO9TD3:Y=--H *OJB$CKPVA0P0B)/2J!7K<_DC6#.\'JW=UN/^S#4,1OZK9E2
M?I5FPZ^UO6'79.X=/KM9'O>^<JRD<'-CR-+%NV"]XL&$P+-TA@=IN=+VMH_?
M#D\Y>?:VS)G9$C(D39&"X@HAE(1@$5D6&!U;'4=SP=G;G1$\[9,R^X23VCM^
MF:G_C_'U5[(ZY@_CT>C'\:3^HUH*[GAT 2+/IKYVT>!04C3A,!-;O#?V;'*8
M#I+P#/?RMLQO]JJN?P*=4\KX[M(NFPP5;F7*(I$#%^L]B,H0"W(0W.10FZ3J
MYA-6CR;<!2V2([#T^ OJ (J=4V[Y5D'G?>NF/UV_Q\EPG =.%<=RTD!">5!*
MD#64E^!1>1T8RB3.IBQK3]G>5M))5E('@IU3!OI6.?\YM\>=G,HZ;YVFN(XD
M)CDS V?)+!2^Y,B+3#Z>3??;/65[6T@G64@="'9.V>I;Y20K%!P^$C4S5-*'
MVCA8@BJQ3E#*&I(102<64;++B82>B/>VG$ZRG+K1K*\4]Z,XLZXH@Y;"5Z'J
M9-N@+,1$(2VS3F+,2JO02\;[\>.EL[3"[U@[_F.^^HJ3\ ?.':3OPPSO$G(?
M+AX4NK H,HC@W"+Y-J0HP3)IF H^A?,9E]&/"BYH?[R8:Z+>*'A1L>_NZAAX
MCU*G'$%R.LB4KMY6T@PX2[GV>O(A\!>X#"]H[9T#^<]P(>_%W(M:O8\O%K8K
M0D2)//H")H9(B@@"G*QE">A8351UN7WUQ[D(_[:.SW,=]\GA"[X]VZX([H3A
M(11 KTOMD^T@2('@+"G&&N>M.)O2Q=;"ORWF\US,?7+X$F_P;B8XW:Z%7)PH
M7@G 1$&2\K4E3;5ES#F2(IS@S;N%GX?D;\OX/)=Q;^R]S#O#[3JPILZE]0J8
M(O&5U;2/F10@<><%IL2+N9RS^-#8^)1U[39G(ZRG)<1KWJ=*M(Z*B!"%9!H#
M\I3?ZMI/?*=W$F.?NJY]0^9]D4'0'D_>SCSSODX@5V@@T@G A!0J\]9#@EY8
MC==>''B^QFL/6UQ*C<PN,KW5>.U7X[4/38Y2XW6 C2^%OUE%ISWY4S$66N):
M!W*+C0>.@1PL94CV\FIYNU^-U[G1=A_3]D#7-:4ETP^__K8L'U+(?<E1U*)A
M"RI(7<=7(4AR>XQ(TCO<J>_,'KQ[%M 9!LB]VWS<E\&.6>_U'B=E//E<!['.
M%;5.BF8%8(<\K%E%6&=)GY2(Z<@9ZEJQKV12416NK&>87:FW^X/#'WORFC%4
MP9LL,W!N:ULP(R&B0^!"I^ *R\&>S2OTGR^T9LP9KW4,",);I ,/:4= 3H$!
M[30B6Q69.YO6OJ^G9FP?YI^X9FP? EUTS1AZ2WML5."-B;5)82'7,"?@V3#F
MA3"^7,YKA]=6,[872T]6,[8/Q2XX\V9 /EGD:#F@-8;DS(RL(4A.KVU*M9]!
MO-3$FK>5=)*5U(%@%YSU,LB.&6MX !O(15!"4\PHHX<B6#(8HI+F<HHO7UG-
MV'DNI X$N\2,DX>B<F3>!0T%.:LOI1-$(PR$[&.P2O!T034NKZ]F[#R74S>:
M76;^Q]*9S5)9Z9,'@85B6)\L.*U(6F\-RMK0Z((2+E]XS5A0B958+(2@:B'C
MO+M8I%T?6?#<1=KG+\>/>#TU8V=^3=0;!2\J]MTC+RX)[HM'BOJ-TW2&F0*!
M20[.EY*BS3SJLVF2]E8S=BKRG^%"WHNY%[5Z]ZVWX=8H)(^'/#M);JB2#CQJ
M!S9R[J3D6N7+B2+>:L9>Q#KND\,7?'NV71%!H?:1HI>B2J 0Q@L(VI--/2=[
M,I69N9S%_%8S]B(6<Y\<OL0;O-VJ;KPU4F2RI66VSIL)AJS*#$1A(U-6<\TN
MYXW36\W8Y2_CWMA[F7>&VW40K4#E:O<I46M?H\D0BA&T[ERP6=AP2>T1+[%F
M3#I$S<D7Y,DJ(J$B_M7AQM88*870C(76R;ZOL6:LTYW>28Q]GC5CHJ!0/F4P
M&&C;-[E #$6#9K3[LY"S36]SP=IQX-F:L7UL<2DU-[O(]%8SME?-V%XT.4;Q
MS2$VOA3^8M**V<) 1_*(5<RJ-@;BD)Q2BC,>?#GZW<;9\':OFK&SH^T^IFU(
MUUIO,]BET&19C!1,2L):.E!X8J!D=.!TCF!R#,D$$;5:>=OUM*)GSV>>833<
MNX''_5OGF*5B<Z!/%/K#M_I'[%P;MM.G-RL&VU^6E>HO5QPO+*F J:B<?(BT
M'*7RDIDD3'"#/9YS\G*O:(+/FG'(ON8:*H'@M;3TQ4G:3T/QY6P:%__<JMSK
M:C3_.[0 UT)9VF@@K,F.T1(WTGE:\<&"2RR"$)$GQ3CSL7D'C)V0G>&.VI9I
M3R*;]@;KHRRJ613H&$M1TL9O0[3DW="!$X,4@$%));FP:.+;M<])*7D:8Y_+
MM<]/UW2JXJ\S6I/UXWZN_Z */6_GP)3R@M:>U$Z TC*!BU+34C3"!CK]56D]
M_/@9.)=_);07/\;]V*F' 'L#M-O.,3N Z^FFYUE@I[FR:6;&W>C1P09')PI%
M7JIX(2'RFC?#1 +/:(G(D!FM#9) M\YX/P%!MMR-G(8?^ZB^!UZ\&T]GM+N&
M$=Z&STD9I6VJ%8B*=DIG:^%#KMV$N%6I<.]EZPFC3T <WS=O:*1Q2PWWX&%_
MP"G2!WZZNL[?XU<<C;]4B9?N_Q)B3,849304%QVHD@-X62QMLC+77P5LGC^V
M ZR71(O65NCC]AY']*L_".'?P^2_<$9_?HS/1<TEBQFBR@I48)[D#[0K"L$,
M"X8KTSJVWX;I)5&DJ?Y[2'?]#[S&21@1OJO\F?0\G4U(]*_X&&1!DS%; S&+
M0B1V$GQ@&8JWD1AL9<'6OL5.P%X24]I;8F-"9=.+\7_@;*&4]SB91V]7L]ED
M&&]F-6:;C2G4^SR^GM\!?QJ/",7T-B <EQ_"Y)H6Q/3V7U+<-TR!-M/AZ&:&
MN<-]>O^@&ES#'UES*[?W64I$E4W15JB +@24DB6=0W$I"S;H'UZWK6OM0^[O
MM&STJ%GM-FA-;75OZBLD6C/&Q%ADCEZ;UC[P\XBZ;M6KG_X!T_@Z#4?#18@3
MZX:19H/D'9.*=AZ+56[&(S@3:Y?%0KL0>1PFMNX4M1NRXV_6#1FRNEOW8(P>
MPH2[)?SS>#H=:&E8?8$*G@L&*EL.07D&5@IK54:3FJ^(1P!.3X 65AJW4G$/
MWOYOU[GZ#763QGPK? 5V]][HX_A]F,R&:?@E5%_T5TPW$S("3N=K8Y!#HB/
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M!KPD!>".9$JHP//8G[R9:K>T]?-KV54&)_(ER)<!"N\203/#8Q+L104B6ZE
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M*DJ<@'5J1<<H(M%M2+XJ;=4)-I%<>-]05:4#ZI;3]"TGRB*_4N\79A .A,_
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M%.#6A-,.:4F=^RT?*/,5O221P%.K<BQX=45SJ-^+OI%,4QQ=#.*!FM&VA8\
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M*$-J_,UQ,?7$ZLHT:#E;2CX'_ 1E#-E2]/A.J&<_J.57Y*<<B207.U."M4]
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MNNR42>]\U] .>9E?X!-;XES"22_-FLKU&ECZ1I4KE^3%MDXG%MMDX.E=MPR
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M7D^SM'5/OP/G!6.W^[261-A08(TK<X'874ZW.V4W@*C;VR:6D2Z0/T"#"KU
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M">8#6\CCG:$"MP+F*GH0S9X]B1>I0*VV&732AS_E?O)]P[FYA]_"QEMRBJC
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MZZ+!1N\=@:B =) F4F-#C(@1$) :D28@("("$A*E"T(4!!0$E"(@)=*EAHZ
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M_WUO:L;Y.L"+K&I[A03K;'G#[N>L0^LH3[_$M'S'9UH:\=85=J8G.O:P"#]
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M+'6PI,:2]BLQD_>B&P6I*]2NB@T@_"3%UJ]$DH0H/\S/V35>HPH"/[%$\P%
M!4WASXM$;^21M:$+61R3&15>=5'OZZ\[?YVU,)T]EJCW*X'6$ Z_A>S+(CZ%
MK N2T.M'QAT3>UM1ML4_K&G3%=IIP?Z3/M[A%\ ;4($'+\;3TX(@G1^4(&/$
M>POQ7X:^BGD6P[L9JN=0N:&OP(_+S@K9G_-L<<HKF;H%:Z<R9]<.1(%%D/R4
MQ\2IH+;Y@_9&Y@Y=BP6?+WBJ[>F?5Z0N*?-?8)[8-E#,P?PJ,BN)_K8R&O<F
M)5[++2OM1<[TFYQ+<RI_Y;)C?_W__PV&IUE"ACH4,""<<QY+"B%<3,:3/: \
M$C?^*O8;2QN+]/XTS@[SZD?(, +:>6JTOE=!=7(V;=!6T[PT>/3,C[)K:./:
M!"W#"?U]C!W[V^4?ZQKM3M^K9$U]Y5K-T7-)\-=_'@+A9YL?IIP6C,N[DS.E
M7LC2S0" DGQ PGC#B6P2I,<0,:J%E/LD9Z6A]J8;\5\/T^%W&QX@?EC_?F*#
M)F:7+8M )%$M%[!N62*TWRA!+3 @)[LA61(:$%@(U8XDU*$7,_](E#P7()Z+
MX%:1^<N6J+98J.^("5S@!I28-PK2;J3++&:U#IPJ4SYS\J+-5AMTP"0NY;;<
M:DPC=\HD58.X'/T,PO)7R)$A2E(Y$S*^3G5Y.[O[I#N'"=PMB-4#@02/[KC+
M ?YMJ@I?-SX0"!G/:_*@JX6R0Q9S2%NOS8H=\5)UDF*LD+<97+FE^QOKAFWY
MX)A7L5.E_M[PG-$4@^V=@;C^WV)(O:2N<'T=DG#+5/[+!GB^\EQJ\82).^HQ
M';0])"]0Q+%_25_R\WSL#F1J;7^+F@IQPC$S]+\=^3KB;N50;MKY4.UK-8;(
MO()WG6>J+1JC@E3\Q!*UU<<7!]K1@'P716"'QK:UH(A[A27>@4?:8L+TA9>"
MQ?)CO#?UB_)>8V-WS EZ%ZR7>)H1PU%,>>+6?_6E\%M\?N*02OFJJ-;AP)1S
M17_R3QN,9)9[K.>$>C]'@]7[+H@$-1@8;<C(^%POG3W2FCS<W?1"Z##B:RS@
M16/I([41 M?W2!=/8T5L6_3H(/>_1Q*_0OI6O2_NZ)5-'^L]+I>TI9M\6TK@
M7.TU68H0.XU]M-#[#:KU.R#K!]'O\\H;8/%M#;6] UE[&4 'I5P?B^X$ ]I'
MX$GPOB=LBK^=(5 62;AXS9*K>ED"T\9>\;I3L_T<;XO"I=<3DY6V'ZB7^2I?
M_$3[^D\&\TI'-/D.K2^-N5U1NB;Z;O5+CZF]^/(3)EX3EI:C]Y[$-N?&YF3_
MS*E"3G8@3-L^GG>0E,-/"9"":J%FA;&?' I'(LPM(H5S[<>^P;R%&_VW^_E:
MVY1_Y;5>BDV6;^4-*&RIVK+X-$OX6N69/IA?-/KWW2+V.XS"6[-O2 U_4$72
MCD:HT4&LO@GG[KJ2L*\?0&5?D]/OUR;\#FBYW1T>]2XRU-E(D#+P:?EC%\]"
MWIM?13TE-K[R>I34ZZG7$TVR(2YM3D\ W5L9(@4=SVX$QE+L\ /'_UH J1VV
MQ5;/K=8^GG]_L/Z9RP;]0-TTZ'D]&17T<(CZA;C5-MT['?"8=1.3<JQM1,Z8
M>I.B&$?]00DM6(/SY1#%[-4G'XT-5ESEYM:/%:_=:U5_M;+S8CQF_+U/:!DQ
M;K\ "" ]/-04H6PHWO,C%RD2U-0VI?S:P,YA(<<=/\+3QQB$S%IMSJ:?9,H?
M'7M_HDCJ^-LK$BP&:UN0,#CO&2").'V3Q''PVX R]@!N)![WXU9N3F).<K?Y
MY=US+W57&4[/F^QP2S>,I>7$$R/$.!G*8)YGL?.9N"KM*57:663_"\.,HAF7
M:BS>2-=A:8<.4A8MV<_MVU+ #K^"WQIT3+'^M#1Y7FI-%'GNF?L<GQ\JW-H1
M=DT,0!B>%T]^D-LP.O#3]Q]5ZXWNQ(3-2:->PXDPR#3$8K#JDOKC]3UR8>5:
M.VCYT8B2(<G@@M.5=]W+"?ZTTV0:^RP==&*!#KI.+3%D,B&QMU;;FY2LBIG/
M9%_5Y2U<R?W&/ZZML#4NE0!QE\,,/P):TMP$DKFD6W[_DB]1-6?3,J=MW)<>
M+TG?T;=YLL=FOM0RDBS\9PO\R7%Y&;X^30<Q*R';X$)- [D4GT'$-6*O1=(Q
M: "[<\%*"]KU1S5< Q,8*1 @6VJX"IB0!N:[NC!<:"$*/U""WQ+RR.4<SP2/
MXNMO=O_%+)9-X-:K&=:S?DL;@A-O02;8]XO(1@<=L,FV:W%6/[I]>8)>2'V%
M"T,ZMZ<%=M)I==&2HT1,!P:X&-Y%!W'H7T=*HUH@V,>A=FU'567*3AX$Z&)E
M;5R3L-EWMK;?W&>>]UIEW24&OL;.^FF5]V#61QVGXLGR73@3\O!TF>%XS'>X
MN)2MP<)F[^8+Q+NC12,DP\?;W!BSV (FFM)!N[Y3L/D&.HB/(NO:GM9(^Z E
M-\9+04V)!>-$(7-U'*'6>2&X?S&(!JTC2P YD(M $*-CFL16U1^8!"C)6@[?
MRX*6C-S6V7O)-+-7RM'5LGFA#9^IJGRWZRX-H3D*IR3;!FZ;/=_T,HYY>C@P
M.=8H_SQMD?*< AL24XP'M!BAD86:K<D-0&DG$0^(RW&/KX8K37%A!+NC#7+O
M/1S4)JLP22:/X7 3*U8:GB\RUJW&Q@8U:X3Y?_*>8S#-"DG!RR<2@T#62Y;$
MB4_*@3<JQ=TJ_3R^9KEEYM>(MOHMQ=5MFA@A']-&<$1_\'HZT;EC',D&\!-Q
MUD"6UIL2P4Z,=\'7]*\WY]]>U]!_VGWA1"B)YX:(PB^N1]04U/P29%)[ 1)7
MHB](FL8W88BM7BM6BJ&.RV:F)K?CNT&L7V\2$GF@Y*5S+UTJY$0QOR$$7N =
M-97ZA9IN,3G%B*:9N+VM]"G4G_PDVG>7.=QDB"LJHXEL1X) "PJ*5=<#[$0"
M#-3W%=.]/J38A<1(<R7F<!05<8G>/!-VZ<Q(U6&OJ9[&Q R#Y5S^?[NM^;_:
M)=B#\ ?*LBGL (0 B9L[$]/KC:<JV%4<JQ[6*Z#.7,Z,G/EV?'6TA^).K4&Y
MHE\:>F/;,6_JK@O__G,QR5F^OH&3.LQQ]J/&:HMQ(T*'[,UP9$N$!ODN16X<
MXNX;AF*NZMZHJHKN'_/]PZZ;R]^E(^_-DW3F\+[,)R=HSU'H 0N1F8<DY'05
MQ@XITNG*]'[:E;CVL?!6]Y0VX#,P$-35;BB.;ZCG/1D7/?9>IOO$X>*&TB'_
M&Y_11=_8GP!NP;US( 9;"6[WOD:(;J<B[:AW:.:7W0P=*FUD'KR&ZDG9S\L=
MR$HG!NO*8;9N&TI&\44\NAO[YEPB5%$ZI5NEZ_#P=3M![</K<8RV?'?U=*!W
MXW3HP&\P<+9K@]\W%\AQI'[4"C4<4RN26M,UVKY:I)3469#8O*[CM_AR+:N^
M'+;%@4P>7]AB8%:+V#(C;'J7R+9//>;RUM?.P<UYJK]\'I$XN_$.NI*X4WB\
M:2A$C!J&(>#$G]Q7 DOTWP]=M8A8JC>=1:J]@?=381MT$!,)6/<%7;T47SCR
MZ0RYY2DV(T]>-;GNI( 9')U5\=_]'DH0;CVZFW'<Y,>XUH;Y7$]/OU#:YO9F
M0(*<E%E*X/,S"B]9I3\QP=-1-=;_E.[TPKOE:+>J3J#:O$B03@O3_?L!R5 N
M](D_&Y8QQJ]5<8%,#Z=%?RI*A4X=.8KBN<XM</B.EA?K%8RW[T=8!T.GU!Q+
MM[(?$SJ71/2;L@R"I\M7J4+KU!- &PF#EUVGSIM@7V/%:&=7#$5^/XX^NI%?
M[%!LMMER5EC_YS*SIYQ2UTM63*_J5!R-G0XB=>TGDGJ1?2@B="#<MK/H&Z[B
MFG#<9J6S7[#"KOK4Y%LKEB[F@=J?;$\'N]Z,:Q$9XI4.8C!K1M.P#&!S>#^:
M\4<NPF5<7^M+[8Z2OL;YEL*8^W\Z3GZ6O/$APEGO[<^;A]G=L_!";/G!NC]9
M&]F9>0H.0O9CV36WN*=T,=.EA&LRBV3TPH\?B&Z-@,Z%R'X!.0+6^*@FVE!B
M[?5[?_L79-[GK<.I!WF-;O6J :MI<2.DPYTWN/D[D2I; 'HP-&M@A+)*?8>:
MGU,51IB0HBF:UA1!"*$_CX#E]50OZ<-%>&L5R@:#R37CY!I#YM[%YJMO.&X9
M]\(+<)PT480>8# _K1J-8FO@S0,"KP[G;*]79DAV*\]'!+:>.2Z]#3.'2B=Z
M/2WTHLD0#R(?G[Y'4JGU</)I=&OX<7_\+SMOT@;\>(>]?_LG5P<3]9(@X_E\
MP=X[["XY)[/+AS:WJS<R2YF56EP'JT16#WQM(-;4LXAKGQ_-*?Y6;5 E*.OJ
M-4+,*Q/'CH9<>TPY8LT&H[^87SD:7]I:?X598VA=#" G64N6!Y;-W@;!.@[,
M6O(<[3\I:B0^5O$?5A+]C/!KV/:3"(U<P$W'X3'1<9. !JQNW(>9_5SX"5$Z
M*#AJ 5#A+D&LD>_^E=0%!G--R+<I9H#0^0JB6[+T=_LK7S<2]>[B)Y-=G[BQ
M/277LFB_JSE?!VA#\E[EQ_;XW<NSBE(1_U16HUZ$FKVC[>%@0MFK0B<M.$H6
MH8LB^HC)SK>:N!"4;:QB[OB6D^+Y]85#.Y/JT,(%5!R8"RG>ZD)*C2M>GU$Q
MJH<VN4D.EMZG^CGJ$7#3[ZK8!]8A$9+':D=47/2<,@]%-B'K;9(VV*W/H45]
MV =;)R@BU%*DN G)RVQ<2S$]/=3<S@%V+='LM-U/KD5UW<1^"5'["XK=KG\*
MM?9J(AJ.SV./V5"C6V@BY<,+4AS>GYFRJ$OD7Z'=6MLV4<=%DQ<\G=2>/"ED
M]C#:S-H;?71@/.$Z&<5^L7FXT^E\_JWL!I=J#SK(SL!B,$N0XDG$=4*U-($D
MDE=;^91)B>%(<O9UT>N6;&;!URHY3K7H09=/_?"D\I/@$0UZ"Z%L*$Z@"!J[
MWX/WDU9/H,9()3M-O.%UE"BE-1L*UV,]*'JD4_L]L^GGV--E/A7L<HA"[J+$
M%O2X/WA[^_CZ.%=4U 2[?6PU$O"TR7C=#.+*S1S==4U=Y_6[&.F*Q/+\*1OI
M*S<8X721OKFHP*Y07O?I^+M/DLDK8!:L*SH:PHI)<HSK']6Z#JYK;#K.D[FD
M*2Y_H"-5)KCRGFD'3M' ;#C-X]);<,+(83[J3V'K# TZ"/3N%K(2U>I$?@[(
MTJXV"7O;:OXU;#O9:4RMY^DB+36]SV9 #'I_&D#C4WDH5P'MQ8M/IFV]KG(/
M6:)ZM08?9=6@6Z=GSM?@9]TZ!JSNYR0S$T2T:7J..&F_7U'RSE96(JY.;XW\
MTW M6Y&.4C,!F.@7FINSKKH(3SKH8.@EK@3D]#>K2K8Y-,1SFG*U^M7 O::H
MFVI[*E]0MFN[<&$ UAY[NFU.=AC3(GJJ9U\'M<OG-:"%G1B>OX%)J2)2YS+[
M1HL#6"'O(YLI16_'L _ G#\[81P4(VS5F<63&VFF1U]@ P),NQ*"_QA =L-@
M?BN]F0X2:9A(VFRM*VEG"+V7/!8[FBA?Y)PA*QV$WI"H>F2Q20?EV-G[@/?;
MHR%H3:;=O"#9#1D&GVZA1D"\N"L=$:[43YKL\>8+,I0KN<W/J)=K__;Y/3;[
M<V;G-;MJ@58"Y/%67)/ @RQ>0XZ8ZD^0S>4*R"&O8TTE;'H:WSC'[TC,+'/I
M*HPP5N?N>IHU5+^]/JS1HZ;(^PJC:RD\%?$)/I?F9EE@UGXML?A>JAOF,.LD
MPI4."G?9\SVQQI "W^F@![BIM?O$,<SCCEVR*G_#.RB_)-+T:KO2NU>_D8OH
M(K^!'ASQ+G<\EFB+F=2;'\&60S:*2 JK:ZU-EV)O:E)=M[Q594<V-C+/9THW
MQ@F?Y (BXB"_>@ I+QZ4?R5LJGY>I38"W>4WK;.:.C;4@0;X57!C34R,/B33
M!!_A)/^I#<&*> +X$;SUK'\ (9B!_34'P[WSJ.^.[6$>EZ]")_:)0KOFZ\@-
M)!V$KXD-_AK:,<%1\SI9W%16,\>\Y)+N^Z6D9S-NB14!.I:+@:7+W<LZ$APJ
M<*MJ]C2^ZF_JB)* NMVF+GPR VAGC9>8MZPIIW7(YD#] F3](P'VRE%KU*TI
M'9]0YLN%]M=+>;3;V_X._S(1>D[GS _VB;-&XF<P0YX4-*._UGL#X;K:;5NO
MTT# NWQNL-?4;'$B8 MELZ>#W&ROSEFVGCK>9R'3U^P=6>WM,!WXAO;#^K!D
MX2(W]RN2AEHDFP_/4W/HU])%EEHM9(*/J5;.7V1O6[*LM4SVG\T-W]IZI!";
M7#;V@L'_AS]A8 6Y?&(:20/)842 00:0GZ*^,SQQ6-VD#G1_G?7D=9&0O>I;
M8[\);N[EPC,PI#32:W'@GWS6'DWG$#?&[%I0Y>#UZ=!"G,D[;[^B-IG9-JZ/
M0BD?6R2_6DEF-PTS,#)N9R+$WE#(+!^K3P<%L@<N991BV_P)&EC>']IGLLK;
M'RXHU#^U:(363*<(5]!!@NC?W[;!\>":U/4,HG!?%>F@TUL.U_9VZD;2V<9Z
M3NI8@D2G!HTVN 5G]*)- =5RGPYZC,517@!%LN&[IS-=AE55.^HJW6LFBCO%
MT=">&OLLN".@REB^%M14"M.B)U@@P!O>.5X81IKY];BX6Z+];C6M,<V*>:AQ
M:\_ZU5,)_^+A:5-?&%LM';1=7,)MZ3*0Q8"#(#)D6*HG](WDJ)]OTO)Z3O!A
M_O.$XP1ABE!7>Y/&&'<XRF5@<OCNZ![K:Z%4L1%?_7+)+.6,+TK()M\1*V:*
M!I8B.+W_B[K5J1HS'"35=L @:H$OE,QR(&W[)I<=2"N&W(W(,(H!8$D<P%],
MT.2.,@0-[K+K<_[V$$,\89:J?PPJ.] Y7_.7#H)OVZ?.XF>^9<@K?QNE[L$L
M^S9;#A4_TT$QP9GNF0=\;J.>'5NWT)L>+PSA+[SZ)K-$$,(,3B9-ZVMBV:[B
MCD/*C.E[!'U0];&?L.&G@^P)SO(4UY9=S#>D.$(4,"&&W]3E;MV*.E()]^RM
MOK_;J'OI30ZUVNPC=SV?U]?L)H@>85.&( ]7Z[B33;/: +\7S&ZZ259"AP/P
MJ,\I=A&1VI1N1]B8SS;J(C* -I%%-.KSLB.Y;K6K3II8#&=7-R5__4%,R%-]
M6[T)E;;M#:MGU;]!OOK\X86<=@0W8Y:\J=4(6.GY#((OVR.:>*7*B;J$/(S=
MKR_^W?>J/403=(^="GG'"/0%F/I>A/?"IQJ5^W<>W2LO_T28&5KYEFA:NFW:
MQ&!U&D35ESOZW0LZ"A9+@4\B$L-#G_EYRTXIRPQUH6F=667Y;5D3P_A?F;S$
M]UL%JW5QN74TK!\+U-?U[M67G[-49'J];W_RD4Z$RD[\L[Y_52@]]TTH?--Y
MS[](.QBZB?N;TJW,-_@(693B^H$CG0EV,NQKX=#7$I&21,JTK]5<R6SCU5BY
M4OX?_W5F0RR$#IHO01'M8:S(%MT%!#.@B$_G%J28>-U+O^MPU8HV\-O<:!8\
M=<)%OT(]V8FMW$E$XT)/40A%JTUG7-CM>V]YW9T\&Z])Z9KWZ8-&@:&/DZ=O
M+G8N/)D,9;9M*!&DV@1G?1:PWDFG@W@9UFRQP.)E:7-T4.1P-C6U;Y;*$$4L
MCAG[]NYZVL&&S_50)0.-H<-D!KBU]&&9&DR)258-U+(&B0 \5N112I%,%39B
MW;6NFL0JS5F]ND&+EY-]GV;ZX0\TZSWR8U80$T'%*"(^:"CJ[,6D>RZ+,J%:
M;W*$1@_\ZNSJ%2O:6TF.9K$%\W_P-.E$\C J'CV2!O3N4QBN.$_["?D.-!*M
MTHNYP4'[N*>H5GE\;Y7:9 \D:GN-(P70%V!:%'>[P.6%'Q"F33,PSPH&* >^
MQB %D1U-H'H@@/BKWWO/].'<WL9PKSYO2.$&!]0BR?MQ?6P91SE375,]]27#
MRB_AY>CU]X\;4*0$EB;9H"6)\I+-*K=3'YWDEJF2@W',#UZ8J#W_R9&MT2'W
M1)OMB:8@4KW=?WSVP5^HSF&(Y^OM88<A1)^7T/[I7Z3#]#^]7QZA!KJ5(1NC
M]8<K,\#6+4"/$2U#&</96OT=E$/8;\)Q-''TZ?:Y>\M45M<]*W-7V-]/CZA[
M__+I^8\1P;-5PYOC*^!U98:+?Z:^A3QPT)6XAD>%G<(0!F1=EQ/TKQ8:9O]Y
M<R%F7KE<\L9$V)\':D\U' <6L E9;(9BBE<(OL*V77XBS=^K#1_C3%\G8HE*
MW"^VP3RTJ4P54L"_E$E5C3H0YL>R&LPH:^:^B,G&(_-B]@1W/ID2W (RY[$5
M%^XF<!^K_F(\&P??W;[5GQ-J7^GK:)?Q02F5,[)PXYNV.6;'Q'K;3G7-XF_M
M<M24T(_:C\[Q JF!#XZAS6&W=F"2M#'LJ0;.IBF)H#5ACW?[H6>OYQANN\C^
M@4HF+SVA]>,JLSH_IM!!"\()Z7<JW6;W=5SYU,G%O+QB-&FPYRZ&"?D3=ZJ!
MMWQI[;JWVT8P^49QJ]% Y8,372/\6_!/DBU+->!*U,9I4F;@<!-G$&NQLDUU
M^L]LOG(ZJ%'SY?6LMU)C)7_!98'Q"%=DTQE@EG0^^"O2D=TC+=B/BKMX1_BO
M8'1>J+"O[\E<5F^O8\9B<O<2M-B^&8 DY'>9N@#V>=56=!1>AC@0H1S9\ZRI
M3O+9X1[7(<.WF)KW2XON?B\??2P[M*=W<U.YU.E1Z9F/QZ5CFJ.LF,-8I'FW
M+,Q,M86?G7^?_/$PE7B#=D!C97"+DQ(C2 ZO@Z?7YE7%H>)6UORU$]4[>J?E
MNPUNJPN_FB"%2[VP7LE#,+#CY#-J"@H?@AS@)DFUZ09^)$".%:?^#O9*_?']
MS.D//]8BS>08N.K"Y5CG"YPWWC"A@SBUR5H33=B"P[GSQ.H^U?;3TZIJEM2^
M[DW$SR[9^MS,Y*,:X;R.&;4H0NR+L<B"AR$[,N0Z-,6OW-=K2M%YVY#3-QPH
M$FRMTOQBOD=LK&70M6 H*LS:P]>K>S-4T$C >I%Y[<N_<Y8&NOS \N69A"O%
MG+YXZS8(G\M:$VAP\V-=MTJ&)!U$7A,%9_@.7I9T*J%U89FJ/E4:"J9U3!=-
MX'JPP)J0V:%U&'(47H&*1/+<]ZAXI&U=,Z9;!#LYH_LAP<A> 8^T!$5Q')YX
M)KAO^31+E":XP@ F5G_\Z</K&C[\]V>]!][IAE>5S?#<>O>WJU%S*O R4A;Q
MB+&\+B.X@/#2 8)JU)P2EO@L55TXI97=LK["2C]+Y:++HT[8+'?E,Q"7W+]@
M_$M @DAV"&^'\R%L4 NBRKG<@A'[11YNOW0D73S[ASC0=7"/OU?$K:>;# $C
M$C>^-.=\%@'+,=-:T"XSXY<:9K9:SA2^EL"R>5*2Z9\?$*QR)+/P,(Z97Z7-
M!C/OWH>=71WB?;66 %WG1,8Q8JQ_.WI]8)T.VE#([!\CZ^_309A/3<-TT'E]
MU![J_#YM?**(LG'@B'NU[=N.!J1DT4WG+A:188S5:MAP=4Z(A(WT=6JH(LY&
MXBN$S=^N.W8^Z5%V.WU#2OK&]'>.H+807PH_FL8^<82.M=B_RS!&BD?)?):D
M1PUD<HTP>^OGI-U,?[YO<L'U%J/WAW10R@?>B\&\#WR.\FVHB4V*%%D[E"A"
MA%1<HQO9P+[?^R@F]L8#)N^/ARY74:]J5P[B$0=D5UH?O )"$;"XYLN-'**)
M&)X /N9?VP^5)=Q(SB=<?V!XW_?S)?6.3XC<Q:?/-2]_(G^$@%WMC5+;I!?N
MUU7FY"G=#L!<&UU=M=@2#O1=\I3W?ZC^#=#%\*<TV4!BN?&IAQ!(K\7N<]$O
M/R)5E!=MI-Y=D\IQN: ?QK(J/PI$DR&T64B-,86'3#B?3KZ$G$2>KB-UM;)7
M=T55E5Q<VU#+*[BT4UE4W=HM%L9NTW,/([)=XXIUPKKCIE3G:S9,B9U="\S-
MON )(.X*5L2D2/L0_Q9D*YKS6%^]](;S$Q$7OS!.1)<(\917JZ=(0<^E-Q(.
M'@_EU^YX98=LPQK@]]9GT_6>KH]%&1(]6G.1<@;CAQB-ZNQ813SWW?]1B8X/
MIVEL5QA! OP/GIR8!_2$T124U_DRS!H?E#F"(NOQI*RO\%<L>X4.<\\K;97#
M)].!!6R_FL&=J'_.A?PP%('A3IILZGVB-9IB,#^KWW-;[$8<WL3D_;T!MB''
MW/XND>Z33X-!S_(8<BB> 8,YG3BBA0&JQ;;O5SZ,Z!O]K$3/^-7KB;(^#XGU
M!.;;'U7N\X^LFU'.-7%CML L#5)X<6T6O+]2+SN'$>*ZE%G=.XLWSEI](IWJ
M#9;9H[.ELWM5B92:& U*:W#$W\'TB =3@Y/5E=Y5I<OK, H_AL8%(ZF^1H1^
MI4A1&S4=)-F5S?'*)89G_H[10:YVT/N1%B&G;@6[9+JA']QAO:K>2^84?ZV@
M5';)]0%;^:<P R.4I"!5']4BCF1TG'! X=? "\<CG/V5CEX2U^N>)?5#@YW+
MZS-[9!\&/W2NN0K]LVRPMHW+Y8X*YF;'$P_'S$S-(Z%DG6$XMT;<>U?!_6=O
MDDQ,BU-J#B[!=#N<\_4OGMW1+,VR<SB?%3J*_LJ8#MH#PXE_?Z;^8ZIJC:$[
M55^G8;L@@!PL&OO0Q,#S:+BU29)XFZ9"FM'U_I.R]:TV^4Q5>>+-V!^1MM>3
M?_-(SWR;O'L%=)00>^B/1[>3<9,'-#;F$EKG^-3HR!P72?;E @D5?F[$U]$_
MIU>\_$J@NWAB!22Q53;C;F+9?"23W?$,:D+)$B.61%%42.@-+9)B^Q&U*"BZ
MO2XRNBUW6*LH_0H^XR*.UZ[/YYUN09TZ<R+TILQ/2\B9Z<O@AX..S POG:3F
M(2S),%KOOJ,\$$N"Q%(@10Y 2(?%U5?F(=-6H!Y0\\F%H$\O01P;+T\IXOYK
MV8EAI^9 YK^"OS-$'H$?SXU&57X-SUYCT[B(]DG"S;:\9=EY4)E@<^[GF?C5
M6@D-1VW& AFE8ALLR)S([K>3"(51L=XN24A3TJW? 2Q J.XL?\#H%&KXNE4\
MSYYUAGWH+^N=C,+5%RE5!0/%7F(1!X&!%IKCUM;J'Z73;DA75*C)?&!0^T13
MU-4@D_F(H!WEX&IWQWO?^WZT7)W9\;JQ)3WR,#.+W3N_JNJ0(3)?9UK#5W?/
MY1G,[EM/VM@YUF>-8-:7&3U2I49@O< \:!;$"6J>IH37?:</ST(B,ELW$<=@
MR2=G_* J(.EUJ^:UV(-;-(/*/ICY8("(5CSX;N;0YIAKVMCJE(7XVY_Y"JL]
M5ZQ.'&/YPPLOPE4<4,0A)(8.=YME;I:43VK%$3]Z^%5G%0#U[3737T<$89NE
M^MD_LTTC!7.?MLR*QHAB_.-I\8<)=E;)=R2^K5DD5>:8==P2@Z=_E,Z34-H0
ME-[(,9WN9(C#Z(CF!\MPM7S50%]W46A]O8V10_[2;'W5^/XW*)^TA^N3;Y]3
MW"Z!7J0QJ&0\F&B&G3B8]TWW(/B^$=)-^2)T9:A!AY9EB!^]W_$^OC$W --+
MM=N/K:46Y&FCJM 4 0:B(<%#TH_[\E2:?&]HC"I5XO?]Z:!C ;YCC6"\>[LJ
MH%T_CX^E@PBJ&W#MA  6HLU6):=#R35WT?O*RCK@]?J;BDMR #2L)^!7IJR@
M%AVD0OSP(A$.7#1;]&I,=(]4T5W0WYN6:QYNLT!M[PB;&3$8?D'3,[)#Y0O<
M&^Q\!5BD2<D+-H^=V-GW:&BJ3XKQ"5 ,]MV\E:D=FC(>(37R<VWU4O$7LBBJ
MQ8(.>OQ0!>7!_0:-=^!;_JA9WTO\_&4E[K32C9L2>:Z^MNN5JH J-X5W 6_U
M)E,<\%J8?%P)D,I[V^@@;E7OAY)DTP9G_8"#X@T[&I?-/UEE5YK3+Y*H-#W;
M($MA?=2PS?"*8[*2JLABYA;GDX;O&][F)?(C1:MY9C)@$TTG%;[\3R$S)IDP
MGLS=PFZSO+\+G"X-FQ__XDXR1A2'*\]OP\C>!>(,2Q9"=EN<"F9.VYFVU;6Q
M<J+=WW55A1K/PZ/!W$TBCWKQN&A)EJ%GIP6[CLZ_R^_R%96J93D%JUW"ZFNA
M %W(/F?53)IQRU:<\&-FCJ.+Z7R2!L@YF*,N,N"7YS^OR4/6)[E0WU&N6^+V
M>]/[C3?Z.8Y"QQ#6 VZ?6!=0 K!T<!3&HL?\S</&<W^RFZ!@YR2G'\Q13KTI
MP_DF_6H-6<7%?VC>6=\$K/_<P=!!S([ #0G<!*2,*\]_W'>*@A(7W>V?ENUX
M.(-J&<()!1330:UGR<>G*3-=2T&M(9FZC-63Z(XF[9>* ,*$./OA9KG2[2(C
MU*9)YC3A3<*^I>^**.H=^:P1\@+C"5UT4,U2Q4 $ZD&C]/$#1"^GU3(.N/B\
MX^X/AO%)J!;7JH%4QMQ\WXHN&::]0+76CMLO#_L[1&Y>ZO3$$EC]<B'Q2@80
MTD-Y3'<9JKC6"[B'RQ4EV]D8&I &(I$B /@^\&XAXZ$RQ.BW9NT>I^V1\[;=
M]+734.GH"84DP)HPVD41Q-+8>PGB\1KS-Y+RW;^@FSO4IFF.YWT98[=MZ-HO
MI59BYVNR!.D@]RT!P&YAYEQO\_C4\P&^#O<O*T_4JKD^GL[YU0(]_GRX)RGK
M?=IZ;X-0E]4ON<$.MP]RG>:Q'@_/+0U[:(D4K*DN.CB\R_"1SA,S?R]WSUMV
M7Z+)AQRHSPCQ\@R3I5,+Z"#O ;"G;6"D?D!QD"K^5R"W9!S>0.RP)(T NFFC
MZO+Z5>8-$1EVD>&716]MFEP!)]+X JP%SM^Q (M "5*NX1NMY*_'A6:O[MC5
M7] YC+TPQQWP..S2F=A%.<R6>'[44XXDA02[\+:K N8UJ@H>ASUT$'^H?2G.
M8GL*F+$Z7U]B[MW;N+^[L0WY @;.XBB"&'MJ8X-,(440("E_HY@0\\(<+G[Q
MYFM/V\^J==8VM,6;/YI]Y\)V#*PE>KE7@4H'P7MDU[WPJFA'76#! P^?'" @
MO\S303RS]^W='8:KXM*%8F<M0HIZO<G-Q9;6$JR*:4>;J E^&AL[@;>^ U?3
M5*4G64^Q*+(/H8-.8YYZ'3*W#[!?$E8BU*')MBFG!/G2LE?Z?;3K?!1TY:K3
M3;[V]'3]%54)3K-J5IVY563K[Z!XA"ND@BPY[3H,17Y?T5V.65>JIFY5S4D'
M+4#:C7V\&$2ZCN%81A0GTC$ZJ,."_,!AAG_$Y.L,@[9_F4%;F/]EK)_K,.X_
M*B7D*Y["UT/Q[OC<."S9 NL)<.]IM/; .P@AA\;,-C3],0/?#?%M.!?[5B%X
M&Q(0@)J"[3_[K2T1LK 55EP=9K>!5*A$BXCJS)[9Z/,7PVY0R:Q_1<7&-W*(
MV9-12&C3V94O";HOFY#0/\\$@9U<5 M?$S-1"Q(C>:E.:HOZ=MKH75806!R5
M.3KD 2<:@2?5;H;@ #MA5[_:AZ23L?)'K[[R,2\8'V'G9\%H70R$B/^$VOT*
MMB/(>T?%[F7005*[.]:,H98PHK>VI@/N,;4**=DT=(4L&R/U8RM!/WNRU-F*
M<7\:U:)4:6ZTO/$JVW .ZS)4Q9X ,-2&U4;6MA>>4XK&LD(6L7V0%8[BJ>+Y
M,;N/%8#H!VY[6P@.KT"(M[@GHG[+0\I\:@M.BC@'$C)<_BQ@D\Z%HHYFS/8@
MQQ]1@HJ?T4%M;&ITT%#XE)]^=:3,ZA]&SU:5K6E<+(Q_;N;1)82MC)PE22![
MY^,?H/[V6C+T56T\XS8# \)<5Q8N9IXG)=-!59B(7/"1UC E;;M$D<9:1!98
M^7SQXS]TI?(]U]<M:Y)$YQW(=(,4L33K%C4&Y=9XX3 -3N$CMY2K4@V"G,UJ
MZ:#!Q#3#LGE+<%B"$X1T*P*U^_8/X;6O@LF@*<WEJ(8B<9SQM(/A%B$(%TT1
M#L9?I$E^OWL'LI)W]%;O6:D[PU3A!1"7'X$H)V0_G-<G2 \Y-L;CGJ!1'=BE
M];<.MCY)K+]USD&6QFI&S'M)+O$C^@^<6=;I+5S6&EZ19!JIO%H.A-!8<<0U
M&"@L;!A_SJB&6=_IBOB.\?YRN "2(Y^7$<0$4+OOP58$'=^8L-U(.DAC:19.
MXZH&X/\$<V<'Y'(IKCJHE45CY<#[3]<+"@H8)=FUTT$22-6@K 7M-YN.#M8=
MNAMCA8B!L]X8S9*SEV'$THW/SY@NBQS#YL1+V5(_/[L-^:>P2,:Q9@YO.]CQ
M#]4+^5=95E&ZE+,,:T?3NIM4J>DT'<^CLM]N, ZOJ=QQ75-"Z_7GVWH:C>FD
M;7WO'R<-[AZGSD/\B*JQ%#U,UL,+.E;P/=W1,\6+MI8.1D+3L4M0HZ(=&P14
M>Q_VD8 XY2NNI#!>M'$NZV;!%/49KKH>,9!5!&O134Z(7S"0LA[9O1^@Z.5P
M9\XK7G>1W?A9W+F*Z\V\R0_8WOWU4F\*8W3J.>WGG#+U*U+WT0$F^S9"-7OU
M[4"Q8X-[;\;H:.(@EV&@?R6/X2H?JHY[%\7KKA/([9*\P_%LQ,,BSGMN?/@Z
MME$VUWRTNACQG)O33OAUI,*M;=^C0Y7\759_LCU"&G#"K\&B(16X-CEKV/<8
MNY7G5E8FSLX^6:UEU\26P>N1=ZHRJ&BR"P*A,ZJ2U?;BWJSST\?#'AO?W=Q%
M:/M7]C!!1$@K)(H.XCK'.K_%,F5[4_C4LMMA^IJ4*WKX4FD"MD>G/^#\LO;S
M/>]-W$=R.511JKWA))F3<NGW+<>@:8M_#O"5A6[SN%-']="$"</DM3E)(C:*
M(OM $\OQR"HME(&"*1=3UL225I_H&"ZG88UNMOZ;U(BG>@7\;_SN$ZO337[F
M]+9Y[T0@YE>)_#_\WP[5 OTSM.16!?@M)!ZKX#L7U1EL>&/WU!BB4+\F.8D.
M4E;<G6OR8/SR*[(70AR"5'C/%>%G]?I)VN$-?19&$Q^#">RT=X_U,OY^>2F>
M^IK9'_X9",QPNJ!3O/VKA0XJ=Y9:_Q:L381UMSJ\.(^[MH/A>WK;34\^/\VU
MEUIQ4M7;A-R->$89(52O#CG \BR3WZN_O2)Z(C /D_)/67ALE39%4W9]@3F\
M 5IPV"1#O(R^,Z+?U3MCNP%Q^W2@\Z_I.F\=VM-!,AW$37^X2CL&^3YMST&Z
M(;=X/,FP(GJG <S[IU)#2?% H0,:;%B&] N,V[EB)&#]-N3LO_LVN:#$[&Q)
M9''-^+A:VPFURB13Q<B;OSE2'@:!N*":0]Z3K)7)DS*"I, N.*"<V@R.FCO[
M@SC0BCWE:7@I<>QJDN<%1^7DN._2O.+%"=L<Z 9^C]6\:$T$*\.*DP@F((EP
M&L5!N4=TRYD/5LEEY<HQ(,S=S^$#\=TJ0(M(4PGIQE8*.A@&_,2X=F5-TD$.
M1Q&'RJB*/E_B/U439 S9:>=2&:MS"F)&^QU=V=@TKDP'K2TV9M%NA^;8HSNX
MP\#<ABHV(@CK'.XJ!>]P\^I6>Z/=QX@V:LJ)$&M+CT OE)?@7OPO_RN:7M(:
MU_&)UZ7.OD]@D7IK!(6S#=_Y11X9MC;NR*K47D<13/6:=?/;!L0 \X$N''<5
M.),.NM58[<&GSM2>)W"8LHV1AK&?<JQ/O83I4W;&HS?@C-CX <CS(]]&MAI>
M' F G+K9LD<'<:PZ;YSV'DGZ,]>:;K7*PSKM+P*5ZA4WCM^@@JS?4QY2$Y$2
ME#LV5:;G! <#/)B4_;UX+O3#*+OHE_Y4?'C_G1?6,\1 L-N,]'+T8CQ"PD'A
M=V&)3FF=WG9O9:KKLZ&R)3<=2X[6X?KXFQ0-.\R.HW$2JN4BPW]*417Y% 'C
MMK*_=5I30<X$P9)JJEWS4?)O]>]F*6E#5T%UT:4WF8:!T2M6OD5K)-G]PW_J
MK%!N DX+@L B^:+T'#_),GF^H9+66>\5HE<?J9=B9S/L.RG[\Z=%%729M1=L
M]P_U9R GRD<8'K[/<,&PY%:$%B%./J5GO"LU!>L6Y7'IF,$-?2:?932N@/>"
MCI\D>\W($N7D>Y(*7'\M+'?5(K;17JD*8TQ1?/&>K!5(D^WS$3?TBFFQO/^X
MVP8;Y85/Q;A3/;X<U1@9>P1[%-@:H9P"Q(DPL6Z.WS]<WHFXJ+]K.<%S1<+S
M%B7@:\;'789;F_\'GA1_(: % /<62<D&4N ;BI%S[HIM0#VLP/-%QM057V^^
M-Q7=4F\+<FJEV0JN6DKG"#[?A0;P>RB64X/&-]!D!/(70^V'0?#JU"^&YZXY
MZY,T/ PER]N/,K\:$UM\6*3=PZ4$XZ&G,_SAS,CI+.*3S$("6HA!#!A*L$4%
MP1R\ !-<M4C70XF@7*!/HAROB(5F#HTKZ9RSN7?C8B*?D5Z1QOXEQA2 *%!@
M= $->*H"BLSM\;!VV_U\A5F3^:HQ,8\\@Q0:R2[R^*N3M4R7[TJ#!##CY3C.
M[S:2;*(8L?$@6W7K2)9)@N?1%3J(,_#]_F3!K,;RFKN6FJ4$1[7AD$DP) QB
MB.E&RK9DU0RT#\3CB/>RXFAJU#I#85KWT5CR/([+PVK,MC,OW[8W4/Q"ZZW<
M _](%K>)M=J[#R\-^K_]>FW; 76_29,$;P5/RN(MHR,1\O.->J;#WI\OUC%'
M[GK=W_@RQ:Q0D.-YIO_^_/9L-Z8?%8\J5UU'D08ZAX/6VB'ERQ&:#+:@WBT<
M?28=%GM#.K$_93N[GN\I5#S3%%G32@=!N< ]<BCWL=Y\&#M4;G#_J45BA&5B
MEEX\SJXPH"JCE,(1R/R0Q+=?5OQIL;BTN)1L2P>].Y0B:R!_X42P7I@WMK!F
M.N@5C3_=<JS*YJ7;/=_S/9S-!GUM+Z_?_:SC;MA\K/TX]1:M%\>DKTU600Y(
M<E$S*3(Z:5VMMAQB+V;53WH5"OHKK3,SY;YMB'A1BTE'.>$D$<S4M.(D?'1D
M$RO@W"KFO1M3X3DG.6S%G-S%-O[XZ7! Y_[#>\\[;Y(O\30S($"<%_X>J"*,
MHGC7AKY<3<J+S)U^8W?'/,EJ*;G2RE8:X]7HL'M0SA&FH^^JTYOV=';7I)QZ
MW\Q($!C<_6_DN.N-R?0*C-*+CLQ@*RZ+5(I -V@?4]?=9MG79-I&_6LFM^Y_
MR>16@=#^/ LPT]C#,6NZZVYZOA(47JO?FZ<W>Y6K1K^9L&6N"YUZJG<LOS$$
MU:HZR=V,.HE4!-(7M",:W FOJ[+$[(TAL?TY!1V:NN_?%17?'CR\;/Q=SWN[
MVOG5<.R*H3*"G6C<>3J#WV[<\0 VKJ^!.$"*D2313\XV#<L\4^M>K+6R@O*\
M#\IPU!:9R3\. JM08$3''!**QJZ=;_OH3NMX*PJT*37F,R+QW238X(]:9SN*
MUR[RB>[;XA K'(47UD?$K<MZSX-YKBKMP9B#ZNV&$%>\U=IL9XV?;]<9ON I
M+_6?:HH!8$0-QD0S;VIEN%_5KCG"O5;E6VO/E!Y309 W[MPS???1'O0M)DOA
M>NR[SS\M1766*';D,Q1-DG8,PKC4H^X@A@+ACA<TCJ_$<'GB7*O';\*4&G*<
M@G(?$=$R]=<W/Y]R:_[,S?O/:P= X+U*ZOL&8Q+;]MS-#7U_TC6;\<HLM9LX
MSSG3NN_,92'!AE7[$G>)F,@&G7D4Y_T@O98CF>KT/(_G[Z96ID(_73E7$RF@
M<$YN'@021/[+9T8*GO\;>^\=U537[8U&44 0$9$F)2I-04#I/:(/(/@@(KU&
MI(,8BG1(% 2D1KK2HM($A$B7&B 4 1'I30@)1>D))032;CQWW/L^[QCGO.,[
M]W[G.^/[QO/'RE@K:R5[KK7GGO/WVWNO.3^M<^M%Z;?$\W+LOG'ZP5H&?D1
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M,Q1ND)I5.S@<[(3=3E(RX"OH<_.&<$,E B&4P,]&QC3V"N1Z@Z01R84L913
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M<KF@N7BB);%?V6'F^5!NV05MJX]A?\02E6RC-6WMZ@ZOJZ%GP&> Y^B 5CI
M>ZUAT@.TXGV%LBT+NDB"6'+.AG2$!,&7ER>)0?^Q#4B +>2"\':89Z#Z3(3W
M CPNCB4R/#3EF'_QD+:W'"M0,7/KQ^::8;XEBR2_Y%:P9.3:^<;Z-V+)NAQ"
M*9^DVO<N)K]'71J2%\+$[%Y=4)"2S;#:0BR,3I<,%X_^&GK;B?M$FI&J$+BJ
M2P> )9=<(OXE_ AAT?G7FG/^V-_]?_?_M_5+]B)F!!=*-KKQ.^LX9"\R[H);
MC*+T/9$#DQQFRX[+5PH$0@HO"NG%?_7QD=Y1(%8P+FPL;0+8$)0D"W+=)DG
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MEX4I;#X-EN,VYNA'86961C](Y#MX5' H=MY$UT_8T63.9@9CT^<2YBWT?5#
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MPHFOQ>=I86V$5JMN  ]U:FZ#NOPT?/>KPNGI'9?U5(1-*OC(<'V-#F!:0+[
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M8=#;WUMJ .(+N61P.4#-PD*H]/<&.,M-)(4K9Q&XR4.V@PZI9[UL$5Q\6D\
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MI^IX@JIVHMV#36^V$BSC:ND #H]AOGS:CJKH?86!ZP)'IY?(; 0XZ0D=,-5
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MV$&9H&D#2@IGP6*85U?N2X[O(WAL[-X7A[@D]ZT$JGX[QI[6(5H!^^.\Y9:
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M6?3S?^>2L$U#[YF!L*0+21='T'K:!W\T)KP9_:G5E6C7JPK?N Z:L7_7+.N
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M9,->=,]!/MPH 8CJSA.]Z-/0)" A/:*:1Q=YO5=3KH=B6OL;TA)$">3$<4[
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M(RS>@BS51.LG=C21H0+["5X%:EN;!ZQ.)KKJNS=?G1JT/K*,&-5S_P114\7
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M0,%'$<"]_C\77[[]P9$:J=Y*/[T@;P:YW& =3+ZA<<]"+L%1]L>'U\*OT2*
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MF"P$5YLOZ<1_+PIBNM4USCF\:?MUA>929_D']< :2UXZJFZGLQ/.(R81\CT
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M3P@H1TJS_WKAJF;QM<I3ILA<TC/4RB*(M^'=^W)>>FJNK3?_68\$K FS)MH
MPWANB" @270A>,=X:MS82'3^85&OMN*7F\QHMRIBG=F<=*/^W\ZN)&X8C:?>
MRI:/A3\$D!SN7=[_F@VQ;^788F.[\['*O/U#AK*/754>K&<2='C_VV==T)Y4
M_SN+CC.FI=X +W5L!.ZRX;?O !(D$U@$BL=.<-9?0*KVHIVK3D KP65)W/)9
MDIY3XJ-!X<=)^G='5+U*'A>HQQ23E0"O*I@+CBU)4PSVX6 A9/VB^\+V_SX+
M.ZRN4'_NU"VAK#1#^/R-#/OLK@(>2(SAYT+*Q*Q_A\!712'5 7?!/RF9^GVA
M$]'H%[=I?=)[\+H8G5Q\WM2 55Y#Y>4VG!S?-EL%K,,RY :CW:3#DS05W,K:
M8_;^UQ=],GVY?,?'QX>[SX2;ZQ>(@W<"F(G"#$LGW@>4-W;93("0VI7UFO3R
M=5WU+03_IVZ7D%P54>JQ-I3^C3B7-'GP6V7QW)MK$9C]I2Q=(!1G$J,&COC0
MW(2W0$%8;-$_@QWT)E[\C2SG:K=I6V[,:"9994Y^]Q@69_;;.B/X& 0:27L&
MYI D].5<3.TK*&>G%':"<Y(3EL:"-,SYU?2@5,I]*U)N*4E>%/R[QZ?[[A:
M_#_(1HOI,\\VVL..=/$&KJS'(FZY0_@TN$A:9)79Z@$Y%^Q[^8?XIL%UHG:V
M9WVA,_5$%J-3"G/W_,-(LX=;ZPURJ"ET8-]V]3:T"3PT(3^(+B%_TBWI*_@%
M?5;WJ3GQR?NZWVZVWYY-^@84/Q5DMJCXK^(XL/7D'A<Y3C=D8V+/KA->[= @
M?B!04]"+?M#J<HOTIZ5M\V=WQ#F"IL43:0=D6]DV/_/??/ J3+?^++\,29J4
MB>,>^M^G($&R \&XVJ4&?AN(*1L.P3$!#AXA3V88.BL-&?RZ%A@<J (_27]K
M2%'1GB*<@G;F<5-HTT%^HZG=&^5N4'RLJUHX= E^ZXM39HBMSH'\VX]SLDYZ
MZ.\*D)O+T@\_[MF,@JC1906L4@/Y+/[)G&0??,^ T-V#11)G?[O1G[HZYC4/
M]T#-QX8O=%8+'9IYV,-93=#Y8:!)Z'"U%+&^?4'C5@5EG"*%UVYJ*IY%]NL7
MPR;[-S,I2N<W_Y@NITW?Q)Z"(L.?<*8HY>N?(7Y/'YB:;%(&MXL@1@*K5;\"
M*1*S1ZHO\]G<VB4:7SL468__/&9.O"JG,=/H$_TFDDKL\6.^ +BM!=&7T',6
M [D!<&/^SK%_X4GM$%J[*2M10Q5W_F,X^@ WQ]74D^3Z2$?_D9(K^F:4XR/6
M;T\-0\S.5,]Z#.29^A0S&4R0?)4[&)"3UT60&YKV0%YL^K6+IIV3^=:>9-AA
M"(L^2!5XZ>&ZX7S)W.+9DCCX$7#\ >Y.D.Q?-42=2=#C^,90ZH'CU#]*P6M-
MKH>#SZI1!G6UZREL[0*;]&F\+*7U9[/G%AZY,WP*HC7"\T1<PH,C>CP@T<%.
M;ZY@GU_"*]2O\ G%Z[^8DE?.E>^0;TQ[+KMC^5H\9[?'W7MIG=@#E"A'=2KB
M+38LHAI[6&"^O!*=383G&9J%FDTA%P9\5U/ZG.Y=JZ=1I7O8U<)UNT?G'P;A
M3;'*NX<N!%UC L\NF'0?<+#$+^1>/$#:PTQ17L^.LV3XDB!J.N*->D+K3T5X
M'HL+6O3\ER\Q)=#DB<3HY)DP+EFNN%/I+GV8D[7C-73TG8S= ?&I,/KJJ$SJ
MOD;V07J<O>.0]2;](5.1R L:=PH\KNO7V+EGHO-27!)1*Y^%/K@6VSP5&E!!
MWFGI"IFX2'60GPQQ@0)7Z=H(ZX^!$<P^6A+;G,\YL( 0FFUB8URQ/?-:3S)'
MDFY.O!)_JY-YF\HW3N6>MEW6G9/W$ \P#UQQ@0PFZ9$#IC5,_'&W0@SC'R0;
MSO*/CB[?:<EV:F^.$RE]N2@RQMD@_'#Q^Q]0;>%_VXQ,[OV'&=G_;YJ1HP=T
M; ,GRH-_U\-^&['UUKF5/NJNST2?5[3\EL3;4B3W%M[H[.FB#ILR0E4'Q>PH
MDS3)CT_>0)Q.I(AP@E(Y]N39!LK\6*IH*U/>A-^VL85SDOLL49\QSD2ME!S<
M# B_'MH<!\)1F,B*"X@+\ LSFN!AI$=H]9);[>5"Y.7-Z./';QH7E5E>M4JW
MW#2\M*'BM];M-PUQ1@+73&(ZH;6P'_=/RBF\0B8#RL\,EROS:4VDBJ_F7UZX
M.6EPYX+S$N^&[%Z@1M(ND?8_ML[&(I@H*X'Y#<QGC-R8CS;4@K#[=]UU4]SG
MMW%+&Z:M;DBK9(ED=_@L*O%:V9_9,06^P^NCR762@\1\;!>.^$A6BR!6 X$?
M .>E9TTY8&:84$%[^/@%<>M WSZ)JQVL0<R!+AJ+"W,/SHE&WHXS!O6.B%-<
MJF4N/J"RV1_LB>IF 5;Q8[: +H'>6-E*+O;EB*<_@]FG->L:Y:L4'M-H\YU1
M-O>?905L.?[Y7]<WZ ?EPM?X3](IRL"QUIPF&$"$<,TWR6BJ#I7BXJ5X=)J:
M\BZ?4[=Y6RBOEV;@># YS;V3K 5T%"&^<I^"+AS96A.#"9(H O;)RT.Z!NPZ
M]Q-;7:FQSE1I96Y2<V+NXTOW68K)R]'KIF?PA.J%4I.-"H#C,YQA2VQZ+_^$
M0&DH&"S^FAL2V#Q[-,9KI?^L(5[BV[79SS.&\D[O=OM%S Q^:M*1Y3L ;;SW
M7<!?LUQHK<B^],?CN7".EIS(R#%_7UWZXRPVZ4B?8Y(%5!L$.YOF9^Q%2[/0
M>;6,? MH(YAB.WW6JIJW<:<@YI_'\66ZS__05#=67=)O3F\ZKK_4=_4R@_<3
MP ._W+].I\G["\RDR?_SEU<)+,0@:4R_,>T1W>=9]WTXA[Z8-"">9GQ>\<OT
MF0Q"3$ :=(>F(I"-M8.0Q#6Y!0VYD%+RHSG/YWO2"K_V[J$?-D8_*3)S2?8:
MPF!N:-I=UZ/L!B-1^='HJ9@S6;*!,XF3\W+I(BB5> B_D\E.7GK98>VO)_)L
M5--;=>^[RF>Z;V'&-T,,KE!_AR2#&_9W_Q"H-U:0%Q%\<!@06O2S7<&;)^JE
MK0/*;TW@LO^RQ*Q3>--8N>,:_8C S<O*GZ'5@!"^A?AU^C+A<AOI-F6Z&[SH
M+Y#(LX.XT/R%K+*PP/]RMRWO.TZFKT; MR_LB9=9RKEN>\6S24@?9D6^?-*,
MN :7[0$423ID;3QM4W2=FT1T6RWL<C\>:O?D,Z/A13=5=FL#0MK'A]]I5PP*
M5,16X#>PU4Q]>0*S9# V5$E=1MZ@+F[*N"$2GG*'@R9)D6CV@'ZF]G^I;?=_
MC_][_/_TX*-<(4"CR.P%*T#I$$+T7W5'A77_,G=E?>;KM97J*?0XC\%3$/8'
MY%,6<9TL=@K"?_GKDM_CDGV2'_3-1>449/OM#^QX-8Z\> H*3T-\S9,Z*=54
M<\^AS6RZ!E-&624T!]/E7HS4OI$8=VLY[,7^)>;'^>U1CY'L$-7%HQ], 'W$
MD--%@NJ0J$^E0LD(J]F(_\OB33[;XZ:JHXX5BA6NI_BR/.V[QRC'5IAQAM+&
ME&GVX=)2:]FHDFUM2+5G,Z1PB@FH[:<H?_'J-,5,L3_90GOAO)OF%+:+<_BR
MYFW/T^,5"Z'Q9[=MU+/,.8AL  \;R=WN6BA!T@%9#^.FH+-.*6\+;UZ_UW';
MF'U#PI#]..5F/E:,&-XC0J!_Y0,_GSO,HDHR,.-1D/2PE73.^77E5XCKK$EU
MUDZWD ^1,[D^Z)D]FXMY[F8YT]I$Y<?\)V/6T,>SMK*CA]Y<B*_K]<A7<&VY
M2+@721>0TIVW%S'\Z(X0;P['GO_U=A7%3-S(.<H!6H;Q_1!,IR:##\=F][G1
M@=TMQ#)"_G?O()S]+]71*>A,KLH3$4!+67,BOF4C)A*N'<*?+I'T&B?ED?V%
MM:0H<8S-3CO _U"7?'&?^ 0/'4I>&AM <BE4TLYT(C%&PJ$A_0B968@/TDNQ
MV!EYY?Y;WZ0R"QKLDTIF+KKN9\ V*1AN!9P)?II=@ \;RC/@YR9\#5C"/<0B
M.3W,(1UOM+S]B(:E=UN_SLK?'?:F<O0?U@"%3E<CEJ#UWU^%!CJ4PY]_(93>
MMY^KV=UC7FA^Q-:9OJ+#?^5)(.NH1;?4ET8C/VV";*H7CHW5@[L]*NJ;E$S)
M[XS^,6;"I\\O_24L]7[>Z:O:CUEGU>#$-_0&NZ#DJ&"^RT9?&N,O-GR:K<:=
M4WBM<UV7P#GRS/=)FK'^Y6ZYD_>:8L,DT3/GIJ\I0_G<G*X!9I6#WUQ3PG]/
M!]_X.?OGH5$@5_L+L==CD\L\C-U63YGK1,#V\/O ,CX9LV*>!G\ O"YQ32XS
M<)CUJGT^[]+E,W\IUNF[_8IHFI3RF49OW-\Y!>%"WA[MBN$F$[P_MH>C;\GB
M?GSNNCF.%84VZ'$_[$JBDHH(#Z9.SN[!I*2Y@QN=XS=,EK=Q QZA&VQ\P(<?
M)C-.;_]$Z$SO]L?N5#=0RI4;]I8321>;C?7_6FQD[?S&U";QY'$2Z)KLO86;
M,#W<O_ZN153R4N5\[?,1F+CPO$/BM9V2S89T=?B#I]1:..3P>@223K*^'GA/
M8#.>>?Y;YH?QIYR[Q\IW$"1=1KK4>=@8K8BC8\(T_L?&<9]<_#'D&6!-L+A+
MH,$MU4A$Z,T5Y>FQVX@%542^C?7E\0CS91BF!PO!?4X*FZ8 R1_DBR&#2&&(
M*S0FYV,I?A9G'E'LEL.6^'+;] 5<Q>O90&8DDE'_1II+PH6)@YLQUT8UTX&K
M!92I4]!%BK0-8@D)TC KW/H"RT<Q%6_S_)4O)SFFWJ^_>[#;9YEJ.1T1A@EZ
M>O(%1/]I^G\65J2"FLT?53.99)DM-%V1D;&WG5FQ&66_$)PI>:XU&7 W"4-Z
M_ULU&97L\?WYT'[#Q.8I:#U$:6-=\5!R5YZ0;P&4;"QW:3(MVO+<;X.])#EY
MIXZF?7RFWB"((3ZBKX$OA$%T%:JA!HLO@29;GD?A>PM.JUR#C873PV5/7[@/
MP@U)\G"7>0HW0)PUR?N]K#VW]TCH[E+NM[L#5]ZRCI?RW9IC_Y7<7 :J4<8%
M[C+A+3 +A2Y%<$,@L=0M\&^DET12KGBT8?F&:72J?8)"%!6F>[6HK6:TFPZ(
M)^EO0?$F8.!*:3+E,F(VCVINKQM,-FN9L<>O#T@Q*;7:"GEYC2JFE]%4>-]4
MU\E71=?3A Z[TB_UL&JJPWD!E/0G^#6@J!#V&M.LO\>I,U?4>EU,7>0FC>28
M>NJBQ]--O6&Z1L0EN#Z>K1_)/+8A]]KN^NS1+5D^#N6NN1IS\9NJ_3IMI,GA
MJ#N9#KTTB_EP)GQ^;SX?^<'"*<BC)ZQ;8EI174[P)[>YU?N]&-'.0#_TF+KT
M#-<OV9$!3UYZ8:MH/J[#13(W$VXO R^% _>"$_G72KU#2@ (CLF=?S_Z$99_
MR\/EWIW@%&[:SG=Z%3\8ZXWX]VBC0*%!^-D->I1<@EKH6@E^<<@\N/Z);6CN
M@R0Z*9EWRUI!?O<P&D:-T8Q;YVF$HXN!9(('-J;OA!>6C*M-/DIF==NL(YZX
MG\@4THL\[4@IRGPXLJ4-_W8*XBHYR?D-X:2L0GD0PAZ!+^!FG5\4O-A0PN=)
MEXM\7+SX#3+EU,]/2[:VAF2"6V]64'-(M8[EI5,8=<MM8?&4\VT$9;/Y3IF0
M8B-(9'&00M?# K?=KP9O69^F/3GLA4A]^C4)*V"[BT_>C2==AI%LFO'#X3UN
MR51;[1G;M/6?Z@A.Q>DV-U0&7,57?FC8WZG5JYU,1G<,Y#=0_I5T-\"#8S3,
MJEP7URY[QR!X(_HRE69U90L4[;U=.[RF]5-4J ;>4H1Z?P^&%I)$+.$/9_]U
M/EP \Z]M=EJP17I:V)(\.%7>W6WC2!]YPTPOF=;7<%LH)EE3!,:##8RJZ?0C
M2 ZI.;\JLO0DV556V95T=:JOB.ZEW>7R':^X&21-'XP"+$G:<!I@PS_( >^Q
MH1RM8::4SZ^/Y(GYW2J+7GV24C)P/R#\SE PYJ]%!+)/!W=2K,C& 5.#4B&&
MB%!>#:H"ID3303NA[GDO,^^]487KDDLE:[-_]&8^<XZF\(F_#EOEX4?69>W2
MDT2 4F(H(6;(9*D#$YV(4:]E6YZ$!V*EY%B6W0*; P,^C8C$89]JKX$X//WR
M:JY7"=VFKP/&B,D ._YXD 73(P"WF'ZY:JSXNJ;Z>:V9T8=1'T[C]8 552QS
ME)9P=LUD2*Z'M4MG>ZL>-I%I1#KI7,6KM($\$/6[Q<]GS&W0PV -/S/DX8@5
M8!;7J%_A#N%5M$4^("0<ECEWRMN:.-^9PL<6FIG]+ (]Z[:+)^:>I1<;Y;PJ
M?AD34(Z3RE:$<)*M6@"O*G?#&QP3)<-7?7/[IFX(P-B.TU^HCGRF_V7RKVZ.
M&"9PT-:M4QV_CTM*KER+#VB-6YO<N=$:IC2KH8J#15Q@3MV[K<?WS<(%*H+L
ML_G]$J E00 V8A2>I2H848)'X5BS?(I#$\]YU;\,"=H)XQVX><^,CYY&1*AR
M^^>JQ!UQ3\9/M'I[5ZA<_ZMSW57Q5%&=3 O&BO/.#F'TY26UP_F *H3">'5C
MGQG('",R =HX_:..JT>PW^!8Y0#3BYF[SJO?W#;?A-?]<9A(16X69%Z',0ML
M P(1#:SJ.#5+8PX#68LWQ;\?A*\9^?],F]DM\6\_/+P_E&D1D1$<1YR6W3VB
MM(,#X29G[W(8V2>O>0&6!Z6'+1+;\;_F1-X,:P3+-*V5I:JH7)NQU+IVE>;"
MG>=L-A8U<)J3,J1+,CH9Y0MK((8 @P5 \^BY#[\:0WZG&9K;IS3<\Q&7UA51
M*Z_]5M.QOY1+S 8&26+P9S,(%3@;P1%MWE1R_SSC[K<U5"M/<^OMVYD\U,PQ
M7\-YST%*#[T_$$U.,N1V5KQ,JDI*&S=??B-9W7@4%_JGY/DXD"/H'4O<7GYD
MDV?13EK-7TG>-HC#G(*<]I/S!$[*3D$NR?2(+WD<87U.N%4ZECM>EBC%JH36
M3#JQ\.G/PC=#'RP&08=YJQ3AW)=AP83-=P()Z:L*.XLC14=ZQHHBI3PO?T/E
MF7"2 ^LQ/0QD><D$BB1LROA+8VOQ$_2Q:?N3U&*'R,1 </97?-G-<1AH41FS
MCNX@OCCS\?31<$E"UMWV^9H:<P8%\TYVJ$(47R])(=<)5*%^SH+7=(KK<(I\
M\11D U3B=7&+??O+/+J 2^ &E :NTCVW/HAF2=M+&U_I3=4MH^WC>PWO%XIF
M#Z,I2_FTAQ" WS])[<$4_EU\A;@%YR5D9H?BV&+^CLS1*%^(;;)F<&K.6;-V
M^P!1&QIZX"LOH'"[4M#YTY6_UPX.9DT:,RF4+161<*6TH.\OROFOC#A+AH%H
MTH(MV/#[Q+R3?(H,+!)FBIT:3!0SGQ-O#LFU#G&;^FO#T&?GX7N;A[U<A">V
M/B$ASV.R!U-., DB@<CW9SSA9E[%JW:NFK956<KQ;.BW!DD+L4\2#^['$J0=
M),9?W58=#)+<F2<H;1-+ 5M\/K%^II/I\GLL.+R;OR/3"'*_M2E4UV(^Z[Z2
M!?<"(:@BDUAW*2/FW<^#?"GV"M D%3&SI<9-6&#FXZ+BKHZ4H;K_ZJWQW28Q
M/FIQ(I]HY] RD7#RNF;S0A_)FJPBWFH,=W$$.7SA<.R5I&M&.N^CZ>^??$3P
M+<&M\8NH?,Z?_+*5YZ:*1G A'JZ.W:\:7C]2<<G(8+W)%+G"9QEX=0+^KSU"
M.4&WMYJ:: _\*")[+W:J>A0@^S<)U!Y*5K_/&-I2P$-1?</O\!*ZUV>$5_ +
M_;K:\Y)2#S4X?W,JDG:U>MQ0IFFB\8/>I@X?<U5Q-(TO V9N<C3.]BLMM7AZ
M+Q=!F7PARP"(^4@9S3E"?[-Z9\?>3FA:66>[-*]%3YFXE@U#^8JZ*3L(\G"P
M+TJN]3SO@"2CIW86:V"F1$\\ X$G]G=7)L?2^V<"0IDWP4<?.49_<N6($*Z:
MMEF9^1P;@3P =>+GDW3-2\#'V5X*]4F)!DNUA_+!VYW&:KE![H858PSWM=2B
MS&<@R5=?.&WE!J#QZ\P4SCLND $HWY*;[L/L#[/5/U*R:X4L_*1O7)&[:O8G
MUDQ%\!WC'U,B!]!%DH%%;,![Z,EF)#J8!P8YE,@ZN"?3.(]O>O/(=OGB5?%F
MB]2[B2)7K%\(/6CFORU8D[Q3A!M;3T+B36N3*6H$ZFQ[P+OTER8'OO.1KS3V
MS83,TIVEO!"OP?84LR#0 _KY/#9"5B1%!'@^.Z1)1Y!(JBV!ZG9//9RM,7=U
M?J"G;JE/3W-!]QF#1MSWWR9H+8Q2_(8??L,,J/MPIZIZ)2!MJ6N+\OW[?=[=
M;\@VP:G4YLN7EE_TJG(13F)VJ:H1H\C&GMT(#)2Y5<TY'LM 1F+'Z/F2EDVS
M3!)K&.S>9N*>9,>89-W2GW(B*<.%IN$69\G@H\E+T(!ZMA.R4!,FU@MR>\9_
M:OR9!G-V;#ORK,Q2BY[^2'& WKD-?F;!0Y C)@&T^&=$%F7<_A"4!?8L))62
MR-U5A7)U/@7YC=MWE/W:M@LYN^@X,(TS05,3N8% @OJ0\HRM^R+_O<S@Q)6)
M;%F)QM;,+Z,_.B I@GF;KVO/#'7X_'(?!+4>WN]J=DC8OJ?5YI=QP]8QE)46
M%)KZ83O8)/:HU;^+Z4'<U@PV\(X/TW-].I^4D*1K\[#273.2ZR]P?6D\G 5;
MRTZ^0N"N]-I(YK3ZN8!>>/^MJZNQOIOQ[3P:IW]W<T$A,F;HRW)KU3X-93EG
MXA2T"_F(&,_G@;AX7X!Q'P_R&TT68=[K/I[WW,LR2UKASA"2>3_861'6W3]^
M6W!#*H7-!H@B&/:>@I@\96H[72H-.>TF[6=W/#TE.SN[WHBIBW,O_#PT[N-Z
M5^4Z<*U!$&3D3&8_*:"P(J;7N/.'H+1D'^_JK^BUKO=[GR7"/0PCAWXZ1SOJ
MV_ND!+27]TU*;7J?673.;N46,E=N+]JHI:^TBU\9%>INQ*:O>?D5]Y;J\\Z6
M+F:=K_'B#R,$X%^%/%8L<-X1G2R$9%- 'L^#2<H*W-AU[M,PV8CU>FX_NRO#
M_/:U1'>'WON\(,:4N+K/.^SOF\M7;M^JB"/41D":E5()UI:$4I3A>K350@:!
MLY?CS.V'H;\O[5W6OZ@@CS8^T&7&?R[F"G EI+;*;DZ]_[?Y(/PM$+^Q]JH
MZ, J[WAM3'@8S,&ALC$U=E8K5J>@@73/7&Y]K>MKRXA 1GCKFYI?OKT7V"K*
M:G/@M*<@6EI"X! ]X4PK1!"U"0'5.# 5D&?+?WRW:WY'1A.6=5.CA47L=DS
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MUAL+0&Z4MRK JOX<'UMI[=C-&'DS6AL#SY'YK!%Y ;9"@UKJ!=C*O0!5#J@
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M@C1VM,U1?,#OC: N3]/. >'JD.SH&-.>?9U3\^!(Z^S%5U3Q_*"$)>6WO5)
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M.OWU.E,9[ =-88"1^4:+OS@ _NX4\.#W1A6@=0&U,C9;28.-8;'+-(51)MJ
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M!"/SE1:[UZ!S ;:20YD74,L.?J^E-VJH.B!MRAXV9ZE2%D-/G!YE#\IA2M2
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MY3JA)$J5$\40))Y:YP4^23DG7L@CH_"SEP^>&Q=L"\EJX>RKZM9878ZM&(K
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MHWW-<_X]6ZVN[N9ZE4W-R/"&EAJ9.(]W=-TI!_K:M=VV0:=??1K4TQ"T*BZ
M4G+4CJXNT!^OI^M5TMVZJZL+: WZNCH99MB\T RRI(@PGT8>#,+8ATC'=F'.
M0O63'P>1AU+&(ALZ;QX[-Q;^HL=H>=B.:EN8S!C27OF1B>WNO,;6)+2OH"/N
M:!\ZZ2>_K\C++_7%7P><[%XH87.T7$U;86Z)!15$\D@M#1/E886$0BKB$*8!
MYA@SQF+?:&/I6D%FN5[<!4,"UA2XTJ&35D=UU]C&X)!U(L1OOY9<G"LXUFHT
MD5DL#DPG,L]$YZ-CF\GN--0!MF<//Z]Y_G1GG0Y0V#O:=/&\83[B6U+H-O#E
M1U'4*8EWM*S#HY8)D\C#B,(HK6.-$@RIFJB@""/,/9]BC*P"-T\--+<I2*_F
MVR+'VQ;F@+R(UFYJ?-_5Z\*NWC?KM6SZEJ^4"<J_V3FB)VUAYIJZ0'CD*:<3
M41^--CG3X/=.3(<;EI>0<.35GAQF4C_WDK(O/=^+UP\CDB8R?5N/\;TVD@Y#
MUQFS82A"M<CDD&$/JW4G\R#V$8+$#T(>2^+S@-APR9FQYD8G;8K(KCAK)^R@
ME.1S()N1A"/H1N:)P:A94X4!'H[8XMQ(DQ*&@<HO.</DE@%+Z'KJO)?_)+J[
M?75??-)]Z=_^$ 7+U'KOW;J)]'BW5I/ONLQ8'=JU#)0'PH(TA'X<^!!Y)( X
M4=S",0V$S_R$<<]X[3Q$@KE13"M\"40K=]TJ\K$)/EJHGUOAP9.6WF*Y-L@\
M!LOGL4$?F9P:AR^7H%5 UX2I5=!KK58);8$N9'6K2!.\.K8!+!;*8QMBHA7R
M6 :Q6QE? ^;9)?&@!T^W%KY&[[U%\%4/&GA"LJXRGJTV5?;4"PY^6Y_="JX+
MT.KLRTWS M_+EZ[SJ^?C#ZC],>H'"<$L:-;.B"4,8AQ2R#S)L(]C@>RJR8XH
MZ]QFM+ZD>_%T USF,4UL>&0T#\.-?0XUS&;VYU/CH^GJT&M$2:<]21L?\H/C
MN0F&'#9EJ"%D7CSH[=BFAEL;T\Q#(GU$".1$)A"1D$&:I(KSTY2%"$F/I4;+
MD@OCS(VJ>V)>*H)H!:<9M3H :61:/,1GA*CP"S XXK-3HTS*11=4?<DCERX?
MZ#8V_6EZ,3NO-T5=)L<7(?*3F,/8)PPBSP^A^OQC2+CZI9_&?LBL6.#D2'/C
M@:YAE6A.I<KZ:"2O:^:P1F*PVBEAZ<*=A)MYC,=ADL PD3%$,L(0"]W (661
M[R>1I FU"FUR O<$T4ZW@=O0WW4!XMC>:HM?3\@%:,5TZ*M>0L*5IWERG&G]
MQ$OJ'GAY%V\8L*G<.("D%+PMD7ZG]Q.^UAO7NPI\7_(OZK?LF[A?B];E"*F4
M6-<FXC[7JW:20N(A 06-%*D(Y>"%1@OVJZ28&Z_7>L!:$=!J GJJ+$"OEF25
M@U:=LTT(')K,8+-Y"D.,3%;#;7#9UW1H#(N-YRF,,M'F\P@?B-V^\[58GMU[
M'OSPZ?:?K]5_;P_ZZH>-VXU(-WCY-7L22R8#GE :0Q]'"43*<) BE*IEAV1A
M$&(<\6B,+D2= '.;IA0 Z3C=A[:0FSF_8P(Y\C0SJ-N0UF'Z=D,OT9NXS=!V
M^%FV%WH)SM"V0@?/&5AB8TNI>LM6K5:;T)$=KY:OG@]I]SLI^/UCW>SQX CP
MGT*?# I^]Z14^"JZOW\L,B:6?IJ&OI0^#!+N0>0S[<4K>@QPY''"I1 RM:K9
M,:GX<^/5M]N0DI^R->#Y:D6*<A<8:UF5>N)7P8RQYVO@"9<5?=7[[FL)Z#,X
MZN)J /1<44-P(M"B P*T2&RO C46#LNBW,2&KNJL3"O\M(5;;F*8@THPMY%B
MV'SY052O2?GMHZ[\SP5_]?R;DNG=NFT7L_YZQZKLJ2DB&2HO7Z2801&E.I\7
M$Y@F@0>9E])0_5'$Q&K[VWSHN>V'ZZP-ID0'CZWLFK=^VC2QD#\#V6D R%8%
MNZG+PBIFT\XX6(\\96B8M=3@8Q_FWSJ8M\*#N\LP6Y.\/6*."-IBX$G)U1Z0
ME\0XX F#3TSSS5HO-S[FJXSI4 R[Y*;3#YC1Y[$3$G12CI+?=!D,=P=+IP::
M^F3I@L)'CI8NW3%P.:OS^SZ)1_7.?"-ZQL^_%N3A;E-]RPM=Y>/N08_K+Y,D
MC!*L:T>FGIJ;6>Q!0IF:JA$*91"'-(FM\B<-QYW; K*IY5QLY=83M!9\ <A6
M=$!JV2W7DH9V,%P$ND=W[-5;#>Q.9/"Q W8G-;@[#ZS].LL.)E<+),-1IUW9
MV$%QL"2QO'U@=O?#XRI_%N*36.EF"T=".A)&?(X9ATF:Z#1O', TT,??Q(M3
MPC")(JO4S(LCSHV@NDB01_*LQEPM=+7;3=DT@"D:);91-I;IW!?!-^,FIY".
MS$J=K+"#;MP &V-H7&5\7QQOVM1O4_4/<L"-;QS&._^+%'69L_ILX75>5DO"
MA8BHXAG*?0X1E022F*<PP*$?<YRB1%IEPQR,,#=>Z00$*RTA8$I$._HXQ-",
M+JY"9F1ZV(+2GBR^/H>*-1N<U-S1UW_X_$F_]I/JO?RZ3U]X11W!5X3](?A!
M*7</\QC%B$$N$P%12CU(O22 -&8D2'R/46YUW'9FK+E]X;6HD-:R]HJ6#2@^
M> );PYT1-XB-O352@]6(.6Z)? ,\7%8U/#'2]*4.SZM\M/[AA5N&L<6+-CVO
M25$\ZZW$>D%SM+=PDJ8HT,Z #)%:>; P@1A+#X8)JQO7(XSDLJEG\+DB167&
M)-9RV'PM+Z49[\-Y);YF:YW<!NB0WJ#VUDBE3[PHY# .8IW(INMK>$A"Y:3Q
M&/N<)E'86N/MFL_&%ITL(ZYMUGQ",YB1_ZC CCPE'#9^Z\1O]ZT6HW?)'@R?
MHQG$?OQ)YY7!\+R<;88_:-@<]'>2K76-Q/NUKI]X+[NZW,L81T2Q6PJCD$GE
MKJ8(ILCS8)2DA+($,YYX%AU4+XUG]+5-WQ!5BPMTK4+=+B27@+;BVG':29!U
M>ZPHCF(H),<0A7$(%;8I])*8I"SA**:QS9K@*G0G7!!\$F15;[M_'1=?LZG!
M!6HCSP#U>_B3%O)G#=>;K'S,RZQJ&_6^NH2:-=U?@L01JY\<9E+ROJ3L2XZ^
M>/TU=2'U@YNJ#?I,=J.XOXT_SM?E*R'S0C37?2$_=)F'JB!JC&RM9HQWE7@H
M/RB5==_N?*5&^OINK;YF42I7E7M^'-,4^F% (-+Y$!1Y#(:(Q=)GOI<PWR;^
M:419YQ8PU598I+4^7<';2FLTI"+E..8UX[F9&&UDJFSMU9*E_MK!3E6PT[6S
M:'M]K>X"[*L'.OU<E]$<U0A.RW".(^D-RGB."OGQ,J#C#CFP*D\A'DG&VYKH
M=VM^KVLA-$T^NM-6[H74)V$ @X1PW=9,ZA;-$4Q(("*1DIA3NPH]E\><FX?:
MBGRN;,20#CHFZ)N1N6-,1R;E#LY6W!K-6N"V@=@()]X6 +DJ^V,PXK0E@,PA
M."@'9''KD-(3RG'6O;\>LE+WGB]U_X8-+5F1-6D$]_*#^*Y&5>.3M;[B?V:Z
M<?WG7-<I4W_7C*I#%+L#H" ,I1=)Y=]RR74,85J?JT$2,RPY9\K93<PK4K@5
M;F[45JL'>OH!I2#8TQ#<2Z!T!$I)L-42-&J"K9Y@JZA-T03'EC_/EK>VY\BT
M.H(I!Q7"<&Q3F_H8M[/M5&4S)OQ<+>MIC(/]^3(;CL><L/K&.&CM%^48:0PW
M'9.^B!_5*X7''TO,L42^E#!.<0*1I 1B3! 4# DA Y&D,;JF9=)VI+G-O3HM
MK-UPV#7V>7EV][KIC_2YUQ_INO9(.^#-UA9.X!QYZCO6($G+"6I!1VR1= #&
M2#V2=N/<M$G2@;J7NB0=WF#''F51+?]!_CTO7F_*2GTH15-!/(A0+&(_@4SW
M5D-1$D&<!#%,4AK)."*(,R,/__CCY\83G7!6A=Q/('?^F[\>CY$_=%,HC#_L
M\QJ?^YK5G;TO6?UK]Q6?>.@DG^YYA;KO]<)50Q;Q>H)Z5Y8;P=]LM!_19/S7
M[2;JO[4U 93#T77>V59)608L]+A>L2?$UP5I?1_20+D 44BH%R<4<<S-5^Q7
M2#*W3W];^2.738M$D+=>OMXTZ_=.!-];76R6:M?8S&2M/9$EQEY8U_@V>H!&
MD6VMEEJ71>.>=65=:MMLVTMM-9K*,#8+YHD,--7J>&1#6:Z('8![?OE[S0 3
MKG4=X+"_L'7QP(%I[.R;X!L=YW&\\$U_>"U/4S%'B?K0_.Y+':VW78%)0D@:
M( ;CQ/,@XH0K/U8RF"0I#A%E 4NMZE&Z%6]ND^'^M[N5'_04L$R&=VM-L_7T
M[6PT]C39*J9]E3.US_:LN#AN1K5ZK_<_1EG#CV, 5TG[;H6;-K=_%& /2@",
M,\JP^>!-5K)57FZ*/7%LRZ7M*$2D"><DI#K5%T'DQ1+22(00!9'@'D\3*JSR
M?1W+-[<9H;\Y"CZ)4A1/BG!D7M1.H'V^B6MSFLT(-S32R%/"3K.7D\*PRIFC
MS@LCF<'1Q.!:NDEGAI&@?3DUC#7,X!#NHAZ)K!J>:EII[>?MO":KU>%R92EP
M&M$$^9"'J82(>02FH130#W6:(1(12ZS.Q*Z096Z<_Z;KEBFD%*S2Q$+T[%X7
MG-GMEAW=&ZO+,=<EF$O+&LS7&--L%IC(1",S?D^+[=%ET[_OY<'FUHYOMW;4
MVAW=FW$:<7TMRNXBJ@=+,G7$]+60'8F(OOJ15_4@?!$;T47;*C>;AKZ?ZD1Z
M1;M!'$.<A"DDDGA1$)(8$:OJ@V='FQNQ=B6]V"YD9% 'O!/8FK&@,\1&YKD.
MK)<!6>.UPSL/B=N6>"?&ND5;O/-JGVB-=^&F8=3QVYIG94-0@G>!#CJKXVY5
M&U'P.@V[RECV6+<(V54(J><ZP9<1H0&BE$-?!SBA4&*($1:::4B<1DRM_OT!
M>=372V;T94V?<;VG&!!=E ]YX4H\]G7KU11: -ZH9\=C#@QM1G83V6T:1MRW
MU38BJTV]VVK4UJ/HV>MSSUYO+MC+FCS=0>R(81T(-"D-NP/P)5<[?/(P0N]2
MM=5$0;-UO3_P2;#\ZUI7(WC'U8R1R;HB7)/I<L?^8Y,5@BMGM%?Y\:Y9>_9_
MTY5H#VD<1KIDH\")\B;C.K!5.9=$9Z"$'DI18N5-CBSOW/S1GHC="O]O=D0^
MMH'-6'Y&9AMY"N@T!3U5%V"G+.AKVR;[@4[?>L'?MWFK\F+OEV/T!9C(0(XF
MD+&EG71VF0CZEU//5,,./E1\S$NR^GN1;QZ;?PA^+U\]ZV7-A[S2V]Q-$KGZ
M]3:'O$V7(A["/E6S3,02G?P8ZE)-*8$Z(S(1'F9<^)8GB(.%F=N,TND":F46
MH%.G+C;T7*_E==&'"O25ZE6)L#Y,'&Y&XY/#28PS_C'A5789H1RJ"V3=G?P-
M%V7J8[ZK03MRIG?],Z\XP".E>".:_[Y;G^C^NO3\F 0L\& 2>Y'N*RV@(N$4
M,D&2B"+JR\"J1H;QR'-CV%T3Y*9^^VHW.0XX;S/"WN)TS36B4YRE:11_ZJ3^
M6;<)?=%H>M=GVO$IF0U:+L_$C,:=_@3,!HZCYUU6#[@V/%D'/>1K'>9P+[=U
MA=H"'J_$6LBL>A&]2I$B*1H1J)U$Q6$^A:GP QA2'GL^2_THL H]NT*6N;%:
M/[)UIXS^UZY>V+::S4^M2K9-GJ\PG1D%3F20D4EQF"TF"B@>#*SSZ&%[26X4
M*CP8LM-QP<,?.9!U!X>:-?%F:M2[-?^H7O,/ZL5_DS^0;+T,) U3'OJ0IX%R
M*7$D89KXH?(P4QJ36+#(KNS:&$+.C:>;&%$M*OB]D= P67I42QJR\XWM,W:\
MA(5I)NQC?QF[FW>K/R/BGZ0G_660W76>-QAK&,F_7I%2S2=M&-I]\4EWLO^P
MT=L,]W)W,JF#UG1'Z"Y<K;VP7"9^0,,DCB"N#P,]PB&A20 Q"EF8!CY*A5&*
MNR-YYD;=K]V&ZUYK+8\()$3$( DY58NA1$ 2)!BFC"#JXYC3Q%\^B8+F,[17
M7Z[_WUC,;):=T HC3ZBU)GK9T\JHR S40BY HT^=<;/K&-:HI+?3MPGOW1T.
MPZL=X>MHTKU6FDGG5T?0O9Q*73UV8$<9_3 A/E>DVC0%B"@/TS#$!&)&,40B
MI#"5DL$ >SCP(Q&FOE7GY(,1YC:SM0*"1D*K&DZG431CNZNP&9F_[&"Q[UER
M2G57S4H.GC]MEY)3ZAVT)SEYX76MT3^+XBECXKBC_B%?/XFR$HTW7G[)FSR/
M[=]U<]4/>?5OHMI%730U/'[-B_97^CI_*6*18LX\&(5(^6$L5;P1IAS&@OL^
MC0B5<3"DS_HTXL^-BGY3?\R+J@[%8OT$W+:P_0)\%YKU=3"6<B+)5P&:+H':
MERAVB@UKZ#[1*V-&C?-]$<;>/S^66[U;6-=-3QJENX(=6LLZ^N)95+U@OD5;
M6JE.M_]D\'(,;E,_K8T<][R?2/AIRX+>Q# 'M49O(\459P3TS(Y6NZ%%7VYH
MM1F0;0$K?6SQSY:C[QJ*_B3T[E:V_MK5:]Z0U1=1//C+! <A2JD/0XD11'',
M8)J&$4R]A!&/!6GJV9WH3J_#W&;05EXU&;8" [:3&"@)'A:@94\=SBQV&@-2
M=9.I6%LF)-WBY;$XM9CO*S'A7'JJH,G9>B:+71VL'A(+T&$!NO=MBP;HP0$T
M'HY/46YC2Y>'+!-K,/T9S&U,=/2(YD:B7!L<]:MZ?"7>9T^"OUM72N!L&^K_
M(K+&PVJ=B3&#A,:^6G\F 4RC2, (R4@R?4 OK>JP#)!A;E/@3MIMNZX/XG2Z
MNS-3V 8YC0+PA,%-C?RP5@ <@#Y10),UB,X#F<PEN%$ DS5$IP.7[!\UM.UC
MSH3@=3O*NG:>/BDOES@,4M\3"$:4*+)#$D'B10A*SU/KA9 GGET4^_%AYL9G
MG91-=]BLK1MX4$(J6VM7?RU8[>!]SZIOH/HF@&@7H>U5CTJJ;SHH^U&-8=L-
M\JA1S&CO>JA'9K9]E)N"C;6,+GL\GL/ 65O'HX-,W,GQG**'S1O/7CV001J'
MKOR2M[F174:E*/]>Y&6YC%D:QKX,(4DC#Z)8>C!-$P$#Y"'A$1;$,;;BD@L#
MSHY56GEUN0O22 SH5F1+9K@$MB%'.(1P;+;HH=<*"W;2+D MKT/F,$3&%8=<
M&FY:-C%4_H!73.\;&CF@GJ&X2V;5,A1)*%G"8!(0IAP3C"!F80!#@<+(0QY.
MDWA9Z:U=TYB![;.M>&,[PIC'XDHT\%C+9ALDL /,-#Q@$ RC!P9H!#Z>1V!
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M^_3[Y(,AG9SZ'Q(<V:<CQPN6[&5=WQPM95TK-+@AB^^B?+S[JZCFG# :LHS
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M#+FO6%7_H8N0MC8#8C.3\-4]=HPW$-KC\%YM/#36'U<XF(&.!P/-XOK#YXD
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M98+',4>1<"I_-X[94Z.[U@%@/ "?U*6]*H",U.EVW#F]KAR8?WOT8D]Y[+%
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ML1X];+2/])P;W8_S[#6W2?E\EK*)\:G6U1SG$0IE%L T);%:&G,):49#&.*
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M"H9U7)D?&4N^8M7\[4KQ7JD/)AINW/WBJ]X%F&.>!82$& H9JP4Y39B:M8H
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MGBE4^*RN;K)F; NPO]'5/V7#D_76)S\"O&UTW.AP,,PCDZ-##<H)V+H#6G]
MY]!V[1>.*X,@&X@Y;[-E4!X- MM+5@W3Z,WE4YIPHZ:JQ#0K<ER5G$,F&8$H
M,86J..*0J(*5@DB>9K1G%97]?L;&BV\/"J>TU4MZ)QR> ]?]LO%&R :X5=R%
M,#9&1JU+<@J'\.5)#GIYK2HEIUR]4*SDY,?[44*SPGN@/XT0T(+K/6^C*&=2
MD^[$_[>IFYO&J5(H*RN40,)M]5N60RJY@KE(TBK-"I5GE0]%./8[-LJP]OGQ
M@BO";CP1 ;?(O/%>J::R4[=CU,:#+T96Z-"%2:LXO^>%7CH]FJJNX>C%$[Y
M=./:ZZ#TXPG%2SKR??QUA,%^LT)5=PMA4BM-_-?#TOQJ[Y;QA?#ZETX4O).
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M3&$C@R<@*](,)CBGN"ISK"HO%?[K78YM*MO:"N;&V E8FX176\RE,=AOE^"
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M[\N5*=<YY4PF.4HYY(SIQ42>,4A816 ADT0BG!:R]-KE7>AK;+31F-I<Y$P
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ML.\2V/HT>7GC;?S23X'WKS)@/O=% P_<4/=) PV@YZU30+ OWTJ%Z&C 6ZN
MN!S>:H5L^):04GNL=]=N1$LN1)F0'/)4Z0U[*I@Y>4-05)*G!=5_F),WWTC2
M_2[&-K^U89#-,?-=GU#1 P =#]YO@B7VB?L!(A&*<)SW/F@<Z$$'KQ#^><K!
MTU&?)S_98T7<(\+ILURII2EV;P/5C>A!5B6%4@F!C',)$>4EI%0HF#$D65EP
M03V46D-8-#[&. CZ/([Y?-IYX%_%.,@8.BR+AQZ9R*1U0]SGGEO^Y9*##)?'
MHGCH81MH43S,\/DMB4-"?7%)'*2CX9;$(7$Y6!(';;AG(!C_+L7&)'!UQMSQ
M_]W,ZID5[WCSO/>W!Z/J-\4X3YBYX=)_"(B0XI!EN8!YB1CC2J72;\'L:\#8
M)L?.?G-DM'VI]UV8&%&@O5^ WZT?GI$OWN/DMBZ/B7[D"3 \\/[Q>SW1"Q7
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M$E4RK_K83KV.;<+?IB_S[@Z8:YOK"9AMS09S;;=O70*W(7"<VD,#&WMZWTL
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M?]Z=5&B2B?,XBV$LF(2((SU#K)1*!<$RH5$2*:LJ';<8,;698">L;1<1.S3
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M48Q0EF,"HR+-(:)Q#AF.,,PR(0N,B<J*J$'V[5*,C&O;8CA4=0O>(;4;Z#R
M%'B ._BFM8G@U;5OVGE4NP*"I]'L4BNCCF)77#T>O:Y=/FS4>M/DZ>LGUD5\
M/LC-+"I0S)2>^\9944#$F2974Z^XP"@1)%-9G,4N,0_G&IE:U$-K8S56T<K*
M2J[9[-L]T\6VGLO1Q6+UNSLQG$79CA5NQ2XP)>Q@,W1PW\#VH8;M;SO8[J_"
MYDP4?;AX8HFS38Q*$7U.'O-#[[4WDT,G'..7U4K\/E\L[I<G%<"._SY+J9GD
M*KUV%DCIR6]!(":D@#F+4,PS7)",#1!'N=DPJR]H? 653A6\FH(&T\S _G+F
MI(#POP"!'41WG90D#$)>MP'HG^D&VO-2M'@;?#T<>N.#!^Y,UGF69HIG#H"V
M>J'^>:4VOYL4_B8ELYPE41J3@@@H,Y9"E*$(8IPA&"&4DX@G6$KBM#UIT>C4
M=A<Z-M?184NZ@-M2@K*Q' CY+!>K[]7)[ #I*:N>L-S ](QOZ%W,#K2MO: U
M^ [L3/:XD^D D*_M3)LFQ]W3= #A9&/3Y5ZONYN/W^CF[ZOM0KQ_TJ_3YJU2
MDF_FSU)?8N*79JC@5*1,3_B4X:HD$U#_G4.4LJ0H&!:L<"KS/LR,J;'7Q;U1
ML-&.@-^-)V!>N:)_(X%L_:DN-D&P7O:EKG7>3=M6'KODI7:UZMZHG "U%V#G
M1G7AI[Z>\+7U90EDV)VQ:T9,8>/,$BC+?37;I]VF*/JX>E//4UJ^GK$BHTJB
M7,_I)(6($P1)035M2JHHB_3++)(;Y$1/&ISN2MC_I.XRZG94=QN((RN);E:@
ML7(W>_.O(GH1"<\2HJ?MO(A^Z$5W+XF'7K[AANH:1HI4BC?;]4[@N([TJW__
M;K5NA'C*62Z81$6N(!,<F>F7_LDL%9&BLI!91'+A%J3MU/S4IET[2=V5.A
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M^;6C]5#.J*(9I03!+(LR(Y/"(2."P#@E<5JP*&%9X5"-Q-D JW=[_((D^_*
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MG9X%!7JQ\*DH<+ZA\24%>AT^JRG0?\<PIG@S+[^O2KKX9;W:?J]8::[FO)I
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M@&G;[LAAF(YPG 9CNC[@$G=U^_A7_=-__T?[&_T_HS/UW__Q_P!02P,$%
M  @ S4"Z5FHSH5JDR@  \VD) !4   !D;V-S+3(P,C,P,S,Q7W!R92YX;6S<
MO5MW6SF2+OA^?D5.S>N@$_=+K^YSEM*7:J^3:7EL5]<Y\\(5  (VIRC20U).
MNW_]!#8IB;I3)+;V5O7%*<L2$9</@8A (.+?_L>/L]DOWW&YFB[F__X7\2_\
M+[_@/"WR=/[EW__RM\]OF?_+__CO_^V__=O_P=C_^NWC[[^\7J3S,YRO?WFU
M1%AC_N7/Z?KK+W_/N/K'+V6Y./OE[XOE/Z;?@;'_WOW2J\6WG\OIEZ_K7R27
MZN:_+O]59R&=BYH)#H%IIR3S3G)F5+8JZ52RT/_7EW_E25KON&884# -J?Y8
M*<PD (XZ@!&E^]#9=/Z/?ZU_1%CA+\3<?-7]]=__\G6]_O:OO_[ZYY]__LN/
MN)S]RV+YY5?)N?KUXJ?_LOWQ'[=^_D_5_;0((?S:_>OECZZF=_T@?:SX]7_]
M\?NG]!7/@$WGJS7,4UU@-?W75??-WQ<)UIW,'Z7KEWM_HOZ-7?P8J]]B0C(E
M_N7'*O_EO_^W7W[9B&.YF.%'++_4__[MX[MK2^;%C^G9=/WS7]+B[-?Z [^^
M6A </L"72F[WZ^N?W_#?_[*:GGV;77[OZQ++O_\E+]**5;URM5GT_[SZY5^O
MUO^VQ!5!IN/W=_K&]C/J:H?1@C_6.,^XX?%BE=DB7?NA697P8GGQFS.(..N^
M.\DXG72??!)7ZR6D]43JQ+66R)1#9#HFPX#;S'@B8*$S!%%]G?5*]HKH[A2R
MPO0O7Q;??Z4/)L5(6;^H<I&=3&XMMY'-871?[+]W\[)8GG4B_0QQAI,"-G@!
MB942--,A9A8]1OI#Y8S6<F'#42S<M_)U;G9U?;),ORR6&9=D6"Z6AF6ZI??K
MH-[^Q*_?8$D?Q-+7Z2Q?_':U,"UTN%XTENA&=43Z7WXA"11<+C'_OM'<O8QV
M7*[)]&+WDX>BXGS%O@!\FWPBH6-EY-4,5JO3\FF]2/\X^3%=3;++SLOD62CH
MR<:**AF?F,M!&"[!2FL>@$:!5>RHWJZTP0?.UJN+[UP!Y5%BAD-+&STO^A#Z
M"-"S2__KQ1E,YY.0HQ8ZTX&B'<FE6,\ K&#>%.,S?:FD:@R;VU0,@Y?&ZETT
ME?48T+(X.UO,.SY._L"SB,M)LMRXH,B',UDQ31N'0<F.F1PBCU*0/R=;H^46
M%<.BY5B]WH3)<4(>%TQ^VW(@9,Y9F\"2BG1*DW?/(CK:0:*X$I6U,93^8/+;
M$V B7QY,#A'R@#"YYU2F$ '?D=DE(RM$,3H!44_GL0ZHF<?$F>8R1 /":CC.
M+7]H]6% TMQ3:2KDD8#E,_WL! C$,D?#C,5"_GX,#*PK+!4AI#)>"IZ;@*.N
M-BJW]4#=W0&()PMR)  XF<_/8?81ORV6ZXG),O.2(QV%*C'BV+ 8M69&!1>5
MUC;+-E9B=]5168=V@#A8L",!Q@=<3A?YS3R_)L=](D-60(XZL]&0O02EF/?D
M."5 D#%F"]HU0<:U9?>"AGIQT#A<M -CX]7YL@KN[7258/:_$987/%AO@K72
M,*XJ#W1\,J^-9YQG"(K^!P4<E_6[9^6]$*)?#$*:"'@D!N3S$N:K:97+U@@6
M'K4U*C-32N7!$0\Q.N8!?=(^>Z<?2IX]P<VXL?)>(#$O!B1-!#PP2-[,U]/U
MS[?3&;X_[P(MP&ASRI9%"89I](9!1B37R04M,SCI\2APW%QQ+U#8%P.*HP0Z
M"C!\Q"_3>@$Q7[^',YQ$8:W-+C.HB-8N"!9\#=@H;*- GL)R*1H XOJJ>X'"
MO3!0'"'840#CW3PMEF3@.J%T>>17B_/Y>OGSU2+C!)4J4DC)LE">:5UE0T$8
MPQ A KG6@<<&.'F0B+U@XU\8;-J)?10H^@P_WF62U+1,-_4"6SN9$! M4+C.
M$X5FFL)U"L\R(Q?<1DBNYHD;X.>>Y?="3GAAR&DAZE%@YB1GTLAJ^Y\J'E&!
MKYVJM^&"DV@2  LV*L:-AH(0K1 /W>7MBY<[EMXO<\9?&%B.E?%(@2(G+EME
MZL$*A5<+&04#@< *DF<.0DDKCRLCN7?I_8#R<G*L;60\)J"\HB]/EY\7?\XG
MW'CDOF264Z@7D<(S[P)G)) ,*++(J<7Y<VOA_4#R<O*N+>0[)HAT'M?I\L-R
M\7TZ3SAQ4F51DF7%&,MT#(6%D,F+5R['H%5JXZ?<O?I^8'DYF=AFDAX38CXL
M5FN8_3_3;YV#7CRW'M"Q>NO$M'"!1>$<2W1\!EOJ/7C#X^?:VONAY>5D91M)
M>>CD?>5AB=#1;:661#%GMG3^. ?F19!D%0,7)J42\*'BD3T2]CNK[8>'EY.
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M8%P4W$!4NOTCKCM)&;;:[?FQ=( "QHBCW3/=))%CT85QDQS)ITX(4<;1']E
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M4RZJWC+.=Q$T$BP=H.G[0'.TV$> H1L\O%Z<P70^445Q*5*=*FP+TZ8(<A?
M$A,246CA??,9:W<2,A+,'*_HFR5"1TM]!-#9*<W] ^L5ZB0@>IU$9L)1\*^C
MH;A?HV><UZ&6-F,PK9\=WR)BX%+$XQ5[?]O> Z0\ IC<,T=ZRXP3PB2E K.Z
M]D5'[VD781W,ZP"U= :A^1RTAP@:N!ZQ.7S:27\,4'I\X/.6,9N,%"YE)@NG
M*-> (IXT9RD( Y)V4&E^@.U-W+ YXAX@UHM61@"WF_.;MUR8J.E_R7<4)DJF
M@R#[&X@I+;/U,FGM1>NH[&Y*ANTJU1Y(#>0] M1<>HV_$R]=HXZ)LT;X1/+
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M4^T%[020+FFCK>JAK_;>] UKCMKBYXZV6_WH::PFZL:-,6S'MK^JM=OS]>Y
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M9MH9K:W3[OK#CH'J"2P'"W@$X/C;"D_+F]5Z2L$,KB:@'$2%BH&O=I(KRP)
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M>LQDY>-\G"TSR<B@I(T<M.8%5! 2@M\66S$NLS;6NK/Y.JTRD[?7Y1D&I6-
MA*P4F8(L%KPQM2ZZ*!N*XRZTOI1W^_F=NFY'Z?_^A?DCY=R!G_8Z?)G3\C7_
M'\S7AWW7L?3M[9O/HBDI>6D@)V=!66^ W-% (;KUB:G .6OMAPVEK5,_JPFV
M1M%/Y[C+>;XM[YOQDAU'Y\DU5*INWP6B+ P,EB2\0:9MZWZ$0^CJU)\:'6]'
MZ:4#K'T(BX^URFW;J^+-YR]AOMKVD_T45A^Q>I]6N!Q];4A+WF=D"2*W"B0W
MY'^RF+B5C5'V.$6='M4VP5=#7?1:@[AKC//+7U]PL<8U^;MO-Y]P]?IRM=I&
M/3<5V"=X[@<_HXD+?QIGK7SY\*T>Y6Y;0%=ZPL7W*ENAD!$(-5CM"9D:"[A,
M_QB=5%:%8\;F]87[R6EPAE;%7;LNU6XBG^?K=2W OY+V+!>':"U",2A!N1@H
M?-9U6(!CKI2DA6^=K7R4H(D]_$:H>."8JY$..M@(?Z&E9?D-:2W;GMO=,MAK
MAJ3EY"E: S(Y!LK0]NY<,8#!<F5*#**T+N!ZDJB)W?N1@-56%U-7Y%SO##NF
MWF^6Z9]_7*[2I[#&ZDA<\Y0XDS$F!R8;\AP=DL'4N7;*,95K%S"&3^Y]ASQP
M8E>],79&$_74\'F'D8S@ 1M@S&O!F0>Y/1E.RH.7C%-HRS,KSF7+TB"\['O"
MQ+[V& !I(LP.=JL/X2]<[R1TS8+@-I!<-!05(ZV)NO;A3P*2T[$H'C+CK3,K
M#Y Q;;?EL7:D4^7= 62.Z+UWS2DF'6*0F>S"U1P4CT"KIX&4=/))16%,ZU.
MXZF==I;56  \D_8ZP.DV;-YMY \LU,(Y+:03(#PCJT-,$+AQP(J6207AM6]]
M4^QQBJ:=1C46WAIJH0-,[6?$2XW6U"[Z.GABQ*O:6%2!-J)HK!?V>>NE[30D
MN>>&I#:R[[4"X8%U>=VB_&#0]S8YN#R<@T:'E0\\N&*O'GZ_2O]].5]O,RK?
MNP2D>O?>(FA1:Z$BX28RRR"'D*)VR7-L785P&(7M+DM?/_?60]8_?;OUTU7!
M;I1DA-%2V)I#(JLL" &E >XSPX@4V]K6Q<Z'TCCQ?*GQ$+;_)O4(RNM@!WV
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MNS1,W/#TC$ Z2?H]H ?3I\7R8OGQVT]A_8"\KIA*(GDCO"8;<+2Z*QX@EL!
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MDJ4B<Y:.WN[%LAZ@?YAQ/)],X^0Z[@#?^\N>;I4Y*:TE&N($2^"TGSH&ON1
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M#!AF61M]U6XI=3GB+)I0HN;E6><C;J^X;\O=Y\U8+JD&SJ"<XJ"");] 8J'
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MD3BLSTS+[$+K6S1C\3)M'/I<;:0E0#IPCXZ7PW)73'"_V.#>\F%-+LX74WM
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M'H/%,"'_O_:^K+FM(UGS??Y+QM2^O$P$+<L>3ZAMA:SN&_.$J"5+PEP*T 5
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M#53= :H?D?96N-\)?9)$YED4A*!5KM.>(GB1$@A76"K)6MF\ '5/$L>]9^@
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M!&]D >$D'3O%Y7+_[N+<^O$& 4Q3N7;@F;8/85OB-3.*)]20#"-(AR+K0*H
M*0KT/!F59.L2P#L$C'OO/JB'.5S0':#DR#CAV]M%R$8Y5 6"3R1&F2E)Q"P
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M\S-]V@S7ZR<7TWA5]5-%O)7ZHA:7+K#^-"R^WOZE[9UAS"0/DT6=Y.) Q1#
M*1,@,Z958-*3$VXLC^,H'C?%:XBN^X[KA(KL]0[O3_RP7??[*\X_+,+GC]/4
MILMFQT]NXO .X:*1\]M^]3O\/%^LYV5? Y,[5YPJ'EQF!A3S&8)>MW_:Z+3V
M0HK69OX8+<<ZO-^OZARR/\K-9?;VBY:3+'W.(F;(F(A)KNH<7N.(-&=Q_>*;
M6[?3/$K,N&ZJ"0[N.Z@V@N\@[[MF9".>VB5_PXDF'^V\C, C)R_J@X)@E  6
M S*/64C>NK3C<6K&O8(:%$-'BG[X VS[%_5?,2SQ?_V/_P902P,$%     @
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M3($SV5O+TM;&++U"8 H!KR-NT<-(D$F""DI9  .=2P,R UDH&"HYM=!BD*7
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M',*S<=/AJD??XH-61KH:Z\R;J$D"HC4L)EZF\LP;)6D^]O*Q\J9)I(.YEXQ
M8-[JB<[G0&-QT/?@:D_#I5DQS'2H_53#FK9@U9$*<GVC(K@0;_#7O[S>V]M]
M:[9T';+B-)E,_7C^-$MHWV7:A<';;2]5UWZ*%.+EJ4]_ZICV21:)%PY>O85]
M54&1@JJ#-?B9!UHI2/40U-101<F,=A]_%>HLB)*L2!4>D8[AX"8^ZD<O2.)
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M;G#+1RIF]^JB@",8[ X/=P82!\.+SV3WO1-<LCG&&<H_>10*)'H<T$Q6^.C
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M#HY6I4YRF$B?2M5^J(+(3TO'BO%E&9!!SGYU66A.[)VK$L7HV_QYYUYA]_7
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MIY9U+C]?CR.,*+Z*>Z.K;8K1."^HP_"*X@X[AJZ*7]TL<+!4#*X3&FQ8::B
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M@5R+,.$VAX0#D&$B],B:6[,QJ-'2H[UF0D>)U#GZ6=)4,O$@R92,.,-M37:
M"<8!,I_XWETTHNF0DP[XZ#I/8.&$Y-X.WW5=G9"T5_Y26'68>G#:\8DEK27,
M>@Q97S:>*%Z9*,9$-LZ'2(:%K>;?H98.&EL$3KH]X RJ]0/['$ZYQ@8 V7+5
M[-M0*MM"&]%<;][%5KR0 Q;%3+Z&REQA /#21&C'=K#BJ1O'"N0%3RYSK>()
M=3@KBN@"*^6"AVVC &?"%RT3P=QY@<Y#+9B@2M@ A"_UCOU3.U*N;?EURU*[
M6NVX46H.APRXV';**  >Y0FUE(ZPG!.+,HX>7A0L:QE\"[DU!.NB/V>.9=\
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MS^[:.4N(<GOO/.NVV'ILLF]-R PKOI+W3?[C"&QW+4_C]+E@[U]02P,$%
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M+3(P,C,P,S,Q+FAT;5!+ 0(4 Q0    ( ,U NE;Z&JCU+!8  *'Z   1
M          "  ;K1 P!D;V-S+3(P,C,P,S,Q+GAS9%!+ 0(4 Q0    ( ,U
MNE;:A)RTE"X  +KD 0 5              "  17H P!D;V-S+3(P,C,P,S,Q
M7V-A;"YX;6Q02P$"% ,4    " #-0+I6 U?Y@FAV   02P4 %0
M    @ '<%@0 9&]C<RTR,#(S,#,S,5]D968N>&UL4$L! A0#%     @ S4"Z
M5O+DU\G33@$ \*@! !0              ( !=XT$ &1O8W,M,C R,S S,S%?
M9S$N:G!G4$L! A0#%     @ S4"Z5GK^5;KH4 $ I!\. !4
M ( !?-P% &1O8W,M,C R,S S,S%?;&%B+GAM;%!+ 0(4 Q0    ( ,U NE9J
M,Z%:I,H  /-I"0 5              "  9<M!P!D;V-S+3(P,C,P,S,Q7W!R
M92YX;6Q02P$"% ,4    " #-0+I60YGMR 8(   &,@  '@
M@ %N^ < 97@M,3 W>&-R86EG;W9E<G!E8VMO9F9E<FPN:'1M4$L! A0#%
M  @ S4"Z5GH02EU[,@  ^3D! !X              ( !L  ( &5X:&EB:70Q
M.3$M:6YS:61E<G1R861I;F=P+FAT;5!+ 0(4 Q0    ( ,U NE:B2L8R[P(
M -$+   >              "  6<S" !E>&AI8FET,C$Q+6QI<W1O9G-U8G-I
M9&EA<BYH=&U02P$"% ,4    " #-0+I6^W^6>RT#  #H"   &@
M    @ &2-@@ 97AH:6)I=#(S,2UC;VYS96YT9GDR,RYH=&U02P$"% ,4
M" #-0+I68W*_T5X(   G*@  $P              @ 'W.0@ 97AH:6)I=#,Q
M,3,S,3(S+FAT;5!+ 0(4 Q0    ( ,U NE9'MF]U7P@  $ J   3
M      "  89"" !E>&AI8FET,S$R,S,Q,C,N:'1M4$L! A0#%     @ S4"Z
M5I$8A5SA!   <A0  !,              ( !%DL( &5X:&EB:70S,C$S,S$R
M,RYH=&U02P$"% ,4    " #-0+I6JO$Y?.H$  "+%   $P
M@ $H4 @ 97AH:6)I=#,R,C,S,3(S+FAT;5!+!08     #P / /P#  !#50@
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
